data_1bc4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bc4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 109.061 -0.718 . . . . 12.0 109.061 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -37.43 74.48 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 122.022 -0.424 . . . . 12.0 110.586 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.98 6.49 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.351 -0.843 . . . . 12.0 110.676 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -62.52 -32.3 73.21 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.211 -1.033 . . . . 12.0 108.211 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 61.4 t80 -72.59 -25.83 61.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.157 -1.053 . . . . 12.0 108.157 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.92 -33.69 62.39 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 1.5 mt-30 -80.39 -37.95 31.28 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.21 -1.404 . . . . 12.0 107.21 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -44.52 -57.33 3.66 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.983 -0.448 . . . . 12.0 111.079 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 4.4 m80 -99.58 -31.04 11.8 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.595 -0.691 . . . . 12.0 111.697 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.93 65.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.668 1.729 . . . . 12.0 115.668 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 8' ' ' GLN . 3.4 mp -95.29 62.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 103.588 -2.745 . . . . 12.0 103.588 173.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -74.21 81.06 1.8 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.709 0.766 . . . . 12.0 110.409 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.6 p -118.5 106.87 43.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.233 -1.025 . . . . 12.0 108.233 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -81.51 37.16 0.66 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 121.921 1.747 . . . . 12.0 111.795 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.13 164.64 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.694 -0.854 . . . . 12.0 108.694 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.5 pt -97.29 33.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-O 121.345 0.593 . . . . 12.0 109.855 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.24 91.36 3.36 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.29 -1.004 . . . . 12.0 108.29 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -76.28 -15.94 59.89 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.904 -0.498 . . . . 12.0 111.287 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -82.99 -50.41 8.58 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 119.019 0.827 . . . . 12.0 109.912 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.27 70.13 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 110.028 -0.36 . . . . 12.0 110.028 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.98 -39.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 120.625 -0.43 . . . . 12.0 109.955 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.52 12.82 23.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.878 -0.514 . . . . 12.0 110.344 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -60.35 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.295 -1.002 . . . . 12.0 108.295 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -172.31 155.54 3.57 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.415 -0.587 . . . . 12.0 109.415 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -71.94 -10.23 59.48 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.922 -0.399 . . . . 12.0 109.922 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.0 mt -85.78 8.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.691 -0.63 . . . . 12.0 110.644 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -135.96 57.19 1.79 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.536 -0.727 . . . . 12.0 110.025 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mt -151.47 145.87 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.959 -1.088 . . . . 12.0 109.889 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.73 -168.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 108.13 -1.063 . . . . 12.0 108.13 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.46 71.38 0.71 Allowed Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.201 -0.937 . . . . 12.0 111.411 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.72 -63.44 0.03 OUTLIER Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.227 -1.549 . . . . 12.0 109.227 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -165.22 -65.44 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.035 -1.098 . . . . 12.0 108.035 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.0 p -141.67 167.75 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 12.0 108.711 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -77.46 149.67 35.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.928 -0.482 . . . . 12.0 109.716 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -77.08 -23.85 51.89 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 110.104 -0.332 . . . . 12.0 110.104 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.3 t -150.28 103.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 120.29 -0.564 . . . . 12.0 110.293 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.453 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 2.7 m-20 -92.59 76.48 5.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.441 -1.688 . . . . 12.0 106.441 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.8 m -79.23 116.49 19.52 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.928 -0.578 . . . . 12.0 110.686 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -107.01 163.59 12.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.087 -1.079 . . . . 12.0 108.087 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 10' ' ' HIS . 16.1 mm -126.71 124.57 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.907 -1.146 . . . . 12.0 107.907 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.3 pt -96.51 98.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.2 t -176.29 157.9 1.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.232 -0.655 . . . . 12.0 109.232 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 p -63.88 128.17 34.64 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 109.244 -0.65 . . . . 12.0 109.244 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.45 -25.06 22.81 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.89 -0.506 . . . . 12.0 110.623 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -76.71 -33.91 58.18 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.523 -0.471 . . . . 12.0 111.231 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -65.19 -39.88 93.47 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.091 -1.448 . . . . 12.0 107.091 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.85 -31.86 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.824 -1.176 . . . . 12.0 107.824 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -67.38 -23.15 65.55 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.734 -0.469 . . . . 12.0 109.734 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -40.23 30.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.908 -0.495 . . . . 12.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.41 -20.67 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.784 -0.572 . . . . 12.0 110.681 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.43 25.09 9.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.831 -0.543 . . . . 12.0 109.829 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -96.33 114.31 25.98 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.767 -0.583 . . . . 12.0 109.577 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.49 -62.68 0.01 OUTLIER Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.099 -1.2 . . . . 12.0 110.099 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 p -152.76 -169.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.517 -0.92 . . . . 12.0 108.517 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 18.3 tt -88.62 26.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 O-C-N 120.915 -1.116 . . . . 12.0 110.796 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 4.4 t30 171.47 110.5 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 107.195 -1.409 . . . . 12.0 107.195 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -172.54 3.31 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.384 0.612 . . . . 12.0 110.684 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.98 114.55 8.02 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.094 -1.076 . . . . 12.0 108.094 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 t -125.27 169.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.501 -0.925 . . . . 12.0 108.501 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.78 120.63 10.59 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.765 -0.774 . . . . 12.0 112.1 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 97.27 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.557 -1.275 . . . . 12.0 107.557 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -40.29 24.97 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.693 -0.484 . . . . 12.0 109.693 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.663 -0.495 . . . . 12.0 109.663 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 177.87 103.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.601 -0.687 . . . . 12.0 110.21 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -98.25 44.51 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.183 -0.607 . . . . 12.0 109.48 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 18.17 107.39 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 114.287 1.217 . . . . 12.0 114.287 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -102.4 153.99 19.51 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.03 0.919 . . . . 12.0 112.274 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -117.8 94.79 4.65 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.718 -1.956 . . . . 12.0 105.718 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 m -100.91 126.81 47.56 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.725 0.774 . . . . 12.0 112.786 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.6 m -106.76 104.76 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 104.589 -2.374 . . . . 12.0 104.589 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 m -101.21 131.36 47.24 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.211 -0.596 . . . . 12.0 111.727 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -63.05 105.82 0.75 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.107 -1.072 . . . . 12.0 108.107 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.501 2.097 0 O-C-N 122.03 -0.419 . . . . 12.0 110.81 -178.492 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 118.519 -0.753 . . . . 12.0 109.344 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.57 145.7 26.51 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.473 1.449 . . . . 12.0 110.279 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.0 m-85 -131.7 134.79 46.29 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.313 0.577 . . . . 12.0 110.512 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -105.84 109.78 21.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.097 -1.075 . . . . 12.0 108.097 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -83.57 133.93 34.84 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.178 0.513 . . . . 12.0 110.261 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -148.72 125.83 11.4 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -105.68 146.39 29.81 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.384 -0.599 . . . . 12.0 109.384 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -172.24 -172.12 0.91 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 120.746 -0.382 . . . . 12.0 110.134 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 m -57.0 139.41 52.23 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.554 -0.536 . . . . 12.0 109.554 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.424 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 4.4 t-20 -112.84 88.01 2.73 Favored 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 119.482 -0.887 . . . . 12.0 112.064 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -95.78 96.23 8.83 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 104.399 -2.445 . . . . 12.0 104.399 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.413 ' CD1' ' CZ ' ' A' ' 104' ' ' PHE . 21.0 tt -130.28 163.68 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 119.854 -0.738 . . . . 12.0 111.708 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.68 114.14 28.12 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.008 -0.542 . . . . 12.0 110.191 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 11.1 p -104.57 161.58 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.281 -0.637 . . . . 12.0 109.281 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 12.7 ttmt -118.31 144.5 45.79 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.885 -0.783 . . . . 12.0 108.885 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.01 124.77 47.78 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.611 0.967 . . . . 12.0 113.611 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.509 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 27.9 tt0 -129.9 144.02 51.1 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 104.44 -2.43 . . . . 12.0 104.44 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.93 15.91 2.53 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.129 -0.982 . . . . 12.0 108.72 -175.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 78.29 -15.36 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 123.581 0.752 . . . . 12.0 112.606 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -98.28 148.66 34.82 Favored Pre-proline 0 N--CA 1.503 2.19 0 N-CA-C 106.497 -1.668 . . . . 12.0 106.497 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.482 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 23.5 Cg_endo -63.23 91.25 0.14 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 N-CA-C 107.955 -1.594 . . . . 12.0 107.955 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.453 HG23 ' CE2' ' A' ' 100' ' ' TYR . 69.4 t -87.61 -11.07 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-N 116.185 -0.461 . . . . 12.0 111.115 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -151.94 148.28 27.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.564 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -99.69 122.41 42.66 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.485 -1.286 . . . . 12.0 108.923 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.17 67.58 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.995 -0.44 . . . . 12.0 109.954 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.55 -149.08 18.59 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.863 -1.295 . . . . 12.0 109.863 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.9 pt -56.43 178.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.203 0.525 . . . . 12.0 110.757 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.824 0 N-CA-C 111.138 -0.785 . . . . 12.0 111.138 -179.15 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 108.568 -0.901 . . . . 12.0 108.568 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -25.03 64.1 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.905 -0.497 . . . . 12.0 110.313 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.38 -63.24 1.33 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.647 -0.658 . . . . 12.0 110.676 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -61.57 -31.58 71.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.935 -1.135 . . . . 12.0 107.935 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.456 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 31.3 t80 -76.08 -25.36 55.42 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.469 -0.937 . . . . 12.0 108.469 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -54.42 -32.69 57.87 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.339 -1.356 . . . . 12.0 107.339 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.44 -37.91 35.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.791 -1.189 . . . . 12.0 107.791 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 15.8 tppt? -47.15 -49.13 22.97 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 122.155 -0.341 . . . . 12.0 110.385 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.456 ' NE2' ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -101.28 -13.13 18.18 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 118.681 -0.676 . . . . 12.0 112.596 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.412 HD13 ' N ' ' A' ' 11' ' ' ILE . 3.7 mp -137.81 72.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 115.354 1.613 . . . . 12.0 115.354 -175.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.423 HD11 ' CD1' ' A' ' 40' ' ' PHE . 11.3 mt -97.65 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 103.737 -2.69 . . . . 12.0 103.737 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.25 80.79 0.24 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.843 0.83 . . . . 12.0 110.512 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 p -150.6 59.79 3.73 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.411 -1.329 . . . . 12.0 107.411 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -73.12 84.77 1.29 Allowed 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 121.94 1.76 . . . . 12.0 110.711 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 16' ' ' ILE . 14.5 pt -124.94 -169.17 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.88 34.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.656 -0.652 . . . . 12.0 109.436 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -150.04 98.4 2.7 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.902 -0.499 . . . . 12.0 109.997 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -81.36 -4.47 55.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.853 -0.529 . . . . 12.0 110.734 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -84.47 -58.11 2.87 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.523 -0.736 . . . . 12.0 111.242 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -26.04 64.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.786 -0.571 . . . . 12.0 110.097 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.3 pt -85.61 -32.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.853 -0.529 . . . . 12.0 109.597 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ttp -100.98 20.28 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.947 -0.39 . . . . 12.0 109.947 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -74.15 86.53 1.89 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -163.96 147.46 9.82 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.779 -0.576 . . . . 12.0 109.574 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -70.9 -8.17 50.98 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.943 -0.391 . . . . 12.0 109.943 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -85.95 7.84 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.601 -0.687 . . . . 12.0 110.026 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -136.04 60.62 1.67 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.581 -0.699 . . . . 12.0 109.371 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mt -146.49 152.57 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 120.768 -1.208 . . . . 12.0 110.936 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.34 169.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.687 -1.227 . . . . 12.0 107.687 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.82 55.6 3.37 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.74 -57.14 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.41 -1.476 . . . . 12.0 109.41 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.31 -71.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.956 -0.732 . . . . 12.0 109.526 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 p -153.68 132.24 12.17 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.697 -0.853 . . . . 12.0 108.697 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.18 171.27 0.28 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 109.82 -0.437 . . . . 12.0 109.82 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.97 -6.33 59.04 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 119.438 -0.315 . . . . 12.0 111.326 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 p -164.72 114.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 C-N-CA 119.545 -0.862 . . . . 12.0 111.691 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.482 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 59.1 m-20 -95.37 82.55 3.71 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 12.0 105.832 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -83.48 116.21 22.43 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.58 0.705 . . . . 12.0 111.862 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 12' ' ' ILE . 18.5 m-85 -104.49 162.46 13.22 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.359 -1.348 . . . . 12.0 107.359 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.89 125.99 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.518 1.054 . . . . 12.0 110.219 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.425 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 6.3 mt -90.85 108.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 108.03 -1.1 . . . . 12.0 108.03 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.6 t 177.71 151.12 0.22 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.684 -0.406 . . . . 12.0 109.971 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -67.02 129.6 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.112 -1.07 . . . . 12.0 108.112 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -26.49 5.73 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.042 -0.411 . . . . 12.0 111.295 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.91 -33.24 30.53 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.916 -0.49 . . . . 12.0 111.829 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -62.59 -37.73 87.37 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.083 -1.451 . . . . 12.0 107.083 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.455 ' CG1' ' CD2' ' A' ' 10' ' ' HIS . 46.8 t -67.39 -34.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -59.38 -23.61 62.73 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.67 -38.66 25.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.968 -0.458 . . . . 12.0 109.77 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -65.93 -19.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.809 -0.557 . . . . 12.0 110.761 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 23.04 15.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.754 -0.591 . . . . 12.0 110.448 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 m -86.2 112.43 21.34 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.55 -65.66 0.01 OUTLIER Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.249 -1.14 . . . . 12.0 110.249 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -160.54 -164.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.407 -0.96 . . . . 12.0 108.407 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 18.1 tt -90.3 28.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.124 -0.985 . . . . 12.0 110.968 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 15.6 t-20 172.1 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.89 177.77 8.31 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.795 0.807 . . . . 12.0 111.742 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -133.37 112.46 11.62 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.064 -1.458 . . . . 12.0 107.064 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.82 168.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.902 -0.499 . . . . 12.0 109.731 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.47 128.52 35.61 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.479 -0.488 . . . . 12.0 110.955 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -62.18 95.81 0.07 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.762 -1.57 . . . . 12.0 106.762 177.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -84.71 -46.66 11.23 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.989 -0.444 . . . . 12.0 110.896 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.4 m -52.16 -94.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.972 -0.455 . . . . 12.0 109.786 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.66 101.9 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.098 -0.704 . . . . 12.0 109.098 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 76.3 m-85 -96.87 44.42 1.06 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 120.483 -0.487 . . . . 12.0 109.818 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 19.48 106.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.106 1.15 . . . . 12.0 114.106 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.28 153.65 18.79 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.093 0.949 . . . . 12.0 112.562 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.425 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 4.2 t-20 -115.1 101.27 8.83 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 104.657 -2.349 . . . . 12.0 104.657 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -106.79 121.8 45.1 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.456 0.909 . . . . 12.0 113.456 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.01 104.64 16.69 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 102.677 -3.083 . . . . 12.0 102.677 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -100.53 140.13 35.23 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.469 0.652 . . . . 12.0 112.333 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.4 ttt180 -60.42 133.69 56.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.905 -0.776 . . . . 12.0 108.905 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.499 2.015 0 N-CA-C 109.512 -0.551 . . . . 12.0 109.512 -179.751 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 109.291 -0.633 . . . . 12.0 109.291 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 35.3 Cg_endo -76.11 128.01 10.33 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.562 1.508 . . . . 12.0 110.797 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.482 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.4 m-85 -148.02 137.26 22.16 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.964 0.411 . . . . 12.0 110.147 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 t -124.45 129.52 50.81 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.329 -0.989 . . . . 12.0 108.329 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -80.49 136.92 36.4 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.151 0.501 . . . . 12.0 110.956 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 121.37 7.81 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.99 -0.744 . . . . 12.0 108.99 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.9 p -98.55 147.16 25.07 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.468 -0.567 . . . . 12.0 109.468 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -168.3 -173.27 1.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.018 0.437 . . . . 12.0 110.054 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.7 m -66.43 142.49 57.56 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 109.461 -0.57 . . . . 12.0 109.461 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -105.73 87.16 2.53 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.88 0.847 . . . . 12.0 111.252 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 6.2 p90 -109.34 106.46 16.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 105.985 -1.857 . . . . 12.0 105.985 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.421 HD13 ' CZ ' ' A' ' 104' ' ' PHE . 19.9 pt -139.18 -171.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.85 -0.74 . . . . 12.0 111.976 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 39.0 t -119.99 114.63 22.31 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.083 -0.71 . . . . 12.0 109.083 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.464 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 8.6 p -113.75 171.35 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 14.3 mttt -130.88 146.03 52.18 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.922 -0.77 . . . . 12.0 108.922 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.4 m -118.18 125.13 49.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.217 1.192 . . . . 12.0 114.217 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 30.0 tt0 -131.62 144.69 51.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 103.818 -2.66 . . . . 12.0 103.818 174.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 27.8 m-80 53.63 29.38 9.22 Favored 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 107.699 -1.222 . . . . 12.0 107.699 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 52.69 9.58 0.12 Allowed 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 125.289 1.436 . . . . 12.0 114.835 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -114.39 145.98 34.89 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 104.532 -2.395 . . . . 12.0 104.532 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.476 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.3 Cg_endo -60.79 90.08 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.275 1.316 . . . . 12.0 108.69 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 69.7 t -86.84 -23.24 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 116.271 -0.422 . . . . 12.0 110.851 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.457 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.62 145.89 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.94 -1.133 . . . . 12.0 107.94 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.464 ' CE1' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -116.47 128.51 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.15 -1.02 . . . . 12.0 109.92 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.99 -37.9 38.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.23 -0.294 . . . . 12.0 110.777 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.08 -134.68 6.88 Favored Glycine 0 N--CA 1.504 3.177 0 C-N-CA 120.066 -1.064 . . . . 12.0 111.493 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 pt -69.15 -171.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.083 0.468 . . . . 12.0 111.129 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.799 0 N-CA-C 110.391 -1.084 . . . . 12.0 110.391 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 10.7 t-20 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 108.817 -0.809 . . . . 12.0 108.817 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.425 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.51 -22.85 61.73 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 121.952 -0.468 . . . . 12.0 110.527 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.64 0.85 Allowed 'General case' 0 N--CA 1.515 2.815 0 O-C-N 121.637 -0.665 . . . . 12.0 110.853 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 m -60.9 -31.54 71.03 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.061 -1.088 . . . . 12.0 108.061 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 26.3 t80 -75.91 -26.14 56.7 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.461 -0.94 . . . . 12.0 108.461 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -51.79 -35.69 44.98 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 107.567 -1.271 . . . . 12.0 107.567 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -77.29 -40.95 42.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -45.87 -51.76 12.53 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.161 -0.337 . . . . 12.0 111.627 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.5 ' NE2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 m170 -94.89 -14.71 24.26 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.552 -0.718 . . . . 12.0 111.363 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.414 ' HA ' HD11 ' A' ' 11' ' ' ILE . 36.5 mm -130.86 73.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 N-CA-C 114.46 1.282 . . . . 12.0 114.46 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.418 HG22 ' CD1' ' A' ' 40' ' ' PHE . 3.0 mp -97.43 61.15 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 103.667 -2.716 . . . . 12.0 103.667 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.98 81.49 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.739 0.78 . . . . 12.0 110.199 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 p -131.79 76.11 74.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.672 -0.862 . . . . 12.0 108.672 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.85 82.0 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.994 1.796 . . . . 12.0 109.223 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -141.69 168.91 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 pt -93.71 41.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 121.437 0.636 . . . . 12.0 109.758 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -149.49 104.81 3.4 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.7 -0.852 . . . . 12.0 108.7 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -81.12 -16.89 51.76 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 120.551 -0.46 . . . . 12.0 111.558 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -84.39 -55.24 4.26 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 118.892 0.769 . . . . 12.0 110.417 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.09 -30.68 64.54 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.264 -0.272 . . . . 12.0 110.443 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 23' ' ' MET . 44.0 pt -80.76 -39.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.268 -0.573 . . . . 12.0 110.171 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.414 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -95.86 17.1 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.496 -0.482 . . . . 12.0 110.246 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -62.49 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.616 -0.883 . . . . 12.0 108.616 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.61 150.15 4.86 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.354 -0.61 . . . . 12.0 109.354 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -69.65 -9.42 54.16 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.878 -0.329 . . . . 12.0 110.342 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -87.06 8.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 12.0 110.307 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -137.27 58.2 1.72 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.6 -0.687 . . . . 12.0 109.73 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -151.31 152.19 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 12.0 110.579 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.26 168.93 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 107.475 -1.306 . . . . 12.0 107.475 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.35 54.77 3.54 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.219 -1.552 . . . . 12.0 109.219 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.88 -57.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.146 -1.582 . . . . 12.0 109.146 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.24 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.022 -0.693 . . . . 12.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 99.0 m -144.05 150.1 37.67 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 176.97 6.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.014 -0.736 . . . . 12.0 109.014 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -17.07 52.37 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.969 -0.457 . . . . 12.0 110.038 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -162.04 117.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 C-N-CA 119.825 -0.75 . . . . 12.0 111.337 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 5.3 m-20 -97.46 83.77 3.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.701 -1.963 . . . . 12.0 105.701 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -80.84 116.4 20.81 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.909 -0.587 . . . . 12.0 111.481 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.418 ' CD1' HG22 ' A' ' 12' ' ' ILE . 21.7 m-85 -100.5 158.96 15.53 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.531 -1.285 . . . . 12.0 107.531 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 41' ' ' ILE . 50.5 mm -129.18 124.23 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.357 -0.84 . . . . 12.0 110.346 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.42 111.44 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 108.324 -0.991 . . . . 12.0 108.324 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 t 178.33 151.23 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 12.0 109.112 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.49 119.41 5.19 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 109.134 -0.691 . . . . 12.0 109.134 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.98 -64.54 0.61 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 113.555 0.946 . . . . 12.0 113.555 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.5 t -62.13 -20.73 64.38 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.912 -0.493 . . . . 12.0 111.552 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.6 m -65.25 -36.07 82.98 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 107.169 -1.419 . . . . 12.0 107.169 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 ' CG1' ' CE1' ' A' ' 10' ' ' HIS . 19.3 t -71.24 -34.39 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -21.51 65.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.663 -0.866 . . . . 12.0 108.663 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.45 -39.05 28.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.885 -0.51 . . . . 12.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 tp -64.32 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 12.0 109.773 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.91 25.57 10.3 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.69 -0.632 . . . . 12.0 110.35 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 m -90.83 115.93 28.28 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.252 -0.647 . . . . 12.0 109.252 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.98 -62.95 0.02 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.573 -1.011 . . . . 12.0 110.573 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 p -161.12 -164.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.581 -0.896 . . . . 12.0 108.581 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 9.9 tt -88.64 27.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 121.053 -1.029 . . . . 12.0 110.665 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.6 t30 172.44 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 106.961 -1.496 . . . . 12.0 106.961 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.87 178.37 9.83 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.921 0.867 . . . . 12.0 111.841 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.66 112.25 7.83 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.923 -1.51 . . . . 12.0 106.923 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.25 167.92 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.325 -0.621 . . . . 12.0 109.325 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.7 mp -136.67 130.32 31.99 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.581 -0.448 . . . . 12.0 111.023 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.12 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 106.544 -1.651 . . . . 12.0 106.544 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 91' ' ' TYR . 3.1 p -80.61 -43.1 21.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.325 -0.234 . . . . 12.0 110.512 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.34 -90.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 109.349 -0.612 . . . . 12.0 109.349 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.7 ptt-85 171.48 101.06 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.211 -0.663 . . . . 12.0 109.211 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -97.25 48.38 1.04 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 120.462 -0.495 . . . . 12.0 109.703 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 16.57 107.92 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.525 1.305 . . . . 12.0 114.525 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -104.06 155.59 18.56 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.066 0.936 . . . . 12.0 112.474 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -116.87 97.42 5.95 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 105.25 -2.13 . . . . 12.0 105.25 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 m -104.18 128.29 51.87 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.5 0.926 . . . . 12.0 113.5 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.2 m -111.01 108.18 17.83 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.44 -2.8 . . . . 12.0 103.44 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -109.55 145.86 35.63 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 120.17 -0.612 . . . . 12.0 112.311 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.7 ttp85 -64.27 116.0 5.59 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.937 -0.764 . . . . 12.0 108.937 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.503 2.212 0 O-C-N 121.934 -0.479 . . . . 12.0 110.742 -179.285 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 108.259 -1.015 . . . . 12.0 108.259 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.427 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 36.6 Cg_endo -76.12 101.71 1.52 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.68 1.587 . . . . 12.0 109.65 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.441 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 18.9 m-85 -139.75 138.33 35.82 Favored 'General case' 0 N--CA 1.509 2.489 0 CA-C-O 121.354 0.597 . . . . 12.0 111.198 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -114.79 121.76 44.29 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 p -84.32 143.99 29.15 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 120.991 0.424 . . . . 12.0 110.395 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -154.66 159.49 40.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.276 -0.638 . . . . 12.0 109.276 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.6 m -130.45 142.14 50.5 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.062 -0.718 . . . . 12.0 109.062 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.94 -169.46 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.309 0.575 . . . . 12.0 110.521 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 98.3 m -64.54 146.47 54.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.082 -0.71 . . . . 12.0 109.082 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -108.67 88.78 2.81 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.989 0.899 . . . . 12.0 111.383 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 63' ' ' THR . 2.3 t80 -98.43 103.95 15.94 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.84 -2.281 . . . . 12.0 104.84 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.444 HG23 ' CE1' ' A' ' 104' ' ' PHE . 33.0 mm -127.75 163.38 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 119.685 -0.806 . . . . 12.0 111.99 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 51.6 t -115.91 106.44 13.8 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.439 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 5.5 p -113.85 172.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.953 -0.388 . . . . 12.0 109.953 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 65.0 mttt -126.65 143.18 51.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -111.0 115.68 29.89 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.265 1.209 . . . . 12.0 114.265 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.7 tt0 -125.77 142.72 51.37 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 104.055 -2.572 . . . . 12.0 104.055 174.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 60.3 m-80 54.84 29.55 12.16 Favored 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 14.5 pt20 52.1 11.11 0.14 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 114.651 1.352 . . . . 12.0 114.651 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -118.12 146.99 40.53 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 174.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.49 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 24.3 Cg_endo -60.54 89.89 0.08 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 121.262 1.308 . . . . 12.0 108.819 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 47.2 t -86.22 -19.63 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 116.345 -0.388 . . . . 12.0 110.887 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.482 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -140.77 144.57 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.657 -0.868 . . . . 12.0 108.657 -177.146 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.5 ' CZ ' ' NE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -109.07 132.11 54.43 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.068 -1.053 . . . . 12.0 108.366 178.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.12 -24.19 14.66 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.092 -0.38 . . . . 12.0 111.992 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.45 178.32 47.75 Favored Glycine 0 N--CA 1.503 3.143 0 N-CA-C 110.577 -1.009 . . . . 12.0 110.577 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.405 ' HA ' HG21 ' A' ' 92' ' ' ILE . 10.4 pt -92.65 25.1 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.45 -0.441 . . . . 12.0 110.692 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.927 0 N-CA-C 109.591 -1.403 . . . . 12.0 109.591 179.631 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.0 t30 . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.85 -31.85 68.68 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 122.157 -0.339 . . . . 12.0 110.874 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.87 2.01 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.542 -0.724 . . . . 12.0 110.474 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.2 m -62.29 -32.56 73.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.503 -0.925 . . . . 12.0 108.503 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 36.3 t80 -73.89 -23.86 59.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.69 -0.855 . . . . 12.0 108.69 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.407 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 17.4 tt0 -57.65 -37.85 74.06 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.129 -1.434 . . . . 12.0 107.129 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.421 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -75.59 -34.14 60.61 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 176.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 17.9 tptt -46.42 -59.0 3.23 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 122.215 -0.303 . . . . 12.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.529 ' CE1' ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -104.11 1.09 30.43 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 118.482 -0.771 . . . . 12.0 112.758 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 4.1 mp -134.74 65.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 117.866 -1.534 . . . . 12.0 114.958 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.427 HD11 HG22 ' A' ' 12' ' ' ILE . 23.3 mt -97.53 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 103.88 -2.637 . . . . 12.0 103.88 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -65.01 83.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.815 0.817 . . . . 12.0 110.186 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 p -129.26 90.54 44.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -73.99 -3.02 13.11 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.679 1.586 . . . . 12.0 112.081 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.4 pt -58.43 -170.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.246 -0.65 . . . . 12.0 109.246 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.9 40.65 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.469 0.652 . . . . 12.0 109.81 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -142.76 101.02 3.78 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.9 -0.5 . . . . 12.0 110.18 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' HA ' ' CG1' ' A' ' 22' ' ' ILE . 10.7 m -81.16 -3.17 51.31 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.934 -0.479 . . . . 12.0 110.829 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -84.7 -58.02 2.89 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.521 -0.737 . . . . 12.0 111.685 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 m -65.47 -23.44 66.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.593 -0.692 . . . . 12.0 110.402 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.416 ' CG1' ' HA ' ' A' ' 19' ' ' CYS . 2.7 pp -84.04 -35.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.419 -0.585 . . . . 12.0 109.419 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.2 ttm -83.28 -5.53 59.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.143 -0.348 . . . . 12.0 110.198 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.68 91.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -168.07 152.98 6.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.428 -0.582 . . . . 12.0 109.428 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.15 -7.97 53.74 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 120.664 -0.414 . . . . 12.0 110.043 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.5 mt -88.41 10.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.687 -0.633 . . . . 12.0 110.317 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -138.46 57.93 1.68 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.744 -0.597 . . . . 12.0 110.391 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.99 -1.069 . . . . 12.0 109.511 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.41 -165.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 108.02 -1.104 . . . . 12.0 108.02 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.91 67.81 0.88 Allowed Glycine 0 N--CA 1.505 3.265 0 O-C-N 121.044 -1.035 . . . . 12.0 112.063 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.85 -63.53 0.03 OUTLIER Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.23 -1.548 . . . . 12.0 109.23 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -164.44 -64.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.667 -1.235 . . . . 12.0 107.667 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.9 p -174.51 126.15 0.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.944 -1.132 . . . . 12.0 107.944 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -56.19 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.986 -0.446 . . . . 12.0 109.941 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 mtm-85 -106.18 21.45 17.35 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.903 -0.319 . . . . 12.0 110.488 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -163.53 133.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.595 -0.691 . . . . 12.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.0 99.07 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.944 -1.502 . . . . 12.0 106.944 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 m -87.4 110.85 20.56 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.291 0.567 . . . . 12.0 111.524 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 12' ' ' ILE . 18.9 m-85 -98.25 162.21 13.3 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.8 128.1 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.183 -0.948 . . . . 12.0 109.756 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.66 107.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.8 t 177.2 148.08 0.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.62 -0.511 . . . . 12.0 109.62 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 p -64.25 129.51 40.22 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.052 -1.092 . . . . 12.0 108.052 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.67 -30.9 5.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.881 -0.512 . . . . 12.0 111.589 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -78.97 -33.88 44.79 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.937 -0.477 . . . . 12.0 111.837 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -62.44 -39.72 94.25 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.281 -1.377 . . . . 12.0 107.281 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.2 t -69.26 -35.79 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.752 -1.203 . . . . 12.0 107.752 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -22.55 66.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.195 -0.668 . . . . 12.0 109.195 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.05 29.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.966 -0.459 . . . . 12.0 109.903 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 tp -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.749 -0.594 . . . . 12.0 110.164 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.06 26.52 8.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.858 -0.526 . . . . 12.0 109.937 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.5 m -88.06 111.51 21.63 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.875 -0.787 . . . . 12.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.46 -60.4 0.02 OUTLIER Glycine 0 N--CA 1.499 2.877 0 N-CA-C 110.643 -0.983 . . . . 12.0 110.643 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 p -163.93 -169.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.866 -0.785 . . . . 12.0 108.904 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.7 pt -87.27 25.55 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 O-C-N 121.11 -0.994 . . . . 12.0 111.197 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.3 t30 174.67 113.48 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 106.86 -1.533 . . . . 12.0 106.86 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.6 ttt -161.21 174.55 13.46 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.855 0.836 . . . . 12.0 111.739 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -132.51 110.67 10.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.593 -1.632 . . . . 12.0 106.593 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.78 168.53 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.745 -0.597 . . . . 12.0 109.827 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.0 112.17 12.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.121 -0.362 . . . . 12.0 110.662 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -60.4 92.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 107.502 -1.295 . . . . 12.0 107.502 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -83.28 -42.26 17.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.916 -0.49 . . . . 12.0 111.019 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 109.771 -0.455 . . . . 12.0 109.771 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 178.53 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.425 -0.797 . . . . 12.0 109.275 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 72.8 m-85 -96.51 43.7 1.07 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 120.446 -0.502 . . . . 12.0 109.678 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 18.91 106.11 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.211 1.189 . . . . 12.0 114.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.56 153.86 18.71 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.782 0.801 . . . . 12.0 111.836 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -119.99 102.47 8.57 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 106.467 -1.679 . . . . 12.0 106.467 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -100.94 124.73 47.08 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.944 -0.703 . . . . 12.0 111.797 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.2 m -108.82 109.39 20.5 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.095 -2.557 . . . . 12.0 104.095 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -114.15 140.84 48.19 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.821 -0.752 . . . . 12.0 111.523 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -58.61 110.49 1.0 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.306 -0.627 . . . . 12.0 109.306 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.5 2.061 0 O-C-N 122.071 -0.393 . . . . 12.0 110.539 -179.389 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.477 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 110.845 -0.057 . . . . 12.0 110.845 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 37.0 Cg_endo -78.93 129.19 8.86 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.323 2.015 . . . . 12.0 108.977 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -120.77 136.48 54.87 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 121.647 0.737 . . . . 12.0 112.354 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -109.03 129.63 55.46 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.814 -1.18 . . . . 12.0 107.814 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.8 p -92.81 145.14 24.62 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.308 0.575 . . . . 12.0 111.819 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -149.97 157.29 43.01 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.578 -0.897 . . . . 12.0 108.578 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 m -128.38 153.68 46.8 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.599 -0.519 . . . . 12.0 109.599 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -173.07 179.0 2.35 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.666 -0.414 . . . . 12.0 109.961 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 m -62.03 143.42 56.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.495 -0.928 . . . . 12.0 108.495 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -107.65 85.77 2.18 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.308 -0.957 . . . . 12.0 112.203 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -100.34 105.17 16.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.226 -2.509 . . . . 12.0 104.226 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.401 ' CD1' ' CE1' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -136.32 -177.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 121.653 0.739 . . . . 12.0 112.062 -175.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 18.1 t -117.76 121.3 40.45 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.707 -0.849 . . . . 12.0 108.707 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.467 ' CG2' ' CZ ' ' A' ' 104' ' ' PHE . 8.1 p -117.5 167.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.844 -0.342 . . . . 12.0 110.595 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 36.9 mttt -129.6 138.39 51.23 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.479 -0.934 . . . . 12.0 108.479 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -111.99 122.24 47.22 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 113.92 1.081 . . . . 12.0 113.92 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 35.0 tt0 -132.23 142.56 49.46 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 103.991 -2.596 . . . . 12.0 103.991 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 33.2 m120 54.13 29.1 9.84 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 107.638 -1.245 . . . . 12.0 107.638 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 98' ' ' ASN . 2.1 pm0 52.94 10.21 0.15 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.168 1.544 . . . . 12.0 115.168 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -115.63 146.24 36.3 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 104.574 -2.38 . . . . 12.0 104.574 174.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.478 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 23.9 Cg_endo -60.84 88.31 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.034 0 C-N-CA 121.293 1.328 . . . . 12.0 108.764 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 67.2 t -84.35 -24.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.272 -0.422 . . . . 12.0 110.395 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.442 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -132.31 144.38 50.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.344 -1.354 . . . . 12.0 107.344 -178.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.529 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -120.76 131.1 54.31 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.833 -1.147 . . . . 12.0 110.905 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.69 -40.78 32.85 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 116.308 -0.405 . . . . 12.0 110.517 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.69 -121.36 3.24 Favored Glycine 0 N--CA 1.504 3.185 0 C-N-CA 120.378 -0.915 . . . . 12.0 111.299 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.5 pt -65.44 -178.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-O 121.372 0.606 . . . . 12.0 111.496 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.01 0 N-CA-C 110.887 -0.885 . . . . 12.0 110.887 -179.189 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 36.5 t30 . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 108.439 -0.948 . . . . 12.0 108.439 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -72.61 -19.74 61.41 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.706 -0.621 . . . . 12.0 110.733 -177.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.83 -62.13 1.69 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.477 -0.764 . . . . 12.0 110.511 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -63.59 -33.4 75.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.664 -1.236 . . . . 12.0 107.664 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 36.5 t80 -74.39 -23.25 58.94 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -54.17 -34.61 60.87 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 106.955 -1.498 . . . . 12.0 106.955 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.2 -41.76 60.91 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.381 -1.34 . . . . 12.0 107.381 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -51.9 -29.44 20.02 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 122.001 -0.437 . . . . 12.0 109.879 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -96.56 -28.38 14.4 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 118.568 -0.729 . . . . 12.0 112.614 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -135.59 72.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.826 1.787 . . . . 12.0 115.826 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.432 HG22 ' CD1' ' A' ' 40' ' ' PHE . 47.2 mm -98.36 61.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 102.211 -3.255 . . . . 12.0 102.211 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.12 74.46 3.69 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.522 -0.763 . . . . 12.0 110.655 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 22' ' ' ILE . 3.1 p -131.21 70.63 82.21 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.867 -0.79 . . . . 12.0 108.867 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.34 81.76 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.048 1.832 . . . . 12.0 109.812 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.3 pt -136.18 -169.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.805 -0.813 . . . . 12.0 108.805 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 pt -105.81 31.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.455 0.645 . . . . 12.0 109.655 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -145.15 95.95 2.76 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.569 -0.9 . . . . 12.0 108.569 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.6 m -81.62 -10.08 59.51 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 120.442 -0.503 . . . . 12.0 111.607 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -81.23 -50.68 9.27 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.009 0.822 . . . . 12.0 111.356 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -67.08 -19.23 65.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.823 -0.548 . . . . 12.0 110.649 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.416 ' CG2' ' HB ' ' A' ' 14' ' ' THR . 35.0 pt -86.33 -39.23 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.737 -0.602 . . . . 12.0 110.536 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.406 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -94.53 10.89 32.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.857 -0.527 . . . . 12.0 110.43 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -60.18 91.57 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -170.74 156.73 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.441 -0.577 . . . . 12.0 109.441 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.13 -9.42 58.4 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.885 -0.413 . . . . 12.0 109.885 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -87.39 9.56 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.718 -0.614 . . . . 12.0 110.411 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -143.36 63.07 1.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.429 -0.794 . . . . 12.0 110.283 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 29' ' ' ILE . 50.6 mt -146.0 151.64 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.866 -1.146 . . . . 12.0 110.639 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.31 170.4 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 107.583 -1.265 . . . . 12.0 107.583 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.89 53.36 3.64 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 109.57 -1.412 . . . . 12.0 109.57 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.13 -58.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.701 -1.76 . . . . 12.0 108.701 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -164.99 -71.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.0 m -138.71 -166.13 1.95 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.753 -0.832 . . . . 12.0 108.753 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.01 173.68 7.39 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -79.2 -21.01 46.92 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.236 -0.29 . . . . 12.0 110.334 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.9 108.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 120.248 -0.581 . . . . 12.0 110.865 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.0 m120 -94.71 85.0 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.269 -1.752 . . . . 12.0 106.269 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 m -79.29 117.1 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.47 0.652 . . . . 12.0 111.824 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.432 ' CD1' HG22 ' A' ' 12' ' ' ILE . 25.2 m-85 -101.89 160.33 14.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.184 -1.413 . . . . 12.0 107.184 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -126.89 127.77 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.989 -1.069 . . . . 12.0 110.006 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 tt -110.82 100.73 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t 173.92 154.28 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 12.0 108.921 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.5 t -51.72 126.37 17.58 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.295 -0.631 . . . . 12.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.98 82.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.987 -0.446 . . . . 12.0 110.639 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -76.48 -24.87 53.83 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 120.838 -0.345 . . . . 12.0 111.715 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -65.8 -40.19 91.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 107.007 -1.479 . . . . 12.0 107.007 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.425 ' CG2' ' CD2' ' A' ' 66' ' ' PHE . 58.7 t -68.55 -39.91 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.791 -1.559 . . . . 12.0 106.791 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -59.67 -22.59 62.14 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.392 -0.596 . . . . 12.0 109.392 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.93 -39.75 41.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.836 -0.54 . . . . 12.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.428 HG13 ' CE1' ' A' ' 66' ' ' PHE . 50.5 mm -66.74 -18.07 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.775 -0.578 . . . . 12.0 110.406 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.2 22.87 9.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.722 -0.611 . . . . 12.0 109.603 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m -87.93 109.95 20.19 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.782 -0.822 . . . . 12.0 108.782 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.77 -61.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.639 -0.984 . . . . 12.0 110.639 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 p -160.96 -168.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 117.716 0.758 . . . . 12.0 109.091 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 12.5 tt -88.16 27.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.603 0 O-C-N 121.378 -0.827 . . . . 12.0 111.053 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.7 t-20 172.58 117.85 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.513 -1.292 . . . . 12.0 107.513 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -161.77 176.19 11.16 Favored 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.635 0.731 . . . . 12.0 111.599 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -131.82 116.42 17.21 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.377 -1.712 . . . . 12.0 106.377 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.5 163.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 120.193 -0.603 . . . . 12.0 110.432 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.5 111.77 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.649 -0.5 . . . . 12.0 109.649 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.409 ' HB2' HG21 ' A' ' 92' ' ' ILE . 18.1 m -59.57 92.25 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.735 -0.839 . . . . 12.0 108.735 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -77.97 -49.93 13.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.832 -0.803 . . . . 12.0 108.832 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 7.4 p -59.78 106.77 0.52 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.747 -1.205 . . . . 12.0 107.747 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 19.3 ptt-85 -37.32 107.13 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 112.863 0.69 . . . . 12.0 112.863 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' CD1' ' O ' ' A' ' 64' ' ' THR . 29.3 m-85 -94.04 41.75 1.09 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 20.24 107.08 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.26 1.207 . . . . 12.0 114.26 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.9 154.55 19.5 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 12.0 111.763 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -113.55 97.65 6.58 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.452 -2.425 . . . . 12.0 104.452 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.4 m -99.05 123.9 43.67 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.796 -0.761 . . . . 12.0 112.85 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.3 m -107.11 105.96 16.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 104.391 -2.448 . . . . 12.0 104.391 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -99.47 144.26 28.78 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 120.43 -0.508 . . . . 12.0 110.754 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -70.22 113.53 7.48 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.715 -0.846 . . . . 12.0 108.715 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.501 2.096 0 O-C-N 122.013 -0.43 . . . . 12.0 110.665 -179.238 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 23.7 m . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 110.002 -0.37 . . . . 12.0 110.002 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 34.3 Cg_endo -79.3 143.62 17.62 Favored 'Trans proline' 0 N--CA 1.48 0.687 0 C-N-CA 122.265 1.977 . . . . 12.0 109.612 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 27.8 m-85 -139.21 142.05 37.89 Favored 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.328 0.585 . . . . 12.0 111.094 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 t -115.42 134.3 55.22 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.841 -1.17 . . . . 12.0 107.841 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.4 m -96.08 139.52 32.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.551 0.691 . . . . 12.0 111.853 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -151.33 120.94 6.95 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.242 -1.021 . . . . 12.0 108.242 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 m -104.6 149.8 25.21 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.557 -0.535 . . . . 12.0 109.557 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -176.89 -171.84 0.39 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.671 -0.411 . . . . 12.0 110.362 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.0 m -49.76 136.26 17.95 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.867 -0.42 . . . . 12.0 109.867 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -107.68 87.09 2.42 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.993 0.902 . . . . 12.0 111.397 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.4 101.44 13.16 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 104.571 -2.381 . . . . 12.0 104.571 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.409 HG21 ' HB2' ' A' ' 62' ' ' SER . 16.0 tt -122.13 161.97 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.523 -0.871 . . . . 12.0 112.862 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.13 113.94 26.1 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.927 -1.138 . . . . 12.0 107.927 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 104' ' ' PHE . 10.8 m -126.57 -172.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 116.15 -0.477 . . . . 12.0 109.963 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.445 ' HB2' ' CD2' ' A' ' 103' ' ' HIS . 54.1 mttt -144.65 157.28 44.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.098 -0.705 . . . . 12.0 109.098 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.2 m -119.47 116.33 25.89 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.802 0.667 . . . . 12.0 112.802 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 17.5 tt0 -124.92 143.62 50.77 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 104.336 -2.468 . . . . 12.0 104.336 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.5 m120 55.17 29.13 12.1 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.7 pt20 53.26 10.37 0.19 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.073 1.349 . . . . 12.0 114.523 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.525 ' CD2' ' CD1' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -115.88 146.88 37.91 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 104.964 -2.236 . . . . 12.0 104.964 174.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.494 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 23.7 Cg_endo -61.02 92.48 0.1 Allowed 'Trans proline' 0 C--O 1.205 -1.172 0 N-CA-C 108.28 -1.469 . . . . 12.0 108.28 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.467 HG23 ' CE2' ' A' ' 100' ' ' TYR . 54.5 t -91.21 -8.66 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 116.263 -0.426 . . . . 12.0 110.731 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -142.71 110.79 5.98 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.555 -1.258 . . . . 12.0 112.101 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 94' ' ' VAL . 5.9 m-30 -100.22 112.19 24.5 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 105.254 -2.128 . . . . 12.0 105.254 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -129.89 7.04 5.12 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.434 0.902 . . . . 12.0 113.434 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.92 160.43 28.83 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.927 -1.269 . . . . 12.0 109.927 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.29 28.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.895 -0.78 . . . . 12.0 108.895 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.754 0 N-CA-C 109.595 -1.402 . . . . 12.0 109.595 179.756 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 33.3 t30 . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 12.0 108.795 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -26.18 63.8 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 122.05 -0.406 . . . . 12.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 7' ' ' GLN . . . -77.48 -60.8 2.22 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 121.597 -0.69 . . . . 12.0 110.396 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.7 m -60.18 -29.49 68.73 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.126 -1.064 . . . . 12.0 108.126 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 26.9 t80 -81.62 -23.96 36.7 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.285 -0.635 . . . . 12.0 109.285 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -57.16 -28.78 63.08 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 178.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.407 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 3.4 mp0 -83.79 -37.3 22.74 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.471 -1.307 . . . . 12.0 107.471 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -48.11 -47.97 34.09 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.771 0.319 . . . . 12.0 110.297 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.445 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -100.95 -17.56 16.73 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 118.53 -0.747 . . . . 12.0 112.149 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' A' ' 45' ' ' ALA . 4.0 mp -139.44 75.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 116.819 2.155 . . . . 12.0 116.819 -175.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.423 ' CG1' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -97.6 62.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.9 -3.0 . . . . 12.0 102.9 171.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -71.75 78.85 0.85 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.989 -1.005 . . . . 12.0 112.533 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 p -121.38 122.69 27.96 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 107.273 -1.38 . . . . 12.0 107.273 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -71.85 -3.04 12.4 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 121.48 1.454 . . . . 12.0 112.114 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.11 159.53 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.6 -0.889 . . . . 12.0 108.6 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 tt -108.59 39.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 108.549 -0.908 . . . . 12.0 108.549 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -128.38 101.05 6.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -74.94 -18.42 60.4 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 120.499 -0.481 . . . . 12.0 111.174 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.89 -55.03 5.08 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 118.8 0.727 . . . . 12.0 110.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.39 -30.87 63.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.214 -0.304 . . . . 12.0 110.229 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 23' ' ' MET . 50.9 pt -81.02 -36.95 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.546 -0.462 . . . . 12.0 110.243 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.403 ' N ' HG13 ' A' ' 22' ' ' ILE . 9.6 ptt? -91.99 8.39 37.8 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.323 -0.551 . . . . 12.0 110.46 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 92.38 0.08 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.271 -1.381 . . . . 12.0 107.271 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -172.28 149.53 2.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.219 -0.659 . . . . 12.0 109.219 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -63.61 -12.87 36.85 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.061 -0.399 . . . . 12.0 109.996 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.6 mt -84.45 11.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.702 -0.624 . . . . 12.0 110.658 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -146.48 64.27 1.2 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.44 -0.787 . . . . 12.0 110.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -146.99 151.25 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.761 -1.212 . . . . 12.0 110.398 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.8 169.1 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.984 -1.117 . . . . 12.0 107.984 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.01 53.02 3.25 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.259 -1.536 . . . . 12.0 109.259 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.52 -57.03 0.02 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.238 -1.545 . . . . 12.0 109.238 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.42 -69.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.046 -0.679 . . . . 12.0 109.447 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.6 m -141.18 -176.82 4.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -109.82 164.06 12.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.996 -0.742 . . . . 12.0 108.996 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -80.13 -20.01 45.95 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.838 -0.345 . . . . 12.0 110.367 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p -159.88 115.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.469 0.652 . . . . 12.0 111.106 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 12.3 m120 -103.18 84.89 2.4 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.385 -1.709 . . . . 12.0 106.385 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.8 m -81.46 115.99 21.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.395 0.617 . . . . 12.0 110.657 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.423 ' HB3' ' CG1' ' A' ' 12' ' ' ILE . 33.1 m-85 -106.84 165.5 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.3 -1.0 . . . . 12.0 108.3 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -125.88 124.08 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 tt -104.37 109.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 108.702 -0.851 . . . . 12.0 108.702 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t 178.18 158.24 0.46 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.067 -0.716 . . . . 12.0 109.067 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.65 118.91 4.59 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.877 0.846 . . . . 12.0 109.449 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 11' ' ' ILE . . . -45.09 -60.74 1.94 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 113.34 0.866 . . . . 12.0 113.34 -177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -25.0 64.98 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.935 -0.478 . . . . 12.0 111.24 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -62.71 -37.64 87.28 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.276 -1.379 . . . . 12.0 107.276 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.445 ' CG1' ' CD2' ' A' ' 10' ' ' HIS . 62.0 t -68.86 -35.49 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.156 -1.424 . . . . 12.0 107.156 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -63.67 -21.41 66.37 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.589 -0.523 . . . . 12.0 109.589 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.22 -37.54 28.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.944 -0.473 . . . . 12.0 109.741 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 tp -67.8 -24.99 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.851 -0.531 . . . . 12.0 110.296 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 22.14 11.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.806 -0.559 . . . . 12.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -87.36 115.02 24.5 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.821 -0.549 . . . . 12.0 109.624 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.29 0.02 OUTLIER Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.046 -1.222 . . . . 12.0 110.046 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 p -161.88 -165.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 pt -90.37 29.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 O-C-N 121.131 -0.98 . . . . 12.0 110.733 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 174.51 118.64 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.324 -1.361 . . . . 12.0 107.324 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.88 177.7 7.69 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.119 0.962 . . . . 12.0 112.501 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -139.07 111.69 7.68 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.237 -1.764 . . . . 12.0 106.237 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.69 163.98 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.309 -0.556 . . . . 12.0 110.367 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.6 114.4 23.35 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.386 -0.227 . . . . 12.0 110.386 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.416 ' HB3' ' CD2' ' A' ' 66' ' ' PHE . 3.5 m -59.55 92.91 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.318 -0.993 . . . . 12.0 108.318 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -83.04 -171.64 3.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.763 -0.458 . . . . 12.0 109.763 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.416 HG21 ' HG2' ' A' ' 65' ' ' ARG . 97.9 m 62.84 -101.7 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.38 -0.971 . . . . 12.0 108.38 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HG2' HG21 ' A' ' 64' ' ' THR . 15.9 ptt180 179.72 107.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 119.441 1.019 . . . . 12.0 110.833 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 51.2 m-85 -96.01 43.62 1.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 108.497 -0.927 . . . . 12.0 108.497 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 22.55 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 113.859 1.059 . . . . 12.0 113.859 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.417 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.06 152.83 18.89 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.039 0.923 . . . . 12.0 111.664 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -118.99 98.29 6.11 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 105.726 -1.953 . . . . 12.0 105.726 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -98.42 123.23 42.44 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.619 0.723 . . . . 12.0 112.153 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.9 m -109.56 108.61 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.379 -2.452 . . . . 12.0 104.379 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -104.36 142.96 33.65 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.061 -0.656 . . . . 12.0 111.596 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.2 ttt180 -71.34 137.92 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.293 -0.632 . . . . 12.0 109.293 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 109.492 -0.558 . . . . 12.0 109.492 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.821 -0.807 . . . . 12.0 108.821 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.2 Cg_endo -78.3 122.63 5.72 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 C-N-CA 121.883 1.722 . . . . 12.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 14.7 m-85 -143.5 131.23 21.36 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.363 0.602 . . . . 12.0 110.854 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -108.78 125.49 52.0 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 107.579 -1.267 . . . . 12.0 107.579 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.0 p -95.44 141.02 29.47 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.084 0.468 . . . . 12.0 110.573 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.16 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.516 -0.92 . . . . 12.0 108.516 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -116.54 148.09 41.18 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 109.615 -0.513 . . . . 12.0 109.615 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.35 -172.32 1.69 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.32 0.581 . . . . 12.0 110.315 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.0 m -67.31 138.38 56.77 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.566 -0.531 . . . . 12.0 109.566 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -106.79 89.68 3.09 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.054 0.93 . . . . 12.0 111.571 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.78 105.28 15.03 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 105.157 -2.164 . . . . 12.0 105.157 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.5 HD13 ' CZ ' ' A' ' 104' ' ' PHE . 4.3 pt -138.95 -175.72 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.943 -0.703 . . . . 12.0 112.404 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 32.1 t -122.63 116.34 23.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.864 -0.607 . . . . 12.0 109.664 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.44 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 8.8 p -116.73 169.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.92 -0.4 . . . . 12.0 109.92 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -124.22 142.77 50.97 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.416 -0.587 . . . . 12.0 109.416 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 121.79 45.67 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 114.44 1.274 . . . . 12.0 114.44 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 23.6 tt0 -133.2 144.95 50.15 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 104.013 -2.588 . . . . 12.0 104.013 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 20.5 m120 54.22 28.04 8.62 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 107.755 -1.202 . . . . 12.0 107.755 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.409 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.8 pt20 52.49 12.84 0.26 Allowed 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 125.316 1.446 . . . . 12.0 114.754 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -120.23 148.05 46.34 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 104.857 -2.275 . . . . 12.0 104.857 174.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.473 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.3 Cg_endo -60.6 89.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.027 0 C-N-CA 121.301 1.334 . . . . 12.0 108.903 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.473 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 55.4 t -86.22 -21.82 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.195 -0.457 . . . . 12.0 110.582 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -137.61 147.18 44.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.026 -1.101 . . . . 12.0 108.026 -177.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.5 ' CZ ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -111.83 133.03 54.31 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.903 -1.119 . . . . 12.0 109.955 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.99 -38.37 19.34 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.22 -0.3 . . . . 12.0 110.668 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.95 -141.48 9.72 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 120.266 -0.969 . . . . 12.0 111.287 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.81 -170.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 122.265 -0.55 . . . . 12.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.857 0 N-CA-C 110.781 -0.927 . . . . 12.0 110.781 -179.093 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 108.963 -0.755 . . . . 12.0 108.963 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -45.39 61.81 Favored 'General case' 0 N--CA 1.511 2.616 0 O-C-N 122.058 -0.401 . . . . 12.0 110.042 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.12 55.25 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.754 -0.591 . . . . 12.0 110.46 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -64.95 -30.03 70.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.419 -0.956 . . . . 12.0 108.419 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.453 ' HA ' ' CB ' ' A' ' 9' ' ' LYS . 30.7 t80 -76.56 -20.12 57.18 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.758 -0.83 . . . . 12.0 108.758 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.14 -38.99 93.04 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.855 -1.535 . . . . 12.0 106.855 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -78.21 -34.75 49.17 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.453 -1.314 . . . . 12.0 107.453 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.51 ' CG ' ' CD2' ' A' ' 10' ' ' HIS . 0.4 OUTLIER -41.48 -60.62 1.25 Allowed 'General case' 0 N--CA 1.506 2.374 0 CA-C-N 116.393 -0.367 . . . . 12.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.51 ' CD2' ' CG ' ' A' ' 9' ' ' LYS . 96.4 m-70 -110.57 -26.22 9.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.362 0.875 . . . . 12.0 113.362 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 4.9 mp -96.62 64.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 119.153 -1.019 . . . . 12.0 113.342 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.41 ' CD1' ' CD1' ' A' ' 40' ' ' PHE . 54.9 mt -91.86 70.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 105.053 -2.202 . . . . 12.0 105.053 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -70.34 81.99 0.55 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.626 0.727 . . . . 12.0 110.479 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -144.1 67.97 15.52 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.58 81.99 2.52 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.868 1.712 . . . . 12.0 109.851 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 16' ' ' ILE . 19.3 pt -129.98 -167.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.102 -1.073 . . . . 12.0 108.102 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 pt -102.26 36.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.728 -0.607 . . . . 12.0 109.663 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -152.57 98.33 2.35 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.722 -0.611 . . . . 12.0 110.557 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -82.49 -4.49 57.58 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 121.75 -0.593 . . . . 12.0 110.626 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.34 -50.5 8.86 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.353 -0.842 . . . . 12.0 111.532 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.2 m -66.29 -23.11 66.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.787 -0.571 . . . . 12.0 110.507 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.4 pt -84.73 -32.56 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.721 -0.612 . . . . 12.0 109.727 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.2 ttm -92.86 2.93 56.51 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 122.096 -0.378 . . . . 12.0 110.646 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.75 91.32 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.476 -0.935 . . . . 12.0 108.476 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -169.79 148.54 3.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.214 -0.662 . . . . 12.0 109.214 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -67.54 -10.9 56.11 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 110.092 -0.336 . . . . 12.0 110.092 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.42 9.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.778 -0.576 . . . . 12.0 110.635 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -142.41 64.2 1.38 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.577 -0.702 . . . . 12.0 109.574 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 29' ' ' ILE . 50.3 mt -141.57 153.42 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.736 -1.228 . . . . 12.0 111.143 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.05 170.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 107.477 -1.305 . . . . 12.0 107.477 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.42 53.78 3.48 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.272 -1.531 . . . . 12.0 109.272 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.68 -57.35 0.02 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.349 -1.501 . . . . 12.0 109.349 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -166.74 -72.54 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.6 p -154.72 142.42 19.89 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.932 -0.766 . . . . 12.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -62.06 -176.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 2.57 34.64 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 121.003 -0.279 . . . . 12.0 110.69 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 4.4 p -161.67 111.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.666 0.746 . . . . 12.0 110.314 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 6.3 m120 -103.79 81.88 1.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.453 -1.684 . . . . 12.0 106.453 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 m -82.85 110.89 18.25 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.977 -0.556 . . . . 12.0 111.225 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 38' ' ' ASN . 11.6 m-85 -105.46 161.18 14.56 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.6 mm -117.79 135.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.435 -0.791 . . . . 12.0 108.992 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -105.19 110.09 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.425 -0.954 . . . . 12.0 108.425 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t 174.32 150.98 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.203 -0.666 . . . . 12.0 109.203 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.6 p -60.63 126.19 26.5 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.393 -0.966 . . . . 12.0 108.393 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.94 -30.9 59.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.057 -0.402 . . . . 12.0 110.825 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -74.74 -31.87 61.94 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.69 -0.404 . . . . 12.0 111.023 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.429 HG21 ' N ' ' A' ' 48' ' ' VAL . 13.7 t -63.98 -33.63 76.17 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 107.406 -1.331 . . . . 12.0 107.406 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' N ' HG21 ' A' ' 47' ' ' THR . 21.0 t -72.88 -36.07 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.403 -1.332 . . . . 12.0 107.403 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -63.06 -21.03 65.89 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.668 -0.493 . . . . 12.0 109.668 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.53 -39.23 24.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.999 -0.438 . . . . 12.0 109.894 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.4 pt -69.6 -18.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.685 -0.634 . . . . 12.0 111.124 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.34 26.73 10.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.872 -0.517 . . . . 12.0 110.425 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -95.69 108.3 20.58 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.686 -0.633 . . . . 12.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.87 -57.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.523 -1.031 . . . . 12.0 110.523 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -157.08 179.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.994 -0.71 . . . . 12.0 109.1 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 pt -83.18 26.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 121.195 -0.94 . . . . 12.0 111.662 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 177.14 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.797 -1.557 . . . . 12.0 106.797 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -156.64 179.09 9.61 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 122.003 0.906 . . . . 12.0 112.016 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.8 118.18 16.75 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.401 -1.703 . . . . 12.0 106.401 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.9 p -141.95 170.13 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.304 -0.628 . . . . 12.0 109.304 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.71 120.55 16.41 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.844 -0.535 . . . . 12.0 111.154 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.461 ' CB ' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -60.41 92.51 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -90.92 -28.18 18.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.052 -0.405 . . . . 12.0 111.102 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -56.2 -77.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 172.14 106.59 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.959 -0.463 . . . . 12.0 110.017 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.461 ' CD1' ' CB ' ' A' ' 62' ' ' SER . 73.9 m-85 -122.02 65.28 0.92 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.803 -1.184 . . . . 12.0 107.803 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -23.31 127.73 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 114.52 1.304 . . . . 12.0 114.52 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 90' ' ' ASN . 4.6 pp -99.85 150.95 21.84 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.694 0.759 . . . . 12.0 111.227 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -118.13 106.37 12.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.646 -1.983 . . . . 12.0 105.646 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.2 m -112.07 126.85 55.61 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.757 -0.777 . . . . 12.0 112.599 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.7 m -103.8 110.08 22.05 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 103.385 -2.821 . . . . 12.0 103.385 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.6 m -109.11 143.02 39.01 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 119.919 -0.712 . . . . 12.0 112.227 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.9 ttt180 -64.15 132.21 49.73 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.502 2.151 0 C-N-CA 120.554 -0.458 . . . . 12.0 110.735 -179.269 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 108.464 -0.939 . . . . 12.0 108.464 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.4 Cg_endo -75.46 124.75 8.55 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 121.758 1.639 . . . . 12.0 109.815 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 17.0 m-85 -143.1 134.38 25.99 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.284 0.564 . . . . 12.0 110.79 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 p -115.03 123.23 48.52 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.43 -0.952 . . . . 12.0 108.43 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 142.46 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.828 -0.434 . . . . 12.0 109.828 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -146.76 157.2 43.62 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.5 m -129.77 147.9 51.59 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.893 -0.78 . . . . 12.0 108.893 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -165.38 156.34 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.382 -0.527 . . . . 12.0 110.48 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -58.1 124.67 20.17 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 66' ' ' PHE . 4.9 t-20 -121.99 101.36 7.5 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.366 1.247 . . . . 12.0 114.366 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.6 126.77 41.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 102.703 -3.073 . . . . 12.0 102.703 172.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.427 ' CG2' ' HA2' ' A' ' 106' ' ' GLY . 1.6 mp -121.9 161.5 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 N-CA-C 113.993 1.108 . . . . 12.0 113.993 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.4 t -100.41 109.45 21.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 106.21 -1.774 . . . . 12.0 106.21 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.492 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 10.6 m -118.66 -177.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.072 0.463 . . . . 12.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.459 ' CB ' ' CD2' ' A' ' 103' ' ' HIS . 38.7 mtpt -143.73 149.26 36.87 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.899 -0.778 . . . . 12.0 108.899 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.45 116.42 28.18 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.96 0.726 . . . . 12.0 112.96 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.0 tt0 -125.43 143.08 51.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 104.42 -2.437 . . . . 12.0 104.42 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 1.6 m-80 58.74 14.96 3.46 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.061 -1.024 . . . . 12.0 108.513 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 15.6 mt-30 75.79 -8.25 1.64 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.112 0.965 . . . . 12.0 113.049 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -105.8 152.55 40.21 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.735 -1.579 . . . . 12.0 106.735 176.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.459 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.6 Cg_endo -61.76 87.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.542 1.495 . . . . 12.0 109.095 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.449 HG23 ' CE2' ' A' ' 100' ' ' TYR . 67.4 t -84.34 -20.72 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.479 -0.328 . . . . 12.0 110.591 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.472 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -130.83 127.49 38.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.925 -1.139 . . . . 12.0 107.925 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.492 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -121.53 122.0 38.72 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.646 -0.872 . . . . 12.0 108.646 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.25 -32.02 12.64 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.775 -0.37 . . . . 12.0 110.506 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.427 ' HA2' ' CG2' ' A' ' 92' ' ' ILE . . . 97.15 162.04 31.84 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.08 -1.608 . . . . 12.0 109.08 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.41 ' O ' ' O ' ' A' ' 106' ' ' GLY . 60.3 mt 57.24 123.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 12.0 111.118 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.921 0 N-CA-C 109.685 -1.366 . . . . 12.0 109.685 179.56 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.4 t30 . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 108.84 -0.8 . . . . 12.0 108.84 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -23.58 64.91 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.614 -0.679 . . . . 12.0 110.357 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.33 -61.44 1.99 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.493 -0.754 . . . . 12.0 110.6 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.53 74.9 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.412 -1.329 . . . . 12.0 107.412 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 24.7 t80 -73.57 -27.49 61.34 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.338 -0.986 . . . . 12.0 108.338 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.91 -33.1 35.56 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 107.72 -1.215 . . . . 12.0 107.72 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -42.02 33.26 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.33 -53.87 6.33 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.232 -0.44 . . . . 12.0 111.18 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.46 ' CD2' HG13 ' A' ' 48' ' ' VAL . 1.1 m-70 -96.75 -15.38 21.41 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.694 -0.629 . . . . 12.0 111.162 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 45' ' ' ALA . 15.7 mm -140.15 87.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 114.231 1.197 . . . . 12.0 114.231 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 12' ' ' ILE . 35.3 mm -96.73 67.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 105.094 -2.187 . . . . 12.0 105.094 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -66.81 84.35 0.11 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.932 0.872 . . . . 12.0 110.636 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -159.39 63.12 2.18 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 106.976 -1.491 . . . . 12.0 106.976 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.49 85.61 1.26 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.041 1.827 . . . . 12.0 110.598 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.27 -173.09 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.847 -0.797 . . . . 12.0 108.847 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pt -98.67 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.293 0.568 . . . . 12.0 109.636 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -145.03 95.56 2.71 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.434 -0.58 . . . . 12.0 109.434 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.4 m -80.45 -3.18 48.88 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.916 -0.49 . . . . 12.0 110.735 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.6 -50.16 10.34 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.613 0.642 . . . . 12.0 110.974 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 m -63.11 -21.18 66.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.748 -0.595 . . . . 12.0 110.429 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 23' ' ' MET . 45.6 pt -85.78 -38.05 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.679 -0.638 . . . . 12.0 109.904 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.406 ' N ' HG13 ' A' ' 22' ' ' ILE . 3.8 ptm -91.53 11.14 25.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.988 -0.445 . . . . 12.0 110.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -66.41 90.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.489 -0.93 . . . . 12.0 108.489 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -173.11 150.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.453 -0.573 . . . . 12.0 109.453 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -70.52 -9.13 55.9 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 110.09 -0.337 . . . . 12.0 110.09 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -88.82 11.6 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.72 -0.613 . . . . 12.0 110.319 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -140.03 58.95 1.58 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.827 -0.546 . . . . 12.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 29' ' ' ILE . 41.3 mt -148.0 146.6 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.631 -1.293 . . . . 12.0 110.559 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -111.67 -164.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.34 -1.355 . . . . 12.0 107.34 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.72 66.3 0.83 Allowed Glycine 0 N--CA 1.506 3.301 0 O-C-N 120.956 -1.09 . . . . 12.0 112.453 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.52 -68.86 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.136 -1.586 . . . . 12.0 109.136 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -164.45 -66.71 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.845 -1.169 . . . . 12.0 107.845 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.0 p -138.8 144.6 39.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.631 -0.877 . . . . 12.0 108.631 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -61.27 -175.03 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.985 -0.447 . . . . 12.0 109.991 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -89.73 -23.11 21.88 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 110.024 -0.361 . . . . 12.0 110.024 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 t -150.01 102.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 5.1 m120 -90.99 80.82 5.69 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.649 -1.612 . . . . 12.0 106.649 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -84.17 115.35 22.37 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.936 -0.574 . . . . 12.0 110.825 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 32.8 m-85 -105.44 165.58 11.03 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.3 mm -127.45 126.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 120.932 -1.105 . . . . 12.0 110.459 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 tt -108.91 127.83 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.11 -0.7 . . . . 12.0 109.11 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.3 t 170.4 160.37 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.363 -0.977 . . . . 12.0 108.363 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.67 117.93 4.73 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -40.85 -64.63 0.51 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.9 1.074 . . . . 12.0 113.9 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -61.29 -26.21 67.63 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.794 -0.566 . . . . 12.0 111.311 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 m -58.61 -35.54 72.62 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 107.456 -1.312 . . . . 12.0 107.456 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.46 HG13 ' CD2' ' A' ' 10' ' ' HIS . 45.7 t -70.19 -37.95 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.294 -1.372 . . . . 12.0 107.294 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -60.68 -21.55 62.96 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.138 -0.69 . . . . 12.0 109.138 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.87 -37.2 27.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 122.009 -0.432 . . . . 12.0 109.919 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 6.8 tp -66.82 -24.36 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 120.414 -0.514 . . . . 12.0 110.425 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 22.95 10.69 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.723 -0.611 . . . . 12.0 109.768 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 m -84.74 109.22 17.89 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.028 -0.73 . . . . 12.0 109.028 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.93 -58.82 0.02 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.616 -0.994 . . . . 12.0 110.616 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 p -164.89 -175.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.0 pt -87.08 27.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.315 -0.865 . . . . 12.0 111.34 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 177.21 116.83 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 107.807 -1.183 . . . . 12.0 107.807 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.5 ttp -165.83 170.81 13.48 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.554 0.692 . . . . 12.0 111.39 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.4 118.03 15.98 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.7 p -150.57 164.55 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.314 -0.624 . . . . 12.0 109.314 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -115.3 128.81 56.36 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.051 -0.352 . . . . 12.0 110.051 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.426 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 49.5 m -53.62 94.11 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.142 -1.059 . . . . 12.0 108.142 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.418 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 1.1 p -77.37 -174.78 3.44 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.834 0.35 . . . . 12.0 110.085 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.9 m 63.47 -94.86 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 174.0 104.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 118.828 0.74 . . . . 12.0 110.006 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 48.5 m-85 -95.99 43.34 1.08 Allowed 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.193 -0.669 . . . . 12.0 109.193 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 29.64 105.2 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.147 0 N-CA-C 113.87 1.063 . . . . 12.0 113.87 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.62 154.68 19.23 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.033 0.92 . . . . 12.0 112.107 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -117.26 97.02 5.69 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 105.524 -2.028 . . . . 12.0 105.524 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -99.95 122.66 43.2 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.803 -0.759 . . . . 12.0 112.971 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -108.75 105.68 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 103.338 -2.838 . . . . 12.0 103.338 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 m -114.34 143.28 45.15 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.9 -0.72 . . . . 12.0 112.613 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 25.7 ttp180 -69.74 109.54 4.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.008 -1.108 . . . . 12.0 108.008 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.505 2.302 0 C-N-CA 120.006 -0.677 . . . . 12.0 112.363 -178.585 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.504 2.27 0 N-CA-C 109.493 -0.558 . . . . 12.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 34.3 Cg_endo -72.25 89.31 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 121.721 1.614 . . . . 12.0 109.468 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.403 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 7.2 m-85 -121.31 140.4 52.14 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-O 121.61 0.719 . . . . 12.0 112.542 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 m -119.15 124.16 46.15 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.559 -1.274 . . . . 12.0 107.559 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -93.12 142.83 26.87 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.924 -0.485 . . . . 12.0 110.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -155.7 132.76 10.71 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.423 -0.584 . . . . 12.0 109.423 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.3 m -92.3 148.82 21.83 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.898 -0.779 . . . . 12.0 108.898 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -169.16 -169.75 1.01 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.23 0.538 . . . . 12.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 m -67.14 139.44 57.49 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.147 -0.686 . . . . 12.0 109.147 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 67.0 t30 -107.46 87.0 2.4 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.091 0.948 . . . . 12.0 112.392 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 63' ' ' THR . 14.5 t80 -99.68 102.39 13.86 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.186 -2.524 . . . . 12.0 104.186 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.47 169.85 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.541 -0.864 . . . . 12.0 112.883 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.8 t -113.14 107.76 16.37 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.275 -1.009 . . . . 12.0 108.275 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 18.0 m -127.33 -170.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.68 -0.489 . . . . 12.0 109.68 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -147.57 161.06 41.89 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.069 -0.652 . . . . 12.0 110.887 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 128.27 52.2 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.646 0.736 . . . . 12.0 111.983 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 14.4 tt0 -147.51 147.08 29.77 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 104.97 -2.233 . . . . 12.0 104.97 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 59.1 18.21 6.22 Favored 'General case' 0 N--CA 1.508 2.472 0 N-CA-C 108.387 -0.968 . . . . 12.0 108.387 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.03 -6.01 1.39 Allowed 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.579 0.752 . . . . 12.0 112.71 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -110.55 145.19 31.75 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 106.332 -1.729 . . . . 12.0 106.332 177.24 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.564 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 28.2 Cg_endo -66.52 100.08 0.47 Allowed 'Trans proline' 0 C--O 1.203 -1.264 0 N-CA-C 107.382 -1.815 . . . . 12.0 107.382 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 100' ' ' TYR . 12.3 p -117.58 7.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 120.057 -0.657 . . . . 12.0 112.654 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -129.87 133.42 46.88 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.669 -1.234 . . . . 12.0 107.669 178.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.02 126.41 50.73 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.967 -0.693 . . . . 12.0 110.684 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 -32.98 13.69 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.89 -0.782 . . . . 12.0 108.89 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 140.14 -149.24 20.73 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.052 -1.219 . . . . 12.0 110.052 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.3 pt -56.16 -172.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.291 -0.535 . . . . 12.0 109.895 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.863 0 N-CA-C 110.234 -1.146 . . . . 12.0 110.234 -179.365 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 108.728 -0.841 . . . . 12.0 108.728 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.25 -25.91 65.42 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.588 -0.695 . . . . 12.0 110.207 -178.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.64 -60.31 2.37 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.694 -0.629 . . . . 12.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.72 -35.55 78.36 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.514 -1.291 . . . . 12.0 107.514 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 28.1 t80 -73.8 -25.07 59.93 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -31.76 54.05 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 107.534 -1.284 . . . . 12.0 107.534 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.96 -37.86 33.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -46.73 -53.04 12.61 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 116.335 -0.393 . . . . 12.0 110.63 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.455 ' CD2' HG13 ' A' ' 48' ' ' VAL . 1.3 m-70 -97.09 -16.01 20.71 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.863 -0.523 . . . . 12.0 110.848 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 11' ' ' ILE . 5.0 mp -144.09 87.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.068 1.136 . . . . 12.0 114.068 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 40' ' ' PHE . 12.6 mt -97.06 65.13 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 103.711 -2.7 . . . . 12.0 103.711 173.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -66.98 83.0 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.903 0.859 . . . . 12.0 110.699 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -155.18 63.18 3.67 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 106.847 -1.538 . . . . 12.0 106.847 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -73.21 84.05 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.086 1.857 . . . . 12.0 111.015 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.65 -167.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.787 -1.19 . . . . 12.0 107.787 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mm -101.91 34.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 108.682 -0.858 . . . . 12.0 108.682 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -145.8 97.6 2.99 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -77.84 -16.28 58.42 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.842 -0.537 . . . . 12.0 111.253 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.18 -49.02 10.6 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 118.854 0.752 . . . . 12.0 110.046 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -31.54 67.27 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.748 -0.464 . . . . 12.0 109.748 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 23' ' ' MET . 47.0 pt -81.12 -36.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 120.627 -0.429 . . . . 12.0 110.208 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -97.03 15.24 22.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.925 -0.484 . . . . 12.0 110.165 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.27 90.78 0.1 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.122 -1.066 . . . . 12.0 108.122 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -166.83 158.06 12.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.236 -0.653 . . . . 12.0 109.236 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -72.89 -10.82 60.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 120.8 -0.36 . . . . 12.0 110.263 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.02 9.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.65 -0.656 . . . . 12.0 110.523 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -142.71 63.23 1.39 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.611 -0.68 . . . . 12.0 109.727 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.3 mt -148.49 153.26 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 120.763 -1.211 . . . . 12.0 110.318 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.0 t -107.03 169.53 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 107.764 -1.199 . . . . 12.0 107.764 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.71 54.16 3.39 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.117 -1.593 . . . . 12.0 109.117 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.9 -56.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.241 -1.544 . . . . 12.0 109.241 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -165.27 -68.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.04 -0.682 . . . . 12.0 109.401 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.0 m -143.51 -175.77 4.69 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.49 -0.559 . . . . 12.0 109.49 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 163.72 12.52 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.339 -0.615 . . . . 12.0 109.339 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -73.85 -24.08 59.72 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 110.058 -0.349 . . . . 12.0 110.058 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -156.35 109.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.481 0.658 . . . . 12.0 110.804 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 3.0 m-20 -91.27 83.3 5.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.527 -1.657 . . . . 12.0 106.527 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 m -82.61 106.43 14.46 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 116.006 -0.543 . . . . 12.0 110.89 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 38' ' ' ASN . 10.5 m-85 -99.11 157.86 16.06 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.167 -1.42 . . . . 12.0 107.167 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.92 125.57 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.175 -0.953 . . . . 12.0 109.005 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.2 tt -106.74 118.37 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.489 -0.56 . . . . 12.0 109.489 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t 173.15 154.86 0.1 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.382 -0.97 . . . . 12.0 108.382 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.21 119.2 5.98 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.22 -52.38 12.58 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.053 0.76 . . . . 12.0 113.053 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -61.7 -29.53 70.16 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.026 -0.421 . . . . 12.0 111.558 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -63.19 -35.18 79.45 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.455 HG13 ' CD2' ' A' ' 10' ' ' HIS . 42.0 t -71.28 -33.91 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.686 -1.227 . . . . 12.0 107.686 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -61.76 -22.37 65.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.173 -0.677 . . . . 12.0 109.173 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -36.67 28.11 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.653 -0.499 . . . . 12.0 109.653 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.409 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 5.9 tp -66.08 -25.26 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 C-N-CA 120.372 -0.531 . . . . 12.0 110.792 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.53 24.27 7.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.614 -0.679 . . . . 12.0 109.908 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -88.3 110.94 21.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.254 -0.647 . . . . 12.0 109.254 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.46 -58.78 0.02 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.396 -1.081 . . . . 12.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 p -161.59 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.013 -0.736 . . . . 12.0 109.013 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.2 tt -83.27 21.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.642 0 O-C-N 121.357 -0.839 . . . . 12.0 111.718 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 175.25 113.36 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.541 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.5 ttm -163.78 -176.78 4.78 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.485 0.659 . . . . 12.0 111.034 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -137.98 123.5 19.65 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.295 -1.372 . . . . 12.0 107.295 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.37 163.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.907 -0.495 . . . . 12.0 109.869 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.72 116.26 23.45 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.587 -0.523 . . . . 12.0 109.587 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.43 ' HB3' ' CD2' ' A' ' 66' ' ' PHE . 1.8 m -55.48 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.699 -0.852 . . . . 12.0 108.699 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -50.45 20.39 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.592 -0.892 . . . . 12.0 108.592 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.7 115.4 3.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.532 -0.914 . . . . 12.0 108.532 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -44.74 106.88 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.152 0.501 . . . . 12.0 111.543 -178.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 28.6 m-85 -94.4 40.08 1.09 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 108.848 -0.797 . . . . 12.0 108.848 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' PHE . 1.4 tp-100 39.86 107.56 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 112.859 0.689 . . . . 12.0 112.859 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.437 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 3.5 pp -95.99 147.94 23.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 12.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.98 97.47 5.71 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 105.292 -2.114 . . . . 12.0 105.292 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.2 m -108.22 128.16 54.48 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.434 -0.906 . . . . 12.0 112.541 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.0 m -112.63 111.9 23.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.288 -2.486 . . . . 12.0 104.288 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -108.64 141.89 39.92 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.12 -0.632 . . . . 12.0 111.401 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -65.3 109.59 2.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.68 -0.859 . . . . 12.0 108.68 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.503 2.185 0 C-N-CA 120.388 -0.525 . . . . 12.0 111.201 -178.547 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 110.787 -0.079 . . . . 12.0 110.787 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.01 137.31 12.25 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.326 2.017 . . . . 12.0 109.012 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -134.54 136.03 42.76 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.525 0.679 . . . . 12.0 112.454 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -108.81 129.8 55.39 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -96.34 145.48 25.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.947 -0.471 . . . . 12.0 111.213 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -159.57 138.96 11.27 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 109.261 -0.644 . . . . 12.0 109.261 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -99.05 150.74 21.69 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 109.534 -0.543 . . . . 12.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.02 -162.44 0.84 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.033 0.444 . . . . 12.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.5 m -79.2 127.92 32.65 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.003 -0.74 . . . . 12.0 109.003 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.402 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 21.2 t-20 -95.0 87.52 4.95 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-O 122.245 1.021 . . . . 12.0 111.983 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 5.2 p90 -103.16 101.79 11.76 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.8 tt -119.78 162.54 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.118 0.785 . . . . 12.0 113.118 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -110.52 107.2 16.75 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.076 -1.453 . . . . 12.0 107.076 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.472 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 17.1 m -128.09 -172.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 12.0 109.437 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.464 ' CB ' ' CD2' ' A' ' 103' ' ' HIS . 4.0 mtpp -143.04 162.94 34.16 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.96 -0.696 . . . . 12.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 9.8 m -115.9 130.26 56.75 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.592 0.711 . . . . 12.0 111.871 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.488 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 39.0 tt0 -138.32 136.97 36.95 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.915 -2.254 . . . . 12.0 104.915 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 12.1 m-20 55.86 20.91 4.43 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.391 -0.818 . . . . 12.0 108.838 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 6.4 mt-30 77.12 -17.08 0.58 Allowed 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 123.517 0.727 . . . . 12.0 112.637 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.503 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -98.65 143.66 26.73 Favored Pre-proline 0 N--CA 1.503 2.192 0 N-CA-C 105.983 -1.858 . . . . 12.0 105.983 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.535 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 24.8 Cg_endo -62.69 104.36 0.37 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 C-N-CA 121.278 1.318 . . . . 12.0 108.92 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 100' ' ' TYR . 3.5 t -115.97 12.25 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 C-N-CA 120.287 -0.565 . . . . 12.0 112.22 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -141.83 133.81 27.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -118.12 129.46 55.55 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 109.084 -0.71 . . . . 12.0 109.084 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.54 -26.17 7.61 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.598 0.592 . . . . 12.0 112.598 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.03 -174.75 43.74 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 119.811 -1.185 . . . . 12.0 111.18 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.3 tt -97.78 31.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.09 0.471 . . . . 12.0 110.384 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.038 0 N-CA-C 110.366 -1.094 . . . . 12.0 110.366 179.055 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.2 t30 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 108.543 -0.91 . . . . 12.0 108.543 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.03 78.65 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 122.045 -0.409 . . . . 12.0 110.609 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.22 -56.45 11.26 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 121.359 -0.838 . . . . 12.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -31.44 72.01 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.917 -1.142 . . . . 12.0 107.917 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 53.7 t80 -72.74 -25.67 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.723 -0.843 . . . . 12.0 108.723 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -53.65 -37.3 62.98 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 107.254 -1.387 . . . . 12.0 107.254 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.39 -40.89 57.45 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.192 -1.41 . . . . 12.0 107.192 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 7.0 tptt -43.32 -61.81 1.24 Allowed 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 116.268 -0.424 . . . . 12.0 111.836 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.595 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 1.9 m80 -99.49 -7.07 26.5 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 119.08 0.854 . . . . 12.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 25.2 mm -134.37 78.41 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 118.684 -1.206 . . . . 12.0 113.33 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.82 64.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.153 -2.165 . . . . 12.0 105.153 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -64.82 85.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.652 0.739 . . . . 12.0 110.372 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 p -160.73 69.9 2.74 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.102 -1.444 . . . . 12.0 107.102 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -79.78 30.64 0.48 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.418 2.079 . . . . 12.0 113.103 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.2 pt -64.56 -169.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.655 -0.869 . . . . 12.0 108.655 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.35 33.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 121.589 0.709 . . . . 12.0 109.46 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -144.94 98.95 3.26 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 108.665 -0.865 . . . . 12.0 108.665 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.0 m -77.36 -18.7 57.16 Favored 'General case' 0 N--CA 1.511 2.581 0 C-N-CA 120.5 -0.48 . . . . 12.0 111.434 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -80.93 -48.54 12.18 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.051 0.841 . . . . 12.0 110.08 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -32.11 68.58 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.916 -0.402 . . . . 12.0 109.916 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 pt -80.26 -34.6 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 122.034 -0.416 . . . . 12.0 110.195 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -99.34 18.25 18.13 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 120.512 -0.475 . . . . 12.0 110.44 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.53 89.9 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.939 -1.134 . . . . 12.0 107.939 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -166.88 159.54 13.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.209 -0.663 . . . . 12.0 109.209 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.8 -10.36 59.71 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.76 -0.376 . . . . 12.0 110.052 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.9 mt -87.77 10.44 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.73 -0.606 . . . . 12.0 110.528 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -146.94 63.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.706 -0.621 . . . . 12.0 110.099 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.3 mt -153.19 149.02 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.57 -1.331 . . . . 12.0 111.07 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.86 168.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 107.678 -1.23 . . . . 12.0 107.678 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.58 53.87 3.43 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.328 -1.509 . . . . 12.0 109.328 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.95 -55.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 12.0 109.388 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -166.43 -77.06 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.929 -0.767 . . . . 12.0 108.929 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -146.47 -170.71 3.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.827 -0.805 . . . . 12.0 108.827 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -174.27 2.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.222 -0.658 . . . . 12.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -85.4 -25.4 27.04 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.981 -0.45 . . . . 12.0 110.591 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 t -151.51 107.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 120.353 -0.539 . . . . 12.0 110.777 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.3 m120 -91.6 85.69 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 105.904 -1.887 . . . . 12.0 105.904 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 m -81.73 112.89 19.31 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.242 0.544 . . . . 12.0 111.763 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 23' ' ' MET . 32.7 m-85 -100.39 158.5 15.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.272 -1.381 . . . . 12.0 107.272 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.52 128.75 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 12.0 109.353 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 tt -111.14 129.28 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t 165.42 157.88 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.188 -1.041 . . . . 12.0 108.188 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -60.19 122.81 15.39 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.671 -0.863 . . . . 12.0 108.671 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.09 -29.24 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.136 -0.352 . . . . 12.0 111.803 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -79.92 -31.57 40.11 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.953 -0.467 . . . . 12.0 111.903 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 p -64.87 -36.04 83.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.474 -1.306 . . . . 12.0 107.474 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.05 -33.5 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.718 -1.215 . . . . 12.0 107.718 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -66.75 -21.54 66.06 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.607 -0.516 . . . . 12.0 109.607 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.69 -41.2 24.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.794 -0.566 . . . . 12.0 109.76 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.421 ' CG2' ' CZ ' ' A' ' 66' ' ' PHE . 18.3 pt -67.15 -20.46 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.782 -0.574 . . . . 12.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 22.34 9.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.853 -0.53 . . . . 12.0 110.101 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -88.78 114.43 25.39 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.005 -0.739 . . . . 12.0 109.005 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.17 -61.21 0.02 OUTLIER Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.418 -1.073 . . . . 12.0 110.418 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.9 p -163.65 -168.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 12.4 tt -87.26 27.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 O-C-N 121.097 -1.002 . . . . 12.0 110.958 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 6.1 t-20 171.1 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 106.403 -1.703 . . . . 12.0 106.403 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.62 179.37 8.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.826 0.822 . . . . 12.0 112.132 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -137.55 115.1 11.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.71 166.35 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.897 -0.502 . . . . 12.0 109.653 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 mp -129.33 117.54 20.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.896 -0.502 . . . . 12.0 111.521 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.458 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 1.4 m -58.1 93.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.105 -1.443 . . . . 12.0 107.105 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.427 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 1.6 p -79.74 -53.5 6.75 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 112.249 0.463 . . . . 12.0 112.249 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.5 m -47.83 -90.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.866 -0.521 . . . . 12.0 110.271 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 174.43 100.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 57.9 m-85 -97.88 54.62 1.15 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.237 -0.653 . . . . 12.0 109.237 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 11.88 109.03 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.431 1.271 . . . . 12.0 114.431 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.04 154.6 17.97 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.819 0.819 . . . . 12.0 111.756 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -119.22 100.23 7.2 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.083 -1.821 . . . . 12.0 106.083 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 m -102.18 127.39 49.13 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.659 0.743 . . . . 12.0 112.355 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -111.7 112.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.367 -2.457 . . . . 12.0 104.367 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 m -111.2 144.99 39.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.091 -0.644 . . . . 12.0 111.648 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -62.34 142.79 57.61 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.297 -1.001 . . . . 12.0 108.297 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.504 2.267 0 O-C-N 121.92 -0.488 . . . . 12.0 110.545 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 119.09 -0.481 . . . . 12.0 110.809 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.33 113.05 2.85 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.119 1.879 . . . . 12.0 109.296 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.425 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 12.1 m-85 -138.58 139.07 38.49 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.195 0.521 . . . . 12.0 111.119 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -111.33 129.35 56.02 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.897 -1.149 . . . . 12.0 107.897 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 t -93.91 149.45 21.22 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.39 0.614 . . . . 12.0 110.883 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -151.79 155.42 38.19 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.032 -0.729 . . . . 12.0 109.032 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.3 m -125.44 141.2 52.19 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.535 -0.543 . . . . 12.0 109.535 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -166.12 -172.03 2.16 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.095 0.474 . . . . 12.0 110.317 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.4 m -65.3 145.59 56.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.991 -0.744 . . . . 12.0 108.991 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -110.22 88.24 2.71 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.907 0.86 . . . . 12.0 111.371 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 63' ' ' THR . 6.6 t80 -98.03 96.63 8.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.987 -2.597 . . . . 12.0 103.987 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.409 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 7.1 tt -130.69 175.12 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.978 -0.689 . . . . 12.0 111.077 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.77 116.63 27.4 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.65 -0.871 . . . . 12.0 108.65 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.8 p -108.88 162.06 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.989 -0.374 . . . . 12.0 109.989 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -120.35 144.8 47.67 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -119.55 120.63 37.31 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 114.003 1.112 . . . . 12.0 114.003 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 20.9 tt0 -128.37 141.8 51.31 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 104.076 -2.564 . . . . 12.0 104.076 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.9 m-80 57.21 28.64 15.41 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 107.683 -1.228 . . . . 12.0 107.683 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 51.22 16.17 0.36 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 124.754 1.222 . . . . 12.0 114.001 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.466 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -120.85 145.44 41.37 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 104.121 -2.548 . . . . 12.0 104.121 174.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.495 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 24.5 Cg_endo -61.33 93.89 0.11 Allowed 'Trans proline' 0 C--O 1.2 -1.393 0 N-CA-C 108.429 -1.412 . . . . 12.0 108.429 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.45 HG23 ' CE2' ' A' ' 100' ' ' TYR . 63.4 t -91.73 -14.15 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 122.239 -0.288 . . . . 12.0 110.901 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -146.35 145.62 30.37 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.595 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -102.23 120.0 39.74 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.481 -1.288 . . . . 12.0 108.914 178.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.46 81.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.863 -0.523 . . . . 12.0 110.042 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.8 -158.86 23.27 Favored Glycine 0 N--CA 1.5 2.95 0 N-CA-C 109.896 -1.282 . . . . 12.0 109.896 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 108' ' ' GLY . 8.3 tp -54.58 162.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 122.173 -0.604 . . . . 12.0 109.725 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' N ' HG13 ' A' ' 107' ' ' ILE . . . . . . . . 0 N--CA 1.499 2.889 0 N-CA-C 109.462 -1.455 . . . . 12.0 109.462 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 109.014 -0.735 . . . . 12.0 109.014 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -25.73 62.87 Favored 'General case' 0 N--CA 1.516 2.84 0 O-C-N 122.141 -0.35 . . . . 12.0 110.625 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.1 -61.83 1.72 Allowed 'General case' 0 N--CA 1.512 2.631 0 O-C-N 121.437 -0.789 . . . . 12.0 110.68 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.1 m -62.33 -32.48 73.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.997 -1.112 . . . . 12.0 107.997 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 31.1 t80 -75.79 -23.63 55.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -55.85 -34.25 65.26 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 106.96 -1.496 . . . . 12.0 106.96 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.99 -38.76 52.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.728 -1.212 . . . . 12.0 107.728 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 11.1 mmtm -45.57 -51.32 12.13 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 122.232 -0.293 . . . . 12.0 110.856 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 6' ' ' PHE . 2.1 m-70 -97.52 -13.97 21.36 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 118.837 -0.601 . . . . 12.0 112.153 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 45' ' ' ALA . 15.5 mm -123.18 64.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 114.896 1.443 . . . . 12.0 114.896 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.426 ' CG2' ' CD1' ' A' ' 40' ' ' PHE . 2.7 mp -98.89 63.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 103.984 -2.598 . . . . 12.0 103.984 173.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -73.09 78.61 1.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.734 0.778 . . . . 12.0 111.65 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 p -139.64 75.15 32.2 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.21 11.72 2.27 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.323 2.015 . . . . 12.0 113.59 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 pt -60.99 -168.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-N 119.15 0.886 . . . . 12.0 108.684 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -106.93 36.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.533 -0.729 . . . . 12.0 109.698 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -142.37 101.45 3.9 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 108.55 -0.907 . . . . 12.0 108.55 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.42 -14.45 58.93 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.961 -0.462 . . . . 12.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -85.03 -55.46 4.05 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-N 118.882 0.765 . . . . 12.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.09 -36.52 63.27 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.048 -0.408 . . . . 12.0 110.054 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.0 pt -81.24 -35.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.428 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 2.3 tmm? -99.07 32.03 2.82 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.399 -0.593 . . . . 12.0 109.399 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.07 48.36 1.64 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.277 0.56 . . . . 12.0 110.002 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -127.47 155.62 43.42 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.075 -0.713 . . . . 12.0 109.075 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -73.44 -10.72 60.03 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.89 -0.324 . . . . 12.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.3 tt -79.06 -0.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.587 -0.696 . . . . 12.0 110.761 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.428 ' CD2' ' HG2' ' A' ' 23' ' ' MET . 66.5 m-85 -119.61 54.91 0.98 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.387 -0.597 . . . . 12.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.8 mm -139.01 152.06 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.108 -0.995 . . . . 12.0 110.376 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.84 169.98 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.719 -1.215 . . . . 12.0 107.719 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.02 53.9 3.27 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.283 -1.527 . . . . 12.0 109.283 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.44 -58.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.746 -1.742 . . . . 12.0 108.746 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.6 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.066 -0.667 . . . . 12.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.54 177.55 8.59 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.71 -0.848 . . . . 12.0 108.71 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 159.74 22.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.341 -0.615 . . . . 12.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -72.05 -9.5 58.48 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.24 -0.287 . . . . 12.0 110.768 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -159.28 129.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.7 0.762 . . . . 12.0 111.037 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 1.7 t-20 -117.29 89.17 3.06 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.819 -1.919 . . . . 12.0 105.819 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.3 m -83.71 118.1 23.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.29 0.567 . . . . 12.0 111.83 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CD1' ' CG2' ' A' ' 12' ' ' ILE . 23.3 m-85 -100.05 156.71 17.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.921 -1.511 . . . . 12.0 106.921 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.31 127.84 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.283 -0.886 . . . . 12.0 108.975 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.5 tt -107.53 107.89 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.44 0.638 . . . . 12.0 109.325 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.9 t 176.57 154.12 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.924 -0.769 . . . . 12.0 108.924 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 p -63.48 126.17 26.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.422 ' N ' HD13 ' A' ' 11' ' ' ILE . . . -53.29 -26.97 20.52 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.074 -0.391 . . . . 12.0 110.942 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -80.14 -32.06 38.98 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.629 -0.428 . . . . 12.0 111.621 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -62.07 -40.31 95.37 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.77 -1.567 . . . . 12.0 106.77 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.469 ' CG1' ' CE1' ' A' ' 10' ' ' HIS . 39.5 t -69.53 -35.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.963 -1.125 . . . . 12.0 107.963 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -57.69 -25.42 60.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.97 -0.752 . . . . 12.0 108.97 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.77 -34.73 33.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.876 -0.515 . . . . 12.0 109.734 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.411 HG21 ' N ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -66.2 -28.62 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.767 -0.583 . . . . 12.0 110.544 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.411 ' N ' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -100.67 19.99 15.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.452 -0.78 . . . . 12.0 110.365 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.0 m -85.46 112.45 20.89 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 109.13 -0.693 . . . . 12.0 109.13 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.46 -63.45 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.925 -0.87 . . . . 12.0 110.925 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -158.65 -167.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 118.015 0.907 . . . . 12.0 109.178 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 3.8 tt -87.82 27.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.593 0 O-C-N 121.132 -0.98 . . . . 12.0 110.968 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 13.9 t-20 173.09 118.84 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 106.652 -1.61 . . . . 12.0 106.652 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.47 175.36 12.25 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.621 0.724 . . . . 12.0 111.528 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -141.49 111.48 6.71 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.04 167.65 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.547 -0.538 . . . . 12.0 109.547 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.88 130.4 31.66 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.264 0.554 . . . . 12.0 111.24 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.52 102.9 0.16 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.353 -1.351 . . . . 12.0 107.353 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -87.9 -37.2 16.67 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.251 -0.28 . . . . 12.0 110.254 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.0 m -59.22 -95.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 177.01 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.919 0.781 . . . . 12.0 109.545 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -97.01 41.57 1.11 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.318 -0.623 . . . . 12.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 23.77 105.89 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 114.196 1.184 . . . . 12.0 114.196 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -104.77 157.1 17.43 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.936 0.874 . . . . 12.0 111.868 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.34 100.7 7.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 104.943 -2.243 . . . . 12.0 104.943 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.2 m -97.22 132.27 43.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.757 0.789 . . . . 12.0 112.471 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' SER . 55.6 m -121.63 116.44 24.59 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 104.068 -2.567 . . . . 12.0 104.068 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -106.77 144.68 33.06 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 120.195 -0.602 . . . . 12.0 111.88 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -68.09 100.2 0.97 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.266 -0.642 . . . . 12.0 109.266 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 109.569 -0.53 . . . . 12.0 109.569 -179.596 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.945 0 N-CA-C 108.467 -0.938 . . . . 12.0 108.467 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 36.6 Cg_endo -75.25 116.64 4.6 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 121.645 1.564 . . . . 12.0 110.448 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 73' ' ' ARG . 15.7 m-85 -145.98 137.07 24.61 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.319 0.58 . . . . 12.0 111.728 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 71' ' ' CYS . 7.9 t -107.83 153.88 22.36 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 106.691 -1.596 . . . . 12.0 106.691 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 t -107.79 156.53 19.02 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.563 -0.71 . . . . 12.0 111.456 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -166.09 158.67 14.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.316 -0.624 . . . . 12.0 109.316 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 p -135.06 147.66 49.67 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.053 -0.721 . . . . 12.0 109.053 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.84 -173.64 1.64 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.483 0.659 . . . . 12.0 110.744 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.8 m -66.69 142.75 57.31 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.206 -1.035 . . . . 12.0 108.206 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -104.96 87.41 2.64 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.451 -0.9 . . . . 12.0 111.567 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -107.22 105.6 15.65 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.445 -2.057 . . . . 12.0 105.445 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.2 pt -137.2 -179.53 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.651 0.738 . . . . 12.0 111.926 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -117.37 109.94 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.425 -0.807 . . . . 12.0 110.316 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -105.57 171.0 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.551 -0.907 . . . . 12.0 108.551 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 9.3 mttp -129.18 140.52 51.47 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -110.45 121.81 46.2 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.626 1.343 . . . . 12.0 114.626 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.0 tt0 -136.45 142.49 43.62 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 103.816 -2.661 . . . . 12.0 103.816 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 56.13 30.92 17.27 Favored 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 107.212 -1.403 . . . . 12.0 107.212 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 47.56 19.24 0.14 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.244 1.201 . . . . 12.0 114.244 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.487 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -126.94 145.55 54.26 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 104.585 -2.376 . . . . 12.0 104.585 175.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.487 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 21.9 Cg_endo -59.9 90.25 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.055 0 N-CA-C 108.899 -1.231 . . . . 12.0 108.899 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.464 HG23 ' CE2' ' A' ' 100' ' ' TYR . 44.0 t -87.57 -20.65 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 115.995 -0.548 . . . . 12.0 110.583 -177.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.468 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -137.66 144.03 41.64 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 12.0 108.367 -177.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' NE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -107.97 126.83 53.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 118.851 -1.14 . . . . 12.0 109.537 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.64 -33.79 53.41 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.995 -0.372 . . . . 12.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.83 -133.66 6.9 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.764 -0.934 . . . . 12.0 110.764 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.7 pt -69.73 -172.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 122.344 -0.504 . . . . 12.0 111.004 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.754 0 N-CA-C 111.0 -0.84 . . . . 12.0 111.0 -179.118 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.058 -0.719 . . . . 12.0 109.058 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -28.75 66.73 Favored 'General case' 0 N--CA 1.514 2.744 0 O-C-N 122.161 -0.337 . . . . 12.0 110.279 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.96 -60.03 2.45 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 121.735 -0.603 . . . . 12.0 110.716 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -62.35 -29.35 70.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.104 -1.073 . . . . 12.0 108.104 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 31.1 t80 -79.35 -23.79 43.14 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.174 -0.676 . . . . 12.0 109.174 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -57.93 -35.61 71.33 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 106.696 -1.594 . . . . 12.0 106.696 177.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.09 -35.61 56.36 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.661 -1.237 . . . . 12.0 107.661 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 11.7 tptt -46.07 -60.49 2.24 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 116.686 -0.234 . . . . 12.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.541 ' CE1' ' CZ ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -103.42 -2.16 27.39 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.645 -0.659 . . . . 12.0 112.039 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 4.2 mp -138.51 73.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.415 1.635 . . . . 12.0 115.415 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 40' ' ' PHE . 19.3 mt -97.34 66.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 102.789 -3.041 . . . . 12.0 102.789 172.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.03 75.87 3.59 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.36 -0.836 . . . . 12.0 112.364 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.46 130.9 22.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 106.487 -1.672 . . . . 12.0 106.487 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.12 -24.43 38.55 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 121.277 1.318 . . . . 12.0 110.513 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.42 148.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.183 -1.043 . . . . 12.0 108.183 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 17' ' ' ILE . 11.7 pt -111.41 85.44 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 121.695 0.76 . . . . 12.0 109.221 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -147.3 104.84 3.69 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 m -75.76 -8.32 56.55 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.63 -0.428 . . . . 12.0 110.847 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -69.68 -46.69 65.49 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 118.804 0.729 . . . . 12.0 109.223 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -82.72 -19.61 37.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.665 -0.494 . . . . 12.0 109.665 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mt -87.17 -6.87 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.765 -0.584 . . . . 12.0 110.809 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm -109.51 -43.52 4.07 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.597 -0.89 . . . . 12.0 108.597 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.21 96.91 0.16 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 107.563 -1.273 . . . . 12.0 107.563 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -169.57 157.8 7.37 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.901 -0.777 . . . . 12.0 108.901 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -69.76 -10.88 60.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.048 -0.407 . . . . 12.0 110.076 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.46 13.67 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.723 -0.611 . . . . 12.0 110.356 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -152.54 67.27 0.82 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.61 -0.681 . . . . 12.0 110.367 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -146.34 135.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 120.593 -1.317 . . . . 12.0 110.477 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -109.92 -162.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.446 -1.316 . . . . 12.0 107.446 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.25 67.72 1.0 Allowed Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.029 -1.044 . . . . 12.0 111.662 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.16 -66.8 0.03 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.31 -1.516 . . . . 12.0 109.31 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -165.56 -65.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -154.55 144.01 21.39 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.868 -0.79 . . . . 12.0 108.868 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -66.25 178.3 1.22 Allowed 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.824 -0.436 . . . . 12.0 109.824 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.15 15.87 22.93 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.249 -0.282 . . . . 12.0 110.61 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -162.8 120.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.854 -0.529 . . . . 12.0 109.816 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.452 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 75.6 m-20 -122.12 88.94 3.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m -83.31 107.37 15.79 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 116.371 -0.377 . . . . 12.0 110.685 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 12' ' ' ILE . 12.9 m-85 -98.57 159.79 14.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.066 -1.457 . . . . 12.0 107.066 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 10' ' ' HIS . 3.7 mp -130.26 129.49 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.748 -0.834 . . . . 12.0 108.748 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 42' ' ' ILE . 10.5 tt -101.34 106.27 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.15 -0.685 . . . . 12.0 109.15 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.1 t 176.66 154.47 0.22 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.808 -0.812 . . . . 12.0 108.808 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -60.62 130.04 44.53 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.818 -0.808 . . . . 12.0 108.818 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.94 -27.21 29.56 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.067 -0.395 . . . . 12.0 111.385 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 t -82.43 -30.92 29.78 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.509 -0.476 . . . . 12.0 111.591 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 p -63.58 -37.01 85.7 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.1 t -70.78 -36.06 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -62.07 -23.46 66.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.221 -0.659 . . . . 12.0 109.221 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.953 -0.467 . . . . 12.0 109.839 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -65.3 -29.41 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.837 -0.539 . . . . 12.0 110.088 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.438 ' N ' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.23 24.53 6.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.753 -0.592 . . . . 12.0 110.069 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -87.8 113.22 23.26 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.496 -0.557 . . . . 12.0 109.496 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.2 -64.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.872 -1.291 . . . . 12.0 109.872 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -160.49 -165.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.42 -0.956 . . . . 12.0 108.42 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 45.6 pt -89.77 26.5 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 O-C-N 121.102 -0.999 . . . . 12.0 111.326 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 50.5 t30 173.22 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 107.642 -1.244 . . . . 12.0 107.642 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.3 178.76 6.66 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 121.909 0.861 . . . . 12.0 111.904 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -134.04 116.52 15.58 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 106.735 -1.58 . . . . 12.0 106.735 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 t -130.25 167.59 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.87 -0.519 . . . . 12.0 109.788 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 61' ' ' LEU . 2.8 mp -122.59 110.53 15.67 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -56.88 91.51 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 108.666 -0.865 . . . . 12.0 108.666 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -81.79 -50.94 8.66 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 109.343 -0.614 . . . . 12.0 109.343 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.428 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 64.7 m -61.02 108.7 0.92 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.786 -1.191 . . . . 12.0 107.786 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -40.0 108.67 0.09 Allowed 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.108 0.48 . . . . 12.0 112.245 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 64' ' ' THR . 47.6 m-85 -95.87 42.73 1.09 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 108.8 -0.815 . . . . 12.0 108.8 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 18.22 105.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 113.904 1.076 . . . . 12.0 113.904 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -101.22 157.3 16.88 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 12.0 112.324 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -121.29 97.16 5.39 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.264 -2.125 . . . . 12.0 105.264 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.6 m -101.87 124.39 47.42 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.811 -0.756 . . . . 12.0 112.034 -176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.4 m -110.65 108.64 18.62 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 104.254 -2.498 . . . . 12.0 104.254 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -111.99 140.3 46.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.817 -0.753 . . . . 12.0 111.869 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -65.03 117.41 7.62 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.089 -1.078 . . . . 12.0 108.089 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.982 -0.747 . . . . 12.0 108.982 -179.215 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.454 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 110.303 -0.258 . . . . 12.0 110.303 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 35.1 Cg_endo -77.13 122.22 6.1 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 122.255 1.97 . . . . 12.0 109.649 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.452 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 5.4 m-85 -115.88 138.67 50.95 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 121.634 0.73 . . . . 12.0 111.832 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 p -110.87 131.0 55.42 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 107.393 -1.336 . . . . 12.0 107.393 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 81.0 p -96.46 141.73 29.4 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.511 0.672 . . . . 12.0 111.608 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -152.88 127.88 9.67 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.35 -0.982 . . . . 12.0 108.35 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 m -109.64 149.85 29.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.031 -0.418 . . . . 12.0 110.209 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -175.21 -168.97 0.36 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 120.909 0.385 . . . . 12.0 110.234 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.8 m -57.68 142.28 45.61 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.994 -0.373 . . . . 12.0 109.994 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -109.21 88.48 2.74 Favored 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 121.901 0.857 . . . . 12.0 110.88 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -104.39 101.23 10.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.75 -1.944 . . . . 12.0 105.75 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.429 ' CD1' ' CE1' ' A' ' 104' ' ' PHE . 6.2 pt -134.09 -179.19 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.586 -0.846 . . . . 12.0 111.719 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 10.3 t -115.18 120.74 40.75 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.175 -1.046 . . . . 12.0 108.175 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 6.9 p -115.69 170.11 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 122.243 -0.286 . . . . 12.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.431 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 18.0 mttt -131.54 140.19 49.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.565 -0.902 . . . . 12.0 108.565 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.3 m -113.49 122.55 47.62 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.19 1.182 . . . . 12.0 114.19 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.1 tt0 -131.73 143.35 50.18 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 15.2 m-80 53.51 29.47 9.09 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.765 -1.198 . . . . 12.0 107.765 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 15.2 pt20 53.83 5.87 0.07 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 114.822 1.415 . . . . 12.0 114.822 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -111.85 145.4 32.62 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 104.765 -2.309 . . . . 12.0 104.765 175.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.476 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 24.5 Cg_endo -60.95 89.47 0.09 OUTLIER 'Trans proline' 0 C--O 1.209 -0.942 0 N-CA-C 108.85 -1.25 . . . . 12.0 108.85 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.441 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 95.1 t -85.61 -22.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-N 116.214 -0.448 . . . . 12.0 110.332 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.68 143.33 48.47 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.258 -1.386 . . . . 12.0 107.258 -178.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.541 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -119.29 128.69 54.38 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.166 -1.014 . . . . 12.0 110.375 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -42.18 62.41 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.568 -0.287 . . . . 12.0 110.312 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.72 -129.54 5.84 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.478 -0.867 . . . . 12.0 111.009 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 tt -60.74 165.97 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.222 -0.575 . . . . 12.0 110.567 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.503 3.156 0 N-CA-C 110.648 -0.981 . . . . 12.0 110.648 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.0 t30 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.194 -0.669 . . . . 12.0 109.194 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.403 ' CZ2' ' HB2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.81 -29.19 64.17 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 122.096 -0.377 . . . . 12.0 110.465 -178.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -58.72 3.12 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.901 -0.499 . . . . 12.0 110.571 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -63.36 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.171 -1.048 . . . . 12.0 108.171 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 30.1 t80 -77.13 -22.75 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.103 -0.703 . . . . 12.0 109.103 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -61.26 -38.34 86.35 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.89 -35.61 57.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.421 -1.325 . . . . 12.0 107.421 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -44.21 -57.06 3.66 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 116.355 -0.384 . . . . 12.0 110.763 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.596 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 76.0 m-70 -108.26 -4.05 17.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.062 1.134 . . . . 12.0 114.062 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 45' ' ' ALA . 39.2 mm -122.38 64.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 118.566 -1.253 . . . . 12.0 113.597 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.2 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.348 -2.093 . . . . 12.0 105.348 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.423 ' O ' ' CG2' ' A' ' 14' ' ' THR . 8.0 p30 -54.58 85.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 CA-C-O 121.46 0.648 . . . . 12.0 111.15 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.444 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 12.7 p -164.66 57.73 0.56 Allowed Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 107.65 -1.241 . . . . 12.0 107.65 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 14' ' ' THR . 35.9 Cg_endo -74.98 82.57 1.97 Allowed 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 121.936 1.757 . . . . 12.0 110.457 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.49 -162.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.154 -1.054 . . . . 12.0 108.154 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.19 30.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 109.073 -0.714 . . . . 12.0 109.073 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -140.79 95.36 2.84 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.279 -1.008 . . . . 12.0 108.279 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.3 m -77.04 -18.61 58.0 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 120.266 -0.574 . . . . 12.0 111.389 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.12 -52.35 7.47 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 119.082 0.855 . . . . 12.0 110.315 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.11 -33.26 38.92 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.511 -0.551 . . . . 12.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.6 pt -82.38 -37.44 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.904 -0.406 . . . . 12.0 109.904 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.68 40.64 1.45 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.444 0.64 . . . . 12.0 109.305 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -87.77 50.07 1.92 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.511 0.672 . . . . 12.0 109.684 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -127.87 161.33 29.31 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.045 -0.724 . . . . 12.0 109.045 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -74.76 -8.91 57.87 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.789 -0.364 . . . . 12.0 110.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.432 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 32.0 pt -80.17 -3.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.574 -0.704 . . . . 12.0 111.113 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CZ ' HD13 ' A' ' 27' ' ' ILE . 64.9 m-85 -112.3 47.52 1.06 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.744 -0.598 . . . . 12.0 110.578 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mt -150.33 144.92 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.027 -1.046 . . . . 12.0 110.302 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.4 t -106.78 169.25 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 107.711 -1.218 . . . . 12.0 107.711 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.77 61.33 3.1 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.05 -65.06 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.052 -1.619 . . . . 12.0 109.052 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -168.95 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 117.703 0.751 . . . . 12.0 109.792 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 t -145.38 131.11 18.98 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -61.77 164.96 5.64 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.479 -0.564 . . . . 12.0 109.479 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -102.05 -3.18 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 122.24 -0.288 . . . . 12.0 111.01 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.6 p -162.48 114.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.603 -0.686 . . . . 12.0 110.645 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 8.3 m120 -107.29 84.78 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.678 -1.601 . . . . 12.0 106.678 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 m -80.9 109.49 15.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 116.071 -0.513 . . . . 12.0 110.648 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -98.73 161.7 13.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.805 -1.554 . . . . 12.0 106.805 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.98 132.54 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.335 0.971 . . . . 12.0 109.54 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tp -108.44 105.42 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.195 -1.039 . . . . 12.0 108.195 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t 179.54 153.33 0.45 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.61 122.07 9.07 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.794 0.807 . . . . 12.0 109.827 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -46.42 -64.96 0.63 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 113.613 0.968 . . . . 12.0 113.613 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.7 p -62.72 -17.03 60.07 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.165 -0.614 . . . . 12.0 111.235 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.2 m -66.01 -36.68 83.94 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.302 -1.369 . . . . 12.0 107.302 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.26 -35.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.048 -1.464 . . . . 12.0 107.048 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -63.73 -21.73 66.55 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 12.0 108.992 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.54 -38.7 25.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.0 -0.438 . . . . 12.0 110.015 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.4 -22.74 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.769 -0.582 . . . . 12.0 109.91 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.1 35.86 2.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.802 -0.561 . . . . 12.0 109.805 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.4 m -96.76 112.8 24.4 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.184 -0.672 . . . . 12.0 109.184 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.03 -63.02 0.02 OUTLIER Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.598 -1.001 . . . . 12.0 110.598 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 p -162.12 -167.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.691 -0.855 . . . . 12.0 108.691 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.9 pt -88.25 26.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 121.024 -1.047 . . . . 12.0 111.317 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 174.05 112.99 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 107.508 -1.293 . . . . 12.0 107.508 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.8 -176.37 4.57 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.984 0.897 . . . . 12.0 111.955 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -140.14 124.59 17.97 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.697 -1.594 . . . . 12.0 106.697 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 94' ' ' VAL . 10.0 p -137.32 166.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.735 -0.603 . . . . 12.0 109.727 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.7 mt -126.27 112.56 15.87 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.904 -0.498 . . . . 12.0 112.193 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 4.0 m -67.7 91.2 0.29 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 105.691 -1.966 . . . . 12.0 105.691 176.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -86.77 -37.41 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.149 -0.344 . . . . 12.0 111.634 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.8 m -53.88 -92.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.195 -0.669 . . . . 12.0 109.195 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.15 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.778 0.717 . . . . 12.0 109.563 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 49.9 m-85 -96.89 44.51 1.06 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 14.79 105.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.254 0 N-CA-C 114.087 1.143 . . . . 12.0 114.087 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.79 156.35 17.89 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.939 0.876 . . . . 12.0 111.972 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.14 99.17 6.55 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.675 -1.972 . . . . 12.0 105.675 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.4 m -100.51 125.06 46.8 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.011 -0.676 . . . . 12.0 112.555 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.9 m -105.79 111.53 24.24 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 104.187 -2.523 . . . . 12.0 104.187 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 m -101.89 140.41 36.2 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 120.014 -0.675 . . . . 12.0 111.519 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -72.6 105.99 4.46 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.122 -0.696 . . . . 12.0 109.122 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.499 2.024 0 N-CA-C 110.014 -0.365 . . . . 12.0 110.014 -179.53 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.652 -0.87 . . . . 12.0 108.652 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.74 113.95 3.89 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 121.492 1.461 . . . . 12.0 109.829 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 12.9 m-85 -140.2 134.22 30.84 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.083 0.468 . . . . 12.0 110.917 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -109.0 128.66 55.14 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.857 -1.164 . . . . 12.0 107.857 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.5 p -89.55 139.88 30.1 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.306 0.574 . . . . 12.0 110.909 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -147.97 158.41 44.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.511 -0.922 . . . . 12.0 108.511 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -139.67 148.72 42.79 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 109.537 -0.542 . . . . 12.0 109.537 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -177.22 -176.49 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.501 -0.48 . . . . 12.0 110.279 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -53.86 141.02 28.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.778 -0.453 . . . . 12.0 109.778 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -110.47 86.11 2.24 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.593 -0.843 . . . . 12.0 112.596 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -95.67 100.73 12.42 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.0 -2.222 . . . . 12.0 105.0 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.451 HG12 ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -122.93 149.6 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.546 0.689 . . . . 12.0 111.929 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.1 t -92.48 136.01 33.57 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 105.523 -2.029 . . . . 12.0 105.523 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.508 ' CG1' ' CZ ' ' A' ' 104' ' ' PHE . 2.8 m -140.57 -176.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 120.275 -0.57 . . . . 12.0 111.004 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.446 ' CB ' ' CD2' ' A' ' 103' ' ' HIS . 40.0 mtmt -147.95 149.22 31.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -118.78 117.57 29.25 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.688 0.756 . . . . 12.0 112.839 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 18.2 tt0 -124.52 143.77 50.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.844 -2.65 . . . . 12.0 103.844 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.7 m120 55.46 27.17 9.79 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-N 119.845 1.202 . . . . 12.0 107.946 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 18.4 pt20 54.59 8.85 0.23 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.098 1.359 . . . . 12.0 114.382 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.486 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -114.88 146.74 36.74 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 104.731 -2.322 . . . . 12.0 104.731 174.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.486 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.5 Cg_endo -59.88 88.92 0.07 OUTLIER 'Trans proline' 0 C--O 1.208 -1.005 0 C-N-CA 121.331 1.354 . . . . 12.0 109.282 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.447 HG23 ' CE2' ' A' ' 100' ' ' TYR . 54.3 t -84.45 -19.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 116.295 -0.411 . . . . 12.0 110.468 -177.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.489 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -136.83 134.42 36.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 -177.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.596 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.2 OUTLIER -123.78 129.81 51.64 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.963 -0.695 . . . . 12.0 109.395 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.91 -41.98 14.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.229 -0.295 . . . . 12.0 110.728 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.95 -99.88 0.59 Allowed Glycine 0 N--CA 1.504 3.186 0 C-N-CA 120.295 -0.955 . . . . 12.0 111.139 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.9 pt -58.29 147.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.844 -0.797 . . . . 12.0 110.294 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.836 -1.306 . . . . 12.0 109.836 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.49 65.23 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 122.031 -0.418 . . . . 12.0 110.009 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.55 42.86 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.804 -0.56 . . . . 12.0 110.451 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -65.39 -29.56 70.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.471 -0.937 . . . . 12.0 108.471 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 35.5 t80 -76.97 -20.0 56.63 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.866 -0.79 . . . . 12.0 108.866 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.452 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 12.3 tt0 -64.2 -38.88 92.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 106.475 -1.676 . . . . 12.0 106.475 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.65 -32.83 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -43.25 -64.4 0.65 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 110.298 -0.26 . . . . 12.0 110.298 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.524 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 88.8 m-70 -110.08 -23.2 11.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.2 0.815 . . . . 12.0 113.2 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 22.9 mm -93.81 57.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 119.254 0.934 . . . . 12.0 113.234 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.13 76.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 105.42 -2.067 . . . . 12.0 105.42 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.15 79.44 2.97 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.794 0.807 . . . . 12.0 110.125 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -135.0 70.36 70.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.261 -1.385 . . . . 12.0 107.261 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -71.94 86.3 0.92 Allowed 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 121.825 1.683 . . . . 12.0 111.045 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.9 pt -136.07 -167.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.201 -1.037 . . . . 12.0 108.201 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.08 38.39 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.666 0.746 . . . . 12.0 109.352 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -153.1 101.36 2.56 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 116.292 -0.413 . . . . 12.0 109.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -81.26 -5.86 58.24 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 122.054 -0.404 . . . . 12.0 111.014 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -83.13 -55.24 4.47 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.496 -0.753 . . . . 12.0 111.501 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -61.54 -23.09 65.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.679 -0.638 . . . . 12.0 110.719 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -84.53 -35.08 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.64 -0.663 . . . . 12.0 109.621 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -95.79 12.78 28.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.004 -0.435 . . . . 12.0 110.625 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.58 90.41 0.26 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.334 -1.358 . . . . 12.0 107.334 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -172.79 152.85 2.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.317 -0.623 . . . . 12.0 109.317 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -68.0 -11.98 59.92 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 110.044 -0.354 . . . . 12.0 110.044 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.8 mt -86.59 9.66 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.727 -0.608 . . . . 12.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -144.12 63.16 1.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.599 -0.688 . . . . 12.0 109.181 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 29' ' ' ILE . 41.3 mt -148.08 151.99 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.593 -1.317 . . . . 12.0 111.02 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.75 170.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 107.376 -1.342 . . . . 12.0 107.376 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.71 52.7 3.34 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.372 -1.491 . . . . 12.0 109.372 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.43 -56.69 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.304 -1.518 . . . . 12.0 109.304 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.87 -69.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.023 -0.732 . . . . 12.0 109.023 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.92 -169.72 2.88 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -115.0 167.16 11.05 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.163 -0.68 . . . . 12.0 109.163 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -76.76 -17.39 59.09 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.859 -0.336 . . . . 12.0 110.465 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p -161.53 118.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.36 0.6 . . . . 12.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -114.22 86.28 2.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.333 -1.729 . . . . 12.0 106.333 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -87.24 123.89 32.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.485 0.659 . . . . 12.0 111.373 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -108.5 163.36 13.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.977 -1.49 . . . . 12.0 106.977 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.1 mt -131.32 132.01 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.218 -0.926 . . . . 12.0 109.458 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.1 mm -100.29 108.83 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 108.979 -0.749 . . . . 12.0 108.979 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 t 177.6 150.21 0.19 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.167 -0.679 . . . . 12.0 109.167 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 p -59.95 130.11 45.13 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.804 -0.813 . . . . 12.0 108.804 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -24.54 4.86 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.486 . . . . 12.0 111.224 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -84.78 -32.27 23.48 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.41 -0.516 . . . . 12.0 111.613 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -62.99 -38.92 93.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.117 -1.438 . . . . 12.0 107.117 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.71 -35.7 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.564 -1.273 . . . . 12.0 107.564 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.15 -23.95 66.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.145 -0.687 . . . . 12.0 109.145 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.14 -36.95 29.61 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.976 -0.452 . . . . 12.0 110.158 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.418 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 8.5 tp -66.45 -23.74 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.801 -0.562 . . . . 12.0 110.386 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.89 27.61 6.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.828 -0.545 . . . . 12.0 109.947 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 m -90.99 114.92 27.56 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.452 -0.573 . . . . 12.0 109.452 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.64 0.02 OUTLIER Glycine 0 N--CA 1.5 2.93 0 N-CA-C 110.152 -1.179 . . . . 12.0 110.152 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 p -159.94 -168.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.69 -0.856 . . . . 12.0 108.69 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 pt -88.14 25.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.118 -0.989 . . . . 12.0 111.39 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 174.0 115.03 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 107.521 -1.288 . . . . 12.0 107.521 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 176.82 10.99 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.69 0.757 . . . . 12.0 111.491 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -138.85 117.4 12.12 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.29 -1.374 . . . . 12.0 107.29 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.15 165.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 mp -125.73 125.64 43.33 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 120.758 -0.377 . . . . 12.0 110.808 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.48 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.31 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 177.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -86.44 -23.17 26.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.956 -0.465 . . . . 12.0 110.943 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -59.57 -88.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.497 -0.557 . . . . 12.0 109.497 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 172.71 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 108.596 -0.89 . . . . 12.0 108.596 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 73.0 m-85 -105.17 57.52 0.68 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 109.253 -0.647 . . . . 12.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' PHE . 5.5 pt20 -4.5 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 114.557 1.317 . . . . 12.0 114.557 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.414 ' N ' ' HB2' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -105.22 158.22 16.75 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.224 1.011 . . . . 12.0 112.94 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -117.8 98.16 6.21 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 105.131 -2.174 . . . . 12.0 105.131 176.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.6 m -100.88 127.65 47.26 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.879 -0.729 . . . . 12.0 112.937 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.8 m -111.29 105.42 14.07 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 103.738 -2.689 . . . . 12.0 103.738 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 m -105.88 145.32 31.4 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 120.258 -0.577 . . . . 12.0 112.008 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 8.0 ttp180 -69.07 138.84 54.68 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.853 -0.795 . . . . 12.0 108.853 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.502 2.146 0 O-C-N 121.919 -0.488 . . . . 12.0 110.435 -179.43 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.521 0 CA-C-O 119.014 -0.517 . . . . 12.0 110.45 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 41.2 Cg_endo -77.07 110.57 3.05 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.778 1.652 . . . . 12.0 109.995 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 23.1 m-85 -143.83 133.56 23.76 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.438 0.637 . . . . 12.0 110.736 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -119.37 129.21 54.7 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -96.05 142.49 28.19 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.254 0.549 . . . . 12.0 110.912 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -151.49 125.86 9.41 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.379 -0.971 . . . . 12.0 108.379 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.9 m -105.53 147.05 28.79 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.707 -0.397 . . . . 12.0 109.983 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -174.87 -171.0 0.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.696 -0.483 . . . . 12.0 109.696 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.6 m -63.83 134.38 55.11 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.414 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -107.12 91.96 3.88 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.552 0.691 . . . . 12.0 112.18 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.69 107.16 19.0 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 mt -110.85 160.94 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 122.2 1.0 . . . . 12.0 113.489 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -112.2 103.85 12.03 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 105.258 -2.127 . . . . 12.0 105.258 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.493 ' CG1' ' CZ ' ' A' ' 104' ' ' PHE . 7.2 m -122.71 -171.71 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.435 0.636 . . . . 12.0 112.018 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 2.2 mtpp -145.24 152.01 39.28 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.03 -0.73 . . . . 12.0 109.03 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.58 119.69 33.64 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.655 0.74 . . . . 12.0 112.853 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 11.7 tt0 -127.36 145.55 50.77 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 104.362 -2.459 . . . . 12.0 104.362 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 52.98 28.6 6.82 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 119.876 1.216 . . . . 12.0 107.998 -176.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 12.0 pt20 55.56 4.08 0.09 Allowed 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 125.418 1.487 . . . . 12.0 114.701 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.481 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -110.14 147.29 35.96 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 105.147 -2.168 . . . . 12.0 105.147 175.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.1 Cg_endo -60.8 89.56 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.37 1.38 . . . . 12.0 108.79 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.458 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 46.6 t -85.07 -14.11 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.619 -0.718 . . . . 12.0 110.654 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.489 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -144.87 117.75 8.76 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.512 -0.875 . . . . 12.0 110.387 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.524 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 1.3 m-85 -101.12 121.0 41.05 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.503 -1.665 . . . . 12.0 106.503 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.62 -28.84 17.25 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 112.966 0.728 . . . . 12.0 112.966 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.88 -169.28 37.29 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.803 -1.189 . . . . 12.0 111.111 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.0 mt -93.38 36.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.051 0.453 . . . . 12.0 110.616 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.037 0 N-CA-C 110.519 -1.032 . . . . 12.0 110.519 178.862 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -69.03 -24.19 64.16 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 121.636 -0.665 . . . . 12.0 110.492 -177.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.76 -64.08 1.07 Allowed 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.607 -0.683 . . . . 12.0 110.655 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.21 80.76 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.419 -1.326 . . . . 12.0 107.419 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 32.0 t80 -70.25 -25.66 63.48 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.384 -0.969 . . . . 12.0 108.384 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -52.0 -31.77 30.88 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 107.186 -1.413 . . . . 12.0 107.186 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -42.82 30.49 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.797 -1.186 . . . . 12.0 107.797 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 9.7 mmtp -44.42 -53.84 6.49 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 122.363 -0.211 . . . . 12.0 111.365 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.472 ' NE2' ' CZ ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -95.47 -17.71 21.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.942 -0.474 . . . . 12.0 111.42 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 45' ' ' ALA . 15.9 mm -129.48 79.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 118.899 -1.121 . . . . 12.0 113.929 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.5 mm -98.09 75.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 104.198 -2.519 . . . . 12.0 104.198 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -82.81 61.92 6.12 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.658 0.742 . . . . 12.0 111.425 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.419 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 60.9 p -146.55 65.19 10.05 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 106.954 -1.499 . . . . 12.0 106.954 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 14' ' ' THR . 37.1 Cg_endo -82.2 45.51 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.372 2.048 . . . . 12.0 112.011 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.62 -165.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.83 -0.804 . . . . 12.0 108.83 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.2 pt -97.81 43.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-O 121.424 0.631 . . . . 12.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -158.02 99.41 1.67 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.063 -0.717 . . . . 12.0 109.063 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.0 m -76.53 -12.72 60.07 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.954 -0.466 . . . . 12.0 110.996 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -63.57 -49.42 73.47 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 119.048 0.84 . . . . 12.0 109.025 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.7 m -74.85 -19.63 60.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.641 -0.503 . . . . 12.0 109.641 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.438 HG23 ' CE1' ' A' ' 40' ' ' PHE . 44.1 mt -84.94 -8.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.765 -0.585 . . . . 12.0 110.663 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.54 4.89 7.57 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.629 -0.669 . . . . 12.0 110.305 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -58.23 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.403 -0.962 . . . . 12.0 108.403 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -173.08 152.14 2.26 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.751 -0.833 . . . . 12.0 108.751 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -70.21 -9.72 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.713 -0.395 . . . . 12.0 110.275 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.71 12.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.689 -0.632 . . . . 12.0 110.685 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -142.28 55.35 1.45 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.657 -0.652 . . . . 12.0 110.802 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.1 mm -148.29 152.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 120.673 -1.267 . . . . 12.0 110.038 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.06 168.28 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 107.71 -1.218 . . . . 12.0 107.71 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.87 54.91 3.35 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.738 -1.745 . . . . 12.0 108.738 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.95 -54.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.531 -1.427 . . . . 12.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -163.57 -76.41 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 122.054 -0.674 . . . . 12.0 109.404 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -133.94 -175.94 4.01 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.533 -0.543 . . . . 12.0 109.533 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -107.1 171.66 7.25 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -79.6 -17.34 54.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.1 -0.375 . . . . 12.0 110.575 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -162.1 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 119.789 -0.764 . . . . 12.0 111.457 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.464 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 11.6 m-20 -97.18 85.81 3.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.753 -1.943 . . . . 12.0 105.753 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.62 123.18 29.52 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.661 0.743 . . . . 12.0 112.555 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.438 ' CE1' HG23 ' A' ' 22' ' ' ILE . 23.6 m-85 -100.32 161.68 13.44 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.929 -1.508 . . . . 12.0 106.929 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.68 122.98 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.956 -1.09 . . . . 12.0 110.091 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 42' ' ' ILE . 4.8 mt -98.54 107.11 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.27 -1.011 . . . . 12.0 108.27 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.7 t 175.93 165.76 0.39 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 109.27 -0.641 . . . . 12.0 109.27 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 p -82.7 125.47 31.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.166 -1.049 . . . . 12.0 108.166 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HB2' ' CZ3' ' A' ' 3' ' ' TRP . . . -50.05 -31.47 13.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.992 -0.442 . . . . 12.0 111.887 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -76.61 -32.88 58.34 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.426 -0.51 . . . . 12.0 111.935 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.2 m -64.59 -34.34 78.02 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.817 -1.179 . . . . 12.0 107.817 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.413 HG21 ' CD1' ' A' ' 66' ' ' PHE . 20.7 t -71.03 -35.38 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.407 -1.331 . . . . 12.0 107.407 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -65.23 -21.43 66.75 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 116.016 -0.538 . . . . 12.0 110.019 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.63 -39.16 24.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.821 -0.55 . . . . 12.0 109.922 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.416 HG23 ' CZ ' ' A' ' 66' ' ' PHE . 7.2 tp -69.16 -18.07 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.788 -0.57 . . . . 12.0 110.401 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -97.34 15.14 23.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.58 -0.7 . . . . 12.0 111.003 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.3 m -66.16 107.27 1.88 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.189 -0.671 . . . . 12.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.79 -63.2 0.01 OUTLIER Glycine 0 N--CA 1.501 2.983 0 C-N-CA 120.484 -0.865 . . . . 12.0 111.013 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 p -167.54 -171.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.067 0.934 . . . . 12.0 109.434 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 15.0 tt -89.21 32.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 O-C-N 121.429 -0.794 . . . . 12.0 110.781 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 5.0 t30 169.75 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 107.257 -1.386 . . . . 12.0 107.257 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -163.17 179.72 7.25 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.121 0.962 . . . . 12.0 112.404 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -137.36 108.41 6.75 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.644 -1.614 . . . . 12.0 106.644 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.9 171.13 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.853 -0.529 . . . . 12.0 109.886 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mp -124.66 124.16 41.6 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.816 -0.439 . . . . 12.0 109.816 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.49 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 108.453 -0.943 . . . . 12.0 108.453 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -75.47 -43.43 49.43 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.638 -0.875 . . . . 12.0 108.638 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -65.65 124.1 21.47 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.17 -1.048 . . . . 12.0 108.17 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.49 105.95 0.18 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 122.088 -0.383 . . . . 12.0 109.982 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.416 ' CZ ' HG23 ' A' ' 51' ' ' ILE . 48.2 m-85 -94.94 41.04 1.09 Allowed 'General case' 0 N--CA 1.512 2.666 0 C-N-CA 120.074 -0.65 . . . . 12.0 109.548 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 24.99 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 114.284 1.216 . . . . 12.0 114.284 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.95 155.58 18.53 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.032 0.92 . . . . 12.0 112.494 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 99.45 6.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 104.787 -2.301 . . . . 12.0 104.787 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -105.43 128.93 53.79 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.033 1.123 . . . . 12.0 114.033 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.35 105.37 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 103.107 -2.923 . . . . 12.0 103.107 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -105.26 144.19 32.39 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.07 -0.652 . . . . 12.0 111.944 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 105.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.593 -0.891 . . . . 12.0 108.593 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.503 2.177 0 C-N-CA 120.595 -0.442 . . . . 12.0 110.311 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 93.8 m . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.963 -0.542 . . . . 12.0 109.759 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.14 134.8 18.01 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 121.831 1.687 . . . . 12.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.464 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 16.5 m-85 -142.93 139.26 30.65 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.283 0.564 . . . . 12.0 110.536 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 t -124.71 126.23 45.35 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 108.323 -0.991 . . . . 12.0 108.323 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 139.97 30.76 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.06 0.457 . . . . 12.0 110.612 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -152.53 124.09 7.79 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.802 -0.814 . . . . 12.0 108.802 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -94.11 152.92 18.41 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -176.09 -167.74 0.24 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.155 0.502 . . . . 12.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -65.31 143.85 57.51 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -108.51 87.73 2.56 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.945 0.879 . . . . 12.0 110.856 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -100.01 112.93 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.938 -2.245 . . . . 12.0 104.938 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.64 175.67 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-O 122.274 1.035 . . . . 12.0 112.406 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.3 t -125.54 99.3 5.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.154 -1.795 . . . . 12.0 106.154 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 9.8 p -111.95 164.19 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.236 0.541 . . . . 12.0 111.193 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -118.04 140.84 49.17 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.88 120.32 33.12 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.505 1.298 . . . . 12.0 114.505 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.455 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 24.9 tt0 -114.99 139.99 49.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.869 -2.641 . . . . 12.0 103.869 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 77.7 m-20 56.46 31.04 18.13 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 5.7 pt20 52.75 10.34 0.15 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 114.569 1.322 . . . . 12.0 114.569 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -112.21 140.73 23.91 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 104.051 -2.574 . . . . 12.0 104.051 174.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.468 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 26.8 Cg_endo -60.78 90.85 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.857 0 N-CA-C 108.713 -1.303 . . . . 12.0 108.713 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 81.5 t -88.84 -19.95 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 116.244 -0.435 . . . . 12.0 110.694 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.455 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -139.9 145.72 38.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.694 -1.225 . . . . 12.0 107.694 -178.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CZ ' ' NE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -109.31 133.52 52.95 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.209 -0.996 . . . . 12.0 109.221 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.72 -19.45 15.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.033 -0.417 . . . . 12.0 111.676 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.29 173.88 44.07 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 110.468 -1.053 . . . . 12.0 110.468 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.3 pt -97.82 26.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.186 -0.596 . . . . 12.0 110.279 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.933 0 N-CA-C 110.076 -1.209 . . . . 12.0 110.076 179.334 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.491 0 N-CA-C 109.928 -0.397 . . . . 12.0 109.928 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -153.4 163.94 39.04 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.061 -0.718 . . . . 12.0 109.061 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -37.43 74.48 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 122.022 -0.424 . . . . 12.0 110.586 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.98 6.49 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.351 -0.843 . . . . 12.0 110.676 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -62.52 -32.3 73.21 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.211 -1.033 . . . . 12.0 108.211 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 61.4 t80 -72.59 -25.83 61.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.157 -1.053 . . . . 12.0 108.157 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.92 -33.69 62.39 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 1.5 mt-30 -80.39 -37.95 31.28 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.21 -1.404 . . . . 12.0 107.21 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -44.52 -57.33 3.66 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.983 -0.448 . . . . 12.0 111.079 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 4.4 m80 -99.58 -31.04 11.8 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.595 -0.691 . . . . 12.0 111.697 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 7.9 mm -102.93 65.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.668 1.729 . . . . 12.0 115.668 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 8' ' ' GLN . 3.4 mp -95.29 62.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 103.588 -2.745 . . . . 12.0 103.588 173.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -74.21 81.06 1.8 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.709 0.766 . . . . 12.0 110.409 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.6 p -118.5 106.87 43.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.233 -1.025 . . . . 12.0 108.233 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -81.51 37.16 0.66 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 121.921 1.747 . . . . 12.0 111.795 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.13 164.64 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.694 -0.854 . . . . 12.0 108.694 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 33.5 pt -97.29 33.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-O 121.345 0.593 . . . . 12.0 109.855 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.24 91.36 3.36 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.29 -1.004 . . . . 12.0 108.29 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -76.28 -15.94 59.89 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.904 -0.498 . . . . 12.0 111.287 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -82.99 -50.41 8.58 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 119.019 0.827 . . . . 12.0 109.912 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.27 70.13 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 110.028 -0.36 . . . . 12.0 110.028 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.98 -39.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 120.625 -0.43 . . . . 12.0 109.955 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.52 12.82 23.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.878 -0.514 . . . . 12.0 110.344 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -60.35 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.295 -1.002 . . . . 12.0 108.295 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -172.31 155.54 3.57 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.415 -0.587 . . . . 12.0 109.415 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -71.94 -10.23 59.48 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.922 -0.399 . . . . 12.0 109.922 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 68.0 mt -85.78 8.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.691 -0.63 . . . . 12.0 110.644 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -135.96 57.19 1.79 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.536 -0.727 . . . . 12.0 110.025 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mt -151.47 145.87 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.959 -1.088 . . . . 12.0 109.889 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -109.73 -168.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 108.13 -1.063 . . . . 12.0 108.13 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.46 71.38 0.71 Allowed Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.201 -0.937 . . . . 12.0 111.411 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.72 -63.44 0.03 OUTLIER Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.227 -1.549 . . . . 12.0 109.227 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -165.22 -65.44 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.035 -1.098 . . . . 12.0 108.035 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.0 p -141.67 167.75 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 12.0 108.711 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -77.46 149.67 35.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.928 -0.482 . . . . 12.0 109.716 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -77.08 -23.85 51.89 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 110.104 -0.332 . . . . 12.0 110.104 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 18.3 t -150.28 103.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 120.29 -0.564 . . . . 12.0 110.293 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.453 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 2.7 m-20 -92.59 76.48 5.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.441 -1.688 . . . . 12.0 106.441 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.8 m -79.23 116.49 19.52 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.928 -0.578 . . . . 12.0 110.686 -177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -107.01 163.59 12.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.087 -1.079 . . . . 12.0 108.087 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.404 ' HB ' ' O ' ' A' ' 10' ' ' HIS . 16.1 mm -126.71 124.57 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.907 -1.146 . . . . 12.0 107.907 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.3 pt -96.51 98.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.2 t -176.29 157.9 1.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.232 -0.655 . . . . 12.0 109.232 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.1 p -63.88 128.17 34.64 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 109.244 -0.65 . . . . 12.0 109.244 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.45 -25.06 22.81 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.89 -0.506 . . . . 12.0 110.623 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -76.71 -33.91 58.18 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.523 -0.471 . . . . 12.0 111.231 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -65.19 -39.88 93.47 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.091 -1.448 . . . . 12.0 107.091 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.85 -31.86 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.824 -1.176 . . . . 12.0 107.824 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -67.38 -23.15 65.55 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.734 -0.469 . . . . 12.0 109.734 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -40.23 30.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.908 -0.495 . . . . 12.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.41 -20.67 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.784 -0.572 . . . . 12.0 110.681 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.43 25.09 9.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.831 -0.543 . . . . 12.0 109.829 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -96.33 114.31 25.98 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.767 -0.583 . . . . 12.0 109.577 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.49 -62.68 0.01 OUTLIER Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.099 -1.2 . . . . 12.0 110.099 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 p -152.76 -169.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.517 -0.92 . . . . 12.0 108.517 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 18.3 tt -88.62 26.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 O-C-N 120.915 -1.116 . . . . 12.0 110.796 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 4.4 t30 171.47 110.5 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 107.195 -1.409 . . . . 12.0 107.195 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -172.54 3.31 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.384 0.612 . . . . 12.0 110.684 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.98 114.55 8.02 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.094 -1.076 . . . . 12.0 108.094 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 t -125.27 169.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.501 -0.925 . . . . 12.0 108.501 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.78 120.63 10.59 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.765 -0.774 . . . . 12.0 112.1 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 97.27 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.557 -1.275 . . . . 12.0 107.557 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -40.29 24.97 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.693 -0.484 . . . . 12.0 109.693 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.663 -0.495 . . . . 12.0 109.663 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 177.87 103.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.601 -0.687 . . . . 12.0 110.21 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -98.25 44.51 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.183 -0.607 . . . . 12.0 109.48 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 18.17 107.39 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 114.287 1.217 . . . . 12.0 114.287 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -102.4 153.99 19.51 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.03 0.919 . . . . 12.0 112.274 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -117.8 94.79 4.65 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.718 -1.956 . . . . 12.0 105.718 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 m -100.91 126.81 47.56 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.725 0.774 . . . . 12.0 112.786 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.6 m -106.76 104.76 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 104.589 -2.374 . . . . 12.0 104.589 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.4 m -101.21 131.36 47.24 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.211 -0.596 . . . . 12.0 111.727 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -63.05 105.82 0.75 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.107 -1.072 . . . . 12.0 108.107 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 p -105.87 -92.88 0.38 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 122.03 -0.419 . . . . 12.0 110.81 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.27 177.86 1.16 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.457 -0.777 . . . . 12.0 109.845 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.3 mt 63.79 139.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.4 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 7.7 m 59.39 58.83 5.09 Favored Pre-proline 0 N--CA 1.497 1.878 0 N-CA-C 109.597 -0.52 . . . . 12.0 109.597 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' N ' ' A' ' 77' ' ' THR . 35.3 Cg_endo -76.32 125.59 8.54 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 121.967 1.778 . . . . 12.0 109.925 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.476 ' N ' ' CA ' ' A' ' 80' ' ' PRO . 9.7 ttp85 -132.73 43.09 0.98 Allowed Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 112.627 0.603 . . . . 12.0 112.627 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' CA ' ' N ' ' A' ' 79' ' ' ARG . 40.2 Cg_endo -88.42 -11.47 38.15 Favored 'Cis proline' 0 CA--C 1.541 0.839 0 N-CA-C 110.366 -0.667 . . . . 12.0 110.366 -3.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.0 m -106.12 115.53 61.0 Favored Pre-proline 0 N--CA 1.495 1.814 0 CA-C-O 118.519 -0.753 . . . . 12.0 109.344 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.57 145.7 26.51 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.473 1.449 . . . . 12.0 110.279 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.0 m-85 -131.7 134.79 46.29 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.313 0.577 . . . . 12.0 110.512 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -105.84 109.78 21.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.097 -1.075 . . . . 12.0 108.097 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -83.57 133.93 34.84 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.178 0.513 . . . . 12.0 110.261 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -148.72 125.83 11.4 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -105.68 146.39 29.81 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.384 -0.599 . . . . 12.0 109.384 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -172.24 -172.12 0.91 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 120.746 -0.382 . . . . 12.0 110.134 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 m -57.0 139.41 52.23 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.554 -0.536 . . . . 12.0 109.554 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.424 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 4.4 t-20 -112.84 88.01 2.73 Favored 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 119.482 -0.887 . . . . 12.0 112.064 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -95.78 96.23 8.83 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 104.399 -2.445 . . . . 12.0 104.399 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.413 ' CD1' ' CZ ' ' A' ' 104' ' ' PHE . 21.0 tt -130.28 163.68 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 119.854 -0.738 . . . . 12.0 111.708 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.68 114.14 28.12 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.008 -0.542 . . . . 12.0 110.191 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 11.1 p -104.57 161.58 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.281 -0.637 . . . . 12.0 109.281 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 12.7 ttmt -118.31 144.5 45.79 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.885 -0.783 . . . . 12.0 108.885 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.01 124.77 47.78 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.611 0.967 . . . . 12.0 113.611 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.509 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 27.9 tt0 -129.9 144.02 51.1 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 104.44 -2.43 . . . . 12.0 104.44 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.93 15.91 2.53 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.129 -0.982 . . . . 12.0 108.72 -175.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 78.29 -15.36 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 123.581 0.752 . . . . 12.0 112.606 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.455 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -98.28 148.66 34.82 Favored Pre-proline 0 N--CA 1.503 2.19 0 N-CA-C 106.497 -1.668 . . . . 12.0 106.497 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.482 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 23.5 Cg_endo -63.23 91.25 0.14 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 N-CA-C 107.955 -1.594 . . . . 12.0 107.955 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.453 HG23 ' CE2' ' A' ' 100' ' ' TYR . 69.4 t -87.61 -11.07 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-N 116.185 -0.461 . . . . 12.0 111.115 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -151.94 148.28 27.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.564 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -99.69 122.41 42.66 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.485 -1.286 . . . . 12.0 108.923 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.17 67.58 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.995 -0.44 . . . . 12.0 109.954 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.55 -149.08 18.59 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.863 -1.295 . . . . 12.0 109.863 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.9 pt -56.43 178.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.203 0.525 . . . . 12.0 110.757 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.21 -56.57 19.54 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 111.138 -0.785 . . . . 12.0 111.138 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.4 mtp85 -49.41 110.86 0.41 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.929 -0.748 . . . . 12.0 110.599 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 169.51 12.16 Favored Pre-proline 0 N--CA 1.498 1.975 0 N-CA-C 109.174 -0.676 . . . . 12.0 109.174 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.482 0.807 0 C-N-CA 121.755 1.636 . . . . 12.0 110.766 179.684 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.346 0 N-CA-C 109.469 -0.567 . . . . 12.0 109.469 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -91.9 155.03 18.46 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.568 -0.901 . . . . 12.0 108.568 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -25.03 64.1 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.905 -0.497 . . . . 12.0 110.313 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.38 -63.24 1.33 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.647 -0.658 . . . . 12.0 110.676 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -61.57 -31.58 71.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.935 -1.135 . . . . 12.0 107.935 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.456 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 31.3 t80 -76.08 -25.36 55.42 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.469 -0.937 . . . . 12.0 108.469 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -54.42 -32.69 57.87 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.339 -1.356 . . . . 12.0 107.339 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.44 -37.91 35.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.791 -1.189 . . . . 12.0 107.791 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 15.8 tppt? -47.15 -49.13 22.97 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 122.155 -0.341 . . . . 12.0 110.385 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.456 ' NE2' ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -101.28 -13.13 18.18 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 118.681 -0.676 . . . . 12.0 112.596 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.412 HD13 ' N ' ' A' ' 11' ' ' ILE . 3.7 mp -137.81 72.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 115.354 1.613 . . . . 12.0 115.354 -175.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.423 HD11 ' CD1' ' A' ' 40' ' ' PHE . 11.3 mt -97.65 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 103.737 -2.69 . . . . 12.0 103.737 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.25 80.79 0.24 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.843 0.83 . . . . 12.0 110.512 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 p -150.6 59.79 3.73 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.411 -1.329 . . . . 12.0 107.411 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -73.12 84.77 1.29 Allowed 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 121.94 1.76 . . . . 12.0 110.711 -178.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 16' ' ' ILE . 14.5 pt -124.94 -169.17 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.88 34.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.656 -0.652 . . . . 12.0 109.436 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -150.04 98.4 2.7 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.902 -0.499 . . . . 12.0 109.997 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -81.36 -4.47 55.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.853 -0.529 . . . . 12.0 110.734 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -84.47 -58.11 2.87 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.523 -0.736 . . . . 12.0 111.242 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -26.04 64.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.786 -0.571 . . . . 12.0 110.097 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.3 pt -85.61 -32.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.853 -0.529 . . . . 12.0 109.597 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ttp -100.98 20.28 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.947 -0.39 . . . . 12.0 109.947 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -74.15 86.53 1.89 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -163.96 147.46 9.82 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.779 -0.576 . . . . 12.0 109.574 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -70.9 -8.17 50.98 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.943 -0.391 . . . . 12.0 109.943 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -85.95 7.84 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.601 -0.687 . . . . 12.0 110.026 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -136.04 60.62 1.67 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.581 -0.699 . . . . 12.0 109.371 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mt -146.49 152.57 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 120.768 -1.208 . . . . 12.0 110.936 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.34 169.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.687 -1.227 . . . . 12.0 107.687 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.82 55.6 3.37 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.74 -57.14 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.41 -1.476 . . . . 12.0 109.41 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.31 -71.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.956 -0.732 . . . . 12.0 109.526 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 p -153.68 132.24 12.17 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.697 -0.853 . . . . 12.0 108.697 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.18 171.27 0.28 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 109.82 -0.437 . . . . 12.0 109.82 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.97 -6.33 59.04 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 119.438 -0.315 . . . . 12.0 111.326 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 p -164.72 114.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 C-N-CA 119.545 -0.862 . . . . 12.0 111.691 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.482 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 59.1 m-20 -95.37 82.55 3.71 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 12.0 105.832 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -83.48 116.21 22.43 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.58 0.705 . . . . 12.0 111.862 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 12' ' ' ILE . 18.5 m-85 -104.49 162.46 13.22 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.359 -1.348 . . . . 12.0 107.359 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.89 125.99 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.518 1.054 . . . . 12.0 110.219 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.425 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 6.3 mt -90.85 108.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 108.03 -1.1 . . . . 12.0 108.03 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.6 t 177.71 151.12 0.22 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.684 -0.406 . . . . 12.0 109.971 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -67.02 129.6 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.112 -1.07 . . . . 12.0 108.112 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -26.49 5.73 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.042 -0.411 . . . . 12.0 111.295 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.91 -33.24 30.53 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.916 -0.49 . . . . 12.0 111.829 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -62.59 -37.73 87.37 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.083 -1.451 . . . . 12.0 107.083 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.455 ' CG1' ' CD2' ' A' ' 10' ' ' HIS . 46.8 t -67.39 -34.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -59.38 -23.61 62.73 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.67 -38.66 25.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.968 -0.458 . . . . 12.0 109.77 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 tp -65.93 -19.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.809 -0.557 . . . . 12.0 110.761 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 23.04 15.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.754 -0.591 . . . . 12.0 110.448 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 m -86.2 112.43 21.34 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.55 -65.66 0.01 OUTLIER Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.249 -1.14 . . . . 12.0 110.249 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -160.54 -164.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.407 -0.96 . . . . 12.0 108.407 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 18.1 tt -90.3 28.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.124 -0.985 . . . . 12.0 110.968 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 15.6 t-20 172.1 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.89 177.77 8.31 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.795 0.807 . . . . 12.0 111.742 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -133.37 112.46 11.62 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.064 -1.458 . . . . 12.0 107.064 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.82 168.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.902 -0.499 . . . . 12.0 109.731 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.4 mp -133.47 128.52 35.61 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.479 -0.488 . . . . 12.0 110.955 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -62.18 95.81 0.07 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.762 -1.57 . . . . 12.0 106.762 177.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -84.71 -46.66 11.23 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.989 -0.444 . . . . 12.0 110.896 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.4 m -52.16 -94.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.972 -0.455 . . . . 12.0 109.786 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.66 101.9 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.098 -0.704 . . . . 12.0 109.098 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 76.3 m-85 -96.87 44.42 1.06 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 120.483 -0.487 . . . . 12.0 109.818 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 19.48 106.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.106 1.15 . . . . 12.0 114.106 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.28 153.65 18.79 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.093 0.949 . . . . 12.0 112.562 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.425 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 4.2 t-20 -115.1 101.27 8.83 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 104.657 -2.349 . . . . 12.0 104.657 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -106.79 121.8 45.1 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.456 0.909 . . . . 12.0 113.456 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.01 104.64 16.69 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 102.677 -3.083 . . . . 12.0 102.677 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -100.53 140.13 35.23 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.469 0.652 . . . . 12.0 112.333 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.4 ttt180 -60.42 133.69 56.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.905 -0.776 . . . . 12.0 108.905 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -125.55 -95.72 0.45 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.512 -0.551 . . . . 12.0 109.512 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 p -171.34 121.21 0.52 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.465 -0.772 . . . . 12.0 109.91 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.3 tt -155.19 144.56 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.987 -0.746 . . . . 12.0 108.987 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.4 ' CB ' ' HD3' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -80.36 -57.04 0.66 Allowed Pre-proline 0 N--CA 1.505 2.283 0 CA-C-O 119.129 -0.462 . . . . 12.0 110.545 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 77' ' ' THR . 34.1 Cg_endo -74.12 178.73 6.55 Favored 'Trans proline' 0 N--CA 1.483 0.865 0 C-N-CA 122.069 1.846 . . . . 12.0 111.133 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 162.97 19.27 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 109.828 -0.434 . . . . 12.0 109.828 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -74.73 -171.55 9.44 Favored 'Cis proline' 0 N--CA 1.488 1.16 0 O-C-N 123.315 1.166 . . . . 12.0 110.537 0.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.3 m -54.26 159.49 3.06 Favored Pre-proline 0 N--CA 1.501 2.119 0 N-CA-C 109.291 -0.633 . . . . 12.0 109.291 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 35.3 Cg_endo -76.11 128.01 10.33 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.562 1.508 . . . . 12.0 110.797 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.482 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.4 m-85 -148.02 137.26 22.16 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.964 0.411 . . . . 12.0 110.147 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 t -124.45 129.52 50.81 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.329 -0.989 . . . . 12.0 108.329 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -80.49 136.92 36.4 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.151 0.501 . . . . 12.0 110.956 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 121.37 7.81 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.99 -0.744 . . . . 12.0 108.99 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.9 p -98.55 147.16 25.07 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.468 -0.567 . . . . 12.0 109.468 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -168.3 -173.27 1.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.018 0.437 . . . . 12.0 110.054 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.7 m -66.43 142.49 57.56 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 109.461 -0.57 . . . . 12.0 109.461 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -105.73 87.16 2.53 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.88 0.847 . . . . 12.0 111.252 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 6.2 p90 -109.34 106.46 16.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 105.985 -1.857 . . . . 12.0 105.985 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.421 HD13 ' CZ ' ' A' ' 104' ' ' PHE . 19.9 pt -139.18 -171.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.85 -0.74 . . . . 12.0 111.976 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 39.0 t -119.99 114.63 22.31 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.083 -0.71 . . . . 12.0 109.083 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.464 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 8.6 p -113.75 171.35 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 14.3 mttt -130.88 146.03 52.18 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.922 -0.77 . . . . 12.0 108.922 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.4 m -118.18 125.13 49.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.217 1.192 . . . . 12.0 114.217 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 30.0 tt0 -131.62 144.69 51.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 103.818 -2.66 . . . . 12.0 103.818 174.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 27.8 m-80 53.63 29.38 9.22 Favored 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 107.699 -1.222 . . . . 12.0 107.699 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 52.69 9.58 0.12 Allowed 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 125.289 1.436 . . . . 12.0 114.835 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -114.39 145.98 34.89 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 104.532 -2.395 . . . . 12.0 104.532 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.476 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.3 Cg_endo -60.79 90.08 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.275 1.316 . . . . 12.0 108.69 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.45 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 69.7 t -86.84 -23.24 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 116.271 -0.422 . . . . 12.0 110.851 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.457 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.62 145.89 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.94 -1.133 . . . . 12.0 107.94 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.464 ' CE1' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -116.47 128.51 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.15 -1.02 . . . . 12.0 109.92 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.99 -37.9 38.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.23 -0.294 . . . . 12.0 110.777 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.08 -134.68 6.88 Favored Glycine 0 N--CA 1.504 3.177 0 C-N-CA 120.066 -1.064 . . . . 12.0 111.493 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 pt -69.15 -171.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.083 0.468 . . . . 12.0 111.129 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.419 ' CA ' ' HA ' ' A' ' 92' ' ' ILE . . . -92.54 60.98 2.46 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 110.391 -1.084 . . . . 12.0 110.391 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.88 73.63 0.48 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.282 -1.007 . . . . 12.0 108.282 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -83.94 -46.24 0.76 Allowed Pre-proline 0 N--CA 1.502 2.141 0 CA-C-O 118.52 -0.752 . . . . 12.0 111.668 -178.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 110' ' ' CYS . 37.2 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 C-N-CA 121.846 1.697 . . . . 12.0 110.427 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.376 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 10.7 t-20 -115.99 156.09 26.9 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.817 -0.809 . . . . 12.0 108.817 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.425 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.51 -22.85 61.73 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 121.952 -0.468 . . . . 12.0 110.527 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.64 0.85 Allowed 'General case' 0 N--CA 1.515 2.815 0 O-C-N 121.637 -0.665 . . . . 12.0 110.853 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 m -60.9 -31.54 71.03 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.061 -1.088 . . . . 12.0 108.061 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 26.3 t80 -75.91 -26.14 56.7 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.461 -0.94 . . . . 12.0 108.461 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -51.79 -35.69 44.98 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 107.567 -1.271 . . . . 12.0 107.567 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -77.29 -40.95 42.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -45.87 -51.76 12.53 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.161 -0.337 . . . . 12.0 111.627 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.5 ' NE2' ' CZ ' ' A' ' 104' ' ' PHE . 1.2 m170 -94.89 -14.71 24.26 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.552 -0.718 . . . . 12.0 111.363 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 ' HA ' HD11 ' A' ' 11' ' ' ILE . 36.5 mm -130.86 73.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 N-CA-C 114.46 1.282 . . . . 12.0 114.46 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.418 HG22 ' CD1' ' A' ' 40' ' ' PHE . 3.0 mp -97.43 61.15 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 103.667 -2.716 . . . . 12.0 103.667 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -70.98 81.49 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.739 0.78 . . . . 12.0 110.199 -176.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 p -131.79 76.11 74.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.672 -0.862 . . . . 12.0 108.672 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.85 82.0 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.994 1.796 . . . . 12.0 109.223 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -141.69 168.91 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.7 pt -93.71 41.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 121.437 0.636 . . . . 12.0 109.758 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -149.49 104.81 3.4 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.7 -0.852 . . . . 12.0 108.7 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -81.12 -16.89 51.76 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 120.551 -0.46 . . . . 12.0 111.558 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -84.39 -55.24 4.26 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 118.892 0.769 . . . . 12.0 110.417 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.09 -30.68 64.54 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.264 -0.272 . . . . 12.0 110.443 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.414 HG13 ' N ' ' A' ' 23' ' ' MET . 44.0 pt -80.76 -39.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.268 -0.573 . . . . 12.0 110.171 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.414 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -95.86 17.1 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.496 -0.482 . . . . 12.0 110.246 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -62.49 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.616 -0.883 . . . . 12.0 108.616 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.61 150.15 4.86 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.354 -0.61 . . . . 12.0 109.354 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -69.65 -9.42 54.16 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.878 -0.329 . . . . 12.0 110.342 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -87.06 8.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 12.0 110.307 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -137.27 58.2 1.72 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.6 -0.687 . . . . 12.0 109.73 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -151.31 152.19 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 12.0 110.579 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.26 168.93 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 107.475 -1.306 . . . . 12.0 107.475 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.35 54.77 3.54 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.219 -1.552 . . . . 12.0 109.219 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.88 -57.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.146 -1.582 . . . . 12.0 109.146 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.24 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.022 -0.693 . . . . 12.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 99.0 m -144.05 150.1 37.67 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.04 176.97 6.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.014 -0.736 . . . . 12.0 109.014 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -17.07 52.37 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.969 -0.457 . . . . 12.0 110.038 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -162.04 117.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 C-N-CA 119.825 -0.75 . . . . 12.0 111.337 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 5.3 m-20 -97.46 83.77 3.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.701 -1.963 . . . . 12.0 105.701 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -80.84 116.4 20.81 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.909 -0.587 . . . . 12.0 111.481 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.418 ' CD1' HG22 ' A' ' 12' ' ' ILE . 21.7 m-85 -100.5 158.96 15.53 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.531 -1.285 . . . . 12.0 107.531 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 41' ' ' ILE . 50.5 mm -129.18 124.23 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.357 -0.84 . . . . 12.0 110.346 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.42 111.44 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 108.324 -0.991 . . . . 12.0 108.324 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 t 178.33 151.23 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 12.0 109.112 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.49 119.41 5.19 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 109.134 -0.691 . . . . 12.0 109.134 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -42.98 -64.54 0.61 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 113.555 0.946 . . . . 12.0 113.555 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.5 t -62.13 -20.73 64.38 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.912 -0.493 . . . . 12.0 111.552 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.6 m -65.25 -36.07 82.98 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 107.169 -1.419 . . . . 12.0 107.169 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 ' CG1' ' CE1' ' A' ' 10' ' ' HIS . 19.3 t -71.24 -34.39 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -21.51 65.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.663 -0.866 . . . . 12.0 108.663 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.45 -39.05 28.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.885 -0.51 . . . . 12.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 tp -64.32 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 12.0 109.773 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.91 25.57 10.3 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.69 -0.632 . . . . 12.0 110.35 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 m -90.83 115.93 28.28 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.252 -0.647 . . . . 12.0 109.252 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.98 -62.95 0.02 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.573 -1.011 . . . . 12.0 110.573 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 p -161.12 -164.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.581 -0.896 . . . . 12.0 108.581 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 9.9 tt -88.64 27.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 121.053 -1.029 . . . . 12.0 110.665 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.6 t30 172.44 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 106.961 -1.496 . . . . 12.0 106.961 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.87 178.37 9.83 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.921 0.867 . . . . 12.0 111.841 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.66 112.25 7.83 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.923 -1.51 . . . . 12.0 106.923 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.25 167.92 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.325 -0.621 . . . . 12.0 109.325 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 110' ' ' CYS . 4.7 mp -136.67 130.32 31.99 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.581 -0.448 . . . . 12.0 111.023 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.12 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 106.544 -1.651 . . . . 12.0 106.544 176.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 91' ' ' TYR . 3.1 p -80.61 -43.1 21.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.325 -0.234 . . . . 12.0 110.512 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.34 -90.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 109.349 -0.612 . . . . 12.0 109.349 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.7 ptt-85 171.48 101.06 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.211 -0.663 . . . . 12.0 109.211 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -97.25 48.38 1.04 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 120.462 -0.495 . . . . 12.0 109.703 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 16.57 107.92 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.525 1.305 . . . . 12.0 114.525 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -104.06 155.59 18.56 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.066 0.936 . . . . 12.0 112.474 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -116.87 97.42 5.95 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 105.25 -2.13 . . . . 12.0 105.25 176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 m -104.18 128.29 51.87 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.5 0.926 . . . . 12.0 113.5 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.2 m -111.01 108.18 17.83 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.44 -2.8 . . . . 12.0 103.44 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -109.55 145.86 35.63 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 120.17 -0.612 . . . . 12.0 112.311 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.7 ttp85 -64.27 116.0 5.59 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.937 -0.764 . . . . 12.0 108.937 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p -111.95 -84.71 0.57 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.934 -0.479 . . . . 12.0 110.742 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 t -142.15 152.57 43.33 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.764 -0.585 . . . . 12.0 110.123 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -64.62 121.12 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.01 0.433 . . . . 12.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.473 ' HB ' ' HD3' ' A' ' 78' ' ' PRO . 1.3 m -173.13 -62.17 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.233 -1.025 . . . . 12.0 108.233 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.473 ' HD3' ' HB ' ' A' ' 77' ' ' THR . 37.1 Cg_endo -75.33 -164.71 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 121.893 1.729 . . . . 12.0 109.673 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 mtt-85 -153.0 162.23 26.93 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.922 -0.486 . . . . 12.0 109.855 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -73.21 -38.55 1.75 Allowed 'Cis proline' 0 N--CA 1.488 1.169 0 O-C-N 123.295 1.155 . . . . 12.0 110.358 1.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.71 162.04 20.97 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.259 -1.015 . . . . 12.0 108.259 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.427 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 36.6 Cg_endo -76.12 101.71 1.52 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.68 1.587 . . . . 12.0 109.65 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.441 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 18.9 m-85 -139.75 138.33 35.82 Favored 'General case' 0 N--CA 1.509 2.489 0 CA-C-O 121.354 0.597 . . . . 12.0 111.198 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -114.79 121.76 44.29 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 p -84.32 143.99 29.15 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 120.991 0.424 . . . . 12.0 110.395 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -154.66 159.49 40.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.276 -0.638 . . . . 12.0 109.276 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.6 m -130.45 142.14 50.5 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.062 -0.718 . . . . 12.0 109.062 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.94 -169.46 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.309 0.575 . . . . 12.0 110.521 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 98.3 m -64.54 146.47 54.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.082 -0.71 . . . . 12.0 109.082 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -108.67 88.78 2.81 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.989 0.899 . . . . 12.0 111.383 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 63' ' ' THR . 2.3 t80 -98.43 103.95 15.94 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.84 -2.281 . . . . 12.0 104.84 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.444 HG23 ' CE1' ' A' ' 104' ' ' PHE . 33.0 mm -127.75 163.38 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 119.685 -0.806 . . . . 12.0 111.99 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 51.6 t -115.91 106.44 13.8 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.439 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 5.5 p -113.85 172.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.953 -0.388 . . . . 12.0 109.953 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 65.0 mttt -126.65 143.18 51.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -111.0 115.68 29.89 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.265 1.209 . . . . 12.0 114.265 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.7 tt0 -125.77 142.72 51.37 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 104.055 -2.572 . . . . 12.0 104.055 174.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 60.3 m-80 54.84 29.55 12.16 Favored 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 14.5 pt20 52.1 11.11 0.14 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 114.651 1.352 . . . . 12.0 114.651 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -118.12 146.99 40.53 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 174.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.49 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 24.3 Cg_endo -60.54 89.89 0.08 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 121.262 1.308 . . . . 12.0 108.819 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 47.2 t -86.22 -19.63 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 116.345 -0.388 . . . . 12.0 110.887 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.482 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -140.77 144.57 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.657 -0.868 . . . . 12.0 108.657 -177.146 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.5 ' CZ ' ' NE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -109.07 132.11 54.43 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.068 -1.053 . . . . 12.0 108.366 178.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.12 -24.19 14.66 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.092 -0.38 . . . . 12.0 111.992 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.45 178.32 47.75 Favored Glycine 0 N--CA 1.503 3.143 0 N-CA-C 110.577 -1.009 . . . . 12.0 110.577 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.405 ' HA ' HG21 ' A' ' 92' ' ' ILE . 10.4 pt -92.65 25.1 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.45 -0.441 . . . . 12.0 110.692 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.75 -53.2 0.79 Allowed Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.591 -1.403 . . . . 12.0 109.591 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 126.07 28.98 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 122.202 -0.587 . . . . 12.0 109.588 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.432 ' HB2' HD22 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -142.08 168.04 14.82 Favored Pre-proline 0 N--CA 1.501 2.108 0 N-CA-C 109.563 -0.532 . . . . 12.0 109.563 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.481 0.736 0 C-N-CA 121.667 1.578 . . . . 12.0 110.222 179.192 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.374 0 N-CA-C 109.911 -0.403 . . . . 12.0 109.911 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -143.13 158.67 43.4 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.85 -31.85 68.68 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 122.157 -0.339 . . . . 12.0 110.874 -178.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.87 2.01 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.542 -0.724 . . . . 12.0 110.474 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.2 m -62.29 -32.56 73.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.503 -0.925 . . . . 12.0 108.503 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 36.3 t80 -73.89 -23.86 59.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.69 -0.855 . . . . 12.0 108.69 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 17.4 tt0 -57.65 -37.85 74.06 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.129 -1.434 . . . . 12.0 107.129 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -75.59 -34.14 60.61 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 176.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 17.9 tptt -46.42 -59.0 3.23 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 122.215 -0.303 . . . . 12.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.529 ' CE1' ' CZ ' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -104.11 1.09 30.43 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 118.482 -0.771 . . . . 12.0 112.758 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 4.1 mp -134.74 65.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 117.866 -1.534 . . . . 12.0 114.958 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.427 HD11 HG22 ' A' ' 12' ' ' ILE . 23.3 mt -97.53 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 103.88 -2.637 . . . . 12.0 103.88 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -65.01 83.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.815 0.817 . . . . 12.0 110.186 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 p -129.26 90.54 44.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -73.99 -3.02 13.11 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.679 1.586 . . . . 12.0 112.081 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 18.4 pt -58.43 -170.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.246 -0.65 . . . . 12.0 109.246 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.9 40.65 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.469 0.652 . . . . 12.0 109.81 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -142.76 101.02 3.78 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.9 -0.5 . . . . 12.0 110.18 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' HA ' ' CG1' ' A' ' 22' ' ' ILE . 10.7 m -81.16 -3.17 51.31 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.934 -0.479 . . . . 12.0 110.829 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -84.7 -58.02 2.89 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.521 -0.737 . . . . 12.0 111.685 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 m -65.47 -23.44 66.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.593 -0.692 . . . . 12.0 110.402 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.416 ' CG1' ' HA ' ' A' ' 19' ' ' CYS . 2.7 pp -84.04 -35.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.419 -0.585 . . . . 12.0 109.419 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.2 ttm -83.28 -5.53 59.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.143 -0.348 . . . . 12.0 110.198 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.68 91.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -168.07 152.98 6.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.428 -0.582 . . . . 12.0 109.428 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.15 -7.97 53.74 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 120.664 -0.414 . . . . 12.0 110.043 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.5 mt -88.41 10.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.687 -0.633 . . . . 12.0 110.317 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -138.46 57.93 1.68 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.744 -0.597 . . . . 12.0 110.391 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.99 -1.069 . . . . 12.0 109.511 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.41 -165.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 108.02 -1.104 . . . . 12.0 108.02 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.91 67.81 0.88 Allowed Glycine 0 N--CA 1.505 3.265 0 O-C-N 121.044 -1.035 . . . . 12.0 112.063 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.85 -63.53 0.03 OUTLIER Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.23 -1.548 . . . . 12.0 109.23 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -164.44 -64.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.667 -1.235 . . . . 12.0 107.667 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.9 p -174.51 126.15 0.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.944 -1.132 . . . . 12.0 107.944 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -56.19 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.986 -0.446 . . . . 12.0 109.941 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 mtm-85 -106.18 21.45 17.35 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.903 -0.319 . . . . 12.0 110.488 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -163.53 133.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.595 -0.691 . . . . 12.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.0 99.07 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.944 -1.502 . . . . 12.0 106.944 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 m -87.4 110.85 20.56 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.291 0.567 . . . . 12.0 111.524 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 12' ' ' ILE . 18.9 m-85 -98.25 162.21 13.3 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -132.8 128.1 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.183 -0.948 . . . . 12.0 109.756 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 mt -94.66 107.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.8 t 177.2 148.08 0.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.62 -0.511 . . . . 12.0 109.62 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 p -64.25 129.51 40.22 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.052 -1.092 . . . . 12.0 108.052 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.67 -30.9 5.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.881 -0.512 . . . . 12.0 111.589 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -78.97 -33.88 44.79 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.937 -0.477 . . . . 12.0 111.837 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -62.44 -39.72 94.25 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.281 -1.377 . . . . 12.0 107.281 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.2 t -69.26 -35.79 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.752 -1.203 . . . . 12.0 107.752 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -22.55 66.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.195 -0.668 . . . . 12.0 109.195 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.05 29.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.966 -0.459 . . . . 12.0 109.903 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 tp -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.749 -0.594 . . . . 12.0 110.164 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.06 26.52 8.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.858 -0.526 . . . . 12.0 109.937 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.5 m -88.06 111.51 21.63 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.875 -0.787 . . . . 12.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.46 -60.4 0.02 OUTLIER Glycine 0 N--CA 1.499 2.877 0 N-CA-C 110.643 -0.983 . . . . 12.0 110.643 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 p -163.93 -169.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.866 -0.785 . . . . 12.0 108.904 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.7 pt -87.27 25.55 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 O-C-N 121.11 -0.994 . . . . 12.0 111.197 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.3 t30 174.67 113.48 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 106.86 -1.533 . . . . 12.0 106.86 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.6 ttt -161.21 174.55 13.46 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.855 0.836 . . . . 12.0 111.739 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -132.51 110.67 10.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.593 -1.632 . . . . 12.0 106.593 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 t -121.78 168.53 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.745 -0.597 . . . . 12.0 109.827 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.0 112.17 12.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.121 -0.362 . . . . 12.0 110.662 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.428 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -60.4 92.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 107.502 -1.295 . . . . 12.0 107.502 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -83.28 -42.26 17.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.916 -0.49 . . . . 12.0 111.019 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 109.771 -0.455 . . . . 12.0 109.771 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 178.53 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.425 -0.797 . . . . 12.0 109.275 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 72.8 m-85 -96.51 43.7 1.07 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 120.446 -0.502 . . . . 12.0 109.678 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 18.91 106.11 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.211 1.189 . . . . 12.0 114.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.56 153.86 18.71 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.782 0.801 . . . . 12.0 111.836 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -119.99 102.47 8.57 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 106.467 -1.679 . . . . 12.0 106.467 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -100.94 124.73 47.08 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.944 -0.703 . . . . 12.0 111.797 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.2 m -108.82 109.39 20.5 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.095 -2.557 . . . . 12.0 104.095 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -114.15 140.84 48.19 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.821 -0.752 . . . . 12.0 111.523 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -58.61 110.49 1.0 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.306 -0.627 . . . . 12.0 109.306 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.8 p -135.24 -94.09 0.27 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.071 -0.393 . . . . 12.0 110.539 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 p -156.74 105.21 2.19 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.372 -0.83 . . . . 12.0 109.501 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 78' ' ' PRO . 8.5 mm -136.27 165.47 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.872 -0.788 . . . . 12.0 108.872 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.45 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 1.3 m -51.11 -48.06 86.09 Favored Pre-proline 0 N--CA 1.505 2.288 0 CA-C-O 118.73 -0.653 . . . . 12.0 112.234 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 77' ' ' THR . 35.5 Cg_endo -77.72 126.78 8.34 Favored 'Trans proline' 0 N--CA 1.478 0.56 0 C-N-CA 122.131 1.887 . . . . 12.0 111.119 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.58 158.96 49.35 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 108.631 -0.878 . . . . 12.0 108.631 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -75.81 -176.31 18.1 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 O-C-N 123.12 1.063 . . . . 12.0 111.034 0.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.477 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER 60.99 54.03 3.08 Favored Pre-proline 0 N--CA 1.495 1.8 0 CA-C-N 116.499 -0.319 . . . . 12.0 110.845 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 37.0 Cg_endo -78.93 129.19 8.86 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.323 2.015 . . . . 12.0 108.977 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -120.77 136.48 54.87 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 121.647 0.737 . . . . 12.0 112.354 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -109.03 129.63 55.46 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.814 -1.18 . . . . 12.0 107.814 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.8 p -92.81 145.14 24.62 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.308 0.575 . . . . 12.0 111.819 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -149.97 157.29 43.01 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.578 -0.897 . . . . 12.0 108.578 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 m -128.38 153.68 46.8 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.599 -0.519 . . . . 12.0 109.599 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -173.07 179.0 2.35 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.666 -0.414 . . . . 12.0 109.961 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.3 m -62.03 143.42 56.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.495 -0.928 . . . . 12.0 108.495 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -107.65 85.77 2.18 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.308 -0.957 . . . . 12.0 112.203 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -100.34 105.17 16.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.226 -2.509 . . . . 12.0 104.226 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.401 ' CD1' ' CE1' ' A' ' 104' ' ' PHE . 0.8 OUTLIER -136.32 -177.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 121.653 0.739 . . . . 12.0 112.062 -175.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 18.1 t -117.76 121.3 40.45 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.707 -0.849 . . . . 12.0 108.707 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.467 ' CG2' ' CZ ' ' A' ' 104' ' ' PHE . 8.1 p -117.5 167.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.844 -0.342 . . . . 12.0 110.595 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 36.9 mttt -129.6 138.39 51.23 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.479 -0.934 . . . . 12.0 108.479 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -111.99 122.24 47.22 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 113.92 1.081 . . . . 12.0 113.92 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.442 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 35.0 tt0 -132.23 142.56 49.46 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 103.991 -2.596 . . . . 12.0 103.991 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 33.2 m120 54.13 29.1 9.84 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 107.638 -1.245 . . . . 12.0 107.638 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 98' ' ' ASN . 2.1 pm0 52.94 10.21 0.15 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.168 1.544 . . . . 12.0 115.168 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -115.63 146.24 36.3 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 104.574 -2.38 . . . . 12.0 104.574 174.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.478 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 23.9 Cg_endo -60.84 88.31 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.034 0 C-N-CA 121.293 1.328 . . . . 12.0 108.764 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.457 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 67.2 t -84.35 -24.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.272 -0.422 . . . . 12.0 110.395 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.442 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -132.31 144.38 50.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.344 -1.354 . . . . 12.0 107.344 -178.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.529 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -120.76 131.1 54.31 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.833 -1.147 . . . . 12.0 110.905 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.69 -40.78 32.85 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 116.308 -0.405 . . . . 12.0 110.517 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.69 -121.36 3.24 Favored Glycine 0 N--CA 1.504 3.185 0 C-N-CA 120.378 -0.915 . . . . 12.0 111.299 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.5 pt -65.44 -178.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-O 121.372 0.606 . . . . 12.0 111.496 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.63 -85.36 0.05 OUTLIER Glycine 0 N--CA 1.501 3.01 0 N-CA-C 110.887 -0.885 . . . . 12.0 110.887 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -49.53 117.41 2.2 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.902 -0.764 . . . . 12.0 109.861 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.511 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 1.7 m -84.23 -43.18 0.75 Allowed Pre-proline 0 N--CA 1.503 2.202 0 CA-C-O 118.564 -0.731 . . . . 12.0 111.122 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 110' ' ' CYS . 37.5 Cg_endo . . . . . 0 N--CA 1.48 0.683 0 C-N-CA 121.784 1.656 . . . . 12.0 110.198 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.356 0 N-CA-C 109.126 -0.694 . . . . 12.0 109.126 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -128.22 162.96 25.77 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.439 -0.948 . . . . 12.0 108.439 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -72.61 -19.74 61.41 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.706 -0.621 . . . . 12.0 110.733 -177.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.83 -62.13 1.69 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.477 -0.764 . . . . 12.0 110.511 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -63.59 -33.4 75.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.664 -1.236 . . . . 12.0 107.664 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 36.5 t80 -74.39 -23.25 58.94 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -54.17 -34.61 60.87 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 106.955 -1.498 . . . . 12.0 106.955 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.2 -41.76 60.91 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.381 -1.34 . . . . 12.0 107.381 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -51.9 -29.44 20.02 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 122.001 -0.437 . . . . 12.0 109.879 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.459 ' CE1' ' CG ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -96.56 -28.38 14.4 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 118.568 -0.729 . . . . 12.0 112.614 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.2 mm -135.59 72.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.826 1.787 . . . . 12.0 115.826 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.432 HG22 ' CD1' ' A' ' 40' ' ' PHE . 47.2 mm -98.36 61.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 102.211 -3.255 . . . . 12.0 102.211 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.12 74.46 3.69 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.522 -0.763 . . . . 12.0 110.655 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 22' ' ' ILE . 3.1 p -131.21 70.63 82.21 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.867 -0.79 . . . . 12.0 108.867 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.34 81.76 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.048 1.832 . . . . 12.0 109.812 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.3 pt -136.18 -169.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.805 -0.813 . . . . 12.0 108.805 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 pt -105.81 31.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.455 0.645 . . . . 12.0 109.655 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -145.15 95.95 2.76 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.569 -0.9 . . . . 12.0 108.569 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.6 m -81.62 -10.08 59.51 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 120.442 -0.503 . . . . 12.0 111.607 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -81.23 -50.68 9.27 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.009 0.822 . . . . 12.0 111.356 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -67.08 -19.23 65.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.823 -0.548 . . . . 12.0 110.649 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.416 ' CG2' ' HB ' ' A' ' 14' ' ' THR . 35.0 pt -86.33 -39.23 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.737 -0.602 . . . . 12.0 110.536 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.406 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -94.53 10.89 32.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.857 -0.527 . . . . 12.0 110.43 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -60.18 91.57 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -170.74 156.73 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.441 -0.577 . . . . 12.0 109.441 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.13 -9.42 58.4 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.885 -0.413 . . . . 12.0 109.885 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 63.0 mt -87.39 9.56 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.718 -0.614 . . . . 12.0 110.411 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -143.36 63.07 1.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.429 -0.794 . . . . 12.0 110.283 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.452 HG22 HD11 ' A' ' 29' ' ' ILE . 50.6 mt -146.0 151.64 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.866 -1.146 . . . . 12.0 110.639 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -105.31 170.4 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 107.583 -1.265 . . . . 12.0 107.583 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -89.89 53.36 3.64 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 109.57 -1.412 . . . . 12.0 109.57 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.13 -58.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.701 -1.76 . . . . 12.0 108.701 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -164.99 -71.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.0 m -138.71 -166.13 1.95 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.753 -0.832 . . . . 12.0 108.753 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.01 173.68 7.39 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -79.2 -21.01 46.92 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.236 -0.29 . . . . 12.0 110.334 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.9 108.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 120.248 -0.581 . . . . 12.0 110.865 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.0 m120 -94.71 85.0 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.269 -1.752 . . . . 12.0 106.269 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 m -79.29 117.1 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.47 0.652 . . . . 12.0 111.824 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.432 ' CD1' HG22 ' A' ' 12' ' ' ILE . 25.2 m-85 -101.89 160.33 14.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.184 -1.413 . . . . 12.0 107.184 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 tt -126.89 127.77 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.989 -1.069 . . . . 12.0 110.006 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 tt -110.82 100.73 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t 173.92 154.28 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 12.0 108.921 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.5 t -51.72 126.37 17.58 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.295 -0.631 . . . . 12.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.52 -37.98 82.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.987 -0.446 . . . . 12.0 110.639 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -76.48 -24.87 53.83 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 120.838 -0.345 . . . . 12.0 111.715 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -65.8 -40.19 91.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 107.007 -1.479 . . . . 12.0 107.007 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.425 ' CG2' ' CD2' ' A' ' 66' ' ' PHE . 58.7 t -68.55 -39.91 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.791 -1.559 . . . . 12.0 106.791 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -59.67 -22.59 62.14 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.392 -0.596 . . . . 12.0 109.392 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.93 -39.75 41.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.836 -0.54 . . . . 12.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.428 HG13 ' CE1' ' A' ' 66' ' ' PHE . 50.5 mm -66.74 -18.07 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.775 -0.578 . . . . 12.0 110.406 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.2 22.87 9.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.722 -0.611 . . . . 12.0 109.603 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m -87.93 109.95 20.19 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.782 -0.822 . . . . 12.0 108.782 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.77 -61.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.639 -0.984 . . . . 12.0 110.639 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 p -160.96 -168.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 117.716 0.758 . . . . 12.0 109.091 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 12.5 tt -88.16 27.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.603 0 O-C-N 121.378 -0.827 . . . . 12.0 111.053 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.7 t-20 172.58 117.85 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.513 -1.292 . . . . 12.0 107.513 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -161.77 176.19 11.16 Favored 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.635 0.731 . . . . 12.0 111.599 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -131.82 116.42 17.21 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.377 -1.712 . . . . 12.0 106.377 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.5 163.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 120.193 -0.603 . . . . 12.0 110.432 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.5 111.77 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.649 -0.5 . . . . 12.0 109.649 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.409 ' HB2' HG21 ' A' ' 92' ' ' ILE . 18.1 m -59.57 92.25 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.735 -0.839 . . . . 12.0 108.735 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 p -77.97 -49.93 13.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.832 -0.803 . . . . 12.0 108.832 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 7.4 p -59.78 106.77 0.52 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.747 -1.205 . . . . 12.0 107.747 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 19.3 ptt-85 -37.32 107.13 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 112.863 0.69 . . . . 12.0 112.863 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' CD1' ' O ' ' A' ' 64' ' ' THR . 29.3 m-85 -94.04 41.75 1.09 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 20.24 107.08 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.26 1.207 . . . . 12.0 114.26 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.9 154.55 19.5 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 12.0 111.763 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -113.55 97.65 6.58 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.452 -2.425 . . . . 12.0 104.452 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.4 m -99.05 123.9 43.67 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.796 -0.761 . . . . 12.0 112.85 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.3 m -107.11 105.96 16.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 104.391 -2.448 . . . . 12.0 104.391 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -99.47 144.26 28.78 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 120.43 -0.508 . . . . 12.0 110.754 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -70.22 113.53 7.48 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.715 -0.846 . . . . 12.0 108.715 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.7 p -137.12 -90.55 0.25 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 122.013 -0.43 . . . . 12.0 110.665 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.42 ' HA ' ' CG ' ' A' ' 82' ' ' PRO . 25.0 p 177.37 120.69 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.554 -0.716 . . . . 12.0 110.311 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.0 pt -150.51 -175.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.748 -0.464 . . . . 12.0 109.748 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.425 ' N ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -51.48 -55.25 30.82 Favored Pre-proline 0 N--CA 1.507 2.394 0 CA-C-O 119.014 -0.517 . . . . 12.0 111.301 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 77' ' ' THR . 33.4 Cg_endo -73.03 124.23 9.44 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.037 1.825 . . . . 12.0 111.453 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -147.33 165.76 18.03 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 108.886 -0.783 . . . . 12.0 108.886 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -76.72 -172.51 11.28 Favored 'Cis proline' 0 N--CA 1.483 0.891 0 O-C-N 123.14 1.074 . . . . 12.0 110.575 0.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 23.7 m 56.57 62.58 6.23 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 110.002 -0.37 . . . . 12.0 110.002 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' CG ' ' HA ' ' A' ' 75' ' ' SER . 34.3 Cg_endo -79.3 143.62 17.62 Favored 'Trans proline' 0 N--CA 1.48 0.687 0 C-N-CA 122.265 1.977 . . . . 12.0 109.612 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 27.8 m-85 -139.21 142.05 37.89 Favored 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.328 0.585 . . . . 12.0 111.094 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 t -115.42 134.3 55.22 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.841 -1.17 . . . . 12.0 107.841 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.4 m -96.08 139.52 32.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.551 0.691 . . . . 12.0 111.853 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -151.33 120.94 6.95 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.242 -1.021 . . . . 12.0 108.242 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.8 m -104.6 149.8 25.21 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.557 -0.535 . . . . 12.0 109.557 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -176.89 -171.84 0.39 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.671 -0.411 . . . . 12.0 110.362 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 66.0 m -49.76 136.26 17.95 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.867 -0.42 . . . . 12.0 109.867 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -107.68 87.09 2.42 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.993 0.902 . . . . 12.0 111.397 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -95.4 101.44 13.16 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 104.571 -2.381 . . . . 12.0 104.571 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.409 HG21 ' HB2' ' A' ' 62' ' ' SER . 16.0 tt -122.13 161.97 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.523 -0.871 . . . . 12.0 112.862 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.13 113.94 26.1 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.927 -1.138 . . . . 12.0 107.927 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 104' ' ' PHE . 10.8 m -126.57 -172.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 116.15 -0.477 . . . . 12.0 109.963 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.445 ' HB2' ' CD2' ' A' ' 103' ' ' HIS . 54.1 mttt -144.65 157.28 44.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.098 -0.705 . . . . 12.0 109.098 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.2 m -119.47 116.33 25.89 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.802 0.667 . . . . 12.0 112.802 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 17.5 tt0 -124.92 143.62 50.77 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 104.336 -2.468 . . . . 12.0 104.336 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.5 m120 55.17 29.13 12.1 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.7 pt20 53.26 10.37 0.19 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.073 1.349 . . . . 12.0 114.523 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.525 ' CD2' ' CD1' ' A' ' 3' ' ' TRP . 0.0 OUTLIER -115.88 146.88 37.91 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 104.964 -2.236 . . . . 12.0 104.964 174.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.494 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 23.7 Cg_endo -61.02 92.48 0.1 Allowed 'Trans proline' 0 C--O 1.205 -1.172 0 N-CA-C 108.28 -1.469 . . . . 12.0 108.28 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.467 HG23 ' CE2' ' A' ' 100' ' ' TYR . 54.5 t -91.21 -8.66 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 116.263 -0.426 . . . . 12.0 110.731 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -142.71 110.79 5.98 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.555 -1.258 . . . . 12.0 112.101 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 94' ' ' VAL . 5.9 m-30 -100.22 112.19 24.5 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 105.254 -2.128 . . . . 12.0 105.254 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -129.89 7.04 5.12 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.434 0.902 . . . . 12.0 113.434 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -151.92 160.43 28.83 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.927 -1.269 . . . . 12.0 109.927 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.29 28.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.895 -0.78 . . . . 12.0 108.895 179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 131.66 -65.13 0.6 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.595 -1.402 . . . . 12.0 109.595 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.7 ttt-85 -60.54 157.76 13.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.149 -0.619 . . . . 12.0 109.556 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.53 167.63 1.18 Allowed Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 109.376 -0.602 . . . . 12.0 109.376 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.481 0.738 0 C-N-CA 121.705 1.603 . . . . 12.0 109.972 179.435 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . 0.412 ' HG3' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.509 2.481 0 CA-C-O 120.797 0.332 . . . . 12.0 110.253 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 33.3 t30 -167.33 159.01 12.21 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 12.0 108.795 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -26.18 63.8 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 122.05 -0.406 . . . . 12.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 7' ' ' GLN . . . -77.48 -60.8 2.22 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 121.597 -0.69 . . . . 12.0 110.396 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 47.7 m -60.18 -29.49 68.73 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.126 -1.064 . . . . 12.0 108.126 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 26.9 t80 -81.62 -23.96 36.7 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.285 -0.635 . . . . 12.0 109.285 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' CG ' ' O ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -57.16 -28.78 63.08 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 178.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.407 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 3.4 mp0 -83.79 -37.3 22.74 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.471 -1.307 . . . . 12.0 107.471 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.0 tptp -48.11 -47.97 34.09 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.771 0.319 . . . . 12.0 110.297 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.445 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -100.95 -17.56 16.73 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 118.53 -0.747 . . . . 12.0 112.149 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' A' ' 45' ' ' ALA . 4.0 mp -139.44 75.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 116.819 2.155 . . . . 12.0 116.819 -175.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.423 ' CG1' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -97.6 62.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.9 -3.0 . . . . 12.0 102.9 171.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -71.75 78.85 0.85 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.989 -1.005 . . . . 12.0 112.533 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 p -121.38 122.69 27.96 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 107.273 -1.38 . . . . 12.0 107.273 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -71.85 -3.04 12.4 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 121.48 1.454 . . . . 12.0 112.114 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.11 159.53 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.6 -0.889 . . . . 12.0 108.6 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 tt -108.59 39.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 108.549 -0.908 . . . . 12.0 108.549 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -128.38 101.05 6.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -74.94 -18.42 60.4 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 120.499 -0.481 . . . . 12.0 111.174 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.89 -55.03 5.08 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 118.8 0.727 . . . . 12.0 110.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.39 -30.87 63.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.214 -0.304 . . . . 12.0 110.229 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 23' ' ' MET . 50.9 pt -81.02 -36.95 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.546 -0.462 . . . . 12.0 110.243 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.403 ' N ' HG13 ' A' ' 22' ' ' ILE . 9.6 ptt? -91.99 8.39 37.8 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.323 -0.551 . . . . 12.0 110.46 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 92.38 0.08 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.271 -1.381 . . . . 12.0 107.271 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -172.28 149.53 2.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.219 -0.659 . . . . 12.0 109.219 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -63.61 -12.87 36.85 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.061 -0.399 . . . . 12.0 109.996 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.6 mt -84.45 11.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.702 -0.624 . . . . 12.0 110.658 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -146.48 64.27 1.2 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.44 -0.787 . . . . 12.0 110.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -146.99 151.25 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.761 -1.212 . . . . 12.0 110.398 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.8 169.1 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.984 -1.117 . . . . 12.0 107.984 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.01 53.02 3.25 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.259 -1.536 . . . . 12.0 109.259 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.52 -57.03 0.02 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.238 -1.545 . . . . 12.0 109.238 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.42 -69.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.046 -0.679 . . . . 12.0 109.447 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.6 m -141.18 -176.82 4.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -109.82 164.06 12.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.996 -0.742 . . . . 12.0 108.996 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -80.13 -20.01 45.95 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.838 -0.345 . . . . 12.0 110.367 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p -159.88 115.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.469 0.652 . . . . 12.0 111.106 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 12.3 m120 -103.18 84.89 2.4 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.385 -1.709 . . . . 12.0 106.385 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.8 m -81.46 115.99 21.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.395 0.617 . . . . 12.0 110.657 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.423 ' HB3' ' CG1' ' A' ' 12' ' ' ILE . 33.1 m-85 -106.84 165.5 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.3 -1.0 . . . . 12.0 108.3 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -125.88 124.08 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.3 tt -104.37 109.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 108.702 -0.851 . . . . 12.0 108.702 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t 178.18 158.24 0.46 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.067 -0.716 . . . . 12.0 109.067 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.65 118.91 4.59 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.877 0.846 . . . . 12.0 109.449 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 11' ' ' ILE . . . -45.09 -60.74 1.94 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 113.34 0.866 . . . . 12.0 113.34 -177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -25.0 64.98 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.935 -0.478 . . . . 12.0 111.24 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -62.71 -37.64 87.28 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.276 -1.379 . . . . 12.0 107.276 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' CG1' ' CD2' ' A' ' 10' ' ' HIS . 62.0 t -68.86 -35.49 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.156 -1.424 . . . . 12.0 107.156 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -63.67 -21.41 66.37 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.589 -0.523 . . . . 12.0 109.589 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.22 -37.54 28.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.944 -0.473 . . . . 12.0 109.741 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 tp -67.8 -24.99 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.851 -0.531 . . . . 12.0 110.296 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 22.14 11.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.806 -0.559 . . . . 12.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -87.36 115.02 24.5 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.821 -0.549 . . . . 12.0 109.624 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.29 0.02 OUTLIER Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.046 -1.222 . . . . 12.0 110.046 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 p -161.88 -165.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 pt -90.37 29.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 O-C-N 121.131 -0.98 . . . . 12.0 110.733 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 174.51 118.64 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.324 -1.361 . . . . 12.0 107.324 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.88 177.7 7.69 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.119 0.962 . . . . 12.0 112.501 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -139.07 111.69 7.68 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.237 -1.764 . . . . 12.0 106.237 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.69 163.98 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.309 -0.556 . . . . 12.0 110.367 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.6 tp -117.6 114.4 23.35 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.386 -0.227 . . . . 12.0 110.386 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.416 ' HB3' ' CD2' ' A' ' 66' ' ' PHE . 3.5 m -59.55 92.91 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.318 -0.993 . . . . 12.0 108.318 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -83.04 -171.64 3.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.763 -0.458 . . . . 12.0 109.763 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.416 HG21 ' HG2' ' A' ' 65' ' ' ARG . 97.9 m 62.84 -101.7 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.38 -0.971 . . . . 12.0 108.38 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HG2' HG21 ' A' ' 64' ' ' THR . 15.9 ptt180 179.72 107.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 119.441 1.019 . . . . 12.0 110.833 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 51.2 m-85 -96.01 43.62 1.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 108.497 -0.927 . . . . 12.0 108.497 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 22.55 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 113.859 1.059 . . . . 12.0 113.859 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.06 152.83 18.89 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.039 0.923 . . . . 12.0 111.664 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -118.99 98.29 6.11 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 105.726 -1.953 . . . . 12.0 105.726 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -98.42 123.23 42.44 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.619 0.723 . . . . 12.0 112.153 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.9 m -109.56 108.61 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.379 -2.452 . . . . 12.0 104.379 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -104.36 142.96 33.65 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.061 -0.656 . . . . 12.0 111.596 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.2 ttt180 -71.34 137.92 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.293 -0.632 . . . . 12.0 109.293 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.05 -90.37 0.45 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.492 -0.558 . . . . 12.0 109.492 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.76 144.76 1.85 Allowed 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.618 -0.676 . . . . 12.0 109.701 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.413 ' CG1' ' HD2' ' A' ' 78' ' ' PRO . 2.1 tt -172.98 151.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.101 -0.703 . . . . 12.0 109.101 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.42 -59.4 0.6 Allowed Pre-proline 0 N--CA 1.507 2.388 0 CA-C-O 118.977 -0.535 . . . . 12.0 111.479 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 76' ' ' ILE . 31.9 Cg_endo -70.03 179.07 4.11 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.071 1.848 . . . . 12.0 111.883 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' CB ' ' HA ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -98.3 170.44 7.03 Favored Pre-proline 0 N--CA 1.502 2.161 0 CA-C-N 116.316 -0.402 . . . . 12.0 110.201 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.403 ' HA ' ' CB ' ' A' ' 79' ' ' ARG . 32.4 Cg_endo -76.04 -75.55 0.0 OUTLIER 'Cis proline' 0 N--CA 1.49 1.277 0 O-C-N 123.325 1.171 . . . . 12.0 110.939 0.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.2 m -134.3 156.72 78.73 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 108.821 -0.807 . . . . 12.0 108.821 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.2 Cg_endo -78.3 122.63 5.72 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 C-N-CA 121.883 1.722 . . . . 12.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 14.7 m-85 -143.5 131.23 21.36 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.363 0.602 . . . . 12.0 110.854 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -108.78 125.49 52.0 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 107.579 -1.267 . . . . 12.0 107.579 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.0 p -95.44 141.02 29.47 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.084 0.468 . . . . 12.0 110.573 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.16 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.516 -0.92 . . . . 12.0 108.516 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -116.54 148.09 41.18 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 109.615 -0.513 . . . . 12.0 109.615 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.35 -172.32 1.69 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.32 0.581 . . . . 12.0 110.315 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.0 m -67.31 138.38 56.77 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.566 -0.531 . . . . 12.0 109.566 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -106.79 89.68 3.09 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.054 0.93 . . . . 12.0 111.571 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.78 105.28 15.03 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 105.157 -2.164 . . . . 12.0 105.157 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.5 HD13 ' CZ ' ' A' ' 104' ' ' PHE . 4.3 pt -138.95 -175.72 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.943 -0.703 . . . . 12.0 112.404 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 32.1 t -122.63 116.34 23.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.864 -0.607 . . . . 12.0 109.664 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.44 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 8.8 p -116.73 169.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.92 -0.4 . . . . 12.0 109.92 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -124.22 142.77 50.97 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.416 -0.587 . . . . 12.0 109.416 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 121.79 45.67 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 114.44 1.274 . . . . 12.0 114.44 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 23.6 tt0 -133.2 144.95 50.15 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 104.013 -2.588 . . . . 12.0 104.013 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 20.5 m120 54.22 28.04 8.62 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 107.755 -1.202 . . . . 12.0 107.755 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.409 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.8 pt20 52.49 12.84 0.26 Allowed 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 125.316 1.446 . . . . 12.0 114.754 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.473 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -120.23 148.05 46.34 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 104.857 -2.275 . . . . 12.0 104.857 174.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.473 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.3 Cg_endo -60.6 89.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.027 0 C-N-CA 121.301 1.334 . . . . 12.0 108.903 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.473 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 55.4 t -86.22 -21.82 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.195 -0.457 . . . . 12.0 110.582 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.464 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -137.61 147.18 44.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.026 -1.101 . . . . 12.0 108.026 -177.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.5 ' CZ ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -111.83 133.03 54.31 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.903 -1.119 . . . . 12.0 109.955 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.99 -38.37 19.34 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.22 -0.3 . . . . 12.0 110.668 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.95 -141.48 9.72 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 120.266 -0.969 . . . . 12.0 111.287 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.81 -170.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 122.265 -0.55 . . . . 12.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.39 -22.45 71.21 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 110.781 -0.927 . . . . 12.0 110.781 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 120.91 29.04 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 117.811 0.806 . . . . 12.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.89 167.73 13.76 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 109.478 -0.564 . . . . 12.0 109.478 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.48 0.722 0 C-N-CA 121.822 1.681 . . . . 12.0 110.225 179.711 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.303 0 N-CA-C 109.474 -0.565 . . . . 12.0 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -112.9 153.95 27.13 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.963 -0.755 . . . . 12.0 108.963 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -45.39 61.81 Favored 'General case' 0 N--CA 1.511 2.616 0 O-C-N 122.058 -0.401 . . . . 12.0 110.042 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.12 55.25 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.754 -0.591 . . . . 12.0 110.46 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -64.95 -30.03 70.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.419 -0.956 . . . . 12.0 108.419 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' HA ' ' CB ' ' A' ' 9' ' ' LYS . 30.7 t80 -76.56 -20.12 57.18 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.758 -0.83 . . . . 12.0 108.758 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.14 -38.99 93.04 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.855 -1.535 . . . . 12.0 106.855 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -78.21 -34.75 49.17 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.453 -1.314 . . . . 12.0 107.453 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' CG ' ' CD2' ' A' ' 10' ' ' HIS . 0.4 OUTLIER -41.48 -60.62 1.25 Allowed 'General case' 0 N--CA 1.506 2.374 0 CA-C-N 116.393 -0.367 . . . . 12.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.51 ' CD2' ' CG ' ' A' ' 9' ' ' LYS . 96.4 m-70 -110.57 -26.22 9.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.362 0.875 . . . . 12.0 113.362 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 4.9 mp -96.62 64.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 119.153 -1.019 . . . . 12.0 113.342 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.41 ' CD1' ' CD1' ' A' ' 40' ' ' PHE . 54.9 mt -91.86 70.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 105.053 -2.202 . . . . 12.0 105.053 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -70.34 81.99 0.55 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.626 0.727 . . . . 12.0 110.479 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 p -144.1 67.97 15.52 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.58 81.99 2.52 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.868 1.712 . . . . 12.0 109.851 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 16' ' ' ILE . 19.3 pt -129.98 -167.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.102 -1.073 . . . . 12.0 108.102 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 pt -102.26 36.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.728 -0.607 . . . . 12.0 109.663 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -152.57 98.33 2.35 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.722 -0.611 . . . . 12.0 110.557 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -82.49 -4.49 57.58 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 121.75 -0.593 . . . . 12.0 110.626 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.34 -50.5 8.86 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.353 -0.842 . . . . 12.0 111.532 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.2 m -66.29 -23.11 66.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.787 -0.571 . . . . 12.0 110.507 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.4 pt -84.73 -32.56 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.721 -0.612 . . . . 12.0 109.727 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.2 ttm -92.86 2.93 56.51 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 122.096 -0.378 . . . . 12.0 110.646 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.75 91.32 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.476 -0.935 . . . . 12.0 108.476 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -169.79 148.54 3.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.214 -0.662 . . . . 12.0 109.214 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -67.54 -10.9 56.11 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 110.092 -0.336 . . . . 12.0 110.092 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.4 mt -85.42 9.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.778 -0.576 . . . . 12.0 110.635 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -142.41 64.2 1.38 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.577 -0.702 . . . . 12.0 109.574 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 29' ' ' ILE . 50.3 mt -141.57 153.42 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.736 -1.228 . . . . 12.0 111.143 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.9 t -109.05 170.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 107.477 -1.305 . . . . 12.0 107.477 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.42 53.78 3.48 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.272 -1.531 . . . . 12.0 109.272 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.68 -57.35 0.02 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.349 -1.501 . . . . 12.0 109.349 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -166.74 -72.54 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.6 p -154.72 142.42 19.89 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.932 -0.766 . . . . 12.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -62.06 -176.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 2.57 34.64 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 121.003 -0.279 . . . . 12.0 110.69 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 37' ' ' VAL . 4.4 p -161.67 111.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.666 0.746 . . . . 12.0 110.314 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 6.3 m120 -103.79 81.88 1.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.453 -1.684 . . . . 12.0 106.453 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 m -82.85 110.89 18.25 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.977 -0.556 . . . . 12.0 111.225 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.413 ' CZ ' ' HB3' ' A' ' 38' ' ' ASN . 11.6 m-85 -105.46 161.18 14.56 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.6 mm -117.79 135.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.435 -0.791 . . . . 12.0 108.992 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -105.19 110.09 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.425 -0.954 . . . . 12.0 108.425 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t 174.32 150.98 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.203 -0.666 . . . . 12.0 109.203 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.6 p -60.63 126.19 26.5 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.393 -0.966 . . . . 12.0 108.393 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.94 -30.9 59.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.057 -0.402 . . . . 12.0 110.825 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -74.74 -31.87 61.94 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.69 -0.404 . . . . 12.0 111.023 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.429 HG21 ' N ' ' A' ' 48' ' ' VAL . 13.7 t -63.98 -33.63 76.17 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 107.406 -1.331 . . . . 12.0 107.406 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' N ' HG21 ' A' ' 47' ' ' THR . 21.0 t -72.88 -36.07 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.403 -1.332 . . . . 12.0 107.403 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -63.06 -21.03 65.89 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.668 -0.493 . . . . 12.0 109.668 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.53 -39.23 24.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.999 -0.438 . . . . 12.0 109.894 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.4 pt -69.6 -18.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.685 -0.634 . . . . 12.0 111.124 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.34 26.73 10.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.872 -0.517 . . . . 12.0 110.425 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -95.69 108.3 20.58 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.686 -0.633 . . . . 12.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.87 -57.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.523 -1.031 . . . . 12.0 110.523 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.6 p -157.08 179.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.994 -0.71 . . . . 12.0 109.1 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 38.7 pt -83.18 26.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 121.195 -0.94 . . . . 12.0 111.662 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 177.14 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.797 -1.557 . . . . 12.0 106.797 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -156.64 179.09 9.61 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 122.003 0.906 . . . . 12.0 112.016 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.8 118.18 16.75 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.401 -1.703 . . . . 12.0 106.401 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.9 p -141.95 170.13 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.304 -0.628 . . . . 12.0 109.304 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.71 120.55 16.41 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.844 -0.535 . . . . 12.0 111.154 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.461 ' CB ' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -60.41 92.51 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -90.92 -28.18 18.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.052 -0.405 . . . . 12.0 111.102 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -56.2 -77.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 172.14 106.59 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.959 -0.463 . . . . 12.0 110.017 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.461 ' CD1' ' CB ' ' A' ' 62' ' ' SER . 73.9 m-85 -122.02 65.28 0.92 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.803 -1.184 . . . . 12.0 107.803 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -23.31 127.73 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 114.52 1.304 . . . . 12.0 114.52 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' CG ' ' HB2' ' A' ' 90' ' ' ASN . 4.6 pp -99.85 150.95 21.84 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.694 0.759 . . . . 12.0 111.227 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -118.13 106.37 12.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.646 -1.983 . . . . 12.0 105.646 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.2 m -112.07 126.85 55.61 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.757 -0.777 . . . . 12.0 112.599 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.7 m -103.8 110.08 22.05 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 103.385 -2.821 . . . . 12.0 103.385 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.6 m -109.11 143.02 39.01 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 119.919 -0.712 . . . . 12.0 112.227 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.9 ttt180 -64.15 132.21 49.73 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 p -115.52 -91.68 0.52 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.554 -0.458 . . . . 12.0 110.735 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -129.54 141.51 50.96 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.473 -0.767 . . . . 12.0 110.01 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.4 tt -68.5 134.86 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-O 121.431 0.634 . . . . 12.0 110.65 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.47 ' CB ' ' HD3' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -178.65 -58.4 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.013 0 N-CA-C 108.798 -0.816 . . . . 12.0 108.798 178.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 77' ' ' THR . 37.9 Cg_endo -82.29 -163.06 0.2 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 122.043 1.829 . . . . 12.0 109.318 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 155.17 46.59 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 109.139 -0.689 . . . . 12.0 109.139 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.21 -41.95 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.14 0 O-C-N 123.135 1.071 . . . . 12.0 110.534 0.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.5 m -132.03 148.82 71.36 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.464 -0.939 . . . . 12.0 108.464 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.441 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.4 Cg_endo -75.46 124.75 8.55 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 121.758 1.639 . . . . 12.0 109.815 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 17.0 m-85 -143.1 134.38 25.99 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.284 0.564 . . . . 12.0 110.79 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 p -115.03 123.23 48.52 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.43 -0.952 . . . . 12.0 108.43 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 142.46 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.828 -0.434 . . . . 12.0 109.828 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -146.76 157.2 43.62 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.5 m -129.77 147.9 51.59 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.893 -0.78 . . . . 12.0 108.893 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -165.38 156.34 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.382 -0.527 . . . . 12.0 110.48 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.8 m -58.1 124.67 20.17 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 66' ' ' PHE . 4.9 t-20 -121.99 101.36 7.5 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.366 1.247 . . . . 12.0 114.366 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.6 126.77 41.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 102.703 -3.073 . . . . 12.0 102.703 172.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.427 ' CG2' ' HA2' ' A' ' 106' ' ' GLY . 1.6 mp -121.9 161.5 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 N-CA-C 113.993 1.108 . . . . 12.0 113.993 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.4 t -100.41 109.45 21.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 106.21 -1.774 . . . . 12.0 106.21 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.492 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 10.6 m -118.66 -177.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.072 0.463 . . . . 12.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.459 ' CB ' ' CD2' ' A' ' 103' ' ' HIS . 38.7 mtpt -143.73 149.26 36.87 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.899 -0.778 . . . . 12.0 108.899 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.45 116.42 28.18 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.96 0.726 . . . . 12.0 112.96 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.0 tt0 -125.43 143.08 51.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 104.42 -2.437 . . . . 12.0 104.42 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 1.6 m-80 58.74 14.96 3.46 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.061 -1.024 . . . . 12.0 108.513 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 15.6 mt-30 75.79 -8.25 1.64 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.112 0.965 . . . . 12.0 113.049 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.459 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.1 OUTLIER -105.8 152.55 40.21 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.735 -1.579 . . . . 12.0 106.735 176.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.459 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.6 Cg_endo -61.76 87.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.542 1.495 . . . . 12.0 109.095 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.449 HG23 ' CE2' ' A' ' 100' ' ' TYR . 67.4 t -84.34 -20.72 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.479 -0.328 . . . . 12.0 110.591 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.472 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -130.83 127.49 38.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.925 -1.139 . . . . 12.0 107.925 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.492 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.2 OUTLIER -121.53 122.0 38.72 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.646 -0.872 . . . . 12.0 108.646 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.25 -32.02 12.64 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.775 -0.37 . . . . 12.0 110.506 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.427 ' HA2' ' CG2' ' A' ' 92' ' ' ILE . . . 97.15 162.04 31.84 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.08 -1.608 . . . . 12.0 109.08 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.41 ' O ' ' O ' ' A' ' 106' ' ' GLY . 60.3 mt 57.24 123.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 12.0 111.118 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.95 80.63 1.74 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 109.685 -1.366 . . . . 12.0 109.685 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.15 95.89 0.97 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 26.6 p 179.76 155.27 0.68 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-O 118.66 -0.686 . . . . 12.0 109.331 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.482 0.811 0 C-N-CA 121.556 1.504 . . . . 12.0 110.202 179.704 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 2.533 0 CA-C-O 120.907 0.384 . . . . 12.0 110.084 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -129.58 166.69 19.21 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.84 -0.8 . . . . 12.0 108.84 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -23.58 64.91 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.614 -0.679 . . . . 12.0 110.357 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.33 -61.44 1.99 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.493 -0.754 . . . . 12.0 110.6 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.53 74.9 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.412 -1.329 . . . . 12.0 107.412 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 24.7 t80 -73.57 -27.49 61.34 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.338 -0.986 . . . . 12.0 108.338 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.91 -33.1 35.56 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 107.72 -1.215 . . . . 12.0 107.72 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -42.02 33.26 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.33 -53.87 6.33 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.232 -0.44 . . . . 12.0 111.18 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.46 ' CD2' HG13 ' A' ' 48' ' ' VAL . 1.1 m-70 -96.75 -15.38 21.41 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.694 -0.629 . . . . 12.0 111.162 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 45' ' ' ALA . 15.7 mm -140.15 87.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 114.231 1.197 . . . . 12.0 114.231 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 12' ' ' ILE . 35.3 mm -96.73 67.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 105.094 -2.187 . . . . 12.0 105.094 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -66.81 84.35 0.11 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.932 0.872 . . . . 12.0 110.636 -177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.2 p -159.39 63.12 2.18 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 106.976 -1.491 . . . . 12.0 106.976 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.49 85.61 1.26 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.041 1.827 . . . . 12.0 110.598 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.27 -173.09 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.847 -0.797 . . . . 12.0 108.847 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pt -98.67 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.293 0.568 . . . . 12.0 109.636 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -145.03 95.56 2.71 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.434 -0.58 . . . . 12.0 109.434 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.4 m -80.45 -3.18 48.88 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.916 -0.49 . . . . 12.0 110.735 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.6 -50.16 10.34 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.613 0.642 . . . . 12.0 110.974 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 m -63.11 -21.18 66.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.748 -0.595 . . . . 12.0 110.429 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 23' ' ' MET . 45.6 pt -85.78 -38.05 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.679 -0.638 . . . . 12.0 109.904 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.406 ' N ' HG13 ' A' ' 22' ' ' ILE . 3.8 ptm -91.53 11.14 25.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.988 -0.445 . . . . 12.0 110.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -66.41 90.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.489 -0.93 . . . . 12.0 108.489 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -173.11 150.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.453 -0.573 . . . . 12.0 109.453 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -70.52 -9.13 55.9 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 110.09 -0.337 . . . . 12.0 110.09 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -88.82 11.6 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.72 -0.613 . . . . 12.0 110.319 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -140.03 58.95 1.58 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.827 -0.546 . . . . 12.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 29' ' ' ILE . 41.3 mt -148.0 146.6 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.631 -1.293 . . . . 12.0 110.559 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 p -111.67 -164.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.34 -1.355 . . . . 12.0 107.34 178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -97.72 66.3 0.83 Allowed Glycine 0 N--CA 1.506 3.301 0 O-C-N 120.956 -1.09 . . . . 12.0 112.453 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.52 -68.86 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.136 -1.586 . . . . 12.0 109.136 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -164.45 -66.71 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.845 -1.169 . . . . 12.0 107.845 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.0 p -138.8 144.6 39.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.631 -0.877 . . . . 12.0 108.631 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -61.27 -175.03 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.985 -0.447 . . . . 12.0 109.991 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -89.73 -23.11 21.88 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 110.024 -0.361 . . . . 12.0 110.024 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 t -150.01 102.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 5.1 m120 -90.99 80.82 5.69 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.649 -1.612 . . . . 12.0 106.649 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -84.17 115.35 22.37 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.936 -0.574 . . . . 12.0 110.825 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.401 ' HB3' ' HB ' ' A' ' 12' ' ' ILE . 32.8 m-85 -105.44 165.58 11.03 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.3 mm -127.45 126.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 120.932 -1.105 . . . . 12.0 110.459 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 tt -108.91 127.83 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.11 -0.7 . . . . 12.0 109.11 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.3 t 170.4 160.37 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.363 -0.977 . . . . 12.0 108.363 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.67 117.93 4.73 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.44 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -40.85 -64.63 0.51 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.9 1.074 . . . . 12.0 113.9 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -61.29 -26.21 67.63 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.794 -0.566 . . . . 12.0 111.311 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 m -58.61 -35.54 72.62 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 107.456 -1.312 . . . . 12.0 107.456 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.46 HG13 ' CD2' ' A' ' 10' ' ' HIS . 45.7 t -70.19 -37.95 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.294 -1.372 . . . . 12.0 107.294 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -60.68 -21.55 62.96 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.138 -0.69 . . . . 12.0 109.138 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.87 -37.2 27.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 122.009 -0.432 . . . . 12.0 109.919 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 6.8 tp -66.82 -24.36 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 120.414 -0.514 . . . . 12.0 110.425 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 22.95 10.69 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.723 -0.611 . . . . 12.0 109.768 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 m -84.74 109.22 17.89 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.028 -0.73 . . . . 12.0 109.028 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.93 -58.82 0.02 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.616 -0.994 . . . . 12.0 110.616 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 p -164.89 -175.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.0 pt -87.08 27.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.315 -0.865 . . . . 12.0 111.34 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 177.21 116.83 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 107.807 -1.183 . . . . 12.0 107.807 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.5 ttp -165.83 170.81 13.48 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.554 0.692 . . . . 12.0 111.39 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.4 118.03 15.98 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.7 p -150.57 164.55 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.314 -0.624 . . . . 12.0 109.314 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 mp -115.3 128.81 56.36 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.051 -0.352 . . . . 12.0 110.051 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.426 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 49.5 m -53.62 94.11 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.142 -1.059 . . . . 12.0 108.142 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.418 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 1.1 p -77.37 -174.78 3.44 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.834 0.35 . . . . 12.0 110.085 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.9 m 63.47 -94.86 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 174.0 104.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 118.828 0.74 . . . . 12.0 110.006 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 48.5 m-85 -95.99 43.34 1.08 Allowed 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.193 -0.669 . . . . 12.0 109.193 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 29.64 105.2 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.147 0 N-CA-C 113.87 1.063 . . . . 12.0 113.87 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.62 154.68 19.23 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.033 0.92 . . . . 12.0 112.107 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -117.26 97.02 5.69 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 105.524 -2.028 . . . . 12.0 105.524 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -99.95 122.66 43.2 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.803 -0.759 . . . . 12.0 112.971 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -108.75 105.68 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 103.338 -2.838 . . . . 12.0 103.338 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.4 m -114.34 143.28 45.15 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.9 -0.72 . . . . 12.0 112.613 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 25.7 ttp180 -69.74 109.54 4.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.008 -1.108 . . . . 12.0 108.008 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -145.11 -79.18 0.18 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 120.006 -0.677 . . . . 12.0 112.363 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 p -94.48 160.38 14.67 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.775 -0.578 . . . . 12.0 110.989 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 pt -55.88 128.67 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.362 0.601 . . . . 12.0 110.296 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 t 172.38 67.5 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 106.935 -1.506 . . . . 12.0 106.935 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.06 109.52 2.72 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 122.025 1.817 . . . . 12.0 112.647 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' N ' ' CA ' ' A' ' 80' ' ' PRO . 2.4 mtp180 -145.78 51.58 1.31 Allowed Pre-proline 0 N--CA 1.486 1.339 0 CA-C-N 115.776 -0.647 . . . . 12.0 109.387 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.415 ' CA ' ' N ' ' A' ' 79' ' ' ARG . 39.2 Cg_endo -88.2 -23.93 8.54 Favored 'Cis proline' 0 N--CA 1.491 1.351 0 O-C-N 122.253 0.607 . . . . 12.0 111.781 -1.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.1 m -86.09 157.63 56.58 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 121.802 -0.561 . . . . 12.0 109.493 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 34.3 Cg_endo -72.25 89.31 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 121.721 1.614 . . . . 12.0 109.468 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.403 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 7.2 m-85 -121.31 140.4 52.14 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-O 121.61 0.719 . . . . 12.0 112.542 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 m -119.15 124.16 46.15 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.559 -1.274 . . . . 12.0 107.559 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -93.12 142.83 26.87 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.924 -0.485 . . . . 12.0 110.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -155.7 132.76 10.71 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.423 -0.584 . . . . 12.0 109.423 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.3 m -92.3 148.82 21.83 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.898 -0.779 . . . . 12.0 108.898 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -169.16 -169.75 1.01 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.23 0.538 . . . . 12.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 m -67.14 139.44 57.49 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.147 -0.686 . . . . 12.0 109.147 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 67.0 t30 -107.46 87.0 2.4 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.091 0.948 . . . . 12.0 112.392 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 63' ' ' THR . 14.5 t80 -99.68 102.39 13.86 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.186 -2.524 . . . . 12.0 104.186 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.9 tt -124.47 169.85 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.541 -0.864 . . . . 12.0 112.883 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.8 t -113.14 107.76 16.37 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.275 -1.009 . . . . 12.0 108.275 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.473 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 18.0 m -127.33 -170.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.68 -0.489 . . . . 12.0 109.68 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -147.57 161.06 41.89 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.069 -0.652 . . . . 12.0 110.887 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 128.27 52.2 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.646 0.736 . . . . 12.0 111.983 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 14.4 tt0 -147.51 147.08 29.77 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 104.97 -2.233 . . . . 12.0 104.97 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 59.1 18.21 6.22 Favored 'General case' 0 N--CA 1.508 2.472 0 N-CA-C 108.387 -0.968 . . . . 12.0 108.387 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.03 -6.01 1.39 Allowed 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.579 0.752 . . . . 12.0 112.71 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -110.55 145.19 31.75 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 106.332 -1.729 . . . . 12.0 106.332 177.24 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.564 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 28.2 Cg_endo -66.52 100.08 0.47 Allowed 'Trans proline' 0 C--O 1.203 -1.264 0 N-CA-C 107.382 -1.815 . . . . 12.0 107.382 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.417 ' HB ' ' CZ ' ' A' ' 100' ' ' TYR . 12.3 p -117.58 7.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 120.057 -0.657 . . . . 12.0 112.654 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -129.87 133.42 46.88 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.669 -1.234 . . . . 12.0 107.669 178.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.473 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.02 126.41 50.73 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.967 -0.693 . . . . 12.0 110.684 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 -32.98 13.69 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.89 -0.782 . . . . 12.0 108.89 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 140.14 -149.24 20.73 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.052 -1.219 . . . . 12.0 110.052 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.3 pt -56.16 -172.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.291 -0.535 . . . . 12.0 109.895 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -88.13 58.13 4.25 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.234 -1.146 . . . . 12.0 110.234 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -143.79 96.95 2.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.423 -0.954 . . . . 12.0 108.423 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 10.1 m -131.66 60.96 55.69 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 109.969 -0.382 . . . . 12.0 109.969 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 N--CA 1.478 0.58 0 C-N-CA 122.187 1.925 . . . . 12.0 110.104 179.648 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 2.531 0 N-CA-C 109.705 -0.48 . . . . 12.0 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -142.48 168.71 19.09 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.728 -0.841 . . . . 12.0 108.728 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.25 -25.91 65.42 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.588 -0.695 . . . . 12.0 110.207 -178.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.64 -60.31 2.37 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.694 -0.629 . . . . 12.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.72 -35.55 78.36 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.514 -1.291 . . . . 12.0 107.514 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 28.1 t80 -73.8 -25.07 59.93 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -31.76 54.05 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 107.534 -1.284 . . . . 12.0 107.534 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.96 -37.86 33.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -46.73 -53.04 12.61 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 116.335 -0.393 . . . . 12.0 110.63 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.455 ' CD2' HG13 ' A' ' 48' ' ' VAL . 1.3 m-70 -97.09 -16.01 20.71 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.863 -0.523 . . . . 12.0 110.848 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 11' ' ' ILE . 5.0 mp -144.09 87.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.068 1.136 . . . . 12.0 114.068 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.425 ' CD1' ' CD1' ' A' ' 40' ' ' PHE . 12.6 mt -97.06 65.13 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 103.711 -2.7 . . . . 12.0 103.711 173.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -66.98 83.0 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.903 0.859 . . . . 12.0 110.699 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 p -155.18 63.18 3.67 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 106.847 -1.538 . . . . 12.0 106.847 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -73.21 84.05 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.086 1.857 . . . . 12.0 111.015 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.65 -167.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.787 -1.19 . . . . 12.0 107.787 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 mm -101.91 34.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 108.682 -0.858 . . . . 12.0 108.682 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -145.8 97.6 2.99 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -77.84 -16.28 58.42 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.842 -0.537 . . . . 12.0 111.253 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.18 -49.02 10.6 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 118.854 0.752 . . . . 12.0 110.046 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -31.54 67.27 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.748 -0.464 . . . . 12.0 109.748 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 23' ' ' MET . 47.0 pt -81.12 -36.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 120.627 -0.429 . . . . 12.0 110.208 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -97.03 15.24 22.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.925 -0.484 . . . . 12.0 110.165 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.27 90.78 0.1 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.122 -1.066 . . . . 12.0 108.122 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -166.83 158.06 12.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.236 -0.653 . . . . 12.0 109.236 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -72.89 -10.82 60.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 120.8 -0.36 . . . . 12.0 110.263 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.02 9.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.65 -0.656 . . . . 12.0 110.523 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -142.71 63.23 1.39 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.611 -0.68 . . . . 12.0 109.727 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.3 mt -148.49 153.26 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 120.763 -1.211 . . . . 12.0 110.318 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.0 t -107.03 169.53 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 107.764 -1.199 . . . . 12.0 107.764 178.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.71 54.16 3.39 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.117 -1.593 . . . . 12.0 109.117 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.9 -56.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.241 -1.544 . . . . 12.0 109.241 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -165.27 -68.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.04 -0.682 . . . . 12.0 109.401 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.0 m -143.51 -175.77 4.69 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.49 -0.559 . . . . 12.0 109.49 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.92 163.72 12.52 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.339 -0.615 . . . . 12.0 109.339 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -73.85 -24.08 59.72 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 110.058 -0.349 . . . . 12.0 110.058 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -156.35 109.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.481 0.658 . . . . 12.0 110.804 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 3.0 m-20 -91.27 83.3 5.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.527 -1.657 . . . . 12.0 106.527 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.9 m -82.61 106.43 14.46 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 116.006 -0.543 . . . . 12.0 110.89 -177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 38' ' ' ASN . 10.5 m-85 -99.11 157.86 16.06 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.167 -1.42 . . . . 12.0 107.167 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.92 125.57 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.175 -0.953 . . . . 12.0 109.005 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.2 tt -106.74 118.37 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.489 -0.56 . . . . 12.0 109.489 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t 173.15 154.86 0.1 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.382 -0.97 . . . . 12.0 108.382 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.21 119.2 5.98 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.22 -52.38 12.58 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.053 0.76 . . . . 12.0 113.053 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -61.7 -29.53 70.16 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.026 -0.421 . . . . 12.0 111.558 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -63.19 -35.18 79.45 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.455 HG13 ' CD2' ' A' ' 10' ' ' HIS . 42.0 t -71.28 -33.91 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.686 -1.227 . . . . 12.0 107.686 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -61.76 -22.37 65.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.173 -0.677 . . . . 12.0 109.173 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -36.67 28.11 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.653 -0.499 . . . . 12.0 109.653 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.409 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 5.9 tp -66.08 -25.26 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 C-N-CA 120.372 -0.531 . . . . 12.0 110.792 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.53 24.27 7.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.614 -0.679 . . . . 12.0 109.908 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -88.3 110.94 21.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.254 -0.647 . . . . 12.0 109.254 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.46 -58.78 0.02 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.396 -1.081 . . . . 12.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.2 p -161.59 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.013 -0.736 . . . . 12.0 109.013 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.2 tt -83.27 21.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.642 0 O-C-N 121.357 -0.839 . . . . 12.0 111.718 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 175.25 113.36 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.541 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.5 ttm -163.78 -176.78 4.78 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.485 0.659 . . . . 12.0 111.034 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -137.98 123.5 19.65 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.295 -1.372 . . . . 12.0 107.295 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.37 163.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.907 -0.495 . . . . 12.0 109.869 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.6 mp -122.72 116.26 23.45 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.587 -0.523 . . . . 12.0 109.587 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.43 ' HB3' ' CD2' ' A' ' 66' ' ' PHE . 1.8 m -55.48 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.699 -0.852 . . . . 12.0 108.699 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -50.45 20.39 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.592 -0.892 . . . . 12.0 108.592 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.7 115.4 3.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.532 -0.914 . . . . 12.0 108.532 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.411 ' O ' ' CG ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -44.74 106.88 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.152 0.501 . . . . 12.0 111.543 -178.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 28.6 m-85 -94.4 40.08 1.09 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 108.848 -0.797 . . . . 12.0 108.848 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' PHE . 1.4 tp-100 39.86 107.56 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 112.859 0.689 . . . . 12.0 112.859 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 3.5 pp -95.99 147.94 23.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 12.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.98 97.47 5.71 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 105.292 -2.114 . . . . 12.0 105.292 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.2 m -108.22 128.16 54.48 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.434 -0.906 . . . . 12.0 112.541 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.0 m -112.63 111.9 23.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.288 -2.486 . . . . 12.0 104.288 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -108.64 141.89 39.92 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.12 -0.632 . . . . 12.0 111.401 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -65.3 109.59 2.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.68 -0.859 . . . . 12.0 108.68 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 p -116.75 -115.12 0.33 Allowed 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 120.388 -0.525 . . . . 12.0 111.201 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.0 p -147.38 164.75 32.31 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.094 -1.004 . . . . 12.0 110.154 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.1 mt 63.64 -138.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 107.644 -1.243 . . . . 12.0 107.644 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.406 ' CB ' ' CD ' ' A' ' 78' ' ' PRO . 0.0 OUTLIER 55.24 -179.58 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.634 0 CA-C-N 120.145 1.338 . . . . 12.0 108.938 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 77' ' ' THR . 30.4 Cg_endo -74.75 106.59 2.29 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 121.08 1.187 . . . . 12.0 109.329 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.474 ' HB2' ' HA ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -96.12 161.73 26.18 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.326 -0.62 . . . . 12.0 109.326 -178.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.474 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 34.9 Cg_endo -74.9 172.95 60.28 Favored 'Cis proline' 0 N--CA 1.487 1.136 0 O-C-N 123.177 1.093 . . . . 12.0 111.311 1.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 90.5 m 61.7 63.69 2.16 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-N 116.346 -0.388 . . . . 12.0 110.787 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.01 137.31 12.25 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.326 2.017 . . . . 12.0 109.012 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -134.54 136.03 42.76 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.525 0.679 . . . . 12.0 112.454 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -108.81 129.8 55.39 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -96.34 145.48 25.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.947 -0.471 . . . . 12.0 111.213 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -159.57 138.96 11.27 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 109.261 -0.644 . . . . 12.0 109.261 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -99.05 150.74 21.69 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 109.534 -0.543 . . . . 12.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.02 -162.44 0.84 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.033 0.444 . . . . 12.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 92.5 m -79.2 127.92 32.65 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.003 -0.74 . . . . 12.0 109.003 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 21.2 t-20 -95.0 87.52 4.95 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-O 122.245 1.021 . . . . 12.0 111.983 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 5.2 p90 -103.16 101.79 11.76 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 15.8 tt -119.78 162.54 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.118 0.785 . . . . 12.0 113.118 -175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -110.52 107.2 16.75 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.076 -1.453 . . . . 12.0 107.076 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.472 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 17.1 m -128.09 -172.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 12.0 109.437 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.464 ' CB ' ' CD2' ' A' ' 103' ' ' HIS . 4.0 mtpp -143.04 162.94 34.16 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.96 -0.696 . . . . 12.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 9.8 m -115.9 130.26 56.75 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.592 0.711 . . . . 12.0 111.871 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.488 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 39.0 tt0 -138.32 136.97 36.95 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.915 -2.254 . . . . 12.0 104.915 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 12.1 m-20 55.86 20.91 4.43 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.391 -0.818 . . . . 12.0 108.838 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 6.4 mt-30 77.12 -17.08 0.58 Allowed 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 123.517 0.727 . . . . 12.0 112.637 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.503 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -98.65 143.66 26.73 Favored Pre-proline 0 N--CA 1.503 2.192 0 N-CA-C 105.983 -1.858 . . . . 12.0 105.983 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.535 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 24.8 Cg_endo -62.69 104.36 0.37 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 C-N-CA 121.278 1.318 . . . . 12.0 108.92 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 100' ' ' TYR . 3.5 t -115.97 12.25 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 C-N-CA 120.287 -0.565 . . . . 12.0 112.22 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -141.83 133.81 27.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -118.12 129.46 55.55 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 109.084 -0.71 . . . . 12.0 109.084 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.54 -26.17 7.61 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.598 0.592 . . . . 12.0 112.598 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -177.03 -174.75 43.74 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 119.811 -1.185 . . . . 12.0 111.18 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 10.3 tt -97.78 31.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.09 0.471 . . . . 12.0 110.384 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 132.84 -67.62 0.56 Allowed Glycine 0 N--CA 1.502 3.038 0 N-CA-C 110.366 -1.094 . . . . 12.0 110.366 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -65.06 135.62 55.78 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.975 -0.75 . . . . 12.0 108.975 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.439 ' N ' ' HD3' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -145.46 60.52 6.85 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 109.407 -0.59 . . . . 12.0 109.407 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 110' ' ' CYS . 37.1 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 C-N-CA 122.249 1.966 . . . . 12.0 110.258 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.383 0 N-CA-C 109.571 -0.529 . . . . 12.0 109.571 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -150.79 157.12 42.55 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.543 -0.91 . . . . 12.0 108.543 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.03 78.65 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 122.045 -0.409 . . . . 12.0 110.609 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.22 -56.45 11.26 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 121.359 -0.838 . . . . 12.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -31.44 72.01 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.917 -1.142 . . . . 12.0 107.917 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 53.7 t80 -72.74 -25.67 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.723 -0.843 . . . . 12.0 108.723 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -53.65 -37.3 62.98 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 107.254 -1.387 . . . . 12.0 107.254 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.39 -40.89 57.45 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.192 -1.41 . . . . 12.0 107.192 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 7.0 tptt -43.32 -61.81 1.24 Allowed 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 116.268 -0.424 . . . . 12.0 111.836 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.595 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 1.9 m80 -99.49 -7.07 26.5 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 119.08 0.854 . . . . 12.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 25.2 mm -134.37 78.41 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 118.684 -1.206 . . . . 12.0 113.33 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 5.0 mp -94.82 64.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.153 -2.165 . . . . 12.0 105.153 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -64.82 85.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.652 0.739 . . . . 12.0 110.372 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.7 p -160.73 69.9 2.74 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.102 -1.444 . . . . 12.0 107.102 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -79.78 30.64 0.48 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.418 2.079 . . . . 12.0 113.103 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.2 pt -64.56 -169.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.655 -0.869 . . . . 12.0 108.655 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.35 33.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 121.589 0.709 . . . . 12.0 109.46 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -144.94 98.95 3.26 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 108.665 -0.865 . . . . 12.0 108.665 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.0 m -77.36 -18.7 57.16 Favored 'General case' 0 N--CA 1.511 2.581 0 C-N-CA 120.5 -0.48 . . . . 12.0 111.434 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -80.93 -48.54 12.18 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.051 0.841 . . . . 12.0 110.08 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -32.11 68.58 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.916 -0.402 . . . . 12.0 109.916 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.8 pt -80.26 -34.6 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 122.034 -0.416 . . . . 12.0 110.195 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -99.34 18.25 18.13 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 120.512 -0.475 . . . . 12.0 110.44 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.53 89.9 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.939 -1.134 . . . . 12.0 107.939 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -166.88 159.54 13.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.209 -0.663 . . . . 12.0 109.209 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.8 -10.36 59.71 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.76 -0.376 . . . . 12.0 110.052 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.9 mt -87.77 10.44 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.73 -0.606 . . . . 12.0 110.528 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -146.94 63.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.706 -0.621 . . . . 12.0 110.099 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.3 mt -153.19 149.02 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.57 -1.331 . . . . 12.0 111.07 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.86 168.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 107.678 -1.23 . . . . 12.0 107.678 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.58 53.87 3.43 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.328 -1.509 . . . . 12.0 109.328 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.95 -55.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 12.0 109.388 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -166.43 -77.06 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.929 -0.767 . . . . 12.0 108.929 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -146.47 -170.71 3.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.827 -0.805 . . . . 12.0 108.827 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -174.27 2.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.222 -0.658 . . . . 12.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -85.4 -25.4 27.04 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.981 -0.45 . . . . 12.0 110.591 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.1 t -151.51 107.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 120.353 -0.539 . . . . 12.0 110.777 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.3 m120 -91.6 85.69 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 105.904 -1.887 . . . . 12.0 105.904 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 m -81.73 112.89 19.31 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.242 0.544 . . . . 12.0 111.763 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 23' ' ' MET . 32.7 m-85 -100.39 158.5 15.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.272 -1.381 . . . . 12.0 107.272 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.3 mp -126.52 128.75 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 12.0 109.353 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 tt -111.14 129.28 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t 165.42 157.88 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.188 -1.041 . . . . 12.0 108.188 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -60.19 122.81 15.39 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.671 -0.863 . . . . 12.0 108.671 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.09 -29.24 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.136 -0.352 . . . . 12.0 111.803 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -79.92 -31.57 40.11 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.953 -0.467 . . . . 12.0 111.903 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 p -64.87 -36.04 83.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.474 -1.306 . . . . 12.0 107.474 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.05 -33.5 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.718 -1.215 . . . . 12.0 107.718 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -66.75 -21.54 66.06 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.607 -0.516 . . . . 12.0 109.607 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.69 -41.2 24.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.794 -0.566 . . . . 12.0 109.76 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.421 ' CG2' ' CZ ' ' A' ' 66' ' ' PHE . 18.3 pt -67.15 -20.46 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.782 -0.574 . . . . 12.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 22.34 9.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.853 -0.53 . . . . 12.0 110.101 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -88.78 114.43 25.39 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.005 -0.739 . . . . 12.0 109.005 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.17 -61.21 0.02 OUTLIER Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.418 -1.073 . . . . 12.0 110.418 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.9 p -163.65 -168.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 12.4 tt -87.26 27.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 O-C-N 121.097 -1.002 . . . . 12.0 110.958 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 6.1 t-20 171.1 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 106.403 -1.703 . . . . 12.0 106.403 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.62 179.37 8.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.826 0.822 . . . . 12.0 112.132 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -137.55 115.1 11.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.71 166.35 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.897 -0.502 . . . . 12.0 109.653 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 mp -129.33 117.54 20.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.896 -0.502 . . . . 12.0 111.521 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.458 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 1.4 m -58.1 93.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.105 -1.443 . . . . 12.0 107.105 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.427 ' HA ' ' CE2' ' A' ' 91' ' ' TYR . 1.6 p -79.74 -53.5 6.75 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 112.249 0.463 . . . . 12.0 112.249 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.5 m -47.83 -90.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.866 -0.521 . . . . 12.0 110.271 -178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 174.43 100.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.458 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 57.9 m-85 -97.88 54.62 1.15 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.237 -0.653 . . . . 12.0 109.237 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 11.88 109.03 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.431 1.271 . . . . 12.0 114.431 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.04 154.6 17.97 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.819 0.819 . . . . 12.0 111.756 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -119.22 100.23 7.2 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.083 -1.821 . . . . 12.0 106.083 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 m -102.18 127.39 49.13 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.659 0.743 . . . . 12.0 112.355 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -111.7 112.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.367 -2.457 . . . . 12.0 104.367 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 m -111.2 144.99 39.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.091 -0.644 . . . . 12.0 111.648 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -62.34 142.79 57.61 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.297 -1.001 . . . . 12.0 108.297 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.99 -85.49 0.55 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.92 -0.488 . . . . 12.0 110.545 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.7 t -155.61 177.22 11.63 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.781 -0.574 . . . . 12.0 109.725 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 19.2 mt 61.91 166.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.67 -0.863 . . . . 12.0 108.67 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.45 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 4.3 t -134.2 59.61 38.64 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.798 -0.564 . . . . 12.0 110.837 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 77' ' ' THR . 38.5 Cg_endo -85.25 175.33 6.48 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 121.923 1.749 . . . . 12.0 109.375 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -120.0 127.48 26.34 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.158 -1.053 . . . . 12.0 108.158 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.15 -178.61 17.7 Favored 'Cis proline' 0 N--CA 1.487 1.143 0 O-C-N 122.856 0.924 . . . . 12.0 111.517 2.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER -60.69 149.52 78.95 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 119.09 -0.481 . . . . 12.0 110.809 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.33 113.05 2.85 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.119 1.879 . . . . 12.0 109.296 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.425 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 12.1 m-85 -138.58 139.07 38.49 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.195 0.521 . . . . 12.0 111.119 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -111.33 129.35 56.02 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.897 -1.149 . . . . 12.0 107.897 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 t -93.91 149.45 21.22 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.39 0.614 . . . . 12.0 110.883 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -151.79 155.42 38.19 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.032 -0.729 . . . . 12.0 109.032 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.3 m -125.44 141.2 52.19 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.535 -0.543 . . . . 12.0 109.535 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -166.12 -172.03 2.16 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.095 0.474 . . . . 12.0 110.317 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.4 m -65.3 145.59 56.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.991 -0.744 . . . . 12.0 108.991 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -110.22 88.24 2.71 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.907 0.86 . . . . 12.0 111.371 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 63' ' ' THR . 6.6 t80 -98.03 96.63 8.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.987 -2.597 . . . . 12.0 103.987 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.409 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 7.1 tt -130.69 175.12 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.978 -0.689 . . . . 12.0 111.077 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.77 116.63 27.4 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.65 -0.871 . . . . 12.0 108.65 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.8 p -108.88 162.06 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.989 -0.374 . . . . 12.0 109.989 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -120.35 144.8 47.67 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -119.55 120.63 37.31 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 114.003 1.112 . . . . 12.0 114.003 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 20.9 tt0 -128.37 141.8 51.31 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 104.076 -2.564 . . . . 12.0 104.076 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.9 m-80 57.21 28.64 15.41 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 107.683 -1.228 . . . . 12.0 107.683 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 51.22 16.17 0.36 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 124.754 1.222 . . . . 12.0 114.001 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.466 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -120.85 145.44 41.37 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 104.121 -2.548 . . . . 12.0 104.121 174.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.495 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 24.5 Cg_endo -61.33 93.89 0.11 Allowed 'Trans proline' 0 C--O 1.2 -1.393 0 N-CA-C 108.429 -1.412 . . . . 12.0 108.429 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.45 HG23 ' CE2' ' A' ' 100' ' ' TYR . 63.4 t -91.73 -14.15 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 122.239 -0.288 . . . . 12.0 110.901 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -146.35 145.62 30.37 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.595 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -102.23 120.0 39.74 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.481 -1.288 . . . . 12.0 108.914 178.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.46 81.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.863 -0.523 . . . . 12.0 110.042 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.8 -158.86 23.27 Favored Glycine 0 N--CA 1.5 2.95 0 N-CA-C 109.896 -1.282 . . . . 12.0 109.896 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 108' ' ' GLY . 8.3 tp -54.58 162.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 122.173 -0.604 . . . . 12.0 109.725 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' N ' HG13 ' A' ' 107' ' ' ILE . . . -57.39 91.4 0.02 OUTLIER Glycine 0 N--CA 1.499 2.889 0 N-CA-C 109.462 -1.455 . . . . 12.0 109.462 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -176.46 107.16 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.318 -0.623 . . . . 12.0 109.318 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 111' ' ' PRO . 11.9 m -151.55 60.66 3.87 Favored Pre-proline 0 N--CA 1.497 1.916 0 C-N-CA 120.759 -0.377 . . . . 12.0 110.086 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 110' ' ' CYS . 36.8 Cg_endo . . . . . 0 N--CA 1.48 0.686 0 C-N-CA 122.217 1.945 . . . . 12.0 110.338 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.47 0 N-CA-C 109.734 -0.469 . . . . 12.0 109.734 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -159.27 155.19 26.5 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.014 -0.735 . . . . 12.0 109.014 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -25.73 62.87 Favored 'General case' 0 N--CA 1.516 2.84 0 O-C-N 122.141 -0.35 . . . . 12.0 110.625 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.1 -61.83 1.72 Allowed 'General case' 0 N--CA 1.512 2.631 0 O-C-N 121.437 -0.789 . . . . 12.0 110.68 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.1 m -62.33 -32.48 73.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.997 -1.112 . . . . 12.0 107.997 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 31.1 t80 -75.79 -23.63 55.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -55.85 -34.25 65.26 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 106.96 -1.496 . . . . 12.0 106.96 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.99 -38.76 52.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.728 -1.212 . . . . 12.0 107.728 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 11.1 mmtm -45.57 -51.32 12.13 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 122.232 -0.293 . . . . 12.0 110.856 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.531 ' CD2' ' CZ ' ' A' ' 6' ' ' PHE . 2.1 m-70 -97.52 -13.97 21.36 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 118.837 -0.601 . . . . 12.0 112.153 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 45' ' ' ALA . 15.5 mm -123.18 64.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 114.896 1.443 . . . . 12.0 114.896 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.426 ' CG2' ' CD1' ' A' ' 40' ' ' PHE . 2.7 mp -98.89 63.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 103.984 -2.598 . . . . 12.0 103.984 173.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -73.09 78.61 1.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.734 0.778 . . . . 12.0 111.65 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.0 p -139.64 75.15 32.2 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.21 11.72 2.27 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.323 2.015 . . . . 12.0 113.59 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 15.8 pt -60.99 -168.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-N 119.15 0.886 . . . . 12.0 108.684 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -106.93 36.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.533 -0.729 . . . . 12.0 109.698 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -142.37 101.45 3.9 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 108.55 -0.907 . . . . 12.0 108.55 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.42 -14.45 58.93 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.961 -0.462 . . . . 12.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -85.03 -55.46 4.05 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-N 118.882 0.765 . . . . 12.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.09 -36.52 63.27 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.048 -0.408 . . . . 12.0 110.054 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.0 pt -81.24 -35.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.428 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 2.3 tmm? -99.07 32.03 2.82 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.399 -0.593 . . . . 12.0 109.399 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.07 48.36 1.64 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.277 0.56 . . . . 12.0 110.002 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -127.47 155.62 43.42 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.075 -0.713 . . . . 12.0 109.075 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -73.44 -10.72 60.03 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.89 -0.324 . . . . 12.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.3 tt -79.06 -0.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.587 -0.696 . . . . 12.0 110.761 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.428 ' CD2' ' HG2' ' A' ' 23' ' ' MET . 66.5 m-85 -119.61 54.91 0.98 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.387 -0.597 . . . . 12.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.8 mm -139.01 152.06 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.108 -0.995 . . . . 12.0 110.376 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.84 169.98 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.719 -1.215 . . . . 12.0 107.719 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -91.02 53.9 3.27 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.283 -1.527 . . . . 12.0 109.283 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.44 -58.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.746 -1.742 . . . . 12.0 108.746 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.6 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.066 -0.667 . . . . 12.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.54 177.55 8.59 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.71 -0.848 . . . . 12.0 108.71 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 159.74 22.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.341 -0.615 . . . . 12.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -72.05 -9.5 58.48 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.24 -0.287 . . . . 12.0 110.768 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -159.28 129.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.7 0.762 . . . . 12.0 111.037 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.42 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 1.7 t-20 -117.29 89.17 3.06 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.819 -1.919 . . . . 12.0 105.819 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.3 m -83.71 118.1 23.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.29 0.567 . . . . 12.0 111.83 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.426 ' CD1' ' CG2' ' A' ' 12' ' ' ILE . 23.3 m-85 -100.05 156.71 17.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.921 -1.511 . . . . 12.0 106.921 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.31 127.84 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.283 -0.886 . . . . 12.0 108.975 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.5 tt -107.53 107.89 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.44 0.638 . . . . 12.0 109.325 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.9 t 176.57 154.12 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.924 -0.769 . . . . 12.0 108.924 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 p -63.48 126.17 26.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' N ' HD13 ' A' ' 11' ' ' ILE . . . -53.29 -26.97 20.52 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.074 -0.391 . . . . 12.0 110.942 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -80.14 -32.06 38.98 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.629 -0.428 . . . . 12.0 111.621 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -62.07 -40.31 95.37 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.77 -1.567 . . . . 12.0 106.77 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.469 ' CG1' ' CE1' ' A' ' 10' ' ' HIS . 39.5 t -69.53 -35.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.963 -1.125 . . . . 12.0 107.963 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -57.69 -25.42 60.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.97 -0.752 . . . . 12.0 108.97 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.77 -34.73 33.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.876 -0.515 . . . . 12.0 109.734 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.411 HG21 ' N ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -66.2 -28.62 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.767 -0.583 . . . . 12.0 110.544 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.411 ' N ' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -100.67 19.99 15.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.452 -0.78 . . . . 12.0 110.365 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.0 m -85.46 112.45 20.89 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 109.13 -0.693 . . . . 12.0 109.13 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.46 -63.45 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.925 -0.87 . . . . 12.0 110.925 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 p -158.65 -167.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 118.015 0.907 . . . . 12.0 109.178 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 3.8 tt -87.82 27.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.593 0 O-C-N 121.132 -0.98 . . . . 12.0 110.968 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 13.9 t-20 173.09 118.84 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 106.652 -1.61 . . . . 12.0 106.652 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.47 175.36 12.25 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.621 0.724 . . . . 12.0 111.528 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -141.49 111.48 6.71 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.04 167.65 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.547 -0.538 . . . . 12.0 109.547 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.88 130.4 31.66 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.264 0.554 . . . . 12.0 111.24 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.52 102.9 0.16 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.353 -1.351 . . . . 12.0 107.353 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -87.9 -37.2 16.67 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.251 -0.28 . . . . 12.0 110.254 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.0 m -59.22 -95.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 177.01 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.919 0.781 . . . . 12.0 109.545 178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -97.01 41.57 1.11 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.318 -0.623 . . . . 12.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 23.77 105.89 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 114.196 1.184 . . . . 12.0 114.196 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.419 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -104.77 157.1 17.43 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.936 0.874 . . . . 12.0 111.868 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.34 100.7 7.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 104.943 -2.243 . . . . 12.0 104.943 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.2 m -97.22 132.27 43.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.757 0.789 . . . . 12.0 112.471 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' SER . 55.6 m -121.63 116.44 24.59 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 104.068 -2.567 . . . . 12.0 104.068 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -106.77 144.68 33.06 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 120.195 -0.602 . . . . 12.0 111.88 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -68.09 100.2 0.97 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.266 -0.642 . . . . 12.0 109.266 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 p -119.1 -112.5 0.34 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.569 -0.53 . . . . 12.0 109.569 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.9 p -158.68 98.13 1.49 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 119.641 1.109 . . . . 12.0 109.647 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -157.89 139.28 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.572 -0.529 . . . . 12.0 109.572 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.3 p 57.19 164.68 0.07 OUTLIER Pre-proline 0 N--CA 1.505 2.31 0 N-CA-C 109.93 -0.396 . . . . 12.0 109.93 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 35.0 Cg_endo -77.85 -71.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 121.753 1.636 . . . . 12.0 111.004 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -113.9 164.79 15.09 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 122.122 -0.362 . . . . 12.0 110.116 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.4 -56.7 0.14 OUTLIER 'Cis proline' 0 N--CA 1.486 1.038 0 O-C-N 123.486 1.256 . . . . 12.0 109.701 0.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -133.14 156.85 79.53 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.467 -0.938 . . . . 12.0 108.467 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 36.6 Cg_endo -75.25 116.64 4.6 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 121.645 1.564 . . . . 12.0 110.448 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.434 ' CE1' ' HG3' ' A' ' 73' ' ' ARG . 15.7 m-85 -145.98 137.07 24.61 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.319 0.58 . . . . 12.0 111.728 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 71' ' ' CYS . 7.9 t -107.83 153.88 22.36 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 106.691 -1.596 . . . . 12.0 106.691 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 t -107.79 156.53 19.02 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.563 -0.71 . . . . 12.0 111.456 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -166.09 158.67 14.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.316 -0.624 . . . . 12.0 109.316 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 p -135.06 147.66 49.67 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.053 -0.721 . . . . 12.0 109.053 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.84 -173.64 1.64 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.483 0.659 . . . . 12.0 110.744 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.8 m -66.69 142.75 57.31 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.206 -1.035 . . . . 12.0 108.206 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -104.96 87.41 2.64 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.451 -0.9 . . . . 12.0 111.567 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -107.22 105.6 15.65 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.445 -2.057 . . . . 12.0 105.445 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.2 pt -137.2 -179.53 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.651 0.738 . . . . 12.0 111.926 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -117.37 109.94 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.425 -0.807 . . . . 12.0 110.316 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' CD1' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -105.57 171.0 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.551 -0.907 . . . . 12.0 108.551 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 9.3 mttp -129.18 140.52 51.47 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -110.45 121.81 46.2 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.626 1.343 . . . . 12.0 114.626 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.0 tt0 -136.45 142.49 43.62 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 103.816 -2.661 . . . . 12.0 103.816 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 56.13 30.92 17.27 Favored 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 107.212 -1.403 . . . . 12.0 107.212 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 47.56 19.24 0.14 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.244 1.201 . . . . 12.0 114.244 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.487 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -126.94 145.55 54.26 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 104.585 -2.376 . . . . 12.0 104.585 175.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 21.9 Cg_endo -59.9 90.25 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.055 0 N-CA-C 108.899 -1.231 . . . . 12.0 108.899 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.464 HG23 ' CE2' ' A' ' 100' ' ' TYR . 44.0 t -87.57 -20.65 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 115.995 -0.548 . . . . 12.0 110.583 -177.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.468 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -137.66 144.03 41.64 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 12.0 108.367 -177.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.501 ' CZ ' ' NE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -107.97 126.83 53.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 118.851 -1.14 . . . . 12.0 109.537 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.64 -33.79 53.41 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.995 -0.372 . . . . 12.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.83 -133.66 6.9 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.764 -0.934 . . . . 12.0 110.764 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.7 pt -69.73 -172.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 122.344 -0.504 . . . . 12.0 111.004 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.08 -47.4 59.68 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 111.0 -0.84 . . . . 12.0 111.0 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -51.99 113.45 1.01 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.844 -0.798 . . . . 12.0 110.495 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 168.38 13.08 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 109.237 -0.653 . . . . 12.0 109.237 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.48 0.701 0 C-N-CA 121.889 1.726 . . . . 12.0 110.253 179.512 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.447 0 N-CA-C 109.593 -0.521 . . . . 12.0 109.593 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -130.7 155.71 46.16 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.058 -0.719 . . . . 12.0 109.058 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -28.75 66.73 Favored 'General case' 0 N--CA 1.514 2.744 0 O-C-N 122.161 -0.337 . . . . 12.0 110.279 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.96 -60.03 2.45 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 121.735 -0.603 . . . . 12.0 110.716 -178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -62.35 -29.35 70.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.104 -1.073 . . . . 12.0 108.104 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 31.1 t80 -79.35 -23.79 43.14 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.174 -0.676 . . . . 12.0 109.174 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.415 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -57.93 -35.61 71.33 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 106.696 -1.594 . . . . 12.0 106.696 177.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.09 -35.61 56.36 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.661 -1.237 . . . . 12.0 107.661 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 11.7 tptt -46.07 -60.49 2.24 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 116.686 -0.234 . . . . 12.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.541 ' CE1' ' CZ ' ' A' ' 104' ' ' PHE . 0.1 OUTLIER -103.42 -2.16 27.39 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.645 -0.659 . . . . 12.0 112.039 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.415 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 4.2 mp -138.51 73.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.415 1.635 . . . . 12.0 115.415 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 40' ' ' PHE . 19.3 mt -97.34 66.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 102.789 -3.041 . . . . 12.0 102.789 172.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.03 75.87 3.59 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.36 -0.836 . . . . 12.0 112.364 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.46 130.9 22.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 106.487 -1.672 . . . . 12.0 106.487 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.12 -24.43 38.55 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 121.277 1.318 . . . . 12.0 110.513 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.42 148.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.183 -1.043 . . . . 12.0 108.183 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 17' ' ' ILE . 11.7 pt -111.41 85.44 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 121.695 0.76 . . . . 12.0 109.221 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -147.3 104.84 3.69 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 m -75.76 -8.32 56.55 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.63 -0.428 . . . . 12.0 110.847 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -69.68 -46.69 65.49 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 118.804 0.729 . . . . 12.0 109.223 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -82.72 -19.61 37.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.665 -0.494 . . . . 12.0 109.665 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mt -87.17 -6.87 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.765 -0.584 . . . . 12.0 110.809 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm -109.51 -43.52 4.07 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.597 -0.89 . . . . 12.0 108.597 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.21 96.91 0.16 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 107.563 -1.273 . . . . 12.0 107.563 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -169.57 157.8 7.37 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.901 -0.777 . . . . 12.0 108.901 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -69.76 -10.88 60.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.048 -0.407 . . . . 12.0 110.076 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.3 mt -91.46 13.67 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.723 -0.611 . . . . 12.0 110.356 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -152.54 67.27 0.82 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.61 -0.681 . . . . 12.0 110.367 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -146.34 135.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 120.593 -1.317 . . . . 12.0 110.477 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 p -109.92 -162.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.446 -1.316 . . . . 12.0 107.446 178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -96.25 67.72 1.0 Allowed Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.029 -1.044 . . . . 12.0 111.662 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.16 -66.8 0.03 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.31 -1.516 . . . . 12.0 109.31 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -165.56 -65.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -154.55 144.01 21.39 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.868 -0.79 . . . . 12.0 108.868 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -66.25 178.3 1.22 Allowed 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.824 -0.436 . . . . 12.0 109.824 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.15 15.87 22.93 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.249 -0.282 . . . . 12.0 110.61 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -162.8 120.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.854 -0.529 . . . . 12.0 109.816 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 75.6 m-20 -122.12 88.94 3.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m -83.31 107.37 15.79 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 116.371 -0.377 . . . . 12.0 110.685 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.432 ' CD1' ' CD1' ' A' ' 12' ' ' ILE . 12.9 m-85 -98.57 159.79 14.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.066 -1.457 . . . . 12.0 107.066 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 10' ' ' HIS . 3.7 mp -130.26 129.49 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.748 -0.834 . . . . 12.0 108.748 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 42' ' ' ILE . 10.5 tt -101.34 106.27 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.15 -0.685 . . . . 12.0 109.15 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.1 t 176.66 154.47 0.22 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.808 -0.812 . . . . 12.0 108.808 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -60.62 130.04 44.53 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.818 -0.808 . . . . 12.0 108.818 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -53.94 -27.21 29.56 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.067 -0.395 . . . . 12.0 111.385 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 t -82.43 -30.92 29.78 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.509 -0.476 . . . . 12.0 111.591 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 p -63.58 -37.01 85.7 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.1 t -70.78 -36.06 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -62.07 -23.46 66.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.221 -0.659 . . . . 12.0 109.221 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.953 -0.467 . . . . 12.0 109.839 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.438 HG21 ' N ' ' A' ' 52' ' ' CYS . 0.0 OUTLIER -65.3 -29.41 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.837 -0.539 . . . . 12.0 110.088 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.438 ' N ' HG21 ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.23 24.53 6.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.753 -0.592 . . . . 12.0 110.069 -179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -87.8 113.22 23.26 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.496 -0.557 . . . . 12.0 109.496 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.2 -64.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.872 -1.291 . . . . 12.0 109.872 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -160.49 -165.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.42 -0.956 . . . . 12.0 108.42 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 45.6 pt -89.77 26.5 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 O-C-N 121.102 -0.999 . . . . 12.0 111.326 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 50.5 t30 173.22 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 107.642 -1.244 . . . . 12.0 107.642 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.3 178.76 6.66 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 121.909 0.861 . . . . 12.0 111.904 -178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -134.04 116.52 15.58 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 106.735 -1.58 . . . . 12.0 106.735 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.0 t -130.25 167.59 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.87 -0.519 . . . . 12.0 109.788 -177.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 61' ' ' LEU . 2.8 mp -122.59 110.53 15.67 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -56.88 91.51 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 108.666 -0.865 . . . . 12.0 108.666 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.0 p -81.79 -50.94 8.66 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 109.343 -0.614 . . . . 12.0 109.343 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.428 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 64.7 m -61.02 108.7 0.92 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.786 -1.191 . . . . 12.0 107.786 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -40.0 108.67 0.09 Allowed 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.108 0.48 . . . . 12.0 112.245 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 64' ' ' THR . 47.6 m-85 -95.87 42.73 1.09 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 108.8 -0.815 . . . . 12.0 108.8 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 18.22 105.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 113.904 1.076 . . . . 12.0 113.904 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.424 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -101.22 157.3 16.88 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 12.0 112.324 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -121.29 97.16 5.39 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.264 -2.125 . . . . 12.0 105.264 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.6 m -101.87 124.39 47.42 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.811 -0.756 . . . . 12.0 112.034 -176.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.4 m -110.65 108.64 18.62 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 104.254 -2.498 . . . . 12.0 104.254 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -111.99 140.3 46.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.817 -0.753 . . . . 12.0 111.869 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -65.03 117.41 7.62 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.089 -1.078 . . . . 12.0 108.089 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.5 p -102.16 -128.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.982 -0.747 . . . . 12.0 108.982 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 t -148.85 174.22 12.46 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.296 -0.877 . . . . 12.0 109.238 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.9 mm 63.72 149.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.914 -0.773 . . . . 12.0 108.914 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.3 m 57.28 68.96 1.79 Allowed Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 109.112 -0.699 . . . . 12.0 109.112 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -75.06 136.53 20.4 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 121.95 1.767 . . . . 12.0 110.498 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.536 ' N ' ' HA ' ' A' ' 80' ' ' PRO . 32.2 mtt180 -93.72 -38.22 0.32 Allowed Pre-proline 0 N--CA 1.492 1.644 0 CA-C-O 117.408 -1.282 . . . . 12.0 113.732 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.536 ' HA ' ' N ' ' A' ' 79' ' ' ARG . 34.3 Cg_endo -73.98 177.38 38.11 Favored 'Cis proline' 0 N--CA 1.487 1.107 0 CA-C-N 120.522 1.222 . . . . 12.0 111.542 1.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.454 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER 72.92 57.62 0.35 Allowed Pre-proline 0 N--CA 1.503 2.18 0 O-C-N 122.144 -0.348 . . . . 12.0 110.303 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 35.1 Cg_endo -77.13 122.22 6.1 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 122.255 1.97 . . . . 12.0 109.649 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.452 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 5.4 m-85 -115.88 138.67 50.95 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 121.634 0.73 . . . . 12.0 111.832 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 p -110.87 131.0 55.42 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 107.393 -1.336 . . . . 12.0 107.393 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 81.0 p -96.46 141.73 29.4 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.511 0.672 . . . . 12.0 111.608 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -152.88 127.88 9.67 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.35 -0.982 . . . . 12.0 108.35 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.3 m -109.64 149.85 29.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.031 -0.418 . . . . 12.0 110.209 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -175.21 -168.97 0.36 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 120.909 0.385 . . . . 12.0 110.234 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.8 m -57.68 142.28 45.61 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.994 -0.373 . . . . 12.0 109.994 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -109.21 88.48 2.74 Favored 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 121.901 0.857 . . . . 12.0 110.88 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -104.39 101.23 10.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.75 -1.944 . . . . 12.0 105.75 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.429 ' CD1' ' CE1' ' A' ' 104' ' ' PHE . 6.2 pt -134.09 -179.19 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.586 -0.846 . . . . 12.0 111.719 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 10.3 t -115.18 120.74 40.75 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.175 -1.046 . . . . 12.0 108.175 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 6.9 p -115.69 170.11 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 122.243 -0.286 . . . . 12.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.431 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 18.0 mttt -131.54 140.19 49.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.565 -0.902 . . . . 12.0 108.565 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.3 m -113.49 122.55 47.62 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.19 1.182 . . . . 12.0 114.19 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.1 tt0 -131.73 143.35 50.18 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 15.2 m-80 53.51 29.47 9.09 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.765 -1.198 . . . . 12.0 107.765 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 15.2 pt20 53.83 5.87 0.07 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 114.822 1.415 . . . . 12.0 114.822 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.476 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -111.85 145.4 32.62 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 104.765 -2.309 . . . . 12.0 104.765 175.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.476 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 24.5 Cg_endo -60.95 89.47 0.09 OUTLIER 'Trans proline' 0 C--O 1.209 -0.942 0 N-CA-C 108.85 -1.25 . . . . 12.0 108.85 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.441 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 95.1 t -85.61 -22.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-N 116.214 -0.448 . . . . 12.0 110.332 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.68 143.33 48.47 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.258 -1.386 . . . . 12.0 107.258 -178.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.541 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -119.29 128.69 54.38 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.166 -1.014 . . . . 12.0 110.375 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.4 -42.18 62.41 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.568 -0.287 . . . . 12.0 110.312 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.72 -129.54 5.84 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.478 -0.867 . . . . 12.0 111.009 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 tt -60.74 165.97 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.222 -0.575 . . . . 12.0 110.567 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 92' ' ' ILE . . . -50.88 -50.66 37.22 Favored Glycine 0 N--CA 1.503 3.156 0 N-CA-C 110.648 -0.981 . . . . 12.0 110.648 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 99.23 0.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 122.214 -0.58 . . . . 12.0 109.462 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 64.3 m -60.03 151.27 66.44 Favored Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 108.795 -0.817 . . . . 12.0 108.795 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.481 0.748 0 C-N-CA 121.601 1.534 . . . . 12.0 110.292 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.329 0 N-CA-C 109.995 -0.372 . . . . 12.0 109.995 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -98.97 155.72 17.28 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.194 -0.669 . . . . 12.0 109.194 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.403 ' CZ2' ' HB2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.81 -29.19 64.17 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 122.096 -0.377 . . . . 12.0 110.465 -178.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -58.72 3.12 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.901 -0.499 . . . . 12.0 110.571 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -63.36 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.171 -1.048 . . . . 12.0 108.171 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.471 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 30.1 t80 -77.13 -22.75 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.103 -0.703 . . . . 12.0 109.103 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -61.26 -38.34 86.35 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.89 -35.61 57.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.421 -1.325 . . . . 12.0 107.421 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.45 ' HG3' ' CD2' ' A' ' 10' ' ' HIS . 0.0 OUTLIER -44.21 -57.06 3.66 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 116.355 -0.384 . . . . 12.0 110.763 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.596 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 76.0 m-70 -108.26 -4.05 17.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.062 1.134 . . . . 12.0 114.062 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 45' ' ' ALA . 39.2 mm -122.38 64.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 118.566 -1.253 . . . . 12.0 113.597 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mp -98.2 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.348 -2.093 . . . . 12.0 105.348 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.423 ' O ' ' CG2' ' A' ' 14' ' ' THR . 8.0 p30 -54.58 85.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 CA-C-O 121.46 0.648 . . . . 12.0 111.15 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.444 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 12.7 p -164.66 57.73 0.56 Allowed Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 107.65 -1.241 . . . . 12.0 107.65 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 14' ' ' THR . 35.9 Cg_endo -74.98 82.57 1.97 Allowed 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 121.936 1.757 . . . . 12.0 110.457 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.49 -162.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.154 -1.054 . . . . 12.0 108.154 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.19 30.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 109.073 -0.714 . . . . 12.0 109.073 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -140.79 95.36 2.84 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.279 -1.008 . . . . 12.0 108.279 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.3 m -77.04 -18.61 58.0 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 120.266 -0.574 . . . . 12.0 111.389 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.12 -52.35 7.47 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 119.082 0.855 . . . . 12.0 110.315 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.11 -33.26 38.92 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.511 -0.551 . . . . 12.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.6 pt -82.38 -37.44 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.904 -0.406 . . . . 12.0 109.904 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.68 40.64 1.45 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.444 0.64 . . . . 12.0 109.305 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -87.77 50.07 1.92 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.511 0.672 . . . . 12.0 109.684 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -127.87 161.33 29.31 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.045 -0.724 . . . . 12.0 109.045 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -74.76 -8.91 57.87 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.789 -0.364 . . . . 12.0 110.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.432 HD13 ' CZ ' ' A' ' 28' ' ' TYR . 32.0 pt -80.17 -3.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.574 -0.704 . . . . 12.0 111.113 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CZ ' HD13 ' A' ' 27' ' ' ILE . 64.9 m-85 -112.3 47.52 1.06 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.744 -0.598 . . . . 12.0 110.578 -179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mt -150.33 144.92 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.027 -1.046 . . . . 12.0 110.302 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.4 t -106.78 169.25 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 107.711 -1.218 . . . . 12.0 107.711 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.77 61.33 3.1 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.05 -65.06 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.052 -1.619 . . . . 12.0 109.052 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -168.95 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 117.703 0.751 . . . . 12.0 109.792 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 t -145.38 131.11 18.98 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -61.77 164.96 5.64 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.479 -0.564 . . . . 12.0 109.479 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -102.05 -3.18 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 122.24 -0.288 . . . . 12.0 111.01 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.6 p -162.48 114.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.603 -0.686 . . . . 12.0 110.645 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 8.3 m120 -107.29 84.78 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.678 -1.601 . . . . 12.0 106.678 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 m -80.9 109.49 15.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 116.071 -0.513 . . . . 12.0 110.648 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -98.73 161.7 13.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.805 -1.554 . . . . 12.0 106.805 178.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.1 mp -130.98 132.54 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.335 0.971 . . . . 12.0 109.54 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.7 tp -108.44 105.42 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.195 -1.039 . . . . 12.0 108.195 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t 179.54 153.33 0.45 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.61 122.07 9.07 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.794 0.807 . . . . 12.0 109.827 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -46.42 -64.96 0.63 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 113.613 0.968 . . . . 12.0 113.613 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.7 p -62.72 -17.03 60.07 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.165 -0.614 . . . . 12.0 111.235 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.2 m -66.01 -36.68 83.94 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.302 -1.369 . . . . 12.0 107.302 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.6 t -71.26 -35.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.048 -1.464 . . . . 12.0 107.048 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -63.73 -21.73 66.55 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 12.0 108.992 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.54 -38.7 25.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.0 -0.438 . . . . 12.0 110.015 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.4 -22.74 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.769 -0.582 . . . . 12.0 109.91 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.1 35.86 2.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.802 -0.561 . . . . 12.0 109.805 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.4 m -96.76 112.8 24.4 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.184 -0.672 . . . . 12.0 109.184 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.03 -63.02 0.02 OUTLIER Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.598 -1.001 . . . . 12.0 110.598 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 p -162.12 -167.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.691 -0.855 . . . . 12.0 108.691 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.9 pt -88.25 26.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 121.024 -1.047 . . . . 12.0 111.317 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 174.05 112.99 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 107.508 -1.293 . . . . 12.0 107.508 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.8 -176.37 4.57 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.984 0.897 . . . . 12.0 111.955 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -140.14 124.59 17.97 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.697 -1.594 . . . . 12.0 106.697 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 94' ' ' VAL . 10.0 p -137.32 166.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.735 -0.603 . . . . 12.0 109.727 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.7 mt -126.27 112.56 15.87 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.904 -0.498 . . . . 12.0 112.193 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.434 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 4.0 m -67.7 91.2 0.29 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 105.691 -1.966 . . . . 12.0 105.691 176.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -86.77 -37.41 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.149 -0.344 . . . . 12.0 111.634 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.8 m -53.88 -92.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.195 -0.669 . . . . 12.0 109.195 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.15 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.778 0.717 . . . . 12.0 109.563 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 49.9 m-85 -96.89 44.51 1.06 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 14.79 105.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.254 0 N-CA-C 114.087 1.143 . . . . 12.0 114.087 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.79 156.35 17.89 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.939 0.876 . . . . 12.0 111.972 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.14 99.17 6.55 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.675 -1.972 . . . . 12.0 105.675 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.4 m -100.51 125.06 46.8 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.011 -0.676 . . . . 12.0 112.555 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.9 m -105.79 111.53 24.24 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 104.187 -2.523 . . . . 12.0 104.187 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 m -101.89 140.41 36.2 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 120.014 -0.675 . . . . 12.0 111.519 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -72.6 105.99 4.46 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.122 -0.696 . . . . 12.0 109.122 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 p -137.8 -83.72 0.32 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 110.014 -0.365 . . . . 12.0 110.014 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.55 108.77 0.1 Allowed 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 109.512 -0.551 . . . . 12.0 109.512 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 tp -179.09 152.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.427 -0.583 . . . . 12.0 109.427 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.4 171.47 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 121.945 -0.472 . . . . 12.0 109.811 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.47 -82.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.109 1.873 . . . . 12.0 111.747 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.441 ' CB ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -125.2 172.59 5.9 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.751 -0.593 . . . . 12.0 109.9 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.441 ' HA ' ' CB ' ' A' ' 79' ' ' ARG . 31.0 Cg_endo -71.57 -65.05 0.03 OUTLIER 'Cis proline' 0 N--CA 1.489 1.232 0 O-C-N 123.26 1.137 . . . . 12.0 110.671 1.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.5 m -110.5 158.27 35.9 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.652 -0.87 . . . . 12.0 108.652 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.74 113.95 3.89 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 121.492 1.461 . . . . 12.0 109.829 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 12.9 m-85 -140.2 134.22 30.84 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.083 0.468 . . . . 12.0 110.917 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -109.0 128.66 55.14 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.857 -1.164 . . . . 12.0 107.857 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.5 p -89.55 139.88 30.1 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.306 0.574 . . . . 12.0 110.909 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -147.97 158.41 44.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.511 -0.922 . . . . 12.0 108.511 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -139.67 148.72 42.79 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 109.537 -0.542 . . . . 12.0 109.537 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -177.22 -176.49 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.501 -0.48 . . . . 12.0 110.279 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.9 m -53.86 141.02 28.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.778 -0.453 . . . . 12.0 109.778 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -110.47 86.11 2.24 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.593 -0.843 . . . . 12.0 112.596 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -95.67 100.73 12.42 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.0 -2.222 . . . . 12.0 105.0 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.451 HG12 ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -122.93 149.6 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.546 0.689 . . . . 12.0 111.929 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 25.1 t -92.48 136.01 33.57 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 105.523 -2.029 . . . . 12.0 105.523 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.508 ' CG1' ' CZ ' ' A' ' 104' ' ' PHE . 2.8 m -140.57 -176.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 120.275 -0.57 . . . . 12.0 111.004 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.446 ' CB ' ' CD2' ' A' ' 103' ' ' HIS . 40.0 mtmt -147.95 149.22 31.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -118.78 117.57 29.25 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.688 0.756 . . . . 12.0 112.839 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 18.2 tt0 -124.52 143.77 50.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.844 -2.65 . . . . 12.0 103.844 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.7 m120 55.46 27.17 9.79 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-N 119.845 1.202 . . . . 12.0 107.946 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 18.4 pt20 54.59 8.85 0.23 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.098 1.359 . . . . 12.0 114.382 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.486 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -114.88 146.74 36.74 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 104.731 -2.322 . . . . 12.0 104.731 174.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.486 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.5 Cg_endo -59.88 88.92 0.07 OUTLIER 'Trans proline' 0 C--O 1.208 -1.005 0 C-N-CA 121.331 1.354 . . . . 12.0 109.282 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.447 HG23 ' CE2' ' A' ' 100' ' ' TYR . 54.3 t -84.45 -19.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 116.295 -0.411 . . . . 12.0 110.468 -177.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.489 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -136.83 134.42 36.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 -177.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.596 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.2 OUTLIER -123.78 129.81 51.64 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.963 -0.695 . . . . 12.0 109.395 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.91 -41.98 14.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.229 -0.295 . . . . 12.0 110.728 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.95 -99.88 0.59 Allowed Glycine 0 N--CA 1.504 3.186 0 C-N-CA 120.295 -0.955 . . . . 12.0 111.139 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.9 pt -58.29 147.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.844 -0.797 . . . . 12.0 110.294 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.29 -35.37 82.43 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.836 -1.306 . . . . 12.0 109.836 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -66.14 117.0 7.83 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.326 -0.62 . . . . 12.0 109.326 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.34 168.95 14.39 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 109.121 -0.696 . . . . 12.0 109.121 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.479 0.646 0 C-N-CA 121.829 1.686 . . . . 12.0 109.973 179.59 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.358 0 N-CA-C 109.921 -0.4 . . . . 12.0 109.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -85.88 154.56 21.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.49 65.23 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 122.031 -0.418 . . . . 12.0 110.009 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.55 42.86 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.804 -0.56 . . . . 12.0 110.451 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -65.39 -29.56 70.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.471 -0.937 . . . . 12.0 108.471 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.44 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 35.5 t80 -76.97 -20.0 56.63 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.866 -0.79 . . . . 12.0 108.866 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.452 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 12.3 tt0 -64.2 -38.88 92.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 106.475 -1.676 . . . . 12.0 106.475 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -77.65 -32.83 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -43.25 -64.4 0.65 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 110.298 -0.26 . . . . 12.0 110.298 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.524 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 88.8 m-70 -110.08 -23.2 11.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.2 0.815 . . . . 12.0 113.2 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 7' ' ' GLN . 22.9 mm -93.81 57.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 119.254 0.934 . . . . 12.0 113.234 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.13 76.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 105.42 -2.067 . . . . 12.0 105.42 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.15 79.44 2.97 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.794 0.807 . . . . 12.0 110.125 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -135.0 70.36 70.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.261 -1.385 . . . . 12.0 107.261 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -71.94 86.3 0.92 Allowed 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 121.825 1.683 . . . . 12.0 111.045 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 24.9 pt -136.07 -167.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.201 -1.037 . . . . 12.0 108.201 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.08 38.39 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.666 0.746 . . . . 12.0 109.352 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -153.1 101.36 2.56 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 116.292 -0.413 . . . . 12.0 109.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.3 m -81.26 -5.86 58.24 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 122.054 -0.404 . . . . 12.0 111.014 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -83.13 -55.24 4.47 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.496 -0.753 . . . . 12.0 111.501 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -61.54 -23.09 65.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.679 -0.638 . . . . 12.0 110.719 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.9 pt -84.53 -35.08 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.64 -0.663 . . . . 12.0 109.621 179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -95.79 12.78 28.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.004 -0.435 . . . . 12.0 110.625 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.58 90.41 0.26 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.334 -1.358 . . . . 12.0 107.334 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -172.79 152.85 2.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.317 -0.623 . . . . 12.0 109.317 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -68.0 -11.98 59.92 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 110.044 -0.354 . . . . 12.0 110.044 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.8 mt -86.59 9.66 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.727 -0.608 . . . . 12.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -144.12 63.16 1.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.599 -0.688 . . . . 12.0 109.181 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 29' ' ' ILE . 41.3 mt -148.08 151.99 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.593 -1.317 . . . . 12.0 111.02 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.75 170.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 107.376 -1.342 . . . . 12.0 107.376 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.71 52.7 3.34 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.372 -1.491 . . . . 12.0 109.372 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.43 -56.69 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.304 -1.518 . . . . 12.0 109.304 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.87 -69.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.023 -0.732 . . . . 12.0 109.023 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.2 m -140.92 -169.72 2.88 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -115.0 167.16 11.05 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.163 -0.68 . . . . 12.0 109.163 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -76.76 -17.39 59.09 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.859 -0.336 . . . . 12.0 110.465 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.4 p -161.53 118.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.36 0.6 . . . . 12.0 110.824 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -114.22 86.28 2.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.333 -1.729 . . . . 12.0 106.333 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -87.24 123.89 32.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.485 0.659 . . . . 12.0 111.373 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -108.5 163.36 13.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.977 -1.49 . . . . 12.0 106.977 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.1 mt -131.32 132.01 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.218 -0.926 . . . . 12.0 109.458 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.1 mm -100.29 108.83 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 108.979 -0.749 . . . . 12.0 108.979 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 t 177.6 150.21 0.19 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.167 -0.679 . . . . 12.0 109.167 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 p -59.95 130.11 45.13 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.804 -0.813 . . . . 12.0 108.804 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -24.54 4.86 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.486 . . . . 12.0 111.224 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -84.78 -32.27 23.48 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.41 -0.516 . . . . 12.0 111.613 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -62.99 -38.92 93.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.117 -1.438 . . . . 12.0 107.117 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 t -70.71 -35.7 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.564 -1.273 . . . . 12.0 107.564 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.15 -23.95 66.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.145 -0.687 . . . . 12.0 109.145 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.14 -36.95 29.61 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.976 -0.452 . . . . 12.0 110.158 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.418 ' HB ' ' CZ ' ' A' ' 66' ' ' PHE . 8.5 tp -66.45 -23.74 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.801 -0.562 . . . . 12.0 110.386 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.89 27.61 6.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.828 -0.545 . . . . 12.0 109.947 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 m -90.99 114.92 27.56 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.452 -0.573 . . . . 12.0 109.452 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.64 0.02 OUTLIER Glycine 0 N--CA 1.5 2.93 0 N-CA-C 110.152 -1.179 . . . . 12.0 110.152 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 p -159.94 -168.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.69 -0.856 . . . . 12.0 108.69 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 7.9 pt -88.14 25.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.118 -0.989 . . . . 12.0 111.39 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 174.0 115.03 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 107.521 -1.288 . . . . 12.0 107.521 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 176.82 10.99 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.69 0.757 . . . . 12.0 111.491 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -138.85 117.4 12.12 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.29 -1.374 . . . . 12.0 107.29 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.15 165.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.3 mp -125.73 125.64 43.33 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 120.758 -0.377 . . . . 12.0 110.808 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.48 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.31 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 177.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -86.44 -23.17 26.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.956 -0.465 . . . . 12.0 110.943 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -59.57 -88.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.497 -0.557 . . . . 12.0 109.497 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 172.71 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 108.596 -0.89 . . . . 12.0 108.596 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.48 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 73.0 m-85 -105.17 57.52 0.68 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 109.253 -0.647 . . . . 12.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' PHE . 5.5 pt20 -4.5 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 114.557 1.317 . . . . 12.0 114.557 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' N ' ' HB2' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -105.22 158.22 16.75 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.224 1.011 . . . . 12.0 112.94 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -117.8 98.16 6.21 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 105.131 -2.174 . . . . 12.0 105.131 176.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.6 m -100.88 127.65 47.26 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.879 -0.729 . . . . 12.0 112.937 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.8 m -111.29 105.42 14.07 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 103.738 -2.689 . . . . 12.0 103.738 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 m -105.88 145.32 31.4 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 120.258 -0.577 . . . . 12.0 112.008 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 8.0 ttp180 -69.07 138.84 54.68 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.853 -0.795 . . . . 12.0 108.853 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -119.26 -84.83 0.66 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.919 -0.488 . . . . 12.0 110.435 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 m -135.68 116.34 13.91 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.66 -0.65 . . . . 12.0 109.978 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.401 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 6.7 mt -65.0 121.61 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.139 0.495 . . . . 12.0 109.91 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.46 ' CB ' ' HD3' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -177.48 -58.68 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.863 -0.792 . . . . 12.0 108.863 179.128 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.46 ' HD3' ' CB ' ' A' ' 77' ' ' THR . 37.4 Cg_endo -81.03 159.76 20.77 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 121.952 1.768 . . . . 12.0 109.948 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.29 143.19 29.32 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.934 -0.765 . . . . 12.0 108.934 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -72.46 -162.66 2.56 Favored 'Cis proline' 0 N--CA 1.488 1.159 0 O-C-N 122.929 0.963 . . . . 12.0 110.743 0.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.68 157.07 0.28 Allowed Pre-proline 0 N--CA 1.509 2.521 0 CA-C-O 119.014 -0.517 . . . . 12.0 110.45 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 41.2 Cg_endo -77.07 110.57 3.05 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.778 1.652 . . . . 12.0 109.995 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 23.1 m-85 -143.83 133.56 23.76 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.438 0.637 . . . . 12.0 110.736 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -119.37 129.21 54.7 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -96.05 142.49 28.19 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.254 0.549 . . . . 12.0 110.912 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -151.49 125.86 9.41 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.379 -0.971 . . . . 12.0 108.379 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.9 m -105.53 147.05 28.79 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.707 -0.397 . . . . 12.0 109.983 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -174.87 -171.0 0.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.696 -0.483 . . . . 12.0 109.696 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.6 m -63.83 134.38 55.11 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.414 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -107.12 91.96 3.88 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.552 0.691 . . . . 12.0 112.18 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.69 107.16 19.0 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 mt -110.85 160.94 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 122.2 1.0 . . . . 12.0 113.489 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -112.2 103.85 12.03 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 105.258 -2.127 . . . . 12.0 105.258 176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.493 ' CG1' ' CZ ' ' A' ' 104' ' ' PHE . 7.2 m -122.71 -171.71 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.435 0.636 . . . . 12.0 112.018 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 2.2 mtpp -145.24 152.01 39.28 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.03 -0.73 . . . . 12.0 109.03 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.58 119.69 33.64 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.655 0.74 . . . . 12.0 112.853 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 11.7 tt0 -127.36 145.55 50.77 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 104.362 -2.459 . . . . 12.0 104.362 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 52.98 28.6 6.82 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 119.876 1.216 . . . . 12.0 107.998 -176.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 12.0 pt20 55.56 4.08 0.09 Allowed 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 125.418 1.487 . . . . 12.0 114.701 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.481 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -110.14 147.29 35.96 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 105.147 -2.168 . . . . 12.0 105.147 175.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.1 Cg_endo -60.8 89.56 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.37 1.38 . . . . 12.0 108.79 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.458 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 46.6 t -85.07 -14.11 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.619 -0.718 . . . . 12.0 110.654 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.489 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -144.87 117.75 8.76 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.512 -0.875 . . . . 12.0 110.387 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.524 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 1.3 m-85 -101.12 121.0 41.05 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.503 -1.665 . . . . 12.0 106.503 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.62 -28.84 17.25 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 112.966 0.728 . . . . 12.0 112.966 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.88 -169.28 37.29 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.803 -1.189 . . . . 12.0 111.111 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.0 mt -93.38 36.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.051 0.453 . . . . 12.0 110.616 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.07 45.62 3.81 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 110.519 -1.032 . . . . 12.0 110.519 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.3 99.73 2.95 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 7.0 p -164.86 64.27 1.07 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 109.427 -0.583 . . . . 12.0 109.427 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.478 0.607 0 C-N-CA 122.285 1.99 . . . . 12.0 110.38 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.333 0 N-CA-C 109.181 -0.674 . . . . 12.0 109.181 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -120.95 164.14 17.17 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.444 ' CZ3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -69.03 -24.19 64.16 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 121.636 -0.665 . . . . 12.0 110.492 -177.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.76 -64.08 1.07 Allowed 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.607 -0.683 . . . . 12.0 110.655 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.21 80.76 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.419 -1.326 . . . . 12.0 107.419 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 32.0 t80 -70.25 -25.66 63.48 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.384 -0.969 . . . . 12.0 108.384 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -52.0 -31.77 30.88 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 107.186 -1.413 . . . . 12.0 107.186 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -42.82 30.49 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.797 -1.186 . . . . 12.0 107.797 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 9.7 mmtp -44.42 -53.84 6.49 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 122.363 -0.211 . . . . 12.0 111.365 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.472 ' NE2' ' CZ ' ' A' ' 104' ' ' PHE . 1.0 OUTLIER -95.47 -17.71 21.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.942 -0.474 . . . . 12.0 111.42 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 HD13 ' N ' ' A' ' 45' ' ' ALA . 15.9 mm -129.48 79.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 118.899 -1.121 . . . . 12.0 113.929 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.5 mm -98.09 75.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 104.198 -2.519 . . . . 12.0 104.198 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -82.81 61.92 6.12 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.658 0.742 . . . . 12.0 111.425 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.419 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 60.9 p -146.55 65.19 10.05 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 106.954 -1.499 . . . . 12.0 106.954 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 14' ' ' THR . 37.1 Cg_endo -82.2 45.51 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.372 2.048 . . . . 12.0 112.011 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.62 -165.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.83 -0.804 . . . . 12.0 108.83 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.2 pt -97.81 43.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-O 121.424 0.631 . . . . 12.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -158.02 99.41 1.67 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.063 -0.717 . . . . 12.0 109.063 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.0 m -76.53 -12.72 60.07 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.954 -0.466 . . . . 12.0 110.996 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -63.57 -49.42 73.47 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 119.048 0.84 . . . . 12.0 109.025 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.7 m -74.85 -19.63 60.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.641 -0.503 . . . . 12.0 109.641 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.438 HG23 ' CE1' ' A' ' 40' ' ' PHE . 44.1 mt -84.94 -8.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.765 -0.585 . . . . 12.0 110.663 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.54 4.89 7.57 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.629 -0.669 . . . . 12.0 110.305 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -58.23 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.403 -0.962 . . . . 12.0 108.403 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -173.08 152.14 2.26 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.751 -0.833 . . . . 12.0 108.751 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -70.21 -9.72 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.713 -0.395 . . . . 12.0 110.275 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.71 12.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.689 -0.632 . . . . 12.0 110.685 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -142.28 55.35 1.45 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.657 -0.652 . . . . 12.0 110.802 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.1 mm -148.29 152.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 120.673 -1.267 . . . . 12.0 110.038 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.1 t -110.06 168.28 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 107.71 -1.218 . . . . 12.0 107.71 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.87 54.91 3.35 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.738 -1.745 . . . . 12.0 108.738 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.95 -54.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.531 -1.427 . . . . 12.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -163.57 -76.41 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 122.054 -0.674 . . . . 12.0 109.404 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -133.94 -175.94 4.01 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.533 -0.543 . . . . 12.0 109.533 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -107.1 171.66 7.25 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -79.6 -17.34 54.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.1 -0.375 . . . . 12.0 110.575 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -162.1 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 119.789 -0.764 . . . . 12.0 111.457 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.464 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 11.6 m-20 -97.18 85.81 3.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.753 -1.943 . . . . 12.0 105.753 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.62 123.18 29.52 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.661 0.743 . . . . 12.0 112.555 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.438 ' CE1' HG23 ' A' ' 22' ' ' ILE . 23.6 m-85 -100.32 161.68 13.44 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.929 -1.508 . . . . 12.0 106.929 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.68 122.98 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.956 -1.09 . . . . 12.0 110.091 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 42' ' ' ILE . 4.8 mt -98.54 107.11 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.27 -1.011 . . . . 12.0 108.27 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.7 t 175.93 165.76 0.39 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 109.27 -0.641 . . . . 12.0 109.27 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 p -82.7 125.47 31.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.166 -1.049 . . . . 12.0 108.166 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.444 ' HB2' ' CZ3' ' A' ' 3' ' ' TRP . . . -50.05 -31.47 13.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.992 -0.442 . . . . 12.0 111.887 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -76.61 -32.88 58.34 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.426 -0.51 . . . . 12.0 111.935 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.2 m -64.59 -34.34 78.02 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.817 -1.179 . . . . 12.0 107.817 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.413 HG21 ' CD1' ' A' ' 66' ' ' PHE . 20.7 t -71.03 -35.38 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.407 -1.331 . . . . 12.0 107.407 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -65.23 -21.43 66.75 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 116.016 -0.538 . . . . 12.0 110.019 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.63 -39.16 24.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.821 -0.55 . . . . 12.0 109.922 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.416 HG23 ' CZ ' ' A' ' 66' ' ' PHE . 7.2 tp -69.16 -18.07 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.788 -0.57 . . . . 12.0 110.401 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -97.34 15.14 23.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.58 -0.7 . . . . 12.0 111.003 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.3 m -66.16 107.27 1.88 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.189 -0.671 . . . . 12.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.79 -63.2 0.01 OUTLIER Glycine 0 N--CA 1.501 2.983 0 C-N-CA 120.484 -0.865 . . . . 12.0 111.013 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 p -167.54 -171.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.067 0.934 . . . . 12.0 109.434 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 15.0 tt -89.21 32.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 O-C-N 121.429 -0.794 . . . . 12.0 110.781 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 5.0 t30 169.75 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 107.257 -1.386 . . . . 12.0 107.257 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -163.17 179.72 7.25 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.121 0.962 . . . . 12.0 112.404 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -137.36 108.41 6.75 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.644 -1.614 . . . . 12.0 106.644 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.9 171.13 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.853 -0.529 . . . . 12.0 109.886 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 mp -124.66 124.16 41.6 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.816 -0.439 . . . . 12.0 109.816 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.49 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 108.453 -0.943 . . . . 12.0 108.453 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -75.47 -43.43 49.43 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.638 -0.875 . . . . 12.0 108.638 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -65.65 124.1 21.47 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.17 -1.048 . . . . 12.0 108.17 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.49 105.95 0.18 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 122.088 -0.383 . . . . 12.0 109.982 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.416 ' CZ ' HG23 ' A' ' 51' ' ' ILE . 48.2 m-85 -94.94 41.04 1.09 Allowed 'General case' 0 N--CA 1.512 2.666 0 C-N-CA 120.074 -0.65 . . . . 12.0 109.548 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 24.99 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 114.284 1.216 . . . . 12.0 114.284 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.95 155.58 18.53 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.032 0.92 . . . . 12.0 112.494 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 99.45 6.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 104.787 -2.301 . . . . 12.0 104.787 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -105.43 128.93 53.79 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.033 1.123 . . . . 12.0 114.033 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.35 105.37 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 103.107 -2.923 . . . . 12.0 103.107 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -105.26 144.19 32.39 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.07 -0.652 . . . . 12.0 111.944 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 105.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.593 -0.891 . . . . 12.0 108.593 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p -137.01 -81.44 0.37 Allowed 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 120.595 -0.442 . . . . 12.0 110.311 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.32 165.63 19.28 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 109.452 -0.573 . . . . 12.0 109.452 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.0 mt 69.29 155.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-O 121.251 0.548 . . . . 12.0 110.314 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.3 p 53.61 62.29 9.48 Favored Pre-proline 0 N--CA 1.5 2.06 0 CA-C-N 116.336 -0.393 . . . . 12.0 111.058 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.98 107.86 1.98 Allowed 'Trans proline' 0 N--CA 1.48 0.713 0 C-N-CA 122.097 1.865 . . . . 12.0 109.383 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.77 58.41 7.04 Favored Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.971 -0.455 . . . . 12.0 111.387 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -87.22 -44.06 0.32 Allowed 'Cis proline' 0 N--CA 1.485 0.976 0 C-N-CA 125.363 -0.682 . . . . 12.0 110.797 -2.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 93.8 m -61.53 150.12 81.94 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 118.963 -0.542 . . . . 12.0 109.759 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.14 134.8 18.01 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 121.831 1.687 . . . . 12.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.464 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 16.5 m-85 -142.93 139.26 30.65 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.283 0.564 . . . . 12.0 110.536 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 t -124.71 126.23 45.35 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 108.323 -0.991 . . . . 12.0 108.323 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 139.97 30.76 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.06 0.457 . . . . 12.0 110.612 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -152.53 124.09 7.79 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.802 -0.814 . . . . 12.0 108.802 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -94.11 152.92 18.41 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -176.09 -167.74 0.24 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.155 0.502 . . . . 12.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -65.31 143.85 57.51 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -108.51 87.73 2.56 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.945 0.879 . . . . 12.0 110.856 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -100.01 112.93 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.938 -2.245 . . . . 12.0 104.938 176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.64 175.67 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-O 122.274 1.035 . . . . 12.0 112.406 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.3 t -125.54 99.3 5.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.154 -1.795 . . . . 12.0 106.154 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.452 ' HB ' ' CE1' ' A' ' 104' ' ' PHE . 9.8 p -111.95 164.19 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.236 0.541 . . . . 12.0 111.193 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -118.04 140.84 49.17 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.88 120.32 33.12 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.505 1.298 . . . . 12.0 114.505 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.455 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 24.9 tt0 -114.99 139.99 49.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.869 -2.641 . . . . 12.0 103.869 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 77.7 m-20 56.46 31.04 18.13 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 5.7 pt20 52.75 10.34 0.15 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 114.569 1.322 . . . . 12.0 114.569 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.467 ' CE1' ' O ' ' A' ' 101' ' ' PRO . 0.0 OUTLIER -112.21 140.73 23.91 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 104.051 -2.574 . . . . 12.0 104.051 174.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.468 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 26.8 Cg_endo -60.78 90.85 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.857 0 N-CA-C 108.713 -1.303 . . . . 12.0 108.713 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.463 ' CG2' ' CE2' ' A' ' 100' ' ' TYR . 81.5 t -88.84 -19.95 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 116.244 -0.435 . . . . 12.0 110.694 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.455 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -139.9 145.72 38.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.694 -1.225 . . . . 12.0 107.694 -178.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CZ ' ' NE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -109.31 133.52 52.95 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.209 -0.996 . . . . 12.0 109.221 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.72 -19.45 15.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.033 -0.417 . . . . 12.0 111.676 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.29 173.88 44.07 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 110.468 -1.053 . . . . 12.0 110.468 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.3 pt -97.82 26.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.186 -0.596 . . . . 12.0 110.279 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.53 -65.59 0.51 Allowed Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.076 -1.209 . . . . 12.0 110.076 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.6 mtm-85 -62.03 144.53 55.04 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.398 -0.593 . . . . 12.0 109.398 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.77 164.62 5.29 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 109.458 -0.571 . . . . 12.0 109.458 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 N--CA 1.481 0.77 0 C-N-CA 121.744 1.63 . . . . 12.0 110.053 179.297 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 109.061 -0.718 . . . . 12.0 109.061 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -37.43 74.48 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 122.022 -0.424 . . . . 12.0 110.586 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.98 6.49 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.351 -0.843 . . . . 12.0 110.676 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -62.52 -32.3 73.21 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.211 -1.033 . . . . 12.0 108.211 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 61.4 t80 -72.59 -25.83 61.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.157 -1.053 . . . . 12.0 108.157 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.92 -33.69 62.39 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 1.5 mt-30 -80.39 -37.95 31.28 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.21 -1.404 . . . . 12.0 107.21 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -44.52 -57.33 3.66 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.983 -0.448 . . . . 12.0 111.079 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 4.4 m80 -99.58 -31.04 11.8 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.595 -0.691 . . . . 12.0 111.697 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.878 HG13 ' HB2' ' A' ' 45' ' ' ALA . 7.9 mm -102.93 65.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.668 1.729 . . . . 12.0 115.668 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 40' ' ' PHE . 3.4 mp -95.29 62.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 103.588 -2.745 . . . . 12.0 103.588 173.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -74.21 81.06 1.8 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.709 0.766 . . . . 12.0 110.409 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.6 p -118.5 106.87 43.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.233 -1.025 . . . . 12.0 108.233 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -81.51 37.16 0.66 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 121.921 1.747 . . . . 12.0 111.795 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 17' ' ' ILE . 4.6 mp -113.13 164.64 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.694 -0.854 . . . . 12.0 108.694 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.48 ' N ' HG22 ' A' ' 16' ' ' ILE . 33.5 pt -97.29 33.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-O 121.345 0.593 . . . . 12.0 109.855 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.24 91.36 3.36 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.29 -1.004 . . . . 12.0 108.29 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -76.28 -15.94 59.89 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.904 -0.498 . . . . 12.0 111.287 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -82.99 -50.41 8.58 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 119.019 0.827 . . . . 12.0 109.912 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.27 70.13 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 110.028 -0.36 . . . . 12.0 110.028 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.597 HD12 ' N ' ' A' ' 23' ' ' MET . 2.7 pp -76.98 -39.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 120.625 -0.43 . . . . 12.0 109.955 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.597 ' N ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -93.52 12.82 23.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.878 -0.514 . . . . 12.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -60.35 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.295 -1.002 . . . . 12.0 108.295 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -172.31 155.54 3.57 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.415 -0.587 . . . . 12.0 109.415 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -71.94 -10.23 59.48 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.922 -0.399 . . . . 12.0 109.922 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 27' ' ' ILE . 68.0 mt -85.78 8.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.691 -0.63 . . . . 12.0 110.644 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -135.96 57.19 1.79 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.536 -0.727 . . . . 12.0 110.025 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mt -151.47 145.87 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.959 -1.088 . . . . 12.0 109.889 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.3 p -109.73 -168.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 108.13 -1.063 . . . . 12.0 108.13 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.558 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -97.46 71.38 0.71 Allowed Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.201 -0.937 . . . . 12.0 111.411 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.72 -63.44 0.03 OUTLIER Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.227 -1.549 . . . . 12.0 109.227 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -165.22 -65.44 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.035 -1.098 . . . . 12.0 108.035 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.0 p -141.67 167.75 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 12.0 108.711 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -77.46 149.67 35.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.928 -0.482 . . . . 12.0 109.716 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -77.08 -23.85 51.89 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 110.104 -0.332 . . . . 12.0 110.104 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.487 HG12 ' OG1' ' A' ' 39' ' ' THR . 18.3 t -150.28 103.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 120.29 -0.564 . . . . 12.0 110.293 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.453 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 2.7 m-20 -92.59 76.48 5.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.441 -1.688 . . . . 12.0 106.441 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.487 ' OG1' HG12 ' A' ' 37' ' ' VAL . 25.8 m -79.23 116.49 19.52 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.928 -0.578 . . . . 12.0 110.686 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.652 ' O ' HD13 ' A' ' 41' ' ' ILE . 17.9 m-85 -107.01 163.59 12.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.087 -1.079 . . . . 12.0 108.087 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 40' ' ' PHE . 16.1 mm -126.71 124.57 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.907 -1.146 . . . . 12.0 107.907 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 69' ' ' ASN . 14.3 pt -96.51 98.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.857 ' O ' HD12 ' A' ' 11' ' ' ILE . 48.2 t -176.29 157.9 1.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.232 -0.655 . . . . 12.0 109.232 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.403 ' HB2' HG22 ' A' ' 46' ' ' THR . 8.1 p -63.88 128.17 34.64 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 109.244 -0.65 . . . . 12.0 109.244 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -54.45 -25.06 22.81 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.89 -0.506 . . . . 12.0 110.623 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 44' ' ' SER . 6.7 t -76.71 -33.91 58.18 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.523 -0.471 . . . . 12.0 111.231 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -65.19 -39.88 93.47 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.091 -1.448 . . . . 12.0 107.091 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.85 -31.86 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.824 -1.176 . . . . 12.0 107.824 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -67.38 -23.15 65.55 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.734 -0.469 . . . . 12.0 109.734 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -40.23 30.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.908 -0.495 . . . . 12.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.557 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 19.9 pt -69.41 -20.67 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.784 -0.572 . . . . 12.0 110.681 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.43 25.09 9.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.831 -0.543 . . . . 12.0 109.829 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -96.33 114.31 25.98 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.767 -0.583 . . . . 12.0 109.577 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.49 -62.68 0.01 OUTLIER Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.099 -1.2 . . . . 12.0 110.099 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.5 p -152.76 -169.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.517 -0.92 . . . . 12.0 108.517 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.616 ' H ' HG22 ' A' ' 55' ' ' VAL . 18.3 tt -88.62 26.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 O-C-N 120.915 -1.116 . . . . 12.0 110.796 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 4.4 t30 171.47 110.5 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 107.195 -1.409 . . . . 12.0 107.195 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -172.54 3.31 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.384 0.612 . . . . 12.0 110.684 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.98 114.55 8.02 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.094 -1.076 . . . . 12.0 108.094 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 51' ' ' ILE . 12.2 t -125.27 169.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.501 -0.925 . . . . 12.0 108.501 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -144.78 120.63 10.59 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.765 -0.774 . . . . 12.0 112.1 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 97.27 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.557 -1.275 . . . . 12.0 107.557 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -40.29 24.97 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.693 -0.484 . . . . 12.0 109.693 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.663 -0.495 . . . . 12.0 109.663 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.765 ' CB ' HG23 ' A' ' 89' ' ' THR . 5.4 ptt-85 177.87 103.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.601 -0.687 . . . . 12.0 110.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 29.6 m-85 -98.25 44.51 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.183 -0.607 . . . . 12.0 109.48 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 18.17 107.39 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 114.287 1.217 . . . . 12.0 114.287 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -102.4 153.99 19.51 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.03 0.919 . . . . 12.0 112.274 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.459 ' HB2' HG23 ' A' ' 42' ' ' ILE . 13.6 t30 -117.8 94.79 4.65 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.718 -1.956 . . . . 12.0 105.718 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 m -100.91 126.81 47.56 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.725 0.774 . . . . 12.0 112.786 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.6 m -106.76 104.76 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 104.589 -2.374 . . . . 12.0 104.589 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.4 HG23 HG22 ' A' ' 37' ' ' VAL . 8.4 m -101.21 131.36 47.24 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.211 -0.596 . . . . 12.0 111.727 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -63.05 105.82 0.75 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.107 -1.072 . . . . 12.0 108.107 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.501 2.097 0 O-C-N 122.03 -0.419 . . . . 12.0 110.81 -178.492 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 118.519 -0.753 . . . . 12.0 109.344 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.57 145.7 26.51 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.473 1.449 . . . . 12.0 110.279 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.0 m-85 -131.7 134.79 46.29 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.313 0.577 . . . . 12.0 110.512 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -105.84 109.78 21.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.097 -1.075 . . . . 12.0 108.097 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -83.57 133.93 34.84 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.178 0.513 . . . . 12.0 110.261 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -148.72 125.83 11.4 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -105.68 146.39 29.81 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.384 -0.599 . . . . 12.0 109.384 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HG3' HD11 ' A' ' 68' ' ' LEU . 14.9 pt-20 -172.24 -172.12 0.91 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 120.746 -0.382 . . . . 12.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.765 HG23 ' CB ' ' A' ' 65' ' ' ARG . 43.5 m -57.0 139.41 52.23 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.554 -0.536 . . . . 12.0 109.554 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.44 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 61.1 t30 -112.84 88.01 2.73 Favored 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 119.482 -0.887 . . . . 12.0 112.064 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -95.78 96.23 8.83 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 104.399 -2.445 . . . . 12.0 104.399 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.719 HD13 ' CZ ' ' A' ' 104' ' ' PHE . 21.0 tt -130.28 163.68 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 119.854 -0.738 . . . . 12.0 111.708 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.68 114.14 28.12 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.008 -0.542 . . . . 12.0 110.191 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 101' ' ' PRO . 11.1 p -104.57 161.58 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.281 -0.637 . . . . 12.0 109.281 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.491 ' N ' HG22 ' A' ' 94' ' ' VAL . 12.7 ttmt -118.31 144.5 45.79 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.885 -0.783 . . . . 12.0 108.885 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.01 124.77 47.78 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.611 0.967 . . . . 12.0 113.611 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 27.9 tt0 -129.9 144.02 51.1 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 104.44 -2.43 . . . . 12.0 104.44 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.93 15.91 2.53 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.129 -0.982 . . . . 12.0 108.72 -175.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 78.29 -15.36 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 123.581 0.752 . . . . 12.0 112.606 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.915 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -98.28 148.66 34.82 Favored Pre-proline 0 N--CA 1.503 2.19 0 N-CA-C 106.497 -1.668 . . . . 12.0 106.497 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.5 Cg_endo -63.23 91.25 0.14 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 N-CA-C 107.955 -1.594 . . . . 12.0 107.955 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.915 HG22 ' CE2' ' A' ' 100' ' ' TYR . 69.4 t -87.61 -11.07 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-N 116.185 -0.461 . . . . 12.0 111.115 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.636 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -151.94 148.28 27.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.719 ' CZ ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -99.69 122.41 42.66 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.485 -1.286 . . . . 12.0 108.923 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.17 67.58 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.995 -0.44 . . . . 12.0 109.954 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.55 -149.08 18.59 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.863 -1.295 . . . . 12.0 109.863 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.9 pt -56.43 178.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.203 0.525 . . . . 12.0 110.757 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.824 0 N-CA-C 111.138 -0.785 . . . . 12.0 111.138 -179.15 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 108.568 -0.901 . . . . 12.0 108.568 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -25.03 64.1 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.905 -0.497 . . . . 12.0 110.313 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.38 -63.24 1.33 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.647 -0.658 . . . . 12.0 110.676 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -61.57 -31.58 71.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.935 -1.135 . . . . 12.0 107.935 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 31.3 t80 -76.08 -25.36 55.42 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.469 -0.937 . . . . 12.0 108.469 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -54.42 -32.69 57.87 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.339 -1.356 . . . . 12.0 107.339 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.44 -37.91 35.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.791 -1.189 . . . . 12.0 107.791 177.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 15.8 tppt? -47.15 -49.13 22.97 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 122.155 -0.341 . . . . 12.0 110.385 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.92 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -101.28 -13.13 18.18 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 118.681 -0.676 . . . . 12.0 112.596 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 11' ' ' ILE . 3.7 mp -137.81 72.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 115.354 1.613 . . . . 12.0 115.354 -175.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.951 HD12 ' CD1' ' A' ' 40' ' ' PHE . 11.3 mt -97.65 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 103.737 -2.69 . . . . 12.0 103.737 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.25 80.79 0.24 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.843 0.83 . . . . 12.0 110.512 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.409 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.5 p -150.6 59.79 3.73 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.411 -1.329 . . . . 12.0 107.411 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 14' ' ' THR . 34.8 Cg_endo -73.12 84.77 1.29 Allowed 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 121.94 1.76 . . . . 12.0 110.711 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 pt -124.94 -169.17 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' HD13 ' A' ' 17' ' ' ILE . 1.3 mm -97.88 34.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.656 -0.652 . . . . 12.0 109.436 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -150.04 98.4 2.7 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.902 -0.499 . . . . 12.0 109.997 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -81.36 -4.47 55.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.853 -0.529 . . . . 12.0 110.734 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -84.47 -58.11 2.87 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.523 -0.736 . . . . 12.0 111.242 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -26.04 64.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.786 -0.571 . . . . 12.0 110.097 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.3 pt -85.61 -32.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.853 -0.529 . . . . 12.0 109.597 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ttp -100.98 20.28 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.947 -0.39 . . . . 12.0 109.947 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -74.15 86.53 1.89 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -163.96 147.46 9.82 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.779 -0.576 . . . . 12.0 109.574 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -70.9 -8.17 50.98 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.943 -0.391 . . . . 12.0 109.943 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -85.95 7.84 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.601 -0.687 . . . . 12.0 110.026 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.535 ' OH ' HD11 ' A' ' 12' ' ' ILE . 35.2 m-85 -136.04 60.62 1.67 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.581 -0.699 . . . . 12.0 109.371 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mt -146.49 152.57 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 120.768 -1.208 . . . . 12.0 110.936 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.544 HG21 ' CA ' ' A' ' 35' ' ' LYS . 52.6 t -104.34 169.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.687 -1.227 . . . . 12.0 107.687 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.82 55.6 3.37 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.74 -57.14 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.41 -1.476 . . . . 12.0 109.41 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.31 -71.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.956 -0.732 . . . . 12.0 109.526 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 p -153.68 132.24 12.17 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.697 -0.853 . . . . 12.0 108.697 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CA ' HG21 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -56.18 171.27 0.28 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 109.82 -0.437 . . . . 12.0 109.82 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.97 -6.33 59.04 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 119.438 -0.315 . . . . 12.0 111.326 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.7 p -164.72 114.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 C-N-CA 119.545 -0.862 . . . . 12.0 111.691 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -95.37 82.55 3.71 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 12.0 105.832 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -83.48 116.21 22.43 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.58 0.705 . . . . 12.0 111.862 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.951 ' CD1' HD12 ' A' ' 12' ' ' ILE . 18.5 m-85 -104.49 162.46 13.22 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.359 -1.348 . . . . 12.0 107.359 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 10' ' ' HIS . 4.9 mp -126.89 125.99 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.518 1.054 . . . . 12.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.443 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 6.3 mt -90.85 108.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 108.03 -1.1 . . . . 12.0 108.03 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.6 t 177.71 151.12 0.22 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.684 -0.406 . . . . 12.0 109.971 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -67.02 129.6 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.112 -1.07 . . . . 12.0 108.112 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -26.49 5.73 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.042 -0.411 . . . . 12.0 111.295 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.91 -33.24 30.53 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.916 -0.49 . . . . 12.0 111.829 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -62.59 -37.73 87.37 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.083 -1.451 . . . . 12.0 107.083 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.92 HG11 ' CD2' ' A' ' 10' ' ' HIS . 46.8 t -67.39 -34.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -59.38 -23.61 62.73 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.67 -38.66 25.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.968 -0.458 . . . . 12.0 109.77 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 48' ' ' VAL . 6.4 tp -65.93 -19.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.809 -0.557 . . . . 12.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 23.04 15.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.754 -0.591 . . . . 12.0 110.448 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 m -86.2 112.43 21.34 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.55 -65.66 0.01 OUTLIER Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.249 -1.14 . . . . 12.0 110.249 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.659 HG12 ' HG3' ' A' ' 58' ' ' MET . 2.4 p -160.54 -164.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.407 -0.96 . . . . 12.0 108.407 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.593 ' H ' HG22 ' A' ' 55' ' ' VAL . 18.1 tt -90.3 28.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.124 -0.985 . . . . 12.0 110.968 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 15.6 t-20 172.1 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.659 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -163.89 177.77 8.31 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.795 0.807 . . . . 12.0 111.742 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -133.37 112.46 11.62 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.064 -1.458 . . . . 12.0 107.064 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 61' ' ' LEU . 14.5 p -131.82 168.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.902 -0.499 . . . . 12.0 109.731 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' N ' HG22 ' A' ' 60' ' ' VAL . 1.4 mp -133.47 128.52 35.61 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.479 -0.488 . . . . 12.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -62.18 95.81 0.07 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.762 -1.57 . . . . 12.0 106.762 177.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -84.71 -46.66 11.23 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.989 -0.444 . . . . 12.0 110.896 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.513 HG22 ' HG2' ' A' ' 65' ' ' ARG . 99.4 m -52.16 -94.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.972 -0.455 . . . . 12.0 109.786 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.687 ' CB ' HG23 ' A' ' 89' ' ' THR . 0.1 OUTLIER 173.66 101.9 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.098 -0.704 . . . . 12.0 109.098 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 76.3 m-85 -96.87 44.42 1.06 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 120.483 -0.487 . . . . 12.0 109.818 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 19.48 106.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.106 1.15 . . . . 12.0 114.106 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.28 153.65 18.79 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.093 0.949 . . . . 12.0 112.562 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.443 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 7.7 t30 -115.1 101.27 8.83 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 104.657 -2.349 . . . . 12.0 104.657 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -106.79 121.8 45.1 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.456 0.909 . . . . 12.0 113.456 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.01 104.64 16.69 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 102.677 -3.083 . . . . 12.0 102.677 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -100.53 140.13 35.23 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.469 0.652 . . . . 12.0 112.333 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.4 ttt180 -60.42 133.69 56.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.905 -0.776 . . . . 12.0 108.905 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.499 2.015 0 N-CA-C 109.512 -0.551 . . . . 12.0 109.512 -179.751 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 109.291 -0.633 . . . . 12.0 109.291 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 35.3 Cg_endo -76.11 128.01 10.33 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.562 1.508 . . . . 12.0 110.797 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 28.4 m-85 -148.02 137.26 22.16 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.964 0.411 . . . . 12.0 110.147 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 t -124.45 129.52 50.81 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.329 -0.989 . . . . 12.0 108.329 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -80.49 136.92 36.4 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.151 0.501 . . . . 12.0 110.956 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 121.37 7.81 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.99 -0.744 . . . . 12.0 108.99 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.9 p -98.55 147.16 25.07 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.468 -0.567 . . . . 12.0 109.468 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -168.3 -173.27 1.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.018 0.437 . . . . 12.0 110.054 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.687 HG23 ' CB ' ' A' ' 65' ' ' ARG . 30.7 m -66.43 142.49 57.56 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 109.461 -0.57 . . . . 12.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.462 HD22 HD23 ' A' ' 68' ' ' LEU . 8.6 t-20 -105.73 87.16 2.53 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.88 0.847 . . . . 12.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 6.2 p90 -109.34 106.46 16.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 105.985 -1.857 . . . . 12.0 105.985 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.463 ' HA ' ' CA ' ' A' ' 108' ' ' GLY . 19.9 pt -139.18 -171.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.85 -0.74 . . . . 12.0 111.976 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 39.0 t -119.99 114.63 22.31 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.083 -0.71 . . . . 12.0 109.083 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 95' ' ' LYS . 8.6 p -113.75 171.35 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 105' ' ' ALA . 14.3 mttt -130.88 146.03 52.18 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.922 -0.77 . . . . 12.0 108.922 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.4 m -118.18 125.13 49.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.217 1.192 . . . . 12.0 114.217 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.65 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 30.0 tt0 -131.62 144.69 51.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 103.818 -2.66 . . . . 12.0 103.818 174.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 27.8 m-80 53.63 29.38 9.22 Favored 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 107.699 -1.222 . . . . 12.0 107.699 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 52.69 9.58 0.12 Allowed 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 125.289 1.436 . . . . 12.0 114.835 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.915 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -114.39 145.98 34.89 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 104.532 -2.395 . . . . 12.0 104.532 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.629 ' HG3' HG12 ' A' ' 48' ' ' VAL . 23.3 Cg_endo -60.79 90.08 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.275 1.316 . . . . 12.0 108.69 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.915 HG22 ' CE2' ' A' ' 100' ' ' TYR . 69.7 t -86.84 -23.24 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 116.271 -0.422 . . . . 12.0 110.851 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.65 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.62 145.89 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.94 -1.133 . . . . 12.0 107.94 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -116.47 128.51 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.15 -1.02 . . . . 12.0 109.92 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 95' ' ' LYS . . . -78.99 -37.9 38.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.23 -0.294 . . . . 12.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.08 -134.68 6.88 Favored Glycine 0 N--CA 1.504 3.177 0 C-N-CA 120.066 -1.064 . . . . 12.0 111.493 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 pt -69.15 -171.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.083 0.468 . . . . 12.0 111.129 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.463 ' CA ' ' HA ' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.799 0 N-CA-C 110.391 -1.084 . . . . 12.0 110.391 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 10.7 t-20 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 108.817 -0.809 . . . . 12.0 108.817 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.425 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.51 -22.85 61.73 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 121.952 -0.468 . . . . 12.0 110.527 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.64 0.85 Allowed 'General case' 0 N--CA 1.515 2.815 0 O-C-N 121.637 -0.665 . . . . 12.0 110.853 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 m -60.9 -31.54 71.03 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.061 -1.088 . . . . 12.0 108.061 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 26.3 t80 -75.91 -26.14 56.7 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.461 -0.94 . . . . 12.0 108.461 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -51.79 -35.69 44.98 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 107.567 -1.271 . . . . 12.0 107.567 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -77.29 -40.95 42.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -45.87 -51.76 12.53 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.161 -0.337 . . . . 12.0 111.627 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.694 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.2 m170 -94.89 -14.71 24.26 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.552 -0.718 . . . . 12.0 111.363 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.694 HD13 ' O ' ' A' ' 10' ' ' HIS . 36.5 mm -130.86 73.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 N-CA-C 114.46 1.282 . . . . 12.0 114.46 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 40' ' ' PHE . 3.0 mp -97.43 61.15 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 103.667 -2.716 . . . . 12.0 103.667 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.42 ' OD1' HG23 ' A' ' 11' ' ' ILE . 3.0 m120 -70.98 81.49 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.739 0.78 . . . . 12.0 110.199 -176.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.535 ' OG1' HD12 ' A' ' 22' ' ' ILE . 9.3 p -131.79 76.11 74.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.672 -0.862 . . . . 12.0 108.672 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.85 82.0 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.994 1.796 . . . . 12.0 109.223 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 17' ' ' ILE . 31.6 mt -141.69 168.91 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.459 ' N ' HG22 ' A' ' 16' ' ' ILE . 10.7 pt -93.71 41.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 121.437 0.636 . . . . 12.0 109.758 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 22' ' ' ILE . 33.8 m-80 -149.49 104.81 3.4 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.7 -0.852 . . . . 12.0 108.7 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -81.12 -16.89 51.76 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 120.551 -0.46 . . . . 12.0 111.558 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -84.39 -55.24 4.26 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 118.892 0.769 . . . . 12.0 110.417 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.09 -30.68 64.54 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.264 -0.272 . . . . 12.0 110.443 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.535 HD12 ' OG1' ' A' ' 14' ' ' THR . 44.0 pt -80.76 -39.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.268 -0.573 . . . . 12.0 110.171 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.434 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -95.86 17.1 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.496 -0.482 . . . . 12.0 110.246 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -62.49 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.616 -0.883 . . . . 12.0 108.616 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.61 150.15 4.86 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.354 -0.61 . . . . 12.0 109.354 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -69.65 -9.42 54.16 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.878 -0.329 . . . . 12.0 110.342 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -87.06 8.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 12.0 110.307 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -137.27 58.2 1.72 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.6 -0.687 . . . . 12.0 109.73 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -151.31 152.19 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 12.0 110.579 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 31' ' ' GLY . 58.5 t -103.26 168.93 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 107.475 -1.306 . . . . 12.0 107.475 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.35 54.77 3.54 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.219 -1.552 . . . . 12.0 109.219 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.88 -57.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.146 -1.582 . . . . 12.0 109.146 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.24 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.022 -0.693 . . . . 12.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 99.0 m -144.05 150.1 37.67 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.04 176.97 6.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.014 -0.736 . . . . 12.0 109.014 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -17.07 52.37 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.969 -0.457 . . . . 12.0 110.038 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 37' ' ' VAL . 12.5 p -162.04 117.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 C-N-CA 119.825 -0.75 . . . . 12.0 111.337 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 5.3 m-20 -97.46 83.77 3.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.701 -1.963 . . . . 12.0 105.701 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -80.84 116.4 20.81 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.909 -0.587 . . . . 12.0 111.481 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.69 ' HA ' HD13 ' A' ' 12' ' ' ILE . 21.7 m-85 -100.5 158.96 15.53 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.531 -1.285 . . . . 12.0 107.531 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.465 HD12 ' ND2' ' A' ' 90' ' ' ASN . 50.5 mm -129.18 124.23 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.357 -0.84 . . . . 12.0 110.346 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 69' ' ' ASN . 4.6 mt -106.42 111.44 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 108.324 -0.991 . . . . 12.0 108.324 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 t 178.33 151.23 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 12.0 109.112 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.49 119.41 5.19 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 109.134 -0.691 . . . . 12.0 109.134 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HA ' HD11 ' A' ' 11' ' ' ILE . . . -42.98 -64.54 0.61 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 113.555 0.946 . . . . 12.0 113.555 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.5 t -62.13 -20.73 64.38 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.912 -0.493 . . . . 12.0 111.552 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.6 m -65.25 -36.07 82.98 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 107.169 -1.419 . . . . 12.0 107.169 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.837 ' O ' HG22 ' A' ' 51' ' ' ILE . 19.3 t -71.24 -34.39 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -21.51 65.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.663 -0.866 . . . . 12.0 108.663 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.45 -39.05 28.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.885 -0.51 . . . . 12.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.837 HG22 ' O ' ' A' ' 48' ' ' VAL . 4.7 tp -64.32 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 12.0 109.773 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.423 ' HA ' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -104.91 25.57 10.3 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.69 -0.632 . . . . 12.0 110.35 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 m -90.83 115.93 28.28 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.252 -0.647 . . . . 12.0 109.252 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.98 -62.95 0.02 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.573 -1.011 . . . . 12.0 110.573 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.6 p -161.12 -164.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.581 -0.896 . . . . 12.0 108.581 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.599 ' H ' HG22 ' A' ' 55' ' ' VAL . 9.9 tt -88.64 27.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 121.053 -1.029 . . . . 12.0 110.665 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.6 t30 172.44 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 106.961 -1.496 . . . . 12.0 106.961 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.87 178.37 9.83 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.921 0.867 . . . . 12.0 111.841 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.66 112.25 7.83 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.923 -1.51 . . . . 12.0 106.923 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.1 p -141.25 167.92 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.325 -0.621 . . . . 12.0 109.325 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 93' ' ' CYS . 4.7 mp -136.67 130.32 31.99 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.581 -0.448 . . . . 12.0 111.023 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -59.12 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 106.544 -1.651 . . . . 12.0 106.544 176.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.79 HG22 ' OH ' ' A' ' 91' ' ' TYR . 3.1 p -80.61 -43.1 21.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.325 -0.234 . . . . 12.0 110.512 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.34 -90.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 109.349 -0.612 . . . . 12.0 109.349 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.788 ' CB ' HG23 ' A' ' 89' ' ' THR . 4.7 ptt-85 171.48 101.06 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.211 -0.663 . . . . 12.0 109.211 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 62.0 m-85 -97.25 48.38 1.04 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 120.462 -0.495 . . . . 12.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 16.57 107.92 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.525 1.305 . . . . 12.0 114.525 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -104.06 155.59 18.56 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.066 0.936 . . . . 12.0 112.474 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.494 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -116.87 97.42 5.95 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 105.25 -2.13 . . . . 12.0 105.25 176.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 m -104.18 128.29 51.87 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.5 0.926 . . . . 12.0 113.5 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.2 m -111.01 108.18 17.83 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.44 -2.8 . . . . 12.0 103.44 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -109.55 145.86 35.63 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 120.17 -0.612 . . . . 12.0 112.311 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.7 ttp85 -64.27 116.0 5.59 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.937 -0.764 . . . . 12.0 108.937 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.503 2.212 0 O-C-N 121.934 -0.479 . . . . 12.0 110.742 -179.285 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 108.259 -1.015 . . . . 12.0 108.259 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 36.6 Cg_endo -76.12 101.71 1.52 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.68 1.587 . . . . 12.0 109.65 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.441 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 18.9 m-85 -139.75 138.33 35.82 Favored 'General case' 0 N--CA 1.509 2.489 0 CA-C-O 121.354 0.597 . . . . 12.0 111.198 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -114.79 121.76 44.29 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 p -84.32 143.99 29.15 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 120.991 0.424 . . . . 12.0 110.395 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -154.66 159.49 40.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.276 -0.638 . . . . 12.0 109.276 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.6 m -130.45 142.14 50.5 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.062 -0.718 . . . . 12.0 109.062 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.94 -169.46 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.309 0.575 . . . . 12.0 110.521 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.788 HG23 ' CB ' ' A' ' 65' ' ' ARG . 98.3 m -64.54 146.47 54.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.082 -0.71 . . . . 12.0 109.082 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' HD12 ' A' ' 41' ' ' ILE . 60.6 t30 -108.67 88.78 2.81 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.989 0.899 . . . . 12.0 111.383 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.79 ' OH ' HG22 ' A' ' 63' ' ' THR . 2.3 t80 -98.43 103.95 15.94 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.84 -2.281 . . . . 12.0 104.84 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.628 HD13 ' O ' ' A' ' 91' ' ' TYR . 33.0 mm -127.75 163.38 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 119.685 -0.806 . . . . 12.0 111.99 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.522 ' HB2' HD23 ' A' ' 61' ' ' LEU . 51.6 t -115.91 106.44 13.8 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 101' ' ' PRO . 5.5 p -113.85 172.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.953 -0.388 . . . . 12.0 109.953 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.534 ' H ' HG22 ' A' ' 94' ' ' VAL . 65.0 mttt -126.65 143.18 51.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -111.0 115.68 29.89 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.265 1.209 . . . . 12.0 114.265 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.7 tt0 -125.77 142.72 51.37 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 104.055 -2.572 . . . . 12.0 104.055 174.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 60.3 m-80 54.84 29.55 12.16 Favored 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 14.5 pt20 52.1 11.11 0.14 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 114.651 1.352 . . . . 12.0 114.651 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.891 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -118.12 146.99 40.53 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 174.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.539 ' HB3' HG21 ' A' ' 94' ' ' VAL . 24.3 Cg_endo -60.54 89.89 0.08 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 121.262 1.308 . . . . 12.0 108.819 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.891 HG22 ' CE2' ' A' ' 100' ' ' TYR . 47.2 t -86.22 -19.63 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 116.345 -0.388 . . . . 12.0 110.887 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -140.77 144.57 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.657 -0.868 . . . . 12.0 108.657 -177.146 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -109.07 132.11 54.43 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.068 -1.053 . . . . 12.0 108.366 178.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.12 -24.19 14.66 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.092 -0.38 . . . . 12.0 111.992 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.45 178.32 47.75 Favored Glycine 0 N--CA 1.503 3.143 0 N-CA-C 110.577 -1.009 . . . . 12.0 110.577 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 92' ' ' ILE . 10.4 pt -92.65 25.1 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.45 -0.441 . . . . 12.0 110.692 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.927 0 N-CA-C 109.591 -1.403 . . . . 12.0 109.591 179.631 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.0 t30 . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.403 ' CZ3' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -70.85 -31.85 68.68 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 122.157 -0.339 . . . . 12.0 110.874 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.87 2.01 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.542 -0.724 . . . . 12.0 110.474 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.2 m -62.29 -32.56 73.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.503 -0.925 . . . . 12.0 108.503 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 36.3 t80 -73.89 -23.86 59.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.69 -0.855 . . . . 12.0 108.69 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 17.4 tt0 -57.65 -37.85 74.06 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.129 -1.434 . . . . 12.0 107.129 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -75.59 -34.14 60.61 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 176.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 17.9 tptt -46.42 -59.0 3.23 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 122.215 -0.303 . . . . 12.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.65 ' HA ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -104.11 1.09 30.43 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 118.482 -0.771 . . . . 12.0 112.758 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 11' ' ' ILE . 4.1 mp -134.74 65.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 117.866 -1.534 . . . . 12.0 114.958 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.914 HD12 ' CD1' ' A' ' 40' ' ' PHE . 23.3 mt -97.53 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 103.88 -2.637 . . . . 12.0 103.88 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -65.01 83.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.815 0.817 . . . . 12.0 110.186 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 p -129.26 90.54 44.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -73.99 -3.02 13.11 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.679 1.586 . . . . 12.0 112.081 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.805 HD11 ' CG2' ' A' ' 22' ' ' ILE . 18.4 pt -58.43 -170.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.246 -0.65 . . . . 12.0 109.246 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.9 40.65 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.469 0.652 . . . . 12.0 109.81 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -142.76 101.02 3.78 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.9 -0.5 . . . . 12.0 110.18 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' CG1' ' A' ' 22' ' ' ILE . 10.7 m -81.16 -3.17 51.31 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.934 -0.479 . . . . 12.0 110.829 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -84.7 -58.02 2.89 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.521 -0.737 . . . . 12.0 111.685 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 m -65.47 -23.44 66.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.593 -0.692 . . . . 12.0 110.402 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.805 ' CG2' HD11 ' A' ' 16' ' ' ILE . 2.7 pp -84.04 -35.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.419 -0.585 . . . . 12.0 109.419 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.509 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.2 ttm -83.28 -5.53 59.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.143 -0.348 . . . . 12.0 110.198 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.68 91.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' HD12 ' A' ' 27' ' ' ILE . 8.0 t-20 -168.07 152.98 6.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.428 -0.582 . . . . 12.0 109.428 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.15 -7.97 53.74 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 120.664 -0.414 . . . . 12.0 110.043 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 27' ' ' ILE . 55.5 mt -88.41 10.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.687 -0.633 . . . . 12.0 110.317 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.87 ' OH ' HD11 ' A' ' 12' ' ' ILE . 47.0 m-85 -138.46 57.93 1.68 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.744 -0.597 . . . . 12.0 110.391 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.99 -1.069 . . . . 12.0 109.511 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.8 p -107.41 -165.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 108.02 -1.104 . . . . 12.0 108.02 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.568 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -96.91 67.81 0.88 Allowed Glycine 0 N--CA 1.505 3.265 0 O-C-N 121.044 -1.035 . . . . 12.0 112.063 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.85 -63.53 0.03 OUTLIER Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.23 -1.548 . . . . 12.0 109.23 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -164.44 -64.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.667 -1.235 . . . . 12.0 107.667 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.9 p -174.51 126.15 0.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.944 -1.132 . . . . 12.0 107.944 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -56.19 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.986 -0.446 . . . . 12.0 109.941 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 mtm-85 -106.18 21.45 17.35 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.903 -0.319 . . . . 12.0 110.488 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -163.53 133.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.595 -0.691 . . . . 12.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.0 99.07 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.944 -1.502 . . . . 12.0 106.944 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 m -87.4 110.85 20.56 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.291 0.567 . . . . 12.0 111.524 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.914 ' CD1' HD12 ' A' ' 12' ' ' ILE . 18.9 m-85 -98.25 162.21 13.3 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.671 HD12 ' C ' ' A' ' 40' ' ' PHE . 4.5 mp -132.8 128.1 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.183 -0.948 . . . . 12.0 109.756 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.405 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 4.4 mt -94.66 107.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.8 t 177.2 148.08 0.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.62 -0.511 . . . . 12.0 109.62 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 p -64.25 129.51 40.22 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.052 -1.092 . . . . 12.0 108.052 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB1' ' CZ3' ' A' ' 3' ' ' TRP . . . -48.67 -30.9 5.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.881 -0.512 . . . . 12.0 111.589 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -78.97 -33.88 44.79 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.937 -0.477 . . . . 12.0 111.837 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -62.44 -39.72 94.25 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.281 -1.377 . . . . 12.0 107.281 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.806 ' O ' HG22 ' A' ' 51' ' ' ILE . 37.2 t -69.26 -35.79 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.752 -1.203 . . . . 12.0 107.752 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -22.55 66.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.195 -0.668 . . . . 12.0 109.195 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.05 29.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.966 -0.459 . . . . 12.0 109.903 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.0 tp -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.749 -0.594 . . . . 12.0 110.164 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.06 26.52 8.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.858 -0.526 . . . . 12.0 109.937 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.5 m -88.06 111.51 21.63 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.875 -0.787 . . . . 12.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.46 -60.4 0.02 OUTLIER Glycine 0 N--CA 1.499 2.877 0 N-CA-C 110.643 -0.983 . . . . 12.0 110.643 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.3 p -163.93 -169.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.866 -0.785 . . . . 12.0 108.904 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.612 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.7 pt -87.27 25.55 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 O-C-N 121.11 -0.994 . . . . 12.0 111.197 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.419 ' H ' HG13 ' A' ' 55' ' ' VAL . 9.3 t30 174.67 113.48 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 106.86 -1.533 . . . . 12.0 106.86 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.6 ttt -161.21 174.55 13.46 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.855 0.836 . . . . 12.0 111.739 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -132.51 110.67 10.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.593 -1.632 . . . . 12.0 106.593 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 61' ' ' LEU . 11.0 t -121.78 168.53 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.745 -0.597 . . . . 12.0 109.827 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.469 ' N ' HG12 ' A' ' 60' ' ' VAL . 5.0 mp -131.0 112.17 12.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.121 -0.362 . . . . 12.0 110.662 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -60.4 92.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 107.502 -1.295 . . . . 12.0 107.502 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -83.28 -42.26 17.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.916 -0.49 . . . . 12.0 111.019 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -53.05 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 109.771 -0.455 . . . . 12.0 109.771 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.738 ' CB ' HG23 ' A' ' 89' ' ' THR . 2.2 ptp180 178.53 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.425 -0.797 . . . . 12.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 72.8 m-85 -96.51 43.7 1.07 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 120.446 -0.502 . . . . 12.0 109.678 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 18.91 106.11 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.211 1.189 . . . . 12.0 114.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.56 153.86 18.71 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.782 0.801 . . . . 12.0 111.836 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.405 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 7.2 t30 -119.99 102.47 8.57 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 106.467 -1.679 . . . . 12.0 106.467 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -100.94 124.73 47.08 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.944 -0.703 . . . . 12.0 111.797 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.2 m -108.82 109.39 20.5 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.095 -2.557 . . . . 12.0 104.095 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -114.15 140.84 48.19 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.821 -0.752 . . . . 12.0 111.523 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -58.61 110.49 1.0 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.306 -0.627 . . . . 12.0 109.306 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.5 2.061 0 O-C-N 122.071 -0.393 . . . . 12.0 110.539 -179.389 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.496 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 110.845 -0.057 . . . . 12.0 110.845 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 37.0 Cg_endo -78.93 129.19 8.86 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.323 2.015 . . . . 12.0 108.977 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -120.77 136.48 54.87 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 121.647 0.737 . . . . 12.0 112.354 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -109.03 129.63 55.46 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.814 -1.18 . . . . 12.0 107.814 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.8 p -92.81 145.14 24.62 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.308 0.575 . . . . 12.0 111.819 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -149.97 157.29 43.01 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.578 -0.897 . . . . 12.0 108.578 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 m -128.38 153.68 46.8 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.599 -0.519 . . . . 12.0 109.599 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -173.07 179.0 2.35 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.666 -0.414 . . . . 12.0 109.961 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.738 HG23 ' CB ' ' A' ' 65' ' ' ARG . 68.3 m -62.03 143.42 56.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.495 -0.928 . . . . 12.0 108.495 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -107.65 85.77 2.18 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.308 -0.957 . . . . 12.0 112.203 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -100.34 105.17 16.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.226 -2.509 . . . . 12.0 104.226 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.412 ' HA ' ' N ' ' A' ' 108' ' ' GLY . 0.8 OUTLIER -136.32 -177.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 121.653 0.739 . . . . 12.0 112.062 -175.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 18.1 t -117.76 121.3 40.45 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.707 -0.849 . . . . 12.0 108.707 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.599 HG23 ' CZ ' ' A' ' 104' ' ' PHE . 8.1 p -117.5 167.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.844 -0.342 . . . . 12.0 110.595 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 94' ' ' VAL . 36.9 mttt -129.6 138.39 51.23 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.479 -0.934 . . . . 12.0 108.479 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -111.99 122.24 47.22 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 113.92 1.081 . . . . 12.0 113.92 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.673 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 35.0 tt0 -132.23 142.56 49.46 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 103.991 -2.596 . . . . 12.0 103.991 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 33.2 m120 54.13 29.1 9.84 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 107.638 -1.245 . . . . 12.0 107.638 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 98' ' ' ASN . 2.1 pm0 52.94 10.21 0.15 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.168 1.544 . . . . 12.0 115.168 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.905 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -115.63 146.24 36.3 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 104.574 -2.38 . . . . 12.0 104.574 174.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.57 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.9 Cg_endo -60.84 88.31 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.034 0 C-N-CA 121.293 1.328 . . . . 12.0 108.764 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.905 HG22 ' CE2' ' A' ' 100' ' ' TYR . 67.2 t -84.35 -24.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.272 -0.422 . . . . 12.0 110.395 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.673 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -132.31 144.38 50.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.344 -1.354 . . . . 12.0 107.344 -178.201 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.599 ' CZ ' HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -120.76 131.1 54.31 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.833 -1.147 . . . . 12.0 110.905 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -78.69 -40.78 32.85 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 116.308 -0.405 . . . . 12.0 110.517 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.69 -121.36 3.24 Favored Glycine 0 N--CA 1.504 3.185 0 C-N-CA 120.378 -0.915 . . . . 12.0 111.299 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.5 pt -65.44 -178.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-O 121.372 0.606 . . . . 12.0 111.496 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.501 3.01 0 N-CA-C 110.887 -0.885 . . . . 12.0 110.887 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 36.5 t30 . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 108.439 -0.948 . . . . 12.0 108.439 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -72.61 -19.74 61.41 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.706 -0.621 . . . . 12.0 110.733 -177.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.83 -62.13 1.69 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.477 -0.764 . . . . 12.0 110.511 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 27' ' ' ILE . 5.2 m -63.59 -33.4 75.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.664 -1.236 . . . . 12.0 107.664 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 36.5 t80 -74.39 -23.25 58.94 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -54.17 -34.61 60.87 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 106.955 -1.498 . . . . 12.0 106.955 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -74.2 -41.76 60.91 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.381 -1.34 . . . . 12.0 107.381 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 9.2 mmtp -51.9 -29.44 20.02 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 122.001 -0.437 . . . . 12.0 109.879 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.718 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -96.56 -28.38 14.4 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 118.568 -0.729 . . . . 12.0 112.614 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 10' ' ' HIS . 23.2 mm -135.59 72.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.826 1.787 . . . . 12.0 115.826 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.865 HG21 ' CD1' ' A' ' 40' ' ' PHE . 47.2 mm -98.36 61.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 102.211 -3.255 . . . . 12.0 102.211 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.12 74.46 3.69 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.522 -0.763 . . . . 12.0 110.655 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.699 ' OG1' HD12 ' A' ' 22' ' ' ILE . 3.1 p -131.21 70.63 82.21 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.867 -0.79 . . . . 12.0 108.867 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.34 81.76 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.048 1.832 . . . . 12.0 109.812 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.554 HD11 ' CG2' ' A' ' 22' ' ' ILE . 12.3 pt -136.18 -169.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.805 -0.813 . . . . 12.0 108.805 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 pt -105.81 31.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.455 0.645 . . . . 12.0 109.655 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' HB2' HD12 ' A' ' 16' ' ' ILE . 61.5 m-20 -145.15 95.95 2.76 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.569 -0.9 . . . . 12.0 108.569 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.6 m -81.62 -10.08 59.51 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 120.442 -0.503 . . . . 12.0 111.607 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -81.23 -50.68 9.27 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.009 0.822 . . . . 12.0 111.356 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -67.08 -19.23 65.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.823 -0.548 . . . . 12.0 110.649 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.699 HD12 ' OG1' ' A' ' 14' ' ' THR . 35.0 pt -86.33 -39.23 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.737 -0.602 . . . . 12.0 110.536 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.425 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -94.53 10.89 32.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.857 -0.527 . . . . 12.0 110.43 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -60.18 91.57 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.527 ' OD1' HD12 ' A' ' 27' ' ' ILE . 9.4 t-20 -170.74 156.73 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.441 -0.577 . . . . 12.0 109.441 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.13 -9.42 58.4 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.885 -0.413 . . . . 12.0 109.885 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 27' ' ' ILE . 63.0 mt -87.39 9.56 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.718 -0.614 . . . . 12.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -143.36 63.07 1.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.429 -0.794 . . . . 12.0 110.283 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -146.0 151.64 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.866 -1.146 . . . . 12.0 110.639 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 31' ' ' GLY . 61.1 t -105.31 170.4 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 107.583 -1.265 . . . . 12.0 107.583 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -89.89 53.36 3.64 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 109.57 -1.412 . . . . 12.0 109.57 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.13 -58.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.701 -1.76 . . . . 12.0 108.701 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -164.99 -71.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.0 m -138.71 -166.13 1.95 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.753 -0.832 . . . . 12.0 108.753 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.01 173.68 7.39 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -79.2 -21.01 46.92 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.236 -0.29 . . . . 12.0 110.334 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.9 108.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 120.248 -0.581 . . . . 12.0 110.865 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.0 m120 -94.71 85.0 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.269 -1.752 . . . . 12.0 106.269 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 m -79.29 117.1 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.47 0.652 . . . . 12.0 111.824 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.865 ' CD1' HG21 ' A' ' 12' ' ' ILE . 25.2 m-85 -101.89 160.33 14.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.184 -1.413 . . . . 12.0 107.184 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 10' ' ' HIS . 1.5 tt -126.89 127.77 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.989 -1.069 . . . . 12.0 110.006 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 42' ' ' ILE . 2.4 tt -110.82 100.73 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t 173.92 154.28 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 12.0 108.921 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.5 t -51.72 126.37 17.58 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.295 -0.631 . . . . 12.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.558 ' HB2' ' CG1' ' A' ' 11' ' ' ILE . . . -60.52 -37.98 82.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.987 -0.446 . . . . 12.0 110.639 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -76.48 -24.87 53.83 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 120.838 -0.345 . . . . 12.0 111.715 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -65.8 -40.19 91.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 107.007 -1.479 . . . . 12.0 107.007 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.722 HG22 ' CD2' ' A' ' 66' ' ' PHE . 58.7 t -68.55 -39.91 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.791 -1.559 . . . . 12.0 106.791 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -59.67 -22.59 62.14 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.392 -0.596 . . . . 12.0 109.392 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.93 -39.75 41.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.836 -0.54 . . . . 12.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.451 HG13 ' CE1' ' A' ' 66' ' ' PHE . 50.5 mm -66.74 -18.07 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.775 -0.578 . . . . 12.0 110.406 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.2 22.87 9.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.722 -0.611 . . . . 12.0 109.603 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m -87.93 109.95 20.19 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.782 -0.822 . . . . 12.0 108.782 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.77 -61.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.639 -0.984 . . . . 12.0 110.639 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.594 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.6 p -160.96 -168.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 117.716 0.758 . . . . 12.0 109.091 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.594 ' H ' HG22 ' A' ' 55' ' ' VAL . 12.5 tt -88.16 27.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.603 0 O-C-N 121.378 -0.827 . . . . 12.0 111.053 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.7 t-20 172.58 117.85 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.513 -1.292 . . . . 12.0 107.513 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -161.77 176.19 11.16 Favored 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.635 0.731 . . . . 12.0 111.599 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -131.82 116.42 17.21 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.377 -1.712 . . . . 12.0 106.377 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 61' ' ' LEU . 10.2 p -132.5 163.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 120.193 -0.603 . . . . 12.0 110.432 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.67 HD11 ' O ' ' A' ' 108' ' ' GLY . 0.6 OUTLIER -127.5 111.77 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.649 -0.5 . . . . 12.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.752 ' HB2' HG22 ' A' ' 92' ' ' ILE . 18.1 m -59.57 92.25 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.735 -0.839 . . . . 12.0 108.735 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.723 HG22 ' OH ' ' A' ' 91' ' ' TYR . 2.1 p -77.97 -49.93 13.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.832 -0.803 . . . . 12.0 108.832 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 7.4 p -59.78 106.77 0.52 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.747 -1.205 . . . . 12.0 107.747 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.903 ' HB3' HG23 ' A' ' 89' ' ' THR . 19.3 ptt-85 -37.32 107.13 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 112.863 0.69 . . . . 12.0 112.863 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.722 ' CD2' HG22 ' A' ' 48' ' ' VAL . 29.3 m-85 -94.04 41.75 1.09 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 20.24 107.08 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.26 1.207 . . . . 12.0 114.26 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.9 154.55 19.5 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 12.0 111.763 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -113.55 97.65 6.58 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.452 -2.425 . . . . 12.0 104.452 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.4 m -99.05 123.9 43.67 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.796 -0.761 . . . . 12.0 112.85 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.3 m -107.11 105.96 16.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 104.391 -2.448 . . . . 12.0 104.391 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -99.47 144.26 28.78 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 120.43 -0.508 . . . . 12.0 110.754 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -70.22 113.53 7.48 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.715 -0.846 . . . . 12.0 108.715 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.501 2.096 0 O-C-N 122.013 -0.43 . . . . 12.0 110.665 -179.238 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 23.7 m . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 110.002 -0.37 . . . . 12.0 110.002 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 34.3 Cg_endo -79.3 143.62 17.62 Favored 'Trans proline' 0 N--CA 1.48 0.687 0 C-N-CA 122.265 1.977 . . . . 12.0 109.612 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 27.8 m-85 -139.21 142.05 37.89 Favored 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.328 0.585 . . . . 12.0 111.094 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 t -115.42 134.3 55.22 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.841 -1.17 . . . . 12.0 107.841 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.4 m -96.08 139.52 32.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.551 0.691 . . . . 12.0 111.853 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -151.33 120.94 6.95 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.242 -1.021 . . . . 12.0 108.242 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 68' ' ' LEU . 22.8 m -104.6 149.8 25.21 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.557 -0.535 . . . . 12.0 109.557 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -176.89 -171.84 0.39 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.671 -0.411 . . . . 12.0 110.362 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.903 HG23 ' HB3' ' A' ' 65' ' ' ARG . 66.0 m -49.76 136.26 17.95 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.867 -0.42 . . . . 12.0 109.867 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' OD1' HD23 ' A' ' 68' ' ' LEU . 65.2 t30 -107.68 87.09 2.42 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.993 0.902 . . . . 12.0 111.397 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.723 ' OH ' HG22 ' A' ' 63' ' ' THR . 0.4 OUTLIER -95.4 101.44 13.16 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 104.571 -2.381 . . . . 12.0 104.571 176.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.752 HG22 ' HB2' ' A' ' 62' ' ' SER . 16.0 tt -122.13 161.97 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.523 -0.871 . . . . 12.0 112.862 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.13 113.94 26.1 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.927 -1.138 . . . . 12.0 107.927 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 104' ' ' PHE . 10.8 m -126.57 -172.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 116.15 -0.477 . . . . 12.0 109.963 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 54.1 mttt -144.65 157.28 44.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.098 -0.705 . . . . 12.0 109.098 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.2 m -119.47 116.33 25.89 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.802 0.667 . . . . 12.0 112.802 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.624 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 17.5 tt0 -124.92 143.62 50.77 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 104.336 -2.468 . . . . 12.0 104.336 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.5 m120 55.17 29.13 12.1 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.7 pt20 53.26 10.37 0.19 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.073 1.349 . . . . 12.0 114.523 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.86 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -115.88 146.88 37.91 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 104.964 -2.236 . . . . 12.0 104.964 174.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.494 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 23.7 Cg_endo -61.02 92.48 0.1 Allowed 'Trans proline' 0 C--O 1.205 -1.172 0 N-CA-C 108.28 -1.469 . . . . 12.0 108.28 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.86 HG22 ' CE2' ' A' ' 100' ' ' TYR . 54.5 t -91.21 -8.66 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 116.263 -0.426 . . . . 12.0 110.731 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.624 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -142.71 110.79 5.98 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.555 -1.258 . . . . 12.0 112.101 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CE1' HG11 ' A' ' 94' ' ' VAL . 5.9 m-30 -100.22 112.19 24.5 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 105.254 -2.128 . . . . 12.0 105.254 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -129.89 7.04 5.12 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.434 0.902 . . . . 12.0 113.434 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 92' ' ' ILE . . . -151.92 160.43 28.83 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.927 -1.269 . . . . 12.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 107' ' ' ILE . 37.6 mt -104.29 28.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.895 -0.78 . . . . 12.0 108.895 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.67 ' O ' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.497 2.754 0 N-CA-C 109.595 -1.402 . . . . 12.0 109.595 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 33.3 t30 . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 12.0 108.795 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -26.18 63.8 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 122.05 -0.406 . . . . 12.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 7' ' ' GLN . . . -77.48 -60.8 2.22 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 121.597 -0.69 . . . . 12.0 110.396 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 HG21 ' A' ' 27' ' ' ILE . 47.7 m -60.18 -29.49 68.73 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.126 -1.064 . . . . 12.0 108.126 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 26.9 t80 -81.62 -23.96 36.7 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.285 -0.635 . . . . 12.0 109.285 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -57.16 -28.78 63.08 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 178.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -83.79 -37.3 22.74 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.471 -1.307 . . . . 12.0 107.471 177.136 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 4.0 tptp -48.11 -47.97 34.09 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.771 0.319 . . . . 12.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.903 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -100.95 -17.56 16.73 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 118.53 -0.747 . . . . 12.0 112.149 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 11' ' ' ILE . 4.0 mp -139.44 75.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 116.819 2.155 . . . . 12.0 116.819 -175.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.437 ' CG1' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -97.6 62.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.9 -3.0 . . . . 12.0 102.9 171.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -71.75 78.85 0.85 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.989 -1.005 . . . . 12.0 112.533 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 p -121.38 122.69 27.96 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 107.273 -1.38 . . . . 12.0 107.273 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -71.85 -3.04 12.4 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 121.48 1.454 . . . . 12.0 112.114 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.11 159.53 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.6 -0.889 . . . . 12.0 108.6 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 tt -108.59 39.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 108.549 -0.908 . . . . 12.0 108.549 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -128.38 101.05 6.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -74.94 -18.42 60.4 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 120.499 -0.481 . . . . 12.0 111.174 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.89 -55.03 5.08 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 118.8 0.727 . . . . 12.0 110.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.39 -30.87 63.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.214 -0.304 . . . . 12.0 110.229 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 23' ' ' MET . 50.9 pt -81.02 -36.95 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.546 -0.462 . . . . 12.0 110.243 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.42 ' N ' HG13 ' A' ' 22' ' ' ILE . 9.6 ptt? -91.99 8.39 37.8 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.323 -0.551 . . . . 12.0 110.46 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 92.38 0.08 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.271 -1.381 . . . . 12.0 107.271 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -172.28 149.53 2.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.219 -0.659 . . . . 12.0 109.219 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -63.61 -12.87 36.85 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.061 -0.399 . . . . 12.0 109.996 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.618 HG21 HG23 ' A' ' 5' ' ' THR . 16.6 mt -84.45 11.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.702 -0.624 . . . . 12.0 110.658 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -146.48 64.27 1.2 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.44 -0.787 . . . . 12.0 110.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -146.99 151.25 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.761 -1.212 . . . . 12.0 110.398 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 31' ' ' GLY . 40.5 t -100.8 169.1 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.984 -1.117 . . . . 12.0 107.984 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -91.01 53.02 3.25 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.259 -1.536 . . . . 12.0 109.259 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.52 -57.03 0.02 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.238 -1.545 . . . . 12.0 109.238 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.42 -69.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.046 -0.679 . . . . 12.0 109.447 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.6 m -141.18 -176.82 4.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -109.82 164.06 12.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.996 -0.742 . . . . 12.0 108.996 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -80.13 -20.01 45.95 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.838 -0.345 . . . . 12.0 110.367 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.4 p -159.88 115.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.469 0.652 . . . . 12.0 111.106 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 12.3 m120 -103.18 84.89 2.4 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.385 -1.709 . . . . 12.0 106.385 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.8 m -81.46 115.99 21.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.395 0.617 . . . . 12.0 110.657 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.475 ' O ' HD13 ' A' ' 41' ' ' ILE . 33.1 m-85 -106.84 165.5 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.3 -1.0 . . . . 12.0 108.3 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.52 HD12 ' ND2' ' A' ' 90' ' ' ASN . 42.5 mm -125.88 124.08 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 42' ' ' ILE . 3.3 tt -104.37 109.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 108.702 -0.851 . . . . 12.0 108.702 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t 178.18 158.24 0.46 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.067 -0.716 . . . . 12.0 109.067 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.65 118.91 4.59 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.877 0.846 . . . . 12.0 109.449 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.09 -60.74 1.94 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 113.34 0.866 . . . . 12.0 113.34 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -25.0 64.98 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.935 -0.478 . . . . 12.0 111.24 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -62.71 -37.64 87.28 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.276 -1.379 . . . . 12.0 107.276 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 10' ' ' HIS . 62.0 t -68.86 -35.49 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.156 -1.424 . . . . 12.0 107.156 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -63.67 -21.41 66.37 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.589 -0.523 . . . . 12.0 109.589 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.22 -37.54 28.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.944 -0.473 . . . . 12.0 109.741 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.6 tp -67.8 -24.99 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.851 -0.531 . . . . 12.0 110.296 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 22.14 11.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.806 -0.559 . . . . 12.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -87.36 115.02 24.5 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.821 -0.549 . . . . 12.0 109.624 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.29 0.02 OUTLIER Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.046 -1.222 . . . . 12.0 110.046 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.9 p -161.88 -165.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.608 ' H ' HG22 ' A' ' 55' ' ' VAL . 3.8 pt -90.37 29.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 O-C-N 121.131 -0.98 . . . . 12.0 110.733 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 174.51 118.64 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.324 -1.361 . . . . 12.0 107.324 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.88 177.7 7.69 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.119 0.962 . . . . 12.0 112.501 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -139.07 111.69 7.68 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.237 -1.764 . . . . 12.0 106.237 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.8 p -130.69 163.98 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.309 -0.556 . . . . 12.0 110.367 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.76 HD11 ' O ' ' A' ' 108' ' ' GLY . 7.6 tp -117.6 114.4 23.35 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.386 -0.227 . . . . 12.0 110.386 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 66' ' ' PHE . 3.5 m -59.55 92.91 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.318 -0.993 . . . . 12.0 108.318 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -83.04 -171.64 3.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.763 -0.458 . . . . 12.0 109.763 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.443 HG22 ' HG2' ' A' ' 65' ' ' ARG . 97.9 m 62.84 -101.7 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.38 -0.971 . . . . 12.0 108.38 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.761 ' HB3' HG23 ' A' ' 89' ' ' THR . 15.9 ptt180 179.72 107.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 119.441 1.019 . . . . 12.0 110.833 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HE2' HD13 ' A' ' 51' ' ' ILE . 51.2 m-85 -96.01 43.62 1.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 108.497 -0.927 . . . . 12.0 108.497 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 22.55 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 113.859 1.059 . . . . 12.0 113.859 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.06 152.83 18.89 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.039 0.923 . . . . 12.0 111.664 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -118.99 98.29 6.11 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 105.726 -1.953 . . . . 12.0 105.726 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -98.42 123.23 42.44 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.619 0.723 . . . . 12.0 112.153 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.9 m -109.56 108.61 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.379 -2.452 . . . . 12.0 104.379 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -104.36 142.96 33.65 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.061 -0.656 . . . . 12.0 111.596 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.2 ttt180 -71.34 137.92 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.293 -0.632 . . . . 12.0 109.293 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 109.492 -0.558 . . . . 12.0 109.492 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.821 -0.807 . . . . 12.0 108.821 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.2 Cg_endo -78.3 122.63 5.72 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 C-N-CA 121.883 1.722 . . . . 12.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 14.7 m-85 -143.5 131.23 21.36 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.363 0.602 . . . . 12.0 110.854 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -108.78 125.49 52.0 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 107.579 -1.267 . . . . 12.0 107.579 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.0 p -95.44 141.02 29.47 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.084 0.468 . . . . 12.0 110.573 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.16 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.516 -0.92 . . . . 12.0 108.516 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -116.54 148.09 41.18 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 109.615 -0.513 . . . . 12.0 109.615 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.35 -172.32 1.69 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.32 0.581 . . . . 12.0 110.315 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 65' ' ' ARG . 42.0 m -67.31 138.38 56.77 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.566 -0.531 . . . . 12.0 109.566 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.52 ' ND2' HD12 ' A' ' 41' ' ' ILE . 63.3 t30 -106.79 89.68 3.09 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.054 0.93 . . . . 12.0 111.571 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.78 105.28 15.03 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 105.157 -2.164 . . . . 12.0 105.157 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.507 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 4.3 pt -138.95 -175.72 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.943 -0.703 . . . . 12.0 112.404 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.449 ' HA ' HD12 ' A' ' 61' ' ' LEU . 32.1 t -122.63 116.34 23.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.864 -0.607 . . . . 12.0 109.664 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' ' 101' ' ' PRO . 8.8 p -116.73 169.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.92 -0.4 . . . . 12.0 109.92 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 94' ' ' VAL . 27.4 mttt -124.22 142.77 50.97 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.416 -0.587 . . . . 12.0 109.416 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 121.79 45.67 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 114.44 1.274 . . . . 12.0 114.44 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 23.6 tt0 -133.2 144.95 50.15 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 104.013 -2.588 . . . . 12.0 104.013 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 20.5 m120 54.22 28.04 8.62 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 107.755 -1.202 . . . . 12.0 107.755 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.409 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.8 pt20 52.49 12.84 0.26 Allowed 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 125.316 1.446 . . . . 12.0 114.754 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.894 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.23 148.05 46.34 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 104.857 -2.275 . . . . 12.0 104.857 174.651 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.591 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.3 Cg_endo -60.6 89.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.027 0 C-N-CA 121.301 1.334 . . . . 12.0 108.903 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.894 HG22 ' CE2' ' A' ' 100' ' ' TYR . 55.4 t -86.22 -21.82 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.195 -0.457 . . . . 12.0 110.582 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.647 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -137.61 147.18 44.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.026 -1.101 . . . . 12.0 108.026 -177.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CZ ' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -111.83 133.03 54.31 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.903 -1.119 . . . . 12.0 109.955 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.99 -38.37 19.34 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.22 -0.3 . . . . 12.0 110.668 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.95 -141.48 9.72 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 120.266 -0.969 . . . . 12.0 111.287 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.81 -170.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 122.265 -0.55 . . . . 12.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.76 ' O ' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.857 0 N-CA-C 110.781 -0.927 . . . . 12.0 110.781 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 108.963 -0.755 . . . . 12.0 108.963 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -45.39 61.81 Favored 'General case' 0 N--CA 1.511 2.616 0 O-C-N 122.058 -0.401 . . . . 12.0 110.042 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.12 55.25 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.754 -0.591 . . . . 12.0 110.46 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -64.95 -30.03 70.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.419 -0.956 . . . . 12.0 108.419 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 30.7 t80 -76.56 -20.12 57.18 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.758 -0.83 . . . . 12.0 108.758 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.14 -38.99 93.04 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.855 -1.535 . . . . 12.0 106.855 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -78.21 -34.75 49.17 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.453 -1.314 . . . . 12.0 107.453 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.51 ' CG ' ' CD2' ' A' ' 10' ' ' HIS . 0.4 OUTLIER -41.48 -60.62 1.25 Allowed 'General case' 0 N--CA 1.506 2.374 0 CA-C-N 116.393 -0.367 . . . . 12.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.51 ' CD2' ' CG ' ' A' ' 9' ' ' LYS . 96.4 m-70 -110.57 -26.22 9.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.362 0.875 . . . . 12.0 113.362 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 11' ' ' ILE . 4.9 mp -96.62 64.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 119.153 -1.019 . . . . 12.0 113.342 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.872 HD12 ' CD1' ' A' ' 40' ' ' PHE . 54.9 mt -91.86 70.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 105.053 -2.202 . . . . 12.0 105.053 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -70.34 81.99 0.55 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.626 0.727 . . . . 12.0 110.479 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 22' ' ' ILE . 1.7 p -144.1 67.97 15.52 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.58 81.99 2.52 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.868 1.712 . . . . 12.0 109.851 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.3 pt -129.98 -167.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.102 -1.073 . . . . 12.0 108.102 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 pt -102.26 36.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.728 -0.607 . . . . 12.0 109.663 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -152.57 98.33 2.35 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.722 -0.611 . . . . 12.0 110.557 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -82.49 -4.49 57.58 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 121.75 -0.593 . . . . 12.0 110.626 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.34 -50.5 8.86 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.353 -0.842 . . . . 12.0 111.532 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.2 m -66.29 -23.11 66.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.787 -0.571 . . . . 12.0 110.507 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 14' ' ' THR . 50.4 pt -84.73 -32.56 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.721 -0.612 . . . . 12.0 109.727 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.2 ttm -92.86 2.93 56.51 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 122.096 -0.378 . . . . 12.0 110.646 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.75 91.32 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.476 -0.935 . . . . 12.0 108.476 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.505 ' ND2' HD12 ' A' ' 27' ' ' ILE . 45.1 t30 -169.79 148.54 3.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.214 -0.662 . . . . 12.0 109.214 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -67.54 -10.9 56.11 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 110.092 -0.336 . . . . 12.0 110.092 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 27' ' ' ILE . 61.4 mt -85.42 9.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.778 -0.576 . . . . 12.0 110.635 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.462 ' OH ' HD11 ' A' ' 12' ' ' ILE . 43.4 m-85 -142.41 64.2 1.38 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.577 -0.702 . . . . 12.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.3 mt -141.57 153.42 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.736 -1.228 . . . . 12.0 111.143 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 31' ' ' GLY . 59.9 t -109.05 170.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 107.477 -1.305 . . . . 12.0 107.477 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.42 53.78 3.48 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.272 -1.531 . . . . 12.0 109.272 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.68 -57.35 0.02 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.349 -1.501 . . . . 12.0 109.349 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -166.74 -72.54 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.6 p -154.72 142.42 19.89 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.932 -0.766 . . . . 12.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' CA ' HG21 ' A' ' 30' ' ' VAL . 3.7 tttm -62.06 -176.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 2.57 34.64 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 121.003 -0.279 . . . . 12.0 110.69 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 37' ' ' VAL . 4.4 p -161.67 111.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.666 0.746 . . . . 12.0 110.314 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 6.3 m120 -103.79 81.88 1.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.453 -1.684 . . . . 12.0 106.453 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 m -82.85 110.89 18.25 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.977 -0.556 . . . . 12.0 111.225 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.872 ' CD1' HD12 ' A' ' 12' ' ' ILE . 11.6 m-85 -105.46 161.18 14.56 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 10' ' ' HIS . 45.6 mm -117.79 135.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.435 -0.791 . . . . 12.0 108.992 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -105.19 110.09 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.425 -0.954 . . . . 12.0 108.425 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t 174.32 150.98 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.203 -0.666 . . . . 12.0 109.203 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.816 ' O ' HG22 ' A' ' 47' ' ' THR . 18.6 p -60.63 126.19 26.5 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.393 -0.966 . . . . 12.0 108.393 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.94 -30.9 59.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.057 -0.402 . . . . 12.0 110.825 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -74.74 -31.87 61.94 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.69 -0.404 . . . . 12.0 111.023 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 44' ' ' SER . 13.7 t -63.98 -33.63 76.17 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 107.406 -1.331 . . . . 12.0 107.406 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' A' ' 101' ' ' PRO . 21.0 t -72.88 -36.07 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.403 -1.332 . . . . 12.0 107.403 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -63.06 -21.03 65.89 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.668 -0.493 . . . . 12.0 109.668 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.53 -39.23 24.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.999 -0.438 . . . . 12.0 109.894 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.565 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 3.4 pt -69.6 -18.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.685 -0.634 . . . . 12.0 111.124 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.34 26.73 10.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.872 -0.517 . . . . 12.0 110.425 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -95.69 108.3 20.58 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.686 -0.633 . . . . 12.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.87 -57.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.523 -1.031 . . . . 12.0 110.523 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 56' ' ' ILE . 9.6 p -157.08 179.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.994 -0.71 . . . . 12.0 109.1 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.561 ' H ' HG22 ' A' ' 55' ' ' VAL . 38.7 pt -83.18 26.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 121.195 -0.94 . . . . 12.0 111.662 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.527 ' H ' HG13 ' A' ' 55' ' ' VAL . 0.8 OUTLIER 177.14 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.797 -1.557 . . . . 12.0 106.797 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.412 ' SD ' HG12 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -156.64 179.09 9.61 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 122.003 0.906 . . . . 12.0 112.016 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.8 118.18 16.75 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.401 -1.703 . . . . 12.0 106.401 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG13 ' CG2' ' A' ' 94' ' ' VAL . 14.9 p -141.95 170.13 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.304 -0.628 . . . . 12.0 109.304 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 61' ' ' LEU . 4.5 mp -137.71 120.55 16.41 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.844 -0.535 . . . . 12.0 111.154 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.54 ' HB3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -60.41 92.51 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -90.92 -28.18 18.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.052 -0.405 . . . . 12.0 111.102 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -56.2 -77.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.675 ' CG ' HG23 ' A' ' 89' ' ' THR . 0.6 OUTLIER 172.14 106.59 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.959 -0.463 . . . . 12.0 110.017 178.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 73.9 m-85 -122.02 65.28 0.92 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.803 -1.184 . . . . 12.0 107.803 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -23.31 127.73 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 114.52 1.304 . . . . 12.0 114.52 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.728 HD13 ' OG1' ' A' ' 70' ' ' THR . 4.6 pp -99.85 150.95 21.84 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.694 0.759 . . . . 12.0 111.227 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -118.13 106.37 12.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.646 -1.983 . . . . 12.0 105.646 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.728 ' OG1' HD13 ' A' ' 68' ' ' LEU . 27.2 m -112.07 126.85 55.61 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.757 -0.777 . . . . 12.0 112.599 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.7 m -103.8 110.08 22.05 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 103.385 -2.821 . . . . 12.0 103.385 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.6 m -109.11 143.02 39.01 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 119.919 -0.712 . . . . 12.0 112.227 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.9 ttt180 -64.15 132.21 49.73 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.502 2.151 0 C-N-CA 120.554 -0.458 . . . . 12.0 110.735 -179.269 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 108.464 -0.939 . . . . 12.0 108.464 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.4 Cg_endo -75.46 124.75 8.55 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 121.758 1.639 . . . . 12.0 109.815 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 17.0 m-85 -143.1 134.38 25.99 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.284 0.564 . . . . 12.0 110.79 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 p -115.03 123.23 48.52 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.43 -0.952 . . . . 12.0 108.43 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 142.46 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.828 -0.434 . . . . 12.0 109.828 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -146.76 157.2 43.62 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.5 m -129.77 147.9 51.59 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.893 -0.78 . . . . 12.0 108.893 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -165.38 156.34 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.382 -0.527 . . . . 12.0 110.48 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CG ' ' A' ' 65' ' ' ARG . 52.8 m -58.1 124.67 20.17 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 68' ' ' LEU . 4.9 t-20 -121.99 101.36 7.5 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.366 1.247 . . . . 12.0 114.366 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.6 126.77 41.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 102.703 -3.073 . . . . 12.0 102.703 172.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.526 HG23 ' HA2' ' A' ' 106' ' ' GLY . 1.6 mp -121.9 161.5 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 N-CA-C 113.993 1.108 . . . . 12.0 113.993 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.499 ' N ' HG22 ' A' ' 92' ' ' ILE . 37.4 t -100.41 109.45 21.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 106.21 -1.774 . . . . 12.0 106.21 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.541 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 10.6 m -118.66 -177.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.072 0.463 . . . . 12.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 38.7 mtpt -143.73 149.26 36.87 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.899 -0.778 . . . . 12.0 108.899 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.45 116.42 28.18 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.96 0.726 . . . . 12.0 112.96 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.66 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.0 tt0 -125.43 143.08 51.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 104.42 -2.437 . . . . 12.0 104.42 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 1.6 m-80 58.74 14.96 3.46 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.061 -1.024 . . . . 12.0 108.513 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 15.6 mt-30 75.79 -8.25 1.64 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.112 0.965 . . . . 12.0 113.049 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.856 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -105.8 152.55 40.21 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.735 -1.579 . . . . 12.0 106.735 176.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.459 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.6 Cg_endo -61.76 87.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.542 1.495 . . . . 12.0 109.095 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.856 HG22 ' CE2' ' A' ' 100' ' ' TYR . 67.4 t -84.34 -20.72 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.479 -0.328 . . . . 12.0 110.591 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.66 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -130.83 127.49 38.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.925 -1.139 . . . . 12.0 107.925 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.541 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -121.53 122.0 38.72 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.646 -0.872 . . . . 12.0 108.646 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.25 -32.02 12.64 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.775 -0.37 . . . . 12.0 110.506 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA2' HG23 ' A' ' 92' ' ' ILE . . . 97.15 162.04 31.84 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.08 -1.608 . . . . 12.0 109.08 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.41 ' O ' ' O ' ' A' ' 106' ' ' GLY . 60.3 mt 57.24 123.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 12.0 111.118 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.921 0 N-CA-C 109.685 -1.366 . . . . 12.0 109.685 179.56 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.4 t30 . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 108.84 -0.8 . . . . 12.0 108.84 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -23.58 64.91 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.614 -0.679 . . . . 12.0 110.357 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.33 -61.44 1.99 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.493 -0.754 . . . . 12.0 110.6 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.53 74.9 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.412 -1.329 . . . . 12.0 107.412 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 24.7 t80 -73.57 -27.49 61.34 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.338 -0.986 . . . . 12.0 108.338 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.91 -33.1 35.56 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 107.72 -1.215 . . . . 12.0 107.72 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -42.02 33.26 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.33 -53.87 6.33 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.232 -0.44 . . . . 12.0 111.18 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.805 ' CG ' HG11 ' A' ' 48' ' ' VAL . 1.1 m-70 -96.75 -15.38 21.41 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.694 -0.629 . . . . 12.0 111.162 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 10' ' ' HIS . 15.7 mm -140.15 87.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 114.231 1.197 . . . . 12.0 114.231 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 35.3 mm -96.73 67.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 105.094 -2.187 . . . . 12.0 105.094 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.534 ' O ' HG23 ' A' ' 14' ' ' THR . 25.2 p-10 -66.81 84.35 0.11 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.932 0.872 . . . . 12.0 110.636 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 13' ' ' ASN . 1.2 p -159.39 63.12 2.18 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 106.976 -1.491 . . . . 12.0 106.976 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.49 85.61 1.26 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.041 1.827 . . . . 12.0 110.598 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.27 -173.09 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.847 -0.797 . . . . 12.0 108.847 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pt -98.67 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.293 0.568 . . . . 12.0 109.636 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -145.03 95.56 2.71 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.434 -0.58 . . . . 12.0 109.434 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.4 m -80.45 -3.18 48.88 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.916 -0.49 . . . . 12.0 110.735 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.6 -50.16 10.34 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.613 0.642 . . . . 12.0 110.974 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 m -63.11 -21.18 66.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.748 -0.595 . . . . 12.0 110.429 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 23' ' ' MET . 45.6 pt -85.78 -38.05 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.679 -0.638 . . . . 12.0 109.904 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.422 ' N ' HG13 ' A' ' 22' ' ' ILE . 3.8 ptm -91.53 11.14 25.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.988 -0.445 . . . . 12.0 110.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -66.41 90.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.489 -0.93 . . . . 12.0 108.489 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.402 HD22 HG22 ' A' ' 27' ' ' ILE . 58.1 t30 -173.11 150.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.453 -0.573 . . . . 12.0 109.453 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -70.52 -9.13 55.9 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 110.09 -0.337 . . . . 12.0 110.09 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -88.82 11.6 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.72 -0.613 . . . . 12.0 110.319 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -140.03 58.95 1.58 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.827 -0.546 . . . . 12.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -148.0 146.6 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.631 -1.293 . . . . 12.0 110.559 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 31' ' ' GLY . 3.5 p -111.67 -164.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.34 -1.355 . . . . 12.0 107.34 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.576 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -97.72 66.3 0.83 Allowed Glycine 0 N--CA 1.506 3.301 0 O-C-N 120.956 -1.09 . . . . 12.0 112.453 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.52 -68.86 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.136 -1.586 . . . . 12.0 109.136 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -164.45 -66.71 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.845 -1.169 . . . . 12.0 107.845 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.0 p -138.8 144.6 39.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.631 -0.877 . . . . 12.0 108.631 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -61.27 -175.03 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.985 -0.447 . . . . 12.0 109.991 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -89.73 -23.11 21.88 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 110.024 -0.361 . . . . 12.0 110.024 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 72' ' ' THR . 4.3 t -150.01 102.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 5.1 m120 -90.99 80.82 5.69 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.649 -1.612 . . . . 12.0 106.649 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -84.17 115.35 22.37 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.936 -0.574 . . . . 12.0 110.825 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.487 ' O ' HD13 ' A' ' 41' ' ' ILE . 32.8 m-85 -105.44 165.58 11.03 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.624 HD12 ' ND2' ' A' ' 90' ' ' ASN . 49.3 mm -127.45 126.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 120.932 -1.105 . . . . 12.0 110.459 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 tt -108.91 127.83 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.11 -0.7 . . . . 12.0 109.11 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.636 ' O ' HD12 ' A' ' 11' ' ' ILE . 30.3 t 170.4 160.37 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.363 -0.977 . . . . 12.0 108.363 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.67 117.93 4.73 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -40.85 -64.63 0.51 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.9 1.074 . . . . 12.0 113.9 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -61.29 -26.21 67.63 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.794 -0.566 . . . . 12.0 111.311 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 m -58.61 -35.54 72.62 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 107.456 -1.312 . . . . 12.0 107.456 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 51' ' ' ILE . 45.7 t -70.19 -37.95 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.294 -1.372 . . . . 12.0 107.294 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -60.68 -21.55 62.96 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.138 -0.69 . . . . 12.0 109.138 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.87 -37.2 27.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 122.009 -0.432 . . . . 12.0 109.919 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.836 HG22 ' O ' ' A' ' 48' ' ' VAL . 6.8 tp -66.82 -24.36 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 120.414 -0.514 . . . . 12.0 110.425 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 22.95 10.69 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.723 -0.611 . . . . 12.0 109.768 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 m -84.74 109.22 17.89 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.028 -0.73 . . . . 12.0 109.028 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.93 -58.82 0.02 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.616 -0.994 . . . . 12.0 110.616 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 56' ' ' ILE . 4.7 p -164.89 -175.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.601 ' H ' HG22 ' A' ' 55' ' ' VAL . 48.0 pt -87.08 27.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.315 -0.865 . . . . 12.0 111.34 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.488 ' H ' HG13 ' A' ' 55' ' ' VAL . 6.1 t-20 177.21 116.83 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 107.807 -1.183 . . . . 12.0 107.807 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.5 ttp -165.83 170.81 13.48 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.554 0.692 . . . . 12.0 111.39 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.4 118.03 15.98 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.7 p -150.57 164.55 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.314 -0.624 . . . . 12.0 109.314 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.5 mp -115.3 128.81 56.36 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.051 -0.352 . . . . 12.0 110.051 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.871 ' HB2' HG22 ' A' ' 92' ' ' ILE . 49.5 m -53.62 94.11 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.142 -1.059 . . . . 12.0 108.142 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 1.1 p -77.37 -174.78 3.44 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.834 0.35 . . . . 12.0 110.085 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.726 HG22 ' HG2' ' A' ' 65' ' ' ARG . 96.9 m 63.47 -94.86 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.906 ' HB3' HG23 ' A' ' 89' ' ' THR . 6.1 ptm180 174.0 104.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 118.828 0.74 . . . . 12.0 110.006 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 48.5 m-85 -95.99 43.34 1.08 Allowed 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.193 -0.669 . . . . 12.0 109.193 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 29.64 105.2 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.147 0 N-CA-C 113.87 1.063 . . . . 12.0 113.87 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.62 154.68 19.23 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.033 0.92 . . . . 12.0 112.107 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -117.26 97.02 5.69 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 105.524 -2.028 . . . . 12.0 105.524 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -99.95 122.66 43.2 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.803 -0.759 . . . . 12.0 112.971 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -108.75 105.68 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 103.338 -2.838 . . . . 12.0 103.338 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.506 HG23 HG22 ' A' ' 37' ' ' VAL . 9.4 m -114.34 143.28 45.15 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.9 -0.72 . . . . 12.0 112.613 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 25.7 ttp180 -69.74 109.54 4.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.008 -1.108 . . . . 12.0 108.008 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.505 2.302 0 C-N-CA 120.006 -0.677 . . . . 12.0 112.363 -178.585 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.504 2.27 0 N-CA-C 109.493 -0.558 . . . . 12.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 34.3 Cg_endo -72.25 89.31 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 121.721 1.614 . . . . 12.0 109.468 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.403 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 7.2 m-85 -121.31 140.4 52.14 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-O 121.61 0.719 . . . . 12.0 112.542 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 m -119.15 124.16 46.15 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.559 -1.274 . . . . 12.0 107.559 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -93.12 142.83 26.87 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.924 -0.485 . . . . 12.0 110.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -155.7 132.76 10.71 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.423 -0.584 . . . . 12.0 109.423 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.3 m -92.3 148.82 21.83 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.898 -0.779 . . . . 12.0 108.898 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -169.16 -169.75 1.01 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.23 0.538 . . . . 12.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.906 HG23 ' HB3' ' A' ' 65' ' ' ARG . 53.3 m -67.14 139.44 57.49 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.147 -0.686 . . . . 12.0 109.147 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.624 ' ND2' HD12 ' A' ' 41' ' ' ILE . 67.0 t30 -107.46 87.0 2.4 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.091 0.948 . . . . 12.0 112.392 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' A' ' 63' ' ' THR . 14.5 t80 -99.68 102.39 13.86 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.186 -2.524 . . . . 12.0 104.186 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.871 HG22 ' HB2' ' A' ' 62' ' ' SER . 13.9 tt -124.47 169.85 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.541 -0.864 . . . . 12.0 112.883 -175.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.8 t -113.14 107.76 16.37 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.275 -1.009 . . . . 12.0 108.275 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 92' ' ' ILE . 18.0 m -127.33 -170.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.68 -0.489 . . . . 12.0 109.68 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.482 ' HB2' ' CG ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -147.57 161.06 41.89 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.069 -0.652 . . . . 12.0 110.887 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 128.27 52.2 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.646 0.736 . . . . 12.0 111.983 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 14.4 tt0 -147.51 147.08 29.77 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 104.97 -2.233 . . . . 12.0 104.97 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 59.1 18.21 6.22 Favored 'General case' 0 N--CA 1.508 2.472 0 N-CA-C 108.387 -0.968 . . . . 12.0 108.387 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 71.03 -6.01 1.39 Allowed 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.579 0.752 . . . . 12.0 112.71 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.734 ' OH ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -110.55 145.19 31.75 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 106.332 -1.729 . . . . 12.0 106.332 177.24 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.564 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 28.2 Cg_endo -66.52 100.08 0.47 Allowed 'Trans proline' 0 C--O 1.203 -1.264 0 N-CA-C 107.382 -1.815 . . . . 12.0 107.382 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.734 HG23 ' OH ' ' A' ' 100' ' ' TYR . 12.3 p -117.58 7.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 120.057 -0.657 . . . . 12.0 112.654 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -129.87 133.42 46.88 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.669 -1.234 . . . . 12.0 107.669 178.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.02 126.41 50.73 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.967 -0.693 . . . . 12.0 110.684 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 -32.98 13.69 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.89 -0.782 . . . . 12.0 108.89 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 140.14 -149.24 20.73 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.052 -1.219 . . . . 12.0 110.052 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.3 pt -56.16 -172.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.291 -0.535 . . . . 12.0 109.895 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.863 0 N-CA-C 110.234 -1.146 . . . . 12.0 110.234 -179.365 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 108.728 -0.841 . . . . 12.0 108.728 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.25 -25.91 65.42 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.588 -0.695 . . . . 12.0 110.207 -178.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.64 -60.31 2.37 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.694 -0.629 . . . . 12.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.72 -35.55 78.36 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.514 -1.291 . . . . 12.0 107.514 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 28.1 t80 -73.8 -25.07 59.93 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -31.76 54.05 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 107.534 -1.284 . . . . 12.0 107.534 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.96 -37.86 33.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -46.73 -53.04 12.61 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 116.335 -0.393 . . . . 12.0 110.63 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.747 ' CG ' HG11 ' A' ' 48' ' ' VAL . 1.3 m-70 -97.09 -16.01 20.71 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.863 -0.523 . . . . 12.0 110.848 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 11' ' ' ILE . 5.0 mp -144.09 87.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.068 1.136 . . . . 12.0 114.068 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.828 HD12 ' CD1' ' A' ' 40' ' ' PHE . 12.6 mt -97.06 65.13 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 103.711 -2.7 . . . . 12.0 103.711 173.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 14' ' ' THR . 8.5 t-20 -66.98 83.0 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.903 0.859 . . . . 12.0 110.699 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 13' ' ' ASN . 1.3 p -155.18 63.18 3.67 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 106.847 -1.538 . . . . 12.0 106.847 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -73.21 84.05 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.086 1.857 . . . . 12.0 111.015 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 17' ' ' ILE . 1.4 mt -121.65 -167.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.787 -1.19 . . . . 12.0 107.787 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.51 ' H ' HG22 ' A' ' 16' ' ' ILE . 2.4 mm -101.91 34.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 108.682 -0.858 . . . . 12.0 108.682 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -145.8 97.6 2.99 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -77.84 -16.28 58.42 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.842 -0.537 . . . . 12.0 111.253 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.18 -49.02 10.6 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 118.854 0.752 . . . . 12.0 110.046 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -31.54 67.27 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.748 -0.464 . . . . 12.0 109.748 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 23' ' ' MET . 47.0 pt -81.12 -36.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 120.627 -0.429 . . . . 12.0 110.208 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -97.03 15.24 22.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.925 -0.484 . . . . 12.0 110.165 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.27 90.78 0.1 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.122 -1.066 . . . . 12.0 108.122 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -166.83 158.06 12.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.236 -0.653 . . . . 12.0 109.236 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -72.89 -10.82 60.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 120.8 -0.36 . . . . 12.0 110.263 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 27' ' ' ILE . 59.6 mt -87.02 9.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.65 -0.656 . . . . 12.0 110.523 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -142.71 63.23 1.39 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.611 -0.68 . . . . 12.0 109.727 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 30' ' ' VAL . 51.3 mt -148.49 153.26 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 120.763 -1.211 . . . . 12.0 110.318 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 35' ' ' LYS . 50.0 t -107.03 169.53 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 107.764 -1.199 . . . . 12.0 107.764 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.71 54.16 3.39 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.117 -1.593 . . . . 12.0 109.117 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.9 -56.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.241 -1.544 . . . . 12.0 109.241 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -165.27 -68.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.04 -0.682 . . . . 12.0 109.401 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.0 m -143.51 -175.77 4.69 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.49 -0.559 . . . . 12.0 109.49 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -105.92 163.72 12.52 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.339 -0.615 . . . . 12.0 109.339 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -73.85 -24.08 59.72 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 110.058 -0.349 . . . . 12.0 110.058 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 37' ' ' VAL . 9.1 p -156.35 109.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.481 0.658 . . . . 12.0 110.804 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 3.0 m-20 -91.27 83.3 5.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.527 -1.657 . . . . 12.0 106.527 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.98 HG21 HD12 ' A' ' 107' ' ' ILE . 23.9 m -82.61 106.43 14.46 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 116.006 -0.543 . . . . 12.0 110.89 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.828 ' CD1' HD12 ' A' ' 12' ' ' ILE . 10.5 m-85 -99.11 157.86 16.06 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.167 -1.42 . . . . 12.0 107.167 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.92 125.57 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.175 -0.953 . . . . 12.0 109.005 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 42' ' ' ILE . 16.2 tt -106.74 118.37 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.489 -0.56 . . . . 12.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t 173.15 154.86 0.1 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.382 -0.97 . . . . 12.0 108.382 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.21 119.2 5.98 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.22 -52.38 12.58 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.053 0.76 . . . . 12.0 113.053 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -61.7 -29.53 70.16 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.026 -0.421 . . . . 12.0 111.558 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -63.19 -35.18 79.45 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.849 ' O ' HG22 ' A' ' 51' ' ' ILE . 42.0 t -71.28 -33.91 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.686 -1.227 . . . . 12.0 107.686 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -61.76 -22.37 65.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.173 -0.677 . . . . 12.0 109.173 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -36.67 28.11 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.653 -0.499 . . . . 12.0 109.653 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 48' ' ' VAL . 5.9 tp -66.08 -25.26 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 C-N-CA 120.372 -0.531 . . . . 12.0 110.792 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.53 24.27 7.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.614 -0.679 . . . . 12.0 109.908 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -88.3 110.94 21.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.254 -0.647 . . . . 12.0 109.254 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.46 -58.78 0.02 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.396 -1.081 . . . . 12.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.609 HG22 ' H ' ' A' ' 56' ' ' ILE . 5.2 p -161.59 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.013 -0.736 . . . . 12.0 109.013 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.609 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.2 tt -83.27 21.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.642 0 O-C-N 121.357 -0.839 . . . . 12.0 111.718 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.583 ' H ' HG13 ' A' ' 55' ' ' VAL . 5.5 t-20 175.25 113.36 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.541 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.5 ttm -163.78 -176.78 4.78 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.485 0.659 . . . . 12.0 111.034 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -137.98 123.5 19.65 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.295 -1.372 . . . . 12.0 107.295 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.6 p -145.37 163.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.907 -0.495 . . . . 12.0 109.869 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 61' ' ' LEU . 2.6 mp -122.72 116.26 23.45 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.587 -0.523 . . . . 12.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 92' ' ' ILE . 1.8 m -55.48 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.699 -0.852 . . . . 12.0 108.699 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -50.45 20.39 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.592 -0.892 . . . . 12.0 108.592 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.7 115.4 3.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.532 -0.914 . . . . 12.0 108.532 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.853 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 106.88 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.152 0.501 . . . . 12.0 111.543 -178.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 28.6 m-85 -94.4 40.08 1.09 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 108.848 -0.797 . . . . 12.0 108.848 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' PHE . 1.4 tp-100 39.86 107.56 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 112.859 0.689 . . . . 12.0 112.859 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.836 HD13 ' OG1' ' A' ' 70' ' ' THR . 3.5 pp -95.99 147.94 23.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 12.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.98 97.47 5.71 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 105.292 -2.114 . . . . 12.0 105.292 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.836 ' OG1' HD13 ' A' ' 68' ' ' LEU . 30.2 m -108.22 128.16 54.48 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.434 -0.906 . . . . 12.0 112.541 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.0 m -112.63 111.9 23.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.288 -2.486 . . . . 12.0 104.288 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -108.64 141.89 39.92 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.12 -0.632 . . . . 12.0 111.401 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -65.3 109.59 2.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.68 -0.859 . . . . 12.0 108.68 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.503 2.185 0 C-N-CA 120.388 -0.525 . . . . 12.0 111.201 -178.547 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 110.787 -0.079 . . . . 12.0 110.787 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.01 137.31 12.25 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.326 2.017 . . . . 12.0 109.012 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -134.54 136.03 42.76 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.525 0.679 . . . . 12.0 112.454 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -108.81 129.8 55.39 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -96.34 145.48 25.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.947 -0.471 . . . . 12.0 111.213 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -159.57 138.96 11.27 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 109.261 -0.644 . . . . 12.0 109.261 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -99.05 150.74 21.69 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 109.534 -0.543 . . . . 12.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.588 ' HB3' HD21 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -162.02 -162.44 0.84 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.033 0.444 . . . . 12.0 110.359 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.853 HG23 ' HB3' ' A' ' 65' ' ' ARG . 92.5 m -79.2 127.92 32.65 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.003 -0.74 . . . . 12.0 109.003 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.42 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 1.2 t30 -95.0 87.52 4.95 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-O 122.245 1.021 . . . . 12.0 111.983 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 5.2 p90 -103.16 101.79 11.76 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 62' ' ' SER . 15.8 tt -119.78 162.54 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.118 0.785 . . . . 12.0 113.118 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -110.52 107.2 16.75 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.076 -1.453 . . . . 12.0 107.076 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.472 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 17.1 m -128.09 -172.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 12.0 109.437 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 4.0 mtpp -143.04 162.94 34.16 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.96 -0.696 . . . . 12.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 9.8 m -115.9 130.26 56.75 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.592 0.711 . . . . 12.0 111.871 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 39.0 tt0 -138.32 136.97 36.95 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.915 -2.254 . . . . 12.0 104.915 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 12.1 m-20 55.86 20.91 4.43 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.391 -0.818 . . . . 12.0 108.838 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 6.4 mt-30 77.12 -17.08 0.58 Allowed 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 123.517 0.727 . . . . 12.0 112.637 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.832 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -98.65 143.66 26.73 Favored Pre-proline 0 N--CA 1.503 2.192 0 N-CA-C 105.983 -1.858 . . . . 12.0 105.983 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.535 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 24.8 Cg_endo -62.69 104.36 0.37 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 C-N-CA 121.278 1.318 . . . . 12.0 108.92 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.832 HG22 ' CE2' ' A' ' 100' ' ' TYR . 3.5 t -115.97 12.25 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 C-N-CA 120.287 -0.565 . . . . 12.0 112.22 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -141.83 133.81 27.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -118.12 129.46 55.55 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 109.084 -0.71 . . . . 12.0 109.084 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.54 -26.17 7.61 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.598 0.592 . . . . 12.0 112.598 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.404 ' O ' HG13 ' A' ' 92' ' ' ILE . . . -177.03 -174.75 43.74 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 119.811 -1.185 . . . . 12.0 111.18 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.98 HD12 HG21 ' A' ' 39' ' ' THR . 10.3 tt -97.78 31.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.09 0.471 . . . . 12.0 110.384 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.038 0 N-CA-C 110.366 -1.094 . . . . 12.0 110.366 179.055 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 108.543 -0.91 . . . . 12.0 108.543 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.03 78.65 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 122.045 -0.409 . . . . 12.0 110.609 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.22 -56.45 11.26 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 121.359 -0.838 . . . . 12.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -31.44 72.01 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.917 -1.142 . . . . 12.0 107.917 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 53.7 t80 -72.74 -25.67 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.723 -0.843 . . . . 12.0 108.723 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -53.65 -37.3 62.98 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 107.254 -1.387 . . . . 12.0 107.254 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.39 -40.89 57.45 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.192 -1.41 . . . . 12.0 107.192 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 7.0 tptt -43.32 -61.81 1.24 Allowed 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 116.268 -0.424 . . . . 12.0 111.836 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.776 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.9 m80 -99.49 -7.07 26.5 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 119.08 0.854 . . . . 12.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 10' ' ' HIS . 25.2 mm -134.37 78.41 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 118.684 -1.206 . . . . 12.0 113.33 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.474 HD12 ' H ' ' A' ' 12' ' ' ILE . 5.0 mp -94.82 64.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.153 -2.165 . . . . 12.0 105.153 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.627 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 t-20 -64.82 85.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.652 0.739 . . . . 12.0 110.372 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' ASN . 5.7 p -160.73 69.9 2.74 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.102 -1.444 . . . . 12.0 107.102 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -79.78 30.64 0.48 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.418 2.079 . . . . 12.0 113.103 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 22' ' ' ILE . 10.2 pt -64.56 -169.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.655 -0.869 . . . . 12.0 108.655 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.35 33.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 121.589 0.709 . . . . 12.0 109.46 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -144.94 98.95 3.26 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 108.665 -0.865 . . . . 12.0 108.665 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' MET . 60.0 m -77.36 -18.7 57.16 Favored 'General case' 0 N--CA 1.511 2.581 0 C-N-CA 120.5 -0.48 . . . . 12.0 111.434 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -80.93 -48.54 12.18 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.051 0.841 . . . . 12.0 110.08 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -32.11 68.58 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.916 -0.402 . . . . 12.0 109.916 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 16' ' ' ILE . 46.8 pt -80.26 -34.6 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 122.034 -0.416 . . . . 12.0 110.195 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -99.34 18.25 18.13 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 120.512 -0.475 . . . . 12.0 110.44 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.53 89.9 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.939 -1.134 . . . . 12.0 107.939 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.419 ' OD1' HD12 ' A' ' 27' ' ' ILE . 10.6 t-20 -166.88 159.54 13.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.209 -0.663 . . . . 12.0 109.209 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.8 -10.36 59.71 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.76 -0.376 . . . . 12.0 110.052 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 27' ' ' ILE . 57.9 mt -87.77 10.44 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.73 -0.606 . . . . 12.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -146.94 63.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.706 -0.621 . . . . 12.0 110.099 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.3 mt -153.19 149.02 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.57 -1.331 . . . . 12.0 111.07 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 31' ' ' GLY . 57.9 t -104.86 168.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 107.678 -1.23 . . . . 12.0 107.678 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.58 53.87 3.43 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.328 -1.509 . . . . 12.0 109.328 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.95 -55.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 12.0 109.388 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -166.43 -77.06 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.929 -0.767 . . . . 12.0 108.929 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -146.47 -170.71 3.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.827 -0.805 . . . . 12.0 108.827 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -174.27 2.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.222 -0.658 . . . . 12.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -85.4 -25.4 27.04 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.981 -0.45 . . . . 12.0 110.591 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 72' ' ' THR . 10.1 t -151.51 107.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 120.353 -0.539 . . . . 12.0 110.777 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.3 m120 -91.6 85.69 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 105.904 -1.887 . . . . 12.0 105.904 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 m -81.73 112.89 19.31 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.242 0.544 . . . . 12.0 111.763 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 23' ' ' MET . 32.7 m-85 -100.39 158.5 15.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.272 -1.381 . . . . 12.0 107.272 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.3 mp -126.52 128.75 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 12.0 109.353 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.403 HG23 ' HG3' ' A' ' 67' ' ' GLN . 4.2 tt -111.14 129.28 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.632 ' O ' HD12 ' A' ' 11' ' ' ILE . 15.3 t 165.42 157.88 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.188 -1.041 . . . . 12.0 108.188 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -60.19 122.81 15.39 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.671 -0.863 . . . . 12.0 108.671 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.09 -29.24 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.136 -0.352 . . . . 12.0 111.803 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -79.92 -31.57 40.11 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.953 -0.467 . . . . 12.0 111.903 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 p -64.87 -36.04 83.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.474 -1.306 . . . . 12.0 107.474 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.05 -33.5 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.718 -1.215 . . . . 12.0 107.718 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -66.75 -21.54 66.06 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.607 -0.516 . . . . 12.0 109.607 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.69 -41.2 24.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.794 -0.566 . . . . 12.0 109.76 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.591 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 18.3 pt -67.15 -20.46 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.782 -0.574 . . . . 12.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 22.34 9.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.853 -0.53 . . . . 12.0 110.101 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -88.78 114.43 25.39 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.005 -0.739 . . . . 12.0 109.005 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.17 -61.21 0.02 OUTLIER Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.418 -1.073 . . . . 12.0 110.418 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.9 p -163.65 -168.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.656 ' H ' HG22 ' A' ' 55' ' ' VAL . 12.4 tt -87.26 27.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 O-C-N 121.097 -1.002 . . . . 12.0 110.958 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 6.1 t-20 171.1 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 106.403 -1.703 . . . . 12.0 106.403 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.62 179.37 8.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.826 0.822 . . . . 12.0 112.132 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -137.55 115.1 11.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.557 HG13 ' CG1' ' A' ' 94' ' ' VAL . 11.9 p -128.71 166.35 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.897 -0.502 . . . . 12.0 109.653 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.503 ' N ' HG22 ' A' ' 60' ' ' VAL . 3.8 mp -129.33 117.54 20.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.896 -0.502 . . . . 12.0 111.521 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 1.4 m -58.1 93.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.105 -1.443 . . . . 12.0 107.105 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.675 HG22 ' OH ' ' A' ' 91' ' ' TYR . 1.6 p -79.74 -53.5 6.75 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 112.249 0.463 . . . . 12.0 112.249 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.685 HG22 ' HG2' ' A' ' 65' ' ' ARG . 47.5 m -47.83 -90.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.866 -0.521 . . . . 12.0 110.271 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.846 ' CB ' HG23 ' A' ' 89' ' ' THR . 11.0 ptm180 174.43 100.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 57.9 m-85 -97.88 54.62 1.15 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.237 -0.653 . . . . 12.0 109.237 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER 11.88 109.03 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.431 1.271 . . . . 12.0 114.431 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.04 154.6 17.97 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.819 0.819 . . . . 12.0 111.756 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.22 100.23 7.2 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.083 -1.821 . . . . 12.0 106.083 177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 m -102.18 127.39 49.13 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.659 0.743 . . . . 12.0 112.355 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -111.7 112.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.367 -2.457 . . . . 12.0 104.367 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.532 HG23 HG22 ' A' ' 37' ' ' VAL . 4.2 m -111.2 144.99 39.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.091 -0.644 . . . . 12.0 111.648 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -62.34 142.79 57.61 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.297 -1.001 . . . . 12.0 108.297 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.504 2.267 0 O-C-N 121.92 -0.488 . . . . 12.0 110.545 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 119.09 -0.481 . . . . 12.0 110.809 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.33 113.05 2.85 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.119 1.879 . . . . 12.0 109.296 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 81' ' ' CYS . 12.1 m-85 -138.58 139.07 38.49 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.195 0.521 . . . . 12.0 111.119 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -111.33 129.35 56.02 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.897 -1.149 . . . . 12.0 107.897 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 t -93.91 149.45 21.22 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.39 0.614 . . . . 12.0 110.883 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -151.79 155.42 38.19 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.032 -0.729 . . . . 12.0 109.032 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.3 m -125.44 141.2 52.19 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.535 -0.543 . . . . 12.0 109.535 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -166.12 -172.03 2.16 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.095 0.474 . . . . 12.0 110.317 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.846 HG23 ' CB ' ' A' ' 65' ' ' ARG . 77.4 m -65.3 145.59 56.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.991 -0.744 . . . . 12.0 108.991 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -110.22 88.24 2.71 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.907 0.86 . . . . 12.0 111.371 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.675 ' OH ' HG22 ' A' ' 63' ' ' THR . 6.6 t80 -98.03 96.63 8.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.987 -2.597 . . . . 12.0 103.987 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.615 HG21 ' HZ ' ' A' ' 104' ' ' PHE . 7.1 tt -130.69 175.12 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.978 -0.689 . . . . 12.0 111.077 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.77 116.63 27.4 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.65 -0.871 . . . . 12.0 108.65 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.557 ' CG1' HG13 ' A' ' 60' ' ' VAL . 14.8 p -108.88 162.06 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.989 -0.374 . . . . 12.0 109.989 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 94' ' ' VAL . 42.7 mtpt -120.35 144.8 47.67 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -119.55 120.63 37.31 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 114.003 1.112 . . . . 12.0 114.003 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.594 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 20.9 tt0 -128.37 141.8 51.31 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 104.076 -2.564 . . . . 12.0 104.076 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.9 m-80 57.21 28.64 15.41 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 107.683 -1.228 . . . . 12.0 107.683 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 51.22 16.17 0.36 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 124.754 1.222 . . . . 12.0 114.001 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.803 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.85 145.44 41.37 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 104.121 -2.548 . . . . 12.0 104.121 174.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.495 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 24.5 Cg_endo -61.33 93.89 0.11 Allowed 'Trans proline' 0 C--O 1.2 -1.393 0 N-CA-C 108.429 -1.412 . . . . 12.0 108.429 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.803 HG22 ' CE2' ' A' ' 100' ' ' TYR . 63.4 t -91.73 -14.15 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 122.239 -0.288 . . . . 12.0 110.901 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -146.35 145.62 30.37 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.615 ' HZ ' HG21 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -102.23 120.0 39.74 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.481 -1.288 . . . . 12.0 108.914 178.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.46 81.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.863 -0.523 . . . . 12.0 110.042 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.8 -158.86 23.27 Favored Glycine 0 N--CA 1.5 2.95 0 N-CA-C 109.896 -1.282 . . . . 12.0 109.896 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 108' ' ' GLY . 8.3 tp -54.58 162.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 122.173 -0.604 . . . . 12.0 109.725 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.416 ' N ' HG13 ' A' ' 107' ' ' ILE . . . . . . . . 0 N--CA 1.499 2.889 0 N-CA-C 109.462 -1.455 . . . . 12.0 109.462 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 109.014 -0.735 . . . . 12.0 109.014 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -25.73 62.87 Favored 'General case' 0 N--CA 1.516 2.84 0 O-C-N 122.141 -0.35 . . . . 12.0 110.625 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.1 -61.83 1.72 Allowed 'General case' 0 N--CA 1.512 2.631 0 O-C-N 121.437 -0.789 . . . . 12.0 110.68 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.691 HG23 HD11 ' A' ' 27' ' ' ILE . 29.1 m -62.33 -32.48 73.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.997 -1.112 . . . . 12.0 107.997 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 31.1 t80 -75.79 -23.63 55.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -55.85 -34.25 65.26 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 106.96 -1.496 . . . . 12.0 106.96 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.99 -38.76 52.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.728 -1.212 . . . . 12.0 107.728 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 11.1 mmtm -45.57 -51.32 12.13 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 122.232 -0.293 . . . . 12.0 110.856 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.926 ' ND1' HG11 ' A' ' 48' ' ' VAL . 2.1 m-70 -97.52 -13.97 21.36 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 118.837 -0.601 . . . . 12.0 112.153 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 10' ' ' HIS . 15.5 mm -123.18 64.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 114.896 1.443 . . . . 12.0 114.896 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.81 HG21 ' CD1' ' A' ' 40' ' ' PHE . 2.7 mp -98.89 63.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 103.984 -2.598 . . . . 12.0 103.984 173.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -73.09 78.61 1.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.734 0.778 . . . . 12.0 111.65 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.677 ' OG1' HD12 ' A' ' 22' ' ' ILE . 3.0 p -139.64 75.15 32.2 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.21 11.72 2.27 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.323 2.015 . . . . 12.0 113.59 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.745 HD11 ' CG2' ' A' ' 22' ' ' ILE . 15.8 pt -60.99 -168.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-N 119.15 0.886 . . . . 12.0 108.684 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -106.93 36.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.533 -0.729 . . . . 12.0 109.698 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -142.37 101.45 3.9 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 108.55 -0.907 . . . . 12.0 108.55 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.42 -14.45 58.93 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.961 -0.462 . . . . 12.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -85.03 -55.46 4.05 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-N 118.882 0.765 . . . . 12.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.09 -36.52 63.27 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.048 -0.408 . . . . 12.0 110.054 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.745 ' CG2' HD11 ' A' ' 16' ' ' ILE . 34.0 pt -81.24 -35.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.445 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 2.3 tmm? -99.07 32.03 2.82 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.399 -0.593 . . . . 12.0 109.399 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.07 48.36 1.64 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.277 0.56 . . . . 12.0 110.002 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.625 ' OD1' HG22 ' A' ' 27' ' ' ILE . 10.3 t-20 -127.47 155.62 43.42 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.075 -0.713 . . . . 12.0 109.075 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -73.44 -10.72 60.03 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.89 -0.324 . . . . 12.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 5' ' ' THR . 21.3 tt -79.06 -0.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.587 -0.696 . . . . 12.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.664 ' O ' HD13 ' A' ' 29' ' ' ILE . 66.5 m-85 -119.61 54.91 0.98 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.387 -0.597 . . . . 12.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 28' ' ' TYR . 44.8 mm -139.01 152.06 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.108 -0.995 . . . . 12.0 110.376 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 31' ' ' GLY . 40.8 t -100.84 169.98 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.719 -1.215 . . . . 12.0 107.719 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -91.02 53.9 3.27 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.283 -1.527 . . . . 12.0 109.283 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.44 -58.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.746 -1.742 . . . . 12.0 108.746 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.6 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.066 -0.667 . . . . 12.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.54 177.55 8.59 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.71 -0.848 . . . . 12.0 108.71 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 159.74 22.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.341 -0.615 . . . . 12.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -72.05 -9.5 58.48 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.24 -0.287 . . . . 12.0 110.768 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.5 p -159.28 129.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.7 0.762 . . . . 12.0 111.037 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.519 ' ND2' ' CE1' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -117.29 89.17 3.06 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.819 -1.919 . . . . 12.0 105.819 177.217 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.3 m -83.71 118.1 23.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.29 0.567 . . . . 12.0 111.83 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.81 ' CD1' HG21 ' A' ' 12' ' ' ILE . 23.3 m-85 -100.05 156.71 17.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.921 -1.511 . . . . 12.0 106.921 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.31 127.84 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.283 -0.886 . . . . 12.0 108.975 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 42' ' ' ILE . 5.5 tt -107.53 107.89 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.44 0.638 . . . . 12.0 109.325 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.659 ' O ' HD12 ' A' ' 11' ' ' ILE . 39.9 t 176.57 154.12 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.924 -0.769 . . . . 12.0 108.924 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 p -63.48 126.17 26.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.667 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -53.29 -26.97 20.52 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.074 -0.391 . . . . 12.0 110.942 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -80.14 -32.06 38.98 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.629 -0.428 . . . . 12.0 111.621 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -62.07 -40.31 95.37 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.77 -1.567 . . . . 12.0 106.77 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.926 HG11 ' ND1' ' A' ' 10' ' ' HIS . 39.5 t -69.53 -35.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.963 -1.125 . . . . 12.0 107.963 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -57.69 -25.42 60.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.97 -0.752 . . . . 12.0 108.97 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.77 -34.73 33.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.876 -0.515 . . . . 12.0 109.734 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.908 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.2 -28.62 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.767 -0.583 . . . . 12.0 110.544 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.67 19.99 15.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.452 -0.78 . . . . 12.0 110.365 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.0 m -85.46 112.45 20.89 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 109.13 -0.693 . . . . 12.0 109.13 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.46 -63.45 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.925 -0.87 . . . . 12.0 110.925 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.0 p -158.65 -167.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 118.015 0.907 . . . . 12.0 109.178 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.615 ' H ' HG22 ' A' ' 55' ' ' VAL . 3.8 tt -87.82 27.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.593 0 O-C-N 121.132 -0.98 . . . . 12.0 110.968 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 13.9 t-20 173.09 118.84 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 106.652 -1.61 . . . . 12.0 106.652 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.47 175.36 12.25 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.621 0.724 . . . . 12.0 111.528 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -141.49 111.48 6.71 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.3 p -140.04 167.65 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.547 -0.538 . . . . 12.0 109.547 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.516 ' N ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -136.88 130.4 31.66 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.264 0.554 . . . . 12.0 111.24 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -59.52 102.9 0.16 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.353 -1.351 . . . . 12.0 107.353 177.67 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -87.9 -37.2 16.67 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.251 -0.28 . . . . 12.0 110.254 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.0 m -59.22 -95.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.77 ' CB ' HG23 ' A' ' 89' ' ' THR . 1.8 ptt-85 177.01 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.919 0.781 . . . . 12.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -97.01 41.57 1.11 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.318 -0.623 . . . . 12.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 23.77 105.89 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 114.196 1.184 . . . . 12.0 114.196 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -104.77 157.1 17.43 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.936 0.874 . . . . 12.0 111.868 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -117.34 100.7 7.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 104.943 -2.243 . . . . 12.0 104.943 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.2 m -97.22 132.27 43.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.757 0.789 . . . . 12.0 112.471 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' SER . 55.6 m -121.63 116.44 24.59 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 104.068 -2.567 . . . . 12.0 104.068 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -106.77 144.68 33.06 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 120.195 -0.602 . . . . 12.0 111.88 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -68.09 100.2 0.97 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.266 -0.642 . . . . 12.0 109.266 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 109.569 -0.53 . . . . 12.0 109.569 -179.596 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.945 0 N-CA-C 108.467 -0.938 . . . . 12.0 108.467 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 36.6 Cg_endo -75.25 116.64 4.6 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 121.645 1.564 . . . . 12.0 110.448 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' A' ' 73' ' ' ARG . 15.7 m-85 -145.98 137.07 24.61 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.319 0.58 . . . . 12.0 111.728 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 71' ' ' CYS . 7.9 t -107.83 153.88 22.36 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 106.691 -1.596 . . . . 12.0 106.691 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 t -107.79 156.53 19.02 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.563 -0.71 . . . . 12.0 111.456 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -166.09 158.67 14.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.316 -0.624 . . . . 12.0 109.316 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 p -135.06 147.66 49.67 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.053 -0.721 . . . . 12.0 109.053 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.84 -173.64 1.64 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.483 0.659 . . . . 12.0 110.744 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.77 HG23 ' CB ' ' A' ' 65' ' ' ARG . 85.8 m -66.69 142.75 57.31 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.206 -1.035 . . . . 12.0 108.206 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 66.1 t30 -104.96 87.41 2.64 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.451 -0.9 . . . . 12.0 111.567 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' SER . 6.1 p90 -107.22 105.6 15.65 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.445 -2.057 . . . . 12.0 105.445 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.606 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt -137.2 -179.53 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.651 0.738 . . . . 12.0 111.926 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -117.37 109.94 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.425 -0.807 . . . . 12.0 110.316 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.561 HG13 ' CE1' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -105.57 171.0 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.551 -0.907 . . . . 12.0 108.551 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 9.3 mttp -129.18 140.52 51.47 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -110.45 121.81 46.2 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.626 1.343 . . . . 12.0 114.626 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.642 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.0 tt0 -136.45 142.49 43.62 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 103.816 -2.661 . . . . 12.0 103.816 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 56.13 30.92 17.27 Favored 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 107.212 -1.403 . . . . 12.0 107.212 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 47.56 19.24 0.14 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.244 1.201 . . . . 12.0 114.244 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.841 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.94 145.55 54.26 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 104.585 -2.376 . . . . 12.0 104.585 175.064 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.506 ' HB3' HG11 ' A' ' 94' ' ' VAL . 21.9 Cg_endo -59.9 90.25 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.055 0 N-CA-C 108.899 -1.231 . . . . 12.0 108.899 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.841 HG22 ' CE2' ' A' ' 100' ' ' TYR . 44.0 t -87.57 -20.65 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 115.995 -0.548 . . . . 12.0 110.583 -177.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.642 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -137.66 144.03 41.64 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 12.0 108.367 -177.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -107.97 126.83 53.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 118.851 -1.14 . . . . 12.0 109.537 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.64 -33.79 53.41 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.995 -0.372 . . . . 12.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.83 -133.66 6.9 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.764 -0.934 . . . . 12.0 110.764 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.7 pt -69.73 -172.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 122.344 -0.504 . . . . 12.0 111.004 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.754 0 N-CA-C 111.0 -0.84 . . . . 12.0 111.0 -179.118 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.058 -0.719 . . . . 12.0 109.058 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -28.75 66.73 Favored 'General case' 0 N--CA 1.514 2.744 0 O-C-N 122.161 -0.337 . . . . 12.0 110.279 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 7' ' ' GLN . . . -73.96 -60.03 2.45 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 121.735 -0.603 . . . . 12.0 110.716 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -62.35 -29.35 70.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.104 -1.073 . . . . 12.0 108.104 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 31.1 t80 -79.35 -23.79 43.14 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.174 -0.676 . . . . 12.0 109.174 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 1.4 mm100 -57.93 -35.61 71.33 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 106.696 -1.594 . . . . 12.0 106.696 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.09 -35.61 56.36 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.661 -1.237 . . . . 12.0 107.661 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 11.7 tptt -46.07 -60.49 2.24 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 116.686 -0.234 . . . . 12.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.616 ' CE1' HD11 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -103.42 -2.16 27.39 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.645 -0.659 . . . . 12.0 112.039 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 11' ' ' ILE . 4.2 mp -138.51 73.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.415 1.635 . . . . 12.0 115.415 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.929 HG21 HG23 ' A' ' 22' ' ' ILE . 19.3 mt -97.34 66.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 102.789 -3.041 . . . . 12.0 102.789 172.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.03 75.87 3.59 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.36 -0.836 . . . . 12.0 112.364 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.46 130.9 22.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 106.487 -1.672 . . . . 12.0 106.487 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.12 -24.43 38.55 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 121.277 1.318 . . . . 12.0 110.513 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.42 148.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.183 -1.043 . . . . 12.0 108.183 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 pt -111.41 85.44 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 121.695 0.76 . . . . 12.0 109.221 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -147.3 104.84 3.69 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 m -75.76 -8.32 56.55 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.63 -0.428 . . . . 12.0 110.847 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -69.68 -46.69 65.49 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 118.804 0.729 . . . . 12.0 109.223 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -82.72 -19.61 37.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.665 -0.494 . . . . 12.0 109.665 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.929 HG23 HG21 ' A' ' 12' ' ' ILE . 40.1 mt -87.17 -6.87 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.765 -0.584 . . . . 12.0 110.809 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm -109.51 -43.52 4.07 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.597 -0.89 . . . . 12.0 108.597 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.21 96.91 0.16 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 107.563 -1.273 . . . . 12.0 107.563 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -169.57 157.8 7.37 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.901 -0.777 . . . . 12.0 108.901 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -69.76 -10.88 60.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.048 -0.407 . . . . 12.0 110.076 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 27' ' ' ILE . 58.3 mt -91.46 13.67 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.723 -0.611 . . . . 12.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.534 ' OH ' HD11 ' A' ' 12' ' ' ILE . 53.5 m-85 -152.54 67.27 0.82 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.61 -0.681 . . . . 12.0 110.367 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -146.34 135.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 120.593 -1.317 . . . . 12.0 110.477 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.563 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.8 p -109.92 -162.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.446 -1.316 . . . . 12.0 107.446 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.563 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -96.25 67.72 1.0 Allowed Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.029 -1.044 . . . . 12.0 111.662 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.16 -66.8 0.03 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.31 -1.516 . . . . 12.0 109.31 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -165.56 -65.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -154.55 144.01 21.39 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.868 -0.79 . . . . 12.0 108.868 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -66.25 178.3 1.22 Allowed 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.824 -0.436 . . . . 12.0 109.824 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.15 15.87 22.93 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.249 -0.282 . . . . 12.0 110.61 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.0 p -162.8 120.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.854 -0.529 . . . . 12.0 109.816 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 13.9 m120 -122.12 88.94 3.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m -83.31 107.37 15.79 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 116.371 -0.377 . . . . 12.0 110.685 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.824 ' CD1' HD12 ' A' ' 12' ' ' ILE . 12.9 m-85 -98.57 159.79 14.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.066 -1.457 . . . . 12.0 107.066 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.755 HD12 ' C ' ' A' ' 40' ' ' PHE . 3.7 mp -130.26 129.49 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.748 -0.834 . . . . 12.0 108.748 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 42' ' ' ILE . 10.5 tt -101.34 106.27 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.15 -0.685 . . . . 12.0 109.15 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.1 t 176.66 154.47 0.22 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.808 -0.812 . . . . 12.0 108.808 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -60.62 130.04 44.53 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.818 -0.808 . . . . 12.0 108.818 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' CA ' HG12 ' A' ' 11' ' ' ILE . . . -53.94 -27.21 29.56 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.067 -0.395 . . . . 12.0 111.385 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 t -82.43 -30.92 29.78 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.509 -0.476 . . . . 12.0 111.591 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 p -63.58 -37.01 85.7 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.862 ' O ' HG22 ' A' ' 51' ' ' ILE . 25.1 t -70.78 -36.06 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -62.07 -23.46 66.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.221 -0.659 . . . . 12.0 109.221 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.953 -0.467 . . . . 12.0 109.839 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.889 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -65.3 -29.41 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.837 -0.539 . . . . 12.0 110.088 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 24.53 6.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.753 -0.592 . . . . 12.0 110.069 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -87.8 113.22 23.26 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.496 -0.557 . . . . 12.0 109.496 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.2 -64.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.872 -1.291 . . . . 12.0 109.872 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 58' ' ' MET . 2.4 p -160.49 -165.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.42 -0.956 . . . . 12.0 108.42 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.586 ' H ' HG22 ' A' ' 55' ' ' VAL . 45.6 pt -89.77 26.5 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 O-C-N 121.102 -0.999 . . . . 12.0 111.326 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 50.5 t30 173.22 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 107.642 -1.244 . . . . 12.0 107.642 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.692 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -165.3 178.76 6.66 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 121.909 0.861 . . . . 12.0 111.904 -178.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -134.04 116.52 15.58 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 106.735 -1.58 . . . . 12.0 106.735 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 61' ' ' LEU . 13.0 t -130.25 167.59 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.87 -0.519 . . . . 12.0 109.788 -177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' N ' HG12 ' A' ' 60' ' ' VAL . 2.8 mp -122.59 110.53 15.67 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -56.88 91.51 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 108.666 -0.865 . . . . 12.0 108.666 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.892 HG22 ' OH ' ' A' ' 91' ' ' TYR . 3.0 p -81.79 -50.94 8.66 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 109.343 -0.614 . . . . 12.0 109.343 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.428 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 64.7 m -61.02 108.7 0.92 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.786 -1.191 . . . . 12.0 107.786 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.821 ' CB ' HG23 ' A' ' 89' ' ' THR . 23.2 ptt85 -40.0 108.67 0.09 Allowed 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.108 0.48 . . . . 12.0 112.245 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.593 ' HB2' HD21 ' A' ' 90' ' ' ASN . 47.6 m-85 -95.87 42.73 1.09 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 108.8 -0.815 . . . . 12.0 108.8 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 18.22 105.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 113.904 1.076 . . . . 12.0 113.904 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -101.22 157.3 16.88 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 12.0 112.324 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -121.29 97.16 5.39 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.264 -2.125 . . . . 12.0 105.264 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.6 m -101.87 124.39 47.42 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.811 -0.756 . . . . 12.0 112.034 -176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.4 m -110.65 108.64 18.62 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 104.254 -2.498 . . . . 12.0 104.254 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -111.99 140.3 46.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.817 -0.753 . . . . 12.0 111.869 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -65.03 117.41 7.62 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.089 -1.078 . . . . 12.0 108.089 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.982 -0.747 . . . . 12.0 108.982 -179.215 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.468 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 110.303 -0.258 . . . . 12.0 110.303 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 35.1 Cg_endo -77.13 122.22 6.1 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 122.255 1.97 . . . . 12.0 109.649 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.88 138.67 50.95 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 121.634 0.73 . . . . 12.0 111.832 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 p -110.87 131.0 55.42 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 107.393 -1.336 . . . . 12.0 107.393 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 81.0 p -96.46 141.73 29.4 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.511 0.672 . . . . 12.0 111.608 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -152.88 127.88 9.67 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.35 -0.982 . . . . 12.0 108.35 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 68' ' ' LEU . 5.3 m -109.64 149.85 29.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.031 -0.418 . . . . 12.0 110.209 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' CG ' HD11 ' A' ' 68' ' ' LEU . 11.4 pt-20 -175.21 -168.97 0.36 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 120.909 0.385 . . . . 12.0 110.234 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.821 HG23 ' CB ' ' A' ' 65' ' ' ARG . 95.8 m -57.68 142.28 45.61 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.994 -0.373 . . . . 12.0 109.994 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.593 HD21 ' HB2' ' A' ' 66' ' ' PHE . 61.9 t30 -109.21 88.48 2.74 Favored 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 121.901 0.857 . . . . 12.0 110.88 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.892 ' OH ' HG22 ' A' ' 63' ' ' THR . 1.1 t80 -104.39 101.23 10.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.75 -1.944 . . . . 12.0 105.75 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.854 HD12 ' CE1' ' A' ' 104' ' ' PHE . 6.2 pt -134.09 -179.19 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.586 -0.846 . . . . 12.0 111.719 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 10.3 t -115.18 120.74 40.75 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.175 -1.046 . . . . 12.0 108.175 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.586 HG23 ' CZ ' ' A' ' 104' ' ' PHE . 6.9 p -115.69 170.11 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 122.243 -0.286 . . . . 12.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 94' ' ' VAL . 18.0 mttt -131.54 140.19 49.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.565 -0.902 . . . . 12.0 108.565 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.3 m -113.49 122.55 47.62 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.19 1.182 . . . . 12.0 114.19 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.666 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.1 tt0 -131.73 143.35 50.18 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 15.2 m-80 53.51 29.47 9.09 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.765 -1.198 . . . . 12.0 107.765 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 15.2 pt20 53.83 5.87 0.07 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 114.822 1.415 . . . . 12.0 114.822 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -111.85 145.4 32.62 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 104.765 -2.309 . . . . 12.0 104.765 175.13 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.535 ' HB3' HG21 ' A' ' 94' ' ' VAL . 24.5 Cg_endo -60.95 89.47 0.09 OUTLIER 'Trans proline' 0 C--O 1.209 -0.942 0 N-CA-C 108.85 -1.25 . . . . 12.0 108.85 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.939 HG22 ' CE2' ' A' ' 100' ' ' TYR . 95.1 t -85.61 -22.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-N 116.214 -0.448 . . . . 12.0 110.332 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.666 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.68 143.33 48.47 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.258 -1.386 . . . . 12.0 107.258 -178.373 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.854 ' CE1' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -119.29 128.69 54.38 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.166 -1.014 . . . . 12.0 110.375 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -73.4 -42.18 62.41 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.568 -0.287 . . . . 12.0 110.312 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.72 -129.54 5.84 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.478 -0.867 . . . . 12.0 111.009 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 tt -60.74 165.97 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.222 -0.575 . . . . 12.0 110.567 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.503 3.156 0 N-CA-C 110.648 -0.981 . . . . 12.0 110.648 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.194 -0.669 . . . . 12.0 109.194 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.413 ' CZ2' ' HB2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.81 -29.19 64.17 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 122.096 -0.377 . . . . 12.0 110.465 -178.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -58.72 3.12 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.901 -0.499 . . . . 12.0 110.571 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -63.36 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.171 -1.048 . . . . 12.0 108.171 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 30.1 t80 -77.13 -22.75 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.103 -0.703 . . . . 12.0 109.103 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -61.26 -38.34 86.35 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.89 -35.61 57.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.421 -1.325 . . . . 12.0 107.421 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.21 -57.06 3.66 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 116.355 -0.384 . . . . 12.0 110.763 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.731 ' ND1' HD13 ' A' ' 41' ' ' ILE . 76.0 m-70 -108.26 -4.05 17.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.062 1.134 . . . . 12.0 114.062 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 45' ' ' ALA . 39.2 mm -122.38 64.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 118.566 -1.253 . . . . 12.0 113.597 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.66 HD13 ' HA ' ' A' ' 40' ' ' PHE . 3.1 mp -98.2 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.348 -2.093 . . . . 12.0 105.348 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.669 ' O ' HG23 ' A' ' 14' ' ' THR . 0.4 OUTLIER -54.58 85.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 CA-C-O 121.46 0.648 . . . . 12.0 111.15 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 13' ' ' ASN . 12.7 p -164.66 57.73 0.56 Allowed Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 107.65 -1.241 . . . . 12.0 107.65 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 14' ' ' THR . 35.9 Cg_endo -74.98 82.57 1.97 Allowed 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 121.936 1.757 . . . . 12.0 110.457 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.49 -162.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.154 -1.054 . . . . 12.0 108.154 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.19 30.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 109.073 -0.714 . . . . 12.0 109.073 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -140.79 95.36 2.84 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.279 -1.008 . . . . 12.0 108.279 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.429 ' HA ' HD11 ' A' ' 22' ' ' ILE . 46.3 m -77.04 -18.61 58.0 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 120.266 -0.574 . . . . 12.0 111.389 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.12 -52.35 7.47 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 119.082 0.855 . . . . 12.0 110.315 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.11 -33.26 38.92 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.511 -0.551 . . . . 12.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 19' ' ' CYS . 44.6 pt -82.38 -37.44 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.904 -0.406 . . . . 12.0 109.904 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -104.68 40.64 1.45 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.444 0.64 . . . . 12.0 109.305 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -87.77 50.07 1.92 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.511 0.672 . . . . 12.0 109.684 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.666 ' OD1' HG23 ' A' ' 27' ' ' ILE . 10.9 t-20 -127.87 161.33 29.31 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.045 -0.724 . . . . 12.0 109.045 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -74.76 -8.91 57.87 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.789 -0.364 . . . . 12.0 110.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.666 HG23 ' OD1' ' A' ' 25' ' ' ASN . 32.0 pt -80.17 -3.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.574 -0.704 . . . . 12.0 111.113 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -112.3 47.52 1.06 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.744 -0.598 . . . . 12.0 110.578 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mt -150.33 144.92 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.027 -1.046 . . . . 12.0 110.302 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 31' ' ' GLY . 49.4 t -106.78 169.25 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 107.711 -1.218 . . . . 12.0 107.711 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.77 61.33 3.1 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.05 -65.06 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.052 -1.619 . . . . 12.0 109.052 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -168.95 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 117.703 0.751 . . . . 12.0 109.792 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 t -145.38 131.11 18.98 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -61.77 164.96 5.64 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.479 -0.564 . . . . 12.0 109.479 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -102.05 -3.18 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 122.24 -0.288 . . . . 12.0 111.01 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 37' ' ' VAL . 12.6 p -162.48 114.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.603 -0.686 . . . . 12.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 8.3 m120 -107.29 84.78 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.678 -1.601 . . . . 12.0 106.678 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 m -80.9 109.49 15.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 116.071 -0.513 . . . . 12.0 110.648 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.66 ' HA ' HD13 ' A' ' 12' ' ' ILE . 19.3 m-85 -98.73 161.7 13.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.805 -1.554 . . . . 12.0 106.805 178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.731 HD13 ' ND1' ' A' ' 10' ' ' HIS . 1.1 mp -130.98 132.54 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.335 0.971 . . . . 12.0 109.54 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 42' ' ' ILE . 5.7 tp -108.44 105.42 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.195 -1.039 . . . . 12.0 108.195 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t 179.54 153.33 0.45 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.61 122.07 9.07 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.794 0.807 . . . . 12.0 109.827 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 11' ' ' ILE . . . -46.42 -64.96 0.63 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 113.613 0.968 . . . . 12.0 113.613 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.7 p -62.72 -17.03 60.07 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.165 -0.614 . . . . 12.0 111.235 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.652 HG22 ' HE2' ' A' ' 66' ' ' PHE . 96.2 m -66.01 -36.68 83.94 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.302 -1.369 . . . . 12.0 107.302 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 51' ' ' ILE . 44.6 t -71.26 -35.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.048 -1.464 . . . . 12.0 107.048 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -63.73 -21.73 66.55 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 12.0 108.992 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.54 -38.7 25.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.0 -0.438 . . . . 12.0 110.015 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.3 tp -65.4 -22.74 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.769 -0.582 . . . . 12.0 109.91 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.1 35.86 2.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.802 -0.561 . . . . 12.0 109.805 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.4 m -96.76 112.8 24.4 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.184 -0.672 . . . . 12.0 109.184 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.03 -63.02 0.02 OUTLIER Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.598 -1.001 . . . . 12.0 110.598 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.611 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.8 p -162.12 -167.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.691 -0.855 . . . . 12.0 108.691 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.9 pt -88.25 26.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 121.024 -1.047 . . . . 12.0 111.317 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 174.05 112.99 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 107.508 -1.293 . . . . 12.0 107.508 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.8 -176.37 4.57 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.984 0.897 . . . . 12.0 111.955 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -140.14 124.59 17.97 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.697 -1.594 . . . . 12.0 106.697 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG13 ' CG2' ' A' ' 94' ' ' VAL . 10.0 p -137.32 166.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.735 -0.603 . . . . 12.0 109.727 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.492 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.7 mt -126.27 112.56 15.87 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.904 -0.498 . . . . 12.0 112.193 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 4.0 m -67.7 91.2 0.29 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 105.691 -1.966 . . . . 12.0 105.691 176.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -86.77 -37.41 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.149 -0.344 . . . . 12.0 111.634 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.697 HG22 ' HG2' ' A' ' 65' ' ' ARG . 89.8 m -53.88 -92.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.195 -0.669 . . . . 12.0 109.195 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.735 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER 176.15 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.778 0.717 . . . . 12.0 109.563 179.003 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.652 ' HE2' HG22 ' A' ' 47' ' ' THR . 49.9 m-85 -96.89 44.51 1.06 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 14.79 105.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.254 0 N-CA-C 114.087 1.143 . . . . 12.0 114.087 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.617 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.79 156.35 17.89 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.939 0.876 . . . . 12.0 111.972 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.14 99.17 6.55 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.675 -1.972 . . . . 12.0 105.675 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.4 m -100.51 125.06 46.8 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.011 -0.676 . . . . 12.0 112.555 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.9 m -105.79 111.53 24.24 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 104.187 -2.523 . . . . 12.0 104.187 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 m -101.89 140.41 36.2 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 120.014 -0.675 . . . . 12.0 111.519 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 3.7 tmt_? -72.6 105.99 4.46 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.122 -0.696 . . . . 12.0 109.122 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.499 2.024 0 N-CA-C 110.014 -0.365 . . . . 12.0 110.014 -179.53 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.652 -0.87 . . . . 12.0 108.652 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 33.0 Cg_endo -72.74 113.95 3.89 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 121.492 1.461 . . . . 12.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 12.9 m-85 -140.2 134.22 30.84 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.083 0.468 . . . . 12.0 110.917 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -109.0 128.66 55.14 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.857 -1.164 . . . . 12.0 107.857 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.5 p -89.55 139.88 30.1 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.306 0.574 . . . . 12.0 110.909 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -147.97 158.41 44.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.511 -0.922 . . . . 12.0 108.511 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -139.67 148.72 42.79 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 109.537 -0.542 . . . . 12.0 109.537 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -177.22 -176.49 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.501 -0.48 . . . . 12.0 110.279 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.735 HG23 ' HB3' ' A' ' 65' ' ' ARG . 58.9 m -53.86 141.02 28.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.778 -0.453 . . . . 12.0 109.778 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.593 ' OD1' HD23 ' A' ' 68' ' ' LEU . 61.8 t30 -110.47 86.11 2.24 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.593 -0.843 . . . . 12.0 112.596 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -95.67 100.73 12.42 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.0 -2.222 . . . . 12.0 105.0 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.445 HG12 ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -122.93 149.6 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.546 0.689 . . . . 12.0 111.929 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 25.1 t -92.48 136.01 33.57 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 105.523 -2.029 . . . . 12.0 105.523 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 60' ' ' VAL . 2.8 m -140.57 -176.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 120.275 -0.57 . . . . 12.0 111.004 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 40.0 mtmt -147.95 149.22 31.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -118.78 117.57 29.25 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.688 0.756 . . . . 12.0 112.839 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.634 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 18.2 tt0 -124.52 143.77 50.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.844 -2.65 . . . . 12.0 103.844 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.7 m120 55.46 27.17 9.79 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-N 119.845 1.202 . . . . 12.0 107.946 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 18.4 pt20 54.59 8.85 0.23 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.098 1.359 . . . . 12.0 114.382 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.869 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -114.88 146.74 36.74 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 104.731 -2.322 . . . . 12.0 104.731 174.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.486 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.5 Cg_endo -59.88 88.92 0.07 OUTLIER 'Trans proline' 0 C--O 1.208 -1.005 0 C-N-CA 121.331 1.354 . . . . 12.0 109.282 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.869 HG22 ' CE2' ' A' ' 100' ' ' TYR . 54.3 t -84.45 -19.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 116.295 -0.411 . . . . 12.0 110.468 -177.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.634 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -136.83 134.42 36.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 -177.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.596 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.2 OUTLIER -123.78 129.81 51.64 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.963 -0.695 . . . . 12.0 109.395 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.599 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -85.91 -41.98 14.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.229 -0.295 . . . . 12.0 110.728 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.95 -99.88 0.59 Allowed Glycine 0 N--CA 1.504 3.186 0 C-N-CA 120.295 -0.955 . . . . 12.0 111.139 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.9 pt -58.29 147.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.844 -0.797 . . . . 12.0 110.294 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.836 -1.306 . . . . 12.0 109.836 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.49 65.23 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 122.031 -0.418 . . . . 12.0 110.009 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.55 42.86 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.804 -0.56 . . . . 12.0 110.451 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -65.39 -29.56 70.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.471 -0.937 . . . . 12.0 108.471 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 35.5 t80 -76.97 -20.0 56.63 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.866 -0.79 . . . . 12.0 108.866 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.471 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 12.3 tt0 -64.2 -38.88 92.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 106.475 -1.676 . . . . 12.0 106.475 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.441 ' O ' HD11 ' A' ' 12' ' ' ILE . 4.5 mp0 -77.65 -32.83 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 176.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -43.25 -64.4 0.65 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 110.298 -0.26 . . . . 12.0 110.298 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.524 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 88.8 m-70 -110.08 -23.2 11.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.2 0.815 . . . . 12.0 113.2 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 43' ' ' SER . 22.9 mm -93.81 57.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 119.254 0.934 . . . . 12.0 113.234 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.567 HD12 ' H ' ' A' ' 12' ' ' ILE . 4.1 mp -90.13 76.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 105.42 -2.067 . . . . 12.0 105.42 175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.15 79.44 2.97 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.794 0.807 . . . . 12.0 110.125 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -135.0 70.36 70.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.261 -1.385 . . . . 12.0 107.261 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -71.94 86.3 0.92 Allowed 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 121.825 1.683 . . . . 12.0 111.045 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 22' ' ' ILE . 24.9 pt -136.07 -167.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.201 -1.037 . . . . 12.0 108.201 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.08 38.39 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.666 0.746 . . . . 12.0 109.352 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -153.1 101.36 2.56 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 116.292 -0.413 . . . . 12.0 109.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.3 m -81.26 -5.86 58.24 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 122.054 -0.404 . . . . 12.0 111.014 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -83.13 -55.24 4.47 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.496 -0.753 . . . . 12.0 111.501 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -61.54 -23.09 65.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.679 -0.638 . . . . 12.0 110.719 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 16' ' ' ILE . 11.9 pt -84.53 -35.08 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.64 -0.663 . . . . 12.0 109.621 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.587 ' HA ' ' HE3' ' A' ' 23' ' ' MET . 0.7 OUTLIER -95.79 12.78 28.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.004 -0.435 . . . . 12.0 110.625 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.58 90.41 0.26 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.334 -1.358 . . . . 12.0 107.334 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.409 HD21 HD12 ' A' ' 27' ' ' ILE . 58.9 t30 -172.79 152.85 2.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.317 -0.623 . . . . 12.0 109.317 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -68.0 -11.98 59.92 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 110.044 -0.354 . . . . 12.0 110.044 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 27' ' ' ILE . 61.8 mt -86.59 9.66 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.727 -0.608 . . . . 12.0 110.811 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -144.12 63.16 1.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.599 -0.688 . . . . 12.0 109.181 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -148.08 151.99 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.593 -1.317 . . . . 12.0 111.02 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 31' ' ' GLY . 49.1 t -102.75 170.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 107.376 -1.342 . . . . 12.0 107.376 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.71 52.7 3.34 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.372 -1.491 . . . . 12.0 109.372 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.43 -56.69 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.304 -1.518 . . . . 12.0 109.304 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.87 -69.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.023 -0.732 . . . . 12.0 109.023 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.41 ' O ' HG21 ' A' ' 30' ' ' VAL . 61.2 m -140.92 -169.72 2.88 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HA ' HG21 ' A' ' 30' ' ' VAL . 1.6 tttp -115.0 167.16 11.05 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.163 -0.68 . . . . 12.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -76.76 -17.39 59.09 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.859 -0.336 . . . . 12.0 110.465 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.4 p -161.53 118.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.36 0.6 . . . . 12.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -114.22 86.28 2.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.333 -1.729 . . . . 12.0 106.333 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -87.24 123.89 32.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.485 0.659 . . . . 12.0 111.373 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -108.5 163.36 13.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.977 -1.49 . . . . 12.0 106.977 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.1 mt -131.32 132.01 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.218 -0.926 . . . . 12.0 109.458 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.4 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 12.1 mm -100.29 108.83 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 108.979 -0.749 . . . . 12.0 108.979 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.518 ' O ' HD12 ' A' ' 11' ' ' ILE . 37.7 t 177.6 150.21 0.19 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.167 -0.679 . . . . 12.0 109.167 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 p -59.95 130.11 45.13 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.804 -0.813 . . . . 12.0 108.804 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -24.54 4.86 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.486 . . . . 12.0 111.224 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -84.78 -32.27 23.48 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.41 -0.516 . . . . 12.0 111.613 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -62.99 -38.92 93.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.117 -1.438 . . . . 12.0 107.117 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 51' ' ' ILE . 25.9 t -70.71 -35.7 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.564 -1.273 . . . . 12.0 107.564 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.15 -23.95 66.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.145 -0.687 . . . . 12.0 109.145 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.14 -36.95 29.61 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.976 -0.452 . . . . 12.0 110.158 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.5 tp -66.45 -23.74 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.801 -0.562 . . . . 12.0 110.386 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.89 27.61 6.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.828 -0.545 . . . . 12.0 109.947 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 m -90.99 114.92 27.56 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.452 -0.573 . . . . 12.0 109.452 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.64 0.02 OUTLIER Glycine 0 N--CA 1.5 2.93 0 N-CA-C 110.152 -1.179 . . . . 12.0 110.152 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.9 p -159.94 -168.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.69 -0.856 . . . . 12.0 108.69 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.593 ' H ' HG22 ' A' ' 55' ' ' VAL . 7.9 pt -88.14 25.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.118 -0.989 . . . . 12.0 111.39 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 174.0 115.03 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 107.521 -1.288 . . . . 12.0 107.521 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 176.82 10.99 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.69 0.757 . . . . 12.0 111.491 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -138.85 117.4 12.12 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.29 -1.374 . . . . 12.0 107.29 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.4 p -150.15 165.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.3 mp -125.73 125.64 43.33 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 120.758 -0.377 . . . . 12.0 110.808 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.503 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.31 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 177.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -86.44 -23.17 26.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.956 -0.465 . . . . 12.0 110.943 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -59.57 -88.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.497 -0.557 . . . . 12.0 109.497 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.821 ' HG3' HG23 ' A' ' 89' ' ' THR . 28.9 ttt-85 172.71 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 108.596 -0.89 . . . . 12.0 108.596 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 73.0 m-85 -105.17 57.52 0.68 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 109.253 -0.647 . . . . 12.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' PHE . 5.5 pt20 -4.5 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 114.557 1.317 . . . . 12.0 114.557 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -105.22 158.22 16.75 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.224 1.011 . . . . 12.0 112.94 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 6.7 t-20 -117.8 98.16 6.21 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 105.131 -2.174 . . . . 12.0 105.131 176.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.6 m -100.88 127.65 47.26 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.879 -0.729 . . . . 12.0 112.937 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.8 m -111.29 105.42 14.07 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 103.738 -2.689 . . . . 12.0 103.738 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 m -105.88 145.32 31.4 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 120.258 -0.577 . . . . 12.0 112.008 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 8.0 ttp180 -69.07 138.84 54.68 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.853 -0.795 . . . . 12.0 108.853 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.502 2.146 0 O-C-N 121.919 -0.488 . . . . 12.0 110.435 -179.43 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.521 0 CA-C-O 119.014 -0.517 . . . . 12.0 110.45 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 41.2 Cg_endo -77.07 110.57 3.05 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.778 1.652 . . . . 12.0 109.995 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 23.1 m-85 -143.83 133.56 23.76 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.438 0.637 . . . . 12.0 110.736 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -119.37 129.21 54.7 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -96.05 142.49 28.19 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.254 0.549 . . . . 12.0 110.912 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -151.49 125.86 9.41 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.379 -0.971 . . . . 12.0 108.379 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.9 m -105.53 147.05 28.79 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.707 -0.397 . . . . 12.0 109.983 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -174.87 -171.0 0.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.696 -0.483 . . . . 12.0 109.696 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.821 HG23 ' HG3' ' A' ' 65' ' ' ARG . 95.6 m -63.83 134.38 55.11 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 68' ' ' LEU . 43.6 t-20 -107.12 91.96 3.88 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.552 0.691 . . . . 12.0 112.18 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.69 107.16 19.0 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.409 HG21 ' CE2' ' A' ' 104' ' ' PHE . 1.1 mt -110.85 160.94 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 122.2 1.0 . . . . 12.0 113.489 -174.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.401 ' N ' HG22 ' A' ' 92' ' ' ILE . 35.7 t -112.2 103.85 12.03 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 105.258 -2.127 . . . . 12.0 105.258 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.691 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 7.2 m -122.71 -171.71 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.435 0.636 . . . . 12.0 112.018 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 2.2 mtpp -145.24 152.01 39.28 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.03 -0.73 . . . . 12.0 109.03 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.58 119.69 33.64 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.655 0.74 . . . . 12.0 112.853 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.624 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 11.7 tt0 -127.36 145.55 50.77 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 104.362 -2.459 . . . . 12.0 104.362 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 52.98 28.6 6.82 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 119.876 1.216 . . . . 12.0 107.998 -176.325 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 12.0 pt20 55.56 4.08 0.09 Allowed 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 125.418 1.487 . . . . 12.0 114.701 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.878 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -110.14 147.29 35.96 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 105.147 -2.168 . . . . 12.0 105.147 175.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.1 Cg_endo -60.8 89.56 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.37 1.38 . . . . 12.0 108.79 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 100' ' ' TYR . 46.6 t -85.07 -14.11 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.619 -0.718 . . . . 12.0 110.654 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.624 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -144.87 117.75 8.76 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.512 -0.875 . . . . 12.0 110.387 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.691 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 1.3 m-85 -101.12 121.0 41.05 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.503 -1.665 . . . . 12.0 106.503 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.62 -28.84 17.25 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 112.966 0.728 . . . . 12.0 112.966 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.88 -169.28 37.29 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.803 -1.189 . . . . 12.0 111.111 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.588 ' O ' HG22 ' A' ' 107' ' ' ILE . 51.0 mt -93.38 36.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.051 0.453 . . . . 12.0 110.616 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.037 0 N-CA-C 110.519 -1.032 . . . . 12.0 110.519 178.862 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TRP . . . . . 0.59 ' CZ3' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -69.03 -24.19 64.16 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 121.636 -0.665 . . . . 12.0 110.492 -177.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.76 -64.08 1.07 Allowed 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.607 -0.683 . . . . 12.0 110.655 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.21 80.76 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.419 -1.326 . . . . 12.0 107.419 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 32.0 t80 -70.25 -25.66 63.48 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.384 -0.969 . . . . 12.0 108.384 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -52.0 -31.77 30.88 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 107.186 -1.413 . . . . 12.0 107.186 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -42.82 30.49 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.797 -1.186 . . . . 12.0 107.797 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.469 ' O ' HD13 ' A' ' 41' ' ' ILE . 9.7 mmtp -44.42 -53.84 6.49 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 122.363 -0.211 . . . . 12.0 111.365 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.885 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -95.47 -17.71 21.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.942 -0.474 . . . . 12.0 111.42 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 43' ' ' SER . 15.9 mm -129.48 79.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 118.899 -1.121 . . . . 12.0 113.929 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.496 HG21 HG22 ' A' ' 22' ' ' ILE . 48.5 mm -98.09 75.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 104.198 -2.519 . . . . 12.0 104.198 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -82.81 61.92 6.12 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.658 0.742 . . . . 12.0 111.425 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.504 ' OG1' HG23 ' A' ' 22' ' ' ILE . 60.9 p -146.55 65.19 10.05 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 106.954 -1.499 . . . . 12.0 106.954 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 14' ' ' THR . 37.1 Cg_endo -82.2 45.51 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.372 2.048 . . . . 12.0 112.011 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.62 -165.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.83 -0.804 . . . . 12.0 108.83 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.2 pt -97.81 43.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-O 121.424 0.631 . . . . 12.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -158.02 99.41 1.67 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.063 -0.717 . . . . 12.0 109.063 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.571 ' HA ' HD12 ' A' ' 22' ' ' ILE . 9.0 m -76.53 -12.72 60.07 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.954 -0.466 . . . . 12.0 110.996 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -63.57 -49.42 73.47 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 119.048 0.84 . . . . 12.0 109.025 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.7 m -74.85 -19.63 60.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.641 -0.503 . . . . 12.0 109.641 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 19' ' ' CYS . 44.1 mt -84.94 -8.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.765 -0.585 . . . . 12.0 110.663 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.54 4.89 7.57 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.629 -0.669 . . . . 12.0 110.305 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -58.23 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.403 -0.962 . . . . 12.0 108.403 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.453 HD21 HD12 ' A' ' 27' ' ' ILE . 57.5 t30 -173.08 152.14 2.26 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.751 -0.833 . . . . 12.0 108.751 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -70.21 -9.72 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.713 -0.395 . . . . 12.0 110.275 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 27' ' ' ILE . 56.4 mt -89.71 12.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.689 -0.632 . . . . 12.0 110.685 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.652 ' O ' HD13 ' A' ' 29' ' ' ILE . 33.8 m-85 -142.28 55.35 1.45 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.657 -0.652 . . . . 12.0 110.802 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 28' ' ' TYR . 33.1 mm -148.29 152.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 120.673 -1.267 . . . . 12.0 110.038 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 35' ' ' LYS . 61.1 t -110.06 168.28 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 107.71 -1.218 . . . . 12.0 107.71 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.87 54.91 3.35 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.738 -1.745 . . . . 12.0 108.738 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.95 -54.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.531 -1.427 . . . . 12.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -163.57 -76.41 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 122.054 -0.674 . . . . 12.0 109.404 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -133.94 -175.94 4.01 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.533 -0.543 . . . . 12.0 109.533 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.584 ' HA ' HG21 ' A' ' 30' ' ' VAL . 1.9 tttt -107.1 171.66 7.25 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -79.6 -17.34 54.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.1 -0.375 . . . . 12.0 110.575 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 37' ' ' VAL . 9.6 p -162.1 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 119.789 -0.764 . . . . 12.0 111.457 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -97.18 85.81 3.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.753 -1.943 . . . . 12.0 105.753 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.62 123.18 29.52 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.661 0.743 . . . . 12.0 112.555 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.447 ' CD1' HG21 ' A' ' 12' ' ' ILE . 23.6 m-85 -100.32 161.68 13.44 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.929 -1.508 . . . . 12.0 106.929 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 9' ' ' LYS . 4.4 mp -130.68 122.98 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.956 -1.09 . . . . 12.0 110.091 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.468 HD11 ' HB2' ' A' ' 69' ' ' ASN . 4.8 mt -98.54 107.11 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.27 -1.011 . . . . 12.0 108.27 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.898 ' O ' HD12 ' A' ' 11' ' ' ILE . 29.7 t 175.93 165.76 0.39 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 109.27 -0.641 . . . . 12.0 109.27 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 p -82.7 125.47 31.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.166 -1.049 . . . . 12.0 108.166 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.707 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -50.05 -31.47 13.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.992 -0.442 . . . . 12.0 111.887 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -76.61 -32.88 58.34 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.426 -0.51 . . . . 12.0 111.935 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.2 m -64.59 -34.34 78.02 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.817 -1.179 . . . . 12.0 107.817 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.655 HG11 ' CE1' ' A' ' 10' ' ' HIS . 20.7 t -71.03 -35.38 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.407 -1.331 . . . . 12.0 107.407 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -65.23 -21.43 66.75 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 116.016 -0.538 . . . . 12.0 110.019 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.63 -39.16 24.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.821 -0.55 . . . . 12.0 109.922 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 48' ' ' VAL . 7.2 tp -69.16 -18.07 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.788 -0.57 . . . . 12.0 110.401 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -97.34 15.14 23.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.58 -0.7 . . . . 12.0 111.003 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.3 m -66.16 107.27 1.88 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.189 -0.671 . . . . 12.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.79 -63.2 0.01 OUTLIER Glycine 0 N--CA 1.501 2.983 0 C-N-CA 120.484 -0.865 . . . . 12.0 111.013 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.62 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.1 p -167.54 -171.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.067 0.934 . . . . 12.0 109.434 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.62 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.0 tt -89.21 32.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 O-C-N 121.429 -0.794 . . . . 12.0 110.781 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 5.0 t30 169.75 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 107.257 -1.386 . . . . 12.0 107.257 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -163.17 179.72 7.25 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.121 0.962 . . . . 12.0 112.404 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -137.36 108.41 6.75 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.644 -1.614 . . . . 12.0 106.644 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 61' ' ' LEU . 2.7 t -132.9 171.13 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.853 -0.529 . . . . 12.0 109.886 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.0 mp -124.66 124.16 41.6 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.816 -0.439 . . . . 12.0 109.816 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.49 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 108.453 -0.943 . . . . 12.0 108.453 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.755 HG22 ' OH ' ' A' ' 91' ' ' TYR . 1.4 p -75.47 -43.43 49.43 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.638 -0.875 . . . . 12.0 108.638 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -65.65 124.1 21.47 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.17 -1.048 . . . . 12.0 108.17 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.737 ' CG ' HG23 ' A' ' 89' ' ' THR . 0.1 OUTLIER -54.49 105.95 0.18 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 122.088 -0.383 . . . . 12.0 109.982 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 51' ' ' ILE . 48.2 m-85 -94.94 41.04 1.09 Allowed 'General case' 0 N--CA 1.512 2.666 0 C-N-CA 120.074 -0.65 . . . . 12.0 109.548 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 24.99 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 114.284 1.216 . . . . 12.0 114.284 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.95 155.58 18.53 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.032 0.92 . . . . 12.0 112.494 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.468 ' HB2' HD11 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -121.18 99.45 6.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 104.787 -2.301 . . . . 12.0 104.787 176.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -105.43 128.93 53.79 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.033 1.123 . . . . 12.0 114.033 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.35 105.37 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 103.107 -2.923 . . . . 12.0 103.107 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -105.26 144.19 32.39 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.07 -0.652 . . . . 12.0 111.944 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 105.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.593 -0.891 . . . . 12.0 108.593 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.503 2.177 0 C-N-CA 120.595 -0.442 . . . . 12.0 110.311 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 93.8 m . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.963 -0.542 . . . . 12.0 109.759 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.14 134.8 18.01 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 121.831 1.687 . . . . 12.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -142.93 139.26 30.65 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.283 0.564 . . . . 12.0 110.536 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 t -124.71 126.23 45.35 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 108.323 -0.991 . . . . 12.0 108.323 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 139.97 30.76 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.06 0.457 . . . . 12.0 110.612 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -152.53 124.09 7.79 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.802 -0.814 . . . . 12.0 108.802 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -94.11 152.92 18.41 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -176.09 -167.74 0.24 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.155 0.502 . . . . 12.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.737 HG23 ' CG ' ' A' ' 65' ' ' ARG . 39.6 m -65.31 143.85 57.51 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.584 ' OD1' HD11 ' A' ' 92' ' ' ILE . 7.7 t-20 -108.51 87.73 2.56 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.945 0.879 . . . . 12.0 110.856 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.755 ' OH ' HG22 ' A' ' 63' ' ' THR . 3.7 t80 -100.01 112.93 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.938 -2.245 . . . . 12.0 104.938 176.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.584 HD11 ' OD1' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -126.64 175.67 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-O 122.274 1.035 . . . . 12.0 112.406 -175.686 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.3 t -125.54 99.3 5.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.154 -1.795 . . . . 12.0 106.154 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' A' ' 101' ' ' PRO . 9.8 p -111.95 164.19 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.236 0.541 . . . . 12.0 111.193 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 94' ' ' VAL . 8.2 mmmt -118.04 140.84 49.17 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.88 120.32 33.12 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.505 1.298 . . . . 12.0 114.505 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 24.9 tt0 -114.99 139.99 49.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.869 -2.641 . . . . 12.0 103.869 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 77.7 m-20 56.46 31.04 18.13 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 5.7 pt20 52.75 10.34 0.15 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 114.569 1.322 . . . . 12.0 114.569 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.986 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.21 140.73 23.91 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 104.051 -2.574 . . . . 12.0 104.051 174.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.679 ' HB3' HG21 ' A' ' 94' ' ' VAL . 26.8 Cg_endo -60.78 90.85 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.857 0 N-CA-C 108.713 -1.303 . . . . 12.0 108.713 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.986 HG22 ' CE2' ' A' ' 100' ' ' TYR . 81.5 t -88.84 -19.95 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 116.244 -0.435 . . . . 12.0 110.694 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.527 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -139.9 145.72 38.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.694 -1.225 . . . . 12.0 107.694 -178.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.55 ' HZ ' ' HE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -109.31 133.52 52.95 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.209 -0.996 . . . . 12.0 109.221 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.72 -19.45 15.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.033 -0.417 . . . . 12.0 111.676 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.29 173.88 44.07 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 110.468 -1.053 . . . . 12.0 110.468 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 92' ' ' ILE . 4.3 pt -97.82 26.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.186 -0.596 . . . . 12.0 110.279 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.933 0 N-CA-C 110.076 -1.209 . . . . 12.0 110.076 179.334 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . 0.469 ' HG2' HG12 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.509 2.491 0 N-CA-C 109.928 -0.397 . . . . 12.0 109.928 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -153.4 163.94 39.04 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.061 -0.718 . . . . 12.0 109.061 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -37.43 74.48 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 122.022 -0.424 . . . . 12.0 110.586 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.98 6.49 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.351 -0.843 . . . . 12.0 110.676 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -62.52 -32.3 73.21 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.211 -1.033 . . . . 12.0 108.211 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 61.4 t80 -72.59 -25.83 61.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.157 -1.053 . . . . 12.0 108.157 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.92 -33.69 62.39 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 1.5 mt-30 -80.39 -37.95 31.28 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.21 -1.404 . . . . 12.0 107.21 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -44.52 -57.33 3.66 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.983 -0.448 . . . . 12.0 111.079 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 4.4 m80 -99.58 -31.04 11.8 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.595 -0.691 . . . . 12.0 111.697 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.878 HG13 ' HB2' ' A' ' 45' ' ' ALA . 7.9 mm -102.93 65.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.668 1.729 . . . . 12.0 115.668 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 40' ' ' PHE . 3.4 mp -95.29 62.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 103.588 -2.745 . . . . 12.0 103.588 173.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -74.21 81.06 1.8 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.709 0.766 . . . . 12.0 110.409 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.6 p -118.5 106.87 43.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.233 -1.025 . . . . 12.0 108.233 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -81.51 37.16 0.66 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 121.921 1.747 . . . . 12.0 111.795 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 17' ' ' ILE . 4.6 mp -113.13 164.64 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.694 -0.854 . . . . 12.0 108.694 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' N ' HG22 ' A' ' 16' ' ' ILE . 33.5 pt -97.29 33.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-O 121.345 0.593 . . . . 12.0 109.855 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.24 91.36 3.36 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.29 -1.004 . . . . 12.0 108.29 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -76.28 -15.94 59.89 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.904 -0.498 . . . . 12.0 111.287 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -82.99 -50.41 8.58 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 119.019 0.827 . . . . 12.0 109.912 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.27 70.13 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 110.028 -0.36 . . . . 12.0 110.028 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.597 HD12 ' N ' ' A' ' 23' ' ' MET . 2.7 pp -76.98 -39.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 120.625 -0.43 . . . . 12.0 109.955 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.597 ' N ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -93.52 12.82 23.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.878 -0.514 . . . . 12.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -60.35 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.295 -1.002 . . . . 12.0 108.295 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -172.31 155.54 3.57 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.415 -0.587 . . . . 12.0 109.415 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -71.94 -10.23 59.48 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.922 -0.399 . . . . 12.0 109.922 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 27' ' ' ILE . 68.0 mt -85.78 8.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.691 -0.63 . . . . 12.0 110.644 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -135.96 57.19 1.79 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.536 -0.727 . . . . 12.0 110.025 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mt -151.47 145.87 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.959 -1.088 . . . . 12.0 109.889 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.3 p -109.73 -168.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 108.13 -1.063 . . . . 12.0 108.13 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.558 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -97.46 71.38 0.71 Allowed Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.201 -0.937 . . . . 12.0 111.411 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.72 -63.44 0.03 OUTLIER Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.227 -1.549 . . . . 12.0 109.227 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -165.22 -65.44 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.035 -1.098 . . . . 12.0 108.035 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.0 p -141.67 167.75 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 12.0 108.711 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -77.46 149.67 35.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.928 -0.482 . . . . 12.0 109.716 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -77.08 -23.85 51.89 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 110.104 -0.332 . . . . 12.0 110.104 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.487 HG12 ' OG1' ' A' ' 39' ' ' THR . 18.3 t -150.28 103.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 120.29 -0.564 . . . . 12.0 110.293 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.453 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 2.7 m-20 -92.59 76.48 5.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.441 -1.688 . . . . 12.0 106.441 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.487 ' OG1' HG12 ' A' ' 37' ' ' VAL . 25.8 m -79.23 116.49 19.52 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.928 -0.578 . . . . 12.0 110.686 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.652 ' O ' HD13 ' A' ' 41' ' ' ILE . 17.9 m-85 -107.01 163.59 12.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.087 -1.079 . . . . 12.0 108.087 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 40' ' ' PHE . 16.1 mm -126.71 124.57 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.907 -1.146 . . . . 12.0 107.907 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 69' ' ' ASN . 14.3 pt -96.51 98.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.857 ' O ' HD12 ' A' ' 11' ' ' ILE . 48.2 t -176.29 157.9 1.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.232 -0.655 . . . . 12.0 109.232 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.403 ' HB2' HG22 ' A' ' 46' ' ' THR . 8.1 p -63.88 128.17 34.64 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 109.244 -0.65 . . . . 12.0 109.244 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -54.45 -25.06 22.81 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.89 -0.506 . . . . 12.0 110.623 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 44' ' ' SER . 6.7 t -76.71 -33.91 58.18 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.523 -0.471 . . . . 12.0 111.231 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -65.19 -39.88 93.47 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.091 -1.448 . . . . 12.0 107.091 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.85 -31.86 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.824 -1.176 . . . . 12.0 107.824 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -67.38 -23.15 65.55 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.734 -0.469 . . . . 12.0 109.734 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -40.23 30.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.908 -0.495 . . . . 12.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.557 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 19.9 pt -69.41 -20.67 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.784 -0.572 . . . . 12.0 110.681 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.43 25.09 9.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.831 -0.543 . . . . 12.0 109.829 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -96.33 114.31 25.98 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.767 -0.583 . . . . 12.0 109.577 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.49 -62.68 0.01 OUTLIER Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.099 -1.2 . . . . 12.0 110.099 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.5 p -152.76 -169.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.517 -0.92 . . . . 12.0 108.517 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.616 ' H ' HG22 ' A' ' 55' ' ' VAL . 18.3 tt -88.62 26.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 O-C-N 120.915 -1.116 . . . . 12.0 110.796 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 4.4 t30 171.47 110.5 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 107.195 -1.409 . . . . 12.0 107.195 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -172.54 3.31 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.384 0.612 . . . . 12.0 110.684 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.98 114.55 8.02 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.094 -1.076 . . . . 12.0 108.094 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 51' ' ' ILE . 12.2 t -125.27 169.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.501 -0.925 . . . . 12.0 108.501 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -144.78 120.63 10.59 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.765 -0.774 . . . . 12.0 112.1 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 97.27 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.557 -1.275 . . . . 12.0 107.557 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -40.29 24.97 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.693 -0.484 . . . . 12.0 109.693 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.663 -0.495 . . . . 12.0 109.663 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.765 ' CB ' HG23 ' A' ' 89' ' ' THR . 5.4 ptt-85 177.87 103.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.601 -0.687 . . . . 12.0 110.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 29.6 m-85 -98.25 44.51 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.183 -0.607 . . . . 12.0 109.48 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 18.17 107.39 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 114.287 1.217 . . . . 12.0 114.287 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -102.4 153.99 19.51 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.03 0.919 . . . . 12.0 112.274 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.459 ' HB2' HG23 ' A' ' 42' ' ' ILE . 13.6 t30 -117.8 94.79 4.65 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.718 -1.956 . . . . 12.0 105.718 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 m -100.91 126.81 47.56 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.725 0.774 . . . . 12.0 112.786 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.6 m -106.76 104.76 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 104.589 -2.374 . . . . 12.0 104.589 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.4 HG23 HG22 ' A' ' 37' ' ' VAL . 8.4 m -101.21 131.36 47.24 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.211 -0.596 . . . . 12.0 111.727 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -63.05 105.82 0.75 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.107 -1.072 . . . . 12.0 108.107 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 p -105.87 -92.88 0.38 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 122.03 -0.419 . . . . 12.0 110.81 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.27 177.86 1.16 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.457 -0.777 . . . . 12.0 109.845 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.3 mt 63.79 139.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.419 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 7.7 m 59.39 58.83 5.09 Favored Pre-proline 0 N--CA 1.497 1.878 0 N-CA-C 109.597 -0.52 . . . . 12.0 109.597 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 77' ' ' THR . 35.3 Cg_endo -76.32 125.59 8.54 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 121.967 1.778 . . . . 12.0 109.925 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.476 ' N ' ' CA ' ' A' ' 80' ' ' PRO . 9.7 ttp85 -132.73 43.09 0.98 Allowed Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 112.627 0.603 . . . . 12.0 112.627 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' CA ' ' N ' ' A' ' 79' ' ' ARG . 40.2 Cg_endo -88.42 -11.47 38.15 Favored 'Cis proline' 0 CA--C 1.541 0.839 0 N-CA-C 110.366 -0.667 . . . . 12.0 110.366 -3.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.0 m -106.12 115.53 61.0 Favored Pre-proline 0 N--CA 1.495 1.814 0 CA-C-O 118.519 -0.753 . . . . 12.0 109.344 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.57 145.7 26.51 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.473 1.449 . . . . 12.0 110.279 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.0 m-85 -131.7 134.79 46.29 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.313 0.577 . . . . 12.0 110.512 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -105.84 109.78 21.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.097 -1.075 . . . . 12.0 108.097 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -83.57 133.93 34.84 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.178 0.513 . . . . 12.0 110.261 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -148.72 125.83 11.4 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -105.68 146.39 29.81 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.384 -0.599 . . . . 12.0 109.384 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HG3' HD11 ' A' ' 68' ' ' LEU . 14.9 pt-20 -172.24 -172.12 0.91 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 120.746 -0.382 . . . . 12.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.765 HG23 ' CB ' ' A' ' 65' ' ' ARG . 43.5 m -57.0 139.41 52.23 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.554 -0.536 . . . . 12.0 109.554 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.44 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 61.1 t30 -112.84 88.01 2.73 Favored 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 119.482 -0.887 . . . . 12.0 112.064 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -95.78 96.23 8.83 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 104.399 -2.445 . . . . 12.0 104.399 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.719 HD13 ' CZ ' ' A' ' 104' ' ' PHE . 21.0 tt -130.28 163.68 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 119.854 -0.738 . . . . 12.0 111.708 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.68 114.14 28.12 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.008 -0.542 . . . . 12.0 110.191 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 101' ' ' PRO . 11.1 p -104.57 161.58 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.281 -0.637 . . . . 12.0 109.281 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.491 ' N ' HG22 ' A' ' 94' ' ' VAL . 12.7 ttmt -118.31 144.5 45.79 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.885 -0.783 . . . . 12.0 108.885 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.01 124.77 47.78 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.611 0.967 . . . . 12.0 113.611 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.636 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 27.9 tt0 -129.9 144.02 51.1 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 104.44 -2.43 . . . . 12.0 104.44 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.93 15.91 2.53 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.129 -0.982 . . . . 12.0 108.72 -175.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 78.29 -15.36 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 123.581 0.752 . . . . 12.0 112.606 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.915 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -98.28 148.66 34.82 Favored Pre-proline 0 N--CA 1.503 2.19 0 N-CA-C 106.497 -1.668 . . . . 12.0 106.497 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.5 Cg_endo -63.23 91.25 0.14 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 N-CA-C 107.955 -1.594 . . . . 12.0 107.955 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.915 HG22 ' CE2' ' A' ' 100' ' ' TYR . 69.4 t -87.61 -11.07 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-N 116.185 -0.461 . . . . 12.0 111.115 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.636 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -151.94 148.28 27.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.719 ' CZ ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -99.69 122.41 42.66 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.485 -1.286 . . . . 12.0 108.923 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.17 67.58 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.995 -0.44 . . . . 12.0 109.954 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.55 -149.08 18.59 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.863 -1.295 . . . . 12.0 109.863 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.9 pt -56.43 178.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.203 0.525 . . . . 12.0 110.757 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.21 -56.57 19.54 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 111.138 -0.785 . . . . 12.0 111.138 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.4 mtp85 -49.41 110.86 0.41 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.929 -0.748 . . . . 12.0 110.599 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 169.51 12.16 Favored Pre-proline 0 N--CA 1.498 1.975 0 N-CA-C 109.174 -0.676 . . . . 12.0 109.174 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.482 0.807 0 C-N-CA 121.755 1.636 . . . . 12.0 110.766 179.684 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . 0.439 ' O ' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.506 2.346 0 N-CA-C 109.469 -0.567 . . . . 12.0 109.469 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -91.9 155.03 18.46 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.568 -0.901 . . . . 12.0 108.568 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -25.03 64.1 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.905 -0.497 . . . . 12.0 110.313 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.38 -63.24 1.33 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.647 -0.658 . . . . 12.0 110.676 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -61.57 -31.58 71.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.935 -1.135 . . . . 12.0 107.935 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 31.3 t80 -76.08 -25.36 55.42 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.469 -0.937 . . . . 12.0 108.469 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -54.42 -32.69 57.87 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.339 -1.356 . . . . 12.0 107.339 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.44 -37.91 35.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.791 -1.189 . . . . 12.0 107.791 177.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 15.8 tppt? -47.15 -49.13 22.97 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 122.155 -0.341 . . . . 12.0 110.385 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.92 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -101.28 -13.13 18.18 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 118.681 -0.676 . . . . 12.0 112.596 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 11' ' ' ILE . 3.7 mp -137.81 72.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 115.354 1.613 . . . . 12.0 115.354 -175.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.951 HD12 ' CD1' ' A' ' 40' ' ' PHE . 11.3 mt -97.65 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 103.737 -2.69 . . . . 12.0 103.737 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.25 80.79 0.24 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.843 0.83 . . . . 12.0 110.512 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.409 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.5 p -150.6 59.79 3.73 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.411 -1.329 . . . . 12.0 107.411 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 14' ' ' THR . 34.8 Cg_endo -73.12 84.77 1.29 Allowed 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 121.94 1.76 . . . . 12.0 110.711 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 pt -124.94 -169.17 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' HD13 ' A' ' 17' ' ' ILE . 1.3 mm -97.88 34.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.656 -0.652 . . . . 12.0 109.436 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -150.04 98.4 2.7 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.902 -0.499 . . . . 12.0 109.997 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -81.36 -4.47 55.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.853 -0.529 . . . . 12.0 110.734 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -84.47 -58.11 2.87 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.523 -0.736 . . . . 12.0 111.242 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -26.04 64.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.786 -0.571 . . . . 12.0 110.097 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.3 pt -85.61 -32.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.853 -0.529 . . . . 12.0 109.597 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ttp -100.98 20.28 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.947 -0.39 . . . . 12.0 109.947 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -74.15 86.53 1.89 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -163.96 147.46 9.82 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.779 -0.576 . . . . 12.0 109.574 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -70.9 -8.17 50.98 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.943 -0.391 . . . . 12.0 109.943 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.432 ' O ' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -85.95 7.84 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.601 -0.687 . . . . 12.0 110.026 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.535 ' OH ' HD11 ' A' ' 12' ' ' ILE . 35.2 m-85 -136.04 60.62 1.67 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.581 -0.699 . . . . 12.0 109.371 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mt -146.49 152.57 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 120.768 -1.208 . . . . 12.0 110.936 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.544 HG21 ' CA ' ' A' ' 35' ' ' LYS . 52.6 t -104.34 169.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.687 -1.227 . . . . 12.0 107.687 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.82 55.6 3.37 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.74 -57.14 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.41 -1.476 . . . . 12.0 109.41 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.31 -71.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.956 -0.732 . . . . 12.0 109.526 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 p -153.68 132.24 12.17 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.697 -0.853 . . . . 12.0 108.697 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CA ' HG21 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -56.18 171.27 0.28 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 109.82 -0.437 . . . . 12.0 109.82 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.97 -6.33 59.04 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 119.438 -0.315 . . . . 12.0 111.326 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.7 p -164.72 114.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 C-N-CA 119.545 -0.862 . . . . 12.0 111.691 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -95.37 82.55 3.71 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 12.0 105.832 176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -83.48 116.21 22.43 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.58 0.705 . . . . 12.0 111.862 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.951 ' CD1' HD12 ' A' ' 12' ' ' ILE . 18.5 m-85 -104.49 162.46 13.22 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.359 -1.348 . . . . 12.0 107.359 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 10' ' ' HIS . 4.9 mp -126.89 125.99 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.518 1.054 . . . . 12.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.443 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 6.3 mt -90.85 108.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 108.03 -1.1 . . . . 12.0 108.03 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.6 t 177.71 151.12 0.22 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.684 -0.406 . . . . 12.0 109.971 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -67.02 129.6 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.112 -1.07 . . . . 12.0 108.112 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -26.49 5.73 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.042 -0.411 . . . . 12.0 111.295 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.91 -33.24 30.53 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.916 -0.49 . . . . 12.0 111.829 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -62.59 -37.73 87.37 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.083 -1.451 . . . . 12.0 107.083 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.92 HG11 ' CD2' ' A' ' 10' ' ' HIS . 46.8 t -67.39 -34.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -59.38 -23.61 62.73 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.67 -38.66 25.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.968 -0.458 . . . . 12.0 109.77 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 48' ' ' VAL . 6.4 tp -65.93 -19.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.809 -0.557 . . . . 12.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 23.04 15.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.754 -0.591 . . . . 12.0 110.448 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 m -86.2 112.43 21.34 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.55 -65.66 0.01 OUTLIER Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.249 -1.14 . . . . 12.0 110.249 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.659 HG12 ' HG3' ' A' ' 58' ' ' MET . 2.4 p -160.54 -164.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.407 -0.96 . . . . 12.0 108.407 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.593 ' H ' HG22 ' A' ' 55' ' ' VAL . 18.1 tt -90.3 28.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.124 -0.985 . . . . 12.0 110.968 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 15.6 t-20 172.1 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.659 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -163.89 177.77 8.31 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.795 0.807 . . . . 12.0 111.742 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -133.37 112.46 11.62 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.064 -1.458 . . . . 12.0 107.064 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 61' ' ' LEU . 14.5 p -131.82 168.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.902 -0.499 . . . . 12.0 109.731 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' N ' HG22 ' A' ' 60' ' ' VAL . 1.4 mp -133.47 128.52 35.61 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.479 -0.488 . . . . 12.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -62.18 95.81 0.07 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.762 -1.57 . . . . 12.0 106.762 177.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -84.71 -46.66 11.23 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.989 -0.444 . . . . 12.0 110.896 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.513 HG22 ' HG2' ' A' ' 65' ' ' ARG . 99.4 m -52.16 -94.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.972 -0.455 . . . . 12.0 109.786 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.687 ' CB ' HG23 ' A' ' 89' ' ' THR . 0.1 OUTLIER 173.66 101.9 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.098 -0.704 . . . . 12.0 109.098 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 76.3 m-85 -96.87 44.42 1.06 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 120.483 -0.487 . . . . 12.0 109.818 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 19.48 106.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.106 1.15 . . . . 12.0 114.106 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.28 153.65 18.79 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.093 0.949 . . . . 12.0 112.562 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.443 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 7.7 t30 -115.1 101.27 8.83 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 104.657 -2.349 . . . . 12.0 104.657 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -106.79 121.8 45.1 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.456 0.909 . . . . 12.0 113.456 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.01 104.64 16.69 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 102.677 -3.083 . . . . 12.0 102.677 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -100.53 140.13 35.23 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.469 0.652 . . . . 12.0 112.333 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.4 ttt180 -60.42 133.69 56.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.905 -0.776 . . . . 12.0 108.905 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -125.55 -95.72 0.45 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.512 -0.551 . . . . 12.0 109.512 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 p -171.34 121.21 0.52 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.465 -0.772 . . . . 12.0 109.91 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.572 HG22 ' CD ' ' A' ' 82' ' ' PRO . 4.3 tt -155.19 144.56 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.987 -0.746 . . . . 12.0 108.987 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.416 ' N ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -80.36 -57.04 0.66 Allowed Pre-proline 0 N--CA 1.505 2.283 0 CA-C-O 119.129 -0.462 . . . . 12.0 110.545 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 77' ' ' THR . 34.1 Cg_endo -74.12 178.73 6.55 Favored 'Trans proline' 0 N--CA 1.483 0.865 0 C-N-CA 122.069 1.846 . . . . 12.0 111.133 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 162.97 19.27 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 109.828 -0.434 . . . . 12.0 109.828 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -74.73 -171.55 9.44 Favored 'Cis proline' 0 N--CA 1.488 1.16 0 O-C-N 123.315 1.166 . . . . 12.0 110.537 0.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.3 m -54.26 159.49 3.06 Favored Pre-proline 0 N--CA 1.501 2.119 0 N-CA-C 109.291 -0.633 . . . . 12.0 109.291 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.572 ' CD ' HG22 ' A' ' 76' ' ' ILE . 35.3 Cg_endo -76.11 128.01 10.33 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.562 1.508 . . . . 12.0 110.797 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.408 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 28.4 m-85 -148.02 137.26 22.16 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.964 0.411 . . . . 12.0 110.147 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 t -124.45 129.52 50.81 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.329 -0.989 . . . . 12.0 108.329 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -80.49 136.92 36.4 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.151 0.501 . . . . 12.0 110.956 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 121.37 7.81 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.99 -0.744 . . . . 12.0 108.99 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.9 p -98.55 147.16 25.07 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.468 -0.567 . . . . 12.0 109.468 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -168.3 -173.27 1.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.018 0.437 . . . . 12.0 110.054 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.687 HG23 ' CB ' ' A' ' 65' ' ' ARG . 30.7 m -66.43 142.49 57.56 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 109.461 -0.57 . . . . 12.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.462 HD22 HD23 ' A' ' 68' ' ' LEU . 8.6 t-20 -105.73 87.16 2.53 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.88 0.847 . . . . 12.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 6.2 p90 -109.34 106.46 16.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 105.985 -1.857 . . . . 12.0 105.985 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.463 ' HA ' ' CA ' ' A' ' 108' ' ' GLY . 19.9 pt -139.18 -171.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.85 -0.74 . . . . 12.0 111.976 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 39.0 t -119.99 114.63 22.31 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.083 -0.71 . . . . 12.0 109.083 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 95' ' ' LYS . 8.6 p -113.75 171.35 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 105' ' ' ALA . 14.3 mttt -130.88 146.03 52.18 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.922 -0.77 . . . . 12.0 108.922 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.4 m -118.18 125.13 49.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.217 1.192 . . . . 12.0 114.217 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.65 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 30.0 tt0 -131.62 144.69 51.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 103.818 -2.66 . . . . 12.0 103.818 174.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 27.8 m-80 53.63 29.38 9.22 Favored 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 107.699 -1.222 . . . . 12.0 107.699 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 52.69 9.58 0.12 Allowed 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 125.289 1.436 . . . . 12.0 114.835 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.915 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -114.39 145.98 34.89 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 104.532 -2.395 . . . . 12.0 104.532 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.629 ' HG3' HG12 ' A' ' 48' ' ' VAL . 23.3 Cg_endo -60.79 90.08 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.275 1.316 . . . . 12.0 108.69 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.915 HG22 ' CE2' ' A' ' 100' ' ' TYR . 69.7 t -86.84 -23.24 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 116.271 -0.422 . . . . 12.0 110.851 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.65 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.62 145.89 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.94 -1.133 . . . . 12.0 107.94 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -116.47 128.51 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.15 -1.02 . . . . 12.0 109.92 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 95' ' ' LYS . . . -78.99 -37.9 38.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.23 -0.294 . . . . 12.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.08 -134.68 6.88 Favored Glycine 0 N--CA 1.504 3.177 0 C-N-CA 120.066 -1.064 . . . . 12.0 111.493 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 pt -69.15 -171.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.083 0.468 . . . . 12.0 111.129 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.463 ' CA ' ' HA ' ' A' ' 92' ' ' ILE . . . -92.54 60.98 2.46 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 110.391 -1.084 . . . . 12.0 110.391 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.88 73.63 0.48 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.282 -1.007 . . . . 12.0 108.282 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -83.94 -46.24 0.76 Allowed Pre-proline 0 N--CA 1.502 2.141 0 CA-C-O 118.52 -0.752 . . . . 12.0 111.668 -178.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 110' ' ' CYS . 37.2 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 C-N-CA 121.846 1.697 . . . . 12.0 110.427 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.376 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 10.7 t-20 -115.99 156.09 26.9 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.817 -0.809 . . . . 12.0 108.817 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.425 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.51 -22.85 61.73 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 121.952 -0.468 . . . . 12.0 110.527 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.64 0.85 Allowed 'General case' 0 N--CA 1.515 2.815 0 O-C-N 121.637 -0.665 . . . . 12.0 110.853 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 m -60.9 -31.54 71.03 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.061 -1.088 . . . . 12.0 108.061 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 26.3 t80 -75.91 -26.14 56.7 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.461 -0.94 . . . . 12.0 108.461 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -51.79 -35.69 44.98 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 107.567 -1.271 . . . . 12.0 107.567 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -77.29 -40.95 42.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -45.87 -51.76 12.53 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.161 -0.337 . . . . 12.0 111.627 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.694 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.2 m170 -94.89 -14.71 24.26 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.552 -0.718 . . . . 12.0 111.363 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.694 HD13 ' O ' ' A' ' 10' ' ' HIS . 36.5 mm -130.86 73.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 N-CA-C 114.46 1.282 . . . . 12.0 114.46 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 40' ' ' PHE . 3.0 mp -97.43 61.15 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 103.667 -2.716 . . . . 12.0 103.667 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.42 ' OD1' HG23 ' A' ' 11' ' ' ILE . 3.0 m120 -70.98 81.49 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.739 0.78 . . . . 12.0 110.199 -176.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.535 ' OG1' HD12 ' A' ' 22' ' ' ILE . 9.3 p -131.79 76.11 74.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.672 -0.862 . . . . 12.0 108.672 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.85 82.0 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.994 1.796 . . . . 12.0 109.223 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 17' ' ' ILE . 31.6 mt -141.69 168.91 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.459 ' N ' HG22 ' A' ' 16' ' ' ILE . 10.7 pt -93.71 41.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 121.437 0.636 . . . . 12.0 109.758 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 22' ' ' ILE . 33.8 m-80 -149.49 104.81 3.4 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.7 -0.852 . . . . 12.0 108.7 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -81.12 -16.89 51.76 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 120.551 -0.46 . . . . 12.0 111.558 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -84.39 -55.24 4.26 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 118.892 0.769 . . . . 12.0 110.417 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.09 -30.68 64.54 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.264 -0.272 . . . . 12.0 110.443 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.535 HD12 ' OG1' ' A' ' 14' ' ' THR . 44.0 pt -80.76 -39.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.268 -0.573 . . . . 12.0 110.171 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.434 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -95.86 17.1 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.496 -0.482 . . . . 12.0 110.246 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -62.49 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.616 -0.883 . . . . 12.0 108.616 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.61 150.15 4.86 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.354 -0.61 . . . . 12.0 109.354 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -69.65 -9.42 54.16 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.878 -0.329 . . . . 12.0 110.342 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.454 ' O ' HD13 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -87.06 8.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 12.0 110.307 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -137.27 58.2 1.72 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.6 -0.687 . . . . 12.0 109.73 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -151.31 152.19 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 12.0 110.579 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 31' ' ' GLY . 58.5 t -103.26 168.93 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 107.475 -1.306 . . . . 12.0 107.475 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.35 54.77 3.54 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.219 -1.552 . . . . 12.0 109.219 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.88 -57.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.146 -1.582 . . . . 12.0 109.146 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.24 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.022 -0.693 . . . . 12.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 99.0 m -144.05 150.1 37.67 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.04 176.97 6.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.014 -0.736 . . . . 12.0 109.014 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -17.07 52.37 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.969 -0.457 . . . . 12.0 110.038 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 37' ' ' VAL . 12.5 p -162.04 117.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 C-N-CA 119.825 -0.75 . . . . 12.0 111.337 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 5.3 m-20 -97.46 83.77 3.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.701 -1.963 . . . . 12.0 105.701 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -80.84 116.4 20.81 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.909 -0.587 . . . . 12.0 111.481 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.69 ' HA ' HD13 ' A' ' 12' ' ' ILE . 21.7 m-85 -100.5 158.96 15.53 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.531 -1.285 . . . . 12.0 107.531 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.465 HD12 ' ND2' ' A' ' 90' ' ' ASN . 50.5 mm -129.18 124.23 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.357 -0.84 . . . . 12.0 110.346 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.494 HD11 ' HB2' ' A' ' 69' ' ' ASN . 4.6 mt -106.42 111.44 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 108.324 -0.991 . . . . 12.0 108.324 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 t 178.33 151.23 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 12.0 109.112 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.49 119.41 5.19 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 109.134 -0.691 . . . . 12.0 109.134 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HA ' HD11 ' A' ' 11' ' ' ILE . . . -42.98 -64.54 0.61 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 113.555 0.946 . . . . 12.0 113.555 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.5 t -62.13 -20.73 64.38 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.912 -0.493 . . . . 12.0 111.552 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.6 m -65.25 -36.07 82.98 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 107.169 -1.419 . . . . 12.0 107.169 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.837 ' O ' HG22 ' A' ' 51' ' ' ILE . 19.3 t -71.24 -34.39 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -21.51 65.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.663 -0.866 . . . . 12.0 108.663 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.45 -39.05 28.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.885 -0.51 . . . . 12.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.837 HG22 ' O ' ' A' ' 48' ' ' VAL . 4.7 tp -64.32 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 12.0 109.773 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.423 ' HA ' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -104.91 25.57 10.3 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.69 -0.632 . . . . 12.0 110.35 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 m -90.83 115.93 28.28 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.252 -0.647 . . . . 12.0 109.252 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.98 -62.95 0.02 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.573 -1.011 . . . . 12.0 110.573 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.6 p -161.12 -164.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.581 -0.896 . . . . 12.0 108.581 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.599 ' H ' HG22 ' A' ' 55' ' ' VAL . 9.9 tt -88.64 27.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 121.053 -1.029 . . . . 12.0 110.665 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.6 t30 172.44 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 106.961 -1.496 . . . . 12.0 106.961 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.87 178.37 9.83 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.921 0.867 . . . . 12.0 111.841 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.66 112.25 7.83 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.923 -1.51 . . . . 12.0 106.923 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.1 p -141.25 167.92 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.325 -0.621 . . . . 12.0 109.325 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 110' ' ' CYS . 4.7 mp -136.67 130.32 31.99 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.581 -0.448 . . . . 12.0 111.023 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -59.12 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 106.544 -1.651 . . . . 12.0 106.544 176.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.79 HG22 ' OH ' ' A' ' 91' ' ' TYR . 3.1 p -80.61 -43.1 21.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.325 -0.234 . . . . 12.0 110.512 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.34 -90.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 109.349 -0.612 . . . . 12.0 109.349 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.788 ' CB ' HG23 ' A' ' 89' ' ' THR . 4.7 ptt-85 171.48 101.06 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.211 -0.663 . . . . 12.0 109.211 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 62.0 m-85 -97.25 48.38 1.04 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 120.462 -0.495 . . . . 12.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 16.57 107.92 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.525 1.305 . . . . 12.0 114.525 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.635 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -104.06 155.59 18.56 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.066 0.936 . . . . 12.0 112.474 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.494 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -116.87 97.42 5.95 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 105.25 -2.13 . . . . 12.0 105.25 176.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 m -104.18 128.29 51.87 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.5 0.926 . . . . 12.0 113.5 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.2 m -111.01 108.18 17.83 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.44 -2.8 . . . . 12.0 103.44 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -109.55 145.86 35.63 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 120.17 -0.612 . . . . 12.0 112.311 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.7 ttp85 -64.27 116.0 5.59 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.937 -0.764 . . . . 12.0 108.937 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p -111.95 -84.71 0.57 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.934 -0.479 . . . . 12.0 110.742 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 t -142.15 152.57 43.33 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.764 -0.585 . . . . 12.0 110.123 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.563 ' O ' HD12 ' A' ' 76' ' ' ILE . 2.0 pp -64.62 121.12 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.01 0.433 . . . . 12.0 109.934 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 78' ' ' PRO . 1.3 m -173.13 -62.17 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.233 -1.025 . . . . 12.0 108.233 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 77' ' ' THR . 37.1 Cg_endo -75.33 -164.71 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 121.893 1.729 . . . . 12.0 109.673 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 mtt-85 -153.0 162.23 26.93 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.922 -0.486 . . . . 12.0 109.855 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -73.21 -38.55 1.75 Allowed 'Cis proline' 0 N--CA 1.488 1.169 0 O-C-N 123.295 1.155 . . . . 12.0 110.358 1.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.1 OUTLIER -106.71 162.04 20.97 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.259 -1.015 . . . . 12.0 108.259 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 36.6 Cg_endo -76.12 101.71 1.52 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.68 1.587 . . . . 12.0 109.65 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.441 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 18.9 m-85 -139.75 138.33 35.82 Favored 'General case' 0 N--CA 1.509 2.489 0 CA-C-O 121.354 0.597 . . . . 12.0 111.198 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -114.79 121.76 44.29 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 p -84.32 143.99 29.15 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 120.991 0.424 . . . . 12.0 110.395 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -154.66 159.49 40.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.276 -0.638 . . . . 12.0 109.276 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.6 m -130.45 142.14 50.5 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.062 -0.718 . . . . 12.0 109.062 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.94 -169.46 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.309 0.575 . . . . 12.0 110.521 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.788 HG23 ' CB ' ' A' ' 65' ' ' ARG . 98.3 m -64.54 146.47 54.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.082 -0.71 . . . . 12.0 109.082 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' HD12 ' A' ' 41' ' ' ILE . 60.6 t30 -108.67 88.78 2.81 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.989 0.899 . . . . 12.0 111.383 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.79 ' OH ' HG22 ' A' ' 63' ' ' THR . 2.3 t80 -98.43 103.95 15.94 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.84 -2.281 . . . . 12.0 104.84 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.628 HD13 ' O ' ' A' ' 91' ' ' TYR . 33.0 mm -127.75 163.38 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 119.685 -0.806 . . . . 12.0 111.99 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.522 ' HB2' HD23 ' A' ' 61' ' ' LEU . 51.6 t -115.91 106.44 13.8 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 101' ' ' PRO . 5.5 p -113.85 172.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.953 -0.388 . . . . 12.0 109.953 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.534 ' H ' HG22 ' A' ' 94' ' ' VAL . 65.0 mttt -126.65 143.18 51.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -111.0 115.68 29.89 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.265 1.209 . . . . 12.0 114.265 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.611 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.7 tt0 -125.77 142.72 51.37 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 104.055 -2.572 . . . . 12.0 104.055 174.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 60.3 m-80 54.84 29.55 12.16 Favored 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 14.5 pt20 52.1 11.11 0.14 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 114.651 1.352 . . . . 12.0 114.651 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.891 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -118.12 146.99 40.53 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 174.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.539 ' HB3' HG21 ' A' ' 94' ' ' VAL . 24.3 Cg_endo -60.54 89.89 0.08 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 121.262 1.308 . . . . 12.0 108.819 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.891 HG22 ' CE2' ' A' ' 100' ' ' TYR . 47.2 t -86.22 -19.63 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 116.345 -0.388 . . . . 12.0 110.887 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -140.77 144.57 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.657 -0.868 . . . . 12.0 108.657 -177.146 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -109.07 132.11 54.43 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.068 -1.053 . . . . 12.0 108.366 178.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.12 -24.19 14.66 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.092 -0.38 . . . . 12.0 111.992 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.45 178.32 47.75 Favored Glycine 0 N--CA 1.503 3.143 0 N-CA-C 110.577 -1.009 . . . . 12.0 110.577 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 92' ' ' ILE . 10.4 pt -92.65 25.1 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.45 -0.441 . . . . 12.0 110.692 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.75 -53.2 0.79 Allowed Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.591 -1.403 . . . . 12.0 109.591 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 126.07 28.98 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 122.202 -0.587 . . . . 12.0 109.588 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.563 ' HB2' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -142.08 168.04 14.82 Favored Pre-proline 0 N--CA 1.501 2.108 0 N-CA-C 109.563 -0.532 . . . . 12.0 109.563 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.481 0.736 0 C-N-CA 121.667 1.578 . . . . 12.0 110.222 179.192 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.374 0 N-CA-C 109.911 -0.403 . . . . 12.0 109.911 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -143.13 158.67 43.4 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.403 ' CZ3' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -70.85 -31.85 68.68 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 122.157 -0.339 . . . . 12.0 110.874 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.87 2.01 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.542 -0.724 . . . . 12.0 110.474 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.2 m -62.29 -32.56 73.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.503 -0.925 . . . . 12.0 108.503 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 36.3 t80 -73.89 -23.86 59.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.69 -0.855 . . . . 12.0 108.69 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 17.4 tt0 -57.65 -37.85 74.06 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.129 -1.434 . . . . 12.0 107.129 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -75.59 -34.14 60.61 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 176.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 17.9 tptt -46.42 -59.0 3.23 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 122.215 -0.303 . . . . 12.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.65 ' HA ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -104.11 1.09 30.43 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 118.482 -0.771 . . . . 12.0 112.758 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 11' ' ' ILE . 4.1 mp -134.74 65.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 117.866 -1.534 . . . . 12.0 114.958 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.914 HD12 ' CD1' ' A' ' 40' ' ' PHE . 23.3 mt -97.53 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 103.88 -2.637 . . . . 12.0 103.88 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -65.01 83.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.815 0.817 . . . . 12.0 110.186 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 p -129.26 90.54 44.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -73.99 -3.02 13.11 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.679 1.586 . . . . 12.0 112.081 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.805 HD11 ' CG2' ' A' ' 22' ' ' ILE . 18.4 pt -58.43 -170.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.246 -0.65 . . . . 12.0 109.246 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.9 40.65 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.469 0.652 . . . . 12.0 109.81 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -142.76 101.02 3.78 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.9 -0.5 . . . . 12.0 110.18 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' CG1' ' A' ' 22' ' ' ILE . 10.7 m -81.16 -3.17 51.31 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.934 -0.479 . . . . 12.0 110.829 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -84.7 -58.02 2.89 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.521 -0.737 . . . . 12.0 111.685 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 m -65.47 -23.44 66.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.593 -0.692 . . . . 12.0 110.402 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.805 ' CG2' HD11 ' A' ' 16' ' ' ILE . 2.7 pp -84.04 -35.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.419 -0.585 . . . . 12.0 109.419 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.509 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.2 ttm -83.28 -5.53 59.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.143 -0.348 . . . . 12.0 110.198 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.68 91.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' HD12 ' A' ' 27' ' ' ILE . 8.0 t-20 -168.07 152.98 6.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.428 -0.582 . . . . 12.0 109.428 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -73.15 -7.97 53.74 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 120.664 -0.414 . . . . 12.0 110.043 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 27' ' ' ILE . 55.5 mt -88.41 10.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.687 -0.633 . . . . 12.0 110.317 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.87 ' OH ' HD11 ' A' ' 12' ' ' ILE . 47.0 m-85 -138.46 57.93 1.68 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.744 -0.597 . . . . 12.0 110.391 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.99 -1.069 . . . . 12.0 109.511 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.8 p -107.41 -165.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 108.02 -1.104 . . . . 12.0 108.02 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.568 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -96.91 67.81 0.88 Allowed Glycine 0 N--CA 1.505 3.265 0 O-C-N 121.044 -1.035 . . . . 12.0 112.063 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.85 -63.53 0.03 OUTLIER Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.23 -1.548 . . . . 12.0 109.23 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -164.44 -64.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.667 -1.235 . . . . 12.0 107.667 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.9 p -174.51 126.15 0.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.944 -1.132 . . . . 12.0 107.944 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -56.19 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.986 -0.446 . . . . 12.0 109.941 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 mtm-85 -106.18 21.45 17.35 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.903 -0.319 . . . . 12.0 110.488 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -163.53 133.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.595 -0.691 . . . . 12.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.0 99.07 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.944 -1.502 . . . . 12.0 106.944 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 m -87.4 110.85 20.56 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.291 0.567 . . . . 12.0 111.524 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.914 ' CD1' HD12 ' A' ' 12' ' ' ILE . 18.9 m-85 -98.25 162.21 13.3 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.671 HD12 ' C ' ' A' ' 40' ' ' PHE . 4.5 mp -132.8 128.1 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.183 -0.948 . . . . 12.0 109.756 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.405 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 4.4 mt -94.66 107.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.8 t 177.2 148.08 0.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.62 -0.511 . . . . 12.0 109.62 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 p -64.25 129.51 40.22 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.052 -1.092 . . . . 12.0 108.052 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB1' ' CZ3' ' A' ' 3' ' ' TRP . . . -48.67 -30.9 5.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.881 -0.512 . . . . 12.0 111.589 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -78.97 -33.88 44.79 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.937 -0.477 . . . . 12.0 111.837 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -62.44 -39.72 94.25 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.281 -1.377 . . . . 12.0 107.281 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.806 ' O ' HG22 ' A' ' 51' ' ' ILE . 37.2 t -69.26 -35.79 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.752 -1.203 . . . . 12.0 107.752 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -22.55 66.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.195 -0.668 . . . . 12.0 109.195 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.05 29.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.966 -0.459 . . . . 12.0 109.903 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.0 tp -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.749 -0.594 . . . . 12.0 110.164 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.06 26.52 8.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.858 -0.526 . . . . 12.0 109.937 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.5 m -88.06 111.51 21.63 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.875 -0.787 . . . . 12.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.46 -60.4 0.02 OUTLIER Glycine 0 N--CA 1.499 2.877 0 N-CA-C 110.643 -0.983 . . . . 12.0 110.643 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.3 p -163.93 -169.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.866 -0.785 . . . . 12.0 108.904 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.612 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.7 pt -87.27 25.55 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 O-C-N 121.11 -0.994 . . . . 12.0 111.197 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.419 ' H ' HG13 ' A' ' 55' ' ' VAL . 9.3 t30 174.67 113.48 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 106.86 -1.533 . . . . 12.0 106.86 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.6 ttt -161.21 174.55 13.46 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.855 0.836 . . . . 12.0 111.739 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -132.51 110.67 10.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.593 -1.632 . . . . 12.0 106.593 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 61' ' ' LEU . 11.0 t -121.78 168.53 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.745 -0.597 . . . . 12.0 109.827 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.469 ' N ' HG12 ' A' ' 60' ' ' VAL . 5.0 mp -131.0 112.17 12.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.121 -0.362 . . . . 12.0 110.662 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -60.4 92.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 107.502 -1.295 . . . . 12.0 107.502 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -83.28 -42.26 17.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.916 -0.49 . . . . 12.0 111.019 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -53.05 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 109.771 -0.455 . . . . 12.0 109.771 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.738 ' CB ' HG23 ' A' ' 89' ' ' THR . 2.2 ptp180 178.53 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.425 -0.797 . . . . 12.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 72.8 m-85 -96.51 43.7 1.07 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 120.446 -0.502 . . . . 12.0 109.678 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 18.91 106.11 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.211 1.189 . . . . 12.0 114.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.56 153.86 18.71 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.782 0.801 . . . . 12.0 111.836 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.405 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 7.2 t30 -119.99 102.47 8.57 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 106.467 -1.679 . . . . 12.0 106.467 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -100.94 124.73 47.08 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.944 -0.703 . . . . 12.0 111.797 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.2 m -108.82 109.39 20.5 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.095 -2.557 . . . . 12.0 104.095 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -114.15 140.84 48.19 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.821 -0.752 . . . . 12.0 111.523 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -58.61 110.49 1.0 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.306 -0.627 . . . . 12.0 109.306 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.8 p -135.24 -94.09 0.27 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.071 -0.393 . . . . 12.0 110.539 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.901 ' O ' HD13 ' A' ' 76' ' ' ILE . 34.8 p -156.74 105.21 2.19 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.372 -0.83 . . . . 12.0 109.501 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.901 HD13 ' O ' ' A' ' 75' ' ' SER . 8.5 mm -136.27 165.47 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.872 -0.788 . . . . 12.0 108.872 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.45 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 1.3 m -51.11 -48.06 86.09 Favored Pre-proline 0 N--CA 1.505 2.288 0 CA-C-O 118.73 -0.653 . . . . 12.0 112.234 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 77' ' ' THR . 35.5 Cg_endo -77.72 126.78 8.34 Favored 'Trans proline' 0 N--CA 1.478 0.56 0 C-N-CA 122.131 1.887 . . . . 12.0 111.119 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.58 158.96 49.35 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 108.631 -0.878 . . . . 12.0 108.631 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -75.81 -176.31 18.1 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 O-C-N 123.12 1.063 . . . . 12.0 111.034 0.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.496 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER 60.99 54.03 3.08 Favored Pre-proline 0 N--CA 1.495 1.8 0 CA-C-N 116.499 -0.319 . . . . 12.0 110.845 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 37.0 Cg_endo -78.93 129.19 8.86 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.323 2.015 . . . . 12.0 108.977 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -120.77 136.48 54.87 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 121.647 0.737 . . . . 12.0 112.354 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.527 ' HB3' HD11 ' A' ' 76' ' ' ILE . 70.7 p -109.03 129.63 55.46 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.814 -1.18 . . . . 12.0 107.814 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.8 p -92.81 145.14 24.62 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.308 0.575 . . . . 12.0 111.819 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -149.97 157.29 43.01 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.578 -0.897 . . . . 12.0 108.578 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 m -128.38 153.68 46.8 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.599 -0.519 . . . . 12.0 109.599 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -173.07 179.0 2.35 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.666 -0.414 . . . . 12.0 109.961 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.738 HG23 ' CB ' ' A' ' 65' ' ' ARG . 68.3 m -62.03 143.42 56.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.495 -0.928 . . . . 12.0 108.495 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -107.65 85.77 2.18 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.308 -0.957 . . . . 12.0 112.203 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -100.34 105.17 16.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.226 -2.509 . . . . 12.0 104.226 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.412 ' HA ' ' N ' ' A' ' 108' ' ' GLY . 0.8 OUTLIER -136.32 -177.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 121.653 0.739 . . . . 12.0 112.062 -175.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 18.1 t -117.76 121.3 40.45 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.707 -0.849 . . . . 12.0 108.707 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.599 HG23 ' CZ ' ' A' ' 104' ' ' PHE . 8.1 p -117.5 167.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.844 -0.342 . . . . 12.0 110.595 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 94' ' ' VAL . 36.9 mttt -129.6 138.39 51.23 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.479 -0.934 . . . . 12.0 108.479 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -111.99 122.24 47.22 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 113.92 1.081 . . . . 12.0 113.92 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.673 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 35.0 tt0 -132.23 142.56 49.46 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 103.991 -2.596 . . . . 12.0 103.991 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 33.2 m120 54.13 29.1 9.84 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 107.638 -1.245 . . . . 12.0 107.638 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 98' ' ' ASN . 2.1 pm0 52.94 10.21 0.15 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.168 1.544 . . . . 12.0 115.168 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.905 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -115.63 146.24 36.3 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 104.574 -2.38 . . . . 12.0 104.574 174.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.57 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.9 Cg_endo -60.84 88.31 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.034 0 C-N-CA 121.293 1.328 . . . . 12.0 108.764 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.905 HG22 ' CE2' ' A' ' 100' ' ' TYR . 67.2 t -84.35 -24.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.272 -0.422 . . . . 12.0 110.395 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.673 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -132.31 144.38 50.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.344 -1.354 . . . . 12.0 107.344 -178.201 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.599 ' CZ ' HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -120.76 131.1 54.31 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.833 -1.147 . . . . 12.0 110.905 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -78.69 -40.78 32.85 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 116.308 -0.405 . . . . 12.0 110.517 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.69 -121.36 3.24 Favored Glycine 0 N--CA 1.504 3.185 0 C-N-CA 120.378 -0.915 . . . . 12.0 111.299 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.5 pt -65.44 -178.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-O 121.372 0.606 . . . . 12.0 111.496 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' A' ' 92' ' ' ILE . . . -61.63 -85.36 0.05 OUTLIER Glycine 0 N--CA 1.501 3.01 0 N-CA-C 110.887 -0.885 . . . . 12.0 110.887 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -49.53 117.41 2.2 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.902 -0.764 . . . . 12.0 109.861 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.511 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 1.7 m -84.23 -43.18 0.75 Allowed Pre-proline 0 N--CA 1.503 2.202 0 CA-C-O 118.564 -0.731 . . . . 12.0 111.122 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 110' ' ' CYS . 37.5 Cg_endo . . . . . 0 N--CA 1.48 0.683 0 C-N-CA 121.784 1.656 . . . . 12.0 110.198 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.356 0 N-CA-C 109.126 -0.694 . . . . 12.0 109.126 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -128.22 162.96 25.77 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.439 -0.948 . . . . 12.0 108.439 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -72.61 -19.74 61.41 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.706 -0.621 . . . . 12.0 110.733 -177.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.83 -62.13 1.69 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.477 -0.764 . . . . 12.0 110.511 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 27' ' ' ILE . 5.2 m -63.59 -33.4 75.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.664 -1.236 . . . . 12.0 107.664 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 36.5 t80 -74.39 -23.25 58.94 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -54.17 -34.61 60.87 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 106.955 -1.498 . . . . 12.0 106.955 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -74.2 -41.76 60.91 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.381 -1.34 . . . . 12.0 107.381 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 9.2 mmtp -51.9 -29.44 20.02 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 122.001 -0.437 . . . . 12.0 109.879 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.718 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -96.56 -28.38 14.4 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 118.568 -0.729 . . . . 12.0 112.614 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 10' ' ' HIS . 23.2 mm -135.59 72.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.826 1.787 . . . . 12.0 115.826 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.865 HG21 ' CD1' ' A' ' 40' ' ' PHE . 47.2 mm -98.36 61.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 102.211 -3.255 . . . . 12.0 102.211 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.12 74.46 3.69 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.522 -0.763 . . . . 12.0 110.655 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.699 ' OG1' HD12 ' A' ' 22' ' ' ILE . 3.1 p -131.21 70.63 82.21 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.867 -0.79 . . . . 12.0 108.867 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.34 81.76 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.048 1.832 . . . . 12.0 109.812 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.554 HD11 ' CG2' ' A' ' 22' ' ' ILE . 12.3 pt -136.18 -169.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.805 -0.813 . . . . 12.0 108.805 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 pt -105.81 31.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.455 0.645 . . . . 12.0 109.655 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' HB2' HD12 ' A' ' 16' ' ' ILE . 61.5 m-20 -145.15 95.95 2.76 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.569 -0.9 . . . . 12.0 108.569 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.6 m -81.62 -10.08 59.51 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 120.442 -0.503 . . . . 12.0 111.607 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -81.23 -50.68 9.27 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.009 0.822 . . . . 12.0 111.356 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -67.08 -19.23 65.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.823 -0.548 . . . . 12.0 110.649 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.699 HD12 ' OG1' ' A' ' 14' ' ' THR . 35.0 pt -86.33 -39.23 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.737 -0.602 . . . . 12.0 110.536 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.425 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -94.53 10.89 32.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.857 -0.527 . . . . 12.0 110.43 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -60.18 91.57 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.527 ' OD1' HD12 ' A' ' 27' ' ' ILE . 9.4 t-20 -170.74 156.73 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.441 -0.577 . . . . 12.0 109.441 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.13 -9.42 58.4 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.885 -0.413 . . . . 12.0 109.885 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 27' ' ' ILE . 63.0 mt -87.39 9.56 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.718 -0.614 . . . . 12.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -143.36 63.07 1.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.429 -0.794 . . . . 12.0 110.283 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -146.0 151.64 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.866 -1.146 . . . . 12.0 110.639 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 31' ' ' GLY . 61.1 t -105.31 170.4 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 107.583 -1.265 . . . . 12.0 107.583 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -89.89 53.36 3.64 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 109.57 -1.412 . . . . 12.0 109.57 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.13 -58.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.701 -1.76 . . . . 12.0 108.701 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -164.99 -71.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.0 m -138.71 -166.13 1.95 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.753 -0.832 . . . . 12.0 108.753 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.01 173.68 7.39 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -79.2 -21.01 46.92 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.236 -0.29 . . . . 12.0 110.334 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.9 108.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 120.248 -0.581 . . . . 12.0 110.865 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.0 m120 -94.71 85.0 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.269 -1.752 . . . . 12.0 106.269 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 m -79.29 117.1 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.47 0.652 . . . . 12.0 111.824 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.865 ' CD1' HG21 ' A' ' 12' ' ' ILE . 25.2 m-85 -101.89 160.33 14.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.184 -1.413 . . . . 12.0 107.184 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 10' ' ' HIS . 1.5 tt -126.89 127.77 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.989 -1.069 . . . . 12.0 110.006 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 42' ' ' ILE . 2.4 tt -110.82 100.73 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t 173.92 154.28 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 12.0 108.921 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.5 t -51.72 126.37 17.58 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.295 -0.631 . . . . 12.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.558 ' HB2' ' CG1' ' A' ' 11' ' ' ILE . . . -60.52 -37.98 82.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.987 -0.446 . . . . 12.0 110.639 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -76.48 -24.87 53.83 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 120.838 -0.345 . . . . 12.0 111.715 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -65.8 -40.19 91.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 107.007 -1.479 . . . . 12.0 107.007 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.722 HG22 ' CD2' ' A' ' 66' ' ' PHE . 58.7 t -68.55 -39.91 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.791 -1.559 . . . . 12.0 106.791 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -59.67 -22.59 62.14 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.392 -0.596 . . . . 12.0 109.392 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.93 -39.75 41.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.836 -0.54 . . . . 12.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.451 HG13 ' CE1' ' A' ' 66' ' ' PHE . 50.5 mm -66.74 -18.07 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.775 -0.578 . . . . 12.0 110.406 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.2 22.87 9.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.722 -0.611 . . . . 12.0 109.603 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m -87.93 109.95 20.19 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.782 -0.822 . . . . 12.0 108.782 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.77 -61.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.639 -0.984 . . . . 12.0 110.639 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.6 p -160.96 -168.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 117.716 0.758 . . . . 12.0 109.091 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.594 ' H ' HG22 ' A' ' 55' ' ' VAL . 12.5 tt -88.16 27.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.603 0 O-C-N 121.378 -0.827 . . . . 12.0 111.053 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.7 t-20 172.58 117.85 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.513 -1.292 . . . . 12.0 107.513 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -161.77 176.19 11.16 Favored 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.635 0.731 . . . . 12.0 111.599 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -131.82 116.42 17.21 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.377 -1.712 . . . . 12.0 106.377 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 61' ' ' LEU . 10.2 p -132.5 163.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 120.193 -0.603 . . . . 12.0 110.432 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.67 HD11 ' O ' ' A' ' 108' ' ' GLY . 0.6 OUTLIER -127.5 111.77 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.649 -0.5 . . . . 12.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.752 ' HB2' HG22 ' A' ' 92' ' ' ILE . 18.1 m -59.57 92.25 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.735 -0.839 . . . . 12.0 108.735 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.723 HG22 ' OH ' ' A' ' 91' ' ' TYR . 2.1 p -77.97 -49.93 13.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.832 -0.803 . . . . 12.0 108.832 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 7.4 p -59.78 106.77 0.52 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.747 -1.205 . . . . 12.0 107.747 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.903 ' HB3' HG23 ' A' ' 89' ' ' THR . 19.3 ptt-85 -37.32 107.13 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 112.863 0.69 . . . . 12.0 112.863 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.722 ' CD2' HG22 ' A' ' 48' ' ' VAL . 29.3 m-85 -94.04 41.75 1.09 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 20.24 107.08 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.26 1.207 . . . . 12.0 114.26 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.9 154.55 19.5 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 12.0 111.763 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -113.55 97.65 6.58 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.452 -2.425 . . . . 12.0 104.452 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.4 m -99.05 123.9 43.67 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.796 -0.761 . . . . 12.0 112.85 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.3 m -107.11 105.96 16.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 104.391 -2.448 . . . . 12.0 104.391 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -99.47 144.26 28.78 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 120.43 -0.508 . . . . 12.0 110.754 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -70.22 113.53 7.48 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.715 -0.846 . . . . 12.0 108.715 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.7 p -137.12 -90.55 0.25 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 122.013 -0.43 . . . . 12.0 110.665 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.441 ' HA ' ' CG ' ' A' ' 82' ' ' PRO . 25.0 p 177.37 120.69 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.554 -0.716 . . . . 12.0 110.311 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.0 pt -150.51 -175.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.748 -0.464 . . . . 12.0 109.748 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.442 ' N ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -51.48 -55.25 30.82 Favored Pre-proline 0 N--CA 1.507 2.394 0 CA-C-O 119.014 -0.517 . . . . 12.0 111.301 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 77' ' ' THR . 33.4 Cg_endo -73.03 124.23 9.44 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.037 1.825 . . . . 12.0 111.453 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -147.33 165.76 18.03 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 108.886 -0.783 . . . . 12.0 108.886 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -76.72 -172.51 11.28 Favored 'Cis proline' 0 N--CA 1.483 0.891 0 O-C-N 123.14 1.074 . . . . 12.0 110.575 0.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 23.7 m 56.57 62.58 6.23 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 110.002 -0.37 . . . . 12.0 110.002 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.441 ' CG ' ' HA ' ' A' ' 75' ' ' SER . 34.3 Cg_endo -79.3 143.62 17.62 Favored 'Trans proline' 0 N--CA 1.48 0.687 0 C-N-CA 122.265 1.977 . . . . 12.0 109.612 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 27.8 m-85 -139.21 142.05 37.89 Favored 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.328 0.585 . . . . 12.0 111.094 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 t -115.42 134.3 55.22 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.841 -1.17 . . . . 12.0 107.841 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.4 m -96.08 139.52 32.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.551 0.691 . . . . 12.0 111.853 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -151.33 120.94 6.95 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.242 -1.021 . . . . 12.0 108.242 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 68' ' ' LEU . 22.8 m -104.6 149.8 25.21 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.557 -0.535 . . . . 12.0 109.557 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -176.89 -171.84 0.39 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.671 -0.411 . . . . 12.0 110.362 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.903 HG23 ' HB3' ' A' ' 65' ' ' ARG . 66.0 m -49.76 136.26 17.95 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.867 -0.42 . . . . 12.0 109.867 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' OD1' HD23 ' A' ' 68' ' ' LEU . 65.2 t30 -107.68 87.09 2.42 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.993 0.902 . . . . 12.0 111.397 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.723 ' OH ' HG22 ' A' ' 63' ' ' THR . 0.4 OUTLIER -95.4 101.44 13.16 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 104.571 -2.381 . . . . 12.0 104.571 176.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.752 HG22 ' HB2' ' A' ' 62' ' ' SER . 16.0 tt -122.13 161.97 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.523 -0.871 . . . . 12.0 112.862 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.13 113.94 26.1 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.927 -1.138 . . . . 12.0 107.927 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 104' ' ' PHE . 10.8 m -126.57 -172.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 116.15 -0.477 . . . . 12.0 109.963 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 54.1 mttt -144.65 157.28 44.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.098 -0.705 . . . . 12.0 109.098 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.2 m -119.47 116.33 25.89 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.802 0.667 . . . . 12.0 112.802 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.624 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 17.5 tt0 -124.92 143.62 50.77 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 104.336 -2.468 . . . . 12.0 104.336 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.5 m120 55.17 29.13 12.1 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.7 pt20 53.26 10.37 0.19 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.073 1.349 . . . . 12.0 114.523 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.86 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -115.88 146.88 37.91 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 104.964 -2.236 . . . . 12.0 104.964 174.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.494 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 23.7 Cg_endo -61.02 92.48 0.1 Allowed 'Trans proline' 0 C--O 1.205 -1.172 0 N-CA-C 108.28 -1.469 . . . . 12.0 108.28 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.86 HG22 ' CE2' ' A' ' 100' ' ' TYR . 54.5 t -91.21 -8.66 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 116.263 -0.426 . . . . 12.0 110.731 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.624 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -142.71 110.79 5.98 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.555 -1.258 . . . . 12.0 112.101 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CE1' HG11 ' A' ' 94' ' ' VAL . 5.9 m-30 -100.22 112.19 24.5 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 105.254 -2.128 . . . . 12.0 105.254 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -129.89 7.04 5.12 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.434 0.902 . . . . 12.0 113.434 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 92' ' ' ILE . . . -151.92 160.43 28.83 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.927 -1.269 . . . . 12.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 107' ' ' ILE . 37.6 mt -104.29 28.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.895 -0.78 . . . . 12.0 108.895 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.67 ' O ' HD11 ' A' ' 61' ' ' LEU . . . 131.66 -65.13 0.6 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.595 -1.402 . . . . 12.0 109.595 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.7 ttt-85 -60.54 157.76 13.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.149 -0.619 . . . . 12.0 109.556 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.53 167.63 1.18 Allowed Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 109.376 -0.602 . . . . 12.0 109.376 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.481 0.738 0 C-N-CA 121.705 1.603 . . . . 12.0 109.972 179.435 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . 0.61 ' HG2' HG12 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.509 2.481 0 CA-C-O 120.797 0.332 . . . . 12.0 110.253 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 33.3 t30 -167.33 159.01 12.21 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 12.0 108.795 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -26.18 63.8 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 122.05 -0.406 . . . . 12.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 7' ' ' GLN . . . -77.48 -60.8 2.22 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 121.597 -0.69 . . . . 12.0 110.396 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 HG21 ' A' ' 27' ' ' ILE . 47.7 m -60.18 -29.49 68.73 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.126 -1.064 . . . . 12.0 108.126 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 26.9 t80 -81.62 -23.96 36.7 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.285 -0.635 . . . . 12.0 109.285 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -57.16 -28.78 63.08 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 178.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -83.79 -37.3 22.74 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.471 -1.307 . . . . 12.0 107.471 177.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 4.0 tptp -48.11 -47.97 34.09 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.771 0.319 . . . . 12.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.903 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -100.95 -17.56 16.73 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 118.53 -0.747 . . . . 12.0 112.149 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 11' ' ' ILE . 4.0 mp -139.44 75.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 116.819 2.155 . . . . 12.0 116.819 -175.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.437 ' CG1' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -97.6 62.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.9 -3.0 . . . . 12.0 102.9 171.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -71.75 78.85 0.85 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.989 -1.005 . . . . 12.0 112.533 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 p -121.38 122.69 27.96 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 107.273 -1.38 . . . . 12.0 107.273 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -71.85 -3.04 12.4 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 121.48 1.454 . . . . 12.0 112.114 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.11 159.53 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.6 -0.889 . . . . 12.0 108.6 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 tt -108.59 39.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 108.549 -0.908 . . . . 12.0 108.549 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -128.38 101.05 6.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -74.94 -18.42 60.4 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 120.499 -0.481 . . . . 12.0 111.174 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.89 -55.03 5.08 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 118.8 0.727 . . . . 12.0 110.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.39 -30.87 63.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.214 -0.304 . . . . 12.0 110.229 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 23' ' ' MET . 50.9 pt -81.02 -36.95 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.546 -0.462 . . . . 12.0 110.243 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.42 ' N ' HG13 ' A' ' 22' ' ' ILE . 9.6 ptt? -91.99 8.39 37.8 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.323 -0.551 . . . . 12.0 110.46 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 92.38 0.08 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.271 -1.381 . . . . 12.0 107.271 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -172.28 149.53 2.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.219 -0.659 . . . . 12.0 109.219 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -63.61 -12.87 36.85 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.061 -0.399 . . . . 12.0 109.996 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.618 HG21 HG23 ' A' ' 5' ' ' THR . 16.6 mt -84.45 11.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.702 -0.624 . . . . 12.0 110.658 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -146.48 64.27 1.2 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.44 -0.787 . . . . 12.0 110.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -146.99 151.25 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.761 -1.212 . . . . 12.0 110.398 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 31' ' ' GLY . 40.5 t -100.8 169.1 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.984 -1.117 . . . . 12.0 107.984 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -91.01 53.02 3.25 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.259 -1.536 . . . . 12.0 109.259 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.52 -57.03 0.02 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.238 -1.545 . . . . 12.0 109.238 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.42 -69.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.046 -0.679 . . . . 12.0 109.447 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.6 m -141.18 -176.82 4.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -109.82 164.06 12.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.996 -0.742 . . . . 12.0 108.996 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -80.13 -20.01 45.95 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.838 -0.345 . . . . 12.0 110.367 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.4 p -159.88 115.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.469 0.652 . . . . 12.0 111.106 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 12.3 m120 -103.18 84.89 2.4 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.385 -1.709 . . . . 12.0 106.385 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.8 m -81.46 115.99 21.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.395 0.617 . . . . 12.0 110.657 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.475 ' O ' HD13 ' A' ' 41' ' ' ILE . 33.1 m-85 -106.84 165.5 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.3 -1.0 . . . . 12.0 108.3 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.52 HD12 ' ND2' ' A' ' 90' ' ' ASN . 42.5 mm -125.88 124.08 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 42' ' ' ILE . 3.3 tt -104.37 109.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 108.702 -0.851 . . . . 12.0 108.702 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t 178.18 158.24 0.46 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.067 -0.716 . . . . 12.0 109.067 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.65 118.91 4.59 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.877 0.846 . . . . 12.0 109.449 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.09 -60.74 1.94 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 113.34 0.866 . . . . 12.0 113.34 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -25.0 64.98 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.935 -0.478 . . . . 12.0 111.24 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -62.71 -37.64 87.28 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.276 -1.379 . . . . 12.0 107.276 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 10' ' ' HIS . 62.0 t -68.86 -35.49 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.156 -1.424 . . . . 12.0 107.156 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -63.67 -21.41 66.37 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.589 -0.523 . . . . 12.0 109.589 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.22 -37.54 28.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.944 -0.473 . . . . 12.0 109.741 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.6 tp -67.8 -24.99 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.851 -0.531 . . . . 12.0 110.296 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 22.14 11.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.806 -0.559 . . . . 12.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -87.36 115.02 24.5 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.821 -0.549 . . . . 12.0 109.624 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.29 0.02 OUTLIER Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.046 -1.222 . . . . 12.0 110.046 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.9 p -161.88 -165.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.608 ' H ' HG22 ' A' ' 55' ' ' VAL . 3.8 pt -90.37 29.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 O-C-N 121.131 -0.98 . . . . 12.0 110.733 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 174.51 118.64 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.324 -1.361 . . . . 12.0 107.324 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.88 177.7 7.69 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.119 0.962 . . . . 12.0 112.501 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -139.07 111.69 7.68 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.237 -1.764 . . . . 12.0 106.237 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.8 p -130.69 163.98 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.309 -0.556 . . . . 12.0 110.367 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.76 HD11 ' O ' ' A' ' 108' ' ' GLY . 7.6 tp -117.6 114.4 23.35 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.386 -0.227 . . . . 12.0 110.386 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 66' ' ' PHE . 3.5 m -59.55 92.91 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.318 -0.993 . . . . 12.0 108.318 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -83.04 -171.64 3.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.763 -0.458 . . . . 12.0 109.763 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.443 HG22 ' HG2' ' A' ' 65' ' ' ARG . 97.9 m 62.84 -101.7 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.38 -0.971 . . . . 12.0 108.38 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.761 ' HB3' HG23 ' A' ' 89' ' ' THR . 15.9 ptt180 179.72 107.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 119.441 1.019 . . . . 12.0 110.833 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HE2' HD13 ' A' ' 51' ' ' ILE . 51.2 m-85 -96.01 43.62 1.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 108.497 -0.927 . . . . 12.0 108.497 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 22.55 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 113.859 1.059 . . . . 12.0 113.859 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.06 152.83 18.89 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.039 0.923 . . . . 12.0 111.664 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -118.99 98.29 6.11 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 105.726 -1.953 . . . . 12.0 105.726 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -98.42 123.23 42.44 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.619 0.723 . . . . 12.0 112.153 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.9 m -109.56 108.61 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.379 -2.452 . . . . 12.0 104.379 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -104.36 142.96 33.65 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.061 -0.656 . . . . 12.0 111.596 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.2 ttt180 -71.34 137.92 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.293 -0.632 . . . . 12.0 109.293 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.05 -90.37 0.45 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.492 -0.558 . . . . 12.0 109.492 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.76 144.76 1.85 Allowed 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.618 -0.676 . . . . 12.0 109.701 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.439 HG22 ' CG ' ' A' ' 82' ' ' PRO . 2.1 tt -172.98 151.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.101 -0.703 . . . . 12.0 109.101 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.412 ' N ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -79.42 -59.4 0.6 Allowed Pre-proline 0 N--CA 1.507 2.388 0 CA-C-O 118.977 -0.535 . . . . 12.0 111.479 -178.174 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 77' ' ' THR . 31.9 Cg_endo -70.03 179.07 4.11 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.071 1.848 . . . . 12.0 111.883 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.418 ' CB ' ' HA ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -98.3 170.44 7.03 Favored Pre-proline 0 N--CA 1.502 2.161 0 CA-C-N 116.316 -0.402 . . . . 12.0 110.201 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.418 ' HA ' ' CB ' ' A' ' 79' ' ' ARG . 32.4 Cg_endo -76.04 -75.55 0.0 OUTLIER 'Cis proline' 0 N--CA 1.49 1.277 0 O-C-N 123.325 1.171 . . . . 12.0 110.939 0.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.2 m -134.3 156.72 78.73 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 108.821 -0.807 . . . . 12.0 108.821 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' CG ' HG22 ' A' ' 76' ' ' ILE . 37.2 Cg_endo -78.3 122.63 5.72 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 C-N-CA 121.883 1.722 . . . . 12.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 14.7 m-85 -143.5 131.23 21.36 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.363 0.602 . . . . 12.0 110.854 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -108.78 125.49 52.0 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 107.579 -1.267 . . . . 12.0 107.579 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.0 p -95.44 141.02 29.47 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.084 0.468 . . . . 12.0 110.573 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.16 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.516 -0.92 . . . . 12.0 108.516 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -116.54 148.09 41.18 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 109.615 -0.513 . . . . 12.0 109.615 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.35 -172.32 1.69 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.32 0.581 . . . . 12.0 110.315 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 65' ' ' ARG . 42.0 m -67.31 138.38 56.77 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.566 -0.531 . . . . 12.0 109.566 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.52 ' ND2' HD12 ' A' ' 41' ' ' ILE . 63.3 t30 -106.79 89.68 3.09 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.054 0.93 . . . . 12.0 111.571 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.78 105.28 15.03 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 105.157 -2.164 . . . . 12.0 105.157 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.507 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 4.3 pt -138.95 -175.72 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.943 -0.703 . . . . 12.0 112.404 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.449 ' HA ' HD12 ' A' ' 61' ' ' LEU . 32.1 t -122.63 116.34 23.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.864 -0.607 . . . . 12.0 109.664 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' ' 101' ' ' PRO . 8.8 p -116.73 169.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.92 -0.4 . . . . 12.0 109.92 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 94' ' ' VAL . 27.4 mttt -124.22 142.77 50.97 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.416 -0.587 . . . . 12.0 109.416 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 121.79 45.67 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 114.44 1.274 . . . . 12.0 114.44 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.647 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 23.6 tt0 -133.2 144.95 50.15 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 104.013 -2.588 . . . . 12.0 104.013 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 20.5 m120 54.22 28.04 8.62 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 107.755 -1.202 . . . . 12.0 107.755 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.409 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.8 pt20 52.49 12.84 0.26 Allowed 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 125.316 1.446 . . . . 12.0 114.754 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.894 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.23 148.05 46.34 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 104.857 -2.275 . . . . 12.0 104.857 174.651 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.591 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.3 Cg_endo -60.6 89.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.027 0 C-N-CA 121.301 1.334 . . . . 12.0 108.903 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.894 HG22 ' CE2' ' A' ' 100' ' ' TYR . 55.4 t -86.22 -21.82 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.195 -0.457 . . . . 12.0 110.582 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.647 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -137.61 147.18 44.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.026 -1.101 . . . . 12.0 108.026 -177.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CZ ' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -111.83 133.03 54.31 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.903 -1.119 . . . . 12.0 109.955 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.99 -38.37 19.34 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.22 -0.3 . . . . 12.0 110.668 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.95 -141.48 9.72 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 120.266 -0.969 . . . . 12.0 111.287 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.81 -170.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 122.265 -0.55 . . . . 12.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.76 ' O ' HD11 ' A' ' 61' ' ' LEU . . . -66.39 -22.45 71.21 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 110.781 -0.927 . . . . 12.0 110.781 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 120.91 29.04 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 117.811 0.806 . . . . 12.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.89 167.73 13.76 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 109.478 -0.564 . . . . 12.0 109.478 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.48 0.722 0 C-N-CA 121.822 1.681 . . . . 12.0 110.225 179.711 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.303 0 N-CA-C 109.474 -0.565 . . . . 12.0 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -112.9 153.95 27.13 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.963 -0.755 . . . . 12.0 108.963 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -45.39 61.81 Favored 'General case' 0 N--CA 1.511 2.616 0 O-C-N 122.058 -0.401 . . . . 12.0 110.042 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.12 55.25 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.754 -0.591 . . . . 12.0 110.46 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -64.95 -30.03 70.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.419 -0.956 . . . . 12.0 108.419 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 30.7 t80 -76.56 -20.12 57.18 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.758 -0.83 . . . . 12.0 108.758 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.14 -38.99 93.04 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.855 -1.535 . . . . 12.0 106.855 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -78.21 -34.75 49.17 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.453 -1.314 . . . . 12.0 107.453 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' CG ' ' CD2' ' A' ' 10' ' ' HIS . 0.4 OUTLIER -41.48 -60.62 1.25 Allowed 'General case' 0 N--CA 1.506 2.374 0 CA-C-N 116.393 -0.367 . . . . 12.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.51 ' CD2' ' CG ' ' A' ' 9' ' ' LYS . 96.4 m-70 -110.57 -26.22 9.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.362 0.875 . . . . 12.0 113.362 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 11' ' ' ILE . 4.9 mp -96.62 64.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 119.153 -1.019 . . . . 12.0 113.342 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.872 HD12 ' CD1' ' A' ' 40' ' ' PHE . 54.9 mt -91.86 70.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 105.053 -2.202 . . . . 12.0 105.053 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -70.34 81.99 0.55 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.626 0.727 . . . . 12.0 110.479 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 22' ' ' ILE . 1.7 p -144.1 67.97 15.52 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.58 81.99 2.52 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.868 1.712 . . . . 12.0 109.851 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.3 pt -129.98 -167.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.102 -1.073 . . . . 12.0 108.102 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 pt -102.26 36.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.728 -0.607 . . . . 12.0 109.663 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -152.57 98.33 2.35 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.722 -0.611 . . . . 12.0 110.557 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -82.49 -4.49 57.58 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 121.75 -0.593 . . . . 12.0 110.626 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.34 -50.5 8.86 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.353 -0.842 . . . . 12.0 111.532 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.2 m -66.29 -23.11 66.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.787 -0.571 . . . . 12.0 110.507 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 14' ' ' THR . 50.4 pt -84.73 -32.56 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.721 -0.612 . . . . 12.0 109.727 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.2 ttm -92.86 2.93 56.51 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 122.096 -0.378 . . . . 12.0 110.646 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.75 91.32 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.476 -0.935 . . . . 12.0 108.476 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.505 ' ND2' HD12 ' A' ' 27' ' ' ILE . 45.1 t30 -169.79 148.54 3.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.214 -0.662 . . . . 12.0 109.214 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -67.54 -10.9 56.11 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 110.092 -0.336 . . . . 12.0 110.092 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 27' ' ' ILE . 61.4 mt -85.42 9.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.778 -0.576 . . . . 12.0 110.635 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.462 ' OH ' HD11 ' A' ' 12' ' ' ILE . 43.4 m-85 -142.41 64.2 1.38 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.577 -0.702 . . . . 12.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.3 mt -141.57 153.42 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.736 -1.228 . . . . 12.0 111.143 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 31' ' ' GLY . 59.9 t -109.05 170.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 107.477 -1.305 . . . . 12.0 107.477 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.42 53.78 3.48 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.272 -1.531 . . . . 12.0 109.272 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.68 -57.35 0.02 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.349 -1.501 . . . . 12.0 109.349 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -166.74 -72.54 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.6 p -154.72 142.42 19.89 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.932 -0.766 . . . . 12.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' CA ' HG21 ' A' ' 30' ' ' VAL . 3.7 tttm -62.06 -176.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 2.57 34.64 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 121.003 -0.279 . . . . 12.0 110.69 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 37' ' ' VAL . 4.4 p -161.67 111.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.666 0.746 . . . . 12.0 110.314 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 6.3 m120 -103.79 81.88 1.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.453 -1.684 . . . . 12.0 106.453 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 m -82.85 110.89 18.25 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.977 -0.556 . . . . 12.0 111.225 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.872 ' CD1' HD12 ' A' ' 12' ' ' ILE . 11.6 m-85 -105.46 161.18 14.56 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 10' ' ' HIS . 45.6 mm -117.79 135.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.435 -0.791 . . . . 12.0 108.992 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -105.19 110.09 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.425 -0.954 . . . . 12.0 108.425 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t 174.32 150.98 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.203 -0.666 . . . . 12.0 109.203 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.816 ' O ' HG22 ' A' ' 47' ' ' THR . 18.6 p -60.63 126.19 26.5 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.393 -0.966 . . . . 12.0 108.393 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.94 -30.9 59.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.057 -0.402 . . . . 12.0 110.825 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -74.74 -31.87 61.94 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.69 -0.404 . . . . 12.0 111.023 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 44' ' ' SER . 13.7 t -63.98 -33.63 76.17 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 107.406 -1.331 . . . . 12.0 107.406 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' A' ' 101' ' ' PRO . 21.0 t -72.88 -36.07 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.403 -1.332 . . . . 12.0 107.403 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -63.06 -21.03 65.89 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.668 -0.493 . . . . 12.0 109.668 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.53 -39.23 24.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.999 -0.438 . . . . 12.0 109.894 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.565 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 3.4 pt -69.6 -18.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.685 -0.634 . . . . 12.0 111.124 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.34 26.73 10.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.872 -0.517 . . . . 12.0 110.425 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -95.69 108.3 20.58 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.686 -0.633 . . . . 12.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.87 -57.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.523 -1.031 . . . . 12.0 110.523 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 56' ' ' ILE . 9.6 p -157.08 179.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.994 -0.71 . . . . 12.0 109.1 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.561 ' H ' HG22 ' A' ' 55' ' ' VAL . 38.7 pt -83.18 26.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 121.195 -0.94 . . . . 12.0 111.662 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.527 ' H ' HG13 ' A' ' 55' ' ' VAL . 0.8 OUTLIER 177.14 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.797 -1.557 . . . . 12.0 106.797 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.412 ' SD ' HG12 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -156.64 179.09 9.61 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 122.003 0.906 . . . . 12.0 112.016 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.8 118.18 16.75 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.401 -1.703 . . . . 12.0 106.401 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG13 ' CG2' ' A' ' 94' ' ' VAL . 14.9 p -141.95 170.13 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.304 -0.628 . . . . 12.0 109.304 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 61' ' ' LEU . 4.5 mp -137.71 120.55 16.41 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.844 -0.535 . . . . 12.0 111.154 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.54 ' HB3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -60.41 92.51 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -90.92 -28.18 18.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.052 -0.405 . . . . 12.0 111.102 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -56.2 -77.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.675 ' CG ' HG23 ' A' ' 89' ' ' THR . 0.6 OUTLIER 172.14 106.59 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.959 -0.463 . . . . 12.0 110.017 178.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 73.9 m-85 -122.02 65.28 0.92 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.803 -1.184 . . . . 12.0 107.803 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -23.31 127.73 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 114.52 1.304 . . . . 12.0 114.52 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.728 HD13 ' OG1' ' A' ' 70' ' ' THR . 4.6 pp -99.85 150.95 21.84 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.694 0.759 . . . . 12.0 111.227 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -118.13 106.37 12.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.646 -1.983 . . . . 12.0 105.646 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.728 ' OG1' HD13 ' A' ' 68' ' ' LEU . 27.2 m -112.07 126.85 55.61 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.757 -0.777 . . . . 12.0 112.599 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.7 m -103.8 110.08 22.05 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 103.385 -2.821 . . . . 12.0 103.385 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.6 m -109.11 143.02 39.01 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 119.919 -0.712 . . . . 12.0 112.227 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.9 ttt180 -64.15 132.21 49.73 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 p -115.52 -91.68 0.52 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.554 -0.458 . . . . 12.0 110.735 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -129.54 141.51 50.96 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.473 -0.767 . . . . 12.0 110.01 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.4 tt -68.5 134.86 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-O 121.431 0.634 . . . . 12.0 110.65 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.49 ' CB ' ' HD3' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -178.65 -58.4 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.013 0 N-CA-C 108.798 -0.816 . . . . 12.0 108.798 178.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' A' ' 77' ' ' THR . 37.9 Cg_endo -82.29 -163.06 0.2 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 122.043 1.829 . . . . 12.0 109.318 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 155.17 46.59 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 109.139 -0.689 . . . . 12.0 109.139 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.21 -41.95 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.14 0 O-C-N 123.135 1.071 . . . . 12.0 110.534 0.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.5 m -132.03 148.82 71.36 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.464 -0.939 . . . . 12.0 108.464 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.4 Cg_endo -75.46 124.75 8.55 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 121.758 1.639 . . . . 12.0 109.815 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 17.0 m-85 -143.1 134.38 25.99 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.284 0.564 . . . . 12.0 110.79 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 p -115.03 123.23 48.52 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.43 -0.952 . . . . 12.0 108.43 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 142.46 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.828 -0.434 . . . . 12.0 109.828 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -146.76 157.2 43.62 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.5 m -129.77 147.9 51.59 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.893 -0.78 . . . . 12.0 108.893 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -165.38 156.34 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.382 -0.527 . . . . 12.0 110.48 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CG ' ' A' ' 65' ' ' ARG . 52.8 m -58.1 124.67 20.17 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 68' ' ' LEU . 4.9 t-20 -121.99 101.36 7.5 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.366 1.247 . . . . 12.0 114.366 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.6 126.77 41.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 102.703 -3.073 . . . . 12.0 102.703 172.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.526 HG23 ' HA2' ' A' ' 106' ' ' GLY . 1.6 mp -121.9 161.5 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 N-CA-C 113.993 1.108 . . . . 12.0 113.993 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.499 ' N ' HG22 ' A' ' 92' ' ' ILE . 37.4 t -100.41 109.45 21.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 106.21 -1.774 . . . . 12.0 106.21 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.541 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 10.6 m -118.66 -177.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.072 0.463 . . . . 12.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 38.7 mtpt -143.73 149.26 36.87 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.899 -0.778 . . . . 12.0 108.899 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.45 116.42 28.18 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.96 0.726 . . . . 12.0 112.96 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.66 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.0 tt0 -125.43 143.08 51.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 104.42 -2.437 . . . . 12.0 104.42 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 1.6 m-80 58.74 14.96 3.46 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.061 -1.024 . . . . 12.0 108.513 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 15.6 mt-30 75.79 -8.25 1.64 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.112 0.965 . . . . 12.0 113.049 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.856 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -105.8 152.55 40.21 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.735 -1.579 . . . . 12.0 106.735 176.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.459 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.6 Cg_endo -61.76 87.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.542 1.495 . . . . 12.0 109.095 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.856 HG22 ' CE2' ' A' ' 100' ' ' TYR . 67.4 t -84.34 -20.72 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.479 -0.328 . . . . 12.0 110.591 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.66 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -130.83 127.49 38.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.925 -1.139 . . . . 12.0 107.925 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.541 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -121.53 122.0 38.72 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.646 -0.872 . . . . 12.0 108.646 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.25 -32.02 12.64 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.775 -0.37 . . . . 12.0 110.506 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA2' HG23 ' A' ' 92' ' ' ILE . . . 97.15 162.04 31.84 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.08 -1.608 . . . . 12.0 109.08 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.41 ' O ' ' O ' ' A' ' 106' ' ' GLY . 60.3 mt 57.24 123.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 12.0 111.118 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.95 80.63 1.74 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 109.685 -1.366 . . . . 12.0 109.685 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.15 95.89 0.97 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.581 ' SG ' HD21 ' A' ' 61' ' ' LEU . 26.6 p 179.76 155.27 0.68 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-O 118.66 -0.686 . . . . 12.0 109.331 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.482 0.811 0 C-N-CA 121.556 1.504 . . . . 12.0 110.202 179.704 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 2.533 0 CA-C-O 120.907 0.384 . . . . 12.0 110.084 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -129.58 166.69 19.21 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.84 -0.8 . . . . 12.0 108.84 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -23.58 64.91 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.614 -0.679 . . . . 12.0 110.357 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.33 -61.44 1.99 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.493 -0.754 . . . . 12.0 110.6 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.53 74.9 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.412 -1.329 . . . . 12.0 107.412 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 24.7 t80 -73.57 -27.49 61.34 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.338 -0.986 . . . . 12.0 108.338 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.91 -33.1 35.56 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 107.72 -1.215 . . . . 12.0 107.72 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -42.02 33.26 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.33 -53.87 6.33 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.232 -0.44 . . . . 12.0 111.18 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.805 ' CG ' HG11 ' A' ' 48' ' ' VAL . 1.1 m-70 -96.75 -15.38 21.41 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.694 -0.629 . . . . 12.0 111.162 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 10' ' ' HIS . 15.7 mm -140.15 87.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 114.231 1.197 . . . . 12.0 114.231 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 35.3 mm -96.73 67.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 105.094 -2.187 . . . . 12.0 105.094 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.534 ' O ' HG23 ' A' ' 14' ' ' THR . 25.2 p-10 -66.81 84.35 0.11 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.932 0.872 . . . . 12.0 110.636 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 13' ' ' ASN . 1.2 p -159.39 63.12 2.18 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 106.976 -1.491 . . . . 12.0 106.976 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.49 85.61 1.26 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.041 1.827 . . . . 12.0 110.598 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.27 -173.09 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.847 -0.797 . . . . 12.0 108.847 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pt -98.67 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.293 0.568 . . . . 12.0 109.636 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -145.03 95.56 2.71 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.434 -0.58 . . . . 12.0 109.434 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.4 m -80.45 -3.18 48.88 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.916 -0.49 . . . . 12.0 110.735 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.6 -50.16 10.34 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.613 0.642 . . . . 12.0 110.974 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 m -63.11 -21.18 66.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.748 -0.595 . . . . 12.0 110.429 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 23' ' ' MET . 45.6 pt -85.78 -38.05 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.679 -0.638 . . . . 12.0 109.904 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.422 ' N ' HG13 ' A' ' 22' ' ' ILE . 3.8 ptm -91.53 11.14 25.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.988 -0.445 . . . . 12.0 110.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -66.41 90.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.489 -0.93 . . . . 12.0 108.489 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.402 HD22 HG22 ' A' ' 27' ' ' ILE . 58.1 t30 -173.11 150.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.453 -0.573 . . . . 12.0 109.453 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -70.52 -9.13 55.9 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 110.09 -0.337 . . . . 12.0 110.09 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -88.82 11.6 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.72 -0.613 . . . . 12.0 110.319 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -140.03 58.95 1.58 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.827 -0.546 . . . . 12.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -148.0 146.6 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.631 -1.293 . . . . 12.0 110.559 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 31' ' ' GLY . 3.5 p -111.67 -164.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.34 -1.355 . . . . 12.0 107.34 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.576 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -97.72 66.3 0.83 Allowed Glycine 0 N--CA 1.506 3.301 0 O-C-N 120.956 -1.09 . . . . 12.0 112.453 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.52 -68.86 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.136 -1.586 . . . . 12.0 109.136 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -164.45 -66.71 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.845 -1.169 . . . . 12.0 107.845 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.0 p -138.8 144.6 39.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.631 -0.877 . . . . 12.0 108.631 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -61.27 -175.03 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.985 -0.447 . . . . 12.0 109.991 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -89.73 -23.11 21.88 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 110.024 -0.361 . . . . 12.0 110.024 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 72' ' ' THR . 4.3 t -150.01 102.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 5.1 m120 -90.99 80.82 5.69 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.649 -1.612 . . . . 12.0 106.649 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -84.17 115.35 22.37 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.936 -0.574 . . . . 12.0 110.825 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.487 ' O ' HD13 ' A' ' 41' ' ' ILE . 32.8 m-85 -105.44 165.58 11.03 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.624 HD12 ' ND2' ' A' ' 90' ' ' ASN . 49.3 mm -127.45 126.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 120.932 -1.105 . . . . 12.0 110.459 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 tt -108.91 127.83 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.11 -0.7 . . . . 12.0 109.11 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.636 ' O ' HD12 ' A' ' 11' ' ' ILE . 30.3 t 170.4 160.37 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.363 -0.977 . . . . 12.0 108.363 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.67 117.93 4.73 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -40.85 -64.63 0.51 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.9 1.074 . . . . 12.0 113.9 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -61.29 -26.21 67.63 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.794 -0.566 . . . . 12.0 111.311 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 m -58.61 -35.54 72.62 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 107.456 -1.312 . . . . 12.0 107.456 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 51' ' ' ILE . 45.7 t -70.19 -37.95 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.294 -1.372 . . . . 12.0 107.294 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -60.68 -21.55 62.96 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.138 -0.69 . . . . 12.0 109.138 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.87 -37.2 27.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 122.009 -0.432 . . . . 12.0 109.919 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.836 HG22 ' O ' ' A' ' 48' ' ' VAL . 6.8 tp -66.82 -24.36 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 120.414 -0.514 . . . . 12.0 110.425 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 22.95 10.69 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.723 -0.611 . . . . 12.0 109.768 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.0 m -84.74 109.22 17.89 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.028 -0.73 . . . . 12.0 109.028 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.93 -58.82 0.02 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.616 -0.994 . . . . 12.0 110.616 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 56' ' ' ILE . 4.7 p -164.89 -175.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.601 ' H ' HG22 ' A' ' 55' ' ' VAL . 48.0 pt -87.08 27.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.315 -0.865 . . . . 12.0 111.34 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.488 ' H ' HG13 ' A' ' 55' ' ' VAL . 6.1 t-20 177.21 116.83 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 107.807 -1.183 . . . . 12.0 107.807 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.5 ttp -165.83 170.81 13.48 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.554 0.692 . . . . 12.0 111.39 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.4 118.03 15.98 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.7 p -150.57 164.55 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.314 -0.624 . . . . 12.0 109.314 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.5 mp -115.3 128.81 56.36 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.051 -0.352 . . . . 12.0 110.051 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.871 ' HB2' HG22 ' A' ' 92' ' ' ILE . 49.5 m -53.62 94.11 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.142 -1.059 . . . . 12.0 108.142 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 1.1 p -77.37 -174.78 3.44 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.834 0.35 . . . . 12.0 110.085 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.726 HG22 ' HG2' ' A' ' 65' ' ' ARG . 96.9 m 63.47 -94.86 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.906 ' HB3' HG23 ' A' ' 89' ' ' THR . 6.1 ptm180 174.0 104.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 118.828 0.74 . . . . 12.0 110.006 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 48.5 m-85 -95.99 43.34 1.08 Allowed 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.193 -0.669 . . . . 12.0 109.193 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 29.64 105.2 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.147 0 N-CA-C 113.87 1.063 . . . . 12.0 113.87 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.62 154.68 19.23 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.033 0.92 . . . . 12.0 112.107 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -117.26 97.02 5.69 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 105.524 -2.028 . . . . 12.0 105.524 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -99.95 122.66 43.2 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.803 -0.759 . . . . 12.0 112.971 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -108.75 105.68 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 103.338 -2.838 . . . . 12.0 103.338 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.506 HG23 HG22 ' A' ' 37' ' ' VAL . 9.4 m -114.34 143.28 45.15 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.9 -0.72 . . . . 12.0 112.613 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 25.7 ttp180 -69.74 109.54 4.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.008 -1.108 . . . . 12.0 108.008 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -145.11 -79.18 0.18 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 120.006 -0.677 . . . . 12.0 112.363 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 77' ' ' THR . 24.5 p -94.48 160.38 14.67 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.775 -0.578 . . . . 12.0 110.989 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 pt -55.88 128.67 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.362 0.601 . . . . 12.0 110.296 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 75' ' ' SER . 2.6 t 172.38 67.5 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 106.935 -1.506 . . . . 12.0 106.935 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.06 109.52 2.72 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 122.025 1.817 . . . . 12.0 112.647 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' N ' ' CA ' ' A' ' 80' ' ' PRO . 2.4 mtp180 -145.78 51.58 1.31 Allowed Pre-proline 0 N--CA 1.486 1.339 0 CA-C-N 115.776 -0.647 . . . . 12.0 109.387 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.415 ' CA ' ' N ' ' A' ' 79' ' ' ARG . 39.2 Cg_endo -88.2 -23.93 8.54 Favored 'Cis proline' 0 N--CA 1.491 1.351 0 O-C-N 122.253 0.607 . . . . 12.0 111.781 -1.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.1 m -86.09 157.63 56.58 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 121.802 -0.561 . . . . 12.0 109.493 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 34.3 Cg_endo -72.25 89.31 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 121.721 1.614 . . . . 12.0 109.468 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.578 ' N ' HG23 ' A' ' 77' ' ' THR . 7.2 m-85 -121.31 140.4 52.14 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-O 121.61 0.719 . . . . 12.0 112.542 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 m -119.15 124.16 46.15 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.559 -1.274 . . . . 12.0 107.559 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -93.12 142.83 26.87 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.924 -0.485 . . . . 12.0 110.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -155.7 132.76 10.71 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.423 -0.584 . . . . 12.0 109.423 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.3 m -92.3 148.82 21.83 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.898 -0.779 . . . . 12.0 108.898 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -169.16 -169.75 1.01 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.23 0.538 . . . . 12.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.906 HG23 ' HB3' ' A' ' 65' ' ' ARG . 53.3 m -67.14 139.44 57.49 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.147 -0.686 . . . . 12.0 109.147 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.624 ' ND2' HD12 ' A' ' 41' ' ' ILE . 67.0 t30 -107.46 87.0 2.4 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.091 0.948 . . . . 12.0 112.392 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' A' ' 63' ' ' THR . 14.5 t80 -99.68 102.39 13.86 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.186 -2.524 . . . . 12.0 104.186 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.871 HG22 ' HB2' ' A' ' 62' ' ' SER . 13.9 tt -124.47 169.85 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.541 -0.864 . . . . 12.0 112.883 -175.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.8 t -113.14 107.76 16.37 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.275 -1.009 . . . . 12.0 108.275 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 92' ' ' ILE . 18.0 m -127.33 -170.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.68 -0.489 . . . . 12.0 109.68 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' HB2' ' CG ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -147.57 161.06 41.89 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.069 -0.652 . . . . 12.0 110.887 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 128.27 52.2 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.646 0.736 . . . . 12.0 111.983 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 14.4 tt0 -147.51 147.08 29.77 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 104.97 -2.233 . . . . 12.0 104.97 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 59.1 18.21 6.22 Favored 'General case' 0 N--CA 1.508 2.472 0 N-CA-C 108.387 -0.968 . . . . 12.0 108.387 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 71.03 -6.01 1.39 Allowed 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.579 0.752 . . . . 12.0 112.71 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.734 ' OH ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -110.55 145.19 31.75 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 106.332 -1.729 . . . . 12.0 106.332 177.24 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.564 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 28.2 Cg_endo -66.52 100.08 0.47 Allowed 'Trans proline' 0 C--O 1.203 -1.264 0 N-CA-C 107.382 -1.815 . . . . 12.0 107.382 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.734 HG23 ' OH ' ' A' ' 100' ' ' TYR . 12.3 p -117.58 7.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 120.057 -0.657 . . . . 12.0 112.654 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -129.87 133.42 46.88 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.669 -1.234 . . . . 12.0 107.669 178.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.02 126.41 50.73 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.967 -0.693 . . . . 12.0 110.684 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 -32.98 13.69 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.89 -0.782 . . . . 12.0 108.89 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 140.14 -149.24 20.73 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.052 -1.219 . . . . 12.0 110.052 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.3 pt -56.16 -172.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.291 -0.535 . . . . 12.0 109.895 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -88.13 58.13 4.25 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.234 -1.146 . . . . 12.0 110.234 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -143.79 96.95 2.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.423 -0.954 . . . . 12.0 108.423 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.412 ' N ' ' HD3' ' A' ' 111' ' ' PRO . 10.1 m -131.66 60.96 55.69 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 109.969 -0.382 . . . . 12.0 109.969 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 110' ' ' CYS . 37.3 Cg_endo . . . . . 0 N--CA 1.478 0.58 0 C-N-CA 122.187 1.925 . . . . 12.0 110.104 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 2.531 0 N-CA-C 109.705 -0.48 . . . . 12.0 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -142.48 168.71 19.09 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.728 -0.841 . . . . 12.0 108.728 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.25 -25.91 65.42 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.588 -0.695 . . . . 12.0 110.207 -178.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.64 -60.31 2.37 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.694 -0.629 . . . . 12.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.72 -35.55 78.36 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.514 -1.291 . . . . 12.0 107.514 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 28.1 t80 -73.8 -25.07 59.93 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -31.76 54.05 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 107.534 -1.284 . . . . 12.0 107.534 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.96 -37.86 33.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -46.73 -53.04 12.61 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 116.335 -0.393 . . . . 12.0 110.63 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.747 ' CG ' HG11 ' A' ' 48' ' ' VAL . 1.3 m-70 -97.09 -16.01 20.71 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.863 -0.523 . . . . 12.0 110.848 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 11' ' ' ILE . 5.0 mp -144.09 87.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.068 1.136 . . . . 12.0 114.068 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.828 HD12 ' CD1' ' A' ' 40' ' ' PHE . 12.6 mt -97.06 65.13 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 103.711 -2.7 . . . . 12.0 103.711 173.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 14' ' ' THR . 8.5 t-20 -66.98 83.0 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.903 0.859 . . . . 12.0 110.699 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 13' ' ' ASN . 1.3 p -155.18 63.18 3.67 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 106.847 -1.538 . . . . 12.0 106.847 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -73.21 84.05 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.086 1.857 . . . . 12.0 111.015 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 17' ' ' ILE . 1.4 mt -121.65 -167.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.787 -1.19 . . . . 12.0 107.787 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.51 ' H ' HG22 ' A' ' 16' ' ' ILE . 2.4 mm -101.91 34.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 108.682 -0.858 . . . . 12.0 108.682 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -145.8 97.6 2.99 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -77.84 -16.28 58.42 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.842 -0.537 . . . . 12.0 111.253 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.18 -49.02 10.6 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 118.854 0.752 . . . . 12.0 110.046 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -31.54 67.27 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.748 -0.464 . . . . 12.0 109.748 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 23' ' ' MET . 47.0 pt -81.12 -36.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 120.627 -0.429 . . . . 12.0 110.208 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -97.03 15.24 22.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.925 -0.484 . . . . 12.0 110.165 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.27 90.78 0.1 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.122 -1.066 . . . . 12.0 108.122 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -166.83 158.06 12.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.236 -0.653 . . . . 12.0 109.236 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -72.89 -10.82 60.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 120.8 -0.36 . . . . 12.0 110.263 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 27' ' ' ILE . 59.6 mt -87.02 9.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.65 -0.656 . . . . 12.0 110.523 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -142.71 63.23 1.39 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.611 -0.68 . . . . 12.0 109.727 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 30' ' ' VAL . 51.3 mt -148.49 153.26 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 120.763 -1.211 . . . . 12.0 110.318 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 35' ' ' LYS . 50.0 t -107.03 169.53 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 107.764 -1.199 . . . . 12.0 107.764 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.71 54.16 3.39 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.117 -1.593 . . . . 12.0 109.117 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.9 -56.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.241 -1.544 . . . . 12.0 109.241 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -165.27 -68.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.04 -0.682 . . . . 12.0 109.401 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.0 m -143.51 -175.77 4.69 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.49 -0.559 . . . . 12.0 109.49 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -105.92 163.72 12.52 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.339 -0.615 . . . . 12.0 109.339 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -73.85 -24.08 59.72 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 110.058 -0.349 . . . . 12.0 110.058 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 37' ' ' VAL . 9.1 p -156.35 109.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.481 0.658 . . . . 12.0 110.804 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 3.0 m-20 -91.27 83.3 5.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.527 -1.657 . . . . 12.0 106.527 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.98 HG21 HD12 ' A' ' 107' ' ' ILE . 23.9 m -82.61 106.43 14.46 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 116.006 -0.543 . . . . 12.0 110.89 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.828 ' CD1' HD12 ' A' ' 12' ' ' ILE . 10.5 m-85 -99.11 157.86 16.06 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.167 -1.42 . . . . 12.0 107.167 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.92 125.57 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.175 -0.953 . . . . 12.0 109.005 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 42' ' ' ILE . 16.2 tt -106.74 118.37 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.489 -0.56 . . . . 12.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t 173.15 154.86 0.1 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.382 -0.97 . . . . 12.0 108.382 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.21 119.2 5.98 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.22 -52.38 12.58 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.053 0.76 . . . . 12.0 113.053 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -61.7 -29.53 70.16 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.026 -0.421 . . . . 12.0 111.558 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -63.19 -35.18 79.45 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.849 ' O ' HG22 ' A' ' 51' ' ' ILE . 42.0 t -71.28 -33.91 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.686 -1.227 . . . . 12.0 107.686 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -61.76 -22.37 65.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.173 -0.677 . . . . 12.0 109.173 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -36.67 28.11 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.653 -0.499 . . . . 12.0 109.653 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 48' ' ' VAL . 5.9 tp -66.08 -25.26 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 C-N-CA 120.372 -0.531 . . . . 12.0 110.792 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.53 24.27 7.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.614 -0.679 . . . . 12.0 109.908 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -88.3 110.94 21.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.254 -0.647 . . . . 12.0 109.254 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.46 -58.78 0.02 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.396 -1.081 . . . . 12.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.609 HG22 ' H ' ' A' ' 56' ' ' ILE . 5.2 p -161.59 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.013 -0.736 . . . . 12.0 109.013 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.609 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.2 tt -83.27 21.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.642 0 O-C-N 121.357 -0.839 . . . . 12.0 111.718 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.583 ' H ' HG13 ' A' ' 55' ' ' VAL . 5.5 t-20 175.25 113.36 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.541 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.5 ttm -163.78 -176.78 4.78 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.485 0.659 . . . . 12.0 111.034 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -137.98 123.5 19.65 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.295 -1.372 . . . . 12.0 107.295 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.6 p -145.37 163.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.907 -0.495 . . . . 12.0 109.869 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 61' ' ' LEU . 2.6 mp -122.72 116.26 23.45 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.587 -0.523 . . . . 12.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 92' ' ' ILE . 1.8 m -55.48 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.699 -0.852 . . . . 12.0 108.699 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -50.45 20.39 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.592 -0.892 . . . . 12.0 108.592 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.7 115.4 3.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.532 -0.914 . . . . 12.0 108.532 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.853 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 106.88 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.152 0.501 . . . . 12.0 111.543 -178.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 28.6 m-85 -94.4 40.08 1.09 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 108.848 -0.797 . . . . 12.0 108.848 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' PHE . 1.4 tp-100 39.86 107.56 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 112.859 0.689 . . . . 12.0 112.859 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.836 HD13 ' OG1' ' A' ' 70' ' ' THR . 3.5 pp -95.99 147.94 23.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 12.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.98 97.47 5.71 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 105.292 -2.114 . . . . 12.0 105.292 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.836 ' OG1' HD13 ' A' ' 68' ' ' LEU . 30.2 m -108.22 128.16 54.48 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.434 -0.906 . . . . 12.0 112.541 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.0 m -112.63 111.9 23.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.288 -2.486 . . . . 12.0 104.288 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -108.64 141.89 39.92 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.12 -0.632 . . . . 12.0 111.401 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -65.3 109.59 2.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.68 -0.859 . . . . 12.0 108.68 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 p -116.75 -115.12 0.33 Allowed 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 120.388 -0.525 . . . . 12.0 111.201 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.0 p -147.38 164.75 32.31 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.094 -1.004 . . . . 12.0 110.154 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.1 mt 63.64 -138.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 107.644 -1.243 . . . . 12.0 107.644 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.553 HG22 ' CD ' ' A' ' 78' ' ' PRO . 0.0 OUTLIER 55.24 -179.58 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.634 0 CA-C-N 120.145 1.338 . . . . 12.0 108.938 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.553 ' CD ' HG22 ' A' ' 77' ' ' THR . 30.4 Cg_endo -74.75 106.59 2.29 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 121.08 1.187 . . . . 12.0 109.329 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -96.12 161.73 26.18 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.326 -0.62 . . . . 12.0 109.326 -178.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 34.9 Cg_endo -74.9 172.95 60.28 Favored 'Cis proline' 0 N--CA 1.487 1.136 0 O-C-N 123.177 1.093 . . . . 12.0 111.311 1.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 90.5 m 61.7 63.69 2.16 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-N 116.346 -0.388 . . . . 12.0 110.787 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.01 137.31 12.25 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.326 2.017 . . . . 12.0 109.012 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -134.54 136.03 42.76 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.525 0.679 . . . . 12.0 112.454 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -108.81 129.8 55.39 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -96.34 145.48 25.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.947 -0.471 . . . . 12.0 111.213 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -159.57 138.96 11.27 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 109.261 -0.644 . . . . 12.0 109.261 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -99.05 150.74 21.69 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 109.534 -0.543 . . . . 12.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.588 ' HB3' HD21 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -162.02 -162.44 0.84 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.033 0.444 . . . . 12.0 110.359 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.853 HG23 ' HB3' ' A' ' 65' ' ' ARG . 92.5 m -79.2 127.92 32.65 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.003 -0.74 . . . . 12.0 109.003 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.42 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 1.2 t30 -95.0 87.52 4.95 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-O 122.245 1.021 . . . . 12.0 111.983 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 5.2 p90 -103.16 101.79 11.76 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 62' ' ' SER . 15.8 tt -119.78 162.54 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.118 0.785 . . . . 12.0 113.118 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -110.52 107.2 16.75 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.076 -1.453 . . . . 12.0 107.076 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.472 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 17.1 m -128.09 -172.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 12.0 109.437 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 4.0 mtpp -143.04 162.94 34.16 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.96 -0.696 . . . . 12.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 9.8 m -115.9 130.26 56.75 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.592 0.711 . . . . 12.0 111.871 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 39.0 tt0 -138.32 136.97 36.95 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.915 -2.254 . . . . 12.0 104.915 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 12.1 m-20 55.86 20.91 4.43 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.391 -0.818 . . . . 12.0 108.838 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 6.4 mt-30 77.12 -17.08 0.58 Allowed 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 123.517 0.727 . . . . 12.0 112.637 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.832 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -98.65 143.66 26.73 Favored Pre-proline 0 N--CA 1.503 2.192 0 N-CA-C 105.983 -1.858 . . . . 12.0 105.983 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.535 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 24.8 Cg_endo -62.69 104.36 0.37 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 C-N-CA 121.278 1.318 . . . . 12.0 108.92 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.832 HG22 ' CE2' ' A' ' 100' ' ' TYR . 3.5 t -115.97 12.25 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 C-N-CA 120.287 -0.565 . . . . 12.0 112.22 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.512 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -141.83 133.81 27.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -118.12 129.46 55.55 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 109.084 -0.71 . . . . 12.0 109.084 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.54 -26.17 7.61 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.598 0.592 . . . . 12.0 112.598 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.404 ' O ' HG13 ' A' ' 92' ' ' ILE . . . -177.03 -174.75 43.74 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 119.811 -1.185 . . . . 12.0 111.18 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.98 HD12 HG21 ' A' ' 39' ' ' THR . 10.3 tt -97.78 31.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.09 0.471 . . . . 12.0 110.384 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 132.84 -67.62 0.56 Allowed Glycine 0 N--CA 1.502 3.038 0 N-CA-C 110.366 -1.094 . . . . 12.0 110.366 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -65.06 135.62 55.78 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.975 -0.75 . . . . 12.0 108.975 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -145.46 60.52 6.85 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 109.407 -0.59 . . . . 12.0 109.407 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 110' ' ' CYS . 37.1 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 C-N-CA 122.249 1.966 . . . . 12.0 110.258 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.383 0 N-CA-C 109.571 -0.529 . . . . 12.0 109.571 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -150.79 157.12 42.55 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.543 -0.91 . . . . 12.0 108.543 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.03 78.65 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 122.045 -0.409 . . . . 12.0 110.609 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.22 -56.45 11.26 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 121.359 -0.838 . . . . 12.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -31.44 72.01 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.917 -1.142 . . . . 12.0 107.917 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 53.7 t80 -72.74 -25.67 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.723 -0.843 . . . . 12.0 108.723 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -53.65 -37.3 62.98 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 107.254 -1.387 . . . . 12.0 107.254 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.39 -40.89 57.45 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.192 -1.41 . . . . 12.0 107.192 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 7.0 tptt -43.32 -61.81 1.24 Allowed 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 116.268 -0.424 . . . . 12.0 111.836 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.776 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.9 m80 -99.49 -7.07 26.5 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 119.08 0.854 . . . . 12.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 10' ' ' HIS . 25.2 mm -134.37 78.41 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 118.684 -1.206 . . . . 12.0 113.33 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.474 HD12 ' H ' ' A' ' 12' ' ' ILE . 5.0 mp -94.82 64.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.153 -2.165 . . . . 12.0 105.153 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.627 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 t-20 -64.82 85.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.652 0.739 . . . . 12.0 110.372 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' ASN . 5.7 p -160.73 69.9 2.74 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.102 -1.444 . . . . 12.0 107.102 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -79.78 30.64 0.48 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.418 2.079 . . . . 12.0 113.103 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 22' ' ' ILE . 10.2 pt -64.56 -169.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.655 -0.869 . . . . 12.0 108.655 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.35 33.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 121.589 0.709 . . . . 12.0 109.46 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -144.94 98.95 3.26 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 108.665 -0.865 . . . . 12.0 108.665 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' MET . 60.0 m -77.36 -18.7 57.16 Favored 'General case' 0 N--CA 1.511 2.581 0 C-N-CA 120.5 -0.48 . . . . 12.0 111.434 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -80.93 -48.54 12.18 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.051 0.841 . . . . 12.0 110.08 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -32.11 68.58 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.916 -0.402 . . . . 12.0 109.916 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 16' ' ' ILE . 46.8 pt -80.26 -34.6 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 122.034 -0.416 . . . . 12.0 110.195 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -99.34 18.25 18.13 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 120.512 -0.475 . . . . 12.0 110.44 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.53 89.9 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.939 -1.134 . . . . 12.0 107.939 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.419 ' OD1' HD12 ' A' ' 27' ' ' ILE . 10.6 t-20 -166.88 159.54 13.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.209 -0.663 . . . . 12.0 109.209 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.8 -10.36 59.71 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.76 -0.376 . . . . 12.0 110.052 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 27' ' ' ILE . 57.9 mt -87.77 10.44 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.73 -0.606 . . . . 12.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -146.94 63.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.706 -0.621 . . . . 12.0 110.099 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.3 mt -153.19 149.02 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.57 -1.331 . . . . 12.0 111.07 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 31' ' ' GLY . 57.9 t -104.86 168.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 107.678 -1.23 . . . . 12.0 107.678 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.58 53.87 3.43 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.328 -1.509 . . . . 12.0 109.328 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.95 -55.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 12.0 109.388 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -166.43 -77.06 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.929 -0.767 . . . . 12.0 108.929 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -146.47 -170.71 3.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.827 -0.805 . . . . 12.0 108.827 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -174.27 2.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.222 -0.658 . . . . 12.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -85.4 -25.4 27.04 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.981 -0.45 . . . . 12.0 110.591 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 72' ' ' THR . 10.1 t -151.51 107.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 120.353 -0.539 . . . . 12.0 110.777 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.3 m120 -91.6 85.69 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 105.904 -1.887 . . . . 12.0 105.904 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 m -81.73 112.89 19.31 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.242 0.544 . . . . 12.0 111.763 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 23' ' ' MET . 32.7 m-85 -100.39 158.5 15.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.272 -1.381 . . . . 12.0 107.272 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.3 mp -126.52 128.75 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 12.0 109.353 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.403 HG23 ' HG3' ' A' ' 67' ' ' GLN . 4.2 tt -111.14 129.28 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.632 ' O ' HD12 ' A' ' 11' ' ' ILE . 15.3 t 165.42 157.88 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.188 -1.041 . . . . 12.0 108.188 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -60.19 122.81 15.39 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.671 -0.863 . . . . 12.0 108.671 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.09 -29.24 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.136 -0.352 . . . . 12.0 111.803 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -79.92 -31.57 40.11 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.953 -0.467 . . . . 12.0 111.903 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 p -64.87 -36.04 83.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.474 -1.306 . . . . 12.0 107.474 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.05 -33.5 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.718 -1.215 . . . . 12.0 107.718 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -66.75 -21.54 66.06 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.607 -0.516 . . . . 12.0 109.607 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.69 -41.2 24.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.794 -0.566 . . . . 12.0 109.76 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.591 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 18.3 pt -67.15 -20.46 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.782 -0.574 . . . . 12.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 22.34 9.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.853 -0.53 . . . . 12.0 110.101 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -88.78 114.43 25.39 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.005 -0.739 . . . . 12.0 109.005 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.17 -61.21 0.02 OUTLIER Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.418 -1.073 . . . . 12.0 110.418 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.9 p -163.65 -168.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.656 ' H ' HG22 ' A' ' 55' ' ' VAL . 12.4 tt -87.26 27.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 O-C-N 121.097 -1.002 . . . . 12.0 110.958 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 6.1 t-20 171.1 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 106.403 -1.703 . . . . 12.0 106.403 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.62 179.37 8.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.826 0.822 . . . . 12.0 112.132 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -137.55 115.1 11.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.557 HG13 ' CG1' ' A' ' 94' ' ' VAL . 11.9 p -128.71 166.35 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.897 -0.502 . . . . 12.0 109.653 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 110' ' ' CYS . 3.8 mp -129.33 117.54 20.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.896 -0.502 . . . . 12.0 111.521 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 1.4 m -58.1 93.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.105 -1.443 . . . . 12.0 107.105 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.675 HG22 ' OH ' ' A' ' 91' ' ' TYR . 1.6 p -79.74 -53.5 6.75 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 112.249 0.463 . . . . 12.0 112.249 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.685 HG22 ' HG2' ' A' ' 65' ' ' ARG . 47.5 m -47.83 -90.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.866 -0.521 . . . . 12.0 110.271 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.846 ' CB ' HG23 ' A' ' 89' ' ' THR . 11.0 ptm180 174.43 100.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 57.9 m-85 -97.88 54.62 1.15 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.237 -0.653 . . . . 12.0 109.237 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER 11.88 109.03 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.431 1.271 . . . . 12.0 114.431 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.04 154.6 17.97 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.819 0.819 . . . . 12.0 111.756 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.22 100.23 7.2 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.083 -1.821 . . . . 12.0 106.083 177.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 m -102.18 127.39 49.13 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.659 0.743 . . . . 12.0 112.355 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -111.7 112.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.367 -2.457 . . . . 12.0 104.367 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.532 HG23 HG22 ' A' ' 37' ' ' VAL . 4.2 m -111.2 144.99 39.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.091 -0.644 . . . . 12.0 111.648 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -62.34 142.79 57.61 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.297 -1.001 . . . . 12.0 108.297 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.99 -85.49 0.55 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.92 -0.488 . . . . 12.0 110.545 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.7 t -155.61 177.22 11.63 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.781 -0.574 . . . . 12.0 109.725 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 77' ' ' THR . 19.2 mt 61.91 166.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.67 -0.863 . . . . 12.0 108.67 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 4.3 t -134.2 59.61 38.64 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.798 -0.564 . . . . 12.0 110.837 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 77' ' ' THR . 38.5 Cg_endo -85.25 175.33 6.48 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 121.923 1.749 . . . . 12.0 109.375 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -120.0 127.48 26.34 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.158 -1.053 . . . . 12.0 108.158 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.15 -178.61 17.7 Favored 'Cis proline' 0 N--CA 1.487 1.143 0 O-C-N 122.856 0.924 . . . . 12.0 111.517 2.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER -60.69 149.52 78.95 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 119.09 -0.481 . . . . 12.0 110.809 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.33 113.05 2.85 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.119 1.879 . . . . 12.0 109.296 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 81' ' ' CYS . 12.1 m-85 -138.58 139.07 38.49 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.195 0.521 . . . . 12.0 111.119 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -111.33 129.35 56.02 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.897 -1.149 . . . . 12.0 107.897 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 t -93.91 149.45 21.22 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.39 0.614 . . . . 12.0 110.883 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -151.79 155.42 38.19 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.032 -0.729 . . . . 12.0 109.032 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.3 m -125.44 141.2 52.19 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.535 -0.543 . . . . 12.0 109.535 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -166.12 -172.03 2.16 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.095 0.474 . . . . 12.0 110.317 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.846 HG23 ' CB ' ' A' ' 65' ' ' ARG . 77.4 m -65.3 145.59 56.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.991 -0.744 . . . . 12.0 108.991 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -110.22 88.24 2.71 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.907 0.86 . . . . 12.0 111.371 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.675 ' OH ' HG22 ' A' ' 63' ' ' THR . 6.6 t80 -98.03 96.63 8.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.987 -2.597 . . . . 12.0 103.987 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.615 HG21 ' HZ ' ' A' ' 104' ' ' PHE . 7.1 tt -130.69 175.12 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.978 -0.689 . . . . 12.0 111.077 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.77 116.63 27.4 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.65 -0.871 . . . . 12.0 108.65 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.557 ' CG1' HG13 ' A' ' 60' ' ' VAL . 14.8 p -108.88 162.06 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.989 -0.374 . . . . 12.0 109.989 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 94' ' ' VAL . 42.7 mtpt -120.35 144.8 47.67 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -119.55 120.63 37.31 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 114.003 1.112 . . . . 12.0 114.003 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.594 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 20.9 tt0 -128.37 141.8 51.31 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 104.076 -2.564 . . . . 12.0 104.076 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.9 m-80 57.21 28.64 15.41 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 107.683 -1.228 . . . . 12.0 107.683 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 51.22 16.17 0.36 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 124.754 1.222 . . . . 12.0 114.001 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.803 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.85 145.44 41.37 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 104.121 -2.548 . . . . 12.0 104.121 174.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.495 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 24.5 Cg_endo -61.33 93.89 0.11 Allowed 'Trans proline' 0 C--O 1.2 -1.393 0 N-CA-C 108.429 -1.412 . . . . 12.0 108.429 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.803 HG22 ' CE2' ' A' ' 100' ' ' TYR . 63.4 t -91.73 -14.15 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 122.239 -0.288 . . . . 12.0 110.901 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.594 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -146.35 145.62 30.37 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.615 ' HZ ' HG21 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -102.23 120.0 39.74 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.481 -1.288 . . . . 12.0 108.914 178.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.46 81.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.863 -0.523 . . . . 12.0 110.042 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.8 -158.86 23.27 Favored Glycine 0 N--CA 1.5 2.95 0 N-CA-C 109.896 -1.282 . . . . 12.0 109.896 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 108' ' ' GLY . 8.3 tp -54.58 162.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 122.173 -0.604 . . . . 12.0 109.725 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' N ' HG13 ' A' ' 107' ' ' ILE . . . -57.39 91.4 0.02 OUTLIER Glycine 0 N--CA 1.499 2.889 0 N-CA-C 109.462 -1.455 . . . . 12.0 109.462 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -176.46 107.16 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.318 -0.623 . . . . 12.0 109.318 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.571 ' HB2' HD21 ' A' ' 61' ' ' LEU . 11.9 m -151.55 60.66 3.87 Favored Pre-proline 0 N--CA 1.497 1.916 0 C-N-CA 120.759 -0.377 . . . . 12.0 110.086 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 110' ' ' CYS . 36.8 Cg_endo . . . . . 0 N--CA 1.48 0.686 0 C-N-CA 122.217 1.945 . . . . 12.0 110.338 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.47 0 N-CA-C 109.734 -0.469 . . . . 12.0 109.734 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -159.27 155.19 26.5 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.014 -0.735 . . . . 12.0 109.014 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -25.73 62.87 Favored 'General case' 0 N--CA 1.516 2.84 0 O-C-N 122.141 -0.35 . . . . 12.0 110.625 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.1 -61.83 1.72 Allowed 'General case' 0 N--CA 1.512 2.631 0 O-C-N 121.437 -0.789 . . . . 12.0 110.68 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.691 HG23 HD11 ' A' ' 27' ' ' ILE . 29.1 m -62.33 -32.48 73.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.997 -1.112 . . . . 12.0 107.997 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 31.1 t80 -75.79 -23.63 55.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -55.85 -34.25 65.26 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 106.96 -1.496 . . . . 12.0 106.96 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.99 -38.76 52.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.728 -1.212 . . . . 12.0 107.728 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 11.1 mmtm -45.57 -51.32 12.13 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 122.232 -0.293 . . . . 12.0 110.856 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.926 ' ND1' HG11 ' A' ' 48' ' ' VAL . 2.1 m-70 -97.52 -13.97 21.36 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 118.837 -0.601 . . . . 12.0 112.153 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 10' ' ' HIS . 15.5 mm -123.18 64.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 114.896 1.443 . . . . 12.0 114.896 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.81 HG21 ' CD1' ' A' ' 40' ' ' PHE . 2.7 mp -98.89 63.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 103.984 -2.598 . . . . 12.0 103.984 173.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -73.09 78.61 1.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.734 0.778 . . . . 12.0 111.65 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.677 ' OG1' HD12 ' A' ' 22' ' ' ILE . 3.0 p -139.64 75.15 32.2 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.21 11.72 2.27 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.323 2.015 . . . . 12.0 113.59 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.745 HD11 ' CG2' ' A' ' 22' ' ' ILE . 15.8 pt -60.99 -168.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-N 119.15 0.886 . . . . 12.0 108.684 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -106.93 36.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.533 -0.729 . . . . 12.0 109.698 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -142.37 101.45 3.9 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 108.55 -0.907 . . . . 12.0 108.55 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.42 -14.45 58.93 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.961 -0.462 . . . . 12.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -85.03 -55.46 4.05 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-N 118.882 0.765 . . . . 12.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.09 -36.52 63.27 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.048 -0.408 . . . . 12.0 110.054 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.745 ' CG2' HD11 ' A' ' 16' ' ' ILE . 34.0 pt -81.24 -35.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.445 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 2.3 tmm? -99.07 32.03 2.82 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.399 -0.593 . . . . 12.0 109.399 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.07 48.36 1.64 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.277 0.56 . . . . 12.0 110.002 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.625 ' OD1' HG22 ' A' ' 27' ' ' ILE . 10.3 t-20 -127.47 155.62 43.42 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.075 -0.713 . . . . 12.0 109.075 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -73.44 -10.72 60.03 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.89 -0.324 . . . . 12.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 5' ' ' THR . 21.3 tt -79.06 -0.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.587 -0.696 . . . . 12.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.664 ' O ' HD13 ' A' ' 29' ' ' ILE . 66.5 m-85 -119.61 54.91 0.98 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.387 -0.597 . . . . 12.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 28' ' ' TYR . 44.8 mm -139.01 152.06 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.108 -0.995 . . . . 12.0 110.376 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 31' ' ' GLY . 40.8 t -100.84 169.98 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.719 -1.215 . . . . 12.0 107.719 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -91.02 53.9 3.27 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.283 -1.527 . . . . 12.0 109.283 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.44 -58.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.746 -1.742 . . . . 12.0 108.746 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.6 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.066 -0.667 . . . . 12.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.54 177.55 8.59 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.71 -0.848 . . . . 12.0 108.71 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 159.74 22.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.341 -0.615 . . . . 12.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -72.05 -9.5 58.48 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.24 -0.287 . . . . 12.0 110.768 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.5 p -159.28 129.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.7 0.762 . . . . 12.0 111.037 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.519 ' ND2' ' CE1' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -117.29 89.17 3.06 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.819 -1.919 . . . . 12.0 105.819 177.217 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.3 m -83.71 118.1 23.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.29 0.567 . . . . 12.0 111.83 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.81 ' CD1' HG21 ' A' ' 12' ' ' ILE . 23.3 m-85 -100.05 156.71 17.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.921 -1.511 . . . . 12.0 106.921 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.31 127.84 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.283 -0.886 . . . . 12.0 108.975 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 42' ' ' ILE . 5.5 tt -107.53 107.89 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.44 0.638 . . . . 12.0 109.325 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.659 ' O ' HD12 ' A' ' 11' ' ' ILE . 39.9 t 176.57 154.12 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.924 -0.769 . . . . 12.0 108.924 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 p -63.48 126.17 26.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.667 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -53.29 -26.97 20.52 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.074 -0.391 . . . . 12.0 110.942 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -80.14 -32.06 38.98 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.629 -0.428 . . . . 12.0 111.621 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -62.07 -40.31 95.37 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.77 -1.567 . . . . 12.0 106.77 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.926 HG11 ' ND1' ' A' ' 10' ' ' HIS . 39.5 t -69.53 -35.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.963 -1.125 . . . . 12.0 107.963 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -57.69 -25.42 60.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.97 -0.752 . . . . 12.0 108.97 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.77 -34.73 33.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.876 -0.515 . . . . 12.0 109.734 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.908 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.2 -28.62 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.767 -0.583 . . . . 12.0 110.544 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.67 19.99 15.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.452 -0.78 . . . . 12.0 110.365 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.0 m -85.46 112.45 20.89 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 109.13 -0.693 . . . . 12.0 109.13 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.46 -63.45 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.925 -0.87 . . . . 12.0 110.925 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.0 p -158.65 -167.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 118.015 0.907 . . . . 12.0 109.178 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.615 ' H ' HG22 ' A' ' 55' ' ' VAL . 3.8 tt -87.82 27.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.593 0 O-C-N 121.132 -0.98 . . . . 12.0 110.968 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 13.9 t-20 173.09 118.84 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 106.652 -1.61 . . . . 12.0 106.652 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.47 175.36 12.25 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.621 0.724 . . . . 12.0 111.528 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -141.49 111.48 6.71 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.3 p -140.04 167.65 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.547 -0.538 . . . . 12.0 109.547 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.516 ' N ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -136.88 130.4 31.66 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.264 0.554 . . . . 12.0 111.24 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -59.52 102.9 0.16 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.353 -1.351 . . . . 12.0 107.353 177.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -87.9 -37.2 16.67 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.251 -0.28 . . . . 12.0 110.254 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.0 m -59.22 -95.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.77 ' CB ' HG23 ' A' ' 89' ' ' THR . 1.8 ptt-85 177.01 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.919 0.781 . . . . 12.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -97.01 41.57 1.11 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.318 -0.623 . . . . 12.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 23.77 105.89 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 114.196 1.184 . . . . 12.0 114.196 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -104.77 157.1 17.43 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.936 0.874 . . . . 12.0 111.868 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -117.34 100.7 7.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 104.943 -2.243 . . . . 12.0 104.943 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.2 m -97.22 132.27 43.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.757 0.789 . . . . 12.0 112.471 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' SER . 55.6 m -121.63 116.44 24.59 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 104.068 -2.567 . . . . 12.0 104.068 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -106.77 144.68 33.06 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 120.195 -0.602 . . . . 12.0 111.88 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -68.09 100.2 0.97 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.266 -0.642 . . . . 12.0 109.266 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 p -119.1 -112.5 0.34 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.569 -0.53 . . . . 12.0 109.569 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 76' ' ' ILE . 15.9 p -158.68 98.13 1.49 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 119.641 1.109 . . . . 12.0 109.647 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.536 HD11 ' O ' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -157.89 139.28 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.572 -0.529 . . . . 12.0 109.572 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.3 p 57.19 164.68 0.07 OUTLIER Pre-proline 0 N--CA 1.505 2.31 0 N-CA-C 109.93 -0.396 . . . . 12.0 109.93 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 35.0 Cg_endo -77.85 -71.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 121.753 1.636 . . . . 12.0 111.004 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -113.9 164.79 15.09 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 122.122 -0.362 . . . . 12.0 110.116 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.4 -56.7 0.14 OUTLIER 'Cis proline' 0 N--CA 1.486 1.038 0 O-C-N 123.486 1.256 . . . . 12.0 109.701 0.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -133.14 156.85 79.53 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.467 -0.938 . . . . 12.0 108.467 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 36.6 Cg_endo -75.25 116.64 4.6 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 121.645 1.564 . . . . 12.0 110.448 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.536 ' O ' HD11 ' A' ' 76' ' ' ILE . 15.7 m-85 -145.98 137.07 24.61 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.319 0.58 . . . . 12.0 111.728 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 71' ' ' CYS . 7.9 t -107.83 153.88 22.36 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 106.691 -1.596 . . . . 12.0 106.691 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 t -107.79 156.53 19.02 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.563 -0.71 . . . . 12.0 111.456 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -166.09 158.67 14.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.316 -0.624 . . . . 12.0 109.316 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 p -135.06 147.66 49.67 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.053 -0.721 . . . . 12.0 109.053 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.84 -173.64 1.64 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.483 0.659 . . . . 12.0 110.744 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.77 HG23 ' CB ' ' A' ' 65' ' ' ARG . 85.8 m -66.69 142.75 57.31 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.206 -1.035 . . . . 12.0 108.206 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 66.1 t30 -104.96 87.41 2.64 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.451 -0.9 . . . . 12.0 111.567 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' SER . 6.1 p90 -107.22 105.6 15.65 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.445 -2.057 . . . . 12.0 105.445 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.606 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt -137.2 -179.53 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.651 0.738 . . . . 12.0 111.926 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -117.37 109.94 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.425 -0.807 . . . . 12.0 110.316 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.561 HG13 ' CE1' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -105.57 171.0 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.551 -0.907 . . . . 12.0 108.551 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 9.3 mttp -129.18 140.52 51.47 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -110.45 121.81 46.2 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.626 1.343 . . . . 12.0 114.626 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.642 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.0 tt0 -136.45 142.49 43.62 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 103.816 -2.661 . . . . 12.0 103.816 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 56.13 30.92 17.27 Favored 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 107.212 -1.403 . . . . 12.0 107.212 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 47.56 19.24 0.14 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.244 1.201 . . . . 12.0 114.244 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.841 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.94 145.55 54.26 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 104.585 -2.376 . . . . 12.0 104.585 175.064 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.506 ' HB3' HG11 ' A' ' 94' ' ' VAL . 21.9 Cg_endo -59.9 90.25 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.055 0 N-CA-C 108.899 -1.231 . . . . 12.0 108.899 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.841 HG22 ' CE2' ' A' ' 100' ' ' TYR . 44.0 t -87.57 -20.65 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 115.995 -0.548 . . . . 12.0 110.583 -177.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.642 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -137.66 144.03 41.64 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 12.0 108.367 -177.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -107.97 126.83 53.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 118.851 -1.14 . . . . 12.0 109.537 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.64 -33.79 53.41 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.995 -0.372 . . . . 12.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.83 -133.66 6.9 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.764 -0.934 . . . . 12.0 110.764 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.7 pt -69.73 -172.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 122.344 -0.504 . . . . 12.0 111.004 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.08 -47.4 59.68 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 111.0 -0.84 . . . . 12.0 111.0 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -51.99 113.45 1.01 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.844 -0.798 . . . . 12.0 110.495 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 168.38 13.08 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 109.237 -0.653 . . . . 12.0 109.237 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.48 0.701 0 C-N-CA 121.889 1.726 . . . . 12.0 110.253 179.512 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.447 0 N-CA-C 109.593 -0.521 . . . . 12.0 109.593 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -130.7 155.71 46.16 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.058 -0.719 . . . . 12.0 109.058 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -28.75 66.73 Favored 'General case' 0 N--CA 1.514 2.744 0 O-C-N 122.161 -0.337 . . . . 12.0 110.279 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 7' ' ' GLN . . . -73.96 -60.03 2.45 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 121.735 -0.603 . . . . 12.0 110.716 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -62.35 -29.35 70.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.104 -1.073 . . . . 12.0 108.104 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 31.1 t80 -79.35 -23.79 43.14 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.174 -0.676 . . . . 12.0 109.174 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 1.4 mm100 -57.93 -35.61 71.33 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 106.696 -1.594 . . . . 12.0 106.696 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.09 -35.61 56.36 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.661 -1.237 . . . . 12.0 107.661 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 11.7 tptt -46.07 -60.49 2.24 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 116.686 -0.234 . . . . 12.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.616 ' CE1' HD11 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -103.42 -2.16 27.39 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.645 -0.659 . . . . 12.0 112.039 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 11' ' ' ILE . 4.2 mp -138.51 73.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.415 1.635 . . . . 12.0 115.415 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.929 HG21 HG23 ' A' ' 22' ' ' ILE . 19.3 mt -97.34 66.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 102.789 -3.041 . . . . 12.0 102.789 172.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.03 75.87 3.59 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.36 -0.836 . . . . 12.0 112.364 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.46 130.9 22.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 106.487 -1.672 . . . . 12.0 106.487 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.12 -24.43 38.55 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 121.277 1.318 . . . . 12.0 110.513 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.42 148.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.183 -1.043 . . . . 12.0 108.183 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 pt -111.41 85.44 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 121.695 0.76 . . . . 12.0 109.221 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -147.3 104.84 3.69 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 m -75.76 -8.32 56.55 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.63 -0.428 . . . . 12.0 110.847 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -69.68 -46.69 65.49 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 118.804 0.729 . . . . 12.0 109.223 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -82.72 -19.61 37.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.665 -0.494 . . . . 12.0 109.665 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.929 HG23 HG21 ' A' ' 12' ' ' ILE . 40.1 mt -87.17 -6.87 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.765 -0.584 . . . . 12.0 110.809 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm -109.51 -43.52 4.07 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.597 -0.89 . . . . 12.0 108.597 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.21 96.91 0.16 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 107.563 -1.273 . . . . 12.0 107.563 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -169.57 157.8 7.37 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.901 -0.777 . . . . 12.0 108.901 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -69.76 -10.88 60.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.048 -0.407 . . . . 12.0 110.076 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 27' ' ' ILE . 58.3 mt -91.46 13.67 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.723 -0.611 . . . . 12.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.534 ' OH ' HD11 ' A' ' 12' ' ' ILE . 53.5 m-85 -152.54 67.27 0.82 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.61 -0.681 . . . . 12.0 110.367 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -146.34 135.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 120.593 -1.317 . . . . 12.0 110.477 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.563 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.8 p -109.92 -162.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.446 -1.316 . . . . 12.0 107.446 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.563 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -96.25 67.72 1.0 Allowed Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.029 -1.044 . . . . 12.0 111.662 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.16 -66.8 0.03 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.31 -1.516 . . . . 12.0 109.31 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -165.56 -65.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -154.55 144.01 21.39 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.868 -0.79 . . . . 12.0 108.868 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -66.25 178.3 1.22 Allowed 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.824 -0.436 . . . . 12.0 109.824 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.15 15.87 22.93 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.249 -0.282 . . . . 12.0 110.61 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.0 p -162.8 120.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.854 -0.529 . . . . 12.0 109.816 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 13.9 m120 -122.12 88.94 3.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m -83.31 107.37 15.79 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 116.371 -0.377 . . . . 12.0 110.685 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.824 ' CD1' HD12 ' A' ' 12' ' ' ILE . 12.9 m-85 -98.57 159.79 14.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.066 -1.457 . . . . 12.0 107.066 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.755 HD12 ' C ' ' A' ' 40' ' ' PHE . 3.7 mp -130.26 129.49 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.748 -0.834 . . . . 12.0 108.748 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 42' ' ' ILE . 10.5 tt -101.34 106.27 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.15 -0.685 . . . . 12.0 109.15 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.1 t 176.66 154.47 0.22 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.808 -0.812 . . . . 12.0 108.808 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -60.62 130.04 44.53 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.818 -0.808 . . . . 12.0 108.818 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' CA ' HG12 ' A' ' 11' ' ' ILE . . . -53.94 -27.21 29.56 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.067 -0.395 . . . . 12.0 111.385 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 t -82.43 -30.92 29.78 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.509 -0.476 . . . . 12.0 111.591 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 p -63.58 -37.01 85.7 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.862 ' O ' HG22 ' A' ' 51' ' ' ILE . 25.1 t -70.78 -36.06 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -62.07 -23.46 66.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.221 -0.659 . . . . 12.0 109.221 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.953 -0.467 . . . . 12.0 109.839 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.889 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -65.3 -29.41 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.837 -0.539 . . . . 12.0 110.088 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 24.53 6.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.753 -0.592 . . . . 12.0 110.069 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -87.8 113.22 23.26 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.496 -0.557 . . . . 12.0 109.496 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.2 -64.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.872 -1.291 . . . . 12.0 109.872 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 58' ' ' MET . 2.4 p -160.49 -165.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.42 -0.956 . . . . 12.0 108.42 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.586 ' H ' HG22 ' A' ' 55' ' ' VAL . 45.6 pt -89.77 26.5 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 O-C-N 121.102 -0.999 . . . . 12.0 111.326 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 50.5 t30 173.22 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 107.642 -1.244 . . . . 12.0 107.642 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.692 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -165.3 178.76 6.66 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 121.909 0.861 . . . . 12.0 111.904 -178.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -134.04 116.52 15.58 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 106.735 -1.58 . . . . 12.0 106.735 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 61' ' ' LEU . 13.0 t -130.25 167.59 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.87 -0.519 . . . . 12.0 109.788 -177.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' N ' HG12 ' A' ' 60' ' ' VAL . 2.8 mp -122.59 110.53 15.67 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -56.88 91.51 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 108.666 -0.865 . . . . 12.0 108.666 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.892 HG22 ' OH ' ' A' ' 91' ' ' TYR . 3.0 p -81.79 -50.94 8.66 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 109.343 -0.614 . . . . 12.0 109.343 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.428 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 64.7 m -61.02 108.7 0.92 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.786 -1.191 . . . . 12.0 107.786 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.821 ' CB ' HG23 ' A' ' 89' ' ' THR . 23.2 ptt85 -40.0 108.67 0.09 Allowed 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.108 0.48 . . . . 12.0 112.245 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.593 ' HB2' HD21 ' A' ' 90' ' ' ASN . 47.6 m-85 -95.87 42.73 1.09 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 108.8 -0.815 . . . . 12.0 108.8 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 18.22 105.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 113.904 1.076 . . . . 12.0 113.904 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.596 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -101.22 157.3 16.88 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 12.0 112.324 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -121.29 97.16 5.39 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.264 -2.125 . . . . 12.0 105.264 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.6 m -101.87 124.39 47.42 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.811 -0.756 . . . . 12.0 112.034 -176.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.4 m -110.65 108.64 18.62 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 104.254 -2.498 . . . . 12.0 104.254 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -111.99 140.3 46.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.817 -0.753 . . . . 12.0 111.869 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -65.03 117.41 7.62 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.089 -1.078 . . . . 12.0 108.089 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.5 p -102.16 -128.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.982 -0.747 . . . . 12.0 108.982 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 t -148.85 174.22 12.46 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.296 -0.877 . . . . 12.0 109.238 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.9 mm 63.72 149.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.914 -0.773 . . . . 12.0 108.914 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.3 m 57.28 68.96 1.79 Allowed Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 109.112 -0.699 . . . . 12.0 109.112 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -75.06 136.53 20.4 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 121.95 1.767 . . . . 12.0 110.498 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.602 ' N ' ' HA ' ' A' ' 80' ' ' PRO . 32.2 mtt180 -93.72 -38.22 0.32 Allowed Pre-proline 0 N--CA 1.492 1.644 0 CA-C-O 117.408 -1.282 . . . . 12.0 113.732 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.602 ' HA ' ' N ' ' A' ' 79' ' ' ARG . 34.3 Cg_endo -73.98 177.38 38.11 Favored 'Cis proline' 0 N--CA 1.487 1.107 0 CA-C-N 120.522 1.222 . . . . 12.0 111.542 1.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.468 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER 72.92 57.62 0.35 Allowed Pre-proline 0 N--CA 1.503 2.18 0 O-C-N 122.144 -0.348 . . . . 12.0 110.303 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 35.1 Cg_endo -77.13 122.22 6.1 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 122.255 1.97 . . . . 12.0 109.649 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -115.88 138.67 50.95 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 121.634 0.73 . . . . 12.0 111.832 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 p -110.87 131.0 55.42 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 107.393 -1.336 . . . . 12.0 107.393 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 81.0 p -96.46 141.73 29.4 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.511 0.672 . . . . 12.0 111.608 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -152.88 127.88 9.67 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.35 -0.982 . . . . 12.0 108.35 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 68' ' ' LEU . 5.3 m -109.64 149.85 29.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.031 -0.418 . . . . 12.0 110.209 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' CG ' HD11 ' A' ' 68' ' ' LEU . 11.4 pt-20 -175.21 -168.97 0.36 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 120.909 0.385 . . . . 12.0 110.234 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.821 HG23 ' CB ' ' A' ' 65' ' ' ARG . 95.8 m -57.68 142.28 45.61 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.994 -0.373 . . . . 12.0 109.994 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.593 HD21 ' HB2' ' A' ' 66' ' ' PHE . 61.9 t30 -109.21 88.48 2.74 Favored 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 121.901 0.857 . . . . 12.0 110.88 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.892 ' OH ' HG22 ' A' ' 63' ' ' THR . 1.1 t80 -104.39 101.23 10.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.75 -1.944 . . . . 12.0 105.75 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.854 HD12 ' CE1' ' A' ' 104' ' ' PHE . 6.2 pt -134.09 -179.19 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.586 -0.846 . . . . 12.0 111.719 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 10.3 t -115.18 120.74 40.75 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.175 -1.046 . . . . 12.0 108.175 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.586 HG23 ' CZ ' ' A' ' 104' ' ' PHE . 6.9 p -115.69 170.11 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 122.243 -0.286 . . . . 12.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 94' ' ' VAL . 18.0 mttt -131.54 140.19 49.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.565 -0.902 . . . . 12.0 108.565 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.3 m -113.49 122.55 47.62 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.19 1.182 . . . . 12.0 114.19 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.666 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.1 tt0 -131.73 143.35 50.18 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 15.2 m-80 53.51 29.47 9.09 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.765 -1.198 . . . . 12.0 107.765 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 15.2 pt20 53.83 5.87 0.07 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 114.822 1.415 . . . . 12.0 114.822 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -111.85 145.4 32.62 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 104.765 -2.309 . . . . 12.0 104.765 175.13 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.535 ' HB3' HG21 ' A' ' 94' ' ' VAL . 24.5 Cg_endo -60.95 89.47 0.09 OUTLIER 'Trans proline' 0 C--O 1.209 -0.942 0 N-CA-C 108.85 -1.25 . . . . 12.0 108.85 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.939 HG22 ' CE2' ' A' ' 100' ' ' TYR . 95.1 t -85.61 -22.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-N 116.214 -0.448 . . . . 12.0 110.332 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.666 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.68 143.33 48.47 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.258 -1.386 . . . . 12.0 107.258 -178.373 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.854 ' CE1' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -119.29 128.69 54.38 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.166 -1.014 . . . . 12.0 110.375 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -73.4 -42.18 62.41 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.568 -0.287 . . . . 12.0 110.312 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.72 -129.54 5.84 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.478 -0.867 . . . . 12.0 111.009 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 tt -60.74 165.97 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.222 -0.575 . . . . 12.0 110.567 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -50.88 -50.66 37.22 Favored Glycine 0 N--CA 1.503 3.156 0 N-CA-C 110.648 -0.981 . . . . 12.0 110.648 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 99.23 0.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 122.214 -0.58 . . . . 12.0 109.462 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 64.3 m -60.03 151.27 66.44 Favored Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 108.795 -0.817 . . . . 12.0 108.795 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.481 0.748 0 C-N-CA 121.601 1.534 . . . . 12.0 110.292 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PCA . . . . . 0.508 ' HA ' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.506 2.329 0 N-CA-C 109.995 -0.372 . . . . 12.0 109.995 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -98.97 155.72 17.28 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.194 -0.669 . . . . 12.0 109.194 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.413 ' CZ2' ' HB2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.81 -29.19 64.17 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 122.096 -0.377 . . . . 12.0 110.465 -178.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -58.72 3.12 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.901 -0.499 . . . . 12.0 110.571 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -63.36 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.171 -1.048 . . . . 12.0 108.171 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 30.1 t80 -77.13 -22.75 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.103 -0.703 . . . . 12.0 109.103 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -61.26 -38.34 86.35 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.89 -35.61 57.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.421 -1.325 . . . . 12.0 107.421 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.21 -57.06 3.66 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 116.355 -0.384 . . . . 12.0 110.763 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.731 ' ND1' HD13 ' A' ' 41' ' ' ILE . 76.0 m-70 -108.26 -4.05 17.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.062 1.134 . . . . 12.0 114.062 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 45' ' ' ALA . 39.2 mm -122.38 64.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 118.566 -1.253 . . . . 12.0 113.597 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.66 HD13 ' HA ' ' A' ' 40' ' ' PHE . 3.1 mp -98.2 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.348 -2.093 . . . . 12.0 105.348 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.669 ' O ' HG23 ' A' ' 14' ' ' THR . 0.4 OUTLIER -54.58 85.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 CA-C-O 121.46 0.648 . . . . 12.0 111.15 -177.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 13' ' ' ASN . 12.7 p -164.66 57.73 0.56 Allowed Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 107.65 -1.241 . . . . 12.0 107.65 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 14' ' ' THR . 35.9 Cg_endo -74.98 82.57 1.97 Allowed 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 121.936 1.757 . . . . 12.0 110.457 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.49 -162.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.154 -1.054 . . . . 12.0 108.154 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.19 30.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 109.073 -0.714 . . . . 12.0 109.073 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -140.79 95.36 2.84 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.279 -1.008 . . . . 12.0 108.279 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.429 ' HA ' HD11 ' A' ' 22' ' ' ILE . 46.3 m -77.04 -18.61 58.0 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 120.266 -0.574 . . . . 12.0 111.389 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.12 -52.35 7.47 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 119.082 0.855 . . . . 12.0 110.315 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.11 -33.26 38.92 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.511 -0.551 . . . . 12.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 19' ' ' CYS . 44.6 pt -82.38 -37.44 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.904 -0.406 . . . . 12.0 109.904 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -104.68 40.64 1.45 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.444 0.64 . . . . 12.0 109.305 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -87.77 50.07 1.92 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.511 0.672 . . . . 12.0 109.684 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.666 ' OD1' HG23 ' A' ' 27' ' ' ILE . 10.9 t-20 -127.87 161.33 29.31 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.045 -0.724 . . . . 12.0 109.045 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -74.76 -8.91 57.87 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.789 -0.364 . . . . 12.0 110.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.666 HG23 ' OD1' ' A' ' 25' ' ' ASN . 32.0 pt -80.17 -3.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.574 -0.704 . . . . 12.0 111.113 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -112.3 47.52 1.06 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.744 -0.598 . . . . 12.0 110.578 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mt -150.33 144.92 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.027 -1.046 . . . . 12.0 110.302 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 31' ' ' GLY . 49.4 t -106.78 169.25 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 107.711 -1.218 . . . . 12.0 107.711 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.77 61.33 3.1 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.05 -65.06 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.052 -1.619 . . . . 12.0 109.052 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -168.95 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 117.703 0.751 . . . . 12.0 109.792 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 t -145.38 131.11 18.98 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -61.77 164.96 5.64 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.479 -0.564 . . . . 12.0 109.479 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -102.05 -3.18 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 122.24 -0.288 . . . . 12.0 111.01 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 37' ' ' VAL . 12.6 p -162.48 114.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.603 -0.686 . . . . 12.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 8.3 m120 -107.29 84.78 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.678 -1.601 . . . . 12.0 106.678 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 m -80.9 109.49 15.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 116.071 -0.513 . . . . 12.0 110.648 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.66 ' HA ' HD13 ' A' ' 12' ' ' ILE . 19.3 m-85 -98.73 161.7 13.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.805 -1.554 . . . . 12.0 106.805 178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.731 HD13 ' ND1' ' A' ' 10' ' ' HIS . 1.1 mp -130.98 132.54 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.335 0.971 . . . . 12.0 109.54 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 42' ' ' ILE . 5.7 tp -108.44 105.42 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.195 -1.039 . . . . 12.0 108.195 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t 179.54 153.33 0.45 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.61 122.07 9.07 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.794 0.807 . . . . 12.0 109.827 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 11' ' ' ILE . . . -46.42 -64.96 0.63 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 113.613 0.968 . . . . 12.0 113.613 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.7 p -62.72 -17.03 60.07 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.165 -0.614 . . . . 12.0 111.235 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.652 HG22 ' HE2' ' A' ' 66' ' ' PHE . 96.2 m -66.01 -36.68 83.94 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.302 -1.369 . . . . 12.0 107.302 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 51' ' ' ILE . 44.6 t -71.26 -35.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.048 -1.464 . . . . 12.0 107.048 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -63.73 -21.73 66.55 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 12.0 108.992 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.54 -38.7 25.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.0 -0.438 . . . . 12.0 110.015 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.3 tp -65.4 -22.74 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.769 -0.582 . . . . 12.0 109.91 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.1 35.86 2.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.802 -0.561 . . . . 12.0 109.805 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.4 m -96.76 112.8 24.4 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.184 -0.672 . . . . 12.0 109.184 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.03 -63.02 0.02 OUTLIER Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.598 -1.001 . . . . 12.0 110.598 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.611 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.8 p -162.12 -167.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.691 -0.855 . . . . 12.0 108.691 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.9 pt -88.25 26.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 121.024 -1.047 . . . . 12.0 111.317 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 174.05 112.99 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 107.508 -1.293 . . . . 12.0 107.508 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.8 -176.37 4.57 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.984 0.897 . . . . 12.0 111.955 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -140.14 124.59 17.97 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.697 -1.594 . . . . 12.0 106.697 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG13 ' CG2' ' A' ' 94' ' ' VAL . 10.0 p -137.32 166.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.735 -0.603 . . . . 12.0 109.727 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.492 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.7 mt -126.27 112.56 15.87 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.904 -0.498 . . . . 12.0 112.193 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 4.0 m -67.7 91.2 0.29 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 105.691 -1.966 . . . . 12.0 105.691 176.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -86.77 -37.41 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.149 -0.344 . . . . 12.0 111.634 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.697 HG22 ' HG2' ' A' ' 65' ' ' ARG . 89.8 m -53.88 -92.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.195 -0.669 . . . . 12.0 109.195 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.735 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER 176.15 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.778 0.717 . . . . 12.0 109.563 179.003 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.652 ' HE2' HG22 ' A' ' 47' ' ' THR . 49.9 m-85 -96.89 44.51 1.06 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 14.79 105.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.254 0 N-CA-C 114.087 1.143 . . . . 12.0 114.087 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.617 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.79 156.35 17.89 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.939 0.876 . . . . 12.0 111.972 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.14 99.17 6.55 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.675 -1.972 . . . . 12.0 105.675 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.4 m -100.51 125.06 46.8 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.011 -0.676 . . . . 12.0 112.555 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.9 m -105.79 111.53 24.24 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 104.187 -2.523 . . . . 12.0 104.187 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 m -101.89 140.41 36.2 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 120.014 -0.675 . . . . 12.0 111.519 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 3.7 tmt_? -72.6 105.99 4.46 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.122 -0.696 . . . . 12.0 109.122 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 p -137.8 -83.72 0.32 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 110.014 -0.365 . . . . 12.0 110.014 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.55 108.77 0.1 Allowed 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 109.512 -0.551 . . . . 12.0 109.512 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 tp -179.09 152.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.427 -0.583 . . . . 12.0 109.427 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.4 171.47 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 121.945 -0.472 . . . . 12.0 109.811 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.47 -82.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.109 1.873 . . . . 12.0 111.747 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.462 ' CB ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -125.2 172.59 5.9 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.751 -0.593 . . . . 12.0 109.9 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 79' ' ' ARG . 31.0 Cg_endo -71.57 -65.05 0.03 OUTLIER 'Cis proline' 0 N--CA 1.489 1.232 0 O-C-N 123.26 1.137 . . . . 12.0 110.671 1.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.5 m -110.5 158.27 35.9 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.652 -0.87 . . . . 12.0 108.652 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 33.0 Cg_endo -72.74 113.95 3.89 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 121.492 1.461 . . . . 12.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 12.9 m-85 -140.2 134.22 30.84 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.083 0.468 . . . . 12.0 110.917 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -109.0 128.66 55.14 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.857 -1.164 . . . . 12.0 107.857 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.5 p -89.55 139.88 30.1 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.306 0.574 . . . . 12.0 110.909 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -147.97 158.41 44.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.511 -0.922 . . . . 12.0 108.511 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -139.67 148.72 42.79 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 109.537 -0.542 . . . . 12.0 109.537 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -177.22 -176.49 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.501 -0.48 . . . . 12.0 110.279 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.735 HG23 ' HB3' ' A' ' 65' ' ' ARG . 58.9 m -53.86 141.02 28.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.778 -0.453 . . . . 12.0 109.778 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.593 ' OD1' HD23 ' A' ' 68' ' ' LEU . 61.8 t30 -110.47 86.11 2.24 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.593 -0.843 . . . . 12.0 112.596 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -95.67 100.73 12.42 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.0 -2.222 . . . . 12.0 105.0 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.445 HG12 ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -122.93 149.6 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.546 0.689 . . . . 12.0 111.929 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 25.1 t -92.48 136.01 33.57 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 105.523 -2.029 . . . . 12.0 105.523 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 60' ' ' VAL . 2.8 m -140.57 -176.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 120.275 -0.57 . . . . 12.0 111.004 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 40.0 mtmt -147.95 149.22 31.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -118.78 117.57 29.25 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.688 0.756 . . . . 12.0 112.839 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.634 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 18.2 tt0 -124.52 143.77 50.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.844 -2.65 . . . . 12.0 103.844 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.7 m120 55.46 27.17 9.79 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-N 119.845 1.202 . . . . 12.0 107.946 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 18.4 pt20 54.59 8.85 0.23 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.098 1.359 . . . . 12.0 114.382 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.869 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -114.88 146.74 36.74 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 104.731 -2.322 . . . . 12.0 104.731 174.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.486 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.5 Cg_endo -59.88 88.92 0.07 OUTLIER 'Trans proline' 0 C--O 1.208 -1.005 0 C-N-CA 121.331 1.354 . . . . 12.0 109.282 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.869 HG22 ' CE2' ' A' ' 100' ' ' TYR . 54.3 t -84.45 -19.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 116.295 -0.411 . . . . 12.0 110.468 -177.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.634 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -136.83 134.42 36.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 -177.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.596 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.2 OUTLIER -123.78 129.81 51.64 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.963 -0.695 . . . . 12.0 109.395 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.599 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -85.91 -41.98 14.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.229 -0.295 . . . . 12.0 110.728 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.95 -99.88 0.59 Allowed Glycine 0 N--CA 1.504 3.186 0 C-N-CA 120.295 -0.955 . . . . 12.0 111.139 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.9 pt -58.29 147.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.844 -0.797 . . . . 12.0 110.294 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.29 -35.37 82.43 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.836 -1.306 . . . . 12.0 109.836 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -66.14 117.0 7.83 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.326 -0.62 . . . . 12.0 109.326 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.462 ' HB2' HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.34 168.95 14.39 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 109.121 -0.696 . . . . 12.0 109.121 -179.496 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.479 0.646 0 C-N-CA 121.829 1.686 . . . . 12.0 109.973 179.59 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PCA . . . . . 0.452 ' HA ' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.506 2.358 0 N-CA-C 109.921 -0.4 . . . . 12.0 109.921 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -85.88 154.56 21.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.49 65.23 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 122.031 -0.418 . . . . 12.0 110.009 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.55 42.86 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.804 -0.56 . . . . 12.0 110.451 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -65.39 -29.56 70.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.471 -0.937 . . . . 12.0 108.471 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 35.5 t80 -76.97 -20.0 56.63 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.866 -0.79 . . . . 12.0 108.866 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 12.3 tt0 -64.2 -38.88 92.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 106.475 -1.676 . . . . 12.0 106.475 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.441 ' O ' HD11 ' A' ' 12' ' ' ILE . 4.5 mp0 -77.65 -32.83 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 176.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -43.25 -64.4 0.65 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 110.298 -0.26 . . . . 12.0 110.298 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.524 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 88.8 m-70 -110.08 -23.2 11.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.2 0.815 . . . . 12.0 113.2 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 43' ' ' SER . 22.9 mm -93.81 57.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 119.254 0.934 . . . . 12.0 113.234 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.567 HD12 ' H ' ' A' ' 12' ' ' ILE . 4.1 mp -90.13 76.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 105.42 -2.067 . . . . 12.0 105.42 175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.15 79.44 2.97 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.794 0.807 . . . . 12.0 110.125 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -135.0 70.36 70.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.261 -1.385 . . . . 12.0 107.261 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -71.94 86.3 0.92 Allowed 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 121.825 1.683 . . . . 12.0 111.045 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 22' ' ' ILE . 24.9 pt -136.07 -167.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.201 -1.037 . . . . 12.0 108.201 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.08 38.39 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.666 0.746 . . . . 12.0 109.352 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -153.1 101.36 2.56 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 116.292 -0.413 . . . . 12.0 109.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.3 m -81.26 -5.86 58.24 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 122.054 -0.404 . . . . 12.0 111.014 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -83.13 -55.24 4.47 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.496 -0.753 . . . . 12.0 111.501 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -61.54 -23.09 65.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.679 -0.638 . . . . 12.0 110.719 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 16' ' ' ILE . 11.9 pt -84.53 -35.08 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.64 -0.663 . . . . 12.0 109.621 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.587 ' HA ' ' HE3' ' A' ' 23' ' ' MET . 0.7 OUTLIER -95.79 12.78 28.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.004 -0.435 . . . . 12.0 110.625 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.58 90.41 0.26 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.334 -1.358 . . . . 12.0 107.334 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.409 HD21 HD12 ' A' ' 27' ' ' ILE . 58.9 t30 -172.79 152.85 2.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.317 -0.623 . . . . 12.0 109.317 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -68.0 -11.98 59.92 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 110.044 -0.354 . . . . 12.0 110.044 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 27' ' ' ILE . 61.8 mt -86.59 9.66 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.727 -0.608 . . . . 12.0 110.811 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -144.12 63.16 1.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.599 -0.688 . . . . 12.0 109.181 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -148.08 151.99 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.593 -1.317 . . . . 12.0 111.02 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 31' ' ' GLY . 49.1 t -102.75 170.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 107.376 -1.342 . . . . 12.0 107.376 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.71 52.7 3.34 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.372 -1.491 . . . . 12.0 109.372 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.43 -56.69 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.304 -1.518 . . . . 12.0 109.304 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.87 -69.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.023 -0.732 . . . . 12.0 109.023 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.41 ' O ' HG21 ' A' ' 30' ' ' VAL . 61.2 m -140.92 -169.72 2.88 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HA ' HG21 ' A' ' 30' ' ' VAL . 1.6 tttp -115.0 167.16 11.05 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.163 -0.68 . . . . 12.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -76.76 -17.39 59.09 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.859 -0.336 . . . . 12.0 110.465 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 37' ' ' VAL . 11.4 p -161.53 118.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.36 0.6 . . . . 12.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -114.22 86.28 2.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.333 -1.729 . . . . 12.0 106.333 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -87.24 123.89 32.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.485 0.659 . . . . 12.0 111.373 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -108.5 163.36 13.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.977 -1.49 . . . . 12.0 106.977 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.1 mt -131.32 132.01 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.218 -0.926 . . . . 12.0 109.458 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.4 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 12.1 mm -100.29 108.83 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 108.979 -0.749 . . . . 12.0 108.979 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.518 ' O ' HD12 ' A' ' 11' ' ' ILE . 37.7 t 177.6 150.21 0.19 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.167 -0.679 . . . . 12.0 109.167 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 p -59.95 130.11 45.13 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.804 -0.813 . . . . 12.0 108.804 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -24.54 4.86 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.486 . . . . 12.0 111.224 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -84.78 -32.27 23.48 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.41 -0.516 . . . . 12.0 111.613 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -62.99 -38.92 93.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.117 -1.438 . . . . 12.0 107.117 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 51' ' ' ILE . 25.9 t -70.71 -35.7 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.564 -1.273 . . . . 12.0 107.564 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.15 -23.95 66.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.145 -0.687 . . . . 12.0 109.145 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.14 -36.95 29.61 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.976 -0.452 . . . . 12.0 110.158 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.5 tp -66.45 -23.74 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.801 -0.562 . . . . 12.0 110.386 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.89 27.61 6.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.828 -0.545 . . . . 12.0 109.947 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 m -90.99 114.92 27.56 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.452 -0.573 . . . . 12.0 109.452 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.64 0.02 OUTLIER Glycine 0 N--CA 1.5 2.93 0 N-CA-C 110.152 -1.179 . . . . 12.0 110.152 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.9 p -159.94 -168.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.69 -0.856 . . . . 12.0 108.69 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.593 ' H ' HG22 ' A' ' 55' ' ' VAL . 7.9 pt -88.14 25.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.118 -0.989 . . . . 12.0 111.39 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 174.0 115.03 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 107.521 -1.288 . . . . 12.0 107.521 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 176.82 10.99 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.69 0.757 . . . . 12.0 111.491 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -138.85 117.4 12.12 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.29 -1.374 . . . . 12.0 107.29 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.4 p -150.15 165.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.3 mp -125.73 125.64 43.33 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 120.758 -0.377 . . . . 12.0 110.808 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.503 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.31 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 177.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -86.44 -23.17 26.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.956 -0.465 . . . . 12.0 110.943 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -59.57 -88.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.497 -0.557 . . . . 12.0 109.497 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.821 ' HG3' HG23 ' A' ' 89' ' ' THR . 28.9 ttt-85 172.71 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 108.596 -0.89 . . . . 12.0 108.596 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 73.0 m-85 -105.17 57.52 0.68 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 109.253 -0.647 . . . . 12.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' PHE . 5.5 pt20 -4.5 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 114.557 1.317 . . . . 12.0 114.557 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -105.22 158.22 16.75 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.224 1.011 . . . . 12.0 112.94 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 6.7 t-20 -117.8 98.16 6.21 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 105.131 -2.174 . . . . 12.0 105.131 176.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.6 m -100.88 127.65 47.26 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.879 -0.729 . . . . 12.0 112.937 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.8 m -111.29 105.42 14.07 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 103.738 -2.689 . . . . 12.0 103.738 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 m -105.88 145.32 31.4 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 120.258 -0.577 . . . . 12.0 112.008 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 8.0 ttp180 -69.07 138.84 54.68 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.853 -0.795 . . . . 12.0 108.853 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -119.26 -84.83 0.66 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.919 -0.488 . . . . 12.0 110.435 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 m -135.68 116.34 13.91 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.66 -0.65 . . . . 12.0 109.978 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 6.7 mt -65.0 121.61 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.139 0.495 . . . . 12.0 109.91 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.478 ' CB ' ' HD3' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -177.48 -58.68 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.863 -0.792 . . . . 12.0 108.863 179.128 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 77' ' ' THR . 37.4 Cg_endo -81.03 159.76 20.77 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 121.952 1.768 . . . . 12.0 109.948 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.29 143.19 29.32 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.934 -0.765 . . . . 12.0 108.934 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -72.46 -162.66 2.56 Favored 'Cis proline' 0 N--CA 1.488 1.159 0 O-C-N 122.929 0.963 . . . . 12.0 110.743 0.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.68 157.07 0.28 Allowed Pre-proline 0 N--CA 1.509 2.521 0 CA-C-O 119.014 -0.517 . . . . 12.0 110.45 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 41.2 Cg_endo -77.07 110.57 3.05 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.778 1.652 . . . . 12.0 109.995 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 23.1 m-85 -143.83 133.56 23.76 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.438 0.637 . . . . 12.0 110.736 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -119.37 129.21 54.7 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -96.05 142.49 28.19 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.254 0.549 . . . . 12.0 110.912 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -151.49 125.86 9.41 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.379 -0.971 . . . . 12.0 108.379 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.9 m -105.53 147.05 28.79 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.707 -0.397 . . . . 12.0 109.983 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -174.87 -171.0 0.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.696 -0.483 . . . . 12.0 109.696 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.821 HG23 ' HG3' ' A' ' 65' ' ' ARG . 95.6 m -63.83 134.38 55.11 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.452 ' ND2' ' HB3' ' A' ' 68' ' ' LEU . 43.6 t-20 -107.12 91.96 3.88 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.552 0.691 . . . . 12.0 112.18 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.69 107.16 19.0 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.409 HG21 ' CE2' ' A' ' 104' ' ' PHE . 1.1 mt -110.85 160.94 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 122.2 1.0 . . . . 12.0 113.489 -174.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.401 ' N ' HG22 ' A' ' 92' ' ' ILE . 35.7 t -112.2 103.85 12.03 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 105.258 -2.127 . . . . 12.0 105.258 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.691 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 7.2 m -122.71 -171.71 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.435 0.636 . . . . 12.0 112.018 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 2.2 mtpp -145.24 152.01 39.28 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.03 -0.73 . . . . 12.0 109.03 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.58 119.69 33.64 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.655 0.74 . . . . 12.0 112.853 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.624 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 11.7 tt0 -127.36 145.55 50.77 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 104.362 -2.459 . . . . 12.0 104.362 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 52.98 28.6 6.82 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 119.876 1.216 . . . . 12.0 107.998 -176.325 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 12.0 pt20 55.56 4.08 0.09 Allowed 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 125.418 1.487 . . . . 12.0 114.701 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.878 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -110.14 147.29 35.96 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 105.147 -2.168 . . . . 12.0 105.147 175.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.1 Cg_endo -60.8 89.56 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.37 1.38 . . . . 12.0 108.79 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 100' ' ' TYR . 46.6 t -85.07 -14.11 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.619 -0.718 . . . . 12.0 110.654 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.624 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -144.87 117.75 8.76 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.512 -0.875 . . . . 12.0 110.387 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.691 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 1.3 m-85 -101.12 121.0 41.05 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.503 -1.665 . . . . 12.0 106.503 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.62 -28.84 17.25 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 112.966 0.728 . . . . 12.0 112.966 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.88 -169.28 37.29 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.803 -1.189 . . . . 12.0 111.111 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.588 ' O ' HG22 ' A' ' 107' ' ' ILE . 51.0 mt -93.38 36.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.051 0.453 . . . . 12.0 110.616 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.07 45.62 3.81 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 110.519 -1.032 . . . . 12.0 110.519 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.3 99.73 2.95 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.565 ' SG ' HD21 ' A' ' 61' ' ' LEU . 7.0 p -164.86 64.27 1.07 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 109.427 -0.583 . . . . 12.0 109.427 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.478 0.607 0 C-N-CA 122.285 1.99 . . . . 12.0 110.38 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.333 0 N-CA-C 109.181 -0.674 . . . . 12.0 109.181 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -120.95 164.14 17.17 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.59 ' CZ3' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -69.03 -24.19 64.16 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 121.636 -0.665 . . . . 12.0 110.492 -177.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.76 -64.08 1.07 Allowed 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.607 -0.683 . . . . 12.0 110.655 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.21 80.76 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.419 -1.326 . . . . 12.0 107.419 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 32.0 t80 -70.25 -25.66 63.48 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.384 -0.969 . . . . 12.0 108.384 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -52.0 -31.77 30.88 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 107.186 -1.413 . . . . 12.0 107.186 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -42.82 30.49 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.797 -1.186 . . . . 12.0 107.797 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.469 ' O ' HD13 ' A' ' 41' ' ' ILE . 9.7 mmtp -44.42 -53.84 6.49 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 122.363 -0.211 . . . . 12.0 111.365 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.885 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -95.47 -17.71 21.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.942 -0.474 . . . . 12.0 111.42 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 43' ' ' SER . 15.9 mm -129.48 79.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 118.899 -1.121 . . . . 12.0 113.929 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.496 HG21 HG22 ' A' ' 22' ' ' ILE . 48.5 mm -98.09 75.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 104.198 -2.519 . . . . 12.0 104.198 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -82.81 61.92 6.12 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.658 0.742 . . . . 12.0 111.425 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.504 ' OG1' HG23 ' A' ' 22' ' ' ILE . 60.9 p -146.55 65.19 10.05 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 106.954 -1.499 . . . . 12.0 106.954 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 14' ' ' THR . 37.1 Cg_endo -82.2 45.51 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.372 2.048 . . . . 12.0 112.011 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.62 -165.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.83 -0.804 . . . . 12.0 108.83 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.2 pt -97.81 43.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-O 121.424 0.631 . . . . 12.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -158.02 99.41 1.67 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.063 -0.717 . . . . 12.0 109.063 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.571 ' HA ' HD12 ' A' ' 22' ' ' ILE . 9.0 m -76.53 -12.72 60.07 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.954 -0.466 . . . . 12.0 110.996 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -63.57 -49.42 73.47 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 119.048 0.84 . . . . 12.0 109.025 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.7 m -74.85 -19.63 60.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.641 -0.503 . . . . 12.0 109.641 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 19' ' ' CYS . 44.1 mt -84.94 -8.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.765 -0.585 . . . . 12.0 110.663 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.54 4.89 7.57 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.629 -0.669 . . . . 12.0 110.305 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -58.23 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.403 -0.962 . . . . 12.0 108.403 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.453 HD21 HD12 ' A' ' 27' ' ' ILE . 57.5 t30 -173.08 152.14 2.26 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.751 -0.833 . . . . 12.0 108.751 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -70.21 -9.72 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.713 -0.395 . . . . 12.0 110.275 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 27' ' ' ILE . 56.4 mt -89.71 12.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.689 -0.632 . . . . 12.0 110.685 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.652 ' O ' HD13 ' A' ' 29' ' ' ILE . 33.8 m-85 -142.28 55.35 1.45 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.657 -0.652 . . . . 12.0 110.802 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 28' ' ' TYR . 33.1 mm -148.29 152.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 120.673 -1.267 . . . . 12.0 110.038 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 35' ' ' LYS . 61.1 t -110.06 168.28 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 107.71 -1.218 . . . . 12.0 107.71 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.87 54.91 3.35 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.738 -1.745 . . . . 12.0 108.738 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.95 -54.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.531 -1.427 . . . . 12.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -163.57 -76.41 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 122.054 -0.674 . . . . 12.0 109.404 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -133.94 -175.94 4.01 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.533 -0.543 . . . . 12.0 109.533 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.584 ' HA ' HG21 ' A' ' 30' ' ' VAL . 1.9 tttt -107.1 171.66 7.25 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -79.6 -17.34 54.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.1 -0.375 . . . . 12.0 110.575 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 37' ' ' VAL . 9.6 p -162.1 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 119.789 -0.764 . . . . 12.0 111.457 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -97.18 85.81 3.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.753 -1.943 . . . . 12.0 105.753 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.62 123.18 29.52 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.661 0.743 . . . . 12.0 112.555 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.447 ' CD1' HG21 ' A' ' 12' ' ' ILE . 23.6 m-85 -100.32 161.68 13.44 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.929 -1.508 . . . . 12.0 106.929 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 9' ' ' LYS . 4.4 mp -130.68 122.98 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.956 -1.09 . . . . 12.0 110.091 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.468 HD11 ' HB2' ' A' ' 69' ' ' ASN . 4.8 mt -98.54 107.11 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.27 -1.011 . . . . 12.0 108.27 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.898 ' O ' HD12 ' A' ' 11' ' ' ILE . 29.7 t 175.93 165.76 0.39 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 109.27 -0.641 . . . . 12.0 109.27 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 p -82.7 125.47 31.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.166 -1.049 . . . . 12.0 108.166 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.707 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -50.05 -31.47 13.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.992 -0.442 . . . . 12.0 111.887 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -76.61 -32.88 58.34 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.426 -0.51 . . . . 12.0 111.935 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.2 m -64.59 -34.34 78.02 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.817 -1.179 . . . . 12.0 107.817 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.655 HG11 ' CE1' ' A' ' 10' ' ' HIS . 20.7 t -71.03 -35.38 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.407 -1.331 . . . . 12.0 107.407 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -65.23 -21.43 66.75 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 116.016 -0.538 . . . . 12.0 110.019 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.63 -39.16 24.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.821 -0.55 . . . . 12.0 109.922 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 48' ' ' VAL . 7.2 tp -69.16 -18.07 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.788 -0.57 . . . . 12.0 110.401 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -97.34 15.14 23.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.58 -0.7 . . . . 12.0 111.003 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.3 m -66.16 107.27 1.88 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.189 -0.671 . . . . 12.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.79 -63.2 0.01 OUTLIER Glycine 0 N--CA 1.501 2.983 0 C-N-CA 120.484 -0.865 . . . . 12.0 111.013 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.62 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.1 p -167.54 -171.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.067 0.934 . . . . 12.0 109.434 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.62 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.0 tt -89.21 32.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 O-C-N 121.429 -0.794 . . . . 12.0 110.781 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 5.0 t30 169.75 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 107.257 -1.386 . . . . 12.0 107.257 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -163.17 179.72 7.25 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.121 0.962 . . . . 12.0 112.404 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -137.36 108.41 6.75 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.644 -1.614 . . . . 12.0 106.644 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 61' ' ' LEU . 2.7 t -132.9 171.13 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.853 -0.529 . . . . 12.0 109.886 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.0 mp -124.66 124.16 41.6 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.816 -0.439 . . . . 12.0 109.816 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.49 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 108.453 -0.943 . . . . 12.0 108.453 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.755 HG22 ' OH ' ' A' ' 91' ' ' TYR . 1.4 p -75.47 -43.43 49.43 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.638 -0.875 . . . . 12.0 108.638 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -65.65 124.1 21.47 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.17 -1.048 . . . . 12.0 108.17 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.737 ' CG ' HG23 ' A' ' 89' ' ' THR . 0.1 OUTLIER -54.49 105.95 0.18 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 122.088 -0.383 . . . . 12.0 109.982 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 51' ' ' ILE . 48.2 m-85 -94.94 41.04 1.09 Allowed 'General case' 0 N--CA 1.512 2.666 0 C-N-CA 120.074 -0.65 . . . . 12.0 109.548 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 24.99 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 114.284 1.216 . . . . 12.0 114.284 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.597 HD12 ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.95 155.58 18.53 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.032 0.92 . . . . 12.0 112.494 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.468 ' HB2' HD11 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -121.18 99.45 6.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 104.787 -2.301 . . . . 12.0 104.787 176.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -105.43 128.93 53.79 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.033 1.123 . . . . 12.0 114.033 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.35 105.37 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 103.107 -2.923 . . . . 12.0 103.107 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -105.26 144.19 32.39 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.07 -0.652 . . . . 12.0 111.944 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 105.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.593 -0.891 . . . . 12.0 108.593 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p -137.01 -81.44 0.37 Allowed 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 120.595 -0.442 . . . . 12.0 110.311 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.426 ' CA ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -165.32 165.63 19.28 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 109.452 -0.573 . . . . 12.0 109.452 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.642 HG22 HG23 ' A' ' 77' ' ' THR . 24.0 mt 69.29 155.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-O 121.251 0.548 . . . . 12.0 110.314 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.642 HG23 HG22 ' A' ' 76' ' ' ILE . 18.3 p 53.61 62.29 9.48 Favored Pre-proline 0 N--CA 1.5 2.06 0 CA-C-N 116.336 -0.393 . . . . 12.0 111.058 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.98 107.86 1.98 Allowed 'Trans proline' 0 N--CA 1.48 0.713 0 C-N-CA 122.097 1.865 . . . . 12.0 109.383 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.77 58.41 7.04 Favored Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.971 -0.455 . . . . 12.0 111.387 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -87.22 -44.06 0.32 Allowed 'Cis proline' 0 N--CA 1.485 0.976 0 C-N-CA 125.363 -0.682 . . . . 12.0 110.797 -2.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 93.8 m -61.53 150.12 81.94 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 118.963 -0.542 . . . . 12.0 109.759 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HB2' ' CA ' ' A' ' 75' ' ' SER . 36.4 Cg_endo -75.14 134.8 18.01 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 121.831 1.687 . . . . 12.0 110.562 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -142.93 139.26 30.65 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.283 0.564 . . . . 12.0 110.536 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 t -124.71 126.23 45.35 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 108.323 -0.991 . . . . 12.0 108.323 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 139.97 30.76 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.06 0.457 . . . . 12.0 110.612 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -152.53 124.09 7.79 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.802 -0.814 . . . . 12.0 108.802 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -94.11 152.92 18.41 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -176.09 -167.74 0.24 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.155 0.502 . . . . 12.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.737 HG23 ' CG ' ' A' ' 65' ' ' ARG . 39.6 m -65.31 143.85 57.51 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.584 ' OD1' HD11 ' A' ' 92' ' ' ILE . 7.7 t-20 -108.51 87.73 2.56 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.945 0.879 . . . . 12.0 110.856 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.755 ' OH ' HG22 ' A' ' 63' ' ' THR . 3.7 t80 -100.01 112.93 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.938 -2.245 . . . . 12.0 104.938 176.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.584 HD11 ' OD1' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -126.64 175.67 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-O 122.274 1.035 . . . . 12.0 112.406 -175.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.3 t -125.54 99.3 5.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.154 -1.795 . . . . 12.0 106.154 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' A' ' 101' ' ' PRO . 9.8 p -111.95 164.19 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.236 0.541 . . . . 12.0 111.193 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 94' ' ' VAL . 8.2 mmmt -118.04 140.84 49.17 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.88 120.32 33.12 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.505 1.298 . . . . 12.0 114.505 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.527 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 24.9 tt0 -114.99 139.99 49.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.869 -2.641 . . . . 12.0 103.869 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 77.7 m-20 56.46 31.04 18.13 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 5.7 pt20 52.75 10.34 0.15 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 114.569 1.322 . . . . 12.0 114.569 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.986 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.21 140.73 23.91 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 104.051 -2.574 . . . . 12.0 104.051 174.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.679 ' HB3' HG21 ' A' ' 94' ' ' VAL . 26.8 Cg_endo -60.78 90.85 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.857 0 N-CA-C 108.713 -1.303 . . . . 12.0 108.713 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.986 HG22 ' CE2' ' A' ' 100' ' ' TYR . 81.5 t -88.84 -19.95 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 116.244 -0.435 . . . . 12.0 110.694 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.527 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -139.9 145.72 38.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.694 -1.225 . . . . 12.0 107.694 -178.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.55 ' HZ ' ' HE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -109.31 133.52 52.95 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.209 -0.996 . . . . 12.0 109.221 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.72 -19.45 15.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.033 -0.417 . . . . 12.0 111.676 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.29 173.88 44.07 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 110.468 -1.053 . . . . 12.0 110.468 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 92' ' ' ILE . 4.3 pt -97.82 26.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.186 -0.596 . . . . 12.0 110.279 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.53 -65.59 0.51 Allowed Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.076 -1.209 . . . . 12.0 110.076 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.6 mtm-85 -62.03 144.53 55.04 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.398 -0.593 . . . . 12.0 109.398 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.77 164.62 5.29 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 109.458 -0.571 . . . . 12.0 109.458 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 N--CA 1.481 0.77 0 C-N-CA 121.744 1.63 . . . . 12.0 110.053 179.297 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 109.061 -0.718 . . . . 12.0 109.061 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -37.43 74.48 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 122.022 -0.424 . . . . 12.0 110.586 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.98 6.49 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.351 -0.843 . . . . 12.0 110.676 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -62.52 -32.3 73.21 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.211 -1.033 . . . . 12.0 108.211 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 61.4 t80 -72.59 -25.83 61.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.157 -1.053 . . . . 12.0 108.157 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.92 -33.69 62.39 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 1.5 mt-30 -80.39 -37.95 31.28 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.21 -1.404 . . . . 12.0 107.21 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -44.52 -57.33 3.66 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.983 -0.448 . . . . 12.0 111.079 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 4.4 m80 -99.58 -31.04 11.8 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.595 -0.691 . . . . 12.0 111.697 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.878 HG13 ' HB2' ' A' ' 45' ' ' ALA . 7.9 mm -102.93 65.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.668 1.729 . . . . 12.0 115.668 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 40' ' ' PHE . 3.4 mp -95.29 62.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 103.588 -2.745 . . . . 12.0 103.588 173.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -74.21 81.06 1.8 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.709 0.766 . . . . 12.0 110.409 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.6 p -118.5 106.87 43.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.233 -1.025 . . . . 12.0 108.233 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -81.51 37.16 0.66 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 121.921 1.747 . . . . 12.0 111.795 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 17' ' ' ILE . 4.6 mp -113.13 164.64 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.694 -0.854 . . . . 12.0 108.694 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.48 ' N ' HG22 ' A' ' 16' ' ' ILE . 33.5 pt -97.29 33.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-O 121.345 0.593 . . . . 12.0 109.855 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.24 91.36 3.36 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.29 -1.004 . . . . 12.0 108.29 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -76.28 -15.94 59.89 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.904 -0.498 . . . . 12.0 111.287 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -82.99 -50.41 8.58 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 119.019 0.827 . . . . 12.0 109.912 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.27 70.13 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 110.028 -0.36 . . . . 12.0 110.028 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.597 HD12 ' N ' ' A' ' 23' ' ' MET . 2.7 pp -76.98 -39.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 120.625 -0.43 . . . . 12.0 109.955 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.597 ' N ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -93.52 12.82 23.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.878 -0.514 . . . . 12.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -60.35 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.295 -1.002 . . . . 12.0 108.295 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -172.31 155.54 3.57 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.415 -0.587 . . . . 12.0 109.415 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -71.94 -10.23 59.48 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.922 -0.399 . . . . 12.0 109.922 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 27' ' ' ILE . 68.0 mt -85.78 8.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.691 -0.63 . . . . 12.0 110.644 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -135.96 57.19 1.79 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.536 -0.727 . . . . 12.0 110.025 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mt -151.47 145.87 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.959 -1.088 . . . . 12.0 109.889 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.3 p -109.73 -168.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 108.13 -1.063 . . . . 12.0 108.13 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.558 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -97.46 71.38 0.71 Allowed Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.201 -0.937 . . . . 12.0 111.411 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.72 -63.44 0.03 OUTLIER Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.227 -1.549 . . . . 12.0 109.227 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -165.22 -65.44 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.035 -1.098 . . . . 12.0 108.035 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.0 p -141.67 167.75 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 12.0 108.711 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -77.46 149.67 35.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.928 -0.482 . . . . 12.0 109.716 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -77.08 -23.85 51.89 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 110.104 -0.332 . . . . 12.0 110.104 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.487 HG12 ' OG1' ' A' ' 39' ' ' THR . 18.3 t -150.28 103.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 120.29 -0.564 . . . . 12.0 110.293 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.453 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 2.7 m-20 -92.59 76.48 5.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.441 -1.688 . . . . 12.0 106.441 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.487 ' OG1' HG12 ' A' ' 37' ' ' VAL . 25.8 m -79.23 116.49 19.52 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.928 -0.578 . . . . 12.0 110.686 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.652 ' O ' HD13 ' A' ' 41' ' ' ILE . 17.9 m-85 -107.01 163.59 12.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.087 -1.079 . . . . 12.0 108.087 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 40' ' ' PHE . 16.1 mm -126.71 124.57 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.907 -1.146 . . . . 12.0 107.907 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 69' ' ' ASN . 14.3 pt -96.51 98.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.857 ' O ' HD12 ' A' ' 11' ' ' ILE . 48.2 t -176.29 157.9 1.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.232 -0.655 . . . . 12.0 109.232 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.403 ' HB2' HG22 ' A' ' 46' ' ' THR . 8.1 p -63.88 128.17 34.64 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 109.244 -0.65 . . . . 12.0 109.244 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -54.45 -25.06 22.81 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.89 -0.506 . . . . 12.0 110.623 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 44' ' ' SER . 6.7 t -76.71 -33.91 58.18 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.523 -0.471 . . . . 12.0 111.231 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -65.19 -39.88 93.47 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.091 -1.448 . . . . 12.0 107.091 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.85 -31.86 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.824 -1.176 . . . . 12.0 107.824 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -67.38 -23.15 65.55 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.734 -0.469 . . . . 12.0 109.734 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -40.23 30.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.908 -0.495 . . . . 12.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.557 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 19.9 pt -69.41 -20.67 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.784 -0.572 . . . . 12.0 110.681 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.43 25.09 9.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.831 -0.543 . . . . 12.0 109.829 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -96.33 114.31 25.98 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.767 -0.583 . . . . 12.0 109.577 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.49 -62.68 0.01 OUTLIER Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.099 -1.2 . . . . 12.0 110.099 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.5 p -152.76 -169.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.517 -0.92 . . . . 12.0 108.517 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.616 ' H ' HG22 ' A' ' 55' ' ' VAL . 18.3 tt -88.62 26.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 O-C-N 120.915 -1.116 . . . . 12.0 110.796 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 4.4 t30 171.47 110.5 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 107.195 -1.409 . . . . 12.0 107.195 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -172.54 3.31 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.384 0.612 . . . . 12.0 110.684 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.98 114.55 8.02 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.094 -1.076 . . . . 12.0 108.094 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 51' ' ' ILE . 12.2 t -125.27 169.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.501 -0.925 . . . . 12.0 108.501 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -144.78 120.63 10.59 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.765 -0.774 . . . . 12.0 112.1 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 97.27 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.557 -1.275 . . . . 12.0 107.557 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -40.29 24.97 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.693 -0.484 . . . . 12.0 109.693 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.663 -0.495 . . . . 12.0 109.663 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.765 ' CB ' HG23 ' A' ' 89' ' ' THR . 5.4 ptt-85 177.87 103.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.601 -0.687 . . . . 12.0 110.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 29.6 m-85 -98.25 44.51 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.183 -0.607 . . . . 12.0 109.48 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 18.17 107.39 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 114.287 1.217 . . . . 12.0 114.287 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -102.4 153.99 19.51 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.03 0.919 . . . . 12.0 112.274 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.459 ' HB2' HG23 ' A' ' 42' ' ' ILE . 13.6 t30 -117.8 94.79 4.65 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.718 -1.956 . . . . 12.0 105.718 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 m -100.91 126.81 47.56 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.725 0.774 . . . . 12.0 112.786 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.6 m -106.76 104.76 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 104.589 -2.374 . . . . 12.0 104.589 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.4 HG23 HG22 ' A' ' 37' ' ' VAL . 8.4 m -101.21 131.36 47.24 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.211 -0.596 . . . . 12.0 111.727 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -63.05 105.82 0.75 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.107 -1.072 . . . . 12.0 108.107 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.501 2.097 0 O-C-N 122.03 -0.419 . . . . 12.0 110.81 -178.492 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 118.519 -0.753 . . . . 12.0 109.344 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.57 145.7 26.51 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.473 1.449 . . . . 12.0 110.279 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.0 m-85 -131.7 134.79 46.29 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.313 0.577 . . . . 12.0 110.512 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -105.84 109.78 21.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.097 -1.075 . . . . 12.0 108.097 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -83.57 133.93 34.84 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.178 0.513 . . . . 12.0 110.261 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -148.72 125.83 11.4 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -105.68 146.39 29.81 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.384 -0.599 . . . . 12.0 109.384 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HG3' HD11 ' A' ' 68' ' ' LEU . 14.9 pt-20 -172.24 -172.12 0.91 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 120.746 -0.382 . . . . 12.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.765 HG23 ' CB ' ' A' ' 65' ' ' ARG . 43.5 m -57.0 139.41 52.23 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.554 -0.536 . . . . 12.0 109.554 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.513 ' ND2' HD23 ' A' ' 68' ' ' LEU . 4.4 t-20 -112.84 88.01 2.73 Favored 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 119.482 -0.887 . . . . 12.0 112.064 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -95.78 96.23 8.83 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 104.399 -2.445 . . . . 12.0 104.399 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.719 HD13 ' CZ ' ' A' ' 104' ' ' PHE . 21.0 tt -130.28 163.68 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 119.854 -0.738 . . . . 12.0 111.708 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.68 114.14 28.12 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.008 -0.542 . . . . 12.0 110.191 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 101' ' ' PRO . 11.1 p -104.57 161.58 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.281 -0.637 . . . . 12.0 109.281 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.491 ' N ' HG22 ' A' ' 94' ' ' VAL . 12.7 ttmt -118.31 144.5 45.79 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.885 -0.783 . . . . 12.0 108.885 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.01 124.77 47.78 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.611 0.967 . . . . 12.0 113.611 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 27.9 tt0 -129.9 144.02 51.1 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 104.44 -2.43 . . . . 12.0 104.44 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.93 15.91 2.53 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.129 -0.982 . . . . 12.0 108.72 -175.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 78.29 -15.36 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 123.581 0.752 . . . . 12.0 112.606 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.915 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -98.28 148.66 34.82 Favored Pre-proline 0 N--CA 1.503 2.19 0 N-CA-C 106.497 -1.668 . . . . 12.0 106.497 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.5 Cg_endo -63.23 91.25 0.14 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 N-CA-C 107.955 -1.594 . . . . 12.0 107.955 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.915 HG22 ' CE2' ' A' ' 100' ' ' TYR . 69.4 t -87.61 -11.07 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-N 116.185 -0.461 . . . . 12.0 111.115 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.557 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -151.94 148.28 27.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.719 ' CZ ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -99.69 122.41 42.66 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.485 -1.286 . . . . 12.0 108.923 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.17 67.58 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.995 -0.44 . . . . 12.0 109.954 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.55 -149.08 18.59 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.863 -1.295 . . . . 12.0 109.863 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.9 pt -56.43 178.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.203 0.525 . . . . 12.0 110.757 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.824 0 N-CA-C 111.138 -0.785 . . . . 12.0 111.138 -179.15 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 108.568 -0.901 . . . . 12.0 108.568 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -25.03 64.1 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.905 -0.497 . . . . 12.0 110.313 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.38 -63.24 1.33 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.647 -0.658 . . . . 12.0 110.676 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -61.57 -31.58 71.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.935 -1.135 . . . . 12.0 107.935 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 31.3 t80 -76.08 -25.36 55.42 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.469 -0.937 . . . . 12.0 108.469 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -54.42 -32.69 57.87 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.339 -1.356 . . . . 12.0 107.339 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.44 -37.91 35.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.791 -1.189 . . . . 12.0 107.791 177.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 15.8 tppt? -47.15 -49.13 22.97 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 122.155 -0.341 . . . . 12.0 110.385 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.92 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -101.28 -13.13 18.18 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 118.681 -0.676 . . . . 12.0 112.596 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 11' ' ' ILE . 3.7 mp -137.81 72.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 115.354 1.613 . . . . 12.0 115.354 -175.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.951 HD12 ' CD1' ' A' ' 40' ' ' PHE . 11.3 mt -97.65 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 103.737 -2.69 . . . . 12.0 103.737 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.25 80.79 0.24 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.843 0.83 . . . . 12.0 110.512 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.409 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.5 p -150.6 59.79 3.73 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.411 -1.329 . . . . 12.0 107.411 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 14' ' ' THR . 34.8 Cg_endo -73.12 84.77 1.29 Allowed 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 121.94 1.76 . . . . 12.0 110.711 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 pt -124.94 -169.17 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' HD13 ' A' ' 17' ' ' ILE . 1.3 mm -97.88 34.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.656 -0.652 . . . . 12.0 109.436 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -150.04 98.4 2.7 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.902 -0.499 . . . . 12.0 109.997 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -81.36 -4.47 55.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.853 -0.529 . . . . 12.0 110.734 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -84.47 -58.11 2.87 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.523 -0.736 . . . . 12.0 111.242 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -26.04 64.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.786 -0.571 . . . . 12.0 110.097 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.3 pt -85.61 -32.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.853 -0.529 . . . . 12.0 109.597 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ttp -100.98 20.28 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.947 -0.39 . . . . 12.0 109.947 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -74.15 86.53 1.89 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -163.96 147.46 9.82 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.779 -0.576 . . . . 12.0 109.574 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -70.9 -8.17 50.98 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.943 -0.391 . . . . 12.0 109.943 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -85.95 7.84 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.601 -0.687 . . . . 12.0 110.026 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.535 ' OH ' HD11 ' A' ' 12' ' ' ILE . 35.2 m-85 -136.04 60.62 1.67 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.581 -0.699 . . . . 12.0 109.371 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mt -146.49 152.57 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 120.768 -1.208 . . . . 12.0 110.936 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.544 HG21 ' CA ' ' A' ' 35' ' ' LYS . 52.6 t -104.34 169.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.687 -1.227 . . . . 12.0 107.687 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.82 55.6 3.37 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.74 -57.14 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.41 -1.476 . . . . 12.0 109.41 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.31 -71.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.956 -0.732 . . . . 12.0 109.526 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 p -153.68 132.24 12.17 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.697 -0.853 . . . . 12.0 108.697 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CA ' HG21 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -56.18 171.27 0.28 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 109.82 -0.437 . . . . 12.0 109.82 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.97 -6.33 59.04 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 119.438 -0.315 . . . . 12.0 111.326 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.7 p -164.72 114.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 C-N-CA 119.545 -0.862 . . . . 12.0 111.691 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.482 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 59.1 m-20 -95.37 82.55 3.71 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 12.0 105.832 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -83.48 116.21 22.43 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.58 0.705 . . . . 12.0 111.862 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.951 ' CD1' HD12 ' A' ' 12' ' ' ILE . 18.5 m-85 -104.49 162.46 13.22 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.359 -1.348 . . . . 12.0 107.359 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 10' ' ' HIS . 4.9 mp -126.89 125.99 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.518 1.054 . . . . 12.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.446 HD11 HD22 ' A' ' 69' ' ' ASN . 6.3 mt -90.85 108.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 108.03 -1.1 . . . . 12.0 108.03 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.6 t 177.71 151.12 0.22 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.684 -0.406 . . . . 12.0 109.971 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -67.02 129.6 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.112 -1.07 . . . . 12.0 108.112 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -26.49 5.73 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.042 -0.411 . . . . 12.0 111.295 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.91 -33.24 30.53 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.916 -0.49 . . . . 12.0 111.829 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -62.59 -37.73 87.37 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.083 -1.451 . . . . 12.0 107.083 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.92 HG11 ' CD2' ' A' ' 10' ' ' HIS . 46.8 t -67.39 -34.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -59.38 -23.61 62.73 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.67 -38.66 25.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.968 -0.458 . . . . 12.0 109.77 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 48' ' ' VAL . 6.4 tp -65.93 -19.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.809 -0.557 . . . . 12.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 23.04 15.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.754 -0.591 . . . . 12.0 110.448 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 m -86.2 112.43 21.34 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.55 -65.66 0.01 OUTLIER Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.249 -1.14 . . . . 12.0 110.249 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.659 HG12 ' HG3' ' A' ' 58' ' ' MET . 2.4 p -160.54 -164.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.407 -0.96 . . . . 12.0 108.407 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.593 ' H ' HG22 ' A' ' 55' ' ' VAL . 18.1 tt -90.3 28.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.124 -0.985 . . . . 12.0 110.968 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 15.6 t-20 172.1 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.659 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -163.89 177.77 8.31 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.795 0.807 . . . . 12.0 111.742 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -133.37 112.46 11.62 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.064 -1.458 . . . . 12.0 107.064 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 61' ' ' LEU . 14.5 p -131.82 168.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.902 -0.499 . . . . 12.0 109.731 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' N ' HG22 ' A' ' 60' ' ' VAL . 1.4 mp -133.47 128.52 35.61 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.479 -0.488 . . . . 12.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -62.18 95.81 0.07 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.762 -1.57 . . . . 12.0 106.762 177.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -84.71 -46.66 11.23 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.989 -0.444 . . . . 12.0 110.896 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.513 HG22 ' HG2' ' A' ' 65' ' ' ARG . 99.4 m -52.16 -94.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.972 -0.455 . . . . 12.0 109.786 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.687 ' CB ' HG23 ' A' ' 89' ' ' THR . 0.1 OUTLIER 173.66 101.9 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.098 -0.704 . . . . 12.0 109.098 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 76.3 m-85 -96.87 44.42 1.06 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 120.483 -0.487 . . . . 12.0 109.818 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 19.48 106.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.106 1.15 . . . . 12.0 114.106 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.28 153.65 18.79 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.093 0.949 . . . . 12.0 112.562 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.446 HD22 HD11 ' A' ' 42' ' ' ILE . 4.2 t-20 -115.1 101.27 8.83 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 104.657 -2.349 . . . . 12.0 104.657 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -106.79 121.8 45.1 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.456 0.909 . . . . 12.0 113.456 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.01 104.64 16.69 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 102.677 -3.083 . . . . 12.0 102.677 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -100.53 140.13 35.23 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.469 0.652 . . . . 12.0 112.333 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.4 ttt180 -60.42 133.69 56.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.905 -0.776 . . . . 12.0 108.905 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.499 2.015 0 N-CA-C 109.512 -0.551 . . . . 12.0 109.512 -179.751 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 109.291 -0.633 . . . . 12.0 109.291 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 35.3 Cg_endo -76.11 128.01 10.33 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.562 1.508 . . . . 12.0 110.797 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.482 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.4 m-85 -148.02 137.26 22.16 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.964 0.411 . . . . 12.0 110.147 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 t -124.45 129.52 50.81 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.329 -0.989 . . . . 12.0 108.329 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -80.49 136.92 36.4 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.151 0.501 . . . . 12.0 110.956 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 121.37 7.81 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.99 -0.744 . . . . 12.0 108.99 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.9 p -98.55 147.16 25.07 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.468 -0.567 . . . . 12.0 109.468 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -168.3 -173.27 1.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.018 0.437 . . . . 12.0 110.054 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.687 HG23 ' CB ' ' A' ' 65' ' ' ARG . 30.7 m -66.43 142.49 57.56 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 109.461 -0.57 . . . . 12.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.462 HD22 HD23 ' A' ' 68' ' ' LEU . 8.6 t-20 -105.73 87.16 2.53 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.88 0.847 . . . . 12.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 6.2 p90 -109.34 106.46 16.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 105.985 -1.857 . . . . 12.0 105.985 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.463 ' HA ' ' CA ' ' A' ' 108' ' ' GLY . 19.9 pt -139.18 -171.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.85 -0.74 . . . . 12.0 111.976 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 39.0 t -119.99 114.63 22.31 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.083 -0.71 . . . . 12.0 109.083 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 95' ' ' LYS . 8.6 p -113.75 171.35 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 105' ' ' ALA . 14.3 mttt -130.88 146.03 52.18 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.922 -0.77 . . . . 12.0 108.922 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.4 m -118.18 125.13 49.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.217 1.192 . . . . 12.0 114.217 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 30.0 tt0 -131.62 144.69 51.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 103.818 -2.66 . . . . 12.0 103.818 174.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 27.8 m-80 53.63 29.38 9.22 Favored 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 107.699 -1.222 . . . . 12.0 107.699 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 52.69 9.58 0.12 Allowed 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 125.289 1.436 . . . . 12.0 114.835 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.915 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -114.39 145.98 34.89 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 104.532 -2.395 . . . . 12.0 104.532 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.629 ' HG3' HG12 ' A' ' 48' ' ' VAL . 23.3 Cg_endo -60.79 90.08 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.275 1.316 . . . . 12.0 108.69 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.915 HG22 ' CE2' ' A' ' 100' ' ' TYR . 69.7 t -86.84 -23.24 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 116.271 -0.422 . . . . 12.0 110.851 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.62 145.89 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.94 -1.133 . . . . 12.0 107.94 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -116.47 128.51 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.15 -1.02 . . . . 12.0 109.92 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 95' ' ' LYS . . . -78.99 -37.9 38.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.23 -0.294 . . . . 12.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.08 -134.68 6.88 Favored Glycine 0 N--CA 1.504 3.177 0 C-N-CA 120.066 -1.064 . . . . 12.0 111.493 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 pt -69.15 -171.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.083 0.468 . . . . 12.0 111.129 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.463 ' CA ' ' HA ' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.498 2.799 0 N-CA-C 110.391 -1.084 . . . . 12.0 110.391 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 10.7 t-20 . . . . . 0 N--CA 1.497 1.882 0 N-CA-C 108.817 -0.809 . . . . 12.0 108.817 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.425 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.51 -22.85 61.73 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 121.952 -0.468 . . . . 12.0 110.527 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.64 0.85 Allowed 'General case' 0 N--CA 1.515 2.815 0 O-C-N 121.637 -0.665 . . . . 12.0 110.853 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 m -60.9 -31.54 71.03 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.061 -1.088 . . . . 12.0 108.061 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 26.3 t80 -75.91 -26.14 56.7 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.461 -0.94 . . . . 12.0 108.461 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -51.79 -35.69 44.98 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 107.567 -1.271 . . . . 12.0 107.567 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -77.29 -40.95 42.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -45.87 -51.76 12.53 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.161 -0.337 . . . . 12.0 111.627 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.694 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.2 m170 -94.89 -14.71 24.26 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.552 -0.718 . . . . 12.0 111.363 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.694 HD13 ' O ' ' A' ' 10' ' ' HIS . 36.5 mm -130.86 73.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 N-CA-C 114.46 1.282 . . . . 12.0 114.46 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 40' ' ' PHE . 3.0 mp -97.43 61.15 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 103.667 -2.716 . . . . 12.0 103.667 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.568 ' ND2' HG23 ' A' ' 11' ' ' ILE . 1.6 m-80 -70.98 81.49 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.739 0.78 . . . . 12.0 110.199 -176.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.535 ' OG1' HD12 ' A' ' 22' ' ' ILE . 9.3 p -131.79 76.11 74.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.672 -0.862 . . . . 12.0 108.672 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.85 82.0 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.994 1.796 . . . . 12.0 109.223 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 17' ' ' ILE . 31.6 mt -141.69 168.91 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.459 ' N ' HG22 ' A' ' 16' ' ' ILE . 10.7 pt -93.71 41.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 121.437 0.636 . . . . 12.0 109.758 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 22' ' ' ILE . 18.9 m120 -149.49 104.81 3.4 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.7 -0.852 . . . . 12.0 108.7 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -81.12 -16.89 51.76 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 120.551 -0.46 . . . . 12.0 111.558 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -84.39 -55.24 4.26 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 118.892 0.769 . . . . 12.0 110.417 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.09 -30.68 64.54 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.264 -0.272 . . . . 12.0 110.443 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.535 HD12 ' OG1' ' A' ' 14' ' ' THR . 44.0 pt -80.76 -39.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.268 -0.573 . . . . 12.0 110.171 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.434 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -95.86 17.1 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.496 -0.482 . . . . 12.0 110.246 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -62.49 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.616 -0.883 . . . . 12.0 108.616 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.61 150.15 4.86 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.354 -0.61 . . . . 12.0 109.354 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -69.65 -9.42 54.16 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.878 -0.329 . . . . 12.0 110.342 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -87.06 8.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 12.0 110.307 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -137.27 58.2 1.72 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.6 -0.687 . . . . 12.0 109.73 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -151.31 152.19 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 12.0 110.579 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 31' ' ' GLY . 58.5 t -103.26 168.93 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 107.475 -1.306 . . . . 12.0 107.475 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.35 54.77 3.54 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.219 -1.552 . . . . 12.0 109.219 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.88 -57.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.146 -1.582 . . . . 12.0 109.146 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.24 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.022 -0.693 . . . . 12.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 99.0 m -144.05 150.1 37.67 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.04 176.97 6.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.014 -0.736 . . . . 12.0 109.014 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -17.07 52.37 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.969 -0.457 . . . . 12.0 110.038 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.5 p -162.04 117.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 C-N-CA 119.825 -0.75 . . . . 12.0 111.337 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 5.3 m-20 -97.46 83.77 3.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.701 -1.963 . . . . 12.0 105.701 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -80.84 116.4 20.81 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.909 -0.587 . . . . 12.0 111.481 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.69 ' HA ' HD13 ' A' ' 12' ' ' ILE . 21.7 m-85 -100.5 158.96 15.53 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.531 -1.285 . . . . 12.0 107.531 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.465 HD12 ' ND2' ' A' ' 90' ' ' ASN . 50.5 mm -129.18 124.23 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.357 -0.84 . . . . 12.0 110.346 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.568 HD11 HD22 ' A' ' 69' ' ' ASN . 4.6 mt -106.42 111.44 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 108.324 -0.991 . . . . 12.0 108.324 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 t 178.33 151.23 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 12.0 109.112 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.49 119.41 5.19 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 109.134 -0.691 . . . . 12.0 109.134 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HA ' HD11 ' A' ' 11' ' ' ILE . . . -42.98 -64.54 0.61 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 113.555 0.946 . . . . 12.0 113.555 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.5 t -62.13 -20.73 64.38 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.912 -0.493 . . . . 12.0 111.552 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.6 m -65.25 -36.07 82.98 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 107.169 -1.419 . . . . 12.0 107.169 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.837 ' O ' HG22 ' A' ' 51' ' ' ILE . 19.3 t -71.24 -34.39 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -21.51 65.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.663 -0.866 . . . . 12.0 108.663 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.45 -39.05 28.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.885 -0.51 . . . . 12.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.837 HG22 ' O ' ' A' ' 48' ' ' VAL . 4.7 tp -64.32 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 12.0 109.773 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.423 ' HA ' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -104.91 25.57 10.3 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.69 -0.632 . . . . 12.0 110.35 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 m -90.83 115.93 28.28 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.252 -0.647 . . . . 12.0 109.252 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.98 -62.95 0.02 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.573 -1.011 . . . . 12.0 110.573 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.6 p -161.12 -164.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.581 -0.896 . . . . 12.0 108.581 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.599 ' H ' HG22 ' A' ' 55' ' ' VAL . 9.9 tt -88.64 27.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 121.053 -1.029 . . . . 12.0 110.665 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.6 t30 172.44 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 106.961 -1.496 . . . . 12.0 106.961 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.87 178.37 9.83 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.921 0.867 . . . . 12.0 111.841 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.66 112.25 7.83 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.923 -1.51 . . . . 12.0 106.923 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.1 p -141.25 167.92 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.325 -0.621 . . . . 12.0 109.325 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 93' ' ' CYS . 4.7 mp -136.67 130.32 31.99 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.581 -0.448 . . . . 12.0 111.023 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -59.12 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 106.544 -1.651 . . . . 12.0 106.544 176.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.79 HG22 ' OH ' ' A' ' 91' ' ' TYR . 3.1 p -80.61 -43.1 21.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.325 -0.234 . . . . 12.0 110.512 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.34 -90.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 109.349 -0.612 . . . . 12.0 109.349 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.788 ' CB ' HG23 ' A' ' 89' ' ' THR . 4.7 ptt-85 171.48 101.06 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.211 -0.663 . . . . 12.0 109.211 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 62.0 m-85 -97.25 48.38 1.04 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 120.462 -0.495 . . . . 12.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 16.57 107.92 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.525 1.305 . . . . 12.0 114.525 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.635 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -104.06 155.59 18.56 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.066 0.936 . . . . 12.0 112.474 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.568 HD22 HD11 ' A' ' 42' ' ' ILE . 13.3 t-20 -116.87 97.42 5.95 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 105.25 -2.13 . . . . 12.0 105.25 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 m -104.18 128.29 51.87 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.5 0.926 . . . . 12.0 113.5 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.2 m -111.01 108.18 17.83 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.44 -2.8 . . . . 12.0 103.44 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -109.55 145.86 35.63 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 120.17 -0.612 . . . . 12.0 112.311 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.7 ttp85 -64.27 116.0 5.59 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.937 -0.764 . . . . 12.0 108.937 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.503 2.212 0 O-C-N 121.934 -0.479 . . . . 12.0 110.742 -179.285 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 108.259 -1.015 . . . . 12.0 108.259 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 36.6 Cg_endo -76.12 101.71 1.52 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.68 1.587 . . . . 12.0 109.65 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.441 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 18.9 m-85 -139.75 138.33 35.82 Favored 'General case' 0 N--CA 1.509 2.489 0 CA-C-O 121.354 0.597 . . . . 12.0 111.198 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -114.79 121.76 44.29 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 p -84.32 143.99 29.15 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 120.991 0.424 . . . . 12.0 110.395 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -154.66 159.49 40.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.276 -0.638 . . . . 12.0 109.276 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.6 m -130.45 142.14 50.5 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.062 -0.718 . . . . 12.0 109.062 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.94 -169.46 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.309 0.575 . . . . 12.0 110.521 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.788 HG23 ' CB ' ' A' ' 65' ' ' ARG . 98.3 m -64.54 146.47 54.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.082 -0.71 . . . . 12.0 109.082 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' HD12 ' A' ' 41' ' ' ILE . 60.6 t30 -108.67 88.78 2.81 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.989 0.899 . . . . 12.0 111.383 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.79 ' OH ' HG22 ' A' ' 63' ' ' THR . 2.3 t80 -98.43 103.95 15.94 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.84 -2.281 . . . . 12.0 104.84 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.628 HD13 ' O ' ' A' ' 91' ' ' TYR . 33.0 mm -127.75 163.38 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 119.685 -0.806 . . . . 12.0 111.99 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.522 ' HB2' HD23 ' A' ' 61' ' ' LEU . 51.6 t -115.91 106.44 13.8 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 101' ' ' PRO . 5.5 p -113.85 172.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.953 -0.388 . . . . 12.0 109.953 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.534 ' H ' HG22 ' A' ' 94' ' ' VAL . 65.0 mttt -126.65 143.18 51.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -111.0 115.68 29.89 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.265 1.209 . . . . 12.0 114.265 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.519 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.7 tt0 -125.77 142.72 51.37 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 104.055 -2.572 . . . . 12.0 104.055 174.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 60.3 m-80 54.84 29.55 12.16 Favored 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 14.5 pt20 52.1 11.11 0.14 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 114.651 1.352 . . . . 12.0 114.651 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.891 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -118.12 146.99 40.53 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 174.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.539 ' HB3' HG21 ' A' ' 94' ' ' VAL . 24.3 Cg_endo -60.54 89.89 0.08 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 121.262 1.308 . . . . 12.0 108.819 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.891 HG22 ' CE2' ' A' ' 100' ' ' TYR . 47.2 t -86.22 -19.63 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 116.345 -0.388 . . . . 12.0 110.887 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -140.77 144.57 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.657 -0.868 . . . . 12.0 108.657 -177.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -109.07 132.11 54.43 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.068 -1.053 . . . . 12.0 108.366 178.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.12 -24.19 14.66 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.092 -0.38 . . . . 12.0 111.992 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.45 178.32 47.75 Favored Glycine 0 N--CA 1.503 3.143 0 N-CA-C 110.577 -1.009 . . . . 12.0 110.577 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 92' ' ' ILE . 10.4 pt -92.65 25.1 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.45 -0.441 . . . . 12.0 110.692 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.927 0 N-CA-C 109.591 -1.403 . . . . 12.0 109.591 179.631 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.0 t30 . . . . . 0 N--CA 1.498 1.956 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.403 ' CZ3' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -70.85 -31.85 68.68 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 122.157 -0.339 . . . . 12.0 110.874 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.87 2.01 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.542 -0.724 . . . . 12.0 110.474 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.2 m -62.29 -32.56 73.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.503 -0.925 . . . . 12.0 108.503 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 36.3 t80 -73.89 -23.86 59.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.69 -0.855 . . . . 12.0 108.69 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 17.4 tt0 -57.65 -37.85 74.06 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.129 -1.434 . . . . 12.0 107.129 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -75.59 -34.14 60.61 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 176.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 17.9 tptt -46.42 -59.0 3.23 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 122.215 -0.303 . . . . 12.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.65 ' HA ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -104.11 1.09 30.43 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 118.482 -0.771 . . . . 12.0 112.758 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.1 mp -134.74 65.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 117.866 -1.534 . . . . 12.0 114.958 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.914 HD12 ' CD1' ' A' ' 40' ' ' PHE . 23.3 mt -97.53 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 103.88 -2.637 . . . . 12.0 103.88 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -65.01 83.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.815 0.817 . . . . 12.0 110.186 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 p -129.26 90.54 44.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -73.99 -3.02 13.11 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.679 1.586 . . . . 12.0 112.081 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.805 HD11 ' CG2' ' A' ' 22' ' ' ILE . 18.4 pt -58.43 -170.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.246 -0.65 . . . . 12.0 109.246 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.9 40.65 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.469 0.652 . . . . 12.0 109.81 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -142.76 101.02 3.78 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.9 -0.5 . . . . 12.0 110.18 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' CG1' ' A' ' 22' ' ' ILE . 10.7 m -81.16 -3.17 51.31 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.934 -0.479 . . . . 12.0 110.829 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -84.7 -58.02 2.89 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.521 -0.737 . . . . 12.0 111.685 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 m -65.47 -23.44 66.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.593 -0.692 . . . . 12.0 110.402 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.805 ' CG2' HD11 ' A' ' 16' ' ' ILE . 2.7 pp -84.04 -35.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.419 -0.585 . . . . 12.0 109.419 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.509 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.2 ttm -83.28 -5.53 59.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.143 -0.348 . . . . 12.0 110.198 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.68 91.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' HD12 ' A' ' 27' ' ' ILE . 8.0 t-20 -168.07 152.98 6.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.428 -0.582 . . . . 12.0 109.428 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.15 -7.97 53.74 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 120.664 -0.414 . . . . 12.0 110.043 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 27' ' ' ILE . 55.5 mt -88.41 10.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.687 -0.633 . . . . 12.0 110.317 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.87 ' OH ' HD11 ' A' ' 12' ' ' ILE . 47.0 m-85 -138.46 57.93 1.68 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.744 -0.597 . . . . 12.0 110.391 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.99 -1.069 . . . . 12.0 109.511 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.8 p -107.41 -165.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 108.02 -1.104 . . . . 12.0 108.02 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.568 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -96.91 67.81 0.88 Allowed Glycine 0 N--CA 1.505 3.265 0 O-C-N 121.044 -1.035 . . . . 12.0 112.063 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.85 -63.53 0.03 OUTLIER Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.23 -1.548 . . . . 12.0 109.23 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -164.44 -64.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.667 -1.235 . . . . 12.0 107.667 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.9 p -174.51 126.15 0.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.944 -1.132 . . . . 12.0 107.944 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -56.19 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.986 -0.446 . . . . 12.0 109.941 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 mtm-85 -106.18 21.45 17.35 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.903 -0.319 . . . . 12.0 110.488 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -163.53 133.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.595 -0.691 . . . . 12.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.0 99.07 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.944 -1.502 . . . . 12.0 106.944 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 m -87.4 110.85 20.56 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.291 0.567 . . . . 12.0 111.524 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.914 ' CD1' HD12 ' A' ' 12' ' ' ILE . 18.9 m-85 -98.25 162.21 13.3 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.671 HD12 ' C ' ' A' ' 40' ' ' PHE . 4.5 mp -132.8 128.1 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.183 -0.948 . . . . 12.0 109.756 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.405 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 4.4 mt -94.66 107.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.8 t 177.2 148.08 0.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.62 -0.511 . . . . 12.0 109.62 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 p -64.25 129.51 40.22 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.052 -1.092 . . . . 12.0 108.052 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB1' ' CZ3' ' A' ' 3' ' ' TRP . . . -48.67 -30.9 5.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.881 -0.512 . . . . 12.0 111.589 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -78.97 -33.88 44.79 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.937 -0.477 . . . . 12.0 111.837 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -62.44 -39.72 94.25 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.281 -1.377 . . . . 12.0 107.281 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.806 ' O ' HG22 ' A' ' 51' ' ' ILE . 37.2 t -69.26 -35.79 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.752 -1.203 . . . . 12.0 107.752 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -22.55 66.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.195 -0.668 . . . . 12.0 109.195 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.05 29.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.966 -0.459 . . . . 12.0 109.903 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.0 tp -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.749 -0.594 . . . . 12.0 110.164 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.06 26.52 8.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.858 -0.526 . . . . 12.0 109.937 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.5 m -88.06 111.51 21.63 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.875 -0.787 . . . . 12.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.46 -60.4 0.02 OUTLIER Glycine 0 N--CA 1.499 2.877 0 N-CA-C 110.643 -0.983 . . . . 12.0 110.643 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.3 p -163.93 -169.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.866 -0.785 . . . . 12.0 108.904 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.612 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.7 pt -87.27 25.55 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 O-C-N 121.11 -0.994 . . . . 12.0 111.197 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.419 ' H ' HG13 ' A' ' 55' ' ' VAL . 9.3 t30 174.67 113.48 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 106.86 -1.533 . . . . 12.0 106.86 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.6 ttt -161.21 174.55 13.46 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.855 0.836 . . . . 12.0 111.739 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -132.51 110.67 10.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.593 -1.632 . . . . 12.0 106.593 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 61' ' ' LEU . 11.0 t -121.78 168.53 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.745 -0.597 . . . . 12.0 109.827 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.469 ' N ' HG12 ' A' ' 60' ' ' VAL . 5.0 mp -131.0 112.17 12.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.121 -0.362 . . . . 12.0 110.662 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -60.4 92.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 107.502 -1.295 . . . . 12.0 107.502 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -83.28 -42.26 17.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.916 -0.49 . . . . 12.0 111.019 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -53.05 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 109.771 -0.455 . . . . 12.0 109.771 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.738 ' CB ' HG23 ' A' ' 89' ' ' THR . 2.2 ptp180 178.53 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.425 -0.797 . . . . 12.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 72.8 m-85 -96.51 43.7 1.07 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 120.446 -0.502 . . . . 12.0 109.678 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 18.91 106.11 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.211 1.189 . . . . 12.0 114.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.56 153.86 18.71 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.782 0.801 . . . . 12.0 111.836 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.405 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 7.2 t30 -119.99 102.47 8.57 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 106.467 -1.679 . . . . 12.0 106.467 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -100.94 124.73 47.08 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.944 -0.703 . . . . 12.0 111.797 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.2 m -108.82 109.39 20.5 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.095 -2.557 . . . . 12.0 104.095 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -114.15 140.84 48.19 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.821 -0.752 . . . . 12.0 111.523 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -58.61 110.49 1.0 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.306 -0.627 . . . . 12.0 109.306 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.5 2.061 0 O-C-N 122.071 -0.393 . . . . 12.0 110.539 -179.389 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.496 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 110.845 -0.057 . . . . 12.0 110.845 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 37.0 Cg_endo -78.93 129.19 8.86 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.323 2.015 . . . . 12.0 108.977 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -120.77 136.48 54.87 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 121.647 0.737 . . . . 12.0 112.354 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 p -109.03 129.63 55.46 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.814 -1.18 . . . . 12.0 107.814 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.8 p -92.81 145.14 24.62 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.308 0.575 . . . . 12.0 111.819 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -149.97 157.29 43.01 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.578 -0.897 . . . . 12.0 108.578 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 m -128.38 153.68 46.8 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.599 -0.519 . . . . 12.0 109.599 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -173.07 179.0 2.35 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.666 -0.414 . . . . 12.0 109.961 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.738 HG23 ' CB ' ' A' ' 65' ' ' ARG . 68.3 m -62.03 143.42 56.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.495 -0.928 . . . . 12.0 108.495 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -107.65 85.77 2.18 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.308 -0.957 . . . . 12.0 112.203 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -100.34 105.17 16.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.226 -2.509 . . . . 12.0 104.226 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.412 ' HA ' ' N ' ' A' ' 108' ' ' GLY . 0.8 OUTLIER -136.32 -177.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 121.653 0.739 . . . . 12.0 112.062 -175.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 18.1 t -117.76 121.3 40.45 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.707 -0.849 . . . . 12.0 108.707 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.599 HG23 ' CZ ' ' A' ' 104' ' ' PHE . 8.1 p -117.5 167.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.844 -0.342 . . . . 12.0 110.595 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 94' ' ' VAL . 36.9 mttt -129.6 138.39 51.23 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.479 -0.934 . . . . 12.0 108.479 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -111.99 122.24 47.22 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 113.92 1.081 . . . . 12.0 113.92 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 35.0 tt0 -132.23 142.56 49.46 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 103.991 -2.596 . . . . 12.0 103.991 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 33.2 m120 54.13 29.1 9.84 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 107.638 -1.245 . . . . 12.0 107.638 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 98' ' ' ASN . 2.1 pm0 52.94 10.21 0.15 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.168 1.544 . . . . 12.0 115.168 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.905 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -115.63 146.24 36.3 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 104.574 -2.38 . . . . 12.0 104.574 174.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.57 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.9 Cg_endo -60.84 88.31 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.034 0 C-N-CA 121.293 1.328 . . . . 12.0 108.764 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.905 HG22 ' CE2' ' A' ' 100' ' ' TYR . 67.2 t -84.35 -24.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.272 -0.422 . . . . 12.0 110.395 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.482 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -132.31 144.38 50.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.344 -1.354 . . . . 12.0 107.344 -178.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.599 ' CZ ' HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -120.76 131.1 54.31 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.833 -1.147 . . . . 12.0 110.905 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -78.69 -40.78 32.85 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 116.308 -0.405 . . . . 12.0 110.517 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.69 -121.36 3.24 Favored Glycine 0 N--CA 1.504 3.185 0 C-N-CA 120.378 -0.915 . . . . 12.0 111.299 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.5 pt -65.44 -178.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-O 121.372 0.606 . . . . 12.0 111.496 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.501 3.01 0 N-CA-C 110.887 -0.885 . . . . 12.0 110.887 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 36.5 t30 . . . . . 0 N--CA 1.498 1.925 0 N-CA-C 108.439 -0.948 . . . . 12.0 108.439 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -72.61 -19.74 61.41 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.706 -0.621 . . . . 12.0 110.733 -177.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.83 -62.13 1.69 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.477 -0.764 . . . . 12.0 110.511 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 27' ' ' ILE . 5.2 m -63.59 -33.4 75.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.664 -1.236 . . . . 12.0 107.664 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 36.5 t80 -74.39 -23.25 58.94 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -54.17 -34.61 60.87 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 106.955 -1.498 . . . . 12.0 106.955 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -74.2 -41.76 60.91 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.381 -1.34 . . . . 12.0 107.381 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 9.2 mmtp -51.9 -29.44 20.02 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 122.001 -0.437 . . . . 12.0 109.879 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.718 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -96.56 -28.38 14.4 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 118.568 -0.729 . . . . 12.0 112.614 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 10' ' ' HIS . 23.2 mm -135.59 72.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.826 1.787 . . . . 12.0 115.826 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.865 HG21 ' CD1' ' A' ' 40' ' ' PHE . 47.2 mm -98.36 61.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 102.211 -3.255 . . . . 12.0 102.211 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.12 74.46 3.69 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.522 -0.763 . . . . 12.0 110.655 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.699 ' OG1' HD12 ' A' ' 22' ' ' ILE . 3.1 p -131.21 70.63 82.21 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.867 -0.79 . . . . 12.0 108.867 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.34 81.76 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.048 1.832 . . . . 12.0 109.812 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.554 HD11 ' CG2' ' A' ' 22' ' ' ILE . 12.3 pt -136.18 -169.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.805 -0.813 . . . . 12.0 108.805 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 pt -105.81 31.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.455 0.645 . . . . 12.0 109.655 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.416 ' HB2' HD12 ' A' ' 16' ' ' ILE . 61.5 m-20 -145.15 95.95 2.76 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.569 -0.9 . . . . 12.0 108.569 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.6 m -81.62 -10.08 59.51 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 120.442 -0.503 . . . . 12.0 111.607 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -81.23 -50.68 9.27 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.009 0.822 . . . . 12.0 111.356 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -67.08 -19.23 65.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.823 -0.548 . . . . 12.0 110.649 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.699 HD12 ' OG1' ' A' ' 14' ' ' THR . 35.0 pt -86.33 -39.23 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.737 -0.602 . . . . 12.0 110.536 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.425 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -94.53 10.89 32.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.857 -0.527 . . . . 12.0 110.43 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -60.18 91.57 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.527 ' OD1' HD12 ' A' ' 27' ' ' ILE . 9.4 t-20 -170.74 156.73 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.441 -0.577 . . . . 12.0 109.441 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.13 -9.42 58.4 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.885 -0.413 . . . . 12.0 109.885 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 27' ' ' ILE . 63.0 mt -87.39 9.56 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.718 -0.614 . . . . 12.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -143.36 63.07 1.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.429 -0.794 . . . . 12.0 110.283 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -146.0 151.64 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.866 -1.146 . . . . 12.0 110.639 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 31' ' ' GLY . 61.1 t -105.31 170.4 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 107.583 -1.265 . . . . 12.0 107.583 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -89.89 53.36 3.64 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 109.57 -1.412 . . . . 12.0 109.57 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.13 -58.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.701 -1.76 . . . . 12.0 108.701 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -164.99 -71.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.0 m -138.71 -166.13 1.95 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.753 -0.832 . . . . 12.0 108.753 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.01 173.68 7.39 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -79.2 -21.01 46.92 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.236 -0.29 . . . . 12.0 110.334 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.9 108.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 120.248 -0.581 . . . . 12.0 110.865 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.0 m120 -94.71 85.0 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.269 -1.752 . . . . 12.0 106.269 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 m -79.29 117.1 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.47 0.652 . . . . 12.0 111.824 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.865 ' CD1' HG21 ' A' ' 12' ' ' ILE . 25.2 m-85 -101.89 160.33 14.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.184 -1.413 . . . . 12.0 107.184 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 10' ' ' HIS . 1.5 tt -126.89 127.77 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.989 -1.069 . . . . 12.0 110.006 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 42' ' ' ILE . 2.4 tt -110.82 100.73 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t 173.92 154.28 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 12.0 108.921 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.5 t -51.72 126.37 17.58 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.295 -0.631 . . . . 12.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.558 ' HB2' ' CG1' ' A' ' 11' ' ' ILE . . . -60.52 -37.98 82.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.987 -0.446 . . . . 12.0 110.639 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -76.48 -24.87 53.83 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 120.838 -0.345 . . . . 12.0 111.715 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -65.8 -40.19 91.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 107.007 -1.479 . . . . 12.0 107.007 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.722 HG22 ' CD2' ' A' ' 66' ' ' PHE . 58.7 t -68.55 -39.91 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.791 -1.559 . . . . 12.0 106.791 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -59.67 -22.59 62.14 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.392 -0.596 . . . . 12.0 109.392 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.93 -39.75 41.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.836 -0.54 . . . . 12.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.451 HG13 ' CE1' ' A' ' 66' ' ' PHE . 50.5 mm -66.74 -18.07 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.775 -0.578 . . . . 12.0 110.406 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.2 22.87 9.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.722 -0.611 . . . . 12.0 109.603 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m -87.93 109.95 20.19 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.782 -0.822 . . . . 12.0 108.782 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.77 -61.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.639 -0.984 . . . . 12.0 110.639 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.594 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.6 p -160.96 -168.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 117.716 0.758 . . . . 12.0 109.091 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.594 ' H ' HG22 ' A' ' 55' ' ' VAL . 12.5 tt -88.16 27.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.603 0 O-C-N 121.378 -0.827 . . . . 12.0 111.053 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.7 t-20 172.58 117.85 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.513 -1.292 . . . . 12.0 107.513 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -161.77 176.19 11.16 Favored 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.635 0.731 . . . . 12.0 111.599 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -131.82 116.42 17.21 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.377 -1.712 . . . . 12.0 106.377 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 61' ' ' LEU . 10.2 p -132.5 163.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 120.193 -0.603 . . . . 12.0 110.432 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.67 HD11 ' O ' ' A' ' 108' ' ' GLY . 0.6 OUTLIER -127.5 111.77 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.649 -0.5 . . . . 12.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.752 ' HB2' HG22 ' A' ' 92' ' ' ILE . 18.1 m -59.57 92.25 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.735 -0.839 . . . . 12.0 108.735 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.723 HG22 ' OH ' ' A' ' 91' ' ' TYR . 2.1 p -77.97 -49.93 13.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.832 -0.803 . . . . 12.0 108.832 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 7.4 p -59.78 106.77 0.52 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.747 -1.205 . . . . 12.0 107.747 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.903 ' HB3' HG23 ' A' ' 89' ' ' THR . 19.3 ptt-85 -37.32 107.13 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 112.863 0.69 . . . . 12.0 112.863 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.722 ' CD2' HG22 ' A' ' 48' ' ' VAL . 29.3 m-85 -94.04 41.75 1.09 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 20.24 107.08 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.26 1.207 . . . . 12.0 114.26 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.659 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.9 154.55 19.5 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 12.0 111.763 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -113.55 97.65 6.58 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.452 -2.425 . . . . 12.0 104.452 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.4 m -99.05 123.9 43.67 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.796 -0.761 . . . . 12.0 112.85 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.3 m -107.11 105.96 16.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 104.391 -2.448 . . . . 12.0 104.391 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -99.47 144.26 28.78 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 120.43 -0.508 . . . . 12.0 110.754 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -70.22 113.53 7.48 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.715 -0.846 . . . . 12.0 108.715 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.501 2.096 0 O-C-N 122.013 -0.43 . . . . 12.0 110.665 -179.238 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 23.7 m . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 110.002 -0.37 . . . . 12.0 110.002 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 34.3 Cg_endo -79.3 143.62 17.62 Favored 'Trans proline' 0 N--CA 1.48 0.687 0 C-N-CA 122.265 1.977 . . . . 12.0 109.612 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 27.8 m-85 -139.21 142.05 37.89 Favored 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.328 0.585 . . . . 12.0 111.094 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 t -115.42 134.3 55.22 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.841 -1.17 . . . . 12.0 107.841 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.4 m -96.08 139.52 32.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.551 0.691 . . . . 12.0 111.853 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -151.33 120.94 6.95 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.242 -1.021 . . . . 12.0 108.242 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 68' ' ' LEU . 22.8 m -104.6 149.8 25.21 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.557 -0.535 . . . . 12.0 109.557 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -176.89 -171.84 0.39 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.671 -0.411 . . . . 12.0 110.362 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.903 HG23 ' HB3' ' A' ' 65' ' ' ARG . 66.0 m -49.76 136.26 17.95 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.867 -0.42 . . . . 12.0 109.867 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' OD1' HD23 ' A' ' 68' ' ' LEU . 65.2 t30 -107.68 87.09 2.42 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.993 0.902 . . . . 12.0 111.397 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.723 ' OH ' HG22 ' A' ' 63' ' ' THR . 0.4 OUTLIER -95.4 101.44 13.16 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 104.571 -2.381 . . . . 12.0 104.571 176.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.752 HG22 ' HB2' ' A' ' 62' ' ' SER . 16.0 tt -122.13 161.97 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.523 -0.871 . . . . 12.0 112.862 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.13 113.94 26.1 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.927 -1.138 . . . . 12.0 107.927 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 104' ' ' PHE . 10.8 m -126.57 -172.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 116.15 -0.477 . . . . 12.0 109.963 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.475 ' HB2' ' CD2' ' A' ' 103' ' ' HIS . 54.1 mttt -144.65 157.28 44.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.098 -0.705 . . . . 12.0 109.098 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.2 m -119.47 116.33 25.89 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.802 0.667 . . . . 12.0 112.802 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 17.5 tt0 -124.92 143.62 50.77 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 104.336 -2.468 . . . . 12.0 104.336 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.5 m120 55.17 29.13 12.1 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.7 pt20 53.26 10.37 0.19 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.073 1.349 . . . . 12.0 114.523 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.86 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -115.88 146.88 37.91 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 104.964 -2.236 . . . . 12.0 104.964 174.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.494 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 23.7 Cg_endo -61.02 92.48 0.1 Allowed 'Trans proline' 0 C--O 1.205 -1.172 0 N-CA-C 108.28 -1.469 . . . . 12.0 108.28 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.86 HG22 ' CE2' ' A' ' 100' ' ' TYR . 54.5 t -91.21 -8.66 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 116.263 -0.426 . . . . 12.0 110.731 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -142.71 110.79 5.98 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.555 -1.258 . . . . 12.0 112.101 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CE1' HG11 ' A' ' 94' ' ' VAL . 5.9 m-30 -100.22 112.19 24.5 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 105.254 -2.128 . . . . 12.0 105.254 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -129.89 7.04 5.12 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.434 0.902 . . . . 12.0 113.434 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 92' ' ' ILE . . . -151.92 160.43 28.83 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.927 -1.269 . . . . 12.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 107' ' ' ILE . 37.6 mt -104.29 28.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.895 -0.78 . . . . 12.0 108.895 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.67 ' O ' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.497 2.754 0 N-CA-C 109.595 -1.402 . . . . 12.0 109.595 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 33.3 t30 . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 12.0 108.795 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -26.18 63.8 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 122.05 -0.406 . . . . 12.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 7' ' ' GLN . . . -77.48 -60.8 2.22 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 121.597 -0.69 . . . . 12.0 110.396 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 HG21 ' A' ' 27' ' ' ILE . 47.7 m -60.18 -29.49 68.73 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.126 -1.064 . . . . 12.0 108.126 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 26.9 t80 -81.62 -23.96 36.7 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.285 -0.635 . . . . 12.0 109.285 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -57.16 -28.78 63.08 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 178.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 3.4 mp0 -83.79 -37.3 22.74 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.471 -1.307 . . . . 12.0 107.471 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 4.0 tptp -48.11 -47.97 34.09 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.771 0.319 . . . . 12.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.903 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -100.95 -17.56 16.73 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 118.53 -0.747 . . . . 12.0 112.149 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.0 mp -139.44 75.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 116.819 2.155 . . . . 12.0 116.819 -175.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.437 ' CG1' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -97.6 62.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.9 -3.0 . . . . 12.0 102.9 171.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -71.75 78.85 0.85 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.989 -1.005 . . . . 12.0 112.533 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 p -121.38 122.69 27.96 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 107.273 -1.38 . . . . 12.0 107.273 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -71.85 -3.04 12.4 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 121.48 1.454 . . . . 12.0 112.114 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.11 159.53 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.6 -0.889 . . . . 12.0 108.6 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 tt -108.59 39.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 108.549 -0.908 . . . . 12.0 108.549 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -128.38 101.05 6.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -74.94 -18.42 60.4 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 120.499 -0.481 . . . . 12.0 111.174 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.89 -55.03 5.08 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 118.8 0.727 . . . . 12.0 110.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.39 -30.87 63.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.214 -0.304 . . . . 12.0 110.229 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 23' ' ' MET . 50.9 pt -81.02 -36.95 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.546 -0.462 . . . . 12.0 110.243 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.42 ' N ' HG13 ' A' ' 22' ' ' ILE . 9.6 ptt? -91.99 8.39 37.8 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.323 -0.551 . . . . 12.0 110.46 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 92.38 0.08 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.271 -1.381 . . . . 12.0 107.271 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -172.28 149.53 2.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.219 -0.659 . . . . 12.0 109.219 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -63.61 -12.87 36.85 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.061 -0.399 . . . . 12.0 109.996 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.618 HG21 HG23 ' A' ' 5' ' ' THR . 16.6 mt -84.45 11.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.702 -0.624 . . . . 12.0 110.658 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -146.48 64.27 1.2 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.44 -0.787 . . . . 12.0 110.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -146.99 151.25 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.761 -1.212 . . . . 12.0 110.398 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 31' ' ' GLY . 40.5 t -100.8 169.1 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.984 -1.117 . . . . 12.0 107.984 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -91.01 53.02 3.25 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.259 -1.536 . . . . 12.0 109.259 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.52 -57.03 0.02 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.238 -1.545 . . . . 12.0 109.238 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.42 -69.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.046 -0.679 . . . . 12.0 109.447 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.6 m -141.18 -176.82 4.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -109.82 164.06 12.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.996 -0.742 . . . . 12.0 108.996 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -80.13 -20.01 45.95 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.838 -0.345 . . . . 12.0 110.367 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.4 p -159.88 115.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.469 0.652 . . . . 12.0 111.106 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 12.3 m120 -103.18 84.89 2.4 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.385 -1.709 . . . . 12.0 106.385 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.8 m -81.46 115.99 21.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.395 0.617 . . . . 12.0 110.657 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.475 ' O ' HD13 ' A' ' 41' ' ' ILE . 33.1 m-85 -106.84 165.5 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.3 -1.0 . . . . 12.0 108.3 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.52 HD12 ' ND2' ' A' ' 90' ' ' ASN . 42.5 mm -125.88 124.08 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 42' ' ' ILE . 3.3 tt -104.37 109.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 108.702 -0.851 . . . . 12.0 108.702 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t 178.18 158.24 0.46 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.067 -0.716 . . . . 12.0 109.067 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.65 118.91 4.59 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.877 0.846 . . . . 12.0 109.449 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.09 -60.74 1.94 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 113.34 0.866 . . . . 12.0 113.34 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -25.0 64.98 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.935 -0.478 . . . . 12.0 111.24 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -62.71 -37.64 87.28 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.276 -1.379 . . . . 12.0 107.276 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 10' ' ' HIS . 62.0 t -68.86 -35.49 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.156 -1.424 . . . . 12.0 107.156 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -63.67 -21.41 66.37 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.589 -0.523 . . . . 12.0 109.589 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.22 -37.54 28.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.944 -0.473 . . . . 12.0 109.741 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.6 tp -67.8 -24.99 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.851 -0.531 . . . . 12.0 110.296 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 22.14 11.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.806 -0.559 . . . . 12.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -87.36 115.02 24.5 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.821 -0.549 . . . . 12.0 109.624 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.29 0.02 OUTLIER Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.046 -1.222 . . . . 12.0 110.046 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.9 p -161.88 -165.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.608 ' H ' HG22 ' A' ' 55' ' ' VAL . 3.8 pt -90.37 29.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 O-C-N 121.131 -0.98 . . . . 12.0 110.733 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 174.51 118.64 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.324 -1.361 . . . . 12.0 107.324 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.88 177.7 7.69 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.119 0.962 . . . . 12.0 112.501 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -139.07 111.69 7.68 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.237 -1.764 . . . . 12.0 106.237 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.8 p -130.69 163.98 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.309 -0.556 . . . . 12.0 110.367 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.76 HD11 ' O ' ' A' ' 108' ' ' GLY . 7.6 tp -117.6 114.4 23.35 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.386 -0.227 . . . . 12.0 110.386 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 66' ' ' PHE . 3.5 m -59.55 92.91 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.318 -0.993 . . . . 12.0 108.318 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -83.04 -171.64 3.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.763 -0.458 . . . . 12.0 109.763 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.443 HG22 ' HG2' ' A' ' 65' ' ' ARG . 97.9 m 62.84 -101.7 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.38 -0.971 . . . . 12.0 108.38 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.761 ' HB3' HG23 ' A' ' 89' ' ' THR . 15.9 ptt180 179.72 107.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 119.441 1.019 . . . . 12.0 110.833 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HE2' HD13 ' A' ' 51' ' ' ILE . 51.2 m-85 -96.01 43.62 1.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 108.497 -0.927 . . . . 12.0 108.497 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 22.55 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 113.859 1.059 . . . . 12.0 113.859 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.625 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.06 152.83 18.89 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.039 0.923 . . . . 12.0 111.664 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -118.99 98.29 6.11 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 105.726 -1.953 . . . . 12.0 105.726 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -98.42 123.23 42.44 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.619 0.723 . . . . 12.0 112.153 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.9 m -109.56 108.61 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.379 -2.452 . . . . 12.0 104.379 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -104.36 142.96 33.65 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.061 -0.656 . . . . 12.0 111.596 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.2 ttt180 -71.34 137.92 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.293 -0.632 . . . . 12.0 109.293 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.501 2.119 0 N-CA-C 109.492 -0.558 . . . . 12.0 109.492 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 108.821 -0.807 . . . . 12.0 108.821 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.2 Cg_endo -78.3 122.63 5.72 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 C-N-CA 121.883 1.722 . . . . 12.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 14.7 m-85 -143.5 131.23 21.36 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.363 0.602 . . . . 12.0 110.854 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -108.78 125.49 52.0 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 107.579 -1.267 . . . . 12.0 107.579 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.0 p -95.44 141.02 29.47 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.084 0.468 . . . . 12.0 110.573 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.16 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.516 -0.92 . . . . 12.0 108.516 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -116.54 148.09 41.18 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 109.615 -0.513 . . . . 12.0 109.615 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.35 -172.32 1.69 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.32 0.581 . . . . 12.0 110.315 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 65' ' ' ARG . 42.0 m -67.31 138.38 56.77 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.566 -0.531 . . . . 12.0 109.566 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.52 ' ND2' HD12 ' A' ' 41' ' ' ILE . 63.3 t30 -106.79 89.68 3.09 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.054 0.93 . . . . 12.0 111.571 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.78 105.28 15.03 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 105.157 -2.164 . . . . 12.0 105.157 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.507 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 4.3 pt -138.95 -175.72 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.943 -0.703 . . . . 12.0 112.404 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.449 ' HA ' HD12 ' A' ' 61' ' ' LEU . 32.1 t -122.63 116.34 23.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.864 -0.607 . . . . 12.0 109.664 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' ' 101' ' ' PRO . 8.8 p -116.73 169.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.92 -0.4 . . . . 12.0 109.92 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 94' ' ' VAL . 27.4 mttt -124.22 142.77 50.97 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.416 -0.587 . . . . 12.0 109.416 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 121.79 45.67 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 114.44 1.274 . . . . 12.0 114.44 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 23.6 tt0 -133.2 144.95 50.15 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 104.013 -2.588 . . . . 12.0 104.013 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 20.5 m120 54.22 28.04 8.62 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 107.755 -1.202 . . . . 12.0 107.755 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.409 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.8 pt20 52.49 12.84 0.26 Allowed 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 125.316 1.446 . . . . 12.0 114.754 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.894 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.23 148.05 46.34 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 104.857 -2.275 . . . . 12.0 104.857 174.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.591 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.3 Cg_endo -60.6 89.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.027 0 C-N-CA 121.301 1.334 . . . . 12.0 108.903 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.894 HG22 ' CE2' ' A' ' 100' ' ' TYR . 55.4 t -86.22 -21.82 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.195 -0.457 . . . . 12.0 110.582 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.501 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -137.61 147.18 44.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.026 -1.101 . . . . 12.0 108.026 -177.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CZ ' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -111.83 133.03 54.31 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.903 -1.119 . . . . 12.0 109.955 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.99 -38.37 19.34 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.22 -0.3 . . . . 12.0 110.668 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.95 -141.48 9.72 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 120.266 -0.969 . . . . 12.0 111.287 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.81 -170.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 122.265 -0.55 . . . . 12.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.76 ' O ' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.857 0 N-CA-C 110.781 -0.927 . . . . 12.0 110.781 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 . . . . . 0 N--CA 1.493 1.723 0 N-CA-C 108.963 -0.755 . . . . 12.0 108.963 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -45.39 61.81 Favored 'General case' 0 N--CA 1.511 2.616 0 O-C-N 122.058 -0.401 . . . . 12.0 110.042 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.12 55.25 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.754 -0.591 . . . . 12.0 110.46 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -64.95 -30.03 70.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.419 -0.956 . . . . 12.0 108.419 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 30.7 t80 -76.56 -20.12 57.18 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.758 -0.83 . . . . 12.0 108.758 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.14 -38.99 93.04 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.855 -1.535 . . . . 12.0 106.855 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -78.21 -34.75 49.17 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.453 -1.314 . . . . 12.0 107.453 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.51 ' CG ' ' CD2' ' A' ' 10' ' ' HIS . 0.4 OUTLIER -41.48 -60.62 1.25 Allowed 'General case' 0 N--CA 1.506 2.374 0 CA-C-N 116.393 -0.367 . . . . 12.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.51 ' CD2' ' CG ' ' A' ' 9' ' ' LYS . 96.4 m-70 -110.57 -26.22 9.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.362 0.875 . . . . 12.0 113.362 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 11' ' ' ILE . 4.9 mp -96.62 64.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 119.153 -1.019 . . . . 12.0 113.342 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.872 HD12 ' CD1' ' A' ' 40' ' ' PHE . 54.9 mt -91.86 70.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 105.053 -2.202 . . . . 12.0 105.053 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -70.34 81.99 0.55 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.626 0.727 . . . . 12.0 110.479 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 22' ' ' ILE . 1.7 p -144.1 67.97 15.52 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.58 81.99 2.52 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.868 1.712 . . . . 12.0 109.851 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.3 pt -129.98 -167.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.102 -1.073 . . . . 12.0 108.102 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 pt -102.26 36.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.728 -0.607 . . . . 12.0 109.663 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -152.57 98.33 2.35 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.722 -0.611 . . . . 12.0 110.557 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -82.49 -4.49 57.58 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 121.75 -0.593 . . . . 12.0 110.626 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.34 -50.5 8.86 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.353 -0.842 . . . . 12.0 111.532 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.2 m -66.29 -23.11 66.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.787 -0.571 . . . . 12.0 110.507 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 14' ' ' THR . 50.4 pt -84.73 -32.56 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.721 -0.612 . . . . 12.0 109.727 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.2 ttm -92.86 2.93 56.51 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 122.096 -0.378 . . . . 12.0 110.646 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.75 91.32 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.476 -0.935 . . . . 12.0 108.476 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.505 ' ND2' HD12 ' A' ' 27' ' ' ILE . 45.1 t30 -169.79 148.54 3.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.214 -0.662 . . . . 12.0 109.214 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -67.54 -10.9 56.11 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 110.092 -0.336 . . . . 12.0 110.092 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 27' ' ' ILE . 61.4 mt -85.42 9.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.778 -0.576 . . . . 12.0 110.635 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.462 ' OH ' HD11 ' A' ' 12' ' ' ILE . 43.4 m-85 -142.41 64.2 1.38 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.577 -0.702 . . . . 12.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.3 mt -141.57 153.42 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.736 -1.228 . . . . 12.0 111.143 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 31' ' ' GLY . 59.9 t -109.05 170.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 107.477 -1.305 . . . . 12.0 107.477 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.42 53.78 3.48 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.272 -1.531 . . . . 12.0 109.272 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.68 -57.35 0.02 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.349 -1.501 . . . . 12.0 109.349 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -166.74 -72.54 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.6 p -154.72 142.42 19.89 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.932 -0.766 . . . . 12.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' CA ' HG21 ' A' ' 30' ' ' VAL . 3.7 tttm -62.06 -176.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 2.57 34.64 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 121.003 -0.279 . . . . 12.0 110.69 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 37' ' ' VAL . 4.4 p -161.67 111.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.666 0.746 . . . . 12.0 110.314 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 6.3 m120 -103.79 81.88 1.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.453 -1.684 . . . . 12.0 106.453 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 m -82.85 110.89 18.25 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.977 -0.556 . . . . 12.0 111.225 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.872 ' CD1' HD12 ' A' ' 12' ' ' ILE . 11.6 m-85 -105.46 161.18 14.56 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 10' ' ' HIS . 45.6 mm -117.79 135.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.435 -0.791 . . . . 12.0 108.992 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -105.19 110.09 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.425 -0.954 . . . . 12.0 108.425 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t 174.32 150.98 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.203 -0.666 . . . . 12.0 109.203 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.816 ' O ' HG22 ' A' ' 47' ' ' THR . 18.6 p -60.63 126.19 26.5 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.393 -0.966 . . . . 12.0 108.393 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.94 -30.9 59.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.057 -0.402 . . . . 12.0 110.825 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -74.74 -31.87 61.94 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.69 -0.404 . . . . 12.0 111.023 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 44' ' ' SER . 13.7 t -63.98 -33.63 76.17 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 107.406 -1.331 . . . . 12.0 107.406 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' A' ' 101' ' ' PRO . 21.0 t -72.88 -36.07 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.403 -1.332 . . . . 12.0 107.403 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -63.06 -21.03 65.89 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.668 -0.493 . . . . 12.0 109.668 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.53 -39.23 24.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.999 -0.438 . . . . 12.0 109.894 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.565 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 3.4 pt -69.6 -18.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.685 -0.634 . . . . 12.0 111.124 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.34 26.73 10.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.872 -0.517 . . . . 12.0 110.425 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -95.69 108.3 20.58 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.686 -0.633 . . . . 12.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.87 -57.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.523 -1.031 . . . . 12.0 110.523 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 56' ' ' ILE . 9.6 p -157.08 179.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.994 -0.71 . . . . 12.0 109.1 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.561 ' H ' HG22 ' A' ' 55' ' ' VAL . 38.7 pt -83.18 26.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 121.195 -0.94 . . . . 12.0 111.662 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.527 ' H ' HG13 ' A' ' 55' ' ' VAL . 0.8 OUTLIER 177.14 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.797 -1.557 . . . . 12.0 106.797 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.412 ' SD ' HG12 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -156.64 179.09 9.61 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 122.003 0.906 . . . . 12.0 112.016 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.8 118.18 16.75 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.401 -1.703 . . . . 12.0 106.401 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG13 ' CG2' ' A' ' 94' ' ' VAL . 14.9 p -141.95 170.13 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.304 -0.628 . . . . 12.0 109.304 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 61' ' ' LEU . 4.5 mp -137.71 120.55 16.41 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.844 -0.535 . . . . 12.0 111.154 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.54 ' HB3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -60.41 92.51 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -90.92 -28.18 18.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.052 -0.405 . . . . 12.0 111.102 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -56.2 -77.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.675 ' CG ' HG23 ' A' ' 89' ' ' THR . 0.6 OUTLIER 172.14 106.59 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.959 -0.463 . . . . 12.0 110.017 178.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 73.9 m-85 -122.02 65.28 0.92 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.803 -1.184 . . . . 12.0 107.803 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -23.31 127.73 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 114.52 1.304 . . . . 12.0 114.52 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.728 HD13 ' OG1' ' A' ' 70' ' ' THR . 4.6 pp -99.85 150.95 21.84 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.694 0.759 . . . . 12.0 111.227 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -118.13 106.37 12.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.646 -1.983 . . . . 12.0 105.646 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.728 ' OG1' HD13 ' A' ' 68' ' ' LEU . 27.2 m -112.07 126.85 55.61 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.757 -0.777 . . . . 12.0 112.599 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.7 m -103.8 110.08 22.05 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 103.385 -2.821 . . . . 12.0 103.385 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.6 m -109.11 143.02 39.01 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 119.919 -0.712 . . . . 12.0 112.227 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.9 ttt180 -64.15 132.21 49.73 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.502 2.151 0 C-N-CA 120.554 -0.458 . . . . 12.0 110.735 -179.269 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.5 m . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 108.464 -0.939 . . . . 12.0 108.464 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.4 Cg_endo -75.46 124.75 8.55 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 121.758 1.639 . . . . 12.0 109.815 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 17.0 m-85 -143.1 134.38 25.99 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.284 0.564 . . . . 12.0 110.79 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 p -115.03 123.23 48.52 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.43 -0.952 . . . . 12.0 108.43 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 142.46 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.828 -0.434 . . . . 12.0 109.828 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -146.76 157.2 43.62 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.5 m -129.77 147.9 51.59 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.893 -0.78 . . . . 12.0 108.893 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -165.38 156.34 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.382 -0.527 . . . . 12.0 110.48 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CG ' ' A' ' 65' ' ' ARG . 52.8 m -58.1 124.67 20.17 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 68' ' ' LEU . 4.9 t-20 -121.99 101.36 7.5 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.366 1.247 . . . . 12.0 114.366 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.6 126.77 41.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 102.703 -3.073 . . . . 12.0 102.703 172.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.526 HG23 ' HA2' ' A' ' 106' ' ' GLY . 1.6 mp -121.9 161.5 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 N-CA-C 113.993 1.108 . . . . 12.0 113.993 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.499 ' N ' HG22 ' A' ' 92' ' ' ILE . 37.4 t -100.41 109.45 21.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 106.21 -1.774 . . . . 12.0 106.21 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.541 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 10.6 m -118.66 -177.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.072 0.463 . . . . 12.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.465 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 38.7 mtpt -143.73 149.26 36.87 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.899 -0.778 . . . . 12.0 108.899 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.45 116.42 28.18 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.96 0.726 . . . . 12.0 112.96 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.0 tt0 -125.43 143.08 51.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 104.42 -2.437 . . . . 12.0 104.42 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 1.6 m-80 58.74 14.96 3.46 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.061 -1.024 . . . . 12.0 108.513 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 15.6 mt-30 75.79 -8.25 1.64 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.112 0.965 . . . . 12.0 113.049 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.856 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -105.8 152.55 40.21 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.735 -1.579 . . . . 12.0 106.735 176.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.459 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.6 Cg_endo -61.76 87.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.542 1.495 . . . . 12.0 109.095 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.856 HG22 ' CE2' ' A' ' 100' ' ' TYR . 67.4 t -84.34 -20.72 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.479 -0.328 . . . . 12.0 110.591 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -130.83 127.49 38.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.925 -1.139 . . . . 12.0 107.925 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.541 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -121.53 122.0 38.72 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.646 -0.872 . . . . 12.0 108.646 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.25 -32.02 12.64 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.775 -0.37 . . . . 12.0 110.506 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA2' HG23 ' A' ' 92' ' ' ILE . . . 97.15 162.04 31.84 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.08 -1.608 . . . . 12.0 109.08 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.41 ' O ' ' O ' ' A' ' 106' ' ' GLY . 60.3 mt 57.24 123.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 12.0 111.118 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.921 0 N-CA-C 109.685 -1.366 . . . . 12.0 109.685 179.56 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.4 t30 . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 108.84 -0.8 . . . . 12.0 108.84 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -23.58 64.91 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.614 -0.679 . . . . 12.0 110.357 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.33 -61.44 1.99 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.493 -0.754 . . . . 12.0 110.6 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.53 74.9 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.412 -1.329 . . . . 12.0 107.412 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 24.7 t80 -73.57 -27.49 61.34 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.338 -0.986 . . . . 12.0 108.338 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.91 -33.1 35.56 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 107.72 -1.215 . . . . 12.0 107.72 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -42.02 33.26 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.33 -53.87 6.33 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.232 -0.44 . . . . 12.0 111.18 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.805 ' CG ' HG11 ' A' ' 48' ' ' VAL . 1.1 m-70 -96.75 -15.38 21.41 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.694 -0.629 . . . . 12.0 111.162 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 10' ' ' HIS . 15.7 mm -140.15 87.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 114.231 1.197 . . . . 12.0 114.231 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 35.3 mm -96.73 67.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 105.094 -2.187 . . . . 12.0 105.094 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.534 ' O ' HG23 ' A' ' 14' ' ' THR . 25.2 p-10 -66.81 84.35 0.11 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.932 0.872 . . . . 12.0 110.636 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 13' ' ' ASN . 1.2 p -159.39 63.12 2.18 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 106.976 -1.491 . . . . 12.0 106.976 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.49 85.61 1.26 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.041 1.827 . . . . 12.0 110.598 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.27 -173.09 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.847 -0.797 . . . . 12.0 108.847 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pt -98.67 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.293 0.568 . . . . 12.0 109.636 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -145.03 95.56 2.71 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.434 -0.58 . . . . 12.0 109.434 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.4 m -80.45 -3.18 48.88 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.916 -0.49 . . . . 12.0 110.735 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.6 -50.16 10.34 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.613 0.642 . . . . 12.0 110.974 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 m -63.11 -21.18 66.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.748 -0.595 . . . . 12.0 110.429 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 23' ' ' MET . 45.6 pt -85.78 -38.05 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.679 -0.638 . . . . 12.0 109.904 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.422 ' N ' HG13 ' A' ' 22' ' ' ILE . 3.8 ptm -91.53 11.14 25.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.988 -0.445 . . . . 12.0 110.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -66.41 90.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.489 -0.93 . . . . 12.0 108.489 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.402 HD22 HG22 ' A' ' 27' ' ' ILE . 58.1 t30 -173.11 150.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.453 -0.573 . . . . 12.0 109.453 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -70.52 -9.13 55.9 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 110.09 -0.337 . . . . 12.0 110.09 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -88.82 11.6 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.72 -0.613 . . . . 12.0 110.319 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -140.03 58.95 1.58 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.827 -0.546 . . . . 12.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -148.0 146.6 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.631 -1.293 . . . . 12.0 110.559 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 31' ' ' GLY . 3.5 p -111.67 -164.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.34 -1.355 . . . . 12.0 107.34 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.576 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -97.72 66.3 0.83 Allowed Glycine 0 N--CA 1.506 3.301 0 O-C-N 120.956 -1.09 . . . . 12.0 112.453 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.52 -68.86 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.136 -1.586 . . . . 12.0 109.136 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -164.45 -66.71 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.845 -1.169 . . . . 12.0 107.845 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.0 p -138.8 144.6 39.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.631 -0.877 . . . . 12.0 108.631 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -61.27 -175.03 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.985 -0.447 . . . . 12.0 109.991 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -89.73 -23.11 21.88 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 110.024 -0.361 . . . . 12.0 110.024 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 72' ' ' THR . 4.3 t -150.01 102.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 5.1 m120 -90.99 80.82 5.69 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.649 -1.612 . . . . 12.0 106.649 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -84.17 115.35 22.37 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.936 -0.574 . . . . 12.0 110.825 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.487 ' O ' HD13 ' A' ' 41' ' ' ILE . 32.8 m-85 -105.44 165.58 11.03 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.624 HD12 ' ND2' ' A' ' 90' ' ' ASN . 49.3 mm -127.45 126.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 120.932 -1.105 . . . . 12.0 110.459 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 tt -108.91 127.83 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.11 -0.7 . . . . 12.0 109.11 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.636 ' O ' HD12 ' A' ' 11' ' ' ILE . 30.3 t 170.4 160.37 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.363 -0.977 . . . . 12.0 108.363 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.67 117.93 4.73 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -40.85 -64.63 0.51 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.9 1.074 . . . . 12.0 113.9 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -61.29 -26.21 67.63 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.794 -0.566 . . . . 12.0 111.311 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 m -58.61 -35.54 72.62 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 107.456 -1.312 . . . . 12.0 107.456 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 51' ' ' ILE . 45.7 t -70.19 -37.95 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.294 -1.372 . . . . 12.0 107.294 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -60.68 -21.55 62.96 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.138 -0.69 . . . . 12.0 109.138 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.87 -37.2 27.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 122.009 -0.432 . . . . 12.0 109.919 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.836 HG22 ' O ' ' A' ' 48' ' ' VAL . 6.8 tp -66.82 -24.36 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 120.414 -0.514 . . . . 12.0 110.425 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 22.95 10.69 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.723 -0.611 . . . . 12.0 109.768 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.541 HG23 HE22 ' A' ' 99' ' ' GLN . 20.0 m -84.74 109.22 17.89 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.028 -0.73 . . . . 12.0 109.028 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.93 -58.82 0.02 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.616 -0.994 . . . . 12.0 110.616 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 56' ' ' ILE . 4.7 p -164.89 -175.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.601 ' H ' HG22 ' A' ' 55' ' ' VAL . 48.0 pt -87.08 27.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.315 -0.865 . . . . 12.0 111.34 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.488 ' H ' HG13 ' A' ' 55' ' ' VAL . 6.1 t-20 177.21 116.83 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 107.807 -1.183 . . . . 12.0 107.807 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.5 ttp -165.83 170.81 13.48 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.554 0.692 . . . . 12.0 111.39 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.4 118.03 15.98 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.7 p -150.57 164.55 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.314 -0.624 . . . . 12.0 109.314 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.5 mp -115.3 128.81 56.36 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.051 -0.352 . . . . 12.0 110.051 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.871 ' HB2' HG22 ' A' ' 92' ' ' ILE . 49.5 m -53.62 94.11 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.142 -1.059 . . . . 12.0 108.142 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 1.1 p -77.37 -174.78 3.44 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.834 0.35 . . . . 12.0 110.085 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.726 HG22 ' HG2' ' A' ' 65' ' ' ARG . 96.9 m 63.47 -94.86 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.906 ' HB3' HG23 ' A' ' 89' ' ' THR . 6.1 ptm180 174.0 104.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 118.828 0.74 . . . . 12.0 110.006 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 48.5 m-85 -95.99 43.34 1.08 Allowed 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.193 -0.669 . . . . 12.0 109.193 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 29.64 105.2 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.147 0 N-CA-C 113.87 1.063 . . . . 12.0 113.87 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.62 154.68 19.23 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.033 0.92 . . . . 12.0 112.107 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -117.26 97.02 5.69 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 105.524 -2.028 . . . . 12.0 105.524 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -99.95 122.66 43.2 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.803 -0.759 . . . . 12.0 112.971 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -108.75 105.68 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 103.338 -2.838 . . . . 12.0 103.338 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.506 HG23 HG22 ' A' ' 37' ' ' VAL . 9.4 m -114.34 143.28 45.15 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.9 -0.72 . . . . 12.0 112.613 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 25.7 ttp180 -69.74 109.54 4.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.008 -1.108 . . . . 12.0 108.008 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.505 2.302 0 C-N-CA 120.006 -0.677 . . . . 12.0 112.363 -178.585 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.504 2.27 0 N-CA-C 109.493 -0.558 . . . . 12.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 34.3 Cg_endo -72.25 89.31 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 121.721 1.614 . . . . 12.0 109.468 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.403 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 7.2 m-85 -121.31 140.4 52.14 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-O 121.61 0.719 . . . . 12.0 112.542 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 m -119.15 124.16 46.15 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.559 -1.274 . . . . 12.0 107.559 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -93.12 142.83 26.87 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.924 -0.485 . . . . 12.0 110.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -155.7 132.76 10.71 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.423 -0.584 . . . . 12.0 109.423 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.3 m -92.3 148.82 21.83 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.898 -0.779 . . . . 12.0 108.898 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -169.16 -169.75 1.01 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.23 0.538 . . . . 12.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.906 HG23 ' HB3' ' A' ' 65' ' ' ARG . 53.3 m -67.14 139.44 57.49 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.147 -0.686 . . . . 12.0 109.147 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.624 ' ND2' HD12 ' A' ' 41' ' ' ILE . 67.0 t30 -107.46 87.0 2.4 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.091 0.948 . . . . 12.0 112.392 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' A' ' 63' ' ' THR . 14.5 t80 -99.68 102.39 13.86 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.186 -2.524 . . . . 12.0 104.186 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.871 HG22 ' HB2' ' A' ' 62' ' ' SER . 13.9 tt -124.47 169.85 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.541 -0.864 . . . . 12.0 112.883 -175.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.8 t -113.14 107.76 16.37 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.275 -1.009 . . . . 12.0 108.275 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 92' ' ' ILE . 18.0 m -127.33 -170.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.68 -0.489 . . . . 12.0 109.68 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.482 ' HB2' ' CG ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -147.57 161.06 41.89 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.069 -0.652 . . . . 12.0 110.887 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 128.27 52.2 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.646 0.736 . . . . 12.0 111.983 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 14.4 tt0 -147.51 147.08 29.77 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 104.97 -2.233 . . . . 12.0 104.97 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 59.1 18.21 6.22 Favored 'General case' 0 N--CA 1.508 2.472 0 N-CA-C 108.387 -0.968 . . . . 12.0 108.387 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.541 HE22 HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER 71.03 -6.01 1.39 Allowed 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.579 0.752 . . . . 12.0 112.71 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.734 ' OH ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -110.55 145.19 31.75 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 106.332 -1.729 . . . . 12.0 106.332 177.24 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.564 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 28.2 Cg_endo -66.52 100.08 0.47 Allowed 'Trans proline' 0 C--O 1.203 -1.264 0 N-CA-C 107.382 -1.815 . . . . 12.0 107.382 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.734 HG23 ' OH ' ' A' ' 100' ' ' TYR . 12.3 p -117.58 7.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 120.057 -0.657 . . . . 12.0 112.654 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -129.87 133.42 46.88 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.669 -1.234 . . . . 12.0 107.669 178.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.02 126.41 50.73 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.967 -0.693 . . . . 12.0 110.684 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 -32.98 13.69 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.89 -0.782 . . . . 12.0 108.89 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 140.14 -149.24 20.73 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.052 -1.219 . . . . 12.0 110.052 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.3 pt -56.16 -172.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.291 -0.535 . . . . 12.0 109.895 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.863 0 N-CA-C 110.234 -1.146 . . . . 12.0 110.234 -179.365 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 . . . . . 0 N--CA 1.499 2.009 0 N-CA-C 108.728 -0.841 . . . . 12.0 108.728 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.25 -25.91 65.42 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.588 -0.695 . . . . 12.0 110.207 -178.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.64 -60.31 2.37 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.694 -0.629 . . . . 12.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.72 -35.55 78.36 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.514 -1.291 . . . . 12.0 107.514 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 28.1 t80 -73.8 -25.07 59.93 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -31.76 54.05 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 107.534 -1.284 . . . . 12.0 107.534 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.96 -37.86 33.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -46.73 -53.04 12.61 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 116.335 -0.393 . . . . 12.0 110.63 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.747 ' CG ' HG11 ' A' ' 48' ' ' VAL . 1.3 m-70 -97.09 -16.01 20.71 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.863 -0.523 . . . . 12.0 110.848 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 11' ' ' ILE . 5.0 mp -144.09 87.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.068 1.136 . . . . 12.0 114.068 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.828 HD12 ' CD1' ' A' ' 40' ' ' PHE . 12.6 mt -97.06 65.13 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 103.711 -2.7 . . . . 12.0 103.711 173.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 14' ' ' THR . 8.5 t-20 -66.98 83.0 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.903 0.859 . . . . 12.0 110.699 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 13' ' ' ASN . 1.3 p -155.18 63.18 3.67 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 106.847 -1.538 . . . . 12.0 106.847 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -73.21 84.05 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.086 1.857 . . . . 12.0 111.015 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 17' ' ' ILE . 1.4 mt -121.65 -167.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.787 -1.19 . . . . 12.0 107.787 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.51 ' H ' HG22 ' A' ' 16' ' ' ILE . 2.4 mm -101.91 34.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 108.682 -0.858 . . . . 12.0 108.682 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -145.8 97.6 2.99 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -77.84 -16.28 58.42 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.842 -0.537 . . . . 12.0 111.253 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.18 -49.02 10.6 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 118.854 0.752 . . . . 12.0 110.046 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -31.54 67.27 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.748 -0.464 . . . . 12.0 109.748 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 23' ' ' MET . 47.0 pt -81.12 -36.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 120.627 -0.429 . . . . 12.0 110.208 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -97.03 15.24 22.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.925 -0.484 . . . . 12.0 110.165 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.27 90.78 0.1 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.122 -1.066 . . . . 12.0 108.122 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -166.83 158.06 12.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.236 -0.653 . . . . 12.0 109.236 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -72.89 -10.82 60.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 120.8 -0.36 . . . . 12.0 110.263 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 27' ' ' ILE . 59.6 mt -87.02 9.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.65 -0.656 . . . . 12.0 110.523 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -142.71 63.23 1.39 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.611 -0.68 . . . . 12.0 109.727 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 30' ' ' VAL . 51.3 mt -148.49 153.26 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 120.763 -1.211 . . . . 12.0 110.318 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 35' ' ' LYS . 50.0 t -107.03 169.53 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 107.764 -1.199 . . . . 12.0 107.764 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.71 54.16 3.39 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.117 -1.593 . . . . 12.0 109.117 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.9 -56.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.241 -1.544 . . . . 12.0 109.241 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -165.27 -68.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.04 -0.682 . . . . 12.0 109.401 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.0 m -143.51 -175.77 4.69 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.49 -0.559 . . . . 12.0 109.49 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -105.92 163.72 12.52 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.339 -0.615 . . . . 12.0 109.339 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -73.85 -24.08 59.72 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 110.058 -0.349 . . . . 12.0 110.058 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 37' ' ' VAL . 9.1 p -156.35 109.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.481 0.658 . . . . 12.0 110.804 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 3.0 m-20 -91.27 83.3 5.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.527 -1.657 . . . . 12.0 106.527 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.98 HG21 HD12 ' A' ' 107' ' ' ILE . 23.9 m -82.61 106.43 14.46 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 116.006 -0.543 . . . . 12.0 110.89 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.828 ' CD1' HD12 ' A' ' 12' ' ' ILE . 10.5 m-85 -99.11 157.86 16.06 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.167 -1.42 . . . . 12.0 107.167 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.92 125.57 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.175 -0.953 . . . . 12.0 109.005 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 42' ' ' ILE . 16.2 tt -106.74 118.37 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.489 -0.56 . . . . 12.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t 173.15 154.86 0.1 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.382 -0.97 . . . . 12.0 108.382 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.21 119.2 5.98 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.22 -52.38 12.58 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.053 0.76 . . . . 12.0 113.053 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -61.7 -29.53 70.16 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.026 -0.421 . . . . 12.0 111.558 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -63.19 -35.18 79.45 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.849 ' O ' HG22 ' A' ' 51' ' ' ILE . 42.0 t -71.28 -33.91 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.686 -1.227 . . . . 12.0 107.686 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -61.76 -22.37 65.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.173 -0.677 . . . . 12.0 109.173 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -36.67 28.11 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.653 -0.499 . . . . 12.0 109.653 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 48' ' ' VAL . 5.9 tp -66.08 -25.26 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 C-N-CA 120.372 -0.531 . . . . 12.0 110.792 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.53 24.27 7.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.614 -0.679 . . . . 12.0 109.908 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -88.3 110.94 21.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.254 -0.647 . . . . 12.0 109.254 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.46 -58.78 0.02 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.396 -1.081 . . . . 12.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.609 HG22 ' H ' ' A' ' 56' ' ' ILE . 5.2 p -161.59 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.013 -0.736 . . . . 12.0 109.013 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.609 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.2 tt -83.27 21.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.642 0 O-C-N 121.357 -0.839 . . . . 12.0 111.718 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.583 ' H ' HG13 ' A' ' 55' ' ' VAL . 5.5 t-20 175.25 113.36 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.541 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.5 ttm -163.78 -176.78 4.78 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.485 0.659 . . . . 12.0 111.034 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -137.98 123.5 19.65 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.295 -1.372 . . . . 12.0 107.295 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.6 p -145.37 163.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.907 -0.495 . . . . 12.0 109.869 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 61' ' ' LEU . 2.6 mp -122.72 116.26 23.45 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.587 -0.523 . . . . 12.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 92' ' ' ILE . 1.8 m -55.48 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.699 -0.852 . . . . 12.0 108.699 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -50.45 20.39 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.592 -0.892 . . . . 12.0 108.592 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.7 115.4 3.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.532 -0.914 . . . . 12.0 108.532 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.853 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 106.88 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.152 0.501 . . . . 12.0 111.543 -178.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 28.6 m-85 -94.4 40.08 1.09 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 108.848 -0.797 . . . . 12.0 108.848 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' PHE . 1.4 tp-100 39.86 107.56 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 112.859 0.689 . . . . 12.0 112.859 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.836 HD13 ' OG1' ' A' ' 70' ' ' THR . 3.5 pp -95.99 147.94 23.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 12.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.98 97.47 5.71 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 105.292 -2.114 . . . . 12.0 105.292 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.836 ' OG1' HD13 ' A' ' 68' ' ' LEU . 30.2 m -108.22 128.16 54.48 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.434 -0.906 . . . . 12.0 112.541 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.0 m -112.63 111.9 23.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.288 -2.486 . . . . 12.0 104.288 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -108.64 141.89 39.92 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.12 -0.632 . . . . 12.0 111.401 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -65.3 109.59 2.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.68 -0.859 . . . . 12.0 108.68 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.503 2.185 0 C-N-CA 120.388 -0.525 . . . . 12.0 111.201 -178.547 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 110.787 -0.079 . . . . 12.0 110.787 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.01 137.31 12.25 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.326 2.017 . . . . 12.0 109.012 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -134.54 136.03 42.76 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.525 0.679 . . . . 12.0 112.454 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -108.81 129.8 55.39 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -96.34 145.48 25.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.947 -0.471 . . . . 12.0 111.213 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -159.57 138.96 11.27 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 109.261 -0.644 . . . . 12.0 109.261 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -99.05 150.74 21.69 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 109.534 -0.543 . . . . 12.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.588 ' HB3' HD21 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -162.02 -162.44 0.84 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.033 0.444 . . . . 12.0 110.359 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.853 HG23 ' HB3' ' A' ' 65' ' ' ARG . 92.5 m -79.2 127.92 32.65 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.003 -0.74 . . . . 12.0 109.003 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.42 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 21.2 t-20 -95.0 87.52 4.95 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-O 122.245 1.021 . . . . 12.0 111.983 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 5.2 p90 -103.16 101.79 11.76 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 62' ' ' SER . 15.8 tt -119.78 162.54 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.118 0.785 . . . . 12.0 113.118 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -110.52 107.2 16.75 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.076 -1.453 . . . . 12.0 107.076 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.472 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 17.1 m -128.09 -172.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 12.0 109.437 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 4.0 mtpp -143.04 162.94 34.16 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.96 -0.696 . . . . 12.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 9.8 m -115.9 130.26 56.75 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.592 0.711 . . . . 12.0 111.871 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 39.0 tt0 -138.32 136.97 36.95 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.915 -2.254 . . . . 12.0 104.915 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 12.1 m-20 55.86 20.91 4.43 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.391 -0.818 . . . . 12.0 108.838 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 6.4 mt-30 77.12 -17.08 0.58 Allowed 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 123.517 0.727 . . . . 12.0 112.637 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.832 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -98.65 143.66 26.73 Favored Pre-proline 0 N--CA 1.503 2.192 0 N-CA-C 105.983 -1.858 . . . . 12.0 105.983 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.535 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 24.8 Cg_endo -62.69 104.36 0.37 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 C-N-CA 121.278 1.318 . . . . 12.0 108.92 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.832 HG22 ' CE2' ' A' ' 100' ' ' TYR . 3.5 t -115.97 12.25 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 C-N-CA 120.287 -0.565 . . . . 12.0 112.22 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -141.83 133.81 27.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -118.12 129.46 55.55 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 109.084 -0.71 . . . . 12.0 109.084 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.54 -26.17 7.61 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.598 0.592 . . . . 12.0 112.598 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.404 ' O ' HG13 ' A' ' 92' ' ' ILE . . . -177.03 -174.75 43.74 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 119.811 -1.185 . . . . 12.0 111.18 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.98 HD12 HG21 ' A' ' 39' ' ' THR . 10.3 tt -97.78 31.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.09 0.471 . . . . 12.0 110.384 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.038 0 N-CA-C 110.366 -1.094 . . . . 12.0 110.366 179.055 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.2 t30 . . . . . 0 N--CA 1.496 1.853 0 N-CA-C 108.543 -0.91 . . . . 12.0 108.543 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.03 78.65 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 122.045 -0.409 . . . . 12.0 110.609 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.22 -56.45 11.26 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 121.359 -0.838 . . . . 12.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -31.44 72.01 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.917 -1.142 . . . . 12.0 107.917 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 53.7 t80 -72.74 -25.67 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.723 -0.843 . . . . 12.0 108.723 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -53.65 -37.3 62.98 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 107.254 -1.387 . . . . 12.0 107.254 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.39 -40.89 57.45 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.192 -1.41 . . . . 12.0 107.192 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 7.0 tptt -43.32 -61.81 1.24 Allowed 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 116.268 -0.424 . . . . 12.0 111.836 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.776 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.9 m80 -99.49 -7.07 26.5 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 119.08 0.854 . . . . 12.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 10' ' ' HIS . 25.2 mm -134.37 78.41 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 118.684 -1.206 . . . . 12.0 113.33 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.474 ' H ' HD12 ' A' ' 12' ' ' ILE . 5.0 mp -94.82 64.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.153 -2.165 . . . . 12.0 105.153 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.627 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 t-20 -64.82 85.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.652 0.739 . . . . 12.0 110.372 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' ASN . 5.7 p -160.73 69.9 2.74 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.102 -1.444 . . . . 12.0 107.102 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -79.78 30.64 0.48 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.418 2.079 . . . . 12.0 113.103 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 22' ' ' ILE . 10.2 pt -64.56 -169.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.655 -0.869 . . . . 12.0 108.655 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.35 33.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 121.589 0.709 . . . . 12.0 109.46 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -144.94 98.95 3.26 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 108.665 -0.865 . . . . 12.0 108.665 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' MET . 60.0 m -77.36 -18.7 57.16 Favored 'General case' 0 N--CA 1.511 2.581 0 C-N-CA 120.5 -0.48 . . . . 12.0 111.434 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -80.93 -48.54 12.18 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.051 0.841 . . . . 12.0 110.08 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -32.11 68.58 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.916 -0.402 . . . . 12.0 109.916 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 16' ' ' ILE . 46.8 pt -80.26 -34.6 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 122.034 -0.416 . . . . 12.0 110.195 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -99.34 18.25 18.13 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 120.512 -0.475 . . . . 12.0 110.44 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.53 89.9 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.939 -1.134 . . . . 12.0 107.939 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.419 ' OD1' HD12 ' A' ' 27' ' ' ILE . 10.6 t-20 -166.88 159.54 13.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.209 -0.663 . . . . 12.0 109.209 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.8 -10.36 59.71 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.76 -0.376 . . . . 12.0 110.052 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 27' ' ' ILE . 57.9 mt -87.77 10.44 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.73 -0.606 . . . . 12.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -146.94 63.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.706 -0.621 . . . . 12.0 110.099 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.3 mt -153.19 149.02 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.57 -1.331 . . . . 12.0 111.07 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 31' ' ' GLY . 57.9 t -104.86 168.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 107.678 -1.23 . . . . 12.0 107.678 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.58 53.87 3.43 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.328 -1.509 . . . . 12.0 109.328 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.95 -55.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 12.0 109.388 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -166.43 -77.06 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.929 -0.767 . . . . 12.0 108.929 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -146.47 -170.71 3.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.827 -0.805 . . . . 12.0 108.827 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -174.27 2.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.222 -0.658 . . . . 12.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -85.4 -25.4 27.04 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.981 -0.45 . . . . 12.0 110.591 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 72' ' ' THR . 10.1 t -151.51 107.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 120.353 -0.539 . . . . 12.0 110.777 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.425 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.3 m120 -91.6 85.69 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 105.904 -1.887 . . . . 12.0 105.904 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 m -81.73 112.89 19.31 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.242 0.544 . . . . 12.0 111.763 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 23' ' ' MET . 32.7 m-85 -100.39 158.5 15.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.272 -1.381 . . . . 12.0 107.272 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.3 mp -126.52 128.75 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 12.0 109.353 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.403 HG23 ' HG3' ' A' ' 67' ' ' GLN . 4.2 tt -111.14 129.28 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.632 ' O ' HD12 ' A' ' 11' ' ' ILE . 15.3 t 165.42 157.88 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.188 -1.041 . . . . 12.0 108.188 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -60.19 122.81 15.39 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.671 -0.863 . . . . 12.0 108.671 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.09 -29.24 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.136 -0.352 . . . . 12.0 111.803 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -79.92 -31.57 40.11 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.953 -0.467 . . . . 12.0 111.903 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 p -64.87 -36.04 83.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.474 -1.306 . . . . 12.0 107.474 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.05 -33.5 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.718 -1.215 . . . . 12.0 107.718 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -66.75 -21.54 66.06 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.607 -0.516 . . . . 12.0 109.607 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.69 -41.2 24.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.794 -0.566 . . . . 12.0 109.76 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.591 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 18.3 pt -67.15 -20.46 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.782 -0.574 . . . . 12.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 22.34 9.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.853 -0.53 . . . . 12.0 110.101 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -88.78 114.43 25.39 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.005 -0.739 . . . . 12.0 109.005 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.17 -61.21 0.02 OUTLIER Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.418 -1.073 . . . . 12.0 110.418 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.9 p -163.65 -168.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.656 ' H ' HG22 ' A' ' 55' ' ' VAL . 12.4 tt -87.26 27.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 O-C-N 121.097 -1.002 . . . . 12.0 110.958 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 6.1 t-20 171.1 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 106.403 -1.703 . . . . 12.0 106.403 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.62 179.37 8.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.826 0.822 . . . . 12.0 112.132 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -137.55 115.1 11.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.557 HG13 ' CG1' ' A' ' 94' ' ' VAL . 11.9 p -128.71 166.35 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.897 -0.502 . . . . 12.0 109.653 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.503 ' N ' HG22 ' A' ' 60' ' ' VAL . 3.8 mp -129.33 117.54 20.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.896 -0.502 . . . . 12.0 111.521 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 1.4 m -58.1 93.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.105 -1.443 . . . . 12.0 107.105 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.675 HG22 ' OH ' ' A' ' 91' ' ' TYR . 1.6 p -79.74 -53.5 6.75 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 112.249 0.463 . . . . 12.0 112.249 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.685 HG22 ' HG2' ' A' ' 65' ' ' ARG . 47.5 m -47.83 -90.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.866 -0.521 . . . . 12.0 110.271 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.846 ' CB ' HG23 ' A' ' 89' ' ' THR . 11.0 ptm180 174.43 100.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 57.9 m-85 -97.88 54.62 1.15 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.237 -0.653 . . . . 12.0 109.237 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER 11.88 109.03 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.431 1.271 . . . . 12.0 114.431 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.04 154.6 17.97 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.819 0.819 . . . . 12.0 111.756 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -119.22 100.23 7.2 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.083 -1.821 . . . . 12.0 106.083 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 m -102.18 127.39 49.13 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.659 0.743 . . . . 12.0 112.355 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -111.7 112.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.367 -2.457 . . . . 12.0 104.367 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.532 HG23 HG22 ' A' ' 37' ' ' VAL . 4.2 m -111.2 144.99 39.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.091 -0.644 . . . . 12.0 111.648 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -62.34 142.79 57.61 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.297 -1.001 . . . . 12.0 108.297 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.504 2.267 0 O-C-N 121.92 -0.488 . . . . 12.0 110.545 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 119.09 -0.481 . . . . 12.0 110.809 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.33 113.05 2.85 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.119 1.879 . . . . 12.0 109.296 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 81' ' ' CYS . 12.1 m-85 -138.58 139.07 38.49 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.195 0.521 . . . . 12.0 111.119 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -111.33 129.35 56.02 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.897 -1.149 . . . . 12.0 107.897 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 t -93.91 149.45 21.22 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.39 0.614 . . . . 12.0 110.883 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -151.79 155.42 38.19 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.032 -0.729 . . . . 12.0 109.032 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.3 m -125.44 141.2 52.19 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.535 -0.543 . . . . 12.0 109.535 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -166.12 -172.03 2.16 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.095 0.474 . . . . 12.0 110.317 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.846 HG23 ' CB ' ' A' ' 65' ' ' ARG . 77.4 m -65.3 145.59 56.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.991 -0.744 . . . . 12.0 108.991 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -110.22 88.24 2.71 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.907 0.86 . . . . 12.0 111.371 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.675 ' OH ' HG22 ' A' ' 63' ' ' THR . 6.6 t80 -98.03 96.63 8.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.987 -2.597 . . . . 12.0 103.987 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.615 HG21 ' HZ ' ' A' ' 104' ' ' PHE . 7.1 tt -130.69 175.12 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.978 -0.689 . . . . 12.0 111.077 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.77 116.63 27.4 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.65 -0.871 . . . . 12.0 108.65 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.557 ' CG1' HG13 ' A' ' 60' ' ' VAL . 14.8 p -108.88 162.06 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.989 -0.374 . . . . 12.0 109.989 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 94' ' ' VAL . 42.7 mtpt -120.35 144.8 47.67 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -119.55 120.63 37.31 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 114.003 1.112 . . . . 12.0 114.003 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 20.9 tt0 -128.37 141.8 51.31 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 104.076 -2.564 . . . . 12.0 104.076 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.9 m-80 57.21 28.64 15.41 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 107.683 -1.228 . . . . 12.0 107.683 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 51.22 16.17 0.36 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 124.754 1.222 . . . . 12.0 114.001 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.803 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.85 145.44 41.37 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 104.121 -2.548 . . . . 12.0 104.121 174.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.495 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 24.5 Cg_endo -61.33 93.89 0.11 Allowed 'Trans proline' 0 C--O 1.2 -1.393 0 N-CA-C 108.429 -1.412 . . . . 12.0 108.429 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.803 HG22 ' CE2' ' A' ' 100' ' ' TYR . 63.4 t -91.73 -14.15 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 122.239 -0.288 . . . . 12.0 110.901 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -146.35 145.62 30.37 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.615 ' HZ ' HG21 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -102.23 120.0 39.74 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.481 -1.288 . . . . 12.0 108.914 178.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.46 81.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.863 -0.523 . . . . 12.0 110.042 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.8 -158.86 23.27 Favored Glycine 0 N--CA 1.5 2.95 0 N-CA-C 109.896 -1.282 . . . . 12.0 109.896 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 108' ' ' GLY . 8.3 tp -54.58 162.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 122.173 -0.604 . . . . 12.0 109.725 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.416 ' N ' HG13 ' A' ' 107' ' ' ILE . . . . . . . . 0 N--CA 1.499 2.889 0 N-CA-C 109.462 -1.455 . . . . 12.0 109.462 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 109.014 -0.735 . . . . 12.0 109.014 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -25.73 62.87 Favored 'General case' 0 N--CA 1.516 2.84 0 O-C-N 122.141 -0.35 . . . . 12.0 110.625 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.1 -61.83 1.72 Allowed 'General case' 0 N--CA 1.512 2.631 0 O-C-N 121.437 -0.789 . . . . 12.0 110.68 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.691 HG23 HD11 ' A' ' 27' ' ' ILE . 29.1 m -62.33 -32.48 73.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.997 -1.112 . . . . 12.0 107.997 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 31.1 t80 -75.79 -23.63 55.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -55.85 -34.25 65.26 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 106.96 -1.496 . . . . 12.0 106.96 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.99 -38.76 52.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.728 -1.212 . . . . 12.0 107.728 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 11.1 mmtm -45.57 -51.32 12.13 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 122.232 -0.293 . . . . 12.0 110.856 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.926 ' ND1' HG11 ' A' ' 48' ' ' VAL . 2.1 m-70 -97.52 -13.97 21.36 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 118.837 -0.601 . . . . 12.0 112.153 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 10' ' ' HIS . 15.5 mm -123.18 64.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 114.896 1.443 . . . . 12.0 114.896 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.81 HG21 ' CD1' ' A' ' 40' ' ' PHE . 2.7 mp -98.89 63.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 103.984 -2.598 . . . . 12.0 103.984 173.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -73.09 78.61 1.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.734 0.778 . . . . 12.0 111.65 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.677 ' OG1' HD12 ' A' ' 22' ' ' ILE . 3.0 p -139.64 75.15 32.2 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.21 11.72 2.27 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.323 2.015 . . . . 12.0 113.59 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.745 HD11 ' CG2' ' A' ' 22' ' ' ILE . 15.8 pt -60.99 -168.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-N 119.15 0.886 . . . . 12.0 108.684 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -106.93 36.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.533 -0.729 . . . . 12.0 109.698 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -142.37 101.45 3.9 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 108.55 -0.907 . . . . 12.0 108.55 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.42 -14.45 58.93 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.961 -0.462 . . . . 12.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -85.03 -55.46 4.05 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-N 118.882 0.765 . . . . 12.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.09 -36.52 63.27 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.048 -0.408 . . . . 12.0 110.054 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.745 ' CG2' HD11 ' A' ' 16' ' ' ILE . 34.0 pt -81.24 -35.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.445 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 2.3 tmm? -99.07 32.03 2.82 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.399 -0.593 . . . . 12.0 109.399 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.07 48.36 1.64 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.277 0.56 . . . . 12.0 110.002 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.625 ' OD1' HG22 ' A' ' 27' ' ' ILE . 10.3 t-20 -127.47 155.62 43.42 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.075 -0.713 . . . . 12.0 109.075 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -73.44 -10.72 60.03 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.89 -0.324 . . . . 12.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 5' ' ' THR . 21.3 tt -79.06 -0.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.587 -0.696 . . . . 12.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.664 ' O ' HD13 ' A' ' 29' ' ' ILE . 66.5 m-85 -119.61 54.91 0.98 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.387 -0.597 . . . . 12.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 28' ' ' TYR . 44.8 mm -139.01 152.06 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.108 -0.995 . . . . 12.0 110.376 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 31' ' ' GLY . 40.8 t -100.84 169.98 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.719 -1.215 . . . . 12.0 107.719 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -91.02 53.9 3.27 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.283 -1.527 . . . . 12.0 109.283 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.44 -58.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.746 -1.742 . . . . 12.0 108.746 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.6 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.066 -0.667 . . . . 12.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.54 177.55 8.59 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.71 -0.848 . . . . 12.0 108.71 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 159.74 22.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.341 -0.615 . . . . 12.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -72.05 -9.5 58.48 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.24 -0.287 . . . . 12.0 110.768 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.5 p -159.28 129.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.7 0.762 . . . . 12.0 111.037 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 1.7 t-20 -117.29 89.17 3.06 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.819 -1.919 . . . . 12.0 105.819 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.3 m -83.71 118.1 23.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.29 0.567 . . . . 12.0 111.83 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.81 ' CD1' HG21 ' A' ' 12' ' ' ILE . 23.3 m-85 -100.05 156.71 17.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.921 -1.511 . . . . 12.0 106.921 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.31 127.84 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.283 -0.886 . . . . 12.0 108.975 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 42' ' ' ILE . 5.5 tt -107.53 107.89 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.44 0.638 . . . . 12.0 109.325 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.659 ' O ' HD12 ' A' ' 11' ' ' ILE . 39.9 t 176.57 154.12 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.924 -0.769 . . . . 12.0 108.924 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 p -63.48 126.17 26.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.667 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -53.29 -26.97 20.52 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.074 -0.391 . . . . 12.0 110.942 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -80.14 -32.06 38.98 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.629 -0.428 . . . . 12.0 111.621 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -62.07 -40.31 95.37 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.77 -1.567 . . . . 12.0 106.77 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.926 HG11 ' ND1' ' A' ' 10' ' ' HIS . 39.5 t -69.53 -35.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.963 -1.125 . . . . 12.0 107.963 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -57.69 -25.42 60.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.97 -0.752 . . . . 12.0 108.97 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.77 -34.73 33.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.876 -0.515 . . . . 12.0 109.734 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.908 HD13 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.2 -28.62 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.767 -0.583 . . . . 12.0 110.544 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.67 19.99 15.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.452 -0.78 . . . . 12.0 110.365 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.0 m -85.46 112.45 20.89 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 109.13 -0.693 . . . . 12.0 109.13 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.46 -63.45 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.925 -0.87 . . . . 12.0 110.925 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.0 p -158.65 -167.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 118.015 0.907 . . . . 12.0 109.178 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.615 ' H ' HG22 ' A' ' 55' ' ' VAL . 3.8 tt -87.82 27.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.593 0 O-C-N 121.132 -0.98 . . . . 12.0 110.968 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 13.9 t-20 173.09 118.84 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 106.652 -1.61 . . . . 12.0 106.652 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.47 175.36 12.25 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.621 0.724 . . . . 12.0 111.528 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -141.49 111.48 6.71 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.3 p -140.04 167.65 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.547 -0.538 . . . . 12.0 109.547 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.516 ' N ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -136.88 130.4 31.66 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.264 0.554 . . . . 12.0 111.24 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -59.52 102.9 0.16 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.353 -1.351 . . . . 12.0 107.353 177.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -87.9 -37.2 16.67 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.251 -0.28 . . . . 12.0 110.254 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.0 m -59.22 -95.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.77 ' CB ' HG23 ' A' ' 89' ' ' THR . 1.8 ptt-85 177.01 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.919 0.781 . . . . 12.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -97.01 41.57 1.11 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.318 -0.623 . . . . 12.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 23.77 105.89 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 114.196 1.184 . . . . 12.0 114.196 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -104.77 157.1 17.43 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.936 0.874 . . . . 12.0 111.868 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.34 100.7 7.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 104.943 -2.243 . . . . 12.0 104.943 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.2 m -97.22 132.27 43.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.757 0.789 . . . . 12.0 112.471 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' SER . 55.6 m -121.63 116.44 24.59 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 104.068 -2.567 . . . . 12.0 104.068 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -106.77 144.68 33.06 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 120.195 -0.602 . . . . 12.0 111.88 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -68.09 100.2 0.97 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.266 -0.642 . . . . 12.0 109.266 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.498 1.94 0 N-CA-C 109.569 -0.53 . . . . 12.0 109.569 -179.596 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.945 0 N-CA-C 108.467 -0.938 . . . . 12.0 108.467 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 36.6 Cg_endo -75.25 116.64 4.6 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 121.645 1.564 . . . . 12.0 110.448 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.454 ' CE1' ' HG3' ' A' ' 73' ' ' ARG . 15.7 m-85 -145.98 137.07 24.61 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.319 0.58 . . . . 12.0 111.728 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 71' ' ' CYS . 7.9 t -107.83 153.88 22.36 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 106.691 -1.596 . . . . 12.0 106.691 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 t -107.79 156.53 19.02 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.563 -0.71 . . . . 12.0 111.456 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -166.09 158.67 14.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.316 -0.624 . . . . 12.0 109.316 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 p -135.06 147.66 49.67 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.053 -0.721 . . . . 12.0 109.053 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.84 -173.64 1.64 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.483 0.659 . . . . 12.0 110.744 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.77 HG23 ' CB ' ' A' ' 65' ' ' ARG . 85.8 m -66.69 142.75 57.31 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.206 -1.035 . . . . 12.0 108.206 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 3.5 t-20 -104.96 87.41 2.64 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.451 -0.9 . . . . 12.0 111.567 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' SER . 6.1 p90 -107.22 105.6 15.65 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.445 -2.057 . . . . 12.0 105.445 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.606 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt -137.2 -179.53 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.651 0.738 . . . . 12.0 111.926 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -117.37 109.94 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.425 -0.807 . . . . 12.0 110.316 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.561 HG13 ' CE1' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -105.57 171.0 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.551 -0.907 . . . . 12.0 108.551 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 9.3 mttp -129.18 140.52 51.47 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -110.45 121.81 46.2 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.626 1.343 . . . . 12.0 114.626 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.0 tt0 -136.45 142.49 43.62 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 103.816 -2.661 . . . . 12.0 103.816 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 56.13 30.92 17.27 Favored 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 107.212 -1.403 . . . . 12.0 107.212 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 47.56 19.24 0.14 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.244 1.201 . . . . 12.0 114.244 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.841 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.94 145.55 54.26 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 104.585 -2.376 . . . . 12.0 104.585 175.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.506 ' HB3' HG11 ' A' ' 94' ' ' VAL . 21.9 Cg_endo -59.9 90.25 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.055 0 N-CA-C 108.899 -1.231 . . . . 12.0 108.899 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.841 HG22 ' CE2' ' A' ' 100' ' ' TYR . 44.0 t -87.57 -20.65 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 115.995 -0.548 . . . . 12.0 110.583 -177.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.493 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -137.66 144.03 41.64 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 12.0 108.367 -177.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -107.97 126.83 53.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 118.851 -1.14 . . . . 12.0 109.537 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.64 -33.79 53.41 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.995 -0.372 . . . . 12.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.83 -133.66 6.9 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.764 -0.934 . . . . 12.0 110.764 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.7 pt -69.73 -172.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 122.344 -0.504 . . . . 12.0 111.004 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.754 0 N-CA-C 111.0 -0.84 . . . . 12.0 111.0 -179.118 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 109.058 -0.719 . . . . 12.0 109.058 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -28.75 66.73 Favored 'General case' 0 N--CA 1.514 2.744 0 O-C-N 122.161 -0.337 . . . . 12.0 110.279 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 7' ' ' GLN . . . -73.96 -60.03 2.45 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 121.735 -0.603 . . . . 12.0 110.716 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -62.35 -29.35 70.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.104 -1.073 . . . . 12.0 108.104 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 31.1 t80 -79.35 -23.79 43.14 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.174 -0.676 . . . . 12.0 109.174 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -57.93 -35.61 71.33 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 106.696 -1.594 . . . . 12.0 106.696 177.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.09 -35.61 56.36 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.661 -1.237 . . . . 12.0 107.661 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 11.7 tptt -46.07 -60.49 2.24 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 116.686 -0.234 . . . . 12.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.616 ' CE1' HD11 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -103.42 -2.16 27.39 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.645 -0.659 . . . . 12.0 112.039 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -138.51 73.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.415 1.635 . . . . 12.0 115.415 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.929 HG21 HG23 ' A' ' 22' ' ' ILE . 19.3 mt -97.34 66.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 102.789 -3.041 . . . . 12.0 102.789 172.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.03 75.87 3.59 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.36 -0.836 . . . . 12.0 112.364 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.46 130.9 22.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 106.487 -1.672 . . . . 12.0 106.487 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.12 -24.43 38.55 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 121.277 1.318 . . . . 12.0 110.513 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.42 148.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.183 -1.043 . . . . 12.0 108.183 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 pt -111.41 85.44 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 121.695 0.76 . . . . 12.0 109.221 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -147.3 104.84 3.69 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 m -75.76 -8.32 56.55 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.63 -0.428 . . . . 12.0 110.847 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -69.68 -46.69 65.49 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 118.804 0.729 . . . . 12.0 109.223 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -82.72 -19.61 37.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.665 -0.494 . . . . 12.0 109.665 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.929 HG23 HG21 ' A' ' 12' ' ' ILE . 40.1 mt -87.17 -6.87 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.765 -0.584 . . . . 12.0 110.809 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm -109.51 -43.52 4.07 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.597 -0.89 . . . . 12.0 108.597 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.21 96.91 0.16 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 107.563 -1.273 . . . . 12.0 107.563 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -169.57 157.8 7.37 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.901 -0.777 . . . . 12.0 108.901 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -69.76 -10.88 60.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.048 -0.407 . . . . 12.0 110.076 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 27' ' ' ILE . 58.3 mt -91.46 13.67 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.723 -0.611 . . . . 12.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.534 ' OH ' HD11 ' A' ' 12' ' ' ILE . 53.5 m-85 -152.54 67.27 0.82 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.61 -0.681 . . . . 12.0 110.367 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -146.34 135.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 120.593 -1.317 . . . . 12.0 110.477 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.563 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.8 p -109.92 -162.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.446 -1.316 . . . . 12.0 107.446 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.563 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -96.25 67.72 1.0 Allowed Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.029 -1.044 . . . . 12.0 111.662 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.16 -66.8 0.03 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.31 -1.516 . . . . 12.0 109.31 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -165.56 -65.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -154.55 144.01 21.39 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.868 -0.79 . . . . 12.0 108.868 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -66.25 178.3 1.22 Allowed 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.824 -0.436 . . . . 12.0 109.824 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.15 15.87 22.93 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.249 -0.282 . . . . 12.0 110.61 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.0 p -162.8 120.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.854 -0.529 . . . . 12.0 109.816 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.452 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 75.6 m-20 -122.12 88.94 3.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m -83.31 107.37 15.79 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 116.371 -0.377 . . . . 12.0 110.685 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.824 ' CD1' HD12 ' A' ' 12' ' ' ILE . 12.9 m-85 -98.57 159.79 14.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.066 -1.457 . . . . 12.0 107.066 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.755 HD12 ' C ' ' A' ' 40' ' ' PHE . 3.7 mp -130.26 129.49 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.748 -0.834 . . . . 12.0 108.748 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' ILE . 10.5 tt -101.34 106.27 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.15 -0.685 . . . . 12.0 109.15 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.1 t 176.66 154.47 0.22 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.808 -0.812 . . . . 12.0 108.808 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -60.62 130.04 44.53 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.818 -0.808 . . . . 12.0 108.818 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' CA ' HG12 ' A' ' 11' ' ' ILE . . . -53.94 -27.21 29.56 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.067 -0.395 . . . . 12.0 111.385 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 t -82.43 -30.92 29.78 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.509 -0.476 . . . . 12.0 111.591 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 p -63.58 -37.01 85.7 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.862 ' O ' HG22 ' A' ' 51' ' ' ILE . 25.1 t -70.78 -36.06 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -62.07 -23.46 66.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.221 -0.659 . . . . 12.0 109.221 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.953 -0.467 . . . . 12.0 109.839 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.889 HD13 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -65.3 -29.41 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.837 -0.539 . . . . 12.0 110.088 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 24.53 6.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.753 -0.592 . . . . 12.0 110.069 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -87.8 113.22 23.26 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.496 -0.557 . . . . 12.0 109.496 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.2 -64.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.872 -1.291 . . . . 12.0 109.872 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 58' ' ' MET . 2.4 p -160.49 -165.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.42 -0.956 . . . . 12.0 108.42 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.586 ' H ' HG22 ' A' ' 55' ' ' VAL . 45.6 pt -89.77 26.5 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 O-C-N 121.102 -0.999 . . . . 12.0 111.326 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 50.5 t30 173.22 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 107.642 -1.244 . . . . 12.0 107.642 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.692 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -165.3 178.76 6.66 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 121.909 0.861 . . . . 12.0 111.904 -178.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -134.04 116.52 15.58 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 106.735 -1.58 . . . . 12.0 106.735 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 61' ' ' LEU . 13.0 t -130.25 167.59 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.87 -0.519 . . . . 12.0 109.788 -177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' N ' HG12 ' A' ' 60' ' ' VAL . 2.8 mp -122.59 110.53 15.67 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -56.88 91.51 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 108.666 -0.865 . . . . 12.0 108.666 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.892 HG22 ' OH ' ' A' ' 91' ' ' TYR . 3.0 p -81.79 -50.94 8.66 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 109.343 -0.614 . . . . 12.0 109.343 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.428 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 64.7 m -61.02 108.7 0.92 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.786 -1.191 . . . . 12.0 107.786 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.821 ' CB ' HG23 ' A' ' 89' ' ' THR . 23.2 ptt85 -40.0 108.67 0.09 Allowed 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.108 0.48 . . . . 12.0 112.245 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 64' ' ' THR . 47.6 m-85 -95.87 42.73 1.09 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 108.8 -0.815 . . . . 12.0 108.8 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 18.22 105.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 113.904 1.076 . . . . 12.0 113.904 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -101.22 157.3 16.88 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 12.0 112.324 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -121.29 97.16 5.39 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.264 -2.125 . . . . 12.0 105.264 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.6 m -101.87 124.39 47.42 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.811 -0.756 . . . . 12.0 112.034 -176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.4 m -110.65 108.64 18.62 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 104.254 -2.498 . . . . 12.0 104.254 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -111.99 140.3 46.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.817 -0.753 . . . . 12.0 111.869 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -65.03 117.41 7.62 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.089 -1.078 . . . . 12.0 108.089 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.5 p . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 108.982 -0.747 . . . . 12.0 108.982 -179.215 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.468 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.18 0 N-CA-C 110.303 -0.258 . . . . 12.0 110.303 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 35.1 Cg_endo -77.13 122.22 6.1 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 122.255 1.97 . . . . 12.0 109.649 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.452 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 5.4 m-85 -115.88 138.67 50.95 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 121.634 0.73 . . . . 12.0 111.832 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 p -110.87 131.0 55.42 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 107.393 -1.336 . . . . 12.0 107.393 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 81.0 p -96.46 141.73 29.4 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.511 0.672 . . . . 12.0 111.608 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -152.88 127.88 9.67 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.35 -0.982 . . . . 12.0 108.35 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 68' ' ' LEU . 5.3 m -109.64 149.85 29.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.031 -0.418 . . . . 12.0 110.209 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' CG ' HD11 ' A' ' 68' ' ' LEU . 11.4 pt-20 -175.21 -168.97 0.36 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 120.909 0.385 . . . . 12.0 110.234 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.821 HG23 ' CB ' ' A' ' 65' ' ' ARG . 95.8 m -57.68 142.28 45.61 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.994 -0.373 . . . . 12.0 109.994 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.413 ' HB3' ' C ' ' A' ' 66' ' ' PHE . 7.2 t-20 -109.21 88.48 2.74 Favored 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 121.901 0.857 . . . . 12.0 110.88 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.892 ' OH ' HG22 ' A' ' 63' ' ' THR . 1.1 t80 -104.39 101.23 10.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.75 -1.944 . . . . 12.0 105.75 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.854 HD12 ' CE1' ' A' ' 104' ' ' PHE . 6.2 pt -134.09 -179.19 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.586 -0.846 . . . . 12.0 111.719 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 10.3 t -115.18 120.74 40.75 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.175 -1.046 . . . . 12.0 108.175 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.586 HG23 ' CZ ' ' A' ' 104' ' ' PHE . 6.9 p -115.69 170.11 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 122.243 -0.286 . . . . 12.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 94' ' ' VAL . 18.0 mttt -131.54 140.19 49.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.565 -0.902 . . . . 12.0 108.565 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.3 m -113.49 122.55 47.62 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.19 1.182 . . . . 12.0 114.19 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.1 tt0 -131.73 143.35 50.18 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 15.2 m-80 53.51 29.47 9.09 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.765 -1.198 . . . . 12.0 107.765 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 15.2 pt20 53.83 5.87 0.07 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 114.822 1.415 . . . . 12.0 114.822 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -111.85 145.4 32.62 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 104.765 -2.309 . . . . 12.0 104.765 175.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.535 ' HB3' HG21 ' A' ' 94' ' ' VAL . 24.5 Cg_endo -60.95 89.47 0.09 OUTLIER 'Trans proline' 0 C--O 1.209 -0.942 0 N-CA-C 108.85 -1.25 . . . . 12.0 108.85 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.939 HG22 ' CE2' ' A' ' 100' ' ' TYR . 95.1 t -85.61 -22.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-N 116.214 -0.448 . . . . 12.0 110.332 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.68 143.33 48.47 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.258 -1.386 . . . . 12.0 107.258 -178.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.854 ' CE1' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -119.29 128.69 54.38 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.166 -1.014 . . . . 12.0 110.375 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -73.4 -42.18 62.41 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.568 -0.287 . . . . 12.0 110.312 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.72 -129.54 5.84 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.478 -0.867 . . . . 12.0 111.009 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 tt -60.74 165.97 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.222 -0.575 . . . . 12.0 110.567 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . . . . . . 0 N--CA 1.503 3.156 0 N-CA-C 110.648 -0.981 . . . . 12.0 110.648 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 4' ' ' ALA . 33.0 t30 . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 109.194 -0.669 . . . . 12.0 109.194 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.413 ' CZ2' ' HB2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.81 -29.19 64.17 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 122.096 -0.377 . . . . 12.0 110.465 -178.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.46 ' HB3' ' ND2' ' A' ' 2' ' ' ASN . . . -72.91 -58.72 3.12 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.901 -0.499 . . . . 12.0 110.571 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -63.36 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.171 -1.048 . . . . 12.0 108.171 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 30.1 t80 -77.13 -22.75 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.103 -0.703 . . . . 12.0 109.103 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -61.26 -38.34 86.35 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.89 -35.61 57.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.421 -1.325 . . . . 12.0 107.421 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.21 -57.06 3.66 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 116.355 -0.384 . . . . 12.0 110.763 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.731 ' ND1' HD13 ' A' ' 41' ' ' ILE . 76.0 m-70 -108.26 -4.05 17.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.062 1.134 . . . . 12.0 114.062 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 45' ' ' ALA . 39.2 mm -122.38 64.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 118.566 -1.253 . . . . 12.0 113.597 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.66 HD13 ' HA ' ' A' ' 40' ' ' PHE . 3.1 mp -98.2 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.348 -2.093 . . . . 12.0 105.348 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.669 ' O ' HG23 ' A' ' 14' ' ' THR . 8.0 p30 -54.58 85.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 CA-C-O 121.46 0.648 . . . . 12.0 111.15 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 13' ' ' ASN . 12.7 p -164.66 57.73 0.56 Allowed Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 107.65 -1.241 . . . . 12.0 107.65 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 14' ' ' THR . 35.9 Cg_endo -74.98 82.57 1.97 Allowed 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 121.936 1.757 . . . . 12.0 110.457 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.49 -162.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.154 -1.054 . . . . 12.0 108.154 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.19 30.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 109.073 -0.714 . . . . 12.0 109.073 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -140.79 95.36 2.84 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.279 -1.008 . . . . 12.0 108.279 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.429 ' HA ' HD11 ' A' ' 22' ' ' ILE . 46.3 m -77.04 -18.61 58.0 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 120.266 -0.574 . . . . 12.0 111.389 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.12 -52.35 7.47 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 119.082 0.855 . . . . 12.0 110.315 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.11 -33.26 38.92 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.511 -0.551 . . . . 12.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 19' ' ' CYS . 44.6 pt -82.38 -37.44 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.904 -0.406 . . . . 12.0 109.904 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -104.68 40.64 1.45 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.444 0.64 . . . . 12.0 109.305 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -87.77 50.07 1.92 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.511 0.672 . . . . 12.0 109.684 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.666 ' OD1' HG23 ' A' ' 27' ' ' ILE . 10.9 t-20 -127.87 161.33 29.31 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.045 -0.724 . . . . 12.0 109.045 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -74.76 -8.91 57.87 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.789 -0.364 . . . . 12.0 110.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.666 HG23 ' OD1' ' A' ' 25' ' ' ASN . 32.0 pt -80.17 -3.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.574 -0.704 . . . . 12.0 111.113 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -112.3 47.52 1.06 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.744 -0.598 . . . . 12.0 110.578 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mt -150.33 144.92 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.027 -1.046 . . . . 12.0 110.302 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 31' ' ' GLY . 49.4 t -106.78 169.25 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 107.711 -1.218 . . . . 12.0 107.711 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.77 61.33 3.1 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.05 -65.06 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.052 -1.619 . . . . 12.0 109.052 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -168.95 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 117.703 0.751 . . . . 12.0 109.792 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 t -145.38 131.11 18.98 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -61.77 164.96 5.64 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.479 -0.564 . . . . 12.0 109.479 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -102.05 -3.18 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 122.24 -0.288 . . . . 12.0 111.01 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.6 p -162.48 114.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.603 -0.686 . . . . 12.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 8.3 m120 -107.29 84.78 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.678 -1.601 . . . . 12.0 106.678 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 m -80.9 109.49 15.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 116.071 -0.513 . . . . 12.0 110.648 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.66 ' HA ' HD13 ' A' ' 12' ' ' ILE . 19.3 m-85 -98.73 161.7 13.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.805 -1.554 . . . . 12.0 106.805 178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.731 HD13 ' ND1' ' A' ' 10' ' ' HIS . 1.1 mp -130.98 132.54 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.335 0.971 . . . . 12.0 109.54 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 42' ' ' ILE . 5.7 tp -108.44 105.42 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.195 -1.039 . . . . 12.0 108.195 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t 179.54 153.33 0.45 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.61 122.07 9.07 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.794 0.807 . . . . 12.0 109.827 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 11' ' ' ILE . . . -46.42 -64.96 0.63 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 113.613 0.968 . . . . 12.0 113.613 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.7 p -62.72 -17.03 60.07 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.165 -0.614 . . . . 12.0 111.235 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.652 HG22 ' HE2' ' A' ' 66' ' ' PHE . 96.2 m -66.01 -36.68 83.94 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.302 -1.369 . . . . 12.0 107.302 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 51' ' ' ILE . 44.6 t -71.26 -35.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.048 -1.464 . . . . 12.0 107.048 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -63.73 -21.73 66.55 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 12.0 108.992 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.54 -38.7 25.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.0 -0.438 . . . . 12.0 110.015 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.3 tp -65.4 -22.74 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.769 -0.582 . . . . 12.0 109.91 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.1 35.86 2.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.802 -0.561 . . . . 12.0 109.805 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.4 m -96.76 112.8 24.4 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.184 -0.672 . . . . 12.0 109.184 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.03 -63.02 0.02 OUTLIER Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.598 -1.001 . . . . 12.0 110.598 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.611 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.8 p -162.12 -167.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.691 -0.855 . . . . 12.0 108.691 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.9 pt -88.25 26.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 121.024 -1.047 . . . . 12.0 111.317 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 174.05 112.99 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 107.508 -1.293 . . . . 12.0 107.508 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.8 -176.37 4.57 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.984 0.897 . . . . 12.0 111.955 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -140.14 124.59 17.97 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.697 -1.594 . . . . 12.0 106.697 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG13 ' CG2' ' A' ' 94' ' ' VAL . 10.0 p -137.32 166.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.735 -0.603 . . . . 12.0 109.727 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.492 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.7 mt -126.27 112.56 15.87 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.904 -0.498 . . . . 12.0 112.193 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 4.0 m -67.7 91.2 0.29 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 105.691 -1.966 . . . . 12.0 105.691 176.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -86.77 -37.41 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.149 -0.344 . . . . 12.0 111.634 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.697 HG22 ' HG2' ' A' ' 65' ' ' ARG . 89.8 m -53.88 -92.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.195 -0.669 . . . . 12.0 109.195 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.735 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER 176.15 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.778 0.717 . . . . 12.0 109.563 179.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.652 ' HE2' HG22 ' A' ' 47' ' ' THR . 49.9 m-85 -96.89 44.51 1.06 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 14.79 105.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.254 0 N-CA-C 114.087 1.143 . . . . 12.0 114.087 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.79 156.35 17.89 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.939 0.876 . . . . 12.0 111.972 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.14 99.17 6.55 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.675 -1.972 . . . . 12.0 105.675 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.4 m -100.51 125.06 46.8 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.011 -0.676 . . . . 12.0 112.555 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.9 m -105.79 111.53 24.24 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 104.187 -2.523 . . . . 12.0 104.187 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 m -101.89 140.41 36.2 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 120.014 -0.675 . . . . 12.0 111.519 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 3.7 tmt_? -72.6 105.99 4.46 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.122 -0.696 . . . . 12.0 109.122 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.499 2.024 0 N-CA-C 110.014 -0.365 . . . . 12.0 110.014 -179.53 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 108.652 -0.87 . . . . 12.0 108.652 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 33.0 Cg_endo -72.74 113.95 3.89 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 121.492 1.461 . . . . 12.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 12.9 m-85 -140.2 134.22 30.84 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.083 0.468 . . . . 12.0 110.917 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -109.0 128.66 55.14 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.857 -1.164 . . . . 12.0 107.857 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.5 p -89.55 139.88 30.1 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.306 0.574 . . . . 12.0 110.909 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -147.97 158.41 44.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.511 -0.922 . . . . 12.0 108.511 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -139.67 148.72 42.79 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 109.537 -0.542 . . . . 12.0 109.537 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -177.22 -176.49 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.501 -0.48 . . . . 12.0 110.279 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.735 HG23 ' HB3' ' A' ' 65' ' ' ARG . 58.9 m -53.86 141.02 28.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.778 -0.453 . . . . 12.0 109.778 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.593 ' OD1' HD23 ' A' ' 68' ' ' LEU . 61.8 t30 -110.47 86.11 2.24 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.593 -0.843 . . . . 12.0 112.596 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -95.67 100.73 12.42 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.0 -2.222 . . . . 12.0 105.0 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.445 HG12 ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -122.93 149.6 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.546 0.689 . . . . 12.0 111.929 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 25.1 t -92.48 136.01 33.57 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 105.523 -2.029 . . . . 12.0 105.523 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 60' ' ' VAL . 2.8 m -140.57 -176.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 120.275 -0.57 . . . . 12.0 111.004 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.451 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 40.0 mtmt -147.95 149.22 31.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -118.78 117.57 29.25 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.688 0.756 . . . . 12.0 112.839 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 18.2 tt0 -124.52 143.77 50.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.844 -2.65 . . . . 12.0 103.844 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.7 m120 55.46 27.17 9.79 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-N 119.845 1.202 . . . . 12.0 107.946 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 18.4 pt20 54.59 8.85 0.23 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.098 1.359 . . . . 12.0 114.382 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.869 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -114.88 146.74 36.74 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 104.731 -2.322 . . . . 12.0 104.731 174.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.486 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.5 Cg_endo -59.88 88.92 0.07 OUTLIER 'Trans proline' 0 C--O 1.208 -1.005 0 C-N-CA 121.331 1.354 . . . . 12.0 109.282 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.869 HG22 ' CE2' ' A' ' 100' ' ' TYR . 54.3 t -84.45 -19.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 116.295 -0.411 . . . . 12.0 110.468 -177.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.489 ' N ' ' CD2' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -136.83 134.42 36.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 -177.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.596 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.2 OUTLIER -123.78 129.81 51.64 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.963 -0.695 . . . . 12.0 109.395 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.599 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -85.91 -41.98 14.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.229 -0.295 . . . . 12.0 110.728 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.95 -99.88 0.59 Allowed Glycine 0 N--CA 1.504 3.186 0 C-N-CA 120.295 -0.955 . . . . 12.0 111.139 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.9 pt -58.29 147.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.844 -0.797 . . . . 12.0 110.294 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.836 -1.306 . . . . 12.0 109.836 179.866 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.49 65.23 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 122.031 -0.418 . . . . 12.0 110.009 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.55 42.86 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.804 -0.56 . . . . 12.0 110.451 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -65.39 -29.56 70.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.471 -0.937 . . . . 12.0 108.471 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 35.5 t80 -76.97 -20.0 56.63 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.866 -0.79 . . . . 12.0 108.866 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.471 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 12.3 tt0 -64.2 -38.88 92.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 106.475 -1.676 . . . . 12.0 106.475 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.441 ' O ' HD11 ' A' ' 12' ' ' ILE . 4.5 mp0 -77.65 -32.83 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 176.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -43.25 -64.4 0.65 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 110.298 -0.26 . . . . 12.0 110.298 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.524 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 88.8 m-70 -110.08 -23.2 11.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.2 0.815 . . . . 12.0 113.2 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 43' ' ' SER . 22.9 mm -93.81 57.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 119.254 0.934 . . . . 12.0 113.234 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 12' ' ' ILE . 4.1 mp -90.13 76.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 105.42 -2.067 . . . . 12.0 105.42 175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.15 79.44 2.97 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.794 0.807 . . . . 12.0 110.125 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -135.0 70.36 70.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.261 -1.385 . . . . 12.0 107.261 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -71.94 86.3 0.92 Allowed 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 121.825 1.683 . . . . 12.0 111.045 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 22' ' ' ILE . 24.9 pt -136.07 -167.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.201 -1.037 . . . . 12.0 108.201 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.08 38.39 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.666 0.746 . . . . 12.0 109.352 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -153.1 101.36 2.56 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 116.292 -0.413 . . . . 12.0 109.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.3 m -81.26 -5.86 58.24 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 122.054 -0.404 . . . . 12.0 111.014 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -83.13 -55.24 4.47 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.496 -0.753 . . . . 12.0 111.501 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -61.54 -23.09 65.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.679 -0.638 . . . . 12.0 110.719 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 16' ' ' ILE . 11.9 pt -84.53 -35.08 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.64 -0.663 . . . . 12.0 109.621 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.587 ' HE3' ' HA ' ' A' ' 23' ' ' MET . 0.7 OUTLIER -95.79 12.78 28.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.004 -0.435 . . . . 12.0 110.625 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.58 90.41 0.26 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.334 -1.358 . . . . 12.0 107.334 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.409 HD21 HD12 ' A' ' 27' ' ' ILE . 58.9 t30 -172.79 152.85 2.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.317 -0.623 . . . . 12.0 109.317 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -68.0 -11.98 59.92 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 110.044 -0.354 . . . . 12.0 110.044 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 27' ' ' ILE . 61.8 mt -86.59 9.66 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.727 -0.608 . . . . 12.0 110.811 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -144.12 63.16 1.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.599 -0.688 . . . . 12.0 109.181 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -148.08 151.99 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.593 -1.317 . . . . 12.0 111.02 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 31' ' ' GLY . 49.1 t -102.75 170.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 107.376 -1.342 . . . . 12.0 107.376 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.71 52.7 3.34 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.372 -1.491 . . . . 12.0 109.372 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.43 -56.69 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.304 -1.518 . . . . 12.0 109.304 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.87 -69.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.023 -0.732 . . . . 12.0 109.023 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.41 ' O ' HG21 ' A' ' 30' ' ' VAL . 61.2 m -140.92 -169.72 2.88 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HA ' HG21 ' A' ' 30' ' ' VAL . 1.6 tttp -115.0 167.16 11.05 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.163 -0.68 . . . . 12.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -76.76 -17.39 59.09 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.859 -0.336 . . . . 12.0 110.465 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.4 p -161.53 118.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.36 0.6 . . . . 12.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -114.22 86.28 2.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.333 -1.729 . . . . 12.0 106.333 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -87.24 123.89 32.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.485 0.659 . . . . 12.0 111.373 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -108.5 163.36 13.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.977 -1.49 . . . . 12.0 106.977 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.1 mt -131.32 132.01 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.218 -0.926 . . . . 12.0 109.458 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.4 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 12.1 mm -100.29 108.83 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 108.979 -0.749 . . . . 12.0 108.979 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.518 ' O ' HD12 ' A' ' 11' ' ' ILE . 37.7 t 177.6 150.21 0.19 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.167 -0.679 . . . . 12.0 109.167 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 p -59.95 130.11 45.13 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.804 -0.813 . . . . 12.0 108.804 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -24.54 4.86 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.486 . . . . 12.0 111.224 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -84.78 -32.27 23.48 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.41 -0.516 . . . . 12.0 111.613 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -62.99 -38.92 93.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.117 -1.438 . . . . 12.0 107.117 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 51' ' ' ILE . 25.9 t -70.71 -35.7 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.564 -1.273 . . . . 12.0 107.564 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.15 -23.95 66.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.145 -0.687 . . . . 12.0 109.145 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.14 -36.95 29.61 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.976 -0.452 . . . . 12.0 110.158 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.5 tp -66.45 -23.74 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.801 -0.562 . . . . 12.0 110.386 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.89 27.61 6.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.828 -0.545 . . . . 12.0 109.947 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 m -90.99 114.92 27.56 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.452 -0.573 . . . . 12.0 109.452 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.64 0.02 OUTLIER Glycine 0 N--CA 1.5 2.93 0 N-CA-C 110.152 -1.179 . . . . 12.0 110.152 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.9 p -159.94 -168.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.69 -0.856 . . . . 12.0 108.69 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.593 ' H ' HG22 ' A' ' 55' ' ' VAL . 7.9 pt -88.14 25.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.118 -0.989 . . . . 12.0 111.39 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 174.0 115.03 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 107.521 -1.288 . . . . 12.0 107.521 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 176.82 10.99 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.69 0.757 . . . . 12.0 111.491 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -138.85 117.4 12.12 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.29 -1.374 . . . . 12.0 107.29 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.4 p -150.15 165.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.3 mp -125.73 125.64 43.33 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 120.758 -0.377 . . . . 12.0 110.808 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.503 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.31 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 177.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -86.44 -23.17 26.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.956 -0.465 . . . . 12.0 110.943 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -59.57 -88.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.497 -0.557 . . . . 12.0 109.497 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.821 ' HG3' HG23 ' A' ' 89' ' ' THR . 28.9 ttt-85 172.71 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 108.596 -0.89 . . . . 12.0 108.596 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 73.0 m-85 -105.17 57.52 0.68 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 109.253 -0.647 . . . . 12.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' PHE . 5.5 pt20 -4.5 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 114.557 1.317 . . . . 12.0 114.557 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -105.22 158.22 16.75 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.224 1.011 . . . . 12.0 112.94 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 6.7 t-20 -117.8 98.16 6.21 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 105.131 -2.174 . . . . 12.0 105.131 176.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.6 m -100.88 127.65 47.26 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.879 -0.729 . . . . 12.0 112.937 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.8 m -111.29 105.42 14.07 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 103.738 -2.689 . . . . 12.0 103.738 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 m -105.88 145.32 31.4 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 120.258 -0.577 . . . . 12.0 112.008 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 8.0 ttp180 -69.07 138.84 54.68 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.853 -0.795 . . . . 12.0 108.853 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.502 2.146 0 O-C-N 121.919 -0.488 . . . . 12.0 110.435 -179.43 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.521 0 CA-C-O 119.014 -0.517 . . . . 12.0 110.45 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 41.2 Cg_endo -77.07 110.57 3.05 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.778 1.652 . . . . 12.0 109.995 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 23.1 m-85 -143.83 133.56 23.76 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.438 0.637 . . . . 12.0 110.736 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -119.37 129.21 54.7 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -96.05 142.49 28.19 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.254 0.549 . . . . 12.0 110.912 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -151.49 125.86 9.41 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.379 -0.971 . . . . 12.0 108.379 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.9 m -105.53 147.05 28.79 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.707 -0.397 . . . . 12.0 109.983 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -174.87 -171.0 0.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.696 -0.483 . . . . 12.0 109.696 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.821 HG23 ' HG3' ' A' ' 65' ' ' ARG . 95.6 m -63.83 134.38 55.11 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.432 ' ND2' HD23 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -107.12 91.96 3.88 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.552 0.691 . . . . 12.0 112.18 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.69 107.16 19.0 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.409 HG21 ' CE2' ' A' ' 104' ' ' PHE . 1.1 mt -110.85 160.94 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 122.2 1.0 . . . . 12.0 113.489 -174.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.401 ' N ' HG22 ' A' ' 92' ' ' ILE . 35.7 t -112.2 103.85 12.03 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 105.258 -2.127 . . . . 12.0 105.258 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.691 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 7.2 m -122.71 -171.71 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.435 0.636 . . . . 12.0 112.018 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.467 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 2.2 mtpp -145.24 152.01 39.28 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.03 -0.73 . . . . 12.0 109.03 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.58 119.69 33.64 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.655 0.74 . . . . 12.0 112.853 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.467 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 11.7 tt0 -127.36 145.55 50.77 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 104.362 -2.459 . . . . 12.0 104.362 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 52.98 28.6 6.82 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 119.876 1.216 . . . . 12.0 107.998 -176.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 12.0 pt20 55.56 4.08 0.09 Allowed 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 125.418 1.487 . . . . 12.0 114.701 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.878 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -110.14 147.29 35.96 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 105.147 -2.168 . . . . 12.0 105.147 175.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.1 Cg_endo -60.8 89.56 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.37 1.38 . . . . 12.0 108.79 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 100' ' ' TYR . 46.6 t -85.07 -14.11 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.619 -0.718 . . . . 12.0 110.654 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.489 ' N ' ' CD2' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -144.87 117.75 8.76 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.512 -0.875 . . . . 12.0 110.387 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.691 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 1.3 m-85 -101.12 121.0 41.05 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.503 -1.665 . . . . 12.0 106.503 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.62 -28.84 17.25 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 112.966 0.728 . . . . 12.0 112.966 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.88 -169.28 37.29 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.803 -1.189 . . . . 12.0 111.111 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 107' ' ' ILE . 51.0 mt -93.38 36.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.051 0.453 . . . . 12.0 110.616 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.037 0 N-CA-C 110.519 -1.032 . . . . 12.0 110.519 178.862 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 N--CA 1.498 1.947 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TRP . . . . . 0.59 ' CZ3' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -69.03 -24.19 64.16 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 121.636 -0.665 . . . . 12.0 110.492 -177.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.76 -64.08 1.07 Allowed 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.607 -0.683 . . . . 12.0 110.655 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.21 80.76 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.419 -1.326 . . . . 12.0 107.419 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 32.0 t80 -70.25 -25.66 63.48 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.384 -0.969 . . . . 12.0 108.384 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -52.0 -31.77 30.88 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 107.186 -1.413 . . . . 12.0 107.186 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -42.82 30.49 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.797 -1.186 . . . . 12.0 107.797 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.469 ' O ' HD13 ' A' ' 41' ' ' ILE . 9.7 mmtp -44.42 -53.84 6.49 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 122.363 -0.211 . . . . 12.0 111.365 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.885 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -95.47 -17.71 21.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.942 -0.474 . . . . 12.0 111.42 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 43' ' ' SER . 15.9 mm -129.48 79.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 118.899 -1.121 . . . . 12.0 113.929 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.496 HG21 HG22 ' A' ' 22' ' ' ILE . 48.5 mm -98.09 75.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 104.198 -2.519 . . . . 12.0 104.198 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -82.81 61.92 6.12 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.658 0.742 . . . . 12.0 111.425 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.504 ' OG1' HG23 ' A' ' 22' ' ' ILE . 60.9 p -146.55 65.19 10.05 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 106.954 -1.499 . . . . 12.0 106.954 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 14' ' ' THR . 37.1 Cg_endo -82.2 45.51 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.372 2.048 . . . . 12.0 112.011 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.62 -165.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.83 -0.804 . . . . 12.0 108.83 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.2 pt -97.81 43.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-O 121.424 0.631 . . . . 12.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -158.02 99.41 1.67 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.063 -0.717 . . . . 12.0 109.063 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.571 ' HA ' HD12 ' A' ' 22' ' ' ILE . 9.0 m -76.53 -12.72 60.07 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.954 -0.466 . . . . 12.0 110.996 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -63.57 -49.42 73.47 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 119.048 0.84 . . . . 12.0 109.025 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.7 m -74.85 -19.63 60.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.641 -0.503 . . . . 12.0 109.641 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 19' ' ' CYS . 44.1 mt -84.94 -8.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.765 -0.585 . . . . 12.0 110.663 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.54 4.89 7.57 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.629 -0.669 . . . . 12.0 110.305 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -58.23 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.403 -0.962 . . . . 12.0 108.403 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.453 HD21 HD12 ' A' ' 27' ' ' ILE . 57.5 t30 -173.08 152.14 2.26 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.751 -0.833 . . . . 12.0 108.751 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -70.21 -9.72 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.713 -0.395 . . . . 12.0 110.275 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 27' ' ' ILE . 56.4 mt -89.71 12.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.689 -0.632 . . . . 12.0 110.685 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.652 ' O ' HD13 ' A' ' 29' ' ' ILE . 33.8 m-85 -142.28 55.35 1.45 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.657 -0.652 . . . . 12.0 110.802 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 28' ' ' TYR . 33.1 mm -148.29 152.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 120.673 -1.267 . . . . 12.0 110.038 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 35' ' ' LYS . 61.1 t -110.06 168.28 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 107.71 -1.218 . . . . 12.0 107.71 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.87 54.91 3.35 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.738 -1.745 . . . . 12.0 108.738 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.95 -54.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.531 -1.427 . . . . 12.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -163.57 -76.41 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 122.054 -0.674 . . . . 12.0 109.404 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -133.94 -175.94 4.01 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.533 -0.543 . . . . 12.0 109.533 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.584 ' HA ' HG21 ' A' ' 30' ' ' VAL . 1.9 tttt -107.1 171.66 7.25 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -79.6 -17.34 54.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.1 -0.375 . . . . 12.0 110.575 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 37' ' ' VAL . 9.6 p -162.1 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 119.789 -0.764 . . . . 12.0 111.457 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.464 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 11.6 m-20 -97.18 85.81 3.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.753 -1.943 . . . . 12.0 105.753 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.62 123.18 29.52 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.661 0.743 . . . . 12.0 112.555 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.447 ' CD1' HG21 ' A' ' 12' ' ' ILE . 23.6 m-85 -100.32 161.68 13.44 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.929 -1.508 . . . . 12.0 106.929 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 9' ' ' LYS . 4.4 mp -130.68 122.98 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.956 -1.09 . . . . 12.0 110.091 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.468 HD11 ' HB2' ' A' ' 69' ' ' ASN . 4.8 mt -98.54 107.11 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.27 -1.011 . . . . 12.0 108.27 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.898 ' O ' HD12 ' A' ' 11' ' ' ILE . 29.7 t 175.93 165.76 0.39 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 109.27 -0.641 . . . . 12.0 109.27 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 p -82.7 125.47 31.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.166 -1.049 . . . . 12.0 108.166 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.707 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -50.05 -31.47 13.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.992 -0.442 . . . . 12.0 111.887 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -76.61 -32.88 58.34 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.426 -0.51 . . . . 12.0 111.935 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.2 m -64.59 -34.34 78.02 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.817 -1.179 . . . . 12.0 107.817 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.655 HG11 ' CE1' ' A' ' 10' ' ' HIS . 20.7 t -71.03 -35.38 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.407 -1.331 . . . . 12.0 107.407 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -65.23 -21.43 66.75 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 116.016 -0.538 . . . . 12.0 110.019 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.63 -39.16 24.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.821 -0.55 . . . . 12.0 109.922 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 48' ' ' VAL . 7.2 tp -69.16 -18.07 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.788 -0.57 . . . . 12.0 110.401 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -97.34 15.14 23.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.58 -0.7 . . . . 12.0 111.003 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.3 m -66.16 107.27 1.88 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.189 -0.671 . . . . 12.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.79 -63.2 0.01 OUTLIER Glycine 0 N--CA 1.501 2.983 0 C-N-CA 120.484 -0.865 . . . . 12.0 111.013 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.62 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.1 p -167.54 -171.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.067 0.934 . . . . 12.0 109.434 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.62 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.0 tt -89.21 32.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 O-C-N 121.429 -0.794 . . . . 12.0 110.781 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 5.0 t30 169.75 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 107.257 -1.386 . . . . 12.0 107.257 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -163.17 179.72 7.25 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.121 0.962 . . . . 12.0 112.404 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -137.36 108.41 6.75 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.644 -1.614 . . . . 12.0 106.644 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 61' ' ' LEU . 2.7 t -132.9 171.13 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.853 -0.529 . . . . 12.0 109.886 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.0 mp -124.66 124.16 41.6 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.816 -0.439 . . . . 12.0 109.816 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.49 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 108.453 -0.943 . . . . 12.0 108.453 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.755 HG22 ' OH ' ' A' ' 91' ' ' TYR . 1.4 p -75.47 -43.43 49.43 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.638 -0.875 . . . . 12.0 108.638 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -65.65 124.1 21.47 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.17 -1.048 . . . . 12.0 108.17 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.737 ' CG ' HG23 ' A' ' 89' ' ' THR . 0.1 OUTLIER -54.49 105.95 0.18 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 122.088 -0.383 . . . . 12.0 109.982 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 51' ' ' ILE . 48.2 m-85 -94.94 41.04 1.09 Allowed 'General case' 0 N--CA 1.512 2.666 0 C-N-CA 120.074 -0.65 . . . . 12.0 109.548 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 24.99 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 114.284 1.216 . . . . 12.0 114.284 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.95 155.58 18.53 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.032 0.92 . . . . 12.0 112.494 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.468 ' HB2' HD11 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -121.18 99.45 6.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 104.787 -2.301 . . . . 12.0 104.787 176.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -105.43 128.93 53.79 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.033 1.123 . . . . 12.0 114.033 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.35 105.37 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 103.107 -2.923 . . . . 12.0 103.107 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -105.26 144.19 32.39 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.07 -0.652 . . . . 12.0 111.944 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 105.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.593 -0.891 . . . . 12.0 108.593 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.503 2.177 0 C-N-CA 120.595 -0.442 . . . . 12.0 110.311 -179.467 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 93.8 m . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.963 -0.542 . . . . 12.0 109.759 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -75.14 134.8 18.01 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 121.831 1.687 . . . . 12.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.464 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 16.5 m-85 -142.93 139.26 30.65 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.283 0.564 . . . . 12.0 110.536 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 t -124.71 126.23 45.35 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 108.323 -0.991 . . . . 12.0 108.323 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 139.97 30.76 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.06 0.457 . . . . 12.0 110.612 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -152.53 124.09 7.79 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.802 -0.814 . . . . 12.0 108.802 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -94.11 152.92 18.41 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -176.09 -167.74 0.24 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.155 0.502 . . . . 12.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.737 HG23 ' CG ' ' A' ' 65' ' ' ARG . 39.6 m -65.31 143.85 57.51 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.584 ' OD1' HD11 ' A' ' 92' ' ' ILE . 7.7 t-20 -108.51 87.73 2.56 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.945 0.879 . . . . 12.0 110.856 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.755 ' OH ' HG22 ' A' ' 63' ' ' THR . 3.7 t80 -100.01 112.93 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.938 -2.245 . . . . 12.0 104.938 176.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.584 HD11 ' OD1' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -126.64 175.67 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-O 122.274 1.035 . . . . 12.0 112.406 -175.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.3 t -125.54 99.3 5.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.154 -1.795 . . . . 12.0 106.154 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' A' ' 101' ' ' PRO . 9.8 p -111.95 164.19 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.236 0.541 . . . . 12.0 111.193 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 94' ' ' VAL . 8.2 mmmt -118.04 140.84 49.17 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.88 120.32 33.12 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.505 1.298 . . . . 12.0 114.505 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 24.9 tt0 -114.99 139.99 49.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.869 -2.641 . . . . 12.0 103.869 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 77.7 m-20 56.46 31.04 18.13 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 5.7 pt20 52.75 10.34 0.15 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 114.569 1.322 . . . . 12.0 114.569 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.986 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.21 140.73 23.91 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 104.051 -2.574 . . . . 12.0 104.051 174.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.679 ' HB3' HG21 ' A' ' 94' ' ' VAL . 26.8 Cg_endo -60.78 90.85 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.857 0 N-CA-C 108.713 -1.303 . . . . 12.0 108.713 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.986 HG22 ' CE2' ' A' ' 100' ' ' TYR . 81.5 t -88.84 -19.95 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 116.244 -0.435 . . . . 12.0 110.694 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -139.9 145.72 38.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.694 -1.225 . . . . 12.0 107.694 -178.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.55 ' HZ ' ' HE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -109.31 133.52 52.95 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.209 -0.996 . . . . 12.0 109.221 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.72 -19.45 15.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.033 -0.417 . . . . 12.0 111.676 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.29 173.88 44.07 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 110.468 -1.053 . . . . 12.0 110.468 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 92' ' ' ILE . 4.3 pt -97.82 26.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.186 -0.596 . . . . 12.0 110.279 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.933 0 N-CA-C 110.076 -1.209 . . . . 12.0 110.076 179.334 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . 0.469 ' HG2' HG12 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.509 2.491 0 N-CA-C 109.928 -0.397 . . . . 12.0 109.928 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -153.4 163.94 39.04 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.061 -0.718 . . . . 12.0 109.061 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.4 -37.43 74.48 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 122.022 -0.424 . . . . 12.0 110.586 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.53 -56.98 6.49 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.351 -0.843 . . . . 12.0 110.676 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -62.52 -32.3 73.21 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.211 -1.033 . . . . 12.0 108.211 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.521 ' CZ ' ' CE1' ' A' ' 10' ' ' HIS . 61.4 t80 -72.59 -25.83 61.47 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.157 -1.053 . . . . 12.0 108.157 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -54.92 -33.69 62.39 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.455 ' O ' HG13 ' A' ' 12' ' ' ILE . 1.5 mt-30 -80.39 -37.95 31.28 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.21 -1.404 . . . . 12.0 107.21 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.9 OUTLIER -44.52 -57.33 3.66 Favored 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.983 -0.448 . . . . 12.0 111.079 -179.707 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.564 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 4.4 m80 -99.58 -31.04 11.8 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.595 -0.691 . . . . 12.0 111.697 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.878 HG13 ' HB2' ' A' ' 45' ' ' ALA . 7.9 mm -102.93 65.64 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 115.668 1.729 . . . . 12.0 115.668 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.577 HD13 ' CD1' ' A' ' 40' ' ' PHE . 3.4 mp -95.29 62.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 103.588 -2.745 . . . . 12.0 103.588 173.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -74.21 81.06 1.8 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.709 0.766 . . . . 12.0 110.409 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 33.6 p -118.5 106.87 43.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 108.233 -1.025 . . . . 12.0 108.233 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -81.51 37.16 0.66 Allowed 'Trans proline' 0 CA--C 1.548 1.194 0 C-N-CA 121.921 1.747 . . . . 12.0 111.795 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 17' ' ' ILE . 4.6 mp -113.13 164.64 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.694 -0.854 . . . . 12.0 108.694 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.48 ' N ' HG22 ' A' ' 16' ' ' ILE . 33.5 pt -97.29 33.99 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-O 121.345 0.593 . . . . 12.0 109.855 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -126.24 91.36 3.36 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.29 -1.004 . . . . 12.0 108.29 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.9 m -76.28 -15.94 59.89 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.904 -0.498 . . . . 12.0 111.287 -178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -82.99 -50.41 8.58 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-N 119.019 0.827 . . . . 12.0 109.912 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.17 -34.27 70.13 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 110.028 -0.36 . . . . 12.0 110.028 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.597 HD12 ' N ' ' A' ' 23' ' ' MET . 2.7 pp -76.98 -39.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 120.625 -0.43 . . . . 12.0 109.955 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.597 ' N ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -93.52 12.82 23.8 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.878 -0.514 . . . . 12.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -60.35 91.76 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 108.295 -1.002 . . . . 12.0 108.295 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -172.31 155.54 3.57 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.415 -0.587 . . . . 12.0 109.415 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -71.94 -10.23 59.48 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 109.922 -0.399 . . . . 12.0 109.922 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 27' ' ' ILE . 68.0 mt -85.78 8.36 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.691 -0.63 . . . . 12.0 110.644 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -135.96 57.19 1.79 Allowed 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.536 -0.727 . . . . 12.0 110.025 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.3 mt -151.47 145.87 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 O-C-N 120.959 -1.088 . . . . 12.0 109.889 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.3 p -109.73 -168.61 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 108.13 -1.063 . . . . 12.0 108.13 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.558 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -97.46 71.38 0.71 Allowed Glycine 0 N--CA 1.503 3.156 0 O-C-N 121.201 -0.937 . . . . 12.0 111.411 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -165.72 -63.44 0.03 OUTLIER Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.227 -1.549 . . . . 12.0 109.227 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -165.22 -65.44 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.035 -1.098 . . . . 12.0 108.035 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 16.0 p -141.67 167.75 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.711 -0.848 . . . . 12.0 108.711 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mttm -77.46 149.67 35.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.928 -0.482 . . . . 12.0 109.716 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -77.08 -23.85 51.89 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 110.104 -0.332 . . . . 12.0 110.104 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.487 HG12 ' OG1' ' A' ' 39' ' ' THR . 18.3 t -150.28 103.35 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 120.29 -0.564 . . . . 12.0 110.293 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.453 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 2.7 m-20 -92.59 76.48 5.02 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.441 -1.688 . . . . 12.0 106.441 177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.487 ' OG1' HG12 ' A' ' 37' ' ' VAL . 25.8 m -79.23 116.49 19.52 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.928 -0.578 . . . . 12.0 110.686 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.652 ' O ' HD13 ' A' ' 41' ' ' ILE . 17.9 m-85 -107.01 163.59 12.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.087 -1.079 . . . . 12.0 108.087 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 40' ' ' PHE . 16.1 mm -126.71 124.57 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 107.907 -1.146 . . . . 12.0 107.907 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 69' ' ' ASN . 14.3 pt -96.51 98.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.857 ' O ' HD12 ' A' ' 11' ' ' ILE . 48.2 t -176.29 157.9 1.81 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.232 -0.655 . . . . 12.0 109.232 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.403 ' HB2' HG22 ' A' ' 46' ' ' THR . 8.1 p -63.88 128.17 34.64 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 109.244 -0.65 . . . . 12.0 109.244 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.878 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -54.45 -25.06 22.81 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.89 -0.506 . . . . 12.0 110.623 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 44' ' ' SER . 6.7 t -76.71 -33.91 58.18 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 120.523 -0.471 . . . . 12.0 111.231 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.1 p -65.19 -39.88 93.47 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.091 -1.448 . . . . 12.0 107.091 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.7 t -67.85 -31.86 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.824 -1.176 . . . . 12.0 107.824 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -67.38 -23.15 65.55 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.734 -0.469 . . . . 12.0 109.734 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.49 -40.23 30.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.908 -0.495 . . . . 12.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.557 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 19.9 pt -69.41 -20.67 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.784 -0.572 . . . . 12.0 110.681 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.43 25.09 9.42 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.831 -0.543 . . . . 12.0 109.829 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -96.33 114.31 25.98 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.767 -0.583 . . . . 12.0 109.577 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.49 -62.68 0.01 OUTLIER Glycine 0 N--CA 1.5 2.917 0 N-CA-C 110.099 -1.2 . . . . 12.0 110.099 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.616 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.5 p -152.76 -169.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.517 -0.92 . . . . 12.0 108.517 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.616 ' H ' HG22 ' A' ' 55' ' ' VAL . 18.3 tt -88.62 26.75 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 O-C-N 120.915 -1.116 . . . . 12.0 110.796 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 4.4 t30 171.47 110.5 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 N-CA-C 107.195 -1.409 . . . . 12.0 107.195 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.92 -172.54 3.31 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.384 0.612 . . . . 12.0 110.684 -178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.98 114.55 8.02 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.094 -1.076 . . . . 12.0 108.094 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 51' ' ' ILE . 12.2 t -125.27 169.63 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.501 -0.925 . . . . 12.0 108.501 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -144.78 120.63 10.59 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.765 -0.774 . . . . 12.0 112.1 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.16 97.27 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 107.557 -1.275 . . . . 12.0 107.557 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.88 -40.29 24.97 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.693 -0.484 . . . . 12.0 109.693 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -56.65 -92.02 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.663 -0.495 . . . . 12.0 109.663 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.765 ' CB ' HG23 ' A' ' 89' ' ' THR . 5.4 ptt-85 177.87 103.1 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.601 -0.687 . . . . 12.0 110.21 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.557 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 29.6 m-85 -98.25 44.51 1.03 Allowed 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.183 -0.607 . . . . 12.0 109.48 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 18.17 107.39 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 114.287 1.217 . . . . 12.0 114.287 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -102.4 153.99 19.51 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 122.03 0.919 . . . . 12.0 112.274 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.459 ' HB2' HG23 ' A' ' 42' ' ' ILE . 13.6 t30 -117.8 94.79 4.65 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 105.718 -1.956 . . . . 12.0 105.718 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 m -100.91 126.81 47.56 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.725 0.774 . . . . 12.0 112.786 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.6 m -106.76 104.76 14.52 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 104.589 -2.374 . . . . 12.0 104.589 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.4 HG23 HG22 ' A' ' 37' ' ' VAL . 8.4 m -101.21 131.36 47.24 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.211 -0.596 . . . . 12.0 111.727 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -63.05 105.82 0.75 Allowed 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.107 -1.072 . . . . 12.0 108.107 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.2 p -105.87 -92.88 0.38 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 122.03 -0.419 . . . . 12.0 110.81 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -177.27 177.86 1.16 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.457 -0.777 . . . . 12.0 109.845 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.3 mt 63.79 139.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.419 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 7.7 m 59.39 58.83 5.09 Favored Pre-proline 0 N--CA 1.497 1.878 0 N-CA-C 109.597 -0.52 . . . . 12.0 109.597 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 77' ' ' THR . 35.3 Cg_endo -76.32 125.59 8.54 Favored 'Trans proline' 0 N--CA 1.481 0.776 0 C-N-CA 121.967 1.778 . . . . 12.0 109.925 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.476 ' N ' ' CA ' ' A' ' 80' ' ' PRO . 9.7 ttp85 -132.73 43.09 0.98 Allowed Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 112.627 0.603 . . . . 12.0 112.627 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' CA ' ' N ' ' A' ' 79' ' ' ARG . 40.2 Cg_endo -88.42 -11.47 38.15 Favored 'Cis proline' 0 CA--C 1.541 0.839 0 N-CA-C 110.366 -0.667 . . . . 12.0 110.366 -3.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 85.0 m -106.12 115.53 61.0 Favored Pre-proline 0 N--CA 1.495 1.814 0 CA-C-O 118.519 -0.753 . . . . 12.0 109.344 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.57 145.7 26.51 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 121.473 1.449 . . . . 12.0 110.279 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.0 m-85 -131.7 134.79 46.29 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.313 0.577 . . . . 12.0 110.512 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.6 p -105.84 109.78 21.85 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 108.097 -1.075 . . . . 12.0 108.097 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.2 m -83.57 133.93 34.84 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.178 0.513 . . . . 12.0 110.261 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.5 ttt-85 -148.72 125.83 11.4 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 20.7 m -105.68 146.39 29.81 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 109.384 -0.599 . . . . 12.0 109.384 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HG3' HD11 ' A' ' 68' ' ' LEU . 14.9 pt-20 -172.24 -172.12 0.91 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 120.746 -0.382 . . . . 12.0 110.134 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.765 HG23 ' CB ' ' A' ' 65' ' ' ARG . 43.5 m -57.0 139.41 52.23 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.554 -0.536 . . . . 12.0 109.554 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.513 ' ND2' HD23 ' A' ' 68' ' ' LEU . 4.4 t-20 -112.84 88.01 2.73 Favored 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 119.482 -0.887 . . . . 12.0 112.064 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -95.78 96.23 8.83 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 104.399 -2.445 . . . . 12.0 104.399 175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.719 HD13 ' CZ ' ' A' ' 104' ' ' PHE . 21.0 tt -130.28 163.68 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 C-N-CA 119.854 -0.738 . . . . 12.0 111.708 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.68 114.14 28.12 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 116.008 -0.542 . . . . 12.0 110.191 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 101' ' ' PRO . 11.1 p -104.57 161.58 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.281 -0.637 . . . . 12.0 109.281 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.491 ' N ' HG22 ' A' ' 94' ' ' VAL . 12.7 ttmt -118.31 144.5 45.79 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.885 -0.783 . . . . 12.0 108.885 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.1 m -119.01 124.77 47.78 Favored 'General case' 0 N--CA 1.507 2.425 0 N-CA-C 113.611 0.967 . . . . 12.0 113.611 -177.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 27.9 tt0 -129.9 144.02 51.1 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 104.44 -2.43 . . . . 12.0 104.44 174.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.93 15.91 2.53 Favored 'General case' 0 N--CA 1.51 2.571 0 O-C-N 121.129 -0.982 . . . . 12.0 108.72 -175.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 78.29 -15.36 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 123.581 0.752 . . . . 12.0 112.606 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.915 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -98.28 148.66 34.82 Favored Pre-proline 0 N--CA 1.503 2.19 0 N-CA-C 106.497 -1.668 . . . . 12.0 106.497 177.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.596 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.5 Cg_endo -63.23 91.25 0.14 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 N-CA-C 107.955 -1.594 . . . . 12.0 107.955 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.915 HG22 ' CE2' ' A' ' 100' ' ' TYR . 69.4 t -87.61 -11.07 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-N 116.185 -0.461 . . . . 12.0 111.115 -177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.557 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -151.94 148.28 27.57 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -176.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.719 ' CZ ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -99.69 122.41 42.66 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.485 -1.286 . . . . 12.0 108.923 178.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.66 -29.17 67.58 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.995 -0.44 . . . . 12.0 109.954 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 129.55 -149.08 18.59 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.863 -1.295 . . . . 12.0 109.863 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 23.9 pt -56.43 178.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.203 0.525 . . . . 12.0 110.757 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.21 -56.57 19.54 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 111.138 -0.785 . . . . 12.0 111.138 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.4 mtp85 -49.41 110.86 0.41 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.929 -0.748 . . . . 12.0 110.599 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 169.51 12.16 Favored Pre-proline 0 N--CA 1.498 1.975 0 N-CA-C 109.174 -0.676 . . . . 12.0 109.174 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.482 0.807 0 C-N-CA 121.755 1.636 . . . . 12.0 110.766 179.684 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . 0.439 ' O ' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.506 2.346 0 N-CA-C 109.469 -0.567 . . . . 12.0 109.469 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -91.9 155.03 18.46 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.568 -0.901 . . . . 12.0 108.568 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -25.03 64.1 Favored 'General case' 0 N--CA 1.515 2.808 0 O-C-N 121.905 -0.497 . . . . 12.0 110.313 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.38 -63.24 1.33 Allowed 'General case' 0 N--CA 1.51 2.557 0 O-C-N 121.647 -0.658 . . . . 12.0 110.676 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 m -61.57 -31.58 71.63 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.935 -1.135 . . . . 12.0 107.935 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.466 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 31.3 t80 -76.08 -25.36 55.42 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.469 -0.937 . . . . 12.0 108.469 177.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -54.42 -32.69 57.87 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 107.339 -1.356 . . . . 12.0 107.339 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.44 -37.91 35.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.791 -1.189 . . . . 12.0 107.791 177.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 15.8 tppt? -47.15 -49.13 22.97 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 122.155 -0.341 . . . . 12.0 110.385 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.92 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.7 OUTLIER -101.28 -13.13 18.18 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 118.681 -0.676 . . . . 12.0 112.596 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 11' ' ' ILE . 3.7 mp -137.81 72.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 N-CA-C 115.354 1.613 . . . . 12.0 115.354 -175.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.951 HD12 ' CD1' ' A' ' 40' ' ' PHE . 11.3 mt -97.65 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 103.737 -2.69 . . . . 12.0 103.737 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -68.25 80.79 0.24 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.843 0.83 . . . . 12.0 110.512 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.409 ' N ' ' HD3' ' A' ' 15' ' ' PRO . 4.5 p -150.6 59.79 3.73 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.411 -1.329 . . . . 12.0 107.411 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 14' ' ' THR . 34.8 Cg_endo -73.12 84.77 1.29 Allowed 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 121.94 1.76 . . . . 12.0 110.711 -178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.5 pt -124.94 -169.17 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' N ' HD13 ' A' ' 17' ' ' ILE . 1.3 mm -97.88 34.58 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.656 -0.652 . . . . 12.0 109.436 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -150.04 98.4 2.7 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.902 -0.499 . . . . 12.0 109.997 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -81.36 -4.47 55.79 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 121.853 -0.529 . . . . 12.0 110.734 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -84.47 -58.11 2.87 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 121.523 -0.736 . . . . 12.0 111.242 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.6 m -59.45 -26.04 64.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.786 -0.571 . . . . 12.0 110.097 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.3 pt -85.61 -32.16 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.853 -0.529 . . . . 12.0 109.597 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ttp -100.98 20.28 15.79 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.947 -0.39 . . . . 12.0 109.947 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -74.15 86.53 1.89 Allowed 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -163.96 147.46 9.82 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.779 -0.576 . . . . 12.0 109.574 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -70.9 -8.17 50.98 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.943 -0.391 . . . . 12.0 109.943 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.432 HD13 ' O ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -85.95 7.84 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.601 -0.687 . . . . 12.0 110.026 179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.535 ' OH ' HD11 ' A' ' 12' ' ' ILE . 35.2 m-85 -136.04 60.62 1.67 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.581 -0.699 . . . . 12.0 109.371 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.4 mt -146.49 152.57 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 120.768 -1.208 . . . . 12.0 110.936 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.544 HG21 ' CA ' ' A' ' 35' ' ' LYS . 52.6 t -104.34 169.24 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 107.687 -1.227 . . . . 12.0 107.687 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.82 55.6 3.37 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.74 -57.14 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.41 -1.476 . . . . 12.0 109.41 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.31 -71.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.956 -0.732 . . . . 12.0 109.526 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 p -153.68 132.24 12.17 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.697 -0.853 . . . . 12.0 108.697 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' CA ' HG21 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -56.18 171.27 0.28 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 109.82 -0.437 . . . . 12.0 109.82 -179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.97 -6.33 59.04 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 119.438 -0.315 . . . . 12.0 111.326 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.574 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.7 p -164.72 114.04 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 C-N-CA 119.545 -0.862 . . . . 12.0 111.691 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.482 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 59.1 m-20 -95.37 82.55 3.71 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 105.832 -1.914 . . . . 12.0 105.832 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.7 m -83.48 116.21 22.43 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.58 0.705 . . . . 12.0 111.862 -176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.951 ' CD1' HD12 ' A' ' 12' ' ' ILE . 18.5 m-85 -104.49 162.46 13.22 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 107.359 -1.348 . . . . 12.0 107.359 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 10' ' ' HIS . 4.9 mp -126.89 125.99 67.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.518 1.054 . . . . 12.0 110.219 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.446 HD11 HD22 ' A' ' 69' ' ' ASN . 6.3 mt -90.85 108.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 N-CA-C 108.03 -1.1 . . . . 12.0 108.03 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.6 t 177.71 151.12 0.22 Allowed 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 120.684 -0.406 . . . . 12.0 109.971 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.4 p -67.02 129.6 40.43 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.112 -1.07 . . . . 12.0 108.112 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.78 -26.49 5.73 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.042 -0.411 . . . . 12.0 111.295 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.91 -33.24 30.53 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.916 -0.49 . . . . 12.0 111.829 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.9 p -62.59 -37.73 87.37 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 107.083 -1.451 . . . . 12.0 107.083 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.92 HG11 ' CD2' ' A' ' 10' ' ' HIS . 46.8 t -67.39 -34.4 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -59.38 -23.61 62.73 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.67 -38.66 25.54 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.968 -0.458 . . . . 12.0 109.77 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 48' ' ' VAL . 6.4 tp -65.93 -19.86 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.809 -0.557 . . . . 12.0 110.761 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.92 23.04 15.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.754 -0.591 . . . . 12.0 110.448 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 22.4 m -86.2 112.43 21.34 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.55 -65.66 0.01 OUTLIER Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.249 -1.14 . . . . 12.0 110.249 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.659 HG12 ' HG3' ' A' ' 58' ' ' MET . 2.4 p -160.54 -164.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.407 -0.96 . . . . 12.0 108.407 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.593 ' H ' HG22 ' A' ' 55' ' ' VAL . 18.1 tt -90.3 28.01 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.124 -0.985 . . . . 12.0 110.968 -178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 15.6 t-20 172.1 116.16 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.659 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -163.89 177.77 8.31 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.795 0.807 . . . . 12.0 111.742 -179.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -133.37 112.46 11.62 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 107.064 -1.458 . . . . 12.0 107.064 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 61' ' ' LEU . 14.5 p -131.82 168.61 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.902 -0.499 . . . . 12.0 109.731 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' N ' HG22 ' A' ' 60' ' ' VAL . 1.4 mp -133.47 128.52 35.61 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 120.479 -0.488 . . . . 12.0 110.955 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.456 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.7 OUTLIER -62.18 95.81 0.07 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.762 -1.57 . . . . 12.0 106.762 177.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -84.71 -46.66 11.23 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.989 -0.444 . . . . 12.0 110.896 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.513 HG22 ' HG2' ' A' ' 65' ' ' ARG . 99.4 m -52.16 -94.65 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.972 -0.455 . . . . 12.0 109.786 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.687 ' CB ' HG23 ' A' ' 89' ' ' THR . 0.1 OUTLIER 173.66 101.9 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.098 -0.704 . . . . 12.0 109.098 179.492 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.456 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 76.3 m-85 -96.87 44.42 1.06 Allowed 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 120.483 -0.487 . . . . 12.0 109.818 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 19.48 106.24 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.106 1.15 . . . . 12.0 114.106 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.28 153.65 18.79 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.093 0.949 . . . . 12.0 112.562 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.446 HD22 HD11 ' A' ' 42' ' ' ILE . 4.2 t-20 -115.1 101.27 8.83 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 104.657 -2.349 . . . . 12.0 104.657 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -106.79 121.8 45.1 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.456 0.909 . . . . 12.0 113.456 -175.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 74.1 m -98.01 104.64 16.69 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 102.677 -3.083 . . . . 12.0 102.677 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -100.53 140.13 35.23 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.469 0.652 . . . . 12.0 112.333 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.4 ttt180 -60.42 133.69 56.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.905 -0.776 . . . . 12.0 108.905 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 p -125.55 -95.72 0.45 Allowed 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.512 -0.551 . . . . 12.0 109.512 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.5 p -171.34 121.21 0.52 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.465 -0.772 . . . . 12.0 109.91 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.572 HG22 ' CD ' ' A' ' 82' ' ' PRO . 4.3 tt -155.19 144.56 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.987 -0.746 . . . . 12.0 108.987 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.416 ' N ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -80.36 -57.04 0.66 Allowed Pre-proline 0 N--CA 1.505 2.283 0 CA-C-O 119.129 -0.462 . . . . 12.0 110.545 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 77' ' ' THR . 34.1 Cg_endo -74.12 178.73 6.55 Favored 'Trans proline' 0 N--CA 1.483 0.865 0 C-N-CA 122.069 1.846 . . . . 12.0 111.133 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 162.97 19.27 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 109.828 -0.434 . . . . 12.0 109.828 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -74.73 -171.55 9.44 Favored 'Cis proline' 0 N--CA 1.488 1.16 0 O-C-N 123.315 1.166 . . . . 12.0 110.537 0.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.3 m -54.26 159.49 3.06 Favored Pre-proline 0 N--CA 1.501 2.119 0 N-CA-C 109.291 -0.633 . . . . 12.0 109.291 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.572 ' CD ' HG22 ' A' ' 76' ' ' ILE . 35.3 Cg_endo -76.11 128.01 10.33 Favored 'Trans proline' 0 N--CA 1.484 0.932 0 C-N-CA 121.562 1.508 . . . . 12.0 110.797 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.482 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 28.4 m-85 -148.02 137.26 22.16 Favored 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 120.964 0.411 . . . . 12.0 110.147 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.1 t -124.45 129.52 50.81 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.329 -0.989 . . . . 12.0 108.329 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -80.49 136.92 36.4 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.151 0.501 . . . . 12.0 110.956 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 121.37 7.81 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.99 -0.744 . . . . 12.0 108.99 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.9 p -98.55 147.16 25.07 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.468 -0.567 . . . . 12.0 109.468 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -168.3 -173.27 1.95 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.018 0.437 . . . . 12.0 110.054 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.687 HG23 ' CB ' ' A' ' 65' ' ' ARG . 30.7 m -66.43 142.49 57.56 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 109.461 -0.57 . . . . 12.0 109.461 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.462 HD22 HD23 ' A' ' 68' ' ' LEU . 8.6 t-20 -105.73 87.16 2.53 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.88 0.847 . . . . 12.0 111.252 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 6.2 p90 -109.34 106.46 16.27 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 105.985 -1.857 . . . . 12.0 105.985 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.463 ' HA ' ' CA ' ' A' ' 108' ' ' GLY . 19.9 pt -139.18 -171.04 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 119.85 -0.74 . . . . 12.0 111.976 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 39.0 t -119.99 114.63 22.31 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.083 -0.71 . . . . 12.0 109.083 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 95' ' ' LYS . 8.6 p -113.75 171.35 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.395 -0.595 . . . . 12.0 109.395 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 105' ' ' ALA . 14.3 mttt -130.88 146.03 52.18 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.922 -0.77 . . . . 12.0 108.922 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.4 m -118.18 125.13 49.57 Favored 'General case' 0 N--CA 1.507 2.4 0 N-CA-C 114.217 1.192 . . . . 12.0 114.217 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 30.0 tt0 -131.62 144.69 51.23 Favored 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 103.818 -2.66 . . . . 12.0 103.818 174.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 27.8 m-80 53.63 29.38 9.22 Favored 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 107.699 -1.222 . . . . 12.0 107.699 -176.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.425 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 52.69 9.58 0.12 Allowed 'General case' 0 N--CA 1.51 2.54 0 C-N-CA 125.289 1.436 . . . . 12.0 114.835 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.915 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -114.39 145.98 34.89 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 104.532 -2.395 . . . . 12.0 104.532 174.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.629 ' HG3' HG12 ' A' ' 48' ' ' VAL . 23.3 Cg_endo -60.79 90.08 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.275 1.316 . . . . 12.0 108.69 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.915 HG22 ' CE2' ' A' ' 100' ' ' TYR . 69.7 t -86.84 -23.24 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 116.271 -0.422 . . . . 12.0 110.851 -177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.5 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.62 145.89 50.42 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.94 -1.133 . . . . 12.0 107.94 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.467 ' CE1' ' HB ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -116.47 128.51 55.53 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.15 -1.02 . . . . 12.0 109.92 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.534 ' HB2' ' HE2' ' A' ' 95' ' ' LYS . . . -78.99 -37.9 38.1 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.23 -0.294 . . . . 12.0 110.777 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 139.08 -134.68 6.88 Favored Glycine 0 N--CA 1.504 3.177 0 C-N-CA 120.066 -1.064 . . . . 12.0 111.493 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 pt -69.15 -171.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-O 121.083 0.468 . . . . 12.0 111.129 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.463 ' CA ' ' HA ' ' A' ' 92' ' ' ILE . . . -92.54 60.98 2.46 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 110.391 -1.084 . . . . 12.0 110.391 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.88 73.63 0.48 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.282 -1.007 . . . . 12.0 108.282 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.465 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 0.7 OUTLIER -83.94 -46.24 0.76 Allowed Pre-proline 0 N--CA 1.502 2.141 0 CA-C-O 118.52 -0.752 . . . . 12.0 111.668 -178.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 110' ' ' CYS . 37.2 Cg_endo . . . . . 0 N--CA 1.481 0.792 0 C-N-CA 121.846 1.697 . . . . 12.0 110.427 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.376 0 N-CA-C 109.575 -0.528 . . . . 12.0 109.575 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 10.7 t-20 -115.99 156.09 26.9 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.817 -0.809 . . . . 12.0 108.817 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.425 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.51 -22.85 61.73 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 121.952 -0.468 . . . . 12.0 110.527 -177.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.86 -65.64 0.85 Allowed 'General case' 0 N--CA 1.515 2.815 0 O-C-N 121.637 -0.665 . . . . 12.0 110.853 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.0 m -60.9 -31.54 71.03 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.061 -1.088 . . . . 12.0 108.061 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.499 ' CE2' ' HG2' ' A' ' 9' ' ' LYS . 26.3 t80 -75.91 -26.14 56.7 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.461 -0.94 . . . . 12.0 108.461 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -51.79 -35.69 44.98 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 107.567 -1.271 . . . . 12.0 107.567 178.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -77.29 -40.95 42.7 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.499 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -45.87 -51.76 12.53 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.161 -0.337 . . . . 12.0 111.627 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.694 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.2 m170 -94.89 -14.71 24.26 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.552 -0.718 . . . . 12.0 111.363 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.694 HD13 ' O ' ' A' ' 10' ' ' HIS . 36.5 mm -130.86 73.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 N-CA-C 114.46 1.282 . . . . 12.0 114.46 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.69 HD13 ' HA ' ' A' ' 40' ' ' PHE . 3.0 mp -97.43 61.15 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 103.667 -2.716 . . . . 12.0 103.667 173.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.568 ' ND2' HG23 ' A' ' 11' ' ' ILE . 1.6 m-80 -70.98 81.49 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.739 0.78 . . . . 12.0 110.199 -176.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.535 ' OG1' HD12 ' A' ' 22' ' ' ILE . 9.3 p -131.79 76.11 74.86 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.672 -0.862 . . . . 12.0 108.672 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -76.85 82.0 2.43 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 121.994 1.796 . . . . 12.0 109.223 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 17' ' ' ILE . 31.6 mt -141.69 168.91 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.459 ' N ' HG22 ' A' ' 16' ' ' ILE . 10.7 pt -93.71 41.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 121.437 0.636 . . . . 12.0 109.758 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 22' ' ' ILE . 18.9 m120 -149.49 104.81 3.4 Favored 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.7 -0.852 . . . . 12.0 108.7 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.4 m -81.12 -16.89 51.76 Favored 'General case' 0 N--CA 1.511 2.6 0 C-N-CA 120.551 -0.46 . . . . 12.0 111.558 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -84.39 -55.24 4.26 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-N 118.892 0.769 . . . . 12.0 110.417 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.09 -30.68 64.54 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.264 -0.272 . . . . 12.0 110.443 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.535 HD12 ' OG1' ' A' ' 14' ' ' THR . 44.0 pt -80.76 -39.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.268 -0.573 . . . . 12.0 110.171 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.434 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -95.86 17.1 15.91 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.496 -0.482 . . . . 12.0 110.246 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -62.49 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.616 -0.883 . . . . 12.0 108.616 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -168.61 150.15 4.86 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.354 -0.61 . . . . 12.0 109.354 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -69.65 -9.42 54.16 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 120.878 -0.329 . . . . 12.0 110.342 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -87.06 8.08 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.732 -0.605 . . . . 12.0 110.307 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -137.27 58.2 1.72 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.6 -0.687 . . . . 12.0 109.73 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -151.31 152.19 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 O-C-N 120.741 -1.224 . . . . 12.0 110.579 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 31' ' ' GLY . 58.5 t -103.26 168.93 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.28 0 N-CA-C 107.475 -1.306 . . . . 12.0 107.475 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.35 54.77 3.54 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.219 -1.552 . . . . 12.0 109.219 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.88 -57.25 0.02 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.146 -1.582 . . . . 12.0 109.146 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.24 -75.45 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 O-C-N 122.022 -0.693 . . . . 12.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 99.0 m -144.05 150.1 37.67 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.427 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -74.04 176.97 6.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.014 -0.736 . . . . 12.0 109.014 179.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -17.07 52.37 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.969 -0.457 . . . . 12.0 110.038 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.542 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.5 p -162.04 117.55 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 C-N-CA 119.825 -0.75 . . . . 12.0 111.337 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.441 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 5.3 m-20 -97.46 83.77 3.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 105.701 -1.963 . . . . 12.0 105.701 176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 m -80.84 116.4 20.81 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 115.909 -0.587 . . . . 12.0 111.481 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.69 ' HA ' HD13 ' A' ' 12' ' ' ILE . 21.7 m-85 -100.5 158.96 15.53 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.531 -1.285 . . . . 12.0 107.531 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.465 HD12 ' ND2' ' A' ' 90' ' ' ASN . 50.5 mm -129.18 124.23 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.357 -0.84 . . . . 12.0 110.346 -179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.568 HD11 HD22 ' A' ' 69' ' ' ASN . 4.6 mt -106.42 111.44 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 108.324 -0.991 . . . . 12.0 108.324 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.0 t 178.33 151.23 0.26 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.112 -0.699 . . . . 12.0 109.112 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.49 119.41 5.19 Favored 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 109.134 -0.691 . . . . 12.0 109.134 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.632 ' HA ' HD11 ' A' ' 11' ' ' ILE . . . -42.98 -64.54 0.61 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 113.555 0.946 . . . . 12.0 113.555 -177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.5 t -62.13 -20.73 64.38 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.912 -0.493 . . . . 12.0 111.552 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.6 m -65.25 -36.07 82.98 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 107.169 -1.419 . . . . 12.0 107.169 178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.837 ' O ' HG22 ' A' ' 51' ' ' ILE . 19.3 t -71.24 -34.39 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.25 -21.51 65.23 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.663 -0.866 . . . . 12.0 108.663 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.45 -39.05 28.9 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.885 -0.51 . . . . 12.0 109.649 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.837 HG22 ' O ' ' A' ' 48' ' ' VAL . 4.7 tp -64.32 -22.19 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.719 -0.613 . . . . 12.0 109.773 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.423 ' HA ' HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -104.91 25.57 10.3 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.69 -0.632 . . . . 12.0 110.35 -179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.1 m -90.83 115.93 28.28 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.252 -0.647 . . . . 12.0 109.252 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.98 -62.95 0.02 OUTLIER Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.573 -1.011 . . . . 12.0 110.573 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.6 p -161.12 -164.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.581 -0.896 . . . . 12.0 108.581 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.599 ' H ' HG22 ' A' ' 55' ' ' VAL . 9.9 tt -88.64 27.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 121.053 -1.029 . . . . 12.0 110.665 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.6 t30 172.44 117.43 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 106.961 -1.496 . . . . 12.0 106.961 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.87 178.37 9.83 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-O 121.921 0.867 . . . . 12.0 111.841 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.66 112.25 7.83 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.923 -1.51 . . . . 12.0 106.923 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.1 p -141.25 167.92 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 109.325 -0.621 . . . . 12.0 109.325 -177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 110' ' ' CYS . 4.7 mp -136.67 130.32 31.99 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 120.581 -0.448 . . . . 12.0 111.023 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.0 OUTLIER -59.12 93.08 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 N-CA-C 106.544 -1.651 . . . . 12.0 106.544 176.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.79 HG22 ' OH ' ' A' ' 91' ' ' TYR . 3.1 p -80.61 -43.1 21.07 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 122.325 -0.234 . . . . 12.0 110.512 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.34 -90.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 109.349 -0.612 . . . . 12.0 109.349 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.788 ' CB ' HG23 ' A' ' 89' ' ' THR . 4.7 ptt-85 171.48 101.06 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.211 -0.663 . . . . 12.0 109.211 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 62.0 m-85 -97.25 48.38 1.04 Allowed 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 120.462 -0.495 . . . . 12.0 109.703 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 16.57 107.92 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.26 0 N-CA-C 114.525 1.305 . . . . 12.0 114.525 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.635 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -104.06 155.59 18.56 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.066 0.936 . . . . 12.0 112.474 179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.568 HD22 HD11 ' A' ' 42' ' ' ILE . 13.3 t-20 -116.87 97.42 5.95 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 105.25 -2.13 . . . . 12.0 105.25 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.0 m -104.18 128.29 51.87 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 113.5 0.926 . . . . 12.0 113.5 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 91.2 m -111.01 108.18 17.83 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 103.44 -2.8 . . . . 12.0 103.44 174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.9 m -109.55 145.86 35.63 Favored 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 120.17 -0.612 . . . . 12.0 112.311 -175.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.7 ttp85 -64.27 116.0 5.59 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.937 -0.764 . . . . 12.0 108.937 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 p -111.95 -84.71 0.57 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.934 -0.479 . . . . 12.0 110.742 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 t -142.15 152.57 43.33 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.764 -0.585 . . . . 12.0 110.123 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.563 ' O ' HD12 ' A' ' 76' ' ' ILE . 2.0 pp -64.62 121.12 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.01 0.433 . . . . 12.0 109.934 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 78' ' ' PRO . 1.3 m -173.13 -62.17 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 108.233 -1.025 . . . . 12.0 108.233 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 77' ' ' THR . 37.1 Cg_endo -75.33 -164.71 0.25 Allowed 'Trans proline' 0 N--CA 1.482 0.841 0 C-N-CA 121.893 1.729 . . . . 12.0 109.673 178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 mtt-85 -153.0 162.23 26.93 Favored Pre-proline 0 N--CA 1.498 1.973 0 O-C-N 121.922 -0.486 . . . . 12.0 109.855 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -73.21 -38.55 1.75 Allowed 'Cis proline' 0 N--CA 1.488 1.169 0 O-C-N 123.295 1.155 . . . . 12.0 110.358 1.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.1 OUTLIER -106.71 162.04 20.97 Favored Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 108.259 -1.015 . . . . 12.0 108.259 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 36.6 Cg_endo -76.12 101.71 1.52 Allowed 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 121.68 1.587 . . . . 12.0 109.65 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.441 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 18.9 m-85 -139.75 138.33 35.82 Favored 'General case' 0 N--CA 1.509 2.489 0 CA-C-O 121.354 0.597 . . . . 12.0 111.198 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -114.79 121.76 44.29 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.4 p -84.32 143.99 29.15 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-O 120.991 0.424 . . . . 12.0 110.395 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 ttm180 -154.66 159.49 40.82 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.276 -0.638 . . . . 12.0 109.276 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.6 m -130.45 142.14 50.5 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 109.062 -0.718 . . . . 12.0 109.062 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.94 -169.46 0.99 Allowed 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.309 0.575 . . . . 12.0 110.521 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.788 HG23 ' CB ' ' A' ' 65' ' ' ARG . 98.3 m -64.54 146.47 54.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.082 -0.71 . . . . 12.0 109.082 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' HD12 ' A' ' 41' ' ' ILE . 60.6 t30 -108.67 88.78 2.81 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.989 0.899 . . . . 12.0 111.383 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.79 ' OH ' HG22 ' A' ' 63' ' ' THR . 2.3 t80 -98.43 103.95 15.94 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.84 -2.281 . . . . 12.0 104.84 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.628 HD13 ' O ' ' A' ' 91' ' ' TYR . 33.0 mm -127.75 163.38 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 C-N-CA 119.685 -0.806 . . . . 12.0 111.99 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.522 ' HB2' HD23 ' A' ' 61' ' ' LEU . 51.6 t -115.91 106.44 13.8 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.33 -0.989 . . . . 12.0 108.33 178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 101' ' ' PRO . 5.5 p -113.85 172.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.953 -0.388 . . . . 12.0 109.953 -178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.534 ' H ' HG22 ' A' ' 94' ' ' VAL . 65.0 mttt -126.65 143.18 51.31 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -111.0 115.68 29.89 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.265 1.209 . . . . 12.0 114.265 -176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.519 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.7 tt0 -125.77 142.72 51.37 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 104.055 -2.572 . . . . 12.0 104.055 174.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 60.3 m-80 54.84 29.55 12.16 Favored 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.441 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 14.5 pt20 52.1 11.11 0.14 Allowed 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 114.651 1.352 . . . . 12.0 114.651 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.891 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -118.12 146.99 40.53 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 174.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.539 ' HB3' HG21 ' A' ' 94' ' ' VAL . 24.3 Cg_endo -60.54 89.89 0.08 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 121.262 1.308 . . . . 12.0 108.819 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.891 HG22 ' CE2' ' A' ' 100' ' ' TYR . 47.2 t -86.22 -19.63 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 CA-C-N 116.345 -0.388 . . . . 12.0 110.887 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -140.77 144.57 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.657 -0.868 . . . . 12.0 108.657 -177.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -109.07 132.11 54.43 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.068 -1.053 . . . . 12.0 108.366 178.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.12 -24.19 14.66 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.092 -0.38 . . . . 12.0 111.992 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.45 178.32 47.75 Favored Glycine 0 N--CA 1.503 3.143 0 N-CA-C 110.577 -1.009 . . . . 12.0 110.577 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.442 ' HA ' HG23 ' A' ' 92' ' ' ILE . 10.4 pt -92.65 25.1 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 122.45 -0.441 . . . . 12.0 110.692 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.75 -53.2 0.79 Allowed Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.591 -1.403 . . . . 12.0 109.591 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 126.07 28.98 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 122.202 -0.587 . . . . 12.0 109.588 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.563 ' HB2' HD21 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -142.08 168.04 14.82 Favored Pre-proline 0 N--CA 1.501 2.108 0 N-CA-C 109.563 -0.532 . . . . 12.0 109.563 -179.516 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.481 0.736 0 C-N-CA 121.667 1.578 . . . . 12.0 110.222 179.192 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.374 0 N-CA-C 109.911 -0.403 . . . . 12.0 109.911 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -143.13 158.67 43.4 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.403 ' CZ3' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -70.85 -31.85 68.68 Favored 'General case' 0 N--CA 1.514 2.749 0 O-C-N 122.157 -0.339 . . . . 12.0 110.874 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.87 2.01 Favored 'General case' 0 N--CA 1.511 2.597 0 O-C-N 121.542 -0.724 . . . . 12.0 110.474 -178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 34.2 m -62.29 -32.56 73.31 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.503 -0.925 . . . . 12.0 108.503 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.478 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 36.3 t80 -73.89 -23.86 59.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.69 -0.855 . . . . 12.0 108.69 178.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.426 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 17.4 tt0 -57.65 -37.85 74.06 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.129 -1.434 . . . . 12.0 107.129 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.453 ' O ' HG13 ' A' ' 12' ' ' ILE . 0.1 OUTLIER -75.59 -34.14 60.61 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 176.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 6' ' ' PHE . 17.9 tptt -46.42 -59.0 3.23 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 122.215 -0.303 . . . . 12.0 110.786 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.65 ' HA ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -104.11 1.09 30.43 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 118.482 -0.771 . . . . 12.0 112.758 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.1 mp -134.74 65.34 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 C-N-CA 117.866 -1.534 . . . . 12.0 114.958 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.914 HD12 ' CD1' ' A' ' 40' ' ' PHE . 23.3 mt -97.53 65.87 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 103.88 -2.637 . . . . 12.0 103.88 173.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -65.01 83.6 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 121.815 0.817 . . . . 12.0 110.186 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 p -129.26 90.54 44.56 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -73.99 -3.02 13.11 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 121.679 1.586 . . . . 12.0 112.081 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.805 HD11 ' CG2' ' A' ' 22' ' ' ILE . 18.4 pt -58.43 -170.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.246 -0.65 . . . . 12.0 109.246 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 tt -121.9 40.65 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.469 0.652 . . . . 12.0 109.81 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -142.76 101.02 3.78 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.9 -0.5 . . . . 12.0 110.18 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' CG1' ' A' ' 22' ' ' ILE . 10.7 m -81.16 -3.17 51.31 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.934 -0.479 . . . . 12.0 110.829 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -84.7 -58.02 2.89 Favored 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.521 -0.737 . . . . 12.0 111.685 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 35.0 m -65.47 -23.44 66.91 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.593 -0.692 . . . . 12.0 110.402 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.805 ' CG2' HD11 ' A' ' 16' ' ' ILE . 2.7 pp -84.04 -35.75 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 N-CA-C 109.419 -0.585 . . . . 12.0 109.419 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.509 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.2 ttm -83.28 -5.53 59.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 122.143 -0.348 . . . . 12.0 110.198 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -59.68 91.42 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.9 -0.778 . . . . 12.0 108.9 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.506 ' OD1' HD12 ' A' ' 27' ' ' ILE . 8.0 t-20 -168.07 152.98 6.58 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.428 -0.582 . . . . 12.0 109.428 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -73.15 -7.97 53.74 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 120.664 -0.414 . . . . 12.0 110.043 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 27' ' ' ILE . 55.5 mt -88.41 10.22 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.687 -0.633 . . . . 12.0 110.317 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.87 ' OH ' HD11 ' A' ' 12' ' ' ILE . 47.0 m-85 -138.46 57.93 1.68 Allowed 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.744 -0.597 . . . . 12.0 110.391 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.0 mt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 120.99 -1.069 . . . . 12.0 109.511 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.568 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.8 p -107.41 -165.77 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 N-CA-C 108.02 -1.104 . . . . 12.0 108.02 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.568 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -96.91 67.81 0.88 Allowed Glycine 0 N--CA 1.505 3.265 0 O-C-N 121.044 -1.035 . . . . 12.0 112.063 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.85 -63.53 0.03 OUTLIER Glycine 0 N--CA 1.498 2.831 0 N-CA-C 109.23 -1.548 . . . . 12.0 109.23 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -164.44 -64.25 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 107.667 -1.235 . . . . 12.0 107.667 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 27.9 p -174.51 126.15 0.31 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.944 -1.132 . . . . 12.0 107.944 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -56.19 -178.43 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.986 -0.446 . . . . 12.0 109.941 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 mtm-85 -106.18 21.45 17.35 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.903 -0.319 . . . . 12.0 110.488 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -163.53 133.09 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 O-C-N 121.595 -0.691 . . . . 12.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -136.0 99.07 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.944 -1.502 . . . . 12.0 106.944 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.6 m -87.4 110.85 20.56 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.291 0.567 . . . . 12.0 111.524 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.914 ' CD1' HD12 ' A' ' 12' ' ' ILE . 18.9 m-85 -98.25 162.21 13.3 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.671 HD12 ' C ' ' A' ' 40' ' ' PHE . 4.5 mp -132.8 128.1 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.183 -0.948 . . . . 12.0 109.756 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.405 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 4.4 mt -94.66 107.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 108.695 -0.854 . . . . 12.0 108.695 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.8 t 177.2 148.08 0.13 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 109.62 -0.511 . . . . 12.0 109.62 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 p -64.25 129.51 40.22 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.052 -1.092 . . . . 12.0 108.052 178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB1' ' CZ3' ' A' ' 3' ' ' TRP . . . -48.67 -30.9 5.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.881 -0.512 . . . . 12.0 111.589 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -78.97 -33.88 44.79 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.937 -0.477 . . . . 12.0 111.837 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.8 p -62.44 -39.72 94.25 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.281 -1.377 . . . . 12.0 107.281 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.806 ' O ' HG22 ' A' ' 51' ' ' ILE . 37.2 t -69.26 -35.79 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.752 -1.203 . . . . 12.0 107.752 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -22.55 66.39 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.195 -0.668 . . . . 12.0 109.195 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.81 -38.05 29.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.966 -0.459 . . . . 12.0 109.903 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.806 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.0 tp -65.8 -22.75 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 O-C-N 121.749 -0.594 . . . . 12.0 110.164 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.06 26.52 8.11 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.858 -0.526 . . . . 12.0 109.937 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.5 m -88.06 111.51 21.63 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.875 -0.787 . . . . 12.0 108.875 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.46 -60.4 0.02 OUTLIER Glycine 0 N--CA 1.499 2.877 0 N-CA-C 110.643 -0.983 . . . . 12.0 110.643 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.3 p -163.93 -169.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.866 -0.785 . . . . 12.0 108.904 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.612 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.7 pt -87.27 25.55 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 O-C-N 121.11 -0.994 . . . . 12.0 111.197 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.419 ' H ' HG13 ' A' ' 55' ' ' VAL . 9.3 t30 174.67 113.48 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 106.86 -1.533 . . . . 12.0 106.86 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.6 ttt -161.21 174.55 13.46 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.855 0.836 . . . . 12.0 111.739 -178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -132.51 110.67 10.65 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 106.593 -1.632 . . . . 12.0 106.593 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 61' ' ' LEU . 11.0 t -121.78 168.53 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.745 -0.597 . . . . 12.0 109.827 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.469 ' N ' HG12 ' A' ' 60' ' ' VAL . 5.0 mp -131.0 112.17 12.69 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 122.121 -0.362 . . . . 12.0 110.662 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.446 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -60.4 92.98 0.03 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 107.502 -1.295 . . . . 12.0 107.502 178.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.2 p -83.28 -42.26 17.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.916 -0.49 . . . . 12.0 111.019 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -53.05 -98.95 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 109.771 -0.455 . . . . 12.0 109.771 -179.15 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.738 ' CB ' HG23 ' A' ' 89' ' ' THR . 2.2 ptp180 178.53 99.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.425 -0.797 . . . . 12.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 72.8 m-85 -96.51 43.7 1.07 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 120.446 -0.502 . . . . 12.0 109.678 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 18.91 106.11 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.211 1.189 . . . . 12.0 114.211 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.56 153.86 18.71 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.782 0.801 . . . . 12.0 111.836 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.405 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 7.2 t30 -119.99 102.47 8.57 Favored 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 106.467 -1.679 . . . . 12.0 106.467 177.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.7 m -100.94 124.73 47.08 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.944 -0.703 . . . . 12.0 111.797 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.2 m -108.82 109.39 20.5 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 104.095 -2.557 . . . . 12.0 104.095 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -114.15 140.84 48.19 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 119.821 -0.752 . . . . 12.0 111.523 -176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -58.61 110.49 1.0 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.306 -0.627 . . . . 12.0 109.306 179.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.8 p -135.24 -94.09 0.27 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 122.071 -0.393 . . . . 12.0 110.539 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.901 ' O ' HD13 ' A' ' 76' ' ' ILE . 34.8 p -156.74 105.21 2.19 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.372 -0.83 . . . . 12.0 109.501 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.901 HD13 ' O ' ' A' ' 75' ' ' SER . 8.5 mm -136.27 165.47 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.872 -0.788 . . . . 12.0 108.872 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.45 ' N ' ' CD ' ' A' ' 78' ' ' PRO . 1.3 m -51.11 -48.06 86.09 Favored Pre-proline 0 N--CA 1.505 2.288 0 CA-C-O 118.73 -0.653 . . . . 12.0 112.234 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 77' ' ' THR . 35.5 Cg_endo -77.72 126.78 8.34 Favored 'Trans proline' 0 N--CA 1.478 0.56 0 C-N-CA 122.131 1.887 . . . . 12.0 111.119 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.58 158.96 49.35 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 108.631 -0.878 . . . . 12.0 108.631 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -75.81 -176.31 18.1 Favored 'Cis proline' 0 N--CA 1.484 0.964 0 O-C-N 123.12 1.063 . . . . 12.0 111.034 0.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.496 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER 60.99 54.03 3.08 Favored Pre-proline 0 N--CA 1.495 1.8 0 CA-C-N 116.499 -0.319 . . . . 12.0 110.845 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 37.0 Cg_endo -78.93 129.19 8.86 Favored 'Trans proline' 0 N--CA 1.485 1.006 0 C-N-CA 122.323 2.015 . . . . 12.0 108.977 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -120.77 136.48 54.87 Favored 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 121.647 0.737 . . . . 12.0 112.354 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.527 ' HB3' HD11 ' A' ' 76' ' ' ILE . 70.7 p -109.03 129.63 55.46 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 107.814 -1.18 . . . . 12.0 107.814 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.8 p -92.81 145.14 24.62 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 121.308 0.575 . . . . 12.0 111.819 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -149.97 157.29 43.01 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.578 -0.897 . . . . 12.0 108.578 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.7 m -128.38 153.68 46.8 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.599 -0.519 . . . . 12.0 109.599 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -173.07 179.0 2.35 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 120.666 -0.414 . . . . 12.0 109.961 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.738 HG23 ' CB ' ' A' ' 65' ' ' ARG . 68.3 m -62.03 143.42 56.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.495 -0.928 . . . . 12.0 108.495 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -107.65 85.77 2.18 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 119.308 -0.957 . . . . 12.0 112.203 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -100.34 105.17 16.66 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 104.226 -2.509 . . . . 12.0 104.226 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.412 ' HA ' ' N ' ' A' ' 108' ' ' GLY . 0.8 OUTLIER -136.32 -177.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-O 121.653 0.739 . . . . 12.0 112.062 -175.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.613 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 18.1 t -117.76 121.3 40.45 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 108.707 -0.849 . . . . 12.0 108.707 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.599 HG23 ' CZ ' ' A' ' 104' ' ' PHE . 8.1 p -117.5 167.85 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 C-N-CA 120.844 -0.342 . . . . 12.0 110.595 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 94' ' ' VAL . 36.9 mttt -129.6 138.39 51.23 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.479 -0.934 . . . . 12.0 108.479 178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -111.99 122.24 47.22 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 113.92 1.081 . . . . 12.0 113.92 -176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 35.0 tt0 -132.23 142.56 49.46 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 103.991 -2.596 . . . . 12.0 103.991 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 99' ' ' GLN . 33.2 m120 54.13 29.1 9.84 Favored 'General case' 0 N--CA 1.516 2.865 0 N-CA-C 107.638 -1.245 . . . . 12.0 107.638 -175.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 98' ' ' ASN . 2.1 pm0 52.94 10.21 0.15 Allowed 'General case' 0 N--CA 1.506 2.351 0 N-CA-C 115.168 1.544 . . . . 12.0 115.168 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.905 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -115.63 146.24 36.3 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 104.574 -2.38 . . . . 12.0 104.574 174.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.57 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.9 Cg_endo -60.84 88.31 0.09 OUTLIER 'Trans proline' 0 C--O 1.207 -1.034 0 C-N-CA 121.293 1.328 . . . . 12.0 108.764 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.905 HG22 ' CE2' ' A' ' 100' ' ' TYR . 67.2 t -84.35 -24.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 116.272 -0.422 . . . . 12.0 110.395 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.482 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -132.31 144.38 50.54 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.344 -1.354 . . . . 12.0 107.344 -178.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.599 ' CZ ' HG23 ' A' ' 94' ' ' VAL . 0.1 OUTLIER -120.76 131.1 54.31 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 118.833 -1.147 . . . . 12.0 110.905 -179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -78.69 -40.78 32.85 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 116.308 -0.405 . . . . 12.0 110.517 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.69 -121.36 3.24 Favored Glycine 0 N--CA 1.504 3.185 0 C-N-CA 120.378 -0.915 . . . . 12.0 111.299 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 43.5 pt -65.44 -178.31 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 CA-C-O 121.372 0.606 . . . . 12.0 111.496 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' A' ' 92' ' ' ILE . . . -61.63 -85.36 0.05 OUTLIER Glycine 0 N--CA 1.501 3.01 0 N-CA-C 110.887 -0.885 . . . . 12.0 110.887 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.6 mmt85 -49.53 117.41 2.2 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.902 -0.764 . . . . 12.0 109.861 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.511 ' N ' ' CD ' ' A' ' 111' ' ' PRO . 1.7 m -84.23 -43.18 0.75 Allowed Pre-proline 0 N--CA 1.503 2.202 0 CA-C-O 118.564 -0.731 . . . . 12.0 111.122 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 110' ' ' CYS . 37.5 Cg_endo . . . . . 0 N--CA 1.48 0.683 0 C-N-CA 121.784 1.656 . . . . 12.0 110.198 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.356 0 N-CA-C 109.126 -0.694 . . . . 12.0 109.126 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -128.22 162.96 25.77 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.439 -0.948 . . . . 12.0 108.439 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.525 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -72.61 -19.74 61.41 Favored 'General case' 0 N--CA 1.514 2.764 0 O-C-N 121.706 -0.621 . . . . 12.0 110.733 -177.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.83 -62.13 1.69 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 121.477 -0.764 . . . . 12.0 110.511 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.449 ' CG2' HG23 ' A' ' 27' ' ' ILE . 5.2 m -63.59 -33.4 75.53 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.664 -1.236 . . . . 12.0 107.664 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.494 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 36.5 t80 -74.39 -23.25 58.94 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -54.17 -34.61 60.87 Favored 'General case' 0 N--CA 1.511 2.621 0 N-CA-C 106.955 -1.498 . . . . 12.0 106.955 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -74.2 -41.76 60.91 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.381 -1.34 . . . . 12.0 107.381 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 9.2 mmtp -51.9 -29.44 20.02 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 122.001 -0.437 . . . . 12.0 109.879 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.718 ' O ' HD13 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -96.56 -28.38 14.4 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 118.568 -0.729 . . . . 12.0 112.614 -178.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 10' ' ' HIS . 23.2 mm -135.59 72.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 N-CA-C 115.826 1.787 . . . . 12.0 115.826 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.865 HG21 ' CD1' ' A' ' 40' ' ' PHE . 47.2 mm -98.36 61.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 102.211 -3.255 . . . . 12.0 102.211 171.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -77.12 74.46 3.69 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 115.522 -0.763 . . . . 12.0 110.655 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.699 ' OG1' HD12 ' A' ' 22' ' ' ILE . 3.1 p -131.21 70.63 82.21 Favored Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.867 -0.79 . . . . 12.0 108.867 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.34 81.76 2.55 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.048 1.832 . . . . 12.0 109.812 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.554 HD11 ' CG2' ' A' ' 22' ' ' ILE . 12.3 pt -136.18 -169.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.805 -0.813 . . . . 12.0 108.805 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.9 pt -105.81 31.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.455 0.645 . . . . 12.0 109.655 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.416 ' HB2' HD12 ' A' ' 16' ' ' ILE . 61.5 m-20 -145.15 95.95 2.76 Favored 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 108.569 -0.9 . . . . 12.0 108.569 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.6 m -81.62 -10.08 59.51 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 120.442 -0.503 . . . . 12.0 111.607 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -81.23 -50.68 9.27 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.009 0.822 . . . . 12.0 111.356 -178.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.0 m -67.08 -19.23 65.62 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.823 -0.548 . . . . 12.0 110.649 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.699 HD12 ' OG1' ' A' ' 14' ' ' THR . 35.0 pt -86.33 -39.23 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.737 -0.602 . . . . 12.0 110.536 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.425 ' N ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -94.53 10.89 32.86 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.857 -0.527 . . . . 12.0 110.43 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -60.18 91.57 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.527 ' OD1' HD12 ' A' ' 27' ' ' ILE . 9.4 t-20 -170.74 156.73 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.441 -0.577 . . . . 12.0 109.441 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -72.13 -9.42 58.4 Favored 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 109.885 -0.413 . . . . 12.0 109.885 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 27' ' ' ILE . 63.0 mt -87.39 9.56 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.718 -0.614 . . . . 12.0 110.411 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -143.36 63.07 1.37 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.429 -0.794 . . . . 12.0 110.283 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.6 mt -146.0 151.64 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.866 -1.146 . . . . 12.0 110.639 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 31' ' ' GLY . 61.1 t -105.31 170.4 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 N-CA-C 107.583 -1.265 . . . . 12.0 107.583 178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -89.89 53.36 3.64 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 109.57 -1.412 . . . . 12.0 109.57 -179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -163.13 -58.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.701 -1.76 . . . . 12.0 108.701 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -164.99 -71.4 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 58.0 m -138.71 -166.13 1.95 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.753 -0.832 . . . . 12.0 108.753 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -122.01 173.68 7.39 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 ptt180 -79.2 -21.01 46.92 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.236 -0.29 . . . . 12.0 110.334 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.9 108.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 C-N-CA 120.248 -0.581 . . . . 12.0 110.865 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.429 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.0 m120 -94.71 85.0 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 106.269 -1.752 . . . . 12.0 106.269 177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.3 m -79.29 117.1 19.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.47 0.652 . . . . 12.0 111.824 -176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.865 ' CD1' HG21 ' A' ' 12' ' ' ILE . 25.2 m-85 -101.89 160.33 14.57 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.184 -1.413 . . . . 12.0 107.184 177.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 10' ' ' HIS . 1.5 tt -126.89 127.77 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.989 -1.069 . . . . 12.0 110.006 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 42' ' ' ILE . 2.4 tt -110.82 100.73 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.2 t 173.92 154.28 0.11 Allowed 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 108.921 -0.77 . . . . 12.0 108.921 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.5 t -51.72 126.37 17.58 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 109.295 -0.631 . . . . 12.0 109.295 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.558 ' HB2' ' CG1' ' A' ' 11' ' ' ILE . . . -60.52 -37.98 82.89 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.987 -0.446 . . . . 12.0 110.639 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 t -76.48 -24.87 53.83 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 120.838 -0.345 . . . . 12.0 111.715 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.3 p -65.8 -40.19 91.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 107.007 -1.479 . . . . 12.0 107.007 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.722 HG22 ' CD2' ' A' ' 66' ' ' PHE . 58.7 t -68.55 -39.91 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.791 -1.559 . . . . 12.0 106.791 177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -59.67 -22.59 62.14 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.392 -0.596 . . . . 12.0 109.392 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.93 -39.75 41.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.836 -0.54 . . . . 12.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.451 HG13 ' CE1' ' A' ' 66' ' ' PHE . 50.5 mm -66.74 -18.07 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.775 -0.578 . . . . 12.0 110.406 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.2 22.87 9.87 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.722 -0.611 . . . . 12.0 109.603 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.8 m -87.93 109.95 20.19 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 108.782 -0.822 . . . . 12.0 108.782 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.77 -61.47 0.01 OUTLIER Glycine 0 N--CA 1.499 2.895 0 N-CA-C 110.639 -0.984 . . . . 12.0 110.639 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.6 p -160.96 -168.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 117.716 0.758 . . . . 12.0 109.091 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.594 ' H ' HG22 ' A' ' 55' ' ' VAL . 12.5 tt -88.16 27.19 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.603 0 O-C-N 121.378 -0.827 . . . . 12.0 111.053 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 8.7 t-20 172.58 117.85 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 N-CA-C 107.513 -1.292 . . . . 12.0 107.513 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -161.77 176.19 11.16 Favored 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 121.635 0.731 . . . . 12.0 111.599 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -131.82 116.42 17.21 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 106.377 -1.712 . . . . 12.0 106.377 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 61' ' ' LEU . 10.2 p -132.5 163.27 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 C-N-CA 120.193 -0.603 . . . . 12.0 110.432 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.67 HD11 ' O ' ' A' ' 108' ' ' GLY . 0.6 OUTLIER -127.5 111.77 14.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.649 -0.5 . . . . 12.0 109.649 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.752 ' HB2' HG22 ' A' ' 92' ' ' ILE . 18.1 m -59.57 92.25 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.735 -0.839 . . . . 12.0 108.735 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.723 HG22 ' OH ' ' A' ' 91' ' ' TYR . 2.1 p -77.97 -49.93 13.15 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.832 -0.803 . . . . 12.0 108.832 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.429 ' O ' ' CD1' ' A' ' 66' ' ' PHE . 7.4 p -59.78 106.77 0.52 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.747 -1.205 . . . . 12.0 107.747 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.903 ' HB3' HG23 ' A' ' 89' ' ' THR . 19.3 ptt-85 -37.32 107.13 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 112.863 0.69 . . . . 12.0 112.863 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.722 ' CD2' HG22 ' A' ' 48' ' ' VAL . 29.3 m-85 -94.04 41.75 1.09 Allowed 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 20.24 107.08 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.138 0 N-CA-C 114.26 1.207 . . . . 12.0 114.26 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.659 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.9 154.55 19.5 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.919 0.866 . . . . 12.0 111.763 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -113.55 97.65 6.58 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 104.452 -2.425 . . . . 12.0 104.452 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.4 m -99.05 123.9 43.67 Favored 'General case' 0 N--CA 1.503 2.224 0 C-N-CA 119.796 -0.761 . . . . 12.0 112.85 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 23.3 m -107.11 105.96 16.22 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 104.391 -2.448 . . . . 12.0 104.391 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.4 m -99.47 144.26 28.78 Favored 'General case' 0 N--CA 1.502 2.148 0 C-N-CA 120.43 -0.508 . . . . 12.0 110.754 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -70.22 113.53 7.48 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.715 -0.846 . . . . 12.0 108.715 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.7 p -137.12 -90.55 0.25 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 122.013 -0.43 . . . . 12.0 110.665 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.441 ' HA ' ' CG ' ' A' ' 82' ' ' PRO . 25.0 p 177.37 120.69 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.554 -0.716 . . . . 12.0 110.311 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.0 pt -150.51 -175.42 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.748 -0.464 . . . . 12.0 109.748 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.442 ' N ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -51.48 -55.25 30.82 Favored Pre-proline 0 N--CA 1.507 2.394 0 CA-C-O 119.014 -0.517 . . . . 12.0 111.301 -179.108 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 77' ' ' THR . 33.4 Cg_endo -73.03 124.23 9.44 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.037 1.825 . . . . 12.0 111.453 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -147.33 165.76 18.03 Favored Pre-proline 0 N--CA 1.496 1.868 0 N-CA-C 108.886 -0.783 . . . . 12.0 108.886 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -76.72 -172.51 11.28 Favored 'Cis proline' 0 N--CA 1.483 0.891 0 O-C-N 123.14 1.074 . . . . 12.0 110.575 0.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 23.7 m 56.57 62.58 6.23 Favored Pre-proline 0 N--CA 1.498 1.933 0 N-CA-C 110.002 -0.37 . . . . 12.0 110.002 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.441 ' CG ' ' HA ' ' A' ' 75' ' ' SER . 34.3 Cg_endo -79.3 143.62 17.62 Favored 'Trans proline' 0 N--CA 1.48 0.687 0 C-N-CA 122.265 1.977 . . . . 12.0 109.612 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.429 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 27.8 m-85 -139.21 142.05 37.89 Favored 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.328 0.585 . . . . 12.0 111.094 -178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.7 t -115.42 134.3 55.22 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.841 -1.17 . . . . 12.0 107.841 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.4 m -96.08 139.52 32.13 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.551 0.691 . . . . 12.0 111.853 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -151.33 120.94 6.95 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.242 -1.021 . . . . 12.0 108.242 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 68' ' ' LEU . 22.8 m -104.6 149.8 25.21 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.557 -0.535 . . . . 12.0 109.557 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -176.89 -171.84 0.39 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.671 -0.411 . . . . 12.0 110.362 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.903 HG23 ' HB3' ' A' ' 65' ' ' ARG . 66.0 m -49.76 136.26 17.95 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 109.867 -0.42 . . . . 12.0 109.867 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' OD1' HD23 ' A' ' 68' ' ' LEU . 65.2 t30 -107.68 87.09 2.42 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-O 121.993 0.902 . . . . 12.0 111.397 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.723 ' OH ' HG22 ' A' ' 63' ' ' THR . 0.4 OUTLIER -95.4 101.44 13.16 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 104.571 -2.381 . . . . 12.0 104.571 176.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.752 HG22 ' HB2' ' A' ' 62' ' ' SER . 16.0 tt -122.13 161.97 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.523 -0.871 . . . . 12.0 112.862 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.7 t -113.13 113.94 26.1 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 107.927 -1.138 . . . . 12.0 107.927 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.471 HG11 ' CE1' ' A' ' 104' ' ' PHE . 10.8 m -126.57 -172.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-N 116.15 -0.477 . . . . 12.0 109.963 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.475 ' HB2' ' CD2' ' A' ' 103' ' ' HIS . 54.1 mttt -144.65 157.28 44.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.098 -0.705 . . . . 12.0 109.098 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.2 m -119.47 116.33 25.89 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 112.802 0.667 . . . . 12.0 112.802 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 17.5 tt0 -124.92 143.62 50.77 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 104.336 -2.468 . . . . 12.0 104.336 175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.424 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.5 m120 55.17 29.13 12.1 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.712 -1.218 . . . . 12.0 107.712 -176.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.424 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.7 pt20 53.26 10.37 0.19 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.073 1.349 . . . . 12.0 114.523 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.86 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -115.88 146.88 37.91 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 104.964 -2.236 . . . . 12.0 104.964 174.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.494 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 23.7 Cg_endo -61.02 92.48 0.1 Allowed 'Trans proline' 0 C--O 1.205 -1.172 0 N-CA-C 108.28 -1.469 . . . . 12.0 108.28 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.86 HG22 ' CE2' ' A' ' 100' ' ' TYR . 54.5 t -91.21 -8.66 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 116.263 -0.426 . . . . 12.0 110.731 -177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.5 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -142.71 110.79 5.98 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.555 -1.258 . . . . 12.0 112.101 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.471 ' CE1' HG11 ' A' ' 94' ' ' VAL . 5.9 m-30 -100.22 112.19 24.5 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 105.254 -2.128 . . . . 12.0 105.254 176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -129.89 7.04 5.12 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.434 0.902 . . . . 12.0 113.434 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 92' ' ' ILE . . . -151.92 160.43 28.83 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.927 -1.269 . . . . 12.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 107' ' ' ILE . 37.6 mt -104.29 28.41 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.895 -0.78 . . . . 12.0 108.895 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.67 ' O ' HD11 ' A' ' 61' ' ' LEU . . . 131.66 -65.13 0.6 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.595 -1.402 . . . . 12.0 109.595 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.7 ttt-85 -60.54 157.76 13.61 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 122.149 -0.619 . . . . 12.0 109.556 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -177.53 167.63 1.18 Allowed Pre-proline 0 N--CA 1.499 2.014 0 N-CA-C 109.376 -0.602 . . . . 12.0 109.376 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 N--CA 1.481 0.738 0 C-N-CA 121.705 1.603 . . . . 12.0 109.972 179.435 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . 0.61 ' HG2' HG12 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.509 2.481 0 CA-C-O 120.797 0.332 . . . . 12.0 110.253 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.406 ' O ' ' CB ' ' A' ' 6' ' ' PHE . 33.3 t30 -167.33 159.01 12.21 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 12.0 108.795 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -26.18 63.8 Favored 'General case' 0 N--CA 1.518 2.932 0 O-C-N 122.05 -0.406 . . . . 12.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 7' ' ' GLN . . . -77.48 -60.8 2.22 Favored 'General case' 0 N--CA 1.514 2.752 0 O-C-N 121.597 -0.69 . . . . 12.0 110.396 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 HG21 ' A' ' 27' ' ' ILE . 47.7 m -60.18 -29.49 68.73 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.126 -1.064 . . . . 12.0 108.126 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 26.9 t80 -81.62 -23.96 36.7 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.285 -0.635 . . . . 12.0 109.285 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' HG3' ' N ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -57.16 -28.78 63.08 Favored 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 107.457 -1.312 . . . . 12.0 107.457 178.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.412 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 3.4 mp0 -83.79 -37.3 22.74 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.471 -1.307 . . . . 12.0 107.471 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.404 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 4.0 tptp -48.11 -47.97 34.09 Favored 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.771 0.319 . . . . 12.0 110.297 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.903 ' CD2' HG11 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -100.95 -17.56 16.73 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 118.53 -0.747 . . . . 12.0 112.149 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.0 mp -139.44 75.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 116.819 2.155 . . . . 12.0 116.819 -175.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.437 ' CG1' ' HB3' ' A' ' 40' ' ' PHE . 1.0 OUTLIER -97.6 62.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 102.9 -3.0 . . . . 12.0 102.9 171.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -71.75 78.85 0.85 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.989 -1.005 . . . . 12.0 112.533 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 p -121.38 122.69 27.96 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 107.273 -1.38 . . . . 12.0 107.273 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -71.85 -3.04 12.4 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 121.48 1.454 . . . . 12.0 112.114 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 9.7 tt -63.11 159.53 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.6 -0.889 . . . . 12.0 108.6 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 tt -108.59 39.25 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 108.549 -0.908 . . . . 12.0 108.549 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -128.38 101.05 6.04 Favored 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 m -74.94 -18.42 60.4 Favored 'General case' 0 N--CA 1.51 2.525 0 C-N-CA 120.499 -0.481 . . . . 12.0 111.174 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -80.89 -55.03 5.08 Favored 'General case' 0 N--CA 1.511 2.596 0 CA-C-N 118.8 0.727 . . . . 12.0 110.158 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -56.39 -30.87 63.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 122.214 -0.304 . . . . 12.0 110.229 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 23' ' ' MET . 50.9 pt -81.02 -36.95 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.546 -0.462 . . . . 12.0 110.243 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.42 ' N ' HG13 ' A' ' 22' ' ' ILE . 9.6 ptt? -91.99 8.39 37.8 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.323 -0.551 . . . . 12.0 110.46 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.19 92.38 0.08 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 107.271 -1.381 . . . . 12.0 107.271 178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -172.28 149.53 2.26 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.219 -0.659 . . . . 12.0 109.219 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -63.61 -12.87 36.85 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 122.061 -0.399 . . . . 12.0 109.996 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.618 HG21 HG23 ' A' ' 5' ' ' THR . 16.6 mt -84.45 11.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.702 -0.624 . . . . 12.0 110.658 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -146.48 64.27 1.2 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.44 -0.787 . . . . 12.0 110.62 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -146.99 151.25 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.761 -1.212 . . . . 12.0 110.398 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 31' ' ' GLY . 40.5 t -100.8 169.1 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 N-CA-C 107.984 -1.117 . . . . 12.0 107.984 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.468 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -91.01 53.02 3.25 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.259 -1.536 . . . . 12.0 109.259 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.52 -57.03 0.02 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.238 -1.545 . . . . 12.0 109.238 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.42 -69.74 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.046 -0.679 . . . . 12.0 109.447 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 35.6 m -141.18 -176.82 4.84 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -109.82 164.06 12.93 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.996 -0.742 . . . . 12.0 108.996 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -80.13 -20.01 45.95 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.838 -0.345 . . . . 12.0 110.367 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.4 p -159.88 115.79 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 121.469 0.652 . . . . 12.0 111.106 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 12.3 m120 -103.18 84.89 2.4 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 106.385 -1.709 . . . . 12.0 106.385 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.8 m -81.46 115.99 21.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.395 0.617 . . . . 12.0 110.657 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.475 ' O ' HD13 ' A' ' 41' ' ' ILE . 33.1 m-85 -106.84 165.5 11.28 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.3 -1.0 . . . . 12.0 108.3 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.52 HD12 ' ND2' ' A' ' 90' ' ' ASN . 42.5 mm -125.88 124.08 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.55 ' O ' HG23 ' A' ' 42' ' ' ILE . 3.3 tt -104.37 109.94 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 N-CA-C 108.702 -0.851 . . . . 12.0 108.702 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.3 t 178.18 158.24 0.46 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.067 -0.716 . . . . 12.0 109.067 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.65 118.91 4.59 Favored 'General case' 0 N--CA 1.504 2.253 0 CA-C-O 121.877 0.846 . . . . 12.0 109.449 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.09 -60.74 1.94 Allowed 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 113.34 0.866 . . . . 12.0 113.34 -177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.4 t -60.03 -25.0 64.98 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.935 -0.478 . . . . 12.0 111.24 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.0 m -62.71 -37.64 87.28 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 107.276 -1.379 . . . . 12.0 107.276 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 10' ' ' HIS . 62.0 t -68.86 -35.49 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 107.156 -1.424 . . . . 12.0 107.156 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -63.67 -21.41 66.37 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.589 -0.523 . . . . 12.0 109.589 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.22 -37.54 28.45 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.944 -0.473 . . . . 12.0 109.741 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.788 HG22 ' O ' ' A' ' 48' ' ' VAL . 1.6 tp -67.8 -24.99 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.851 -0.531 . . . . 12.0 110.296 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.42 22.14 11.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.806 -0.559 . . . . 12.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 m -87.36 115.02 24.5 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.821 -0.549 . . . . 12.0 109.624 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.29 0.02 OUTLIER Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.046 -1.222 . . . . 12.0 110.046 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.9 p -161.88 -165.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.608 ' H ' HG22 ' A' ' 55' ' ' VAL . 3.8 pt -90.37 29.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 O-C-N 121.131 -0.98 . . . . 12.0 110.733 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 174.51 118.64 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 107.324 -1.361 . . . . 12.0 107.324 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.88 177.7 7.69 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.119 0.962 . . . . 12.0 112.501 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -139.07 111.69 7.68 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.237 -1.764 . . . . 12.0 106.237 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.8 p -130.69 163.98 34.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.309 -0.556 . . . . 12.0 110.367 -177.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.76 HD11 ' O ' ' A' ' 108' ' ' GLY . 7.6 tp -117.6 114.4 23.35 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 110.386 -0.227 . . . . 12.0 110.386 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 66' ' ' PHE . 3.5 m -59.55 92.91 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.318 -0.993 . . . . 12.0 108.318 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.4 p -83.04 -171.64 3.68 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.763 -0.458 . . . . 12.0 109.763 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.443 HG22 ' HG2' ' A' ' 65' ' ' ARG . 97.9 m 62.84 -101.7 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.38 -0.971 . . . . 12.0 108.38 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.761 ' HB3' HG23 ' A' ' 89' ' ' THR . 15.9 ptt180 179.72 107.49 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 119.441 1.019 . . . . 12.0 110.833 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HE2' HD13 ' A' ' 51' ' ' ILE . 51.2 m-85 -96.01 43.62 1.08 Allowed 'General case' 0 N--CA 1.506 2.347 0 N-CA-C 108.497 -0.927 . . . . 12.0 108.497 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 22.55 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.109 0 N-CA-C 113.859 1.059 . . . . 12.0 113.859 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.625 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -98.06 152.83 18.89 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 122.039 0.923 . . . . 12.0 111.664 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -118.99 98.29 6.11 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 105.726 -1.953 . . . . 12.0 105.726 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -98.42 123.23 42.44 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.619 0.723 . . . . 12.0 112.153 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.9 m -109.56 108.61 19.12 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 104.379 -2.452 . . . . 12.0 104.379 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -104.36 142.96 33.65 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 120.061 -0.656 . . . . 12.0 111.596 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 1.2 ttt180 -71.34 137.92 48.83 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.293 -0.632 . . . . 12.0 109.293 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.05 -90.37 0.45 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.492 -0.558 . . . . 12.0 109.492 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.76 144.76 1.85 Allowed 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.618 -0.676 . . . . 12.0 109.701 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.439 HG22 ' CG ' ' A' ' 82' ' ' PRO . 2.1 tt -172.98 151.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.101 -0.703 . . . . 12.0 109.101 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.412 ' N ' ' HD2' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -79.42 -59.4 0.6 Allowed Pre-proline 0 N--CA 1.507 2.388 0 CA-C-O 118.977 -0.535 . . . . 12.0 111.479 -178.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 77' ' ' THR . 31.9 Cg_endo -70.03 179.07 4.11 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.071 1.848 . . . . 12.0 111.883 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.418 ' CB ' ' HA ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -98.3 170.44 7.03 Favored Pre-proline 0 N--CA 1.502 2.161 0 CA-C-N 116.316 -0.402 . . . . 12.0 110.201 -178.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.418 ' HA ' ' CB ' ' A' ' 79' ' ' ARG . 32.4 Cg_endo -76.04 -75.55 0.0 OUTLIER 'Cis proline' 0 N--CA 1.49 1.277 0 O-C-N 123.325 1.171 . . . . 12.0 110.939 0.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.2 m -134.3 156.72 78.73 Favored Pre-proline 0 N--CA 1.494 1.727 0 N-CA-C 108.821 -0.807 . . . . 12.0 108.821 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' CG ' HG22 ' A' ' 76' ' ' ILE . 37.2 Cg_endo -78.3 122.63 5.72 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 C-N-CA 121.883 1.722 . . . . 12.0 110.85 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 14.7 m-85 -143.5 131.23 21.36 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.363 0.602 . . . . 12.0 110.854 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -108.78 125.49 52.0 Favored 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 107.579 -1.267 . . . . 12.0 107.579 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.0 p -95.44 141.02 29.47 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.084 0.468 . . . . 12.0 110.573 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.16 31.72 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.516 -0.92 . . . . 12.0 108.516 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.3 p -116.54 148.09 41.18 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 109.615 -0.513 . . . . 12.0 109.615 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.35 -172.32 1.69 Allowed 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.32 0.581 . . . . 12.0 110.315 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 65' ' ' ARG . 42.0 m -67.31 138.38 56.77 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 109.566 -0.531 . . . . 12.0 109.566 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.52 ' ND2' HD12 ' A' ' 41' ' ' ILE . 63.3 t30 -106.79 89.68 3.09 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.054 0.93 . . . . 12.0 111.571 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -107.78 105.28 15.03 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 105.157 -2.164 . . . . 12.0 105.157 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.507 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 4.3 pt -138.95 -175.72 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 C-N-CA 119.943 -0.703 . . . . 12.0 112.404 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.449 ' HA ' HD12 ' A' ' 61' ' ' LEU . 32.1 t -122.63 116.34 23.65 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 115.864 -0.607 . . . . 12.0 109.664 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.591 HG21 ' HB3' ' A' ' 101' ' ' PRO . 8.8 p -116.73 169.77 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 109.92 -0.4 . . . . 12.0 109.92 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.474 ' N ' HG22 ' A' ' 94' ' ' VAL . 27.4 mttt -124.22 142.77 50.97 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.416 -0.587 . . . . 12.0 109.416 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 121.79 45.67 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 114.44 1.274 . . . . 12.0 114.44 -177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 23.6 tt0 -133.2 144.95 50.15 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 104.013 -2.588 . . . . 12.0 104.013 174.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.409 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 20.5 m120 54.22 28.04 8.62 Favored 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 107.755 -1.202 . . . . 12.0 107.755 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.409 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 4.8 pt20 52.49 12.84 0.26 Allowed 'General case' 0 N--CA 1.51 2.572 0 C-N-CA 125.316 1.446 . . . . 12.0 114.754 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.894 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.23 148.05 46.34 Favored Pre-proline 0 N--CA 1.502 2.129 0 N-CA-C 104.857 -2.275 . . . . 12.0 104.857 174.651 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.591 ' HB3' HG21 ' A' ' 94' ' ' VAL . 23.3 Cg_endo -60.6 89.43 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.027 0 C-N-CA 121.301 1.334 . . . . 12.0 108.903 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.894 HG22 ' CE2' ' A' ' 100' ' ' TYR . 55.4 t -86.22 -21.82 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.195 -0.457 . . . . 12.0 110.582 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.501 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -137.61 147.18 44.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.026 -1.101 . . . . 12.0 108.026 -177.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.507 ' CZ ' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -111.83 133.03 54.31 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 118.903 -1.119 . . . . 12.0 109.955 179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -84.99 -38.37 19.34 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.22 -0.3 . . . . 12.0 110.668 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.95 -141.48 9.72 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 120.266 -0.969 . . . . 12.0 111.287 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.4 pt -69.81 -170.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 122.265 -0.55 . . . . 12.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.76 ' O ' HD11 ' A' ' 61' ' ' LEU . . . -66.39 -22.45 71.21 Favored Glycine 0 N--CA 1.499 2.857 0 N-CA-C 110.781 -0.927 . . . . 12.0 110.781 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 120.91 29.04 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-N 117.811 0.806 . . . . 12.0 109.285 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.89 167.73 13.76 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 109.478 -0.564 . . . . 12.0 109.478 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.48 0.722 0 C-N-CA 121.822 1.681 . . . . 12.0 110.225 179.711 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.303 0 N-CA-C 109.474 -0.565 . . . . 12.0 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -112.9 153.95 27.13 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.963 -0.755 . . . . 12.0 108.963 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -45.39 61.81 Favored 'General case' 0 N--CA 1.511 2.616 0 O-C-N 122.058 -0.401 . . . . 12.0 110.042 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.94 -53.12 55.25 Favored 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.754 -0.591 . . . . 12.0 110.46 -178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -64.95 -30.03 70.99 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.419 -0.956 . . . . 12.0 108.419 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.487 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 30.7 t80 -76.56 -20.12 57.18 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.758 -0.83 . . . . 12.0 108.758 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -64.14 -38.99 93.04 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 106.855 -1.535 . . . . 12.0 106.855 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -78.21 -34.75 49.17 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.453 -1.314 . . . . 12.0 107.453 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.51 ' CG ' ' CD2' ' A' ' 10' ' ' HIS . 0.4 OUTLIER -41.48 -60.62 1.25 Allowed 'General case' 0 N--CA 1.506 2.374 0 CA-C-N 116.393 -0.367 . . . . 12.0 110.356 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.51 ' CD2' ' CG ' ' A' ' 9' ' ' LYS . 96.4 m-70 -110.57 -26.22 9.58 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 113.362 0.875 . . . . 12.0 113.362 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 11' ' ' ILE . 4.9 mp -96.62 64.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 119.153 -1.019 . . . . 12.0 113.342 -177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.872 HD12 ' CD1' ' A' ' 40' ' ' PHE . 54.9 mt -91.86 70.75 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 105.053 -2.202 . . . . 12.0 105.053 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -70.34 81.99 0.55 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.626 0.727 . . . . 12.0 110.479 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.48 ' HB ' HG21 ' A' ' 22' ' ' ILE . 1.7 p -144.1 67.97 15.52 Favored Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -77.58 81.99 2.52 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 121.868 1.712 . . . . 12.0 109.851 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.3 pt -129.98 -167.66 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.102 -1.073 . . . . 12.0 108.102 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 15.4 pt -102.26 36.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.728 -0.607 . . . . 12.0 109.663 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -152.57 98.33 2.35 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.722 -0.611 . . . . 12.0 110.557 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.4 m -82.49 -4.49 57.58 Favored 'General case' 0 N--CA 1.514 2.768 0 O-C-N 121.75 -0.593 . . . . 12.0 110.626 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -82.34 -50.5 8.86 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 121.353 -0.842 . . . . 12.0 111.532 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.2 m -66.29 -23.11 66.33 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.787 -0.571 . . . . 12.0 110.507 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HB ' ' A' ' 14' ' ' THR . 50.4 pt -84.73 -32.56 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.721 -0.612 . . . . 12.0 109.727 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.2 ttm -92.86 2.93 56.51 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 122.096 -0.378 . . . . 12.0 110.646 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -63.75 91.32 0.06 Allowed 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 108.476 -0.935 . . . . 12.0 108.476 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.505 ' ND2' HD12 ' A' ' 27' ' ' ILE . 45.1 t30 -169.79 148.54 3.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.214 -0.662 . . . . 12.0 109.214 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -67.54 -10.9 56.11 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 110.092 -0.336 . . . . 12.0 110.092 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 27' ' ' ILE . 61.4 mt -85.42 9.9 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.778 -0.576 . . . . 12.0 110.635 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.462 ' OH ' HD11 ' A' ' 12' ' ' ILE . 43.4 m-85 -142.41 64.2 1.38 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 121.577 -0.702 . . . . 12.0 109.574 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.3 mt -141.57 153.42 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.736 -1.228 . . . . 12.0 111.143 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 31' ' ' GLY . 59.9 t -109.05 170.39 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 107.477 -1.305 . . . . 12.0 107.477 178.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.492 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.42 53.78 3.48 Favored Glycine 0 N--CA 1.5 2.952 0 N-CA-C 109.272 -1.531 . . . . 12.0 109.272 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.68 -57.35 0.02 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.349 -1.501 . . . . 12.0 109.349 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -166.74 -72.54 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.913 -0.773 . . . . 12.0 108.913 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.6 p -154.72 142.42 19.89 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.932 -0.766 . . . . 12.0 108.932 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' CA ' HG21 ' A' ' 30' ' ' VAL . 3.7 tttm -62.06 -176.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.19 2.57 34.64 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 121.003 -0.279 . . . . 12.0 110.69 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.527 ' O ' HG13 ' A' ' 37' ' ' VAL . 4.4 p -161.67 111.14 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.666 0.746 . . . . 12.0 110.314 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 6.3 m120 -103.79 81.88 1.93 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 106.453 -1.684 . . . . 12.0 106.453 178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.0 m -82.85 110.89 18.25 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.977 -0.556 . . . . 12.0 111.225 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.872 ' CD1' HD12 ' A' ' 12' ' ' ILE . 11.6 m-85 -105.46 161.18 14.56 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.333 -1.358 . . . . 12.0 107.333 178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 10' ' ' HIS . 45.6 mm -117.79 135.54 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.435 -0.791 . . . . 12.0 108.992 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.7 tp -105.19 110.09 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.425 -0.954 . . . . 12.0 108.425 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.4 t 174.32 150.98 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.203 -0.666 . . . . 12.0 109.203 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.816 ' O ' HG22 ' A' ' 47' ' ' THR . 18.6 p -60.63 126.19 26.5 Favored 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.393 -0.966 . . . . 12.0 108.393 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -54.94 -30.9 59.84 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.057 -0.402 . . . . 12.0 110.825 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -74.74 -31.87 61.94 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.69 -0.404 . . . . 12.0 111.023 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.816 HG22 ' O ' ' A' ' 44' ' ' SER . 13.7 t -63.98 -33.63 76.17 Favored 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 107.406 -1.331 . . . . 12.0 107.406 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.41 HG12 ' HG3' ' A' ' 101' ' ' PRO . 21.0 t -72.88 -36.07 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.403 -1.332 . . . . 12.0 107.403 177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -63.06 -21.03 65.89 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.668 -0.493 . . . . 12.0 109.668 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.53 -39.23 24.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.999 -0.438 . . . . 12.0 109.894 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.565 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 3.4 pt -69.6 -18.3 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.685 -0.634 . . . . 12.0 111.124 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.34 26.73 10.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.872 -0.517 . . . . 12.0 110.425 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.2 m -95.69 108.3 20.58 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.686 -0.633 . . . . 12.0 109.459 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.87 -57.31 0.02 OUTLIER Glycine 0 N--CA 1.499 2.871 0 N-CA-C 110.523 -1.031 . . . . 12.0 110.523 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 56' ' ' ILE . 9.6 p -157.08 179.09 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.994 -0.71 . . . . 12.0 109.1 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.561 ' H ' HG22 ' A' ' 55' ' ' VAL . 38.7 pt -83.18 26.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.733 0 O-C-N 121.195 -0.94 . . . . 12.0 111.662 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.527 ' H ' HG13 ' A' ' 55' ' ' VAL . 0.8 OUTLIER 177.14 109.6 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.797 -1.557 . . . . 12.0 106.797 179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.412 ' SD ' HG12 ' A' ' 55' ' ' VAL . 0.1 OUTLIER -156.64 179.09 9.61 Favored 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 122.003 0.906 . . . . 12.0 112.016 -177.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -134.8 118.18 16.75 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.401 -1.703 . . . . 12.0 106.401 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG13 ' CG2' ' A' ' 94' ' ' VAL . 14.9 p -141.95 170.13 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 109.304 -0.628 . . . . 12.0 109.304 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 61' ' ' LEU . 4.5 mp -137.71 120.55 16.41 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.844 -0.535 . . . . 12.0 111.154 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.54 ' HB3' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -60.41 92.51 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.559 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -90.92 -28.18 18.25 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 122.052 -0.405 . . . . 12.0 111.102 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -56.2 -77.36 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.675 ' CG ' HG23 ' A' ' 89' ' ' THR . 0.6 OUTLIER 172.14 106.59 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.959 -0.463 . . . . 12.0 110.017 178.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.565 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 73.9 m-85 -122.02 65.28 0.92 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.803 -1.184 . . . . 12.0 107.803 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -23.31 127.73 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 114.52 1.304 . . . . 12.0 114.52 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.728 HD13 ' OG1' ' A' ' 70' ' ' THR . 4.6 pp -99.85 150.95 21.84 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-O 121.694 0.759 . . . . 12.0 111.227 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -118.13 106.37 12.79 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.646 -1.983 . . . . 12.0 105.646 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.728 ' OG1' HD13 ' A' ' 68' ' ' LEU . 27.2 m -112.07 126.85 55.61 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.757 -0.777 . . . . 12.0 112.599 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.7 m -103.8 110.08 22.05 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 103.385 -2.821 . . . . 12.0 103.385 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.6 m -109.11 143.02 39.01 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 119.919 -0.712 . . . . 12.0 112.227 -176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 2.9 ttt180 -64.15 132.21 49.73 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.396 -0.964 . . . . 12.0 108.396 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 p -115.52 -91.68 0.52 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.554 -0.458 . . . . 12.0 110.735 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -129.54 141.51 50.96 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.473 -0.767 . . . . 12.0 110.01 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 11.4 tt -68.5 134.86 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-O 121.431 0.634 . . . . 12.0 110.65 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.49 ' CB ' ' HD3' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -178.65 -58.4 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.013 0 N-CA-C 108.798 -0.816 . . . . 12.0 108.798 178.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' A' ' 77' ' ' THR . 37.9 Cg_endo -82.29 -163.06 0.2 Allowed 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 122.043 1.829 . . . . 12.0 109.318 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 155.17 46.59 Favored Pre-proline 0 N--CA 1.501 2.078 0 N-CA-C 109.139 -0.689 . . . . 12.0 109.139 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -74.21 -41.95 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.14 0 O-C-N 123.135 1.071 . . . . 12.0 110.534 0.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 68.5 m -132.03 148.82 71.36 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.464 -0.939 . . . . 12.0 108.464 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 37.4 Cg_endo -75.46 124.75 8.55 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 121.758 1.639 . . . . 12.0 109.815 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 17.0 m-85 -143.1 134.38 25.99 Favored 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.284 0.564 . . . . 12.0 110.79 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 p -115.03 123.23 48.52 Favored 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.43 -0.952 . . . . 12.0 108.43 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 142.46 39.62 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.828 -0.434 . . . . 12.0 109.828 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.9 ttt85 -146.76 157.2 43.62 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 19.5 m -129.77 147.9 51.59 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 108.893 -0.78 . . . . 12.0 108.893 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -165.38 156.34 14.02 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 120.382 -0.527 . . . . 12.0 110.48 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CG ' ' A' ' 65' ' ' ARG . 52.8 m -58.1 124.67 20.17 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 107.346 -1.353 . . . . 12.0 107.346 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 68' ' ' LEU . 4.9 t-20 -121.99 101.36 7.5 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.366 1.247 . . . . 12.0 114.366 -176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -95.6 126.77 41.11 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 102.703 -3.073 . . . . 12.0 102.703 172.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.526 HG23 ' HA2' ' A' ' 106' ' ' GLY . 1.6 mp -121.9 161.5 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.615 0 N-CA-C 113.993 1.108 . . . . 12.0 113.993 -174.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.499 ' N ' HG22 ' A' ' 92' ' ' ILE . 37.4 t -100.41 109.45 21.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 106.21 -1.774 . . . . 12.0 106.21 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.541 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 10.6 m -118.66 -177.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.072 0.463 . . . . 12.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.465 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 38.7 mtpt -143.73 149.26 36.87 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.899 -0.778 . . . . 12.0 108.899 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -115.45 116.42 28.18 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 112.96 0.726 . . . . 12.0 112.96 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 15.0 tt0 -125.43 143.08 51.15 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 104.42 -2.437 . . . . 12.0 104.42 174.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 1.6 m-80 58.74 14.96 3.46 Favored 'General case' 0 N--CA 1.51 2.566 0 O-C-N 121.061 -1.024 . . . . 12.0 108.513 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 15.6 mt-30 75.79 -8.25 1.64 Allowed 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 124.112 0.965 . . . . 12.0 113.049 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.856 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.1 OUTLIER -105.8 152.55 40.21 Favored Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 106.735 -1.579 . . . . 12.0 106.735 176.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.459 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 23.6 Cg_endo -61.76 87.74 0.1 OUTLIER 'Trans proline' 0 C--N 1.322 -0.823 0 C-N-CA 121.542 1.495 . . . . 12.0 109.095 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.856 HG22 ' CE2' ' A' ' 100' ' ' TYR . 67.4 t -84.34 -20.72 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-N 116.479 -0.328 . . . . 12.0 110.591 -178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -130.83 127.49 38.73 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.925 -1.139 . . . . 12.0 107.925 -177.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.541 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 0.2 OUTLIER -121.53 122.0 38.72 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.646 -0.872 . . . . 12.0 108.646 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -96.25 -32.02 12.64 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 120.775 -0.37 . . . . 12.0 110.506 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA2' HG23 ' A' ' 92' ' ' ILE . . . 97.15 162.04 31.84 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.08 -1.608 . . . . 12.0 109.08 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.41 ' O ' ' O ' ' A' ' 106' ' ' GLY . 60.3 mt 57.24 123.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.372 0.606 . . . . 12.0 111.118 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.95 80.63 1.74 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 109.685 -1.366 . . . . 12.0 109.685 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.15 95.89 0.97 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.581 ' SG ' HD21 ' A' ' 61' ' ' LEU . 26.6 p 179.76 155.27 0.68 Allowed Pre-proline 0 N--CA 1.502 2.148 0 CA-C-O 118.66 -0.686 . . . . 12.0 109.331 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.482 0.811 0 C-N-CA 121.556 1.504 . . . . 12.0 110.202 179.704 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 2.533 0 CA-C-O 120.907 0.384 . . . . 12.0 110.084 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -129.58 166.69 19.21 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.84 -0.8 . . . . 12.0 108.84 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -23.58 64.91 Favored 'General case' 0 N--CA 1.519 2.983 0 O-C-N 121.614 -0.679 . . . . 12.0 110.357 -178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.33 -61.44 1.99 Allowed 'General case' 0 N--CA 1.514 2.737 0 O-C-N 121.493 -0.754 . . . . 12.0 110.6 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -34.53 74.9 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 107.412 -1.329 . . . . 12.0 107.412 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.564 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 24.7 t80 -73.57 -27.49 61.34 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.338 -0.986 . . . . 12.0 108.338 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.91 -33.1 35.56 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 107.72 -1.215 . . . . 12.0 107.72 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.11 -42.02 33.26 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.33 -53.87 6.33 Favored 'General case' 0 N--CA 1.505 2.307 0 CA-C-N 116.232 -0.44 . . . . 12.0 111.18 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.805 ' CG ' HG11 ' A' ' 48' ' ' VAL . 1.1 m-70 -96.75 -15.38 21.41 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.694 -0.629 . . . . 12.0 111.162 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.728 HD13 ' O ' ' A' ' 10' ' ' HIS . 15.7 mm -140.15 87.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 114.231 1.197 . . . . 12.0 114.231 -176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 40' ' ' PHE . 35.3 mm -96.73 67.67 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 105.094 -2.187 . . . . 12.0 105.094 174.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.534 ' O ' HG23 ' A' ' 14' ' ' THR . 25.2 p-10 -66.81 84.35 0.11 Allowed 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.932 0.872 . . . . 12.0 110.636 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 13' ' ' ASN . 1.2 p -159.39 63.12 2.18 Favored Pre-proline 0 N--CA 1.495 1.796 0 N-CA-C 106.976 -1.491 . . . . 12.0 106.976 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.49 85.61 1.26 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.041 1.827 . . . . 12.0 110.598 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 14.9 pt -134.27 -173.09 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.847 -0.797 . . . . 12.0 108.847 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pt -98.67 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 121.293 0.568 . . . . 12.0 109.636 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -145.03 95.56 2.71 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.434 -0.58 . . . . 12.0 109.434 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 27.4 m -80.45 -3.18 48.88 Favored 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.916 -0.49 . . . . 12.0 110.735 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.6 -50.16 10.34 Favored 'General case' 0 N--CA 1.509 2.476 0 CA-C-N 118.613 0.642 . . . . 12.0 110.974 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.6 m -63.11 -21.18 66.02 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.748 -0.595 . . . . 12.0 110.429 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 23' ' ' MET . 45.6 pt -85.78 -38.05 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.679 -0.638 . . . . 12.0 109.904 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.422 ' N ' HG13 ' A' ' 22' ' ' ILE . 3.8 ptm -91.53 11.14 25.09 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.988 -0.445 . . . . 12.0 110.312 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -66.41 90.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.489 -0.93 . . . . 12.0 108.489 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.402 HD22 HG22 ' A' ' 27' ' ' ILE . 58.1 t30 -173.11 150.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.453 -0.573 . . . . 12.0 109.453 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -70.52 -9.13 55.9 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 110.09 -0.337 . . . . 12.0 110.09 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -88.82 11.6 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.72 -0.613 . . . . 12.0 110.319 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -140.03 58.95 1.58 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.827 -0.546 . . . . 12.0 110.363 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -148.0 146.6 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 120.631 -1.293 . . . . 12.0 110.559 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.576 HG22 ' H ' ' A' ' 31' ' ' GLY . 3.5 p -111.67 -164.47 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.34 -1.355 . . . . 12.0 107.34 178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.576 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -97.72 66.3 0.83 Allowed Glycine 0 N--CA 1.506 3.301 0 O-C-N 120.956 -1.09 . . . . 12.0 112.453 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.52 -68.86 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.136 -1.586 . . . . 12.0 109.136 178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -164.45 -66.71 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 107.845 -1.169 . . . . 12.0 107.845 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 19.0 p -138.8 144.6 39.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.631 -0.877 . . . . 12.0 108.631 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -61.27 -175.03 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.985 -0.447 . . . . 12.0 109.991 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -89.73 -23.11 21.88 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 110.024 -0.361 . . . . 12.0 110.024 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.506 HG22 HG23 ' A' ' 72' ' ' THR . 4.3 t -150.01 102.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 5.1 m120 -90.99 80.82 5.69 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 106.649 -1.612 . . . . 12.0 106.649 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 m -84.17 115.35 22.37 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.936 -0.574 . . . . 12.0 110.825 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.487 ' O ' HD13 ' A' ' 41' ' ' ILE . 32.8 m-85 -105.44 165.58 11.03 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.624 HD12 ' ND2' ' A' ' 90' ' ' ASN . 49.3 mm -127.45 126.23 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 120.932 -1.105 . . . . 12.0 110.459 -179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 tt -108.91 127.83 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.11 -0.7 . . . . 12.0 109.11 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.636 ' O ' HD12 ' A' ' 11' ' ' ILE . 30.3 t 170.4 160.37 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.363 -0.977 . . . . 12.0 108.363 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.67 117.93 4.73 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -40.85 -64.63 0.51 Allowed 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 113.9 1.074 . . . . 12.0 113.9 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -61.29 -26.21 67.63 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.794 -0.566 . . . . 12.0 111.311 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.7 m -58.61 -35.54 72.62 Favored 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 107.456 -1.312 . . . . 12.0 107.456 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.836 ' O ' HG22 ' A' ' 51' ' ' ILE . 45.7 t -70.19 -37.95 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.294 -1.372 . . . . 12.0 107.294 176.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -60.68 -21.55 62.96 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.138 -0.69 . . . . 12.0 109.138 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.87 -37.2 27.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 122.009 -0.432 . . . . 12.0 109.919 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.836 HG22 ' O ' ' A' ' 48' ' ' VAL . 6.8 tp -66.82 -24.36 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 C-N-CA 120.414 -0.514 . . . . 12.0 110.425 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 22.95 10.69 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.723 -0.611 . . . . 12.0 109.768 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.541 HG23 HE22 ' A' ' 99' ' ' GLN . 20.0 m -84.74 109.22 17.89 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.028 -0.73 . . . . 12.0 109.028 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.93 -58.82 0.02 OUTLIER Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.616 -0.994 . . . . 12.0 110.616 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 56' ' ' ILE . 4.7 p -164.89 -175.1 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.897 -0.779 . . . . 12.0 108.897 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.601 ' H ' HG22 ' A' ' 55' ' ' VAL . 48.0 pt -87.08 27.69 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.427 0 O-C-N 121.315 -0.865 . . . . 12.0 111.34 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.488 ' H ' HG13 ' A' ' 55' ' ' VAL . 6.1 t-20 177.21 116.83 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.524 0 N-CA-C 107.807 -1.183 . . . . 12.0 107.807 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.5 ttp -165.83 170.81 13.48 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.554 0.692 . . . . 12.0 111.39 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.4 118.03 15.98 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.49 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.7 p -150.57 164.55 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.314 -0.624 . . . . 12.0 109.314 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.5 mp -115.3 128.81 56.36 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 110.051 -0.352 . . . . 12.0 110.051 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.871 ' HB2' HG22 ' A' ' 92' ' ' ILE . 49.5 m -53.62 94.11 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 108.142 -1.059 . . . . 12.0 108.142 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.423 ' HA ' ' CE1' ' A' ' 91' ' ' TYR . 1.1 p -77.37 -174.78 3.44 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 120.834 0.35 . . . . 12.0 110.085 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.726 HG22 ' HG2' ' A' ' 65' ' ' ARG . 96.9 m 63.47 -94.86 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.906 ' HB3' HG23 ' A' ' 89' ' ' THR . 6.1 ptm180 174.0 104.35 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 118.828 0.74 . . . . 12.0 110.006 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 48.5 m-85 -95.99 43.34 1.08 Allowed 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 109.193 -0.669 . . . . 12.0 109.193 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 29.64 105.2 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.147 0 N-CA-C 113.87 1.063 . . . . 12.0 113.87 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -103.62 154.68 19.23 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 122.033 0.92 . . . . 12.0 112.107 179.113 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -117.26 97.02 5.69 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 105.524 -2.028 . . . . 12.0 105.524 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.9 m -99.95 122.66 43.2 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.803 -0.759 . . . . 12.0 112.971 -176.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.3 m -108.75 105.68 15.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 103.338 -2.838 . . . . 12.0 103.338 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.506 HG23 HG22 ' A' ' 37' ' ' VAL . 9.4 m -114.34 143.28 45.15 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.9 -0.72 . . . . 12.0 112.613 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 25.7 ttp180 -69.74 109.54 4.44 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.008 -1.108 . . . . 12.0 108.008 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.2 p -145.11 -79.18 0.18 Allowed 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 120.006 -0.677 . . . . 12.0 112.363 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.613 ' O ' HG22 ' A' ' 77' ' ' THR . 24.5 p -94.48 160.38 14.67 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.775 -0.578 . . . . 12.0 110.989 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 pt -55.88 128.67 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 121.362 0.601 . . . . 12.0 110.296 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 75' ' ' SER . 2.6 t 172.38 67.5 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.164 0 N-CA-C 106.935 -1.506 . . . . 12.0 106.935 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -72.06 109.52 2.72 Favored 'Trans proline' 0 N--CA 1.482 0.805 0 C-N-CA 122.025 1.817 . . . . 12.0 112.647 -176.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' N ' ' CA ' ' A' ' 80' ' ' PRO . 2.4 mtp180 -145.78 51.58 1.31 Allowed Pre-proline 0 N--CA 1.486 1.339 0 CA-C-N 115.776 -0.647 . . . . 12.0 109.387 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.415 ' CA ' ' N ' ' A' ' 79' ' ' ARG . 39.2 Cg_endo -88.2 -23.93 8.54 Favored 'Cis proline' 0 N--CA 1.491 1.351 0 O-C-N 122.253 0.607 . . . . 12.0 111.781 -1.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 1.1 m -86.09 157.63 56.58 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 121.802 -0.561 . . . . 12.0 109.493 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 34.3 Cg_endo -72.25 89.31 0.8 Allowed 'Trans proline' 0 N--CA 1.483 0.873 0 C-N-CA 121.721 1.614 . . . . 12.0 109.468 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.578 ' N ' HG23 ' A' ' 77' ' ' THR . 7.2 m-85 -121.31 140.4 52.14 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-O 121.61 0.719 . . . . 12.0 112.542 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.8 m -119.15 124.16 46.15 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 107.559 -1.274 . . . . 12.0 107.559 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -93.12 142.83 26.87 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.924 -0.485 . . . . 12.0 110.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -155.7 132.76 10.71 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 109.423 -0.584 . . . . 12.0 109.423 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.3 m -92.3 148.82 21.83 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.898 -0.779 . . . . 12.0 108.898 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -169.16 -169.75 1.01 Allowed 'General case' 0 N--CA 1.502 2.171 0 CA-C-O 121.23 0.538 . . . . 12.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.906 HG23 ' HB3' ' A' ' 65' ' ' ARG . 53.3 m -67.14 139.44 57.49 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 109.147 -0.686 . . . . 12.0 109.147 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.624 ' ND2' HD12 ' A' ' 41' ' ' ILE . 67.0 t30 -107.46 87.0 2.4 Favored 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 122.091 0.948 . . . . 12.0 112.392 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' A' ' 63' ' ' THR . 14.5 t80 -99.68 102.39 13.86 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 104.186 -2.524 . . . . 12.0 104.186 175.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.871 HG22 ' HB2' ' A' ' 62' ' ' SER . 13.9 tt -124.47 169.85 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 C-N-CA 119.541 -0.864 . . . . 12.0 112.883 -175.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 43.8 t -113.14 107.76 16.37 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.275 -1.009 . . . . 12.0 108.275 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.531 HG13 HG23 ' A' ' 92' ' ' ILE . 18.0 m -127.33 -170.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.68 -0.489 . . . . 12.0 109.68 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.482 ' HB2' ' CG ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -147.57 161.06 41.89 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 120.069 -0.652 . . . . 12.0 110.887 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -121.27 128.27 52.2 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.646 0.736 . . . . 12.0 111.983 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.518 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 14.4 tt0 -147.51 147.08 29.77 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 104.97 -2.233 . . . . 12.0 104.97 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 59.1 18.21 6.22 Favored 'General case' 0 N--CA 1.508 2.472 0 N-CA-C 108.387 -0.968 . . . . 12.0 108.387 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.541 HE22 HG23 ' A' ' 53' ' ' THR . 0.0 OUTLIER 71.03 -6.01 1.39 Allowed 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 123.579 0.752 . . . . 12.0 112.71 -179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.734 ' OH ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -110.55 145.19 31.75 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 106.332 -1.729 . . . . 12.0 106.332 177.24 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.564 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 28.2 Cg_endo -66.52 100.08 0.47 Allowed 'Trans proline' 0 C--O 1.203 -1.264 0 N-CA-C 107.382 -1.815 . . . . 12.0 107.382 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.734 HG23 ' OH ' ' A' ' 100' ' ' TYR . 12.3 p -117.58 7.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 C-N-CA 120.057 -0.657 . . . . 12.0 112.654 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.518 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -129.87 133.42 46.88 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.669 -1.234 . . . . 12.0 107.669 178.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.489 ' CE1' HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -120.02 126.41 50.73 Favored 'General case' 0 N--CA 1.503 2.181 0 C-N-CA 119.967 -0.693 . . . . 12.0 110.684 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -93.88 -32.98 13.69 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.89 -0.782 . . . . 12.0 108.89 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 140.14 -149.24 20.73 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.052 -1.219 . . . . 12.0 110.052 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 30.3 pt -56.16 -172.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 122.291 -0.535 . . . . 12.0 109.895 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -88.13 58.13 4.25 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 110.234 -1.146 . . . . 12.0 110.234 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -143.79 96.95 2.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.423 -0.954 . . . . 12.0 108.423 179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.412 ' N ' ' HD3' ' A' ' 111' ' ' PRO . 10.1 m -131.66 60.96 55.69 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 109.969 -0.382 . . . . 12.0 109.969 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 110' ' ' CYS . 37.3 Cg_endo . . . . . 0 N--CA 1.478 0.58 0 C-N-CA 122.187 1.925 . . . . 12.0 110.104 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.51 2.531 0 N-CA-C 109.705 -0.48 . . . . 12.0 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -142.48 168.71 19.09 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.728 -0.841 . . . . 12.0 108.728 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CD1' ' CD2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -68.25 -25.91 65.42 Favored 'General case' 0 N--CA 1.518 2.966 0 O-C-N 121.588 -0.695 . . . . 12.0 110.207 -178.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.64 -60.31 2.37 Favored 'General case' 0 N--CA 1.512 2.669 0 O-C-N 121.694 -0.629 . . . . 12.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.72 -35.55 78.36 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 107.514 -1.291 . . . . 12.0 107.514 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 101' ' ' PRO . 28.1 t80 -73.8 -25.07 59.93 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.22 -31.76 54.05 Favored 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 107.534 -1.284 . . . . 12.0 107.534 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.96 -37.86 33.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -46.73 -53.04 12.61 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 116.335 -0.393 . . . . 12.0 110.63 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.747 ' CG ' HG11 ' A' ' 48' ' ' VAL . 1.3 m-70 -97.09 -16.01 20.71 Favored 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.863 -0.523 . . . . 12.0 110.848 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 11' ' ' ILE . 5.0 mp -144.09 87.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 114.068 1.136 . . . . 12.0 114.068 -176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.828 HD12 ' CD1' ' A' ' 40' ' ' PHE . 12.6 mt -97.06 65.13 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 103.711 -2.7 . . . . 12.0 103.711 173.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 14' ' ' THR . 8.5 t-20 -66.98 83.0 0.11 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.903 0.859 . . . . 12.0 110.699 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 13' ' ' ASN . 1.3 p -155.18 63.18 3.67 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 106.847 -1.538 . . . . 12.0 106.847 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -73.21 84.05 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.086 1.857 . . . . 12.0 111.015 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 17' ' ' ILE . 1.4 mt -121.65 -167.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 107.787 -1.19 . . . . 12.0 107.787 179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.51 ' H ' HG22 ' A' ' 16' ' ' ILE . 2.4 mm -101.91 34.19 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.44 0 N-CA-C 108.682 -0.858 . . . . 12.0 108.682 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -145.8 97.6 2.99 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -77.84 -16.28 58.42 Favored 'General case' 0 N--CA 1.514 2.75 0 O-C-N 121.842 -0.537 . . . . 12.0 111.253 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -82.18 -49.02 10.6 Favored 'General case' 0 N--CA 1.511 2.606 0 CA-C-N 118.854 0.752 . . . . 12.0 110.046 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.12 -31.54 67.27 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.748 -0.464 . . . . 12.0 109.748 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 23' ' ' MET . 47.0 pt -81.12 -36.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 120.627 -0.429 . . . . 12.0 110.208 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -97.03 15.24 22.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.925 -0.484 . . . . 12.0 110.165 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -65.27 90.78 0.1 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.122 -1.066 . . . . 12.0 108.122 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -166.83 158.06 12.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.236 -0.653 . . . . 12.0 109.236 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -72.89 -10.82 60.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 120.8 -0.36 . . . . 12.0 110.263 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 27' ' ' ILE . 59.6 mt -87.02 9.71 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.65 -0.656 . . . . 12.0 110.523 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -142.71 63.23 1.39 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.611 -0.68 . . . . 12.0 109.727 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 30' ' ' VAL . 51.3 mt -148.49 153.26 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 120.763 -1.211 . . . . 12.0 110.318 -179.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG21 ' HA ' ' A' ' 35' ' ' LYS . 50.0 t -107.03 169.53 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 107.764 -1.199 . . . . 12.0 107.764 178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.71 54.16 3.39 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.117 -1.593 . . . . 12.0 109.117 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.9 -56.23 0.02 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.241 -1.544 . . . . 12.0 109.241 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -165.27 -68.18 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.04 -0.682 . . . . 12.0 109.401 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 68.0 m -143.51 -175.77 4.69 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.49 -0.559 . . . . 12.0 109.49 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HA ' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -105.92 163.72 12.52 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.339 -0.615 . . . . 12.0 109.339 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -73.85 -24.08 59.72 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 110.058 -0.349 . . . . 12.0 110.058 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 37' ' ' VAL . 9.1 p -156.35 109.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.481 0.658 . . . . 12.0 110.804 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 3.0 m-20 -91.27 83.3 5.49 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.527 -1.657 . . . . 12.0 106.527 178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.98 HG21 HD12 ' A' ' 107' ' ' ILE . 23.9 m -82.61 106.43 14.46 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 116.006 -0.543 . . . . 12.0 110.89 -177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.828 ' CD1' HD12 ' A' ' 12' ' ' ILE . 10.5 m-85 -99.11 157.86 16.06 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.167 -1.42 . . . . 12.0 107.167 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.5 mp -112.92 125.57 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.175 -0.953 . . . . 12.0 109.005 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 42' ' ' ILE . 16.2 tt -106.74 118.37 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.489 -0.56 . . . . 12.0 109.489 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t 173.15 154.86 0.1 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.382 -0.97 . . . . 12.0 108.382 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.21 119.2 5.98 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.22 -52.38 12.58 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 113.053 0.76 . . . . 12.0 113.053 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -61.7 -29.53 70.16 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 122.026 -0.421 . . . . 12.0 111.558 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.2 m -63.19 -35.18 79.45 Favored 'General case' 0 N--CA 1.506 2.36 0 N-CA-C 107.122 -1.436 . . . . 12.0 107.122 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.849 ' O ' HG22 ' A' ' 51' ' ' ILE . 42.0 t -71.28 -33.91 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.686 -1.227 . . . . 12.0 107.686 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -61.76 -22.37 65.35 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.173 -0.677 . . . . 12.0 109.173 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.81 -36.67 28.11 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.653 -0.499 . . . . 12.0 109.653 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 48' ' ' VAL . 5.9 tp -66.08 -25.26 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 C-N-CA 120.372 -0.531 . . . . 12.0 110.792 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.53 24.27 7.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.614 -0.679 . . . . 12.0 109.908 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.7 m -88.3 110.94 21.16 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.254 -0.647 . . . . 12.0 109.254 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.46 -58.78 0.02 OUTLIER Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.396 -1.081 . . . . 12.0 110.396 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.609 HG22 ' H ' ' A' ' 56' ' ' ILE . 5.2 p -161.59 -177.76 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 109.013 -0.736 . . . . 12.0 109.013 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.609 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.2 tt -83.27 21.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.642 0 O-C-N 121.357 -0.839 . . . . 12.0 111.718 -178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.583 ' H ' HG13 ' A' ' 55' ' ' VAL . 5.5 t-20 175.25 113.36 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.541 0 N-CA-C 108.292 -1.003 . . . . 12.0 108.292 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.5 ttm -163.78 -176.78 4.78 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.485 0.659 . . . . 12.0 111.034 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -137.98 123.5 19.65 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.295 -1.372 . . . . 12.0 107.295 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.6 p -145.37 163.73 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.907 -0.495 . . . . 12.0 109.869 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.55 ' N ' HD12 ' A' ' 61' ' ' LEU . 2.6 mp -122.72 116.26 23.45 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.587 -0.523 . . . . 12.0 109.587 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.484 ' HB2' HG22 ' A' ' 92' ' ' ILE . 1.8 m -55.48 92.0 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.699 -0.852 . . . . 12.0 108.699 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.82 -50.45 20.39 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.592 -0.892 . . . . 12.0 108.592 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.7 115.4 3.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.532 -0.914 . . . . 12.0 108.532 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.853 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 106.88 0.08 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.152 0.501 . . . . 12.0 111.543 -178.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 28.6 m-85 -94.4 40.08 1.09 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 108.848 -0.797 . . . . 12.0 108.848 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' PHE . 1.4 tp-100 39.86 107.56 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.918 0 N-CA-C 112.859 0.689 . . . . 12.0 112.859 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.836 HD13 ' OG1' ' A' ' 70' ' ' THR . 3.5 pp -95.99 147.94 23.17 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -0.816 . . . . 12.0 111.259 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.98 97.47 5.71 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 105.292 -2.114 . . . . 12.0 105.292 175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.836 ' OG1' HD13 ' A' ' 68' ' ' LEU . 30.2 m -108.22 128.16 54.48 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.434 -0.906 . . . . 12.0 112.541 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.0 m -112.63 111.9 23.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 104.288 -2.486 . . . . 12.0 104.288 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 m -108.64 141.89 39.92 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 120.12 -0.632 . . . . 12.0 111.401 -177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -65.3 109.59 2.31 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.68 -0.859 . . . . 12.0 108.68 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.4 p -116.75 -115.12 0.33 Allowed 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 120.388 -0.525 . . . . 12.0 111.201 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 51.0 p -147.38 164.75 32.31 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.094 -1.004 . . . . 12.0 110.154 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.1 mt 63.64 -138.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 107.644 -1.243 . . . . 12.0 107.644 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.553 HG22 ' CD ' ' A' ' 78' ' ' PRO . 0.0 OUTLIER 55.24 -179.58 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.634 0 CA-C-N 120.145 1.338 . . . . 12.0 108.938 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.553 ' CD ' HG22 ' A' ' 77' ' ' THR . 30.4 Cg_endo -74.75 106.59 2.29 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 121.08 1.187 . . . . 12.0 109.329 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 80' ' ' PRO . 0.0 OUTLIER -96.12 161.73 26.18 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.326 -0.62 . . . . 12.0 109.326 -178.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' A' ' 79' ' ' ARG . 34.9 Cg_endo -74.9 172.95 60.28 Favored 'Cis proline' 0 N--CA 1.487 1.136 0 O-C-N 123.177 1.093 . . . . 12.0 111.311 1.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 90.5 m 61.7 63.69 2.16 Favored Pre-proline 0 N--CA 1.498 1.944 0 CA-C-N 116.346 -0.388 . . . . 12.0 110.787 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.01 137.31 12.25 Favored 'Trans proline' 0 N--CA 1.481 0.736 0 C-N-CA 122.326 2.017 . . . . 12.0 109.012 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -134.54 136.03 42.76 Favored 'General case' 0 N--CA 1.509 2.523 0 CA-C-O 121.525 0.679 . . . . 12.0 112.454 -178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.8 p -108.81 129.8 55.39 Favored 'General case' 0 N--CA 1.506 2.343 0 N-CA-C 107.495 -1.298 . . . . 12.0 107.495 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.8 m -96.34 145.48 25.57 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.947 -0.471 . . . . 12.0 111.213 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.2 ttm105 -159.57 138.96 11.27 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 109.261 -0.644 . . . . 12.0 109.261 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.9 m -99.05 150.74 21.69 Favored 'General case' 0 N--CA 1.506 2.344 0 N-CA-C 109.534 -0.543 . . . . 12.0 109.534 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.588 ' HB3' HD21 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -162.02 -162.44 0.84 Allowed 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.033 0.444 . . . . 12.0 110.359 -179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.853 HG23 ' HB3' ' A' ' 65' ' ' ARG . 92.5 m -79.2 127.92 32.65 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 109.003 -0.74 . . . . 12.0 109.003 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.42 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 21.2 t-20 -95.0 87.52 4.95 Favored 'General case' 0 N--CA 1.512 2.671 0 CA-C-O 122.245 1.021 . . . . 12.0 111.983 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 5.2 p90 -103.16 101.79 11.76 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 104.712 -2.329 . . . . 12.0 104.712 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 62' ' ' SER . 15.8 tt -119.78 162.54 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 N-CA-C 113.118 0.785 . . . . 12.0 113.118 -175.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 17.4 t -110.52 107.2 16.75 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 107.076 -1.453 . . . . 12.0 107.076 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.472 ' CG1' ' CE1' ' A' ' 104' ' ' PHE . 17.1 m -128.09 -172.83 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 109.437 -0.579 . . . . 12.0 109.437 -178.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 4.0 mtpp -143.04 162.94 34.16 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.96 -0.696 . . . . 12.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 9.8 m -115.9 130.26 56.75 Favored 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.592 0.711 . . . . 12.0 111.871 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.512 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 39.0 tt0 -138.32 136.97 36.95 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 104.915 -2.254 . . . . 12.0 104.915 177.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' A' ' 99' ' ' GLN . 12.1 m-20 55.86 20.91 4.43 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 121.391 -0.818 . . . . 12.0 108.838 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 6.4 mt-30 77.12 -17.08 0.58 Allowed 'General case' 0 N--CA 1.506 2.337 0 C-N-CA 123.517 0.727 . . . . 12.0 112.637 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.832 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -98.65 143.66 26.73 Favored Pre-proline 0 N--CA 1.503 2.192 0 N-CA-C 105.983 -1.858 . . . . 12.0 105.983 177.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.535 ' O ' ' CZ ' ' A' ' 6' ' ' PHE . 24.8 Cg_endo -62.69 104.36 0.37 Allowed 'Trans proline' 0 C--O 1.203 -1.269 0 C-N-CA 121.278 1.318 . . . . 12.0 108.92 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.832 HG22 ' CE2' ' A' ' 100' ' ' TYR . 3.5 t -115.97 12.25 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.51 0 C-N-CA 120.287 -0.565 . . . . 12.0 112.22 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -141.83 133.81 27.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.796 -0.816 . . . . 12.0 108.796 178.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.472 ' CE1' ' CG1' ' A' ' 94' ' ' VAL . 0.8 OUTLIER -118.12 129.46 55.55 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 109.084 -0.71 . . . . 12.0 109.084 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -115.54 -26.17 7.61 Favored 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 112.598 0.592 . . . . 12.0 112.598 -177.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.404 ' O ' HG13 ' A' ' 92' ' ' ILE . . . -177.03 -174.75 43.74 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 119.811 -1.185 . . . . 12.0 111.18 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.98 HD12 HG21 ' A' ' 39' ' ' THR . 10.3 tt -97.78 31.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.09 0.471 . . . . 12.0 110.384 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 132.84 -67.62 0.56 Allowed Glycine 0 N--CA 1.502 3.038 0 N-CA-C 110.366 -1.094 . . . . 12.0 110.366 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -65.06 135.62 55.78 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.975 -0.75 . . . . 12.0 108.975 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -145.46 60.52 6.85 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 109.407 -0.59 . . . . 12.0 109.407 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 110' ' ' CYS . 37.1 Cg_endo . . . . . 0 N--CA 1.479 0.64 0 C-N-CA 122.249 1.966 . . . . 12.0 110.258 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.383 0 N-CA-C 109.571 -0.529 . . . . 12.0 109.571 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -150.79 157.12 42.55 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.543 -0.91 . . . . 12.0 108.543 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -41.03 78.65 Favored 'General case' 0 N--CA 1.512 2.657 0 O-C-N 122.045 -0.409 . . . . 12.0 110.609 -178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.22 -56.45 11.26 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 121.359 -0.838 . . . . 12.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.26 -31.44 72.01 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 107.917 -1.142 . . . . 12.0 107.917 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 53.7 t80 -72.74 -25.67 61.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.723 -0.843 . . . . 12.0 108.723 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.431 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.8 OUTLIER -53.65 -37.3 62.98 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 107.254 -1.387 . . . . 12.0 107.254 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.39 -40.89 57.45 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.192 -1.41 . . . . 12.0 107.192 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 7.0 tptt -43.32 -61.81 1.24 Allowed 'General case' 0 N--CA 1.505 2.283 0 CA-C-N 116.268 -0.424 . . . . 12.0 111.836 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.776 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.9 m80 -99.49 -7.07 26.5 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 119.08 0.854 . . . . 12.0 111.677 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.776 HD13 ' O ' ' A' ' 10' ' ' HIS . 25.2 mm -134.37 78.41 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 118.684 -1.206 . . . . 12.0 113.33 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.474 ' H ' HD12 ' A' ' 12' ' ' ILE . 5.0 mp -94.82 64.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.153 -2.165 . . . . 12.0 105.153 175.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.627 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 t-20 -64.82 85.16 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.652 0.739 . . . . 12.0 110.372 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 13' ' ' ASN . 5.7 p -160.73 69.9 2.74 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 107.102 -1.444 . . . . 12.0 107.102 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -79.78 30.64 0.48 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.418 2.079 . . . . 12.0 113.103 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 22' ' ' ILE . 10.2 pt -64.56 -169.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 108.655 -0.869 . . . . 12.0 108.655 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 23.1 pt -100.35 33.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 121.589 0.709 . . . . 12.0 109.46 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -144.94 98.95 3.26 Favored 'General case' 0 N--CA 1.505 2.281 0 N-CA-C 108.665 -0.865 . . . . 12.0 108.665 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 23' ' ' MET . 60.0 m -77.36 -18.7 57.16 Favored 'General case' 0 N--CA 1.511 2.581 0 C-N-CA 120.5 -0.48 . . . . 12.0 111.434 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -80.93 -48.54 12.18 Favored 'General case' 0 N--CA 1.512 2.641 0 CA-C-N 119.051 0.841 . . . . 12.0 110.08 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -32.11 68.58 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.916 -0.402 . . . . 12.0 109.916 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 16' ' ' ILE . 46.8 pt -80.26 -34.6 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 122.034 -0.416 . . . . 12.0 110.195 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -99.34 18.25 18.13 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 120.512 -0.475 . . . . 12.0 110.44 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -68.53 89.9 0.37 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 107.939 -1.134 . . . . 12.0 107.939 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.419 ' OD1' HD12 ' A' ' 27' ' ' ILE . 10.6 t-20 -166.88 159.54 13.62 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.209 -0.663 . . . . 12.0 109.209 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -72.8 -10.36 59.71 Favored 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 120.76 -0.376 . . . . 12.0 110.052 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 27' ' ' ILE . 57.9 mt -87.77 10.44 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.73 -0.606 . . . . 12.0 110.528 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -146.94 63.4 1.18 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.706 -0.621 . . . . 12.0 110.099 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.3 mt -153.19 149.02 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.57 -1.331 . . . . 12.0 111.07 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 31' ' ' GLY . 57.9 t -104.86 168.93 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 107.678 -1.23 . . . . 12.0 107.678 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.58 53.87 3.43 Favored Glycine 0 N--CA 1.501 2.991 0 N-CA-C 109.328 -1.509 . . . . 12.0 109.328 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.95 -55.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.388 -1.485 . . . . 12.0 109.388 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -166.43 -77.06 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.929 -0.767 . . . . 12.0 108.929 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 61.7 m -146.47 -170.71 3.57 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.827 -0.805 . . . . 12.0 108.827 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.5 -174.27 2.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.222 -0.658 . . . . 12.0 109.222 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -85.4 -25.4 27.04 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.981 -0.45 . . . . 12.0 110.591 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 72' ' ' THR . 10.1 t -151.51 107.37 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 C-N-CA 120.353 -0.539 . . . . 12.0 110.777 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.425 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 7.3 m120 -91.6 85.69 5.78 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 105.904 -1.887 . . . . 12.0 105.904 176.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.1 m -81.73 112.89 19.31 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.242 0.544 . . . . 12.0 111.763 -176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 23' ' ' MET . 32.7 m-85 -100.39 158.5 15.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.272 -1.381 . . . . 12.0 107.272 177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.3 mp -126.52 128.75 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 12.0 109.353 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.403 HG23 ' HG3' ' A' ' 67' ' ' GLN . 4.2 tt -111.14 129.28 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.632 ' O ' HD12 ' A' ' 11' ' ' ILE . 15.3 t 165.42 157.88 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 108.188 -1.041 . . . . 12.0 108.188 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.9 p -60.19 122.81 15.39 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 108.671 -0.863 . . . . 12.0 108.671 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.09 -29.24 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.136 -0.352 . . . . 12.0 111.803 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -79.92 -31.57 40.11 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.953 -0.467 . . . . 12.0 111.903 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 p -64.87 -36.04 83.06 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 107.474 -1.306 . . . . 12.0 107.474 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.05 -33.5 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.718 -1.215 . . . . 12.0 107.718 178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -66.75 -21.54 66.06 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.607 -0.516 . . . . 12.0 109.607 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.69 -41.2 24.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.794 -0.566 . . . . 12.0 109.76 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.591 HG21 ' CZ ' ' A' ' 66' ' ' PHE . 18.3 pt -67.15 -20.46 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.782 -0.574 . . . . 12.0 110.352 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.12 22.34 9.59 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.853 -0.53 . . . . 12.0 110.101 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 m -88.78 114.43 25.39 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.005 -0.739 . . . . 12.0 109.005 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.17 -61.21 0.02 OUTLIER Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.418 -1.073 . . . . 12.0 110.418 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.656 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.9 p -163.65 -168.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 -179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.656 ' H ' HG22 ' A' ' 55' ' ' VAL . 12.4 tt -87.26 27.09 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.6 0 O-C-N 121.097 -1.002 . . . . 12.0 110.958 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 6.1 t-20 171.1 113.8 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 N-CA-C 106.403 -1.703 . . . . 12.0 106.403 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.62 179.37 8.23 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.826 0.822 . . . . 12.0 112.132 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -137.55 115.1 11.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.617 -1.253 . . . . 12.0 107.617 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.557 HG13 ' CG1' ' A' ' 94' ' ' VAL . 11.9 p -128.71 166.35 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 121.897 -0.502 . . . . 12.0 109.653 -178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.571 HD21 ' HB2' ' A' ' 110' ' ' CYS . 3.8 mp -129.33 117.54 20.81 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.896 -0.502 . . . . 12.0 111.521 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.47 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 1.4 m -58.1 93.73 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 107.105 -1.443 . . . . 12.0 107.105 176.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.675 HG22 ' OH ' ' A' ' 91' ' ' TYR . 1.6 p -79.74 -53.5 6.75 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 112.249 0.463 . . . . 12.0 112.249 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.685 HG22 ' HG2' ' A' ' 65' ' ' ARG . 47.5 m -47.83 -90.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.866 -0.521 . . . . 12.0 110.271 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.846 ' CB ' HG23 ' A' ' 89' ' ' THR . 11.0 ptm180 174.43 100.9 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.591 ' CZ ' HG21 ' A' ' 51' ' ' ILE . 57.9 m-85 -97.88 54.62 1.15 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 109.237 -0.653 . . . . 12.0 109.237 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 42' ' ' ILE . 0.0 OUTLIER 11.88 109.03 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.431 1.271 . . . . 12.0 114.431 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -99.04 154.6 17.97 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.819 0.819 . . . . 12.0 111.756 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -119.22 100.23 7.2 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 106.083 -1.821 . . . . 12.0 106.083 177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 m -102.18 127.39 49.13 Favored 'General case' 0 N--CA 1.505 2.289 0 CA-C-O 121.659 0.743 . . . . 12.0 112.355 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.0 m -111.7 112.81 24.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 104.367 -2.457 . . . . 12.0 104.367 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.532 HG23 HG22 ' A' ' 37' ' ' VAL . 4.2 m -111.2 144.99 39.48 Favored 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 120.091 -0.644 . . . . 12.0 111.648 -176.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 -62.34 142.79 57.61 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.297 -1.001 . . . . 12.0 108.297 178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.99 -85.49 0.55 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.92 -0.488 . . . . 12.0 110.545 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.7 t -155.61 177.22 11.63 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.781 -0.574 . . . . 12.0 109.725 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.437 HG22 ' N ' ' A' ' 77' ' ' THR . 19.2 mt 61.91 166.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.67 -0.863 . . . . 12.0 108.67 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 78' ' ' PRO . 4.3 t -134.2 59.61 38.64 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.798 -0.564 . . . . 12.0 110.837 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 77' ' ' THR . 38.5 Cg_endo -85.25 175.33 6.48 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 121.923 1.749 . . . . 12.0 109.375 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -120.0 127.48 26.34 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.158 -1.053 . . . . 12.0 108.158 178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.15 -178.61 17.7 Favored 'Cis proline' 0 N--CA 1.487 1.143 0 O-C-N 122.856 0.924 . . . . 12.0 111.517 2.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER -60.69 149.52 78.95 Favored Pre-proline 0 N--CA 1.501 2.088 0 CA-C-O 119.09 -0.481 . . . . 12.0 110.809 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -80.33 113.05 2.85 Favored 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 122.119 1.879 . . . . 12.0 109.296 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 81' ' ' CYS . 12.1 m-85 -138.58 139.07 38.49 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.195 0.521 . . . . 12.0 111.119 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 m -111.33 129.35 56.02 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 107.897 -1.149 . . . . 12.0 107.897 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 t -93.91 149.45 21.22 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.39 0.614 . . . . 12.0 110.883 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.8 ttp180 -151.79 155.42 38.19 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.032 -0.729 . . . . 12.0 109.032 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.3 m -125.44 141.2 52.19 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 109.535 -0.543 . . . . 12.0 109.535 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -166.12 -172.03 2.16 Favored 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 121.095 0.474 . . . . 12.0 110.317 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.846 HG23 ' CB ' ' A' ' 65' ' ' ARG . 77.4 m -65.3 145.59 56.01 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.991 -0.744 . . . . 12.0 108.991 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -110.22 88.24 2.71 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.907 0.86 . . . . 12.0 111.371 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.675 ' OH ' HG22 ' A' ' 63' ' ' THR . 6.6 t80 -98.03 96.63 8.27 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 103.987 -2.597 . . . . 12.0 103.987 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.615 HG21 ' HZ ' ' A' ' 104' ' ' PHE . 7.1 tt -130.69 175.12 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 119.978 -0.689 . . . . 12.0 111.077 -175.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -117.77 116.63 27.4 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.65 -0.871 . . . . 12.0 108.65 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.557 ' CG1' HG13 ' A' ' 60' ' ' VAL . 14.8 p -108.88 162.06 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.989 -0.374 . . . . 12.0 109.989 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 94' ' ' VAL . 42.7 mtpt -120.35 144.8 47.67 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.307 -0.627 . . . . 12.0 109.307 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -119.55 120.63 37.31 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 114.003 1.112 . . . . 12.0 114.003 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 20.9 tt0 -128.37 141.8 51.31 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 104.076 -2.564 . . . . 12.0 104.076 174.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.9 m-80 57.21 28.64 15.41 Favored 'General case' 0 N--CA 1.514 2.73 0 N-CA-C 107.683 -1.228 . . . . 12.0 107.683 -176.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.423 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 3.7 pt20 51.22 16.17 0.36 Allowed 'General case' 0 N--CA 1.508 2.454 0 C-N-CA 124.754 1.222 . . . . 12.0 114.001 -178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.803 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -120.85 145.44 41.37 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 104.121 -2.548 . . . . 12.0 104.121 174.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.495 ' O ' ' CE2' ' A' ' 6' ' ' PHE . 24.5 Cg_endo -61.33 93.89 0.11 Allowed 'Trans proline' 0 C--O 1.2 -1.393 0 N-CA-C 108.429 -1.412 . . . . 12.0 108.429 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.803 HG22 ' CE2' ' A' ' 100' ' ' TYR . 63.4 t -91.73 -14.15 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 122.239 -0.288 . . . . 12.0 110.901 -177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.521 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -146.35 145.62 30.37 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.055 -1.091 . . . . 12.0 108.055 -177.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.615 ' HZ ' HG21 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -102.23 120.0 39.74 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.481 -1.288 . . . . 12.0 108.914 178.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.46 81.49 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.863 -0.523 . . . . 12.0 110.042 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.8 -158.86 23.27 Favored Glycine 0 N--CA 1.5 2.95 0 N-CA-C 109.896 -1.282 . . . . 12.0 109.896 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.416 HG13 ' N ' ' A' ' 108' ' ' GLY . 8.3 tp -54.58 162.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 122.173 -0.604 . . . . 12.0 109.725 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' N ' HG13 ' A' ' 107' ' ' ILE . . . -57.39 91.4 0.02 OUTLIER Glycine 0 N--CA 1.499 2.889 0 N-CA-C 109.462 -1.455 . . . . 12.0 109.462 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -176.46 107.16 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.318 -0.623 . . . . 12.0 109.318 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.571 ' HB2' HD21 ' A' ' 61' ' ' LEU . 11.9 m -151.55 60.66 3.87 Favored Pre-proline 0 N--CA 1.497 1.916 0 C-N-CA 120.759 -0.377 . . . . 12.0 110.086 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 110' ' ' CYS . 36.8 Cg_endo . . . . . 0 N--CA 1.48 0.686 0 C-N-CA 122.217 1.945 . . . . 12.0 110.338 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.47 0 N-CA-C 109.734 -0.469 . . . . 12.0 109.734 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -159.27 155.19 26.5 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.014 -0.735 . . . . 12.0 109.014 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -25.73 62.87 Favored 'General case' 0 N--CA 1.516 2.84 0 O-C-N 122.141 -0.35 . . . . 12.0 110.625 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.1 -61.83 1.72 Allowed 'General case' 0 N--CA 1.512 2.631 0 O-C-N 121.437 -0.789 . . . . 12.0 110.68 -178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.691 HG23 HD11 ' A' ' 27' ' ' ILE . 29.1 m -62.33 -32.48 73.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.997 -1.112 . . . . 12.0 107.997 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.531 ' CZ ' ' CD2' ' A' ' 10' ' ' HIS . 31.1 t80 -75.79 -23.63 55.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.636 -0.876 . . . . 12.0 108.636 177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -55.85 -34.25 65.26 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 106.96 -1.496 . . . . 12.0 106.96 177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.99 -38.76 52.51 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.728 -1.212 . . . . 12.0 107.728 177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 6' ' ' PHE . 11.1 mmtm -45.57 -51.32 12.13 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 122.232 -0.293 . . . . 12.0 110.856 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.926 ' ND1' HG11 ' A' ' 48' ' ' VAL . 2.1 m-70 -97.52 -13.97 21.36 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 118.837 -0.601 . . . . 12.0 112.153 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 10' ' ' HIS . 15.5 mm -123.18 64.53 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 114.896 1.443 . . . . 12.0 114.896 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.81 HG21 ' CD1' ' A' ' 40' ' ' PHE . 2.7 mp -98.89 63.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 103.984 -2.598 . . . . 12.0 103.984 173.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -73.09 78.61 1.23 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.734 0.778 . . . . 12.0 111.65 -176.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.677 ' OG1' HD12 ' A' ' 22' ' ' ILE . 3.0 p -139.64 75.15 32.2 Favored Pre-proline 0 N--CA 1.498 1.957 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.21 11.72 2.27 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.323 2.015 . . . . 12.0 113.59 -177.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.745 HD11 ' CG2' ' A' ' 22' ' ' ILE . 15.8 pt -60.99 -168.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-N 119.15 0.886 . . . . 12.0 108.684 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mm -106.93 36.85 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.533 -0.729 . . . . 12.0 109.698 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -142.37 101.45 3.9 Favored 'General case' 0 N--CA 1.507 2.392 0 N-CA-C 108.55 -0.907 . . . . 12.0 108.55 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.4 m -79.42 -14.45 58.93 Favored 'General case' 0 N--CA 1.511 2.583 0 O-C-N 121.961 -0.462 . . . . 12.0 111.108 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -85.03 -55.46 4.05 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-N 118.882 0.765 . . . . 12.0 110.12 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.09 -36.52 63.27 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 122.048 -0.408 . . . . 12.0 110.054 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.745 ' CG2' HD11 ' A' ' 16' ' ' ILE . 34.0 pt -81.24 -35.01 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.07 -0.715 . . . . 12.0 109.07 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.445 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 2.3 tmm? -99.07 32.03 2.82 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.399 -0.593 . . . . 12.0 109.399 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -87.07 48.36 1.64 Allowed 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.277 0.56 . . . . 12.0 110.002 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.625 ' OD1' HG22 ' A' ' 27' ' ' ILE . 10.3 t-20 -127.47 155.62 43.42 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.075 -0.713 . . . . 12.0 109.075 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -73.44 -10.72 60.03 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.89 -0.324 . . . . 12.0 110.711 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 5' ' ' THR . 21.3 tt -79.06 -0.91 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.587 -0.696 . . . . 12.0 110.761 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.664 ' O ' HD13 ' A' ' 29' ' ' ILE . 66.5 m-85 -119.61 54.91 0.98 Allowed 'General case' 0 N--CA 1.503 2.187 0 N-CA-C 109.387 -0.597 . . . . 12.0 109.387 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 28' ' ' TYR . 44.8 mm -139.01 152.06 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 121.108 -0.995 . . . . 12.0 110.376 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 31' ' ' GLY . 40.8 t -100.84 169.98 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 107.719 -1.215 . . . . 12.0 107.719 178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -91.02 53.9 3.27 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.283 -1.527 . . . . 12.0 109.283 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.44 -58.59 0.02 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.746 -1.742 . . . . 12.0 108.746 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -167.6 -73.24 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.066 -0.667 . . . . 12.0 109.482 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -144.54 177.55 8.59 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.71 -0.848 . . . . 12.0 108.71 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 159.74 22.4 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.341 -0.615 . . . . 12.0 109.341 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -72.05 -9.5 58.48 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 122.24 -0.287 . . . . 12.0 110.768 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.5 p -159.28 129.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-O 121.7 0.762 . . . . 12.0 111.037 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB2' ' CE2' ' A' ' 83' ' ' TYR . 1.7 t-20 -117.29 89.17 3.06 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 105.819 -1.919 . . . . 12.0 105.819 177.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.3 m -83.71 118.1 23.66 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.29 0.567 . . . . 12.0 111.83 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.81 ' CD1' HG21 ' A' ' 12' ' ' ILE . 23.3 m-85 -100.05 156.71 17.03 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.921 -1.511 . . . . 12.0 106.921 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.6 mt -133.31 127.84 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.283 -0.886 . . . . 12.0 108.975 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 42' ' ' ILE . 5.5 tt -107.53 107.89 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 121.44 0.638 . . . . 12.0 109.325 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.659 ' O ' HD12 ' A' ' 11' ' ' ILE . 39.9 t 176.57 154.12 0.21 Allowed 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.924 -0.769 . . . . 12.0 108.924 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.2 p -63.48 126.17 26.6 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.478 -0.934 . . . . 12.0 108.478 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.667 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -53.29 -26.97 20.52 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.074 -0.391 . . . . 12.0 110.942 -178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.7 t -80.14 -32.06 38.98 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.629 -0.428 . . . . 12.0 111.621 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.2 p -62.07 -40.31 95.37 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 106.77 -1.567 . . . . 12.0 106.77 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.926 HG11 ' ND1' ' A' ' 10' ' ' HIS . 39.5 t -69.53 -35.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.963 -1.125 . . . . 12.0 107.963 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -57.69 -25.42 60.27 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.97 -0.752 . . . . 12.0 108.97 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.77 -34.73 33.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.876 -0.515 . . . . 12.0 109.734 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.908 HD13 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -66.2 -28.62 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.767 -0.583 . . . . 12.0 110.544 -179.43 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.67 19.99 15.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.452 -0.78 . . . . 12.0 110.365 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.0 m -85.46 112.45 20.89 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 109.13 -0.693 . . . . 12.0 109.13 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.46 -63.45 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.925 -0.87 . . . . 12.0 110.925 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.0 p -158.65 -167.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 CA-C-N 118.015 0.907 . . . . 12.0 109.178 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.615 ' H ' HG22 ' A' ' 55' ' ' VAL . 3.8 tt -87.82 27.2 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.593 0 O-C-N 121.132 -0.98 . . . . 12.0 110.968 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 13.9 t-20 173.09 118.84 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 106.652 -1.61 . . . . 12.0 106.652 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.47 175.36 12.25 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 121.621 0.724 . . . . 12.0 111.528 -178.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -141.49 111.48 6.71 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.551 -1.277 . . . . 12.0 107.551 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.516 HG22 ' N ' ' A' ' 61' ' ' LEU . 8.3 p -140.04 167.65 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.547 -0.538 . . . . 12.0 109.547 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.516 ' N ' HG22 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -136.88 130.4 31.66 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.264 0.554 . . . . 12.0 111.24 -179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -59.52 102.9 0.16 Allowed 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.353 -1.351 . . . . 12.0 107.353 177.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.3 p -87.9 -37.2 16.67 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 122.251 -0.28 . . . . 12.0 110.254 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.0 m -59.22 -95.81 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.77 ' CB ' HG23 ' A' ' 89' ' ' THR . 1.8 ptt-85 177.01 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 118.919 0.781 . . . . 12.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -97.01 41.57 1.11 Allowed 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 109.318 -0.623 . . . . 12.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 23.77 105.89 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.255 0 N-CA-C 114.196 1.184 . . . . 12.0 114.196 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.593 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -104.77 157.1 17.43 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.936 0.874 . . . . 12.0 111.868 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -117.34 100.7 7.86 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 104.943 -2.243 . . . . 12.0 104.943 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 20.2 m -97.22 132.27 43.14 Favored 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.757 0.789 . . . . 12.0 112.471 -176.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 84' ' ' SER . 55.6 m -121.63 116.44 24.59 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 104.068 -2.567 . . . . 12.0 104.068 176.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 m -106.77 144.68 33.06 Favored 'General case' 0 N--CA 1.508 2.434 0 C-N-CA 120.195 -0.602 . . . . 12.0 111.88 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' A' ' 83' ' ' TYR . 0.3 OUTLIER -68.09 100.2 0.97 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.266 -0.642 . . . . 12.0 109.266 179.274 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 p -119.1 -112.5 0.34 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.569 -0.53 . . . . 12.0 109.569 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 76' ' ' ILE . 15.9 p -158.68 98.13 1.49 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 119.641 1.109 . . . . 12.0 109.647 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.536 HD11 ' O ' ' A' ' 83' ' ' TYR . 1.0 OUTLIER -157.89 139.28 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.572 -0.529 . . . . 12.0 109.572 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 78' ' ' PRO . 16.3 p 57.19 164.68 0.07 OUTLIER Pre-proline 0 N--CA 1.505 2.31 0 N-CA-C 109.93 -0.396 . . . . 12.0 109.93 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 35.0 Cg_endo -77.85 -71.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.481 0.74 0 C-N-CA 121.753 1.636 . . . . 12.0 111.004 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -113.9 164.79 15.09 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 122.122 -0.362 . . . . 12.0 110.116 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.4 -56.7 0.14 OUTLIER 'Cis proline' 0 N--CA 1.486 1.038 0 O-C-N 123.486 1.256 . . . . 12.0 109.701 0.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -133.14 156.85 79.53 Favored Pre-proline 0 N--CA 1.498 1.945 0 N-CA-C 108.467 -0.938 . . . . 12.0 108.467 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 83' ' ' TYR . 36.6 Cg_endo -75.25 116.64 4.6 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 121.645 1.564 . . . . 12.0 110.448 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.536 ' O ' HD11 ' A' ' 76' ' ' ILE . 15.7 m-85 -145.98 137.07 24.61 Favored 'General case' 0 N--CA 1.507 2.384 0 CA-C-O 121.319 0.58 . . . . 12.0 111.728 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 71' ' ' CYS . 7.9 t -107.83 153.88 22.36 Favored 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 106.691 -1.596 . . . . 12.0 106.691 176.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 t -107.79 156.53 19.02 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.563 -0.71 . . . . 12.0 111.456 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.7 ttt85 -166.09 158.67 14.68 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.316 -0.624 . . . . 12.0 109.316 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.8 p -135.06 147.66 49.67 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 109.053 -0.721 . . . . 12.0 109.053 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -169.84 -173.64 1.64 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.483 0.659 . . . . 12.0 110.744 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.77 HG23 ' CB ' ' A' ' 65' ' ' ARG . 85.8 m -66.69 142.75 57.31 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.206 -1.035 . . . . 12.0 108.206 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.401 ' HB2' ' N ' ' A' ' 68' ' ' LEU . 3.5 t-20 -104.96 87.41 2.64 Favored 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 119.451 -0.9 . . . . 12.0 111.567 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' SER . 6.1 p90 -107.22 105.6 15.65 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 105.445 -2.057 . . . . 12.0 105.445 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.606 HD12 ' CZ ' ' A' ' 104' ' ' PHE . 8.2 pt -137.2 -179.53 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 121.651 0.738 . . . . 12.0 111.926 -176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -117.37 109.94 17.43 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.425 -0.807 . . . . 12.0 110.316 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.561 HG13 ' CE1' ' A' ' 104' ' ' PHE . 0.6 OUTLIER -105.57 171.0 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 108.551 -0.907 . . . . 12.0 108.551 179.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 101' ' ' PRO . 9.3 mttp -129.18 140.52 51.47 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.531 -0.915 . . . . 12.0 108.531 178.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.7 m -110.45 121.81 46.2 Favored 'General case' 0 N--CA 1.508 2.474 0 N-CA-C 114.626 1.343 . . . . 12.0 114.626 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.493 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.0 tt0 -136.45 142.49 43.62 Favored 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 103.816 -2.661 . . . . 12.0 103.816 174.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 56.13 30.92 17.27 Favored 'General case' 0 N--CA 1.516 2.831 0 N-CA-C 107.212 -1.403 . . . . 12.0 107.212 -175.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 47.56 19.24 0.14 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 114.244 1.201 . . . . 12.0 114.244 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.841 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -126.94 145.55 54.26 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 104.585 -2.376 . . . . 12.0 104.585 175.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.506 ' HB3' HG11 ' A' ' 94' ' ' VAL . 21.9 Cg_endo -59.9 90.25 0.08 OUTLIER 'Trans proline' 0 C--O 1.207 -1.055 0 N-CA-C 108.899 -1.231 . . . . 12.0 108.899 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.841 HG22 ' CE2' ' A' ' 100' ' ' TYR . 44.0 t -87.57 -20.65 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-N 115.995 -0.548 . . . . 12.0 110.583 -177.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.493 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -137.66 144.03 41.64 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.367 -0.975 . . . . 12.0 108.367 -177.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.606 ' CZ ' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -107.97 126.83 53.17 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 118.851 -1.14 . . . . 12.0 109.537 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.64 -33.79 53.41 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.995 -0.372 . . . . 12.0 109.995 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.83 -133.66 6.9 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 110.764 -0.934 . . . . 12.0 110.764 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.7 pt -69.73 -172.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 122.344 -0.504 . . . . 12.0 111.004 -178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.08 -47.4 59.68 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 111.0 -0.84 . . . . 12.0 111.0 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -51.99 113.45 1.01 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.844 -0.798 . . . . 12.0 110.495 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.42 168.38 13.08 Favored Pre-proline 0 N--CA 1.5 2.038 0 N-CA-C 109.237 -0.653 . . . . 12.0 109.237 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 N--CA 1.48 0.701 0 C-N-CA 121.889 1.726 . . . . 12.0 110.253 179.512 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.508 2.447 0 N-CA-C 109.593 -0.521 . . . . 12.0 109.593 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -130.7 155.71 46.16 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.058 -0.719 . . . . 12.0 109.058 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -28.75 66.73 Favored 'General case' 0 N--CA 1.514 2.744 0 O-C-N 122.161 -0.337 . . . . 12.0 110.279 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 7' ' ' GLN . . . -73.96 -60.03 2.45 Favored 'General case' 0 N--CA 1.513 2.678 0 O-C-N 121.735 -0.603 . . . . 12.0 110.716 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m -62.35 -29.35 70.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.104 -1.073 . . . . 12.0 108.104 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 31.1 t80 -79.35 -23.79 43.14 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.174 -0.676 . . . . 12.0 109.174 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -57.93 -35.61 71.33 Favored 'General case' 0 N--CA 1.507 2.403 0 N-CA-C 106.696 -1.594 . . . . 12.0 106.696 177.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.09 -35.61 56.36 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.661 -1.237 . . . . 12.0 107.661 176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 11.7 tptt -46.07 -60.49 2.24 Favored 'General case' 0 N--CA 1.508 2.427 0 CA-C-N 116.686 -0.234 . . . . 12.0 110.407 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.616 ' CE1' HD11 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -103.42 -2.16 27.39 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.645 -0.659 . . . . 12.0 112.039 178.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 11' ' ' ILE . 4.2 mp -138.51 73.72 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.415 1.635 . . . . 12.0 115.415 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.929 HG21 HG23 ' A' ' 22' ' ' ILE . 19.3 mt -97.34 66.56 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 102.789 -3.041 . . . . 12.0 102.789 172.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -77.03 75.87 3.59 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 115.36 -0.836 . . . . 12.0 112.364 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.46 130.9 22.18 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 106.487 -1.672 . . . . 12.0 106.487 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.12 -24.43 38.55 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 121.277 1.318 . . . . 12.0 110.513 -178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 pt -72.42 148.49 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.183 -1.043 . . . . 12.0 108.183 178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.7 pt -111.41 85.44 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 CA-C-O 121.695 0.76 . . . . 12.0 109.221 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 36.0 m120 -147.3 104.84 3.69 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 16.1 m -75.76 -8.32 56.55 Favored 'General case' 0 N--CA 1.507 2.386 0 C-N-CA 120.63 -0.428 . . . . 12.0 110.847 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -69.68 -46.69 65.49 Favored 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 118.804 0.729 . . . . 12.0 109.223 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.4 m -82.72 -19.61 37.65 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.665 -0.494 . . . . 12.0 109.665 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.929 HG23 HG21 ' A' ' 12' ' ' ILE . 40.1 mt -87.17 -6.87 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.765 -0.584 . . . . 12.0 110.809 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm -109.51 -43.52 4.07 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.597 -0.89 . . . . 12.0 108.597 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.21 96.91 0.16 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 107.563 -1.273 . . . . 12.0 107.563 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -169.57 157.8 7.37 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.901 -0.777 . . . . 12.0 108.901 -178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -69.76 -10.88 60.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.048 -0.407 . . . . 12.0 110.076 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 27' ' ' ILE . 58.3 mt -91.46 13.67 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.723 -0.611 . . . . 12.0 110.356 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.534 ' OH ' HD11 ' A' ' 12' ' ' ILE . 53.5 m-85 -152.54 67.27 0.82 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.61 -0.681 . . . . 12.0 110.367 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 46.4 mt -146.34 135.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 120.593 -1.317 . . . . 12.0 110.477 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.563 HG22 ' H ' ' A' ' 31' ' ' GLY . 2.8 p -109.92 -162.69 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 107.446 -1.316 . . . . 12.0 107.446 178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.563 ' H ' HG22 ' A' ' 30' ' ' VAL . . . -96.25 67.72 1.0 Allowed Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.029 -1.044 . . . . 12.0 111.662 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -166.16 -66.8 0.03 OUTLIER Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.31 -1.516 . . . . 12.0 109.31 178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -165.56 -65.56 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 108.533 -0.914 . . . . 12.0 108.533 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 30.5 p -154.55 144.01 21.39 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.868 -0.79 . . . . 12.0 108.868 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -66.25 178.3 1.22 Allowed 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 109.824 -0.436 . . . . 12.0 109.824 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.15 15.87 22.93 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 122.249 -0.282 . . . . 12.0 110.61 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.0 p -162.8 120.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 O-C-N 121.854 -0.529 . . . . 12.0 109.816 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 75.6 m-20 -122.12 88.94 3.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.556 -1.276 . . . . 12.0 107.556 178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m -83.31 107.37 15.79 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 116.371 -0.377 . . . . 12.0 110.685 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.824 ' CD1' HD12 ' A' ' 12' ' ' ILE . 12.9 m-85 -98.57 159.79 14.71 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.066 -1.457 . . . . 12.0 107.066 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.755 HD12 ' C ' ' A' ' 40' ' ' PHE . 3.7 mp -130.26 129.49 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 108.748 -0.834 . . . . 12.0 108.748 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' ILE . 10.5 tt -101.34 106.27 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 109.15 -0.685 . . . . 12.0 109.15 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.1 t 176.66 154.47 0.22 Allowed 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 108.808 -0.812 . . . . 12.0 108.808 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 p -60.62 130.04 44.53 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 108.818 -0.808 . . . . 12.0 108.818 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' CA ' HG12 ' A' ' 11' ' ' ILE . . . -53.94 -27.21 29.56 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 122.067 -0.395 . . . . 12.0 111.385 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 t -82.43 -30.92 29.78 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 120.509 -0.476 . . . . 12.0 111.591 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.6 p -63.58 -37.01 85.7 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 106.874 -1.528 . . . . 12.0 106.874 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.862 ' O ' HG22 ' A' ' 51' ' ' ILE . 25.1 t -70.78 -36.06 63.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 107.311 -1.366 . . . . 12.0 107.311 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tttp -62.07 -23.46 66.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.221 -0.659 . . . . 12.0 109.221 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.99 -36.48 30.62 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.953 -0.467 . . . . 12.0 109.839 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.889 HD13 ' O ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -65.3 -29.41 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.837 -0.539 . . . . 12.0 110.088 -179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.23 24.53 6.33 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.753 -0.592 . . . . 12.0 110.069 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 25.2 m -87.8 113.22 23.26 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.496 -0.557 . . . . 12.0 109.496 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.2 -64.46 0.01 OUTLIER Glycine 0 N--CA 1.498 2.825 0 N-CA-C 109.872 -1.291 . . . . 12.0 109.872 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.692 HG12 ' HG3' ' A' ' 58' ' ' MET . 2.4 p -160.49 -165.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.42 -0.956 . . . . 12.0 108.42 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.586 ' H ' HG22 ' A' ' 55' ' ' VAL . 45.6 pt -89.77 26.5 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.567 0 O-C-N 121.102 -0.999 . . . . 12.0 111.326 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 50.5 t30 173.22 115.94 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 N-CA-C 107.642 -1.244 . . . . 12.0 107.642 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.692 ' HG3' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -165.3 178.76 6.66 Favored 'General case' 0 N--CA 1.505 2.325 0 CA-C-O 121.909 0.861 . . . . 12.0 111.904 -178.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -134.04 116.52 15.58 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 106.735 -1.58 . . . . 12.0 106.735 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 61' ' ' LEU . 13.0 t -130.25 167.59 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.87 -0.519 . . . . 12.0 109.788 -177.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' N ' HG12 ' A' ' 60' ' ' VAL . 2.8 mp -122.59 110.53 15.67 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.9 -0.407 . . . . 12.0 109.9 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 4.6 m -56.88 91.51 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.371 0 N-CA-C 108.666 -0.865 . . . . 12.0 108.666 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.892 HG22 ' OH ' ' A' ' 91' ' ' TYR . 3.0 p -81.79 -50.94 8.66 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 109.343 -0.614 . . . . 12.0 109.343 -178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.428 ' O ' ' CD2' ' A' ' 66' ' ' PHE . 64.7 m -61.02 108.7 0.92 Allowed 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 107.786 -1.191 . . . . 12.0 107.786 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.821 ' CB ' HG23 ' A' ' 89' ' ' THR . 23.2 ptt85 -40.0 108.67 0.09 Allowed 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.108 0.48 . . . . 12.0 112.245 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.428 ' CD2' ' O ' ' A' ' 64' ' ' THR . 47.6 m-85 -95.87 42.73 1.09 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 108.8 -0.815 . . . . 12.0 108.8 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 18.22 105.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 113.904 1.076 . . . . 12.0 113.904 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -101.22 157.3 16.88 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 12.0 112.324 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -121.29 97.16 5.39 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 105.264 -2.125 . . . . 12.0 105.264 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.6 m -101.87 124.39 47.42 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.811 -0.756 . . . . 12.0 112.034 -176.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 46.4 m -110.65 108.64 18.62 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 104.254 -2.498 . . . . 12.0 104.254 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -111.99 140.3 46.78 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 119.817 -0.753 . . . . 12.0 111.869 -176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -65.03 117.41 7.62 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.089 -1.078 . . . . 12.0 108.089 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.5 p -102.16 -128.81 0.23 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.982 -0.747 . . . . 12.0 108.982 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 18.3 t -148.85 174.22 12.46 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.296 -0.877 . . . . 12.0 109.238 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 23.9 mm 63.72 149.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.914 -0.773 . . . . 12.0 108.914 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.3 m 57.28 68.96 1.79 Allowed Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 109.112 -0.699 . . . . 12.0 109.112 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -75.06 136.53 20.4 Favored 'Trans proline' 0 N--CA 1.478 0.604 0 C-N-CA 121.95 1.767 . . . . 12.0 110.498 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.602 ' N ' ' HA ' ' A' ' 80' ' ' PRO . 32.2 mtt180 -93.72 -38.22 0.32 Allowed Pre-proline 0 N--CA 1.492 1.644 0 CA-C-O 117.408 -1.282 . . . . 12.0 113.732 -178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.602 ' HA ' ' N ' ' A' ' 79' ' ' ARG . 34.3 Cg_endo -73.98 177.38 38.11 Favored 'Cis proline' 0 N--CA 1.487 1.107 0 CA-C-N 120.522 1.222 . . . . 12.0 111.542 1.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.468 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 0.1 OUTLIER 72.92 57.62 0.35 Allowed Pre-proline 0 N--CA 1.503 2.18 0 O-C-N 122.144 -0.348 . . . . 12.0 110.303 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 81' ' ' CYS . 35.1 Cg_endo -77.13 122.22 6.1 Favored 'Trans proline' 0 N--CA 1.482 0.825 0 C-N-CA 122.255 1.97 . . . . 12.0 109.649 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.452 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 5.4 m-85 -115.88 138.67 50.95 Favored 'General case' 0 N--CA 1.507 2.422 0 CA-C-O 121.634 0.73 . . . . 12.0 111.832 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 56.9 p -110.87 131.0 55.42 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 107.393 -1.336 . . . . 12.0 107.393 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 81.0 p -96.46 141.73 29.4 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-O 121.511 0.672 . . . . 12.0 111.608 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -152.88 127.88 9.67 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.35 -0.982 . . . . 12.0 108.35 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 68' ' ' LEU . 5.3 m -109.64 149.85 29.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 122.031 -0.418 . . . . 12.0 110.209 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' CG ' HD11 ' A' ' 68' ' ' LEU . 11.4 pt-20 -175.21 -168.97 0.36 Allowed 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 120.909 0.385 . . . . 12.0 110.234 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.821 HG23 ' CB ' ' A' ' 65' ' ' ARG . 95.8 m -57.68 142.28 45.61 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.994 -0.373 . . . . 12.0 109.994 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.413 ' HB3' ' C ' ' A' ' 66' ' ' PHE . 7.2 t-20 -109.21 88.48 2.74 Favored 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 121.901 0.857 . . . . 12.0 110.88 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.892 ' OH ' HG22 ' A' ' 63' ' ' THR . 1.1 t80 -104.39 101.23 10.93 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.75 -1.944 . . . . 12.0 105.75 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.854 HD12 ' CE1' ' A' ' 104' ' ' PHE . 6.2 pt -134.09 -179.19 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.586 -0.846 . . . . 12.0 111.719 -176.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 10.3 t -115.18 120.74 40.75 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.175 -1.046 . . . . 12.0 108.175 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.586 HG23 ' CZ ' ' A' ' 104' ' ' PHE . 6.9 p -115.69 170.11 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 122.243 -0.286 . . . . 12.0 110.295 -178.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.488 ' H ' HG22 ' A' ' 94' ' ' VAL . 18.0 mttt -131.54 140.19 49.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.565 -0.902 . . . . 12.0 108.565 178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.3 m -113.49 122.55 47.62 Favored 'General case' 0 N--CA 1.506 2.345 0 N-CA-C 114.19 1.182 . . . . 12.0 114.19 -177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 16.1 tt0 -131.73 143.35 50.18 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 174.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 15.2 m-80 53.51 29.47 9.09 Favored 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.765 -1.198 . . . . 12.0 107.765 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.445 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 15.2 pt20 53.83 5.87 0.07 Allowed 'General case' 0 N--CA 1.51 2.57 0 N-CA-C 114.822 1.415 . . . . 12.0 114.822 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -111.85 145.4 32.62 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 104.765 -2.309 . . . . 12.0 104.765 175.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.535 ' HB3' HG21 ' A' ' 94' ' ' VAL . 24.5 Cg_endo -60.95 89.47 0.09 OUTLIER 'Trans proline' 0 C--O 1.209 -0.942 0 N-CA-C 108.85 -1.25 . . . . 12.0 108.85 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.939 HG22 ' CE2' ' A' ' 100' ' ' TYR . 95.1 t -85.61 -22.49 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 CA-C-N 116.214 -0.448 . . . . 12.0 110.332 -178.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.491 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -133.68 143.33 48.47 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.258 -1.386 . . . . 12.0 107.258 -178.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.854 ' CE1' HD12 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -119.29 128.69 54.38 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.166 -1.014 . . . . 12.0 110.375 -179.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.697 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -73.4 -42.18 62.41 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 116.568 -0.287 . . . . 12.0 110.312 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.72 -129.54 5.84 Favored Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.478 -0.867 . . . . 12.0 111.009 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 tt -60.74 165.97 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 122.222 -0.575 . . . . 12.0 110.567 -178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 92' ' ' ILE . . . -50.88 -50.66 37.22 Favored Glycine 0 N--CA 1.503 3.156 0 N-CA-C 110.648 -0.981 . . . . 12.0 110.648 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.26 99.23 0.13 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 122.214 -0.58 . . . . 12.0 109.462 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 64.3 m -60.03 151.27 66.44 Favored Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 108.795 -0.817 . . . . 12.0 108.795 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.481 0.748 0 C-N-CA 121.601 1.534 . . . . 12.0 110.292 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . 0.508 ' HA ' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.506 2.329 0 N-CA-C 109.995 -0.372 . . . . 12.0 109.995 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 4' ' ' ALA . 33.0 t30 -98.97 155.72 17.28 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.194 -0.669 . . . . 12.0 109.194 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.413 ' CZ2' ' HB2' ' A' ' 100' ' ' TYR . 0.0 OUTLIER -71.81 -29.19 64.17 Favored 'General case' 0 N--CA 1.512 2.653 0 O-C-N 122.096 -0.377 . . . . 12.0 110.465 -178.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.46 ' HB3' ' ND2' ' A' ' 2' ' ' ASN . . . -72.91 -58.72 3.12 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.901 -0.499 . . . . 12.0 110.571 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.1 m -63.36 -30.85 71.91 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.171 -1.048 . . . . 12.0 108.171 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.484 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 30.1 t80 -77.13 -22.75 52.17 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 109.103 -0.703 . . . . 12.0 109.103 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -61.26 -38.34 86.35 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.084 -1.45 . . . . 12.0 107.084 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.89 -35.61 57.27 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.421 -1.325 . . . . 12.0 107.421 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -44.21 -57.06 3.66 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 116.355 -0.384 . . . . 12.0 110.763 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.731 ' ND1' HD13 ' A' ' 41' ' ' ILE . 76.0 m-70 -108.26 -4.05 17.88 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 114.062 1.134 . . . . 12.0 114.062 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 45' ' ' ALA . 39.2 mm -122.38 64.83 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 C-N-CA 118.566 -1.253 . . . . 12.0 113.597 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.66 HD13 ' HA ' ' A' ' 40' ' ' PHE . 3.1 mp -98.2 56.81 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.348 -2.093 . . . . 12.0 105.348 174.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.669 ' O ' HG23 ' A' ' 14' ' ' THR . 8.0 p30 -54.58 85.46 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 CA-C-O 121.46 0.648 . . . . 12.0 111.15 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 13' ' ' ASN . 12.7 p -164.66 57.73 0.56 Allowed Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 107.65 -1.241 . . . . 12.0 107.65 178.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' N ' ' A' ' 14' ' ' THR . 35.9 Cg_endo -74.98 82.57 1.97 Allowed 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 121.936 1.757 . . . . 12.0 110.457 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.49 -162.66 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 N-CA-C 108.154 -1.054 . . . . 12.0 108.154 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 13.5 pt -102.19 30.96 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 N-CA-C 109.073 -0.714 . . . . 12.0 109.073 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -140.79 95.36 2.84 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 108.279 -1.008 . . . . 12.0 108.279 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.429 ' HA ' HD11 ' A' ' 22' ' ' ILE . 46.3 m -77.04 -18.61 58.0 Favored 'General case' 0 N--CA 1.507 2.4 0 C-N-CA 120.266 -0.574 . . . . 12.0 111.389 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.12 -52.35 7.47 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 119.082 0.855 . . . . 12.0 110.315 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -52.11 -33.26 38.92 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 109.511 -0.551 . . . . 12.0 109.511 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 19' ' ' CYS . 44.6 pt -82.38 -37.44 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 109.904 -0.406 . . . . 12.0 109.904 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -104.68 40.64 1.45 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.444 0.64 . . . . 12.0 109.305 179.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -87.77 50.07 1.92 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.511 0.672 . . . . 12.0 109.684 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.666 ' OD1' HG23 ' A' ' 27' ' ' ILE . 10.9 t-20 -127.87 161.33 29.31 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.045 -0.724 . . . . 12.0 109.045 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -74.76 -8.91 57.87 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 120.789 -0.364 . . . . 12.0 110.795 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.666 HG23 ' OD1' ' A' ' 25' ' ' ASN . 32.0 pt -80.17 -3.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.574 -0.704 . . . . 12.0 111.113 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -112.3 47.52 1.06 Allowed 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.744 -0.598 . . . . 12.0 110.578 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mt -150.33 144.92 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.027 -1.046 . . . . 12.0 110.302 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 31' ' ' GLY . 49.4 t -106.78 169.25 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 N-CA-C 107.711 -1.218 . . . . 12.0 107.711 178.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.77 61.33 3.1 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.013 -1.635 . . . . 12.0 109.013 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -146.05 -65.06 0.01 OUTLIER Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.052 -1.619 . . . . 12.0 109.052 179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -168.95 -79.13 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-N 117.703 0.751 . . . . 12.0 109.792 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.9 t -145.38 131.11 18.98 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.647 -0.871 . . . . 12.0 108.647 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.0 tttm -61.77 164.96 5.64 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.479 -0.564 . . . . 12.0 109.479 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -102.05 -3.18 28.05 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 122.24 -0.288 . . . . 12.0 111.01 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 37' ' ' VAL . 12.6 p -162.48 114.58 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.603 -0.686 . . . . 12.0 110.645 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.417 ' OD1' ' CE2' ' A' ' 83' ' ' TYR . 8.3 m120 -107.29 84.78 2.02 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.678 -1.601 . . . . 12.0 106.678 177.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 m -80.9 109.49 15.52 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 116.071 -0.513 . . . . 12.0 110.648 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.66 ' HA ' HD13 ' A' ' 12' ' ' ILE . 19.3 m-85 -98.73 161.7 13.51 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.805 -1.554 . . . . 12.0 106.805 178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.731 HD13 ' ND1' ' A' ' 10' ' ' HIS . 1.1 mp -130.98 132.54 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-N 119.335 0.971 . . . . 12.0 109.54 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 42' ' ' ILE . 5.7 tp -108.44 105.42 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.195 -1.039 . . . . 12.0 108.195 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.9 t 179.54 153.33 0.45 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.183 -0.673 . . . . 12.0 109.183 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.61 122.07 9.07 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-O 121.794 0.807 . . . . 12.0 109.827 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.638 ' HA ' HD11 ' A' ' 11' ' ' ILE . . . -46.42 -64.96 0.63 Allowed 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 113.613 0.968 . . . . 12.0 113.613 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.7 p -62.72 -17.03 60.07 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.165 -0.614 . . . . 12.0 111.235 -177.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.652 HG22 ' HE2' ' A' ' 66' ' ' PHE . 96.2 m -66.01 -36.68 83.94 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 107.302 -1.369 . . . . 12.0 107.302 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.768 ' O ' HG22 ' A' ' 51' ' ' ILE . 44.6 t -71.26 -35.72 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.048 -1.464 . . . . 12.0 107.048 176.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -63.73 -21.73 66.55 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.992 -0.744 . . . . 12.0 108.992 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.54 -38.7 25.78 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 122.0 -0.438 . . . . 12.0 110.015 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.768 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.3 tp -65.4 -22.74 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.769 -0.582 . . . . 12.0 109.91 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.1 35.86 2.27 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.802 -0.561 . . . . 12.0 109.805 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.4 m -96.76 112.8 24.4 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 109.184 -0.672 . . . . 12.0 109.184 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.03 -63.02 0.02 OUTLIER Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.598 -1.001 . . . . 12.0 110.598 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.611 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.8 p -162.12 -167.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.691 -0.855 . . . . 12.0 108.691 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.9 pt -88.25 26.21 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.537 0 O-C-N 121.024 -1.047 . . . . 12.0 111.317 -178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 174.05 112.99 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 N-CA-C 107.508 -1.293 . . . . 12.0 107.508 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.8 -176.37 4.57 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.984 0.897 . . . . 12.0 111.955 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -140.14 124.59 17.97 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 106.697 -1.594 . . . . 12.0 106.697 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG13 ' CG2' ' A' ' 94' ' ' VAL . 10.0 p -137.32 166.01 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.735 -0.603 . . . . 12.0 109.727 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.492 ' N ' HG22 ' A' ' 60' ' ' VAL . 4.7 mt -126.27 112.56 15.87 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.904 -0.498 . . . . 12.0 112.193 -178.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.454 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 4.0 m -67.7 91.2 0.29 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 105.691 -1.966 . . . . 12.0 105.691 176.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -86.77 -37.41 17.88 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 122.149 -0.344 . . . . 12.0 111.634 -176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.697 HG22 ' HG2' ' A' ' 65' ' ' ARG . 89.8 m -53.88 -92.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 109.195 -0.669 . . . . 12.0 109.195 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.735 ' HB3' HG23 ' A' ' 89' ' ' THR . 0.0 OUTLIER 176.15 103.47 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.778 0.717 . . . . 12.0 109.563 179.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.652 ' HE2' HG22 ' A' ' 47' ' ' THR . 49.9 m-85 -96.89 44.51 1.06 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 108.486 -0.931 . . . . 12.0 108.486 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 14.79 105.65 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.254 0 N-CA-C 114.087 1.143 . . . . 12.0 114.087 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.79 156.35 17.89 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.939 0.876 . . . . 12.0 111.972 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.14 99.17 6.55 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 105.675 -1.972 . . . . 12.0 105.675 177.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.4 m -100.51 125.06 46.8 Favored 'General case' 0 N--CA 1.503 2.199 0 C-N-CA 120.011 -0.676 . . . . 12.0 112.555 -176.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.9 m -105.79 111.53 24.24 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 104.187 -2.523 . . . . 12.0 104.187 175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 m -101.89 140.41 36.2 Favored 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 120.014 -0.675 . . . . 12.0 111.519 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 3.7 tmt_? -72.6 105.99 4.46 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.122 -0.696 . . . . 12.0 109.122 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 p -137.8 -83.72 0.32 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 110.014 -0.365 . . . . 12.0 110.014 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.55 108.77 0.1 Allowed 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 109.512 -0.551 . . . . 12.0 109.512 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.4 tp -179.09 152.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 N-CA-C 109.427 -0.583 . . . . 12.0 109.427 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 56.4 171.47 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.361 0 O-C-N 121.945 -0.472 . . . . 12.0 109.811 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -79.47 -82.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.109 1.873 . . . . 12.0 111.747 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.462 ' CB ' ' HA ' ' A' ' 80' ' ' PRO . 0.1 OUTLIER -125.2 172.59 5.9 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.751 -0.593 . . . . 12.0 109.9 -178.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HA ' ' CB ' ' A' ' 79' ' ' ARG . 31.0 Cg_endo -71.57 -65.05 0.03 OUTLIER 'Cis proline' 0 N--CA 1.489 1.232 0 O-C-N 123.26 1.137 . . . . 12.0 110.671 1.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 4.5 m -110.5 158.27 35.9 Favored Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 108.652 -0.87 . . . . 12.0 108.652 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 33.0 Cg_endo -72.74 113.95 3.89 Favored 'Trans proline' 0 N--CA 1.483 0.86 0 C-N-CA 121.492 1.461 . . . . 12.0 109.829 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE2' ' OD1' ' A' ' 38' ' ' ASN . 12.9 m-85 -140.2 134.22 30.84 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.083 0.468 . . . . 12.0 110.917 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.9 p -109.0 128.66 55.14 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 107.857 -1.164 . . . . 12.0 107.857 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.5 p -89.55 139.88 30.1 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.306 0.574 . . . . 12.0 110.909 -178.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -147.97 158.41 44.03 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.511 -0.922 . . . . 12.0 108.511 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 18.3 m -139.67 148.72 42.79 Favored 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 109.537 -0.542 . . . . 12.0 109.537 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -177.22 -176.49 0.65 Allowed 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.501 -0.48 . . . . 12.0 110.279 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.735 HG23 ' HB3' ' A' ' 65' ' ' ARG . 58.9 m -53.86 141.02 28.64 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.778 -0.453 . . . . 12.0 109.778 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.593 ' OD1' HD23 ' A' ' 68' ' ' LEU . 61.8 t30 -110.47 86.11 2.24 Favored 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 119.593 -0.843 . . . . 12.0 112.596 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -95.67 100.73 12.42 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 105.0 -2.222 . . . . 12.0 105.0 175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.445 HG12 ' CE2' ' A' ' 104' ' ' PHE . 0.7 OUTLIER -122.93 149.6 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-O 121.546 0.689 . . . . 12.0 111.929 -175.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 25.1 t -92.48 136.01 33.57 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 105.523 -2.029 . . . . 12.0 105.523 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.533 ' CG2' HG13 ' A' ' 60' ' ' VAL . 2.8 m -140.57 -176.58 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 C-N-CA 120.275 -0.57 . . . . 12.0 111.004 -176.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.451 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 40.0 mtmt -147.95 149.22 31.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.371 -0.603 . . . . 12.0 109.371 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.0 m -118.78 117.57 29.25 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.688 0.756 . . . . 12.0 112.839 -177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.478 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 18.2 tt0 -124.52 143.77 50.49 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 103.844 -2.65 . . . . 12.0 103.844 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 2.7 m120 55.46 27.17 9.79 Favored 'General case' 0 N--CA 1.514 2.756 0 CA-C-N 119.845 1.202 . . . . 12.0 107.946 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.417 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 18.4 pt20 54.59 8.85 0.23 Allowed 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 125.098 1.359 . . . . 12.0 114.382 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.869 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -114.88 146.74 36.74 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 104.731 -2.322 . . . . 12.0 104.731 174.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.486 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.5 Cg_endo -59.88 88.92 0.07 OUTLIER 'Trans proline' 0 C--O 1.208 -1.005 0 C-N-CA 121.331 1.354 . . . . 12.0 109.282 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.869 HG22 ' CE2' ' A' ' 100' ' ' TYR . 54.3 t -84.45 -19.14 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 116.295 -0.411 . . . . 12.0 110.468 -177.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.489 ' N ' ' CD2' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -136.83 134.42 36.93 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.633 -0.877 . . . . 12.0 108.633 -177.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.596 ' CD2' ' CE1' ' A' ' 10' ' ' HIS . 0.2 OUTLIER -123.78 129.81 51.64 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.963 -0.695 . . . . 12.0 109.395 -179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.599 ' HB3' ' HB3' ' A' ' 93' ' ' CYS . . . -85.91 -41.98 14.47 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.229 -0.295 . . . . 12.0 110.728 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 124.95 -99.88 0.59 Allowed Glycine 0 N--CA 1.504 3.186 0 C-N-CA 120.295 -0.955 . . . . 12.0 111.139 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.9 pt -58.29 147.59 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.844 -0.797 . . . . 12.0 110.294 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.29 -35.37 82.43 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.836 -1.306 . . . . 12.0 109.836 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -66.14 117.0 7.83 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.326 -0.62 . . . . 12.0 109.326 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.462 ' HB2' HD21 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.34 168.95 14.39 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 109.121 -0.696 . . . . 12.0 109.121 -179.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 N--CA 1.479 0.646 0 C-N-CA 121.829 1.686 . . . . 12.0 109.973 179.59 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . 0.452 ' HA ' HG13 ' A' ' 102' ' ' VAL . . . . . . . . 0 N--CA 1.506 2.358 0 N-CA-C 109.921 -0.4 . . . . 12.0 109.921 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -85.88 154.56 21.43 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.418 -0.586 . . . . 12.0 109.418 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -42.49 65.23 Favored 'General case' 0 N--CA 1.513 2.716 0 O-C-N 122.031 -0.418 . . . . 12.0 110.009 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.55 42.86 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.804 -0.56 . . . . 12.0 110.451 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -65.39 -29.56 70.29 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.471 -0.937 . . . . 12.0 108.471 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.459 ' HA ' ' HB2' ' A' ' 9' ' ' LYS . 35.5 t80 -76.97 -20.0 56.63 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.866 -0.79 . . . . 12.0 108.866 178.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.471 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 12.3 tt0 -64.2 -38.88 92.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 106.475 -1.676 . . . . 12.0 106.475 178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.441 ' O ' HD11 ' A' ' 12' ' ' ILE . 4.5 mp0 -77.65 -32.83 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.618 -1.252 . . . . 12.0 107.618 176.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 6' ' ' PHE . 0.7 OUTLIER -43.25 -64.4 0.65 Allowed 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 110.298 -0.26 . . . . 12.0 110.298 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.524 ' CE1' ' CD2' ' A' ' 104' ' ' PHE . 88.8 m-70 -110.08 -23.2 11.42 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.2 0.815 . . . . 12.0 113.2 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 43' ' ' SER . 22.9 mm -93.81 57.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 CA-C-N 119.254 0.934 . . . . 12.0 113.234 -177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 12' ' ' ILE . 4.1 mp -90.13 76.25 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 105.42 -2.067 . . . . 12.0 105.42 175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -76.15 79.44 2.97 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 121.794 0.807 . . . . 12.0 110.125 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.2 p -135.0 70.36 70.22 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 107.261 -1.385 . . . . 12.0 107.261 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -71.94 86.3 0.92 Allowed 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 121.825 1.683 . . . . 12.0 111.045 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.586 HD11 HG23 ' A' ' 22' ' ' ILE . 24.9 pt -136.07 -167.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.201 -1.037 . . . . 12.0 108.201 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.08 38.39 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.666 0.746 . . . . 12.0 109.352 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -153.1 101.36 2.56 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 116.292 -0.413 . . . . 12.0 109.963 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.533 ' HA ' HD11 ' A' ' 22' ' ' ILE . 5.3 m -81.26 -5.86 58.24 Favored 'General case' 0 N--CA 1.511 2.575 0 O-C-N 122.054 -0.404 . . . . 12.0 111.014 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -83.13 -55.24 4.47 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.496 -0.753 . . . . 12.0 111.501 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.0 m -61.54 -23.09 65.71 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.679 -0.638 . . . . 12.0 110.719 -178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 16' ' ' ILE . 11.9 pt -84.53 -35.08 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.64 -0.663 . . . . 12.0 109.621 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.587 ' HE3' ' HA ' ' A' ' 23' ' ' MET . 0.7 OUTLIER -95.79 12.78 28.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 122.004 -0.435 . . . . 12.0 110.625 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -67.58 90.41 0.26 Allowed 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 107.334 -1.358 . . . . 12.0 107.334 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.409 HD21 HD12 ' A' ' 27' ' ' ILE . 58.9 t30 -172.79 152.85 2.55 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.317 -0.623 . . . . 12.0 109.317 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -68.0 -11.98 59.92 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 110.044 -0.354 . . . . 12.0 110.044 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 27' ' ' ILE . 61.8 mt -86.59 9.66 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 121.727 -0.608 . . . . 12.0 110.811 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -144.12 63.16 1.34 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.599 -0.688 . . . . 12.0 109.181 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -148.08 151.99 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.33 0 O-C-N 120.593 -1.317 . . . . 12.0 111.02 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 31' ' ' GLY . 49.1 t -102.75 170.23 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.208 0 N-CA-C 107.376 -1.342 . . . . 12.0 107.376 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.489 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.71 52.7 3.34 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.372 -1.491 . . . . 12.0 109.372 -179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -164.43 -56.69 0.02 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.304 -1.518 . . . . 12.0 109.304 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -165.87 -69.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.023 -0.732 . . . . 12.0 109.023 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.41 ' O ' HG21 ' A' ' 30' ' ' VAL . 61.2 m -140.92 -169.72 2.88 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.726 -0.842 . . . . 12.0 108.726 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HA ' HG21 ' A' ' 30' ' ' VAL . 1.6 tttp -115.0 167.16 11.05 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.163 -0.68 . . . . 12.0 109.163 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -76.76 -17.39 59.09 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.859 -0.336 . . . . 12.0 110.465 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 37' ' ' VAL . 11.4 p -161.53 118.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 121.36 0.6 . . . . 12.0 110.824 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -114.22 86.28 2.39 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.333 -1.729 . . . . 12.0 106.333 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -87.24 123.89 32.73 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.485 0.659 . . . . 12.0 111.373 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -108.5 163.36 13.29 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.977 -1.49 . . . . 12.0 106.977 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.1 mt -131.32 132.01 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.218 -0.926 . . . . 12.0 109.458 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.4 ' CG1' ' HB2' ' A' ' 69' ' ' ASN . 12.1 mm -100.29 108.83 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 108.979 -0.749 . . . . 12.0 108.979 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.518 ' O ' HD12 ' A' ' 11' ' ' ILE . 37.7 t 177.6 150.21 0.19 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.167 -0.679 . . . . 12.0 109.167 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.8 p -59.95 130.11 45.13 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.804 -0.813 . . . . 12.0 108.804 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -51.36 -24.54 4.86 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.486 . . . . 12.0 111.224 -178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -84.78 -32.27 23.48 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.41 -0.516 . . . . 12.0 111.613 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.7 p -62.99 -38.92 93.11 Favored 'General case' 0 N--CA 1.505 2.308 0 N-CA-C 107.117 -1.438 . . . . 12.0 107.117 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.787 ' O ' HG22 ' A' ' 51' ' ' ILE . 25.9 t -70.71 -35.7 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.564 -1.273 . . . . 12.0 107.564 177.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.15 -23.95 66.88 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.145 -0.687 . . . . 12.0 109.145 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.14 -36.95 29.61 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.976 -0.452 . . . . 12.0 110.158 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 48' ' ' VAL . 8.5 tp -66.45 -23.74 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.801 -0.562 . . . . 12.0 110.386 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.89 27.61 6.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.828 -0.545 . . . . 12.0 109.947 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 m -90.99 114.92 27.56 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 109.452 -0.573 . . . . 12.0 109.452 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.48 -62.64 0.02 OUTLIER Glycine 0 N--CA 1.5 2.93 0 N-CA-C 110.152 -1.179 . . . . 12.0 110.152 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 56' ' ' ILE . 2.9 p -159.94 -168.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.69 -0.856 . . . . 12.0 108.69 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.593 ' H ' HG22 ' A' ' 55' ' ' VAL . 7.9 pt -88.14 25.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.655 0 O-C-N 121.118 -0.989 . . . . 12.0 111.39 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 174.0 115.03 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 107.521 -1.288 . . . . 12.0 107.521 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 176.82 10.99 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.69 0.757 . . . . 12.0 111.491 -178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -138.85 117.4 12.12 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.29 -1.374 . . . . 12.0 107.29 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 61' ' ' LEU . 7.4 p -150.15 165.27 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.977 -0.749 . . . . 12.0 108.977 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.3 mp -125.73 125.64 43.33 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 120.758 -0.377 . . . . 12.0 110.808 -179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.503 ' HB3' ' CD1' ' A' ' 66' ' ' PHE . 0.8 OUTLIER -58.31 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 177.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 p -86.44 -23.17 26.14 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.956 -0.465 . . . . 12.0 110.943 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.2 m -59.57 -88.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.497 -0.557 . . . . 12.0 109.497 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.821 ' HG3' HG23 ' A' ' 89' ' ' THR . 28.9 ttt-85 172.71 96.01 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 108.596 -0.89 . . . . 12.0 108.596 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.503 ' CD1' ' HB3' ' A' ' 62' ' ' SER . 73.0 m-85 -105.17 57.52 0.68 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 109.253 -0.647 . . . . 12.0 109.253 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 66' ' ' PHE . 5.5 pt20 -4.5 114.26 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.366 0 N-CA-C 114.557 1.317 . . . . 12.0 114.557 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -105.22 158.22 16.75 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.224 1.011 . . . . 12.0 112.94 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.4 ' HB2' ' CG1' ' A' ' 42' ' ' ILE . 6.7 t-20 -117.8 98.16 6.21 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 105.131 -2.174 . . . . 12.0 105.131 176.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.6 m -100.88 127.65 47.26 Favored 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 119.879 -0.729 . . . . 12.0 112.937 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.8 m -111.29 105.42 14.07 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 103.738 -2.689 . . . . 12.0 103.738 175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.2 m -105.88 145.32 31.4 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 120.258 -0.577 . . . . 12.0 112.008 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 82' ' ' PRO . 8.0 ttp180 -69.07 138.84 54.68 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.853 -0.795 . . . . 12.0 108.853 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -119.26 -84.83 0.66 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.919 -0.488 . . . . 12.0 110.435 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 m -135.68 116.34 13.91 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.66 -0.65 . . . . 12.0 109.978 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HA ' ' HG3' ' A' ' 82' ' ' PRO . 6.7 mt -65.0 121.61 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 CA-C-O 121.139 0.495 . . . . 12.0 109.91 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.478 ' CB ' ' HD3' ' A' ' 78' ' ' PRO . 0.0 OUTLIER -177.48 -58.68 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.863 -0.792 . . . . 12.0 108.863 179.128 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.478 ' HD3' ' CB ' ' A' ' 77' ' ' THR . 37.4 Cg_endo -81.03 159.76 20.77 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 121.952 1.768 . . . . 12.0 109.948 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.29 143.19 29.32 Favored Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.934 -0.765 . . . . 12.0 108.934 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -72.46 -162.66 2.56 Favored 'Cis proline' 0 N--CA 1.488 1.159 0 O-C-N 122.929 0.963 . . . . 12.0 110.743 0.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -43.68 157.07 0.28 Allowed Pre-proline 0 N--CA 1.509 2.521 0 CA-C-O 119.014 -0.517 . . . . 12.0 110.45 -178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 41.2 Cg_endo -77.07 110.57 3.05 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 121.778 1.652 . . . . 12.0 109.995 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 82' ' ' PRO . 23.1 m-85 -143.83 133.56 23.76 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.438 0.637 . . . . 12.0 110.736 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.0 t -119.37 129.21 54.7 Favored 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 107.369 -1.345 . . . . 12.0 107.369 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.7 t -96.05 142.49 28.19 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.254 0.549 . . . . 12.0 110.912 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -151.49 125.86 9.41 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.379 -0.971 . . . . 12.0 108.379 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.9 m -105.53 147.05 28.79 Favored 'General case' 0 N--CA 1.501 2.114 0 C-N-CA 120.707 -0.397 . . . . 12.0 109.983 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -174.87 -171.0 0.5 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.696 -0.483 . . . . 12.0 109.696 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.821 HG23 ' HG3' ' A' ' 65' ' ' ARG . 95.6 m -63.83 134.38 55.11 Favored 'General case' 0 N--CA 1.505 2.301 0 N-CA-C 109.588 -0.523 . . . . 12.0 109.588 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.432 ' ND2' HD23 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -107.12 91.96 3.88 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.552 0.691 . . . . 12.0 112.18 -179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -90.69 107.16 19.0 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 103.988 -2.597 . . . . 12.0 103.988 175.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.409 HG21 ' CE2' ' A' ' 104' ' ' PHE . 1.1 mt -110.85 160.94 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 122.2 1.0 . . . . 12.0 113.489 -174.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.401 ' N ' HG22 ' A' ' 92' ' ' ILE . 35.7 t -112.2 103.85 12.03 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 105.258 -2.127 . . . . 12.0 105.258 176.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.691 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 7.2 m -122.71 -171.71 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.435 0.636 . . . . 12.0 112.018 -175.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.467 ' HB3' ' CD2' ' A' ' 103' ' ' HIS . 2.2 mtpp -145.24 152.01 39.28 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.03 -0.73 . . . . 12.0 109.03 178.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.2 m -120.58 119.69 33.64 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.655 0.74 . . . . 12.0 112.853 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.467 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 11.7 tt0 -127.36 145.55 50.77 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 104.362 -2.459 . . . . 12.0 104.362 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 1.0 OUTLIER 52.98 28.6 6.82 Favored 'General case' 0 N--CA 1.517 2.91 0 CA-C-N 119.876 1.216 . . . . 12.0 107.998 -176.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 12.0 pt20 55.56 4.08 0.09 Allowed 'General case' 0 N--CA 1.511 2.593 0 C-N-CA 125.418 1.487 . . . . 12.0 114.701 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.878 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -110.14 147.29 35.96 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 105.147 -2.168 . . . . 12.0 105.147 175.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.481 ' O ' ' CE1' ' A' ' 100' ' ' TYR . 20.1 Cg_endo -60.8 89.56 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.869 0 C-N-CA 121.37 1.38 . . . . 12.0 108.79 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.878 HG22 ' CE2' ' A' ' 100' ' ' TYR . 46.6 t -85.07 -14.11 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.619 -0.718 . . . . 12.0 110.654 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.489 ' N ' ' CD2' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -144.87 117.75 8.76 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.512 -0.875 . . . . 12.0 110.387 -177.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.691 ' CZ ' HG11 ' A' ' 94' ' ' VAL . 1.3 m-85 -101.12 121.0 41.05 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 106.503 -1.665 . . . . 12.0 106.503 177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.62 -28.84 17.25 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 112.966 0.728 . . . . 12.0 112.966 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -175.88 -169.28 37.29 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.803 -1.189 . . . . 12.0 111.111 -179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 107' ' ' ILE . 51.0 mt -93.38 36.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.051 0.453 . . . . 12.0 110.616 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 92.07 45.62 3.81 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 110.519 -1.032 . . . . 12.0 110.519 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.3 99.73 2.95 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.809 -0.811 . . . . 12.0 108.809 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.565 ' SG ' HD21 ' A' ' 61' ' ' LEU . 7.0 p -164.86 64.27 1.07 Allowed Pre-proline 0 N--CA 1.493 1.697 0 N-CA-C 109.427 -0.583 . . . . 12.0 109.427 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.478 0.607 0 C-N-CA 122.285 1.99 . . . . 12.0 110.38 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.333 0 N-CA-C 109.181 -0.674 . . . . 12.0 109.181 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -120.95 164.14 17.17 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.993 -0.743 . . . . 12.0 108.993 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.59 ' CZ3' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -69.03 -24.19 64.16 Favored 'General case' 0 N--CA 1.52 3.073 0 O-C-N 121.636 -0.665 . . . . 12.0 110.492 -177.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.76 -64.08 1.07 Allowed 'General case' 0 N--CA 1.512 2.638 0 O-C-N 121.607 -0.683 . . . . 12.0 110.655 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.65 -37.21 80.76 Favored 'General case' 0 N--CA 1.506 2.373 0 N-CA-C 107.419 -1.326 . . . . 12.0 107.419 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 32.0 t80 -70.25 -25.66 63.48 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.384 -0.969 . . . . 12.0 108.384 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -52.0 -31.77 30.88 Favored 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 107.186 -1.413 . . . . 12.0 107.186 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -42.82 30.49 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.797 -1.186 . . . . 12.0 107.797 176.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.469 ' O ' HD13 ' A' ' 41' ' ' ILE . 9.7 mmtp -44.42 -53.84 6.49 Favored 'General case' 0 N--CA 1.509 2.499 0 O-C-N 122.363 -0.211 . . . . 12.0 111.365 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.885 ' O ' HD13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -95.47 -17.71 21.27 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.942 -0.474 . . . . 12.0 111.42 -179.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.898 HD12 ' O ' ' A' ' 43' ' ' SER . 15.9 mm -129.48 79.09 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 C-N-CA 118.899 -1.121 . . . . 12.0 113.929 -176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.496 HG21 HG22 ' A' ' 22' ' ' ILE . 48.5 mm -98.09 75.63 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 104.198 -2.519 . . . . 12.0 104.198 174.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -82.81 61.92 6.12 Favored 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 121.658 0.742 . . . . 12.0 111.425 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.504 ' OG1' HG23 ' A' ' 22' ' ' ILE . 60.9 p -146.55 65.19 10.05 Favored Pre-proline 0 N--CA 1.491 1.607 0 N-CA-C 106.954 -1.499 . . . . 12.0 106.954 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' N ' ' A' ' 14' ' ' THR . 37.1 Cg_endo -82.2 45.51 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.372 2.048 . . . . 12.0 112.011 -178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.0 pt -71.62 -165.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.83 -0.804 . . . . 12.0 108.83 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 44.2 pt -97.81 43.01 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-O 121.424 0.631 . . . . 12.0 109.958 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -158.02 99.41 1.67 Allowed 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 109.063 -0.717 . . . . 12.0 109.063 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.571 ' HA ' HD12 ' A' ' 22' ' ' ILE . 9.0 m -76.53 -12.72 60.07 Favored 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.954 -0.466 . . . . 12.0 110.996 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -63.57 -49.42 73.47 Favored 'General case' 0 N--CA 1.508 2.46 0 CA-C-N 119.048 0.84 . . . . 12.0 109.025 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 47.7 m -74.85 -19.63 60.09 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.641 -0.503 . . . . 12.0 109.641 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.571 HD12 ' HA ' ' A' ' 19' ' ' CYS . 44.1 mt -84.94 -8.75 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.765 -0.585 . . . . 12.0 110.663 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -125.54 4.89 7.57 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.629 -0.669 . . . . 12.0 110.305 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -58.23 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.403 -0.962 . . . . 12.0 108.403 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.453 HD21 HD12 ' A' ' 27' ' ' ILE . 57.5 t30 -173.08 152.14 2.26 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.751 -0.833 . . . . 12.0 108.751 -178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -70.21 -9.72 56.66 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.713 -0.395 . . . . 12.0 110.275 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 27' ' ' ILE . 56.4 mt -89.71 12.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.689 -0.632 . . . . 12.0 110.685 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.652 ' O ' HD13 ' A' ' 29' ' ' ILE . 33.8 m-85 -142.28 55.35 1.45 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.657 -0.652 . . . . 12.0 110.802 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' O ' ' A' ' 28' ' ' TYR . 33.1 mm -148.29 152.64 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.605 0 O-C-N 120.673 -1.267 . . . . 12.0 110.038 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG21 ' HA ' ' A' ' 35' ' ' LYS . 61.1 t -110.06 168.28 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 107.71 -1.218 . . . . 12.0 107.71 178.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' N ' HG12 ' A' ' 30' ' ' VAL . . . -90.87 54.91 3.35 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 108.738 -1.745 . . . . 12.0 108.738 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.95 -54.37 0.02 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.531 -1.427 . . . . 12.0 109.531 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -163.57 -76.41 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 122.054 -0.674 . . . . 12.0 109.404 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.6 m -133.94 -175.94 4.01 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.533 -0.543 . . . . 12.0 109.533 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.584 ' HA ' HG21 ' A' ' 30' ' ' VAL . 1.9 tttt -107.1 171.66 7.25 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.044 -0.725 . . . . 12.0 109.044 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.4 ptt180 -79.6 -17.34 54.09 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 122.1 -0.375 . . . . 12.0 110.575 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 37' ' ' VAL . 9.6 p -162.1 112.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 C-N-CA 119.789 -0.764 . . . . 12.0 111.457 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.464 ' ND2' ' CE2' ' A' ' 83' ' ' TYR . 11.6 m-20 -97.18 85.81 3.79 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 105.753 -1.943 . . . . 12.0 105.753 177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.0 m -83.62 123.18 29.52 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.661 0.743 . . . . 12.0 112.555 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.447 ' CD1' HG21 ' A' ' 12' ' ' ILE . 23.6 m-85 -100.32 161.68 13.44 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 106.929 -1.508 . . . . 12.0 106.929 176.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.469 HD13 ' O ' ' A' ' 9' ' ' LYS . 4.4 mp -130.68 122.98 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 120.956 -1.09 . . . . 12.0 110.091 -179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.468 HD11 ' HB2' ' A' ' 69' ' ' ASN . 4.8 mt -98.54 107.11 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 N-CA-C 108.27 -1.011 . . . . 12.0 108.27 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.898 ' O ' HD12 ' A' ' 11' ' ' ILE . 29.7 t 175.93 165.76 0.39 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 109.27 -0.641 . . . . 12.0 109.27 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 p -82.7 125.47 31.27 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 108.166 -1.049 . . . . 12.0 108.166 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.707 ' HB2' HG13 ' A' ' 11' ' ' ILE . . . -50.05 -31.47 13.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.992 -0.442 . . . . 12.0 111.887 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -76.61 -32.88 58.34 Favored 'General case' 0 N--CA 1.502 2.159 0 C-N-CA 120.426 -0.51 . . . . 12.0 111.935 -177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.2 m -64.59 -34.34 78.02 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 107.817 -1.179 . . . . 12.0 107.817 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.655 HG11 ' CE1' ' A' ' 10' ' ' HIS . 20.7 t -71.03 -35.38 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.407 -1.331 . . . . 12.0 107.407 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -65.23 -21.43 66.75 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 116.016 -0.538 . . . . 12.0 110.019 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.63 -39.16 24.85 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.821 -0.55 . . . . 12.0 109.922 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 48' ' ' VAL . 7.2 tp -69.16 -18.07 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 O-C-N 121.788 -0.57 . . . . 12.0 110.401 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -97.34 15.14 23.82 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.58 -0.7 . . . . 12.0 111.003 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.3 m -66.16 107.27 1.88 Allowed 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.189 -0.671 . . . . 12.0 109.189 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -152.79 -63.2 0.01 OUTLIER Glycine 0 N--CA 1.501 2.983 0 C-N-CA 120.484 -0.865 . . . . 12.0 111.013 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.62 HG22 ' H ' ' A' ' 56' ' ' ILE . 3.1 p -167.54 -171.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 CA-C-N 118.067 0.934 . . . . 12.0 109.434 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.62 ' H ' HG22 ' A' ' 55' ' ' VAL . 15.0 tt -89.21 32.36 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 O-C-N 121.429 -0.794 . . . . 12.0 110.781 -179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' ILE . 5.0 t30 169.75 113.91 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 107.257 -1.386 . . . . 12.0 107.257 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -163.17 179.72 7.25 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.121 0.962 . . . . 12.0 112.404 -178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -137.36 108.41 6.75 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.644 -1.614 . . . . 12.0 106.644 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG12 ' H ' ' A' ' 61' ' ' LEU . 2.7 t -132.9 171.13 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.853 -0.529 . . . . 12.0 109.886 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.0 mp -124.66 124.16 41.6 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.816 -0.439 . . . . 12.0 109.816 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.49 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 108.453 -0.943 . . . . 12.0 108.453 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.755 HG22 ' OH ' ' A' ' 91' ' ' TYR . 1.4 p -75.47 -43.43 49.43 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.638 -0.875 . . . . 12.0 108.638 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.8 m -65.65 124.1 21.47 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.17 -1.048 . . . . 12.0 108.17 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.737 ' CG ' HG23 ' A' ' 89' ' ' THR . 0.1 OUTLIER -54.49 105.95 0.18 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 122.088 -0.383 . . . . 12.0 109.982 -179.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.608 ' CE2' HG21 ' A' ' 51' ' ' ILE . 48.2 m-85 -94.94 41.04 1.09 Allowed 'General case' 0 N--CA 1.512 2.666 0 C-N-CA 120.074 -0.65 . . . . 12.0 109.548 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 24.99 104.99 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 114.284 1.216 . . . . 12.0 114.284 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.597 ' O ' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.95 155.58 18.53 Favored 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.032 0.92 . . . . 12.0 112.494 179.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.468 ' HB2' HD11 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -121.18 99.45 6.49 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 104.787 -2.301 . . . . 12.0 104.787 176.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 m -105.43 128.93 53.79 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 114.033 1.123 . . . . 12.0 114.033 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.7 m -103.35 105.37 15.62 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 103.107 -2.923 . . . . 12.0 103.107 174.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.6 m -105.26 144.19 32.39 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 120.07 -0.652 . . . . 12.0 111.944 -176.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.05 105.39 1.04 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.593 -0.891 . . . . 12.0 108.593 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p -137.01 -81.44 0.37 Allowed 'General case' 0 N--CA 1.503 2.177 0 C-N-CA 120.595 -0.442 . . . . 12.0 110.311 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.426 ' CA ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -165.32 165.63 19.28 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 109.452 -0.573 . . . . 12.0 109.452 -179.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.642 HG22 HG23 ' A' ' 77' ' ' THR . 24.0 mt 69.29 155.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 CA-C-O 121.251 0.548 . . . . 12.0 110.314 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.642 HG23 HG22 ' A' ' 76' ' ' ILE . 18.3 p 53.61 62.29 9.48 Favored Pre-proline 0 N--CA 1.5 2.06 0 CA-C-N 116.336 -0.393 . . . . 12.0 111.058 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.98 107.86 1.98 Allowed 'Trans proline' 0 N--CA 1.48 0.713 0 C-N-CA 122.097 1.865 . . . . 12.0 109.383 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.77 58.41 7.04 Favored Pre-proline 0 N--CA 1.499 2.023 0 O-C-N 121.971 -0.455 . . . . 12.0 111.387 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -87.22 -44.06 0.32 Allowed 'Cis proline' 0 N--CA 1.485 0.976 0 C-N-CA 125.363 -0.682 . . . . 12.0 110.797 -2.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 93.8 m -61.53 150.12 81.94 Favored Pre-proline 0 N--CA 1.495 1.817 0 CA-C-O 118.963 -0.542 . . . . 12.0 109.759 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HB2' ' CA ' ' A' ' 75' ' ' SER . 36.4 Cg_endo -75.14 134.8 18.01 Favored 'Trans proline' 0 N--CA 1.483 0.898 0 C-N-CA 121.831 1.687 . . . . 12.0 110.562 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.464 ' CE2' ' ND2' ' A' ' 38' ' ' ASN . 16.5 m-85 -142.93 139.26 30.65 Favored 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.283 0.564 . . . . 12.0 110.536 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 t -124.71 126.23 45.35 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 108.323 -0.991 . . . . 12.0 108.323 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 139.97 30.76 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.06 0.457 . . . . 12.0 110.612 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -152.53 124.09 7.79 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 108.802 -0.814 . . . . 12.0 108.802 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -94.11 152.92 18.41 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 109.31 -0.626 . . . . 12.0 109.31 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -176.09 -167.74 0.24 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.155 0.502 . . . . 12.0 109.992 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.737 HG23 ' CG ' ' A' ' 65' ' ' ARG . 39.6 m -65.31 143.85 57.51 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 109.366 -0.605 . . . . 12.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.584 ' OD1' HD11 ' A' ' 92' ' ' ILE . 7.7 t-20 -108.51 87.73 2.56 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.945 0.879 . . . . 12.0 110.856 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.755 ' OH ' HG22 ' A' ' 63' ' ' THR . 3.7 t80 -100.01 112.93 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 104.938 -2.245 . . . . 12.0 104.938 176.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.584 HD11 ' OD1' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -126.64 175.67 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-O 122.274 1.035 . . . . 12.0 112.406 -175.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.3 t -125.54 99.3 5.95 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.154 -1.795 . . . . 12.0 106.154 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.679 HG21 ' HB3' ' A' ' 101' ' ' PRO . 9.8 p -111.95 164.19 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-O 121.236 0.541 . . . . 12.0 111.193 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.476 ' N ' HG22 ' A' ' 94' ' ' VAL . 8.2 mmmt -118.04 140.84 49.17 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.383 -1.34 . . . . 12.0 107.383 178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.8 m -122.88 120.32 33.12 Favored 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 114.505 1.298 . . . . 12.0 114.505 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.489 ' HB2' ' CE1' ' A' ' 103' ' ' HIS . 24.9 tt0 -114.99 139.99 49.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.869 -2.641 . . . . 12.0 103.869 174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' CG ' ' A' ' 99' ' ' GLN . 77.7 m-20 56.46 31.04 18.13 Favored 'General case' 0 N--CA 1.515 2.783 0 N-CA-C 107.584 -1.265 . . . . 12.0 107.584 -175.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.44 ' CG ' ' O ' ' A' ' 98' ' ' ASN . 5.7 pt20 52.75 10.34 0.15 Allowed 'General case' 0 N--CA 1.509 2.48 0 N-CA-C 114.569 1.322 . . . . 12.0 114.569 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.986 ' CE2' HG22 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -112.21 140.73 23.91 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 104.051 -2.574 . . . . 12.0 104.051 174.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.679 ' HB3' HG21 ' A' ' 94' ' ' VAL . 26.8 Cg_endo -60.78 90.85 0.09 OUTLIER 'Trans proline' 0 C--O 1.211 -0.857 0 N-CA-C 108.713 -1.303 . . . . 12.0 108.713 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.986 HG22 ' CE2' ' A' ' 100' ' ' TYR . 81.5 t -88.84 -19.95 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 116.244 -0.435 . . . . 12.0 110.694 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -139.9 145.72 38.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.694 -1.225 . . . . 12.0 107.694 -178.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.55 ' HZ ' ' HE2' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -109.31 133.52 52.95 Favored 'General case' 0 N--CA 1.505 2.291 0 C-N-CA 119.209 -0.996 . . . . 12.0 109.221 179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -101.72 -19.45 15.38 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 122.033 -0.417 . . . . 12.0 111.676 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.29 173.88 44.07 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 110.468 -1.053 . . . . 12.0 110.468 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 92' ' ' ILE . 4.3 pt -97.82 26.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 122.186 -0.596 . . . . 12.0 110.279 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 140.53 -65.59 0.51 Allowed Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.076 -1.209 . . . . 12.0 110.076 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.6 mtm-85 -62.03 144.53 55.04 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.398 -0.593 . . . . 12.0 109.398 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.77 164.62 5.29 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 109.458 -0.571 . . . . 12.0 109.458 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo . . . . . 0 N--CA 1.481 0.77 0 C-N-CA 121.744 1.63 . . . . 12.0 110.053 179.297 . . . . . . . . 0 0 . 1 stop_ save_